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Abstract 
 
The stem cell microenvironment contains soluble factors, support cells, and 
components of the extracellular matrix (ECM) that combine to effect cellular behavior.  
Mass spectrometry based proteomics offers the opportunity to directly assay 
components of extracellular microenvironments, thereby providing a sensitive means for 
obtaining insight into the stem cell niche.  In this study we present the generation and 
analysis of human embryonic stem cell (hESC) and human induced pluripotent stem cell 
(hiPSC) matrix microenvironments using an MS-based proteomics approach.  
One of the primary limitations in the proteomics analysis of hESCs and hiPSCs is the 
reproducible generation of sufficient cell numbers amenable to experimentation.  In 
Chapter 2 we develop reliable methods for the maintenance and proliferation of hESCs 
in metabolic labeling medium for use in stable isotope labeling with amino acids in cell 
culture (SILAC) experiments.  Previously, the application of SILAC with hESCs was 
hindered by the use of medium insufficient for their reproducible culture and the 
problematic conversion of isotopically labeled arginine to proline.  To address these 
issues, we demonstrate the culture of hESCs, hiPSCs, and mouse ESCs in SILAC 
conditions using a serum-replacement mixture and alternatively in defined medium.  In 
these optimized conditions we show that the problematic conversion of arginine to 
proline can be eliminated through the simple addition of exogenous proline to the 
culture medium.   
Within the in vitro microenvironment, the ECM plays a significant role in the 
maintenance and regulation of hESCs and hiPSCs. In order to better understand the 
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communication between hESCs and hiPSCs and the extracellular matrix, we focused 
our investigation on this portion of the microenvironment.  To facilitate the proteomic 
analysis of complex ECM mixtures, in Chapter 3 we describe methods for the 
fractionation and MS-based proteomics analysis of these matrices.  Application to a 
variety of cell-derived and recombinant growth matrices demonstrates not only the 
effectiveness of our methods, but also the utility of directly assaying matrices used in 
hESC culture for the determination of factors beneficial for the maintenance of self-
renewal and pluripotency.  
Through combination of the SILAC growth (Chapter 2) and matrix analysis (Chapter 3) 
methods, the protein compositions of conditioned matrices from multiple pluripotent 
stem cell lines are determined (Chapter 4).  Within these matrices, numerous 
antagonists of core pluripotency pathways are identified, such as soluble frizzled related 
protein (sFRP) 1 and 2.  In Chapter 5 we focus on characterizing the functions of sFRP1 
and sFRP2 in hESC self-renewal and pluripotency.  Taken together, the work presented 
here illustrates the utility of assaying interactions between stem cells and their matrix 
microenvironment for the determination of pathways involved in the regulation of the 
pluripotent phenotype.        
 
 
Key Words: human embryonic stem cells, microenvironment, mass spectrometry, 
proteomics, extracellular matrix, protein digestion, peptide sequencing, pluripotency, 
differentiation, induced pluripotent stem cell 
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Chapter 1 
Introduction 
 
1.0 Pluripotency and Stem Cells 
Stem cells are broadly defined by two primary characteristics: (i) the ability to self-
renew, generating daughter cells equal to the parent and (ii) the unique capacity to 
differentiate into an array of cellular sub-types.  Stem cells can provide valuable insight 
into human development and disease, have exciting potential in regenerative medicine, 
and can be used as models for drug discovery and toxicity analyses (reviewed in [1]).  
These properties have prompted the initiation of numerous research studies using stem 
cells as a model system with the goal of potentially unlocking the molecular 
mechanisms behind the regulation of the stem cell phenotype.         
 
 
 
This chapter contains excerpts with permission from the following papers:  
Hughes, C.S.*, Nuhn, A.*, Postovit, L.M., Lajoie, G.A.. (2011) “Proteomics of Human 
Embryonic Stem Cells”. Proteomics. 11;4:675 – 690 
Hughes, C.S., Ma, B., Lajoie, G.A.. (2010) “De Novo Sequencing Methods in 
Proteomics”. Methods in Molecular Biology. 604:105 - 121 
*Denotes equal author contribution  
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Stem cells can be further characterized by their differentiation capabilities and tissue-
type of origin.  A variety of cell and tissue types can give rise to cells of varying 
developmental potential.  In mammals, pioneering work with teratocarcinomas 
established the presence of an undifferentiated cell type within these germ-line tumors 
(reviewed in [2]).  These embryonal carcinoma (EC) cells were later cultured in a 
pluripotent state in vitro [3].  EC cells were later observed to have the capacity to 
differentiate in vitro through the formation of embryoid bodies (EB) [4].  Similar work in 
vivo demonstrated the ability of EC cells to generate chimeras and populate the 
germline in mice [5].  Together these findings suggested the similarity of EC cells to 
those that populate the inner cell mass (ICM) and contributed towards the discovery of 
embryonic stem cells (ESC).   
Utilizing many of the findings gained from the study of EC cells, the derivation of ESCs 
from mice was demonstrated by Evans and Martin [6, 7].  ESCs are classified as being 
pluripotent, meaning they have the ability to differentiate into derivatives of the three 
primary germ layers (Figure 1.1).  In vitro, pluripotency is conventionally demonstrated 
using an EB formation assay as previously mentioned for EC cells.  These EBs can be 
assayed for the presence of markers delineating the three primary germ layers as 
indicators of differentiation capacity.  More stringent tests of pluripotency are carried out 
in vivo using teratoma, chimera, or tetraploid complementation assays.  Using a 
chimera assay to illustrate the ability to contribute to the germ line of injected mice, the 
in vivo pluripotency of mESCs was later demonstrated [8, 9].    
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Figure 1.1. Derivation and distinction between stem cell types.  Embryonic stem 
cells are the pluripotent derivatives of the inner cell mass of the blastocyst.  Embryonic 
stem cells can be differentiated into any of the cells comprising the three primary germ 
layers.  Adult somatic cells will contain tissue-specific populations of adult stem cells 
that are considered multipotent.  Adult somatic cells derived from normal development 
can be reprogrammed using different combinations of transcription factors to generate 
induced pluripotent cells.  These stem cells are also considered pluripotent and can 
mimic the differentiation capabilities of their embryonic counterparts.  It is currently 
unknown whether embryonic and induced pluripotent cells are truly equivalent. 
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Soon after the work in mouse, derivation of pluripotent stem cells from the ICM of 
blastocyst stage embryos was demonstrated in humans (Figure 1.1) [10].  These 
hESCs shared the key properties of mESCs in that they could multiply indefinitely and 
generate cells of the three primary germ layers.  Pluripotency could be assayed in vitro 
and in vivo using EB and teratoma formation respectively, but due to ethical concerns 
chimera and tetraploid complementation assays could not be undertaken.  Since this 
time, alternative methods for the derivation of hESCs have been demonstrated, such as 
from biopsied blastomeres [11, 12].   
Comparisons of mouse and human ESC lines have revealed several defining 
characteristics for each cell type.  Identification of an undifferentiated colony is typically 
performed through the examination of intracellular and cell surface markers.  mESCs 
and hESCs are both known to have strong expression for the nuclear cell markers 
Oct3/4 and Nanog [13].  On the cell surface, mESCs can be identified by the stage-
specific embryonic antigen marker – 1 (SSEA-1) and the absence of SSEA-3 and -4.  In 
hESCs, SSEA-3 and -4 mark undifferentiated cells whereas SSEA-1 is only present on 
those that have differentiated.  Additional differences are observed when examining 
culture conditions for mESCs and hESCs.  mESCs can be maintained in an 
undifferentiated and pluripotent state on a minimal matrix with supplementation of 
leukemic inhibitor factor (LIF) and bone morphogenic protein (BMP), whereas hESCs 
cannot [14, 15].  hESCs are typically grown on a layer of mitotically inactivated mouse 
feeder (MEF) cells in media supplemented with fibroblast growth factor 2 (FGF2 or 
basic FGF) [10].  Recent work has suggested that hESCs share several properties with 
mouse epiblast derived stem cells, whereas mESCs are indicative of a more naïve state 
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of the ICM [16, 17].  These findings have recently been advanced by the generation of 
naïve hESCs that share many of the defining properties of mESCs in vitro [18].    
In contrast to embryonic, adult stem cells (ASC) are classified as being multipotent, 
meaning they can typically only generate differentiated cells that are a sub-type specific 
for the lineage to which they already belong (Figure 1.1).  In addition to their limited 
differentiation capacity, ASCs are also have limited self-renewal capacity in culture, 
making their study difficult.  Adult stem cells are thought to act as reservoirs of 
multipotent progenitors serving to regenerate cellular sub-types residing within specific 
tissues.  This was originally validated in pioneering work with hematopoietic stem cells 
by Till and McCulloch where it was demonstrated that bone marrow cells could give rise 
to different types of blood cells [19, 20].  Since this time ASCs have been identified from 
heart, lung, skin, fat, and liver tissues (reviewed in [21]).            
1.1 Inducing Pluripotency in Somatic Cells 
The ability to reprogram somatic cells to induced pluripotent stem cells (iPSC) was first 
demonstrated in mice by Takahashi and Yamanaka [22].  The retroviral introduction of 
POU5F1 (herein referred to as Oct3/4), Nanog, Sox 2, and c-Myc into mouse fibroblasts 
generated cells that shared the characteristic morphology of embryonic stem cells 
(Figure 1.1).  However, due to deficiencies in their developmental potential, they were 
not classified as pluripotent.  Reprogrammed fibroblasts that had the developmental 
potential of ESCs and were germline competent were later demonstrated in mouse [23, 
24].  Shortly after the demonstration of mouse iPSCs, human fibroblasts were 
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reprogrammed by using different combinations of Oct3/4, Nanog, Sox 2, c-Myc, Lin28, 
and Klf4 [25-27].  These hiPSCs shared similar gene expression patterns and in vitro 
differentiation capabilities to their ESC counterparts.       
Since these original discoveries, research on the reprogramming factors and methods 
for transgene introduction have been extensive (reviewed in [28]).  Currently, the only 
factor that is verified to be absolutely essential for reprogramming is Oct3/4.  Removal 
of unnecessary reprogramming factors, such as c-Myc, is deemed necessary for 
reducing the potential tumorigenicity of iPSCs to facilitate their use in therapeutic 
applications.  Alternative methods for transgene introduction that have been 
demonstrated include: retroviral, adenoviral, lentiviral, Epstein-Barr Virus, piggyBAC 
transposase, recombinant protein, and synthetic RNA [28].  The main focus of these 
alternative methods is the generation of ‘footprint’ free iPSCs that do not contain any 
exogenous genetic material resulting from methods used for transgene expression.  
Using methods such as recombinant proteins and synthetic RNAs, fibroblasts can be 
efficiently reprogrammed to generate iPSCs free of exogeneous genetic material [28].   
The observation that somatic cells can be reprogrammed to an embryonic-like state was 
a groundbreaking step forward in the stem cell field.  The ability to generate embryonic-
like cells in the lab side-stepped many of the ethical concerns surrounding stem cell 
research, and brought the prospect of cell-based therapeutics closer to reality.  Tissue 
specific material could now be generated using a patient’s own cells, overcoming 
immunocompatibility concerns.  However, the risk of tumor formation in humans has to 
be eliminated before any significant in vivo studies can be carried out.  In addition to any 
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potential clinical applications, these cells also provide new avenues for the study of 
stem cells and significantly increase the accessibility to this research area.  However, 
due to limited information on the equivalency of induced pluripotent and embryonic stem 
cells, iPSCs are currently not yet recognized as a suitable replacement for hESCs in 
research. 
1.2 Genomic and Proteomic Characterization of hESCs 
Since the establishment of the first hESC line in 1998 by Thomson et al., a significant 
amount of research on hESC biology has been published [10].  In an effort to better 
characterize this cell type, many of these studies employed large screens directed at 
the identification of genes that regulate the pluripotent state [29-36].  Comparisons of 
gene expression patterns between hESCs, other pluripotent cells, or their differentiated 
derivatives, have led to the identification of growth and transcription factors that are 
hallmarks of hESC pluripotency, such as Oct 3/4, Nanog, and Sox 2 (Figure 1.2) [29, 
32, 34-42].  The largest of these screens was undertaken by the International Stem Cell 
Initiative (ISCI).  This group undertook characterization of 59 different hESC lines using 
a variety of analysis methods to identify hallmarks of pluripotency that are cell line 
independent [13, 43].  When global gene expression patterns were compared with that 
of the core pluripotency factor Nanog, a positive correlation was observed for many 
known hESC markers, such as Oct4, Nodal, LIN28, and DNMT3B.  The findings of this 
global analysis led to the discovery of a set of genes that exhibited minimal variance 
across hESC lines that can be used as true markers of pluripotency.  However, with the 
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Figure 1.2. Regulation of human embryonic stem cell self-renewal and 
pluripotency.  The pathways shown represent those believed to play the most 
significant roles in the regulation of hESCs in vitro based on current knowledge.  FGF 
and Activin/Nodal pathways are key regulators required for maintenance of an 
undifferentiated state and as such is commonly supplemented into culture medium.  
BMP signaling is known to promote mESC maintenance but induces hESC 
differentiation.  Canonical Wnt signaling has been shown to promote both differentiation 
and the maintenance of pluripotency.  Oct4/Sox2/Nanog are critical for hESC 
pluripotency, however little is known about their regulation outside of the nucleus or cell 
itself.  The bulk of the knowledge concerning these key pathways has been derived 
from comparative genomic and proteomic screens of differentiated and undifferentiated 
stem cells. 
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rapid generation of new hESC and hiPSC lines, reconciling heterogeneity across 
populations remains a challenge, especially in proteomics (reviewed in [44]).   
Since proteins are the effectors of cellular processes, it is important to investigate how 
stem cells are regulated by changes at the protein level in addition to genomic analyses.  
Post-translational modifications (PTM), such as phosphorylation, may influence the 
activity of pivotal proteins, and this information can only be determined by studying the 
proteome.  The importance of the analysis of the proteome is further emphasized by the 
fact that changes in RNA abundance do not always correspond to those in their 
respective proteins.  This discordance is the result of post-transcriptional factors, such 
as stability of mRNA and the rates of translation and protein degradation [45-49].  
Discordance between RNA and protein abundance has been observed in the analysis 
of stem cell populations [45-49].  In one of the first studies to analyze both mRNA and 
protein abundance levels in stem cells, Fathi et al. utilized mass spectrometry (MS)-
based proteomics and qRT-PCR genomics approaches to characterize differences 
between hESCs and EBs [50].  When the proteomic and genomic data were compared 
there was minimal correlation between the two sets.  These findings highlight the 
necessity for complementary genomic and proteomic analyses in order to fully validate 
observations made when studying hESC populations.   
Technological advances in protein and peptide fractionation techniques, mass 
spectrometers, and quantitative methods have greatly increased the capacity to analyze 
and extract biological information from complex cellular samples.  With recent advances 
in the ability to proliferate hESCs to numbers amenable to proteomic experiments, there 
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have been a surge of proteomic studies looking at hESCs (reviewed in [51-53]).  Initial 
efforts focused on the analysis of the cellular proteomes of hESCs using 2D-SDS-PAGE 
methods coupled with MS for protein identification [50, 54].  However, these studies 
were limited in the depth of proteome coverage due to the use of methods that hindered 
the detection of low abundance proteins.  Since this time, multiple large-scale analyses 
of the proteomes of hESCs and hiPSCs have been completed through utilization of 
high-resolution MS platforms coupled to multi-dimensional fractionation chromatography 
[55-57].  Although these studies provide valuable resources, in order to extract greater 
biological significance from their data and facilitate comparative analysis of hESCs with 
their differentiated counterparts, researchers have turned to quantitative proteomic 
methods [58-63].  Quantitative studies have also been applied to the direct analysis of 
the hESC phosphoproteome during maintenance and differentiation [64-67].  The 
results of these studies have provided valuable information on the dynamic state of the 
proteome in hESCs.  Collectively, the genomic and proteomic studies that have been 
completed on hESCs to date have revealed and characterized many of the intracellular 
pathways currently considered to be critical for pluripotency (Figure 1.2).  
1.3 Mass Spectrometry-based Proteomics 
The goal of proteomics is to study the entire protein complement of cells or tissues.  
This not only encompasses the quantitative and qualitative analysis of protein 
abundance and turnover, but also their PTMs.  Reaching this goal has conventionally 
relied upon technologies such as two-dimensional gel electrophoresis and western 
blotting.  However, these methods offer limited information on a global proteome scale.  
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Although techniques for obtaining high-resolution and throughput genomic data sets 
have been available for some time, methods for the acquisition of complementary 
proteome data have lagged behind.   
1.3.1 Mass Spectrometry-based Proteomics - In the field of proteomics, MS has 
become a central technology for the analysis of protein and peptide samples.  This is 
due to the ability of MS instrumentation to rapidly acquire high quality spectra for 
thousands of peptides from a single sample injection.  MS-based proteomics 
experiments are typically done in a ‘bottom-up’ approach, in which proteins are 
enzymatically digested to peptides prior to fractionation and analysis. Analysis of these 
complex peptide mixtures can yield high resolution and sensitivity data on the protein 
composition of a sample of interest.  Greater instrument capabilities and new software 
advancements have resulted in the emergence of “top-down” experiments, in which 
intact proteins are analyzed (reviewed in [68, 69]).  Until very recently, top-down 
experiments had not been amenable to large-scale analyses [70].    
1.3.2 Mass Spectrometry of Proteins and Peptides - A typical MS analysis takes place 
in three steps. First, the mass of the intact peptide ions entering an MS in a given time 
window is measured.  In the second step, specific precursor ions are selected in the first 
mass analyzer (e.g., Quadrupole 1), typically based on their relative abundance to one 
another, and fragmented in a collision cell (Quadrupole 2). The mass, or more 
accurately the mass-to-charge ratio (m/z), of each fragment ion is detected in a second 
mass analyzer (e.g., Time of Flight, Linear Ion Trap, Orbitrap, Ion Cyclotron Resonance 
cell), for each of the previously selected precursors.  This type of experiment is referred 
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to as a tandem MS, or MS/MS analysis. Detailed investigation of the product ion 
masses within an MS/MS spectrum provides information on the sequence of the peptide 
selected for fragmentation and, by inference, identification of the protein to which it 
belongs. 
Early forms of MS were not amenable to the analysis of protein samples. Ionization 
techniques such as electron and chemical ionization would cause high levels of in-
source fragmentation for biomolecules. The development of soft ionization techniques, 
such as matrix-assisted laser desorption ionization (MALDI) and electrospray ionization 
(ESI), revolutionized the analysis of biomolecules by MS [71-73]. Both of these 
ionization types are classified as ‘soft’ techniques because there is little in-source 
fragmentation of the ionized species, such that the mass of the intact molecular ion can 
be measured.  ESI and MALDI sources can be interfaced to a variety of mass analyzers 
and instrument architectures compatible with proteomics experiments.  The most 
frequently used designs in proteomics are hybrid instruments that contain a combination 
of mass analyzers, such as: time of flight (TOF) [74, 75], quadrupole (Q), ion trap (LIT) 
[76], Fourier transform ion cyclotron resonance (FT-ICR) [77], and Orbitrap [78].  All of 
these platforms have advantages and disadvantages, for a comprehensive review of 
instruments types and their characteristics see ([76, 79]).   
1.3.3 Proteomic Analysis of Complex Mixtures - Even with advancements in instrument 
scan speed, mass spectrometers can only detect a limited number of ions in a given 
period of time.  To spread the components of an injected sample across a wider time 
window, chromatographic methods of separation are used prior to MS (Figure 1.3).  The 
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conventional method of fractionation utilized prior to MS analysis is separation with a 
reversed phase (RP) column that partitions based on the hydrophobic character of the 
sample components.  It is becoming increasingly common for researchers to employ a 
secondary orthogonal fractionation method prior to RP, such as strong cation exchange 
(SCX) or 1D-SDS-PAGE.  The decrease in fraction complexity and complementary 
nature of these methods aids in providing an increase in depth of proteome coverage 
[80, 81].  One distinct advantage of ESI is its compatibility with a number of these on-
line separation techniques employed prior to MS analysis.   
1.3.4 Peptide Identification from Mass Spectra - In order to obtain information on the 
amino acid series of ions that enter the MS, sequence ions can be generated through 
fragmentation of the peptide parent ion in an MS collision cell.  Each peptide ion 
dissociates in one place along the backbone so that the difference in mass between the 
resulting fragment ions potentially corresponds to the mass of an amino acid (reviewed 
in [82]).  The most common form of fragmentation found in MS instrumentation is 
collision induced dissociation (CID) [83-85].  In CID, peptide ions are induced to 
fragment through collisions with inert gas molecules.  Aside from CID, electron capture 
(ECD) and electron transfer dissociation (ETD) have been implemented in more recent 
mass spectrometers [86-88].  The combination of CID and ETD is now available on 
instrument platforms such as Orbitrap and qFT-ICR mass spectrometers.  This allows 
for the acquisition of spectra from the same sample using two fragmentation techniques 
generating complementary series of fragment ions [89]. 
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The identification of peptides from fragment ion data relies on spectral interpretation 
software (Figure 1.3).   Conventional search engines perform comparisons between 
observed and theoretical peptide spectra from an in silico digest of a sequence 
database (reviewed in [90]).  Search engines will score peptide matches based on a 
variety of metrics designed to generate a score representative of the quality of match 
between the observed and theoretical spectra [90, 91].  However, there has been a 
recent emergence in software designed to search peptide spectra against a database of 
previously acquired MS/MS experimental spectra identification [92].  These search 
engines offer greater sensitivity and speed, but are limited by the content of the 
experimental spectral databases.   
An alternative to the previously mentioned database-dependent approaches are de 
novo methods that make use of computerized methods for determining the sequences 
of peptides directly from MS/MS spectra [93].  De novo methods use the knowledge of 
the fragmentation methods employed in the MS and basic search parameters input by 
the user to rebuild the peptide ion series [94-101].  De novo sequencing approaches 
hold a lot of potential due to their ability to identify previously unknown peptide 
sequences and post-translational modifications. However, utilizing a combination of 
multiple search engine strategies has been shown to be beneficial to achieving greater 
depth of coverage in proteomics experiments [102-104].     
1.3.5 Quantitative Proteomics - To increase the biological significance of their data, 
quantitative proteomic strategies are frequently used to compare different cellular states 
or conditions (Figure 1.3).  Mass spectrometers are not strictly quantitative, so 
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quantitative labeling is often used; however, label-free techniques are becoming 
increasingly popular (reviewed in [105, 106]).  Application of the quantitative label can 
be done at the protein or peptide level, prior to analysis on the MS (Figure 1.3).  
Reagents that are applied at the peptide level normally target primary amines to obtain 
complete sample coverage.  In methods such as isobaric tags for relative and absolute 
quantification (iTRAQ) and tandem mass tags (TMT), samples are tagged following 
proteolytic digestion [107] (Figure 1.3).  Peptides in different experimental conditions 
can be distinguished and quantified in MS/MS spectra based on the label applied.  
Dimethyl labeling approaches for peptide tagging have also been employed 
successfully, with the added advantage of minimal reagent expense [108, 109].   
The most common alternatives to peptide tagging approaches are based on metabolic 
incorporation of isotopically labeled amino acids.  One such isotopic labeling method, 
termed stable isotope labeling with amino acids in cell culture (SILAC) involves 
metabolic incorporation of 13C and 15N containing amino acids into a cell’s proteome 
[110, 111].  Other methods based on metabolic incorporation of 15N have been widely 
applied both in vitro and in vivo [112].  Both methods rely on the depletion of native 
versions of the targeted amino acids or elements and re-supplementation of isotopically 
labeled versions that can be incorporated into newly synthesized proteins.  Metabolic 
incorporation can also be achieved through the feeding of labeled populations of cells to 
higher organisms [113].  In all mentioned metabolic approaches, differentially labeled 
samples are mixed at a defined ratio, and the relative abundance of proteins can be 
compared quantitatively based on the relative intensities of the peptide forms in MS 
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Figure 1.3. Conventional methods used in proteomics analysis of in vitro cell 
populations.  Comparison of multiple experimental conditions can be performed 
separately or together.  Separate sample analysis is conventionally done using 2D-
SDS-PAGE fractionation followed by quantification of spot intensity on the gel.  Spots 
that exhibit changes in intensity can be extracted from the gel and subjected to 
enzymatic digestion and subsequent identification through MS analysis.  Alternatively, 
separate samples can be quantified in a label-free manner based on peptide abundance 
in the mass spectrum.  When an isotopic label is used, samples from separate 
experimental conditions can be combined for analysis.  When metabolic labeling with 
SILAC is used samples can be combined prior to fractionation and digestion.  
Alternatively, if iTRAQ or TMT approaches are used samples must remain separate 
until after enzymatic digestion and labeling.  In both cases, peptides are analyzed and 
quantified in the mass spectrometer in a single analysis.   For SILAC, quantification is 
completed at the MS level, whereas iTRAQ and TMT are performed in the MS/MS 
spectrum. 
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spectra.  Isotopic labeling using any of the previously mentioned methods offer powerful 
tools for researchers to directly compare minute changes between cellular states over 
time (Figure 1.3).     
1.4 In Vitro Culture of hESCs    
Many experiments and therapeutic applications of hESCs require the cells to be 
pluripotent and free of non-human contamination.  A major limitation to the use of 
hESCs in medical research is that they can undergo spontaneous differentiation in 
culture if proper conditions for retaining pluripotency are not maintained.  At present, 
there is limited information about which culture conditions effectively maintain 
differentiated hESCs in vitro, and this restricts the amount of suitable material that can 
be generated for analysis [114-116].  One reason for this is that many advances in 
culture conditions for mouse embryonic stem cells are not applicable to hESCs [117].   
Since the correct mixture of factors that maintains hESC pluripotency is unknown, 
hESCs are often derived on a feeder layer of MEF cells (Figure 1.4).  This layer 
provides a growth substrate and secretes various growth factors, cytokines, and 
adhesion related proteins that promote pluripotency [118, 119].  Other human 
fibroblasts have also been shown to be supportive of sustained pluripotent hESC growth 
[120-124].  Due to the potential variability that culture on feeder layers presents and the 
risk of xeno-transmission from non-human sources, there has been a shift in the field to 
feeder-free growth of hESCs on defined matrices (Figure 1.4).  A significant step 
forward in hESC culture methods was the discovery by Xu et al. that hESCs can be 
maintained on a layer of basement membrane matrix called Matrigel™™, in medium 
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that has been conditioned by irradiated MEFs (MEF-CM) [125].  Matrigel™™, which is 
extracted from Englebreth-Holm-Swarm tumors in mice, is a complex mixture of 
extracellular matrix (ECM) proteins that is composed primarily of laminin, collagen-IV, 
and enactin [126-128].  Matrigel™ has proven to be effective as a growth matrix for a 
wide variety of hESC lines using a variety of media formulations [129].  However, 
concerns regarding the composition and complexity of Matrigel™ and its suitability in 
research applications have been raised [126, 128, 130-132].  To overcome these 
limitations, a variety of ECM proteins or synthetic matrices have been evaluated for their 
ability to support hESC proliferation [133-148]. 
In parallel to matrix development, there have been numerous advances towards the 
generation of defined culture medium for hESC growth [149, 150].  All formulations 
contain growth factors designed to promote the maintenance of pluripotent hESCs, such 
as bFGF and Activin.  In order to elucidate factors essential for the maintenance of 
hESCs, analyses of the secretomes of supportive feeder layers have been performed 
[151-154].  Factors supportive of the maintenance of hESC pluripotency, such as 
pigment epithelium derived factor (PEDF), have been identified through examination of 
these datasets.  It was later demonstrated that PEDF can maintain undifferentiated 
hESCs without the addition of other exogenous supplements [155].  Other factors, such 
as Activin A and TGF-β1, were also identified in screens of conditioned media, both of 
which have been shown to promote the feeder-independent growth of hESCs in the 
absence of pre-conditioning with MEF layers [115, 156, 157].  Although these screens 
provide valuable information on extracellular regulation of hESC fate in vitro, our 
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Figure 1.4. Derivation and culture of human embryonic stem cells.  hESCs derived 
from the inner cell mass of the blastocyst are conventionally cultured on a layer of 
mouse embryonic fibroblast feeder cells in medium supplemented with FGF2.  
Alternatively, hESCs can be derived in xeno-free conditions by culturing them on human 
derived feeders, such as foreskin fibroblasts.  hESCs derived in either condition can be 
passaged to feeder-free conditions where a culture matrix is substituted as the growth 
surface.  The most commonly employed matrix is Matrigel™ in combination with culture 
media that has been conditioned on a mouse or human feeder-cell layer.  If xeno-free 
conditions are desired, human cell-derived or recombinant protein matrices can be 
substituted and used in combination with defined culture medium. 
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understanding of how these pathways exact this control, alone or in combination, 
remains inadequate.  
1.5 In Vitro Microenvironment and hESC Cell Fate 
Based on advances in our knowledge regarding the optimal conditions for hESC culture 
in vitro, it is clear that extracellular processes are critical for maintaining the delicate 
balance between self-renewal and differentiation.  Control over these extracellular 
processes is governed by a dynamic interplay between the various contributors to the 
microenvironment.  This supportive environment is often referred to as the ‘niche’ and 
consists of a combination of accessory support cells, extracellular structure, and 
autocrine/paracrine signals (Figure 1.5).  In stem cells, the concept of the niche was first 
defined for the hematopoietic system in mammals [158].  Additional evidence from 
Drosophila and C. elegans contributed to the development of the understanding of the 
stem cell niche (reviewed in [159, 160]).  Research in mouse has contributed to the bulk 
of our current insight into the stem cell niche in mammalian systems.  An example of 
this is recent work where the ability of mESCs to interact to form local 
microenvironments within single colonies that regulate cell-fate decisions dependent on 
the presence or absence of exogenous factors was demonstrated [161].  Studies such 
as these provide detailed insight into niche control of stem cells in vitro.   
Studies directed at the analysis of the hESC niche have been limited due to the 
complexity its analysis presents.  However, as illustrated by the intricate requirements 
for efficient proliferation in vitro, proteomic characterization of the microenvironment 
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from human stem cells should be a fruitful source of information.  The necessity for 
supplementation of multiple exogenous factors illustrates the dynamic array of 
extracellular processes that combine to create a suitable hESC niche in vitro.  Recent 
work using a global proteomics approach has demonstrated the valuable data that can 
yield from analysis of this soluble environment [162].  In addition to the components 
supplemented or secreted into the microenvironment, in this study it was observed that 
hESCs generate fibroblast cells supportive of self-renewal [162].  From proteomic 
analysis comparing the secretome of MEF feeders and hESCs, a novel mechanism was 
proposed wherein the supportive fibroblast cells responded to FGF supplementation to 
secrete factors that aided in the prevention of cellular differentiation [163, 164].  
Although this was not the first global analysis of the hESC secretome, it generated the 
greatest depth of coverage leading to the identification of numerous stem cell regulatory 
proteins in the extracellular space.   
In order to obtain a complete understanding of the hESC in vitro microenvironment, 
analysis of components other than soluble media components is required.  Although 
numerous studies have focused on analysis of the soluble portion of the 
microenvironment, the interactions between hESCs and ECM in the niche is poorly 
understood.  The ECM is known to provide structural support for processes such as cell 
attachment and migration.  Moreover, it is widely postulated that the ECM interacts with 
an array of growth factors, acting to provide sustained release or co-factors required for 
activation (reviewed in [165]).  The complex matrix requirements for the efficient culture 
of hESCs in vitro emphasize the importance of the ECM and the necessity for analysis 
of this contributor to the niche.  Moreover, it was recently observed that metastatic cells 
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Figure 1.5. Maintenance of human embryonic stem cells in a dynamic 
microenvironment.  Cultures maintained on Matrigel™ have been observed to contain 
hESC-derived cells that support stem cell maintenance through paracrine signaling 
pathways.  On mouse or human fibroblast layers, maintenance of pluripotency is 
maintained through paracrine signaling with the feeder cells.  Alternatively, on 
Matrigel™ or other matrices, hESCs can be maintained in medium that contains 
supportive factors secreted from feeder cells during conditioning.  Many studies have 
focused on analysis of factors secreted during conditioning to elucidate hESC 
supportive pathways.  Recent work has demonstrated the ability of hESC conditioned 
matrices to reprogram metastatic cells.  This observation highlights the potential 
importance of the interactions between hESCs and the growth matrix used in vitro.  
However, few studies have focused on the elucidation of these interactions or the 
identification of hESC-derived factors in conditioned matrix. 
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could be ‘reprogrammed’ to a state that resembled their non-metastatic counterparts 
following exposure to an hESC conditioned matrix [166].  This observation was 
dependent on contact with the matrix portion of the microenvironment, and was not 
observed after exposure to hESC conditioned medium [167].  Studies such as these 
illustrate the potentially complex interactions between hESCs and the ECM in vitro.  
However, this area of the hESC microenvironment remains poorly understood as a 
result of the difficulty analysis of the ECM and its interactions presents.   
1.6 Thesis Objective 
With the potential wealth of information that can be extracted from the analysis of the 
hESC microenvironment, studies directed at the large-scale analysis of this dynamic 
environment needs to be undertaken.  Critical to these studies will be the development 
of efficient methods for the analysis of the in-solution and matrix portions of the 
microenvironment.  Moreover, integration of data obtained through the analysis of 
secreted factors with that of other supportive components of the microenvironment will 
be paramount for a more comprehensive understanding hESC regulation in vitro.  With 
the recent observation that matrix deposited factors have the potential to reprogram 
metastatic melanoma cells, the ECM component of the hESC microenvironment 
necessitates further analysis [168].  To this end, one of the goals of this thesis will be 
directed at creating proteomic methods to facilitate the analysis of hESC and hiPSC 
conditioned matrices, as well as functional validation of identified candidates of interest.    
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In working towards these objectives we first develop methods for the efficient growth of 
hESCs in conditions amenable to SILAC experimentation in vitro (Chapter 2).  We 
demonstrate that mouse and human ESCs can be maintained in an undifferentiated and 
pluripotent state in medium containing isotopically labeled arginine and lysine.  We also 
extend this protocol to the feeder-free growth of hESCs and hiPSCs in SILAC medium 
that is completely defined.  For both of these media formulations, we are able to 
overcome conversion of isotopically labeled arginine into proline, a typical occurrence in 
SILAC experiments.  Application of these culture methods facilitated the expansion of 
labeled hESCs for further proteomic experimentation.   
In order to extract information on the composition of hESC-derived matrices, proteomic 
methods directed at the fractionation and analysis of complex ECM-like mixtures were 
required.  To this end, we developed methods aimed at the analysis of the complex 
ECM Matrigel™ (Chapter 3).  By employing a range of fractionation and digestion 
protocols we demonstrate the complex proteomic profile of Matrigel™.  Following this, 
we applied these methods to other cell-derived and recombinant matrix mixtures 
commonly used in hESC culture.  These analyses revealed commonalities between 
matrices used in hESC culture.  Based on the proteomics data, fibronectin was found to 
be enriched in all of the cell-derived hESC supportive matrices.  To validate the ability of 
our proteomics approach to identify components critical for the maintenance of hESCs 
in vitro, we exhibit the maintenance of an undifferentiated and pluripotent state for cells 
grown on fibronectin as a sole matrix support.    
26 
 
After validation of our culture (Chapter 2) and matrix analysis methods (Chapter 3), we 
applied these conditions to the characterization of hESC and hiPSC conditioned 
matrices (Chapter 4).  From our proteomics screen, we identify over 80 extracellular 
proteins in matrix conditioned by hESCs and hiPSCs.  Comparative analyses with 
published stem cell secretome datasets aided in the identification of hESC regulatory 
proteins from our dataset.  Based on the ability of the hESC-derived CMTX to enhance 
the maintenance of an undifferentiated state, we carry out functional validation of 
candidates identified in the CMTX to determine their roles in hESC pluripotency 
(Chapter 5).  Focusing on the candidate soluble frizzled-related protein 1 & 2 (sFRP) 
proteins, we utilize a combination of approaches to elucidate their effects on hESC 
behavior.  Taken together, our improved culture methods, matrix analysis protocols, and 
detailed composition of hESC derived matrices provide an effective toolbox for obtaining 
a more comprehensive understanding of how this dynamic cell type is regulated in vitro.    
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Chapter 2  
Development and Optimization of Growth Conditions for SILAC 
Experiments in Pluripotent Stem Cells 
 
2.1 Introduction 
 
Large scale identification of proteins using mass spectrometry (MS)-based proteomics 
has been made possible by recent advances in instrumentation, separation sciences, 
and bioinformatics [1].  However, the generation of increasingly long lists of proteins 
now confronts researchers with the more challenging problem of determining the 
biological significance of particular proteins. For this reason, quantitative proteomic 
strategies can now be used in order to extract more meaningful information from their 
datasets.  By comparing multiple samples and different conditions vs controls, it is often 
possible to discern proteins that are altered in a given set of experimental or biological 
conditions from the thousands that are identified [2].   
 
 
This chapter contains excerpts with permission from the following paper:  
Bendall, S.C.*, Hughes, C.S.*, Stewart, M.H., Doble, B., Bhatia, M., Lajoie, G.A.. (2008) 
“Prevention of Amino Acid Conversion in SILAC Experiments with Embryonic Stem 
Cells”. Molecular and Cellular Proteomics. 7:1587 – 1597 
*Denotes equal author contribution  
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In MS-based proteomics, quantitative strategies typically involve the use of stable 
isotopic reagents to generate ‘heavy’ and ‘light’ samples, which retain their chemical 
identity and can then be differentiated and directly compared by MS analysis. While 
chemical labeling methods such as ICAT have demonstrated widespread applicability 
[1], metabolic incorporation strategies such as stable isotope labeling with amino acids 
in cell culture (SILAC) are becoming more common for cell types that can be grown for 
extensive periods of time in vitro. Though there are numerous advantages for using 
SILAC based methods, compared to chemical labeling, a major drawback is the 
unintended metabolic inter-conversion of isotopic amino acids in the labeling process, 
generating artifacts affecting the quantification. This is a particular problem with arginine 
which is a metabolic precursor for proline biosynthesis (Figure 2.1).  In general, large 
scale SILAC experiments use both arginine and lysine to obtain labeling of all possible 
tryptic peptides thereby maximizing quantitative coverage of all potential peptides in a 
given experiment.   
Several studies using SILAC have described the problematic conversion of isotopically 
labeled arginine to labeled proline in cells [3-7] (Figure 2.1) which results in an 
underestimation of the abundance of ‘heavy’ tryptic peptides containing proline in a 
relative quantification experiment.  This is of particular concern since ~50% of all tryptic 
peptides between 700 and 6000 Da in the international protein index (IPI) human 
database contains at least one proline.  Moreover, in a recent study it was reported that 
~30-40% of all observable proline containing peptides exhibited some level of 
conversion from heavy arginine [7].  Besides acting to skew the relative abundance 
observed, conversion of ‘heavy’ arginine to ‘heavy’ proline also further complicates the  
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Figure 2.1. Metabolic conversion of isotope-coded arginine to proline in SILAC 
experiments. The unpredictable conversion of isotopic arginine to proline creates 
inaccuracy in SILAC based quantitative proteomic experiments.  (A) A conceptual mass 
spectra of a non-proline containing peptide ion from a 1:1 mixture of ‘light’ and ‘heavy’ 
labeled samples. Here the expected ‘light’ and ‘heavy’ peptide ions have an equivalent 
signal. (B) A spectra from a proline containing peptide where arginine to proline 
conversion has occurred in the same 1:1 mixture.  The resulting heavy proline peptide 
signal (red) has been subtracted from the expected ‘heavy’ peptide ion signal. (C) 
Metabolic pathway outlining the inter-conversion of arginine and proline.  Isotope-coded 
arginine with carbon 13 (red) and nitrogen 15 (green) that when used as a synthetic 
precursor increases the expected mass of proline. 
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mass spectrometry data by increasing the number of peptide ion peaks.  One proposed 
strategy to minimize this problem is the reduction of the arginine concentration in the 
SILAC media rendering it metabolically unfavorable as a precursor for proline synthesis 
[8].  While this does reduce the conversion, it does not prevent it completely [3].  The 
other is to avoid the use of arginine altogether or by removing the ability to perform 
arginine catabolism [3, 9, 10].  Finally, alternative corrections can be done 
mathematically, post-analysis, but these are inaccurate and do not solve the problem of 
increased peptide ion complexity [4, 11-14].   
While reducing the concentration of available arginine in SILAC labeling media was a 
simple method for preventing its conversion to proline, this approach would be 
problematic for particular cells types like those with rapid cellular metabolism [15]. 
Moreover, certain sensitive cell types, such as human embryonic stem cells (hESCs) 
die or differentiate under restrictive metabolic conditions [7, 16].  To this end, Vanhoof et 
al. [7] sought to compensate for arginine to proline conversion in SILAC experiments by 
advocating the use of isotopically labeled arginine (15N4 Arg) in ‘light’ SILAC media as 
well as (15N4 13C6 Arg) in the ‘heavy’ media.  With the assumption that arginine to proline 
conversion would be the same under both conditions, the monoisotopic peak of ‘light’ 
and ‘heavy’ proline containing peptide ions could be compared to correctly determine 
relative abundance, as both would be reduced proportionately. This method does 
provide a solution but it further complicates the procedure by generating additional 
converted proline peptide ions in the MS spectra and by adding the cost of expensive 
isotopic reagents.  Also, there is no guarantee that the rate of arginine to proline 
conversion will be the same when comparing different cell types or treatments.  Adding 
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to these difficulties is the fact that SILAC labeling of both hESCs [7] and ESCs from the 
mouse (mESC) [17] required the use of mouse embryonic fibroblast (MEF) feeder cells 
which precludes the attainment of high cell numbers necessary for large scale, SILAC-
based proteomic applications [8, 18-21].  Faced with these challenges, we sought a 
simple solution, for arginine to proline conversion in SILAC experiments that would be 
compatible with a robust hESC culture protocol free of feeder cells.   
In this chapter, we demonstrate that by supplementing SILAC media with standard L-
proline, the conversion of isotope coded arginine to labeled proline can be prevented.  
In addition, when providing sufficient amounts of arginine, no back conversion from the 
increased proline supplement was observed.  When proline supplementation of SILAC 
media was adapted to both mouse and human ESC culture reagents complete labeling 
with isotope-coded lysine and arginine can be routinely achieved using standard 
procedures in the absence of feeder cells without compromising the ESC phenotype.  
We then extend our approach to demonstrate the growth of hESC and hiPSC lines in 
SILAC conditions using fully-defined, serum-free growth medium.  
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2.2 Results 
In mammalian cells, the metabolism of arginine and proline are related and each can 
serve as precursors for one another through slightly different, but related pathways 
(Figure 2.1 C, reviewed in [22]).  In a related pathway, both glutamate and glutamine 
can be precursors for arginine biosynthesis and products of arginine metabolism (Figure 
2.1 C).  However, only artifacts of proline synthesis from isotopic arginine have been 
reported in SILAC experiments.  This observation raised the question of availability of 
amino acids in vitro cell culture media, particularly in SILAC formulations, since previous 
in vivo mammalian studies have demonstrated that the inter-conversion of amino acids 
in this pathway (Figure 2.1 C) is primarily dependent on their bioavailability [23].  Since 
L-proline is a non-essential amino acid, its concentration in the two main basal media 
used in standard SILAC experiments, RPMI and DMEM, is only 20 and 0 mg/L, 
respectively.  At the same time, the typical concentration of arginine, a metabolic 
precursor of proline (Figure 1B), is 200 and 84 mg/L, respectively.  Based on this we 
surmised that the arginine to proline conversion artifacts in SILAC experiments were a 
direct result of the low or absent concentration of proline in standard SILAC labeling 
formulations. 
2.2.1 - Proline availability effects on isotopic arginine conversion to proline.  In standard 
DMEM based SILAC media, in the absence of proline supplement, cells readily convert 
isotopic arginine to proline, which is then incorporated into newly synthesized proteins.  
This conversion divides the MS signal of the ‘heavy’ proline containing peptide in a 
complex fashion, resulting in false relative abundance values when compared to an 
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equal amount of ‘light’ sample (Figure 2.1 A-B).  To eliminate this artifact in arginine-
based SILAC procedures, we investigated whether increased L-proline supplementation 
could prevent the conversion in a concentration dependent manner. 
Equal amounts of cell lysates extracted from HeLa cells cultured in SILAC media (13C6 
Arg) containing 0 – 800 mg/L proline were digested with trypsin and subjected to LC-
MS/MS analysis.  Detected proline conversion peptides were used to build a list of 
peptide candidates for quantification.  By using +2 or +3 charge states, the selection of 
the peptide candidates was based on whether they were observed in all samples, the 
number of proline residues, the extent of conversion observed, and whether the 
sequence contained arginine. Based on the triplicate analysis of all lysates, a list of 
thirteen peptide candidates was chosen and quantified across the 0 – 800 mg/L proline 
concentrations.  
Throughout the titration of L-proline in SILAC media signals of the converted proline 
containing peptides were monitored (Figure 2.2 A-B).  In addition, the ratio of ‘heavy’ 
labeled Arg peptide to light peptide was measured in order to detect whether a 
decrease in the converted proline peptide signal resulted in a subsequent increase in 
the expected ‘heavy’ peptide (Figure 2.2 A-B).  Within the set of peptide candidates 
proline conversion consumed an average of 28% of the monoisotopic signal of the 
‘heavy’ arginine peptide in the 0 mg/L proline sample (standard SILAC media) [5].  As 
the proline concentration was increased to 50, 100, and 200mg/L the monoisotopic 
‘heavy’ proline peak occupied 9%, 3%, and 2%, respectively.   However, within this list 
of proline containing peptides no peaks corresponding to a converted proline could be  
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Figure 2.2. Titration of proline during SILAC labeling with isotope coded arginine. 
Candidate proline containing tryptic peptides were monitored in whole cell extracts in 
13C6 arginine samples with 0-800 mg/L L-proline. (A) A conceptual mass spectra 
indicating the possible peptide ion peaks observed in the arginine labeling experiment. 
Both the ratio of labeled to unlabeled peptide as well as relative intensity of converted 
proline peptide ion were monitored in the experiment across 0 – 800 mg/L proline (B) 
where * indicates no converted proline peptide ions were detectable from background. 
(C) A mass spectrum from 0 mg/L proline sample representing the peptide 
VAPEEHPVLLTEAPLNPK at m/z 652 demonstrating a prevalent converted proline peak 
at +1.7 m/z from the expected peptide ion. (D) Mass spectrum from the 200 mg/L 
proline sample depicting the same peptide ion as in (C) and the converted proline ion is 
notably absent. 
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detected in the MS spectrum beyond 100 mg/L of proline.  As such, the 2% of total 
signal seen at 200 mg/L of proline was a result of un-subtracted background in the MS 
spectrum where there was low signal-to-noise.  Moreover, maximum relative signal of 
‘heavy’ arginine labeled peptide (~20% increase vs 0 mg/L Pro) was seen at 200 mg/L 
and beyond (Figure 2.2 B).  Consequently, even in some of the worst cases of proline 
conversion (Figure 2.2 C) no proline conversion could be observed in cells 
supplemented with 200 mg/L of proline or greater (Figure 2.2 D).  Taken together, these 
data not only demonstrate that supplementation of standard SILAC media can eliminate 
the proline conversion, but also return the “lost signal” to the expected peak within the 
‘heavy’ SILAC sample.  Most surprisingly, this critical improvement in arginine-based 
SILAC methods can be achieved by supplementing cell culture media with as little as 
200 mg/L of L-proline. 
2.2.2 - Proline availability effects on isotopic arginine labeling.  One concern with 
supplementing an arginine-based SILAC experiment with proline is that, by a similar 
biosynthetic mechanism (Figure 2.1 C), the excess proline might be a precursor for 
arginine synthesis thereby decreasing the efficiency of labeling by the isotope-coded 
arginine provided.   While proline is known to be one of the main substrates in the 
formation of citrulline, a direct precursor for arginine biosynthesis, it has been 
demonstrated that this process is only favorable when there is a lack of available 
arginine [23, 24].  Moreover, to date, the presence of other citrulline precursors, such as 
glutamine in standard SILAC media, has had no reported detrimental effect on SILAC 
procedures.  
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To prevent back conversion of proline into arginine and to increase the media’s 
compatibility with nutritionally sensitive cell types like ESCs [7], we re-supplemented the 
DMEM-based SILAC media with its standard complement of isotope-coded arginine 
(0.398 mM).  This was in direct contrast to the reported reduction of the concentration of 
isotope-coded arginine in order to prevent its availability for conversion to proline [5, 8].  
At the endpoint in the same proline titration experiments we monitored the ‘heavy’ 
arginine labeling efficiency by tracking the ratio of ‘heavy’ to ‘light’ peptides which 
contained arginine (Figure 2.3 A).  To minimize proline conversion artifacts that would 
interfere with these calculations, we avoided peptides with proline in their sequence. 
In comparison to 0 mg/L proline (standard SILAC media), the average relative peak 
area for the 50 – 800 mg/L proline samples exhibited only slight deviations, but overall 
remained  unchanged (Figure 2.3 B).   Larger deviations were only observed for 
peptides with lower signal-to-noise ratios and did not have a noticeable trend as a 
function of proline concentration.  None of the arginine peptides examined in the 0 mg/L 
proline sample (Figure 2.3 C) or even in samples that were supplemented with 800 
mg/L of proline (Figure 2.3 D) exhibited an increase in unlabeled ‘light’ peptide signal. 
These data provide evidence that our SILAC media formulation (standard arginine in 
combination with proline supplementation) is effective in minimizing arginine to proline 
conversion artifacts without compromising the efficiency of isotope-coded arginine 
labeling.  Thus, in the cell types examined here, an arginine concentration of 0.398 mM, 
even in the presence of high exogenous proline (up to 800 mg/L), is sufficient to prevent 
observable proline to arginine back conversion that would interfere with SILAC labeling 
efficiency. 
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Figure 2.3. Isotope coded arginine labeling efficiency across the titration of 
proline. Candidate arginine containing tryptic peptides lacking proline were monitored 
in whole cell extracts in 13C6 arginine samples with 0-800 mg/L L-proline. (A) A 
conceptual mass spectra indicating the possible peptide ion peaks observed in the 
arginine labeling experiment. The peak area ratio between the ‘heavy’ and ‘light’ 
arginine monoisotopic peaks was monitored across the 0 - 800 mg/L proline samples 
and plotted relative to 0 mg/L proline (B). (C) A mass spectrum representing the peptide 
AAVEEGIVLGGGCALLR at m/z 845 from the 0mg/L proline sample. (D) Mass spectra 
of the same peptide ion in the 800 mg/L proline sample demonstrating no compromise 
in the isotope-coded arginine labeling efficiency or proline to arginine back-conversion.  
Isotopic amino acids are underlined. 
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2.2.3 - Adaptation of SILAC labeling to feeder-free hESC culture.  In order to perform a 
wide variety of large-scale SILAC-based proteomic experiments with hESCs the ability 
to generate large numbers of labeled cells has to be achieved.  It became clear that 
SILAC methods compatible with feeder-cell free culture systems would be necessary to 
attain these high cell numbers (reviewed in [16]).  In an attempt to extend standard 
SILAC labeling procedures to feeder-free hESC culture we confirmed incompatibilities 
previously highlighted using a feeder-cell based culture system [7]. Using standard 
SILAC media with 13C6 arginine and supplemented with 36 ng/mL basic fibroblast 
growth factor (bFGF) [25], hESC cultures achieved maximum levels of isotope-coded 
arginine incorporation after only 2 passages or after more than 12 days under SILAC 
culture conditions (Figure 2.4 A).  By day 15 in SILAC media, hESCs had reached 
96.5% average efficiency in isotope coded amino acid labeling.  However, in the same 
period of time the hESCs rapidly differentiated as demonstrated by the loss of SSEA3 
expression (Figure 2.4 A), a marker of pluripotent stem cells.  We also observed the 
loss of defined hESC undifferentiated colony structure and tight cell morphology 
indicating the presence of differentiated cell types (Figure 2.4 B).  Moreover, manual 
inspection of the MS data showed that the conversion of arginine to proline was 
exacerbated in these cells.  While it was clear that arginine incorporation was complete 
in day 14 samples the proline converted peptide ions were prevalent (Figure 2.4 C).  In 
some extreme cases, converted proline peptide ions consumed greater than 50% of the 
expected peptide ion signal (Figure 2.4 D).  The instability of the hESC phenotype 
combined with the pronounced arginine to proline conversion artifacts indicated that the  
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Figure 2.4. Labeling feeder cell free hESCs in standard SILAC media. hESCs 
culture on Matrigel™ were grown in standard SILAC media (13C6 Arg, dialyzed FBS, 0 
mg/L proline) for two weeks. Arginine incorporation, conversion to proline, and hESC 
phenotype were monitored. (A) The relative SSEA3 frequency and percent heavy 
arginine incorporation over the SILAC labeling time-course. (B) Differentiated phenotype 
of hESC after 14 days in standard SILAC media as observed by light microscopy. Scale 
bars equal 250 µm. (C) A mass spectrum of heavy arginine peptide ion 
MSVQPTVSLGGFEITPPVVLR at 745 m/z.  Indicated are the prominent converted 
proline peptide ion shifted +1.7 m/z, and the absence of the unlabeled ‘light’ arginine 
peptide ion corresponding to the high level of isotopic amino acid incorporation. (D) A 
mass spectrum of the peptide ion VAPEEHPVLLTEAPLNPK at 652 m/z.  Indicated are 
the peptide ions shifted +1.7 m/z and +3.4 m/z corresponding to the incorporation of 1 
and 2 converted ‘heavy’ proline and consuming more than half of the expected peptide 
ion intensity. Isotopic amino acids are underlined. 
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standard SILAC media formulation was not a suitable protocol to adapt to feeder-cell 
free hESC culture.   
There are two main factors responsible for the incompatibility of standard SILAC media 
with hESC culture, the first being the dialyzed fetal bovine serum (FBS) and the second, 
the limited growth factor microenvironment (problems reviewed in [16]).  To address 
these issues we revisited the original development of feeder-cell free hESC culture 
protocols [26].  Xu and co-workers formulated a DMEM based hESC media using a 
serum replacement reagent [27] that is now commercially available as knockout serum 
replacement (KOSR – Invitrogen).  The hESC media was then pre-conditioned on MEF 
cell feeder layers to supply the appropriate complement of signaling molecules and 
growth factors to maintain hESC homeostasis.  This method has since become the 
most widely adopted form of feeder-cell free hESC culture.  Coincidently, the KOSR 
formulation contains no free lysine or arginine, making it compatible with most popular 
SILAC applications.  Moreover, as we demonstrate to be important here, KOSR 
contributes 800 mg/L of proline when used at 20% (v/v) in hESC media [27].   
A hESC SILAC media with 20% KOSR and 13C 15N arginine and lysine was formulated 
taking into account the SILAC compatibility of the media (see experimental methods). 
The hESC SILAC media was then pre-conditioned on irradiated MEFs according to 
previously established protocols [26].  The resulting media, when supplemented with 8 
ng/mL of bFGF, allowed hESCs to incorporate the isotope coded amino acids at the 
same rate as observed with standard SILAC media where after 2 passages and more 
than 12 days in SILAC culture hESC had reached their maximum levels of incorporation 
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(Figure 2.5 A).  Consistent with the preliminary proline titration data, there was no 
difficulty encountered in isotopic amino acid labeling since the cells were on average 
96.1% labeled by day 14. Moreover, in the new media formulation the cells were now 
able to maintain SSEA3 expression (Figure 2.5 A) and continue to form tight, 
undifferentiated colony structures (Figure 2.5 B).  Inspection of the MS spectra (Figure 
2.5 C) of the hESC lysates labeled using the new formulation demonstrated the same 
level of isotopic amino acid incorporation as standard SILAC media when examining the 
same peptides (Figure 2.4 C).  Additionally, for the same peptide there was no longer 
any arginine to proline conversion artifacts observed (Figure 2.5 C), even when 
examining peptides with the highest proportion of converted proline peptide ions (Figure 
2.5 D vs 2.4 D).  Consequently, when a 14 day SILAC labeled (13C 15N Arg and Lys) 
hESC extract was mixed 1:1 with a ‘light’ hESC lysate, equivalent levels of the expected 
‘light’ and ‘heavy’ peptides are observed even in sequences most susceptible to proline 
conversion artifacts (Figure 2.5 D).  These observations clearly demonstrate that 
combining KOSR as an alternative serum supplement with both a SILAC compatible 
hESC media formulation and pre-conditioning on feeder cells offers a reliable solution 
for large-scale hESC applications in quantitative proteomic without compromising data 
quality.   
2.2.4 - SILAC procedures with feeder-free mESC cultures. Recently, a landmark 
analysis of mESCs using a SILAC approach was reported by Graumann et al. in which 
a total of 5111 proteins were identified [17].  However, this study was also routed in a 
feeder-cell based culture system which, by the authors own admission, contributed to 
contamination in the analysis.  To circumvent this issue these authors performed a  
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Figure 2.5. Labeling feeder cell free hESCs in conditioned SILAC media with 
KOSR. hESCs cultured on Matrigel™ were grown in MEF conditioned ESC optimized 
SILAC media (13C 15N Arg and Lys, 20% KOSR providing 800 mg/L L-proline) for two 
weeks. Amino acid incorporation, conversion of arginine to proline, and hESC 
phenotype were monitored. (A) The relative SSEA3 frequency and percent heavy amino 
acid incorporation over the SILAC labeling time-course. (B) Undifferentiated phenotype 
maintained by hESCs after more than 15 days in optimized SILAC media as observed 
by light microscopy. Scale bars equal 250 µm. (C) A mass spectrum of heavy arginine 
peptide ion MSVQPTVSLGGFEITPPVLR at ~747 m/z.  Indicated are the absence of 
both a converted proline peptide ion and the unlabeled ‘light’ arginine peptide ion. The 
absent ‘light’ peptide ion at 743 m/z also indicates no back-conversion of proline to 
unlabeled arginine. (D) A mass spectrum of the 1:1 mixed labeled and unlabeled hESC 
lysates showing ‘light’ and ‘heavy’ peptide ion VAPEEHPVLLTEAPLNPK at ~652 m/z 
and 655 m/z.  The prominent converted proline peptide ions are now almost 
undetectable and do not effect the observed 1:1 ratio. Isotopic amino acids are 
underlined. 
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cumbersome transition from feeder cell to feeder cell free culture during the labeling 
process.  As these authors noted, the use of dialyzed FBS, prescribed in standard 
SILAC media [28], made feeder cell independent culture of mESCs difficult.  Moreover, 
having to culture mESCs on feeder layers and/or transition those to feeder cell 
independent conditions could negatively impact both the scalability of this procedure 
and the integrity of the mESC phenotype.  Because KOSR was originally designed and 
used as an alternative to FBS for the culture of mESCs [27] we hypothesize that the 
formulation that we successfully applied to hESCs could also be used in creating a 
protocol to perform SILAC on completely feeder-cell independent mESC cultures. 
Therefore a mESC SILAC media containing 15% KOSR was formulated [27] and the 
media supplemented with 1000 U/mL of leukemia inhibitory factor (LIF) prior to addition 
to feeder cell free mESC cultures.  After 4 passages in our mESC SILAC media the 
pluripotent culture morphology was indiscernible from those mESCs cultured under 
standard conditions (Figure 2.6 A-B).  After the same period of time mESCs also 
achieved maximum incorporation of isotopic amino acids (13C 15N Arg and Lys) (Figure 
2.6 C) with an average labeling of 96.3%.  Moreover, visual inspection of SILAC labeled 
mESC MS spectra demonstrates similar results as observed with hESCs samples 
where there is no compromise with levels of isotopic arginine incorporation and no 
detectable incidence of proline conversion artifacts even in peptide ions with multiple 
proline residues in the sequence (Figure 2.6 D).  In accordance with the observations in 
the hESC system, the application of a KOSR based SILAC media to a feeder-cell free 
mouse ESC culture, now provides a robust protocol for routine, large-scale quantitative 
proteomic experiments using SILAC in mESCs as well. 
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Figure 2.6. Labeling feeder cell free mESCs in conditioned SILAC media with 
KOSR. mESCs cultured on gelatin were grown in ESC optimized SILAC media (13C 
15N Arg and Lys, 15% KOSR providing 600 mg/L L-proline) for 4 passages (8 days). 
Amino acid incorporation, conversion of arginine to proline, and mESC phenotype were 
monitored. The undifferentiated phenotype of mESCs grown under standard feeder cell 
free conditions (A) compared to those grown in optimized SILAC media for 8 days (B) 
as observed by light microscopy. Scale bars equal 250 µm. (C) The average heavy Lys 
and Arg incorporation over the SILAC labeling time-course. (D) A mass spectrum of 
peptide ERPPNPIEFLASYLLK at 635.6 m/z from mESCs in ESC optimized SILAC 
media.  The ‘heavy’ Lys and Arg peptide ion is prominent while the unlabeled ‘light’ 
peptide or converted ‘heavy’ proline peptide ions are absent. The absent ‘light’ peptide 
ion at m/z 633 also indicates no back-conversion of proline to unlabeled arginine. 
Isotopic amino acids are underlined. 
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2.2.5 - SILAC of hESCs and hiPSCs in Defined Conditions.  With the recent 
demonstration that somatic cells can be reprogrammed to generate pluripotent cells, a 
significant increase in the number of studies employing these induced pluripotent stem 
cells (iPSC) have been carried out [29].  The clinical potential of human iPSCs (hiPSC) 
necessitates the need for their culture in defined, xeno-free conditions.  As such, a 
variety of formulations have recently become commercially available [30], many of 
which can be paired with xeno-free growth matrices.  However, very few of these 
alternatives offer the tested stability and universality of MEF-CM combined with the 
basement matrix Matrigel™™.   
Our previously discussed methods for performing SILAC in human and mouse ESCs 
utilizes an undefined KOSR-based medium.  Since this medium requires pre-
conditioning on MEF feeder layers, it is xenogenic and undefined in nature.  Coupled 
with this is the potential for contamination with unlabeled amino acids as a result of 
conditioning.  Although proteomic analyses have attempted to profile the MEF derived 
contribution to MEF-CM, the composition can vary significantly from batch to batch [31-
33].  In order to perform SILAC in any cell system, the ability to control culture medium 
components is essential.  Development of a defined culture medium amenable to SILAC 
experimentation in hESCs and hiPSCs would be a significant development for 
proteomics researchers. 
Based on this, we have adapted a commercially available, fully-defined, serum-free 
medium formulation for performing SILAC in hESCs and hiPSCs [34].  After 10 
passages in SILAC medium (>60 days), H9, CA1, and BJ-1D stem cell lines maintained 
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expression for Oct3/4 and Nanog as indicated by RT-PCR (Figure 2.7 A).  All of the 
tested stem cell lines also retained Oct3/4 and SSEA4 marker expression as visualized 
using immunofluroescence (Figure 2.7 B).  Marker expression was further validated 
using flow cytometry for SSEA4 and SSEA1 in all cell lines (Figure 2.7 C).  After the 
induction of differentiation in vitro using embryoid body assays, all cell lines exhibited 
increased expression of markers characteristic of each of the three primary germ layers 
(Figure 2.7 D).  Additionally, H9 and CA1 hESCs also retained the ability to differentiate 
in vivo as observed using a teratoma assay.  Taken together, these data indicate that 
extended culture in StemPro-based SILAC medium is capable of maintaining hESC and 
hiPSC lines in an undifferentiated and pluripotent state. 
To test the compatibility of the defined medium for SILAC experimentation, we 
monitored incorporation of isotopically labeled versions of arginine and lysine.  
Examining multiple peptides revealed that >96% incorporation can be achieved after 
just 7 days in defined medium supplemented with isotopically labeled arginine and 
lysine (Figure 2.8 A).  By examining the amino acid composition of the defined culture 
medium we determined that there was no significant source of L-proline.  When cells 
were grown in defined medium containing no exogenous L-proline, significant 
conversion from arginine can be observed (Figure 2.8 B).  After the addition of 800mg/L 
of L-proline, there is no longer any signal observable for the isotopically labeled proline 
containing peptide (Figure 2.8 C).  Analysis of 1:1 mixed light and heavy lysates reveals 
that the addition of L-proline in defined medium restores the previously skewed 
expected peptide abundance ratio (Figure 2.8 B-C).   These observations validate our 
previous data for SILAC experiments performed in KOSR-based medium.  
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Figure 2.7. Labeling feeder cell free hESCs and hiPSCs in defined serum-free 
SILAC media.  H9, CA1, and BJ-1D were maintained in StemPro SILAC medium with 
13C, 15N Arg and Lys, as well as 800mg/L of L-Proline.  Following 10 passages, each 
cell line was assayed for conventional markers of an undifferentiated state. (A) Each cell 
line maintained strong expression for the markers Oct3/4 and Nanog as determined by 
RT-PCR.  Data is relative to specific matched cell line controls on Matrigel™ in MEF-
CM.  Error bars represent SD, n=3 (B) Immunocytochemistry data demonstrate 
expression of Oct3/4 and SSEA4 in all cultures.  Scale bars indicate 250um.  (C) Flow 
cytometry data for all cell lines assaying SSEA4 and SSEA1 expression, n=3.  All lines 
maintained strong signal for SSEA4 with minimal SSEA1.  Viability was determined 
using 7-AAD staining.  Populations were gated based on 7-AAD exclusion.  (D)  
Embryoid bodies were generated using cells grown in SILAC medium.  Phase contrast 
images showing representative embryoid bodies for each cell line.  Scale bars represent 
250um.  Graphs below show RT-PCR analysis for the markers of pluripotency (Oct3/4, 
Nanog), trophoblast (CDX2), ectoderm (NeuroD1, PAX6), endoderm (GATA6, GATA4, 
alpha-fetoprotein), mesoderm (T).  Values are fold change relative to cell line specific 
undifferentiated controls.  Error bars represent SD, n=2.  RT-PCR assays in both (A) 
and (D) use RPLPO as a positive control.  (E) In vivo analysis of pluripotency.  
Representative tissues from the three primary germ layers are displayed.  Endoderm : 
gut epithelium (i), columnar epithelium (iv), Mesoderm: muscle tissue (ii, v), cartilage 
(iv), Ectoderm: neural epithelium (iii), neural-like tissue (vi).  Arrows denote structures of 
interest.  Scale bars represent 100um. 
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Figure 2.8. Efficient isotopic label incorporation achieved through the use of 
defined SILAC medium.  hESCs and hiPSCs were grown for a period of 7 days in 
StemPro SILAC medium containing 13C, 15N arginine and lysine. (A) H9, CA1, and BJ-
1D stem cells were harvested at 0,1,3, and 7 days following application of StemPro 
SILAC medium.  Label incorporation was obtained by comparing peak areas for 
combined scans of light and heavy peptides.  A total of 5 peptides were compared in 
each cell line.  (B-C) H9 stem cells grown in the presence and absence of L-proline 
were tryptically digested and analyzed by MS.   Analysis of the proline containing 
peptide MSVQPTVSLGGFEITPPVVLR revealed a significant heavy proline amino acid 
signal in the absence of exogenous L-proline.  The resulting skew in expected peptide 
ratio from a 1:1 mixture of light and heavy cell lysate can be seen in (C).  Following the 
addition of L-proline, negligible signal for the heavy proline containing peptide remains 
and the expected peptide ratio is restored in (C).  Isotopically labeled amino acids are 
underlined. 
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2.3 Discussion 
Most SILAC procedures take a reductionist approach in controlling amino acid content 
in cell culture to achieve the desired labeling outcome.  These include the use of 
dialyzed FBS, reduced concentration or total removal of many amino acids (i.e. Arg and 
Pro), and overall culture conditions optimized using immortalized tissue culture.  We 
believed these methodological aspects preclude the extension of SILAC procedures to 
ESCs and were at the heart of amino acid conversion artifacts seen using the general 
labeling procedure. In this chapter, we demonstrate that through supplementation of 
isotope-coded arginine based SILAC experiments with as little as 200 mg/L of L-proline, 
isotopic arginine to proline conversion artifacts can be virtually eliminated in a variety of 
cell types.  In addition, using KOSR which provides 800 mg/L of L-proline at 20% as a 
serum supplement in lysine and arginine based SILAC experiments instead of dialyzed 
FBS creates a robust media formulation for completely feeder-cell free SILAC 
experiments using ESCs from both the mouse and the human.  We also tested the 
compatibility of a fully-defined, serum-free medium for use in SILAC experiments with 
hESCs and hiPSCs.  With this medium we were able to maintain all hESC and hiPSC 
lines tested for an extended period in an undifferentiated and pluripotent state.  
Moreover, with the addition of L-proline at a concentration of 800mg/L to the medium, 
we could successfully eliminate conversion from isotopically labeled arginine.  
Based on the cellular pathways of proline and arginine metabolism, the addition of 
proline is an obvious solution to the conversion issue, however the concern has always 
been the potential back conversion to arginine which would interfere with isotope-coded 
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arginine labeling [8].  Some studies, such as the recent one using SILAC in mESCs 
stress that all reagents were prepared without proline for this very reason [17].  To our 
knowledge, no study to date has demonstrated that the presence of proline actually 
induces significant back conversion to arginine in a concentration dependent manner 
during a SILAC procedure.  In fact, we demonstrate here that between 0 and 800 mg/L 
proline that there is no significant change detectable in the labeling of cells with isotope-
coded arginine.   
Proline is a preferred precursor for arginine biosynthesis in neonates in vivo just as 
arginine is for proline.  However it has been clearly demonstrated in a number of studies 
that the de novo biosynthesis of either arginine or proline using the other as a precursor 
is most strongly influenced by their bioavailability [23, 24, 35].  In other words, if there is 
sufficient free proline present to maintain cellular homeostasis the endogenous 
production of proline will not be favored, regardless of the concentration of its available 
precursors.  The same statement can be made in the opposite direction for arginine. 
With respect to energy and metabolism this observation makes sense as it would be the 
most efficient.  Even though a diminished arginine concentration may be sufficient in 
certain cell types, it has been reported that this is not completely efficient at preventing 
proline conversion artifacts [3, 8].  Our study suggests that this was due to the absence 
of proline in the standard SILAC media formulation.  While the inter-conversion of 
proline and arginine may still exist in cells labeled with isotope-coded arginine using our 
media formulation, we were unable to detect it with any level of significance. More 
importantly, our strategy of supplying additional or high concentrations of amino acids 
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appears to be more effective at eliminating the problem and makes our strategy the 
most applicable to biologically important in vitro cell types like embryonic stem cells. 
This work however, is limited in the number of cell lines and peptides tested.  Recent 
research from two groups has expanded this analysis to include a variety of cell lines 
and thousands of peptides [36, 37].  Comparing the log2 ratios of peptides and proteins 
from 293T cells harvested under conventional SILAC conditions or those where proline 
is supplemented, Lossner et al. observed a shift in the expected peptide ratio only in the 
absence of exogenous proline supplementation.  Marcilla et al. were able to virtually 
abolish arginine conversion by supplementing with as little as 300 mg/L of proline [37].  
They also observed that there was no back conversion to arginine after proline 
supplementation as has been suggested previously [38], further validating our results.  
Both of these studies indicated no negative effects on cell viability as a result of proline 
addition.   
We have illustrated the ability to eliminate conversion of isotopically labeled arginine to 
proline when performing SILAC experiments in ESCs.  Through the supplementation of 
as little as 200mg/L of L-proline, conversion can be eliminated to undetectable levels.  
We also demonstrated the growth and maintenance of hESC and hiPSC lines in fully 
defined SILAC medium.  Since our publication other groups have demonstrated large-
scale characterization of hESCs using our methods [39].  Although the ability to perform 
SILAC in defined conditions is a significant step for hESCs and hiPSCs, extension of 
this work to a xeno-free medium is desirable.   
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2.4 Experimental Methods 
2.4.1 SILAC media formulations - All SILAC media formulations and labeling procedures 
were modified from previously described protocols [5, 28]. With the exception of the 
defined SILAC medium, all SILAC labeling experiments used embryonic stem cell 
qualified Dulbecco’s Modified Eagle’s Medium (DMEM – 4500mg/L glucose, with Na 
pyruvate, and no L-glutamine) that was custom ordered without lysine or arginine 
(Specialty Media – Millipore). Before use, media was re-supplemented with 2.5 mM L-
glutamine (Invitrogen), 0.798 mM isotope-coded L-lysine (13C6 15N2), and 0.398 mM 
isotope-coded L-arginine (either 13C6 or 13C6 15N4). In the case of ‘light’ media, standard 
L-lysine and L-arginine were used. The DMEM for ESC cell culture was supplemented 
with 0.1 mM 2-mercaptoethanol, 1% non-essential amino acids (NEAA - Invitrogen), 
and 20% or 15% Knockout Serum Replacement (KOSR - Invitrogen) reagent for hESC 
or mESC culture, respectively. Note that ESC media with 1% NEAA will have 11.5 mg/L 
proline while KOSR at 20% and 15% (v/v) will contribute an additional 800 and 600 
mg/L of L-proline, respectively [27].  For HeLa cell culture the DMEM was supplemented 
with 10% (v/v) dialyzed fetal bovine serum (FBS), 1% (v/v) penicillin-streptomycin (both 
Invitrogen), and 0 to 800 mg/L of L-proline (Sigma). All media were filter sterilized at 0.2 
µM. 
2.4.2 SILAC labeling of human and mouse ESCs and iPSCs - For SILAC labeling of 
both hESC, hiPSC, and mESC cultures measures were taken to remove all non-isotopic 
Arg and Lys from the system.  All cells were washed with either PBS or DMEM lacking 
Arg and Lys prior to exposure to SILAC media.  Any reagents requiring dilution with 
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DMEM were prepared in DMEM lacking Arg and Lys as well.  hESC lines H1 and H9 
[40] were maintained in feeder-free culture on 1:15 Matrigel™™ (BD Biosciences) 
coated plates.  hESC SILAC media was supplemented with 4 ng/mL basic fibroblast 
growth factor (bFGF – Invitrogen) and pre-conditioned on irradiated mouse embryonic 
fibroblasts (MEFs) according to previously established protocols [26]. The MEF 
conditioned hESC SILAC media was further supplemented with 8 ng/ml bFGF prior to 
addition to hESC cultures and changed daily.  Cells were passaged every 5-7 days 
through dissociation with 200 U/mL collagenase IV (Invitrogen).  hESCs were cultured 
for two passages (> 12 days) in SILAC media to achieve maximum isotopic amino acid 
incorporation. Analysis of hESC culture integrity and expression of pluripotent cell 
surface markers was performed as previously described [41].  E14K mESC 
cultures from 129Ola mice were also maintained in the absence of feeder cells on 
0.1%(v/v) gelatin (Sigma) coated plates as previously described [42].  mESC SILAC 
media was supplemented with 1000 units/ml leukemia inhibitory factor (LIF – ESGROW, 
Millipore) prior to addition to cultures.  Cells were passaged 1:3 every 2 days through 
dissociation in 0.25% trypsin, 2.21 mM EDTA (Wisent).  mESCs were cultured for 4 
passages (> 8 days) in SILAC media to achieve maximum isotopic amino acid 
incorporation. 
For SILAC experiments in defined medium, hESC (H9, CA1) and hiPSC (BJ-1D) cell 
lines were grown in feeder-free conditions on 1:30 Matrigel™™ (BD Biosciences.  The 
CA1 hESC line used in all experiments was obtained from Dr. Cheryle Séguin of The 
University of Western Ontario [43, 44].  The hiPSC line BJ-1D was derived by 
reprogramming using retroviral transduction of BJ fibroblasts with the Yamanaka factors 
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essentially as we have previously described [45] and validated as pluripotent using in 
vitro and in vivo differentiation assays and expression profiling (unpublished results).  
Custom DMEM/F12-glutamax that contained no L-arginine or L-lysine was ordered from 
Invitrogen.  SILAC medium was prepared using the StemPro hESC Media system with 
our custom DMEM/F12 (Invitrogen) according to manufacturer instructions.  [13C6, 15N4] 
– L-arginine and [13C6, 15N2] – L-lysine (Cambridge Isotope Laboratories, Andover, MA) 
were supplemented into the SILAC medium at 71.42mg/L and 80mg/L respectively.  
Unlabeled L-proline was added to the SILAC medium at a final concentration of 
800mg/L.  Culture medium was changed daily and cells were passaged every 4-5 days 
by manual dissection and harvesting of colonies. 
Embryoid bodies (EB) were generated using Aggrewell 400Ex plates (StemCell 
Technologies, Vancouver, Canada). Briefly, 2 x 106 hESCs were harvested 
enzymatically using Accutase (Invitrogen) from Matrigel™™ coated plates.  Cells were 
reconstituted in Aggrewell medium supplemented with Rock inhibitor (Y-27632, Sigma-
Aldrich, St. Louis, MO) at a final concentration of 10μM.  After plating in Aggrewell 
dishes, EBs were grown for 48 hours at 37°C prior to transfer to ultra-low adherence 
tissue culture dishes (Corning, Lowell, MA).  After 15 days of culture, EB RNA was 
harvested using Trizol extraction according to the manufacturer’s instructions 
(Invitrogen).  EBs were assayed for expression of CDX2, alpha-feto protein (AFP), 
GATA-6, GATA-4, Oct3/4, PAX-6, T-brachyury, Nanog, and Neurogenic differentiation 1 
(NeuroD1) using TaqMan primer probe sets (Invitrogen).  Assay information can be 
found in Appendix Table 1.15.  All EB assays were performed in biological and technical 
duplicate for each cell line and condition.  
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2.4.3 Preparation and digestion of cell samples - To monitor isotopic amino acid 
incorporation and conversion trypsin digests were prepared from whole cell lysates for 
LC-MS analysis.  Cell culture media was removed and cells were washed with PBS.  
Cells were then mechanically removed from the plate, lysed by dissociation in 8M urea 
and 50 mM ammonium bicarbonate, and frozen at -80°C. The protein content was 
determined by Bradford assay and, where indicated, ‘light’ and ‘heavy’ isotopic samples 
were mixed 1:1 based on total protein concentration prior to digestion. For trypsin 
digestion, samples were reduced with 10 mM DTT, alkylated with 30 mM 
iodoacetamide, diluted 1:4 with 50 mM NH4CO3 and treated with modified trypsin (1:25 
enzyme/substrate ratio - Promega) at 37°C overnight.  The resulting tryptic peptides 
were extracted using a 1-mL C18 solid phase extraction cartridge (Waters), eluted with 
50% (v/v) ACN, 0.1% (v/v) formic acid (FA) to remove urea and salts and were re-
concentrated in a vacuum centrifuge.  Dried fractions were reconstituted in 10% FA for 
LC-MS/MS analysis. 
2.4.4 Liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis - 
Between 1.0 and 0.5 µg of each original sample was injected on a NanoAcquity UPLC 
(Waters) equipped with a 15cm x 75µm C18 reverse phase column employing a 90-
minute LC gradient (5-40% ACN, 0.1% FA) and detected in a data-dependent 
acquisition (DDA) mode by tandem MS (Q-ToF Ultima - Waters). The MS was directed 
to use the following DDA parameters: survey scan range 400-1800 m/z, 1 s scan, 1-4 
precursors selected based on charge state (+2, +3 and +4 ions). MS/MS fragmentation 
was then performed on the ions using the charge state collision energy profile function. 
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2.4.5 Analysis of isotopic amino acid labeling and conversion - Data analysis for all 
samples was performed in PEAKS 5.3 software (Bioinformatic Solutions Inc., Waterloo, 
Canada) [46, 47].  After import into PEAKS, MS/MS spectra from raw data files were 
refined using the following settings: merge spectra – true (100ppm mass tolerance, 60 
second retention time tolerance), correct precursor mass – true, determine precursor 
charge state – true (minimum charge +2, maximum charge +5), spectral quality filter – 
true (0.65 threshold), centroid, deisotope, and deconvolute – true.  Resulting MS/MS 
spectra were then de novo sequenced using the following parameters: parent 
monoisotopic mass tolerance – 100ppm, fragment monoisotopic mass tolerance – 0.15 
daltons, enzyme specificity –Trypsin, fixed modifications – carbamidomethylation and 
+10 daltons on Arginine and +8 daltons on Lysine for SILAC, variable modifications – 
oxidized methionine.  After de novo analysis, data were searched against the UniProt 
sequence database (Human taxonomy specified, 20236 total entries) using the 
following parameters: parent monoisotopic mass tolerance – 100ppm, fragment 
monoisotopic mass tolerance – 0.15 daltons, , enzyme specificity –Trypsin, fixed 
modifications – carbamidomethylation and +10 daltons on Arginine and +8 daltons on 
Lysine for SILAC, variable modifications – oxidized methionine, estimate false-discovery 
rate – true.  Identified peptides were chosen randomly to be investigated manually using 
MassLynx 4.1.  The peak area was determined by integration using the built-in 
algorithm in MassLynx 4.1 to output peak area values. Peak area of the monoisotopic 
ions were used for comparison and determination of quantitative ratios of peptide 
candidates.   
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2.4.6 Titration of proline - HeLa cells were passaged twice at a ratio of 1:8 in SILAC 
media containing the indicated amount of L-proline to ensure maximum incorporation of 
the isotopic arginine label (either 13C6 or 13C6 15N4 Arg). SILAC media was changed 
every 3 days, or as needed based on phenol red indicator.  Whole cell lysates were 
digested and subject to LC-MS/MS in the initial sample analysis. Both potential and 
confirmed (by MS/MS) proline containing peptides resulting from the conversion of 
isotopic arginine were noted. All samples were then re-run in triplicate using the “include 
only” function to target previously detected/suspected proline containing peptides 
across all samples. The candidate list of proline containing peptides was then used to 
follow the conversion of arginine to proline over varying proline supplement 
concentrations. Peptides containing labeled proline derived from isotope-coded arginine 
were confirmed by MS/MS in the 0 and 50 mg/L proline samples. Thirteen proline 
converted peptides observed in the replicate analysis and confirmed by MS/MS were 
used to monitor isotopic arginine to proline conversion in these experiments.  These 
were: VAPEEHPVLLTEAPINPK, LILPGELAK, PMFIVNTNVPR, NTGIICTIGPASR, 
MSVQPTVSLGGFEITPPVVLR, PPYTVVYFPVRGR, YSSLVPIEK, AVFPSLVGRPR, 
VAPEEHPVLLTEAPINPK, SSGPYGGGGQYFAKPR, QYPKVPR, LAVNMVPFPR, and 
SSRAGLQFPVGR.   
To investigate the possible back conversion of proline to arginine, a similar process was 
repeated except the arginine containing peptide candidates did not have a proline in 
their sequence, so that proline conversion could not interfere with arginine incorporation 
calculations. Based on replicate analysis, those peptides used for arginine incorporation 
that were consistently observed and confirmed MS/MS were: STELLIR, 
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AGTGVDNVDLEAATR, VIGSGCNLDSAR, TIAQDYGVLKADEGISFR, 
GKVKVGVDGFGR, and GITINAAHVEYSTAAR.     
2.4.7 SILAC Label Incorporation - In order to monitor isotope-coded amino acid 
incorporation and determine the optimum times for SILAC adaptation a list of both Lys 
and Arg containing candidate peptides for both human and mouse ESCs was 
generated. Incorporation was obtained by comparing peak areas from combined scans 
of light and heavy peptides.  Those candidate peptides that were consistently identified 
by MS/MS across all samples during the labeling time course were: 
NLPQYVSNELLEEAFSVFGQVER, IHFPLATYAPVISAEK, 
SLQDIIAILGMDELSEEDKLTVSR, LISWYDNEFGYSNR, GVDEVTIVNILTNR, 
SSGPTSLFAVTVAPPGAR, ALMLQGVDLLADAVAVTMGPK, 
EVAAFAQFGSDLDAATQQLLSR, LLEDGEDFNLGDALDSSNSMQTIQK, 
EKPYFPIPEEYTFIQNVPLEDR, VGKDELFALEQSCAQVVLQAANER, 
GFGFVTYATVEEVDAAMNARPHK, VVLAYEPVWAIGTGK, and YPIEHGIITNWDDMEK 
for hESCs; and  KATGPPVSELITK, ALLFVPR, GLFIIDDK, YQAVTATLEEK, 
ALMLQGVDLLADAVAVTMGPK, SGETEDTFIADLVVGLCTGQIK, MVNHFIAEFK, 
IGYPAPNFK, IAIYELLFK, ALYETELADARR, SLMDEVVKATSR, 
ERPPNPIEFLASYLLK, TKVHAELADVLTEAVVDSILAIR for mESCs. 
For hESCs and hiPSCs grown in defined SILAC medium, label incorporation was 
monitored for 7 days after exposure to heavy medium.  Incorporation was determined 
through examination of the following peptides:  HQGVMVGMGQKDSYVGDEAQSKR, 
HLEINPDHPIVETLR, HVFGESDELIGQK, IHEGCEEPATHNALAK, 
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GVVDSEDIPLNLSR, FQSSHHPTDITSLDQYVER, SNYNFEKPFLWLAR, 
ISEQFTAMFR, VIHDNFGIVEGLMTTVHAITATQK, HSQFIGYPITLYLEKER, 
VILHLKEDQTEYLEERR, MTDQEAIQDLWQWRK. 
2.4.8 Real-time PCR – RNA was purified using Trizol reagent according to the 
manufacturer’s instructions (Invitrogen) or with the 5 Prime PerfectPure RNA Extraction 
Kit (5 Prime, Gaithersburg, MD).  After NanoDrop quantification, 1µg of cDNA was 
synthesized using the High Capacity cDNA Reverse Transcription Kit with RNase 
inhibitor (Invitrogen).  Real-time PCR was performed using the TaqMan® Universal 
PCR Master Mix (Invitrogen).  Samples were incubated at 50°C for 2 minutes followed 
by 10 minutes at 95°C.  Samples were then amplified at 95°C for 15 seconds followed 
by 1 minute at 58°C for 46 cycles.  All samples were normalized to RPLPO as a positive 
control.  All primers were obtained from Invitrogen and assay information can be found 
in Appendix Table 1.15.  Each biological replicate was run in triplicate for every marker 
assayed.  All reagents were used according to the manufacturer’s instructions. 
2.4.9 Immunofluorescence – After 10 passages in SILAC medium, H9, CA1, and BJ-1D 
cells were plated in 6-well dishes coated with Matrigel™™.  After 4 days of culture, cells 
were rinsed and fixed with 4% para-formaldehyde containing 20 mM sucrose.  Prior to 
staining, cells were blocked using the Dako Serum Free Protein Block solution (Dako, 
Cambridgeshire, UK).  Oct-4 (clone 10H11.2), SSEA-4 (clone MC-813-70), and SSEA-1 
(clone MC-480) primary antibodies were obtained from Millipore (Billerica, MA).  Cells 
for Oct-4 labeling were permeabilized using a 0.1% Triton X-100 solution prior to 
blocking.  Cells were labeled with primary antibodies for Oct-4 or SSEA-4 as 
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undifferentiated markers and SSEA-1 for differentiated cells all at concentrations 
concentrations of 2 μg/mL for 60 minutes at room temperature.  Secondary Alexa-fluor 
488 goat anti-mouse IgG and Alexa-fluor 568 goat anti-mouse IgM were obtained from 
Invitrogen (Carlsbad, CA).  Secondary antibodies were probed at concentrations of 1 
μg/mL for 60 minutes at room temperature.  All products were used according to 
manufacturer’s instructions. 
2.4.10 Flow Cytometry – All reagents and probes for flow cytometry were obtained from 
eBiosciences (San Diego, CA) unless noted otherwise.  Cells were enzymatically 
harvested using Accutase (Invitrogen) to obtain a single cell suspension.  After 
centrifugation, cell pellets were resuspended in 5% FBS in PBS.  Alexa-488 conjugated 
SSEA-4 and Alexa-647 conjugated SSEA1 were diluted into the cell mixture according 
to the manufacturer’s instructions.  Negative control samples contained respective 
isotype controls for the primary antibodies used.  Solutions were incubated for 2 hours 
and analyzed using an Accuri C6 (BD Biosciences) flow cytometer after rinsing to 
remove unbound antibody.  Populations were gated according to forward and side 
scatter patterns with filtering for viable cells using 7-aminoactinomycin D staining.  Data 
were analyzed using FlowJo software (Tree Star, Ashland, OR).  
2.4.11 Teratoma Formation and Histological Analysis – All animal protocols used here 
have been approved by the University of Western Ontario Council on Animal 
Care. Nude (Crl:NU-Foxn1nu; Charles River) mice were injected in the flank 
subcutaneously with H9 or CA1 hESCs grown for >10 passages in StemPro SILAC 
medium.  Prior to injection, hESCs were rinsed with PBS, trypsinized, and counted 
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using trypan blue exclusion.  Approximately 1x106 cells based on live cell counts were 
resuspended in a 50:50 DMEM:Matrigel™™ mixture totaling 100μL in volume.  
Injections were performed on each side of three separate mice for each treatment 
(n=3).  Teratomas were allowed to form for 6 – 8 weeks.  Teratomas were removed, 
fixed and embedded in paraffin.  Sections were taken from three areas spaced evenly 
through the tissue and tissue types were defined with hematoxylin and eosin staining.  
2.4.12 Statistical Analysis – Statistical analyses were performed using GraphPad Prism 
software.  Results are expressed as SD or SEM as indicated in figure legends.  
Statistical significance was determined using unpaired Students T-tests.  Differences 
were reported as follows: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Chapter 3 
Proteomic Analysis of Complex Matrices used in Human Embryonic 
Stem Cell Culture 
 
3.1 Introduction 
The in vivo and in vitro extracellular matrix (ECM) is known to play an important role in 
numerous decisions that direct cell fate and behavior [1-4].  Typical ECM mixtures 
include combinations of laminins, collagens, glycoproteins, and proteoglycans [5, 6].  
However, the constituents of the ECM differ greatly between tissue types.  In vitro, the 
main function of the extracellular matrix is to support cell growth and maintenance.  For 
example, the ECM provides physical support for cells whilst maintaining cellular 
polarization and tissue morphology.  Moreover, the ECM is a reservoir for cell signals as 
it contains specific carbohydrates, proteins, nutrients and growth factors that can direct 
cellular processes and behavior.  An example ECM component being laminin, which 
cells sense via integrin receptors.  Such interactions between cells and laminin have 
been shown to affect a variety of biological functions, such as cell growth, morphology, 
differentiation, and migration in a cell-specific manner [7].   
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Required for Optimal Growth of Cell Culture”. Proteomics. 10;9:1886 – 1890 
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3991 
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In vitro, protein matrices are commonly used when cell proliferation is not favorable on 
chemically treated tissue culture plastic.  Depending on the cellular system of interest, 
these matrices can consist of a range of components.  The most widely utilized example 
of this is the basement-membrane matrix commercialized as Matrigel™ [8, 9].  
Matrigel™ is an assortment of extracellular matrix proteins that have been extracted 
from Englebreth-Holm-Swarm tumors in mice [8-10].  Matrigel™, which primarily 
consists of laminin, collagen IV, and enactin, is considered to be a reconstituted 
basement membrane preparation.  Previous research studies have emphasized the 
need for caution when drawing conclusions based on changes in cellular activity when 
using Matrigel™ [11].  This recommendation was based on the detection of several 
growth factors in standard Matrigel™ through the use of immunoassays; these included 
bFGF, EGF, IGF-1, TGF-β, PDGF, and NGF [11].  Growth factor reduced (GFR) is a 
version of Matrigel™ that has been modified to reduce the abundance levels of these 
growth factors [11]. 
One important application of Matrigel™ is its use for the growth of human embryonic 
stem cells (hESC).  In contrast to mouse ESC culture, hESCs cannot be maintained in 
an undifferentiated and pluripotent state on gelatin.  Thus, Matrigel™ is conventionally 
used as a substitute for gelatin in feeder-free hESC culture.  Unfortunately, the 
derivation of Matrigel™ from mouse tissue makes it undesirable for the growth of 
hESCs that can be potentially applied in therapeutic treatments [12, 13].  A variety of 
alternative ECM proteins or culture systems have been evaluated for their ability to 
support hESC proliferation [14-28].  In combination or individually, some of these 
promote the pluripotent growth of undifferentiated hESCs in 2D, 3D, and suspension 
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culture [16, 29].  Cell-derived matrices generated from human fibroblasts have also 
been shown to promote pluripotent hESC growth, but the supportive constituents of 
such preparations are largely unknown or proprietary [30-35].  While most of the 
previously noted matrices have been shown to support the maintenance of self-renewal 
and pluripotency in hESCs, none have proven as effective as Matrigel™ [36]. 
The lack of a defined xeno-free growth matrix remains a significant limitation for the 
potential extension of hESCs to therapeutic applications [17, 37, 38].  It would be of 
tremendous value if support proteins that enhance the in vitro culture of hESCs could be 
identified.  The development of a defined matrix for hESC growth is currently limited by 
our understanding of the ECM proteins that regulate hESC attachment and proliferation.  
Although it has been the subject of a number of studies, there is still a lack of 
understanding of how ESCs interact with the surrounding ECM in vitro and in vivo [39-
45].  Proteomic analysis of supportive matrices could help elucidate components that 
promote hESC growth, analogous to the characterization of conditioned medium from 
supportive fibroblast feeder layers for the identification of soluble regulatory cytokines 
[46-50].   
A major obstacle that examination of these matrices presents is the significant 
challenge in proteomic analysis due to the complex nature of the samples.  ECM 
mixtures typically consist of large amounts of high molecular weight protein and a 
variety of low abundance species.  Identification of these low abundance proteins can 
only be obtained by extensive fractionation prior to liquid chromatography (LC) mass 
spectrometry (MS) analysis [51, 52].  The two most common methods used in 
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proteomics are fractionation with one dimensional SDS-PAGE at the protein level or, 
after digestion with trypsin, by ion exchange chromatography at the peptide level.  
These fractionation steps are typically followed by further separation on a reversed-
phase column prior to MS  analysis [53].  It has recently been shown that some 
fractionation protocols prior to LC-MS are in fact complementary [46, 54].   
In this chapter we utilize a combination of fractionation and digestion protocols for the 
analysis of complex ECM samples to attempt to identify hESC supportive proteins.  We 
show that Matrigel™ contains an array of proteins in addition to those known to be 
directly involved in the structural basis of the basement matrix.  This is accomplished by 
utilizing an in-depth proteomic approach that employs ammonium sulfate precipitation 
and a dynamic iterative exclusion MS (IE-MS) strategy to detect low abundance 
components [46].  Using a combination of strong anion and cation exchange as well as 
SDS-PAGE methods [46, 55], we analyze CellStart, StemXVivo, BridgeECM, and 
HumanBME, four previously uncharacterized ECM matrices.  We also analyze a matrix 
deposited by irradiated mouse embryonic feeder layers (MEF-CMTX) after maintenance 
on gelatin for 7 days.  After MEF lysis, the remaining matrix has been shown to promote 
the undifferentiated growth of pluripotent hESCs [56].  By comparing the proteins 
identified from these samples, we identify fibronectin as a primary component of nearly 
all the matrix samples, suggesting its importance in the promotion of hESC 
maintenance and pluripotency.  To validate this observation, H9 and CA1 hESCs were 
cultured in mTeSR1 medium on fibronectin as the sole matrix component. 
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3.2 Results 
3.2.1 Fractionation of Matrigel.  Matrigel™ is known to be highly enriched in laminin, 
collagen, and enactin.  Previously published research that revealed the presence of 
multiple active growth factors in Matrigel™ was based upon detection using 
immunoassays that are not amenable to a more global analysis of protein composition 
[11].  Comprehensive analysis of Matrigel™ using MS-based proteomics could 
potentially reveal the presence of other growth factors and cytokines.  The main protein 
components of Matrigel™, laminin (800,000 Da), collagen IV (540,000 Da), and enactin 
(158,000 Da) are all significantly larger than the average size of most protein growth 
factors (<~45,000Da).  To facilitate identification of these low abundance factors, 
fractionation that depletes the abundant high molecular weight (MW) components of 
Matrigel™ is critical.   
Using size exclusion chromatography (SEC) to fractionate Matrigel™ samples, we were 
unable to obtain effective separation.  We observed a large peak early due to the more 
rapid elution of large proteins from both the standard (N-GFR) and GFR Matrigel™.  
SEC runs were repeated for 3 technical replicates and typically resulted in ~15 fractions 
dependent on the elution profile of the sample.  Analysis of each SEC fraction with one 
dimensional SDS-PAGE (1D-SDS-Gel) resulted in gels with very poor resolution, and 
showed minute amounts of low molecular weight proteins, as determined by Coomassie 
blue staining.  Nevertheless fractions resulting from SEC runs were digested in-solution 
with trypsin prior to analysis by LC-MS.   
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Due to the limited separation and loading capacity provided by 1D-SDS-Gels, and the 
poor resolution of SEC, we adapted a two step ammonium sulfate (AS) precipitation 
protocol to fractionate both N-GFR and GFR Matrigel™ (Figure 3.1).  AS precipitation is 
not commonly used in proteomics, but has been used for the depletion of N-GFR 
Matrigel™ to generate the GFR variety [11].  The two step procedure utilized here 
precipitates protein from Matrigel™ at 15% and 90% AS (w/v).  Treatment of Matrigel™ 
with 15% AS gave a precipitate that was further fractionated by SEC prior to in-solution 
trypsin digestion.  The supernatants from the 15% AS step were further adjusted to 90% 
AS. The resulting pellets were reconstituted in 8M urea and separated on a 1D-SDS-
Gel.  These gels contained visible amounts of low molecular weight proteins after 
staining that were then digested with trypsin and subjected to IE-MS analysis.   
3.2.2 LC-MS Analysis of Fractionated Matrigel.  LC-MS analysis of the SEC fractions 
from N-GFR Matrigel™ resulted in identification of 1117 unique peptides.  The same 
analysis on GFR Matrigel™ SEC fractions resulted in the identification of 1521 unique 
peptides (Figure 3.2 C).  The overlap between the two datasets indicates (~20% 
common) significant differences between the two types of Matrigel™ based on unique 
peptide identifications.  LC-MS analysis of the pellets from 90% AS precipitation after 
1D-SDS-Gel fractionation resulted in the identification of 5465 unique peptides for N-
GFR and 5080 from GFR (Figure 3.2 C).  Combination of SEC and AS precipitation 
datasets resulted in an increase in the total number of unique peptide identifications to 
5910 for N-GFR and 5604 for GFR Matrigel™.  Of these peptides, only 457 were 
matched to laminin/enactin from N-GFR Matrigel™, and 681 from GFR.   
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Figure 3.1.  Schematic of experimental preparation of N-GFR and GFR Matrigel 
samples for proteomic analysis.  Aliquots of Matrigel were subject to fractionation 
with SEC without prior precipitation using AS methods.  The pellets of Matrigel aliquots 
that were precipitated with 15% AS were also subjected to SEC fractionation prior to in-
solution digestion with trypsin and LC-MS analysis.  The retained supernatent from 15% 
AS precipitation was further adjusted to 90% AS.  Following centrifugation, the re-
solubilized pellet was subject to in-solution digestion with trypsin or further fractionation 
using a 1D-SDS-Gel.  All samples were analyzed using a combination of LC-MS and IE-
MS approaches to maximize the depth of sample coverage. 
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Even with utilization of SEC and AS precipitation coupled with 1D-SDS-Gels, there was 
still a considerable dynamic range in each fraction to address.   To address this, we 
employed IE analysis to facilitate identification of low-abundance peptide species in the 
MS as demonstrated previously [11].  IE-MS analysis of the SEC fractions resulted in an 
increase in the number of unique peptides identified in N-GFR and GFR Matrigel™ to 
2588 and 3781 respectively after 4 exclusion rounds (Figure 3.2 B).  Six rounds of IE-
MS analysis of the fractions resulting from 1D-SDS-Gel separation of the reconstituted 
pellets from 90% AS precipitation resulted in an increase in unique peptides identified to 
11955 and 10368 for N-GFR and GFR Matrigel™ respectively (Figure 3.2 B).  
Combination of the IE-MS datasets from the SEC and AS methods resulted in an 
increase in the total number of unique peptides identified to 13016 in N-GFR Matrigel™, 
corresponding to 1180 proteins (Appendix Table 1.1 – 1.2).  Combination of the data for 
GFR Matrigel™ increased the total number of identifications to 12033 for peptides and 
1007 for proteins.  These values represent an approximate 2-fold increase in the 
number of proteins identified through the use of IE-MS with samples from all 
fractionation types (Figure 3.2 A).  
Through the combination of the data from N-GFR and GFR Matrigel™, we can generate 
a comprehensive dataset.  Combination of the SEC datasets from N-GFR and GFR 
Matrigel™ resulted in the identification 5288 peptides and 452 unique proteins (Figure 
3.2 C).  Combination of the AS precipitation data resulted in 16995 peptide and 1343 
protein identifications (Figure 3.2 C).  Of the peptide hits, 748 were assigned to 
laminin/enactin for samples from SEC fractionation and 1046 for the samples from AS 
precipitation.  These results illustrate the utility of the AS precipitation protocol for the  
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Figure 3.2. Iterative exclusion analysis of Matrigel samples.  Samples of N-GFR 
and GFR Matrigel were fractionated using either SEC or AS precipitation coupled with 
1D-SDS-Gel methods prior to IE-MS analysis.  All LC-MS data files were searched 
using PEAKS 5.3 software as described in the Methods.  (A) Total numbers of unique 
peptides identified in each round of IE-MS analysis. The number of peptide hits is given 
above each set of exclusion bars in the format protein# (peptide#) with N-GFR values in 
normal font and GFR in italics.  Values represent total identifications following the 
combination of SEC and AS datasets.  (B)  Relative number of laminin/enactin peptides 
to the total number of identifications as assigned by PEAKS 5.3 across 6 exclusion 
rounds.  As before, total numbers are found above with GFR in italics.  (C) Lists the total 
numbers of peptide identifications found using conventional LC-MS analysis compared 
with IE-MS for SEC or AS fractionation of N-GFR and GFR Matrigel.  LC-MS represents 
a single injection for each sample, whereas IE-MS represents multiple injections with 
exclusion lists applied during data acquisition. 
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depletion of high-MW components in comparison with SEC in order to facilitate the 
identification of other proteins in Matrigel™.  Combining the data from all Matrigel™ 
batches and fractionation protocols, we identified a total of 19063 unique peptides and 
1466 unique proteins from 280 LC-MS datafiles (Figure 3.3).  Gene ontology analysis of 
the N-GFR and GFR Matrigel™ datasets revealed the presence of numerous 
intracellular proteins in both formulations (Figure 3.3).  Taken together, these data 
indicate the significant complexity at the protein level for both N-GFR and GFR 
Matrigel™.   
3.2.3 Comparative Analysis of N-GFR and GFR Matrigel.  GFR is a variant of N-GFR 
Matrigel™ that has decreased levels of the growth factors and other low molecular 
weight proteins [11]. This is achieved using an AS precipitation protocol which we have 
adapted to facilitate analysis of all Matrigel™ samples tested in this study (Figure 3.4 
A).  Comparison of N-GFR and GFR Matrigel™ revealed that there are at least 721 
proteins in common between the two preparations (Figure 3.4 B).  N-GFR and GFR 
Matrigel™ yielded an additional 459 and 286 protein identifications specific to each 
dataset.  Primary structural proteins common between the two types of Matrigel™ such 
as laminin, nidogen, and fibronectin were more abundant in GFR based on unique 
peptide number.  In N-GFR proteins secondary to the main structural components of 
Matrigel™, such as SPARC and transferrin were more abundant.  Interestingly, a 
variety of growth factors and their associated pathway members were identified in N-
GFR that were not in GFR Matrigel™ (Figure 3.4 C).   
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Figure 3.3. Comprehensive proteomics dataset from the analysis of N-GFR and 
GFR Matrigel.  The number in the green circle on the left represents the total number of 
protein identifications obtained following the analysis of the combined N-GFR and GFR 
Matrigel datasets.  Identifications were made using PEAKS 5.3 software.  Protein 
identifiers from the list of N-GFR and GFR proteins were mapped to Gene Ontology 
terms using STRAP software.  The three graphs represent Biological Process, Cellular 
Component, and Molecular Function ontology groupings.  The number of mapped 
annotations for each term for N-GFR can be found in red and for GFR in blue.  The wide 
range of terms that the identifiers mapped to indicates the complexity and range of 
cellular localizations present for the proteins found in either variety of Matrigel.
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Figure 3.4. Comparative analysis of N-GFR and GFR Matrigel.  (A) Representative 
lanes from N-GFR and GFR Matrigel samples that were subject to electrophoresis on 
1D-SDS gels.  Lane A is neat Matrigel directly as it comes from the manufacturer.  Lane 
B is the pellet that remains after precipitation using a solution of 15% ammonium sulfate 
precipitation.  Lane C is the supernatent after precipitation with 90% ammonium sulfate.  
Following AS precipitation, a significant increase in protein staining can be seen in the 
low-MW range in 1D-SDS-Gels of N-GFR and GFR Matrigel samples.  (B) Venn 
diagram illustrating the number of protein and peptide identifications for N-GFR (blue) 
and GFR (red) Matrigel.  Numbers represent total numbers of identifications from data 
generated by employing IE-MS analysis of Matrigel samples prepared using SEC and 
AS precipitation fractionation protocols.   Data files were analyzed using PEAKS 5.3 
software as discussed in the Methods.  (C) Table of growth factor and associated 
binding proteins found in N-GFR or GFR Matrigel.  Values in the N-GFR and GFR 
columns represent the number of unique peptide identifications in each matrix as 
determined by PEAKS 5.3 software.  If the protein was not found, it is denoted by “N/A”. 
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3.2.4 Fractionation of Alternative hESC Supportive Matrices.  Adaptation of the AS 
protocol to the analysis of the HumanBME proved straightforward due to the similar 
protein abundance profile it shares with Matrigel™.  Fractionation of CellStart with the 
AS protocol proved difficult due to the increased abundance of high-MW protein in this 
matrix compared with Matrigel™.  Due to the limited amount of material we could obtain 
for MEF-CMTX, BridgeECM, and StemXVivo matrices, we were unable to apply the AS 
protocol.  The limited utility of the AS protocol for the analysis of these matrices 
highlights the primary shortcoming of this method: the requirement for a large amount of 
sample due to the high potential for protein loss during the procedure.   
In order to overcome the dynamic range of abundance and detect low abundance 
proteins in these new matrices, we employed a combination of conventional proteomic 
fractionation and digestion techniques.  By utilizing an in-solution digestion protocol 
coupled to fractionation on strong cation and anion exchange chromatography columns, 
we could overcome loading constraints caused by lane bleeding on 1D-SDS-Gels to 
facilitate detection of low-abundance proteins.  However, 1D-SDS-Gel fractionation 
proved applicable to HumanBME, StemXVivo, BridgeECM, and MEF-CMTX, but could 
not be used for the CellStart matrix due to lane bleeding problems caused by the large 
abundance of high-MW proteins.     
Optimization of the fractionation methods on a HeLa whole cell lysate revealed that 
numerous peptide identifications were isolated to a single method (Figure 3.5).  We also 
observed that the number of unique peptides identified could be increased by employing 
IE-MS analysis as described previously [46].  Comparison of the peptides identified for  
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Figure 3.5. Comparison of methods used to fractionate a complex HeLa cell 
lysate.  Following enzymatic digestion using trypsin with an in-solution protocol, 
samples were fractionated using SCX or SAX with a pH gradient elution.  Alternatively, 
cell lysate was separated using a 1D-SDS-Gel and subsequently digested using trypsin 
with an in-gel protocol.  Samples were analyzed by MS with (Single Exclusion Round) 
or without (No Exclusion) IE-MS.  Numbers represent the number of unique peptides 
identified in the combined fractions for each sample following analysis in PEAKS 5.3 
software.  Score thresholds were set to ensure an FDR<1% in all datasets. 
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the three primary fractionation methods tested (SDS-PAGE, SCX, and SAX), revealed 
that there was only a 2.0% overlap prior to iterative exclusion, and 2.6% after IE-MS 
analysis (Figure 3.5).  This indicates that the differences in identifications are a result of 
the fractionation methods, as IE analysis will limit changes due to under-sampling of 
ions in the MS.  These results prompted us to employ a combination of in-solution 
digestion followed by SCX, SAX, or SDS-PAGE fractionation and analysis using IE-MS.   
3.2.5 Analysis of Alternative hESC Supportive Matrices.  Using SAX and SCX 
fractionation with pH elution, a total of 70 proteins were identified in the CellStart matrix 
(Figure 3.6, Appendix Table 1.3).  From these LC-MS analyses, the two most abundant 
proteins were fibronectin and serum albumin, representing >60% of all unique peptide 
identifications.  These two high abundance proteins were likely the cause of the 
difficulties in the 1D-SDS-Gel method, where increasing the gel load resulted in their 
overloading.  The other proteins identified represented a mix of intra and extracellular 
proteins, the majority of which were identified in Matrigel™.   
Fractionation of HumanBME with SAX, SCX, and SDS-PAGE methods yielded 208 
protein identifications (Figure 3.6, Appendix Table 1.4).  From the analysis we observed 
that HumanBME is primarily composed of fibronectin, nidogen-1, and alpha-2, gamma-
1, and beta-2 laminin isoforms based on the number of unique peptides identified.  
Other proteins identified included vitronectin, biglycan, insulin-like growth factor – 2, 
transforming growth factor beta 2, and growth receptor bound protein 2 (Grb2).  
Comparing the composition of HumanBME with that of Matrigel™ based on protein 
identifiers indicates a significant similarity between the two matrices.  Although the  
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Figure 3.6. Comparison of the most abundant components of the ECM samples 
tested.  Each sample was fractionated using either SCX or SAX chromatography, or 
1D-SDS-Gel separation.  Fractions were analyzed using IE-MS for a single exclusion 
round.  Numbers in each circle represent the total number of protein identifications for 
the labeled matrix following the combination of data from all fractionation methods.  
Protein lists for CellStart, Human BME, StemXVivo, BridgeECM, and MEF-CMTX were 
generated and compared using PEAKS 5.3 software.  Identification numbers include 
proteins that were matched with 2 unique peptides and had scores above the 1% FDR 
threshold. Six proteins commonly found at high abundances across the ECM samples 
are listed in the lower table.  Of the proteins identified, fibronectin was an abundant 
component of 5 of the 6 matrices. 
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HumanBME dataset appears less complex based the total number of proteins identified 
when compared with Matrigel™, only a single exclusion round of IE-MS for was 
performed for the analysis.   
Fractionation of StemXVivo with SCX, SAX, and SDS-PAGE methods resulted in a total 
of 67 unique proteins (Figure 3.6, Appendix Table 1.5).  StemXVivo is primarily 
composed of nidogen-1 and vitronectin.  These two proteins comprised >50% of the 
total unique peptides identified from analysis of StemXVivo.  In addition to the primary 
components identified, a variety of other intra and extracellular proteins were also 
found, such as syndecan-2, multiple isoforms of actin, and pigment epithelium derived 
factor (PEDF).  A search of unidentified spectra from the StemXVivo dataset against the 
entire UniProt database (not species restricted, Appendix Table 1.6) yielded numerous 
non-human peptides, such as 24 for bovine albumin.  StemXVivo is marketed as a 
mixture of recombinant proteins, so the presence of non-human proteins is somewhat 
surprising.        
After fractionation of the MEF-CMTX layer with SAX, SCX, and SDS-PAGE, a total of 
460 proteins were identified (Figure 3.6, Appendix Table 1.7).  As this matrix is 
generated through the lysis of mouse feeder cells, the increase in complexity as 
indicated by the number of proteins identified is not surprising.  However, the primary 
constituents, fibronectin and perlecan, are both classified as extracellular based on 
gene ontology.  The data for MEF-CMTX correlates well with a previous LC-MS analysis 
of a matrix generated through the lysis of human foreskin fibroblasts [30].  Although the 
analysis of matrix composition completed by Meng et al. was only to a minimal depth, 
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the majority of proteins identified in their matrices are present in MEF-CMTX based on 
comparison with our data.      
Fractionation of the BridgeECM matrix with SAX, SCX, and SDS-PAGE resulted in 25 
protein identifications (Figure 3.6, Appendix Table 1.8).  BridgeECM matrix is primarily 
composed of albumin, comprising 45 of the total 142 identified unique peptides.  The 
matrix also contained the fibronectin, retinol-binding protein 4, plasminogen activator 
inhibitor 1, and SPARC.  Gene ontology analysis of the proteins found in BridgeECM 
and the other cell-derived ECMs indicates the presence of a range of cellular 
localization assignments, and a variety of non-ECM proteins (Figure 3.7).    
3.2.6 hESC Growth on a Defined Fibronectin Surface.  Of the ECM samples analyzed, 
CellStart, BridgeECM, and StemXVivo are marketed as products for the maintenance of 
hESCs [35, 56].  CellStart and BridgeECM are sold as humanized growth matrices, and 
StemXVivo as a defined recombinant protein mixture for hESC growth.  We were able 
to maintain H9 hESCs that retained expression of Oct4 and Nanog on CellStart, 
StemXVivo, and MEF-CMTX matrices using mTeSR1 medium for a maximum of 5 
passages (Figure 3.8 A).  We were, however, unable to maintain H9 hESCs on 
BridgeECM or HumanBME matrices for >1 passage using mTeSR1.  Despite the limited 
ability of these matrices to promote hESC growth with mTeSR1, we decided to 
investigate the viability of a defined matrix based upon the abundant components 
identified in the matrices analyzed.   
Upon comparative examination of the matrix datasets, we observed that fibronectin is a 
primary component of the all of the cell-derived matrices (Figure 3.6).  Based on  
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Figure 3.7. Gene ontology analysis of the cell-derived matrices tested.  Analysis 
was done using Scaffold 3.0 software to search protein identifiers against the NCBI 
Entrez Gene knowledgebase.  Protein identifiers were generated using IE-MS analysis 
of fractionated matrices.  With the exception of BridgeECM, all of the matrices tested 
share similar cellular component profiles with Matrigel (Figure 3.3) and are composed of 
numerous intracellular proteins.  Complete protein identification datasets can be found 
in the Appendix. 
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previous evidence that hESCs can be maintained on a combination of collagen IV, 
laminin, fibronectin, and vitronectin with TeSR1 [17] or on fibronectin alone with defined 
medium [18, 37], we evaluated a defined system that utilized a combination of 
fibronectin and mTeSR1.  After 10 and 5 passages on fibronectin coated plates, H9 and 
CA1 hESCs retained typical colony morphology and strong staining for both Oct4 and 
SSEA-4 markers (Figure 3.8 C-D).  For CA1 hESCs, cell growth was not as robust on 
fibronectin as with H9’s, making it difficult to retain a stable culture free of differentiation 
and amenable to expansion.  On other matrices, as well as fibronectin, H9 hESCs 
retained high levels of Oct4 and Nanog transcript as evidenced by RT-PCR data when 
compared with hESCs grown on Matrigel™ (Figure 3.8 A).  Embryoid bodies generated 
from H9 cells displayed strong signal for markers of endoderm, ectoderm, and 
mesoderm lineages in comparison to undifferentiated hESCs grown on fibronectin 
(Figure 3.8 B).  Taken together, these results indicate the ability of fibronectin to sustain 
H9 hESC self-renewal and pluripotency in vitro. 
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Figure 3.8. hESC growth characteristics on fibronectin.  H9 and CA1 hESCs were 
grown on fibronectin for a period of 10 or 5 passages and analyzed for markers of an 
undifferentiated phenotype.  (A) Shows fold change values for Oct4 and Nanog 
expression in H9 hESCs relative to those grown on Matrigel™ based on RT-PCR 
analysis.  (B) RT-PCR data for embryoid body markers and the pluripotency marker 
Oct3/4.  Values are shown as fold change for embryoid bodies relative to 
undifferentiated hESCs grown on fibronectin using GAPDH as a control.  In both (A) and 
(B), error bars represent SD, n=3.  (C) Phase contrast image illustrating colony 
morphology during growth on fibronectin coated plates for H9 hESCs.  White arrows 
indicate areas for point of reference to observe undifferentiated cells. (D) Shows 
immunofluorescence pictures from H9 and CA1 hESCs grown on fibronectin coated 
plates for 10 or 5 passages respectively.  Immunofluorescence was done directly in 24-
well fibronectin coated dishes for the markers Oct3/4 and SSEA-4.  Scale bars 
represent 0.2mm on all images. 
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3.3 Discussion 
An often overlooked aspect in stem cell culture systems is the composition of the ECM.  
The primary matrix currently in use continues to be Matrigel™ in the absence of an 
acceptable alternative that is supportive of a wide range of hESC lines and media 
formulations.  Exactly how Matrigel™ helps stem cells remain in an undifferentiated 
state remains poorly understood.  With the rising demand for xeno-free hESC products, 
the development of a suitable defined growth matrix is of paramount importance.  A 
contributing factor to the recent developments of defined culture media for hESC growth 
were data yielded from the analyses of conditioned medium from supportive feeder-cell 
layers [46-48, 50, 57].  Analogous to the analysis of conditioned medium, 
characterization of the components of cell-derived matrices could potentially aid in the 
development of defined surfaces for hESC culture.  However, proteomic analysis of 
complex ECM mixtures is difficult due to the abundance profiles of the common 
constituents.  Here, we demonstrate the development and optimization of methods for 
the fractionation and analysis of complex ECM mixtures to aid in the identification of 
hESC supportive matrix components.   
In the analysis of Matrigel™, SEC fractionation proved to be of limited utility, even when 
used in combination with IE-MS.  A significant number of the unique peptides identified 
were assigned to laminin/enactin, the primary components of Matrigel™.  AS 
precipitation in combination with 1D-SDS-Gel fractionation facilitated the identification of 
a large number of peptides outside of those belonging to laminin and enactin.  Gene 
ontology analysis of the Matrigel™ dataset indicates the presence of numerous cellular 
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proteins that were either cytoplasmic or nuclear in origin.  This implies that although 
structurally important proteins such as laminin constitute the bulk of what is being 
extracted from the EHS sarcoma cells, there are also numerous intracellular proteins 
present.  Depletion of low molecular weight components using AS precipitation to create 
GFR Matrigel™ results in the enrichment of laminin/enactin peptides in comparison to 
N-GFR.  However, the lack of specificity for this method means that numerous other 
matrix components are lost, as shown through analysis of the supernatant obtained 
after 15% AS precipitation.  This lack of reproducibility combined with limitations in the 
MS approach due to dynamic range constraints likely contributed to the identification of 
proteins apparently unique to GFR Matrigel™.  As GFR is derived from N-GFR 
Matrigel™, the identification of proteins unique to GFR Matrigel™ is unexpected.  
Further proteomic analysis of Matrigel™ using the SAX and SCX methods utilized on 
the other matrices tested would potentially reconcile these differences by obtaining 
greater depth of coverage.  However, differences between N-GFR and GFR are 
potentially derived from batch-to-batch variability of Matrigel™ that cannot be addressed 
in the proteomics approach.     
As noted above, Matrigel™ was previously reported to contain specific growth factors 
[11].  With the optimized proteomics protocol used here we identified several growth 
and transcription factors such as Grb2 and connective tissue growth factor (CTGF).  
However, the growth and transcription factors represent only a small fraction of the 
proteins identified in the analysis of the matrix.  We identified numerous proteins directly 
related to binding and signaling of growth factors.   Other ECM proteins identified in this 
study, fibronectin [58], collagen type IV [59], follistatin [60], and thrombospondin [61], 
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have been proposed to interact with members TGF-β superfamily.  The presumed 
functions of these interactions are to enhance activity and stability of these cytokines in 
culture.  Examples of these ECM interactions have been found to be involved in a 
variety of pathways, such as fibronectin and vitronectin binding to hepatocyte growth 
factor receptors leading to enhanced cell migration [62].  Fibronectin type-III domains 
have also been shown to be involved with vascular endothelial growth factor (VEGF) 
signaling [63].  Similar interactions have also been demonstrated for a variety of other 
growth factors [64-67]. 
The in-depth proteomic analysis of Matrigel™ presented in this study reveals a complex 
and intricate mixture consisting of numerous structural, growth factors and their binding 
partners, as well as several other proteins of roles that are not clear in cell culture.  We 
speculate that many of these of proteins play a role in the self-renewal of stem cells 
when cultured in the presence of Matrigel™.  Our analysis of Matrigel™ revealed that it 
was primarily composed of laminin, collagen, enactin, and fibronectin.  Of these, 
laminin, nidogen-1, and different collagen isoforms have all been shown to be beneficial 
for hESC maintenance [17, 23, 24, 68-71].  It is perhaps not surprising then that 
Matrigel™ is the gold standard for the maintenance of a wide array of hESC lines, as it 
contains most of the proteins shown to promote hESC growth when used individually.  
However, as a result of the significant depth of coverage we were able to obtain with the 
use of AS-IE-MS methods, this study also suggests that it will be challenging to replace 
Matrigel™ in a variety of cell culture and experimental assays due to its complexity. 
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To complement the Matrigel™ data and facilitate the identification of hESC supportive 
proteins, we sought to compare matrix components from a variety of cell-culture 
matrices.  Employing a combination of SCX, SAX, and 1D-SDS-Gel approaches, we 
analyzed other cell-derived and commercial matrices used in hESC culture.  Upon 
inspection of CellStart, StemXVivo, BridgeECM, HumanBME, MEF-CMTX, and 
Matrigel™ proteomic data, the complexity of these protein mixtures becomes apparent.  
Based on the number of proteins identified StemXVivo, BridgeECM, and CellStart are 
more defined matrices in comparison with HumanBME, MEF-CMTX, and Matrigel™.  
However, based on the proteomics data presented here, none of these matrices are 
fully defined.  Although CellStart and StemXVivo are marketed as such, the number of 
proteins found indicates they are not as well defined as suggested by the 
manufacturers.   
With the exception of StemXVivo, fibronectin was found to be highly abundant in all of 
the matrices analyzed.  StemXVivo is manufactured as a recombinant protein mixture, 
and based on our analysis is primarily composed of vitronectin.  Vitronectin has 
previously been shown to sustain hESC pluripotency and survival [15, 19].  This is 
highlighted in our study by the ability of StemXVivo to promote the growth of H9 hESCs 
that retain expression of markers indicative of an undifferentiated state (Figure 3.7 A).  It 
has previously been shown that fibronectin and vitronectin both bind integrins that 
support hESC adhesion [15, 72].   Recent research into synthetic growth surfaces has 
revealed that integrin RGD and heparin binding peptides promote attachment and 
proliferation of hESCs [25-28, 73]. These studies suggest that integrin binding by the 
primary proteins present in ECM mixtures regulate attachment and proliferation.  
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Undifferentiated hESCs are known to express the fibronectin-specific integrin receptor 
α5β1 [18], thus supporting the observation of fibronectin as an effective growth matrix.  
However, it is likely that other proteins detected in these matrices are also of importance 
for the growth of a wide range of hESC lines, such as is the case with culture on 
Matrigel™ or MEFs.  This is highlighted by the identification of other proteins like serum 
albumin and PEDF in several of the matrices analyzed.  FBS, of which serum albumin is 
a primary component, has previously been used as a growth matrix for hESCs [74].  
Moreover, PEDF has recently been shown to be beneficial for the feeder-free 
maintenance of hESCs [75].    
Here, we have illustrated the utility of employing different and complementary 
fractionation methods for the analysis of complex ECM samples in order to elucidate 
factors essential for hESC survival.  Our proteomics analysis reveals the ubiquity of 
fibronectin in the majority of commonly available matrices.  It is noteworthy that none of 
the matrices tested, including fibronectin, were able to promote and maintain the growth 
of hESCs with the same efficiency and stability of Matrigel™ when using mTeSR1 
medium.  H9 and CA1 hESCs differentiated and proliferated poorly after 15 and 5 
passages on fibronectin respectively.  This indicates that while a defined matrix 
consisting of a sole component, such as fibronectin is suitable for hESC growth, long-
term maintenance and expansion requires a mixture of supportive components in the 
matrix, medium, or both.  Revealing these components through characterization of 
hESC supportive matrices is a valuable tool for elucidating factors that can have a 
positive effect on the maintenance of pluripotency. 
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3.4 Methods  
3.4.1 Cell culture and harvest – H9 (passage 26) and CA1 (passage 27) hESCs were 
maintained on hESC Qualified Geltrex (Invitrogen, Carlsbad, CA) before passage on to 
fibronectin coated plates (Millipore, Billerica, MA or BD Biosciences, Franklin Lake, NJ).  
H9 cells were obtained from WiCell (Wisconsin).  The CA1 hESC line used in all 
experiments was obtained from Dr. Cheryle Séguin of The University of Western 
Ontario [76, 77].  For all fibronectin experiments conventional 6 well dishes were used.  
Geltrex, StemXVivo, and BridgeECM were used according to the manufacturer’s 
instructions.  CellStart was used as a 25X solution instead of the manufacturer 
recommended 50X.  Cells were maintained in mTeSR1 medium (StemCell 
Technologies, Vancouver, Canada) on all matrices.  Cells were passaged mechanically 
to minimize variability from enzymatic methods.   
Embryoid bodies were generated using the RCCS-2SC 3D bioreactor (Synthecon, 
Houston, TX) with 2 x10 mL high aspect ratio vessels (HARV).  Briefly, ~2 x 106 hESCs 
were harvested from fibronectin coated plates.  The equivalent of ~1 x 106 hESCs were 
re-suspended in 8 mL of EB medium containing Knockout DMEM/F12, 20% KOSR 
(Invitrogen), 2 mM L-glutamine, 0.1 mM β-mercaptoethanol, and 1% non-essential 
amino acids.  The remaining 2 mL was added using syringes to ensure the removal of 
air bubbles from the vessels.  Vessels were left in a 37°C incubator with a rotation rate 
of 8 rpm.  Once EBs had formed (typically after 3-4 days), they were transferred to ultra-
low adherence cell culture dishes and grown for a period of 21 days.  Cells were then 
harvested and assayed by RT-PCR for the differentiation markers CDX2, alpha-feto 
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protein (AFP), GATA-6, GATA-4, Sox-1, PAX-6, T-brachyury, Vimentin, and Neurogenic 
differentiation 1 (NeuroD1) using TaqMan primer probe sets (Appendix Table 1.15).     
3.4.2 Extracellular matrix analysis – Human Cultrex basement membrane extract from 
Trevigen (Gaithersberg, MD), BridgeECM (GlobalStem, Rockville, MD), and CellStart 
matrix from Invitrogen (Carlsbad, CA) were assayed for protein content using a Bradford 
assay (data not shown).  StemXVivo (R&D Systems, Minneapolis, MN) and BridgeECM 
were concentrated from their stock solutions using 3 kDa centrifugal filters and 
reconstituted in 8M Urea and 100mM ammonium bicarbonate (ABC).  Lysed MEF 
matrix was generated by plating of 250,000 irradiated CF-1 cells in each well of a 6-well 
plate coated with 0.1% gelatin.  After 7 days the cells were lysed using a 20 mM NH4OH 
solution.  MEF-matrix layers were harvested using a solution of 8 M urea and 100 mM 
ABC.  All matrix samples were analyzed using in-solution digestion followed by 
fractionation on SCX and SAX columns with pH elution.  All samples were also 
fractionated with 1D-SDS-PAGE and prepared with an in-gel digestion as described 
earlier.  Each fractionation method was run using iterative exclusion as a single 
technical replicate for each matrix analyzed, for a total of 2 injections per sample.     
3.4.3 Matrigel Preparation -  Two separate lots of growth factor reduced Matrigel™ 
(A1105 & A3105, CAT# 356234, BD Biosciences, Mississauga, Canada), and one lot of 
standard Matrigel™ (A3873, CAT# 356230) were aliquoted into 100 µl fractions and 
stored at -80°C until use.  The stock solution of Matrigel™ is at a concentration of ~10 
mg/mL based on manufacturer specifications.  Protein concentration was assessed with 
the Bradford assay.  
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3.4.4 Reduced Matrigel by Precipitation - Individual aliquots of standard and GFR 
Matrigel™ were precipitated using a 15% AS solution as described previously [11].  
While the previous study employed a 20% AS solution, we found the 15% AS solution 
provided a precipitation that resulted in a greater removal of low molecular weight 
components as deduced from SDS gels analysis.  Aliquots were diluted 1:1 using a 
30% saturated AS solution to give a final concentration of 15%.  Mixtures were left at 
4°C for 60 minutes before centrifuging at 12000 g for 15 minutes.  The supernatant was 
drawn into a new tube and brought to 90% AS saturation to precipitate any remaining 
protein.  Solutions were centrifuged for 15 minutes at 12000g and the pellet was 
reconstituted in 100 mM NH4CO3.  The reconstituted pellet was then subjected to an in-
solution digestion with trypsin, or in-gel following 1D-SDS PAGE [46, 78].   
3.4.5 Size Exclusion Chromatrography – 500 µg equivalents of Matrigel™ (as 
determined by the Bradford assay), as well as pellets from the 15% AS precipitation 
were run through an off-line size exclusion system.  A BioSep-SEC-S2000 column 
(Phenomenex) fitted with a Security Guard pre-column (Phenomenex) with a phosphate 
buffer (BioShop Canada Inc.)(0.5 M, pH 7.0) mobile phase was used for separation.  
The sample was injected manually to an Agilent 1100 HPLC system (Agilent 
Technologies Inc.) system that provided flow (1 ml/min) as well as detection at 210 nm 
and 280 nm using a diode array detector.   
3.4.6 In-solution trypsin digestion – Matrix samples were reduced with 10 mM 
dithiothreitol (DTT) for 60 minutes.  Samples were then alkylated with 40 mM 
iodoacetamide (IAA) for 60 minutes.  The reactions were quenched through the addition 
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of DTT and left to incubate for another 60 minutes.  Samples were then diluted 1/6 in 50 
mM ABC.  Trypsin (Promega, Madison, WI) at a concentration of 1 µg enzyme to 25 µg 
of total protein was added to the mixtures and left to incubate for 24 hours at 37°C.  The 
next day, digests were acidified using neat trifluoroacetic acid and desalted on C18 
cartridges (CAT# 2001, Applied Separations, Lehigh Valley, PA).  After elution with 50% 
acetonitrile, samples were evaporated using a SpeedVac.  Prior to loading on an SCX 
column, dried samples were reconstituted in 0.5% formic acid at a pH of ~2.  Samples 
for SAX analysis were reconstituted in 0.5% NaOH at a pH of ~12.   
3.4.7 In-gel trypsin digestion – 40 μg of each matrix was diluted in Laemmli buffer.  After 
heating, matrix samples were loaded in each of two lanes on a 12% SDS-Gel.  The gel 
was stained with Coomassie blue and the gel lanes were divided into 12 fractions based 
on visual assessment of protein concentration.  Gel cubes in each fraction were 
destained using 20% acetonitrile (ACN) in 1M ABC.  Proteins were reduced using 10 
mM DTT for 60 minutes, followed by alkylation with 100 mM IAA for 60 minutes.  
Digestion was carried out using trypsin at a 1/25 ratio overnight in a 37°C water bath.  
Fractions were extracted the next day using 10% formic acid, sonication, and a final 
ACN step.  Each fraction was dried using a SpeedVac and reconstituted in 10% formic 
acid prior to injection on to the MS.   
3.4.8 Column preparation – Columns were packed in 360 O.D. x 200 I.D. capillaries 
(PolyMicro Technologies, Phoenix, AZ) using a conventional pressure bomb (Next 
Advance, Averill Park, NY).  Frits were prepared by mixing 75 µL of potassium silicate 
with 25 µL of formamide, vortexing for 1 minute and rapidly inserting and removing the 
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capillary end from the resulting mixture.  Capillary frits were dried and hardened in a 
100°C oven for 2 hours.  Capillaries were then rinsed with forward and reverse flow of 
methanol using the pressure bomb at 200 psi.  Prior to packing, capillaries were rinsed 
for 30 minutes with 0.5% formic acid for SCX and 0.5% NaOH for SAX columns.  
PolySULFOETHYL A SCX beads (5 µm, 300Å, CAT# PLBMSE0503) were purchased 
from PolyLC (Columbia, MD) and reconstituted in 10 mM citric acid.  SAX beads were 
purchased from Varian Inc. (10 µm, 1000Å, CAT# PL1451-2102, Palo Alto, CA) and 
reconstituted in 10 mM NH4OH.  SCX and SAX columns were packed to a length of ~3 
cm for all experiments.  All packing was done at a pressure of 200 psi until the desired 
column length was obtained, then pressurized to 1000 psi to complete packing.  Packed 
columns were rinsed with solvents for conditioning as recommended by the 
manufacturer. 
3.4.9 Peptide Fractionation – Peptides were fractionated with SCX and SAX columns 
using a CapLC system (Waters, Milford, MA) with a flow rate of 2 µL/min.  Mobile phase 
A was composed of 10mM citric acid at a pH of ~2.3, mobile phase B was pH 11.4 10 
mM NH4OH, and mobile phase C was 500 mM ammonium acetate.  Mobile phases 
were all prepared fresh prior to fractionation to ensure the stability of pH from run to run.  
Fractionation with pH was carried out using a 120 minute gradient from pH 2 to 12 for 
SCX, and 12 to 2 for SAX.  Salt fractionation was carried using the following steps:  
 0 mM, 7.5 mM, 15 mM, 30 mM, 45 mM, 60 mM, 75 mM, 90 mM, 105 mM, 120 mM, 150 
mM, 300 mM, 500 mM ammonium acetate over 120 minutes.  Each fraction was 
collected offline in a volume of 20 µL.  Fractions were dried using a SpeedVac, and 
reconstituted in 10% formic acid prior to injection on the MS.  
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3.4.10 MS Data Acquisition – Fractions were injected and separated using a 
nanoAcquity system (Waters, Milford, MA) equipped with a 25 cm x 75 µm I.D. C18 
column.  Fractions were separated using a 1 to 40% ACN gradient over 90 minutes at a 
flow rate of 300 nL/min.  MS analysis was done on a Q-ToF Ultima (Micromass/Waters) 
using data-dependent acquisition with selection of the four top precursor masses per 
survey scan.  Survey scans were set at 1s, and MS/MS acquisition set at 1s or 6000 
cps TIC cut-off.  Exclusion lists were generated using in-house software that 
automatically adds 0.7amu to the precursor masses selected in previous runs and 
outputs a file also containing retention time information.  Each fraction was analyzed for 
a single exclusion round (2 injections total), adjusting the injection volume dependent on 
signal intensity in the previous run.  In analyses of Matrigel™, each fraction was injected 
a total of 7 times (6 exclusion rounds).   
3.4.11 MS Data analysis – Data analysis for all matrices tested was performed in 
PEAKS 5.3 software (Bioinformatic Solutions Inc., Waterloo, Canada) [79, 80].  After 
import into PEAKS, MS/MS spectra from raw data files were refined using the following 
settings: merge spectra – true (100 ppm mass tolerance, 60 second retention time 
tolerance), correct precursor mass – true, determine precursor charge state – true 
(minimum charge +2, maximum charge +5), spectral quality filter – true (0.65 threshold), 
centroid, deisotope, and deconvolute – true.  Resulting MS/MS spectra were then de 
novo sequenced using the following parameters: parent monoisotopic mass tolerance – 
100ppm, fragment monoisotopic mass tolerance – 0.15 daltons, enzyme specificity – 
semi-Trypsin, fixed modifications – carbamidomethylation, variable modifications – N-
terminal acetylation and oxidized methionine.  After de novo analysis, data were 
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searched against the UniProt sequence database (Human taxonomy specified, 20236 
total entries or Mouse taxonomy specified, 16376 total entries) using the following 
parameters: parent monoisotopic mass tolerance – 100 ppm, fragment monoisotopic 
mass tolerance – 0.15 daltons, enzyme specificity – semi-Trypsin, fixed modifications – 
carbamidomethylation, variable modifications – N-terminal acetylation and oxidized 
methionine, estimate false-discovery rate – true.    
3.4.12 Protein identification – Resultant protein identification data from the database 
search were processed using PEAKS 5.3 software [81].  Identifications were filtered by 
assigned score to give a <1.0% false-discovery rate for peptide-spectral matches based 
on estimation from a decoy-fusion method of database search.  Identified proteins were 
also required to be matched by >2 unique peptides.  Proteins that contained similar 
peptides and could not be differentiated based on MS/MS analysis alone were grouped 
to satisfy the principles of parsimony.  For all matrices analyzed, keratin hits were 
manually removed from the final datasets.   
3.4.13 Real-time PCR – RNA was purified using Trizol reagent according to the 
manufacturer’s instructions (Invitrogen) or with the 5 Prime PerfectPure RNA Extraction 
Kit (5 Prime, Gaithersburg, MD).  After NanoDrop quantification, 1 µg of cDNA was 
synthesized using the High Capacity cDNA Reverse Transcription Kit with RNase 
inhibitor (Invitrogen).  Real-time PCR was performed using the TaqMan® Universal 
PCR Master Mix (Invitrogen).  Samples were incubated at 50°C for 2 minutes followed 
by 10 minutes at 95°C.  Samples were then amplified at 95°C for 15 seconds followed 
by 1 minute at 58°C for 46 cycles.  All samples were normalized to large ribosomal 
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protein RPLPO as a positive control.  All primers were obtained from Invitrogen and 
assay information can be found in Appendix Table 1.15.  Each biological replicate was 
run in triplicate for every marker assayed.  All reagents were used according to the 
manufacturer’s instructions.    
3.4.14 Immunofluorescence – Passage 10 H9 and 5 CA1 hESCs grown on fibronectin 
were plated in wells of a 24-well dish coated with the same matrix.  After 4 days of 
culture in mTeSR1 medium cells were rinsed and fixed with 4% para-formaldehyde 
containing 20 mM sucrose.  Prior to staining, cells were blocked using the Dako Serum 
Free Protein Block solution (Dako, Cambridgeshire, UK).  Oct-4 (clone 10H11.2), 
SSEA-4 (clone MC-813-70), and SSEA-1 (clone MC-480) primary antibodies were 
obtained from Millipore (Billerica, MA).  Cells for Oct-4 labeling were permeabilized 
using a 0.1% Triton X-100 solution prior to blocking.  Cells were labeled with primary 
antibodies for Oct-4 or SSEA-4 as undifferentiated markers and SSEA-1 for 
differentiated cells all at concentrations of 2 μg/mL for 60 minutes at room temperature.  
Secondary Alexa-fluor 488 goat anti-mouse IgG and Alexa-fluor 568 goat anti-mouse 
IgM were obtained from Invitrogen (Carlsbad, CA).  Secondary antibodies were probed 
at concentrations of 1 μg/mL for 60 minutes at room temperature.  All products were 
used according to manufacturer’s instructions.   
109 
 
3.4 References 
[1] Lin, C. Q., Bissell, M. J., Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 
1993, 7, 737-743. 
[2] Martin, G. R., Kleinman, H. K., Extracellular matrix proteins give new life to cell culture. Hepatology 
1981, 1, 264-266. 
[3] Kleinman, H. K., Graf, J., Iwamoto, Y., Kitten, G. T., Ogle, R. C., Sasaki, M., et al., Role of basement 
membranes in cell differentiation. Ann N Y Acad Sci 1987, 513, 134-145. 
[4] Kleinman, H. K., Klebe, R. J., Martin, G. R., Role of collagenous matrices in the adhesion and growth 
of cells. J Cell Biol 1981, 88, 473-485. 
[5] Erickson, A. C., Couchman, J. R., Still more complexity in mammalian basement membranes. J 
Histochem Cytochem 2000, 48, 1291-1306. 
[6] Sawada, N., Tomomura, A., Sattler, C. A., Sattler, G. L., Kleinman, H. K., Pitot, H. C., Extracellular 
matrix components influence DNA synthesis of rat hepatocytes in primary culture. Exp Cell Res 1986, 
167, 458-470. 
[7] Kleinman, H. K., Cannon, F. B., Laurie, G. W., Hassell, J. R., Aumailley, M., Terranova, V. P., et al., 
Biological activities of laminin. J Cell Biochem 1985, 27, 317-325. 
[8] Kleinman, H. K., Martin, G. R., Matrigel: basement membrane matrix with biological activity. Semin 
Cancer Biol 2005, 15, 378-386. 
[9] Kleinman, H. K., McGarvey, M. L., Liotta, L. A., Robey, P. G., Tryggvason, K., Martin, G. R., Isolation 
and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS 
sarcoma. Biochemistry 1982, 21, 6188-6193. 
[10] Orkin, R. W., Gehron, P., McGoodwin, E. B., Martin, G. R., Valentine, T., Swarm, R., A murine tumor 
producing a matrix of basement membrane. J Exp Med 1977, 145, 204-220. 
[11] Vukicevic, S., Kleinman, H. K., Luyten, F. P., Roberts, A. B., Roche, N. S., Reddi, A. H., Identification 
of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of 
cellular activity related to extracellular matrix components. Exp Cell Res 1992, 202, 1-8. 
[12] Lei, T., Jacob, S., Ajil-Zaraa, I., Dubuisson, J. B., Irion, O., Jaconi, M., et al., Xeno-free derivation and 
culture of human embryonic stem cells: current status, problems and challenges. Cell Research 2007, 17, 
682-688. 
[13] Skottman, H., Narkilahti, S., Hovatta, O., Challenges and approaches to the culture of pluripotent 
human embryonic stem cells. Regen Med 2007, 2, 265-273. 
[14] Gerecht, S., Burdick, J. A., Ferreira, L. S., Townsend, S. A., Langer, R., Vunjak-Novakovic, G., 
Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. 
Proc Natl Acad Sci U S A 2007, 104, 11298-11303. 
[15] Braam, S. R., Zeinstra, L., Litjens, S., Ward-van Oostwaard, D., van den Brink, S., van Laake, L., et 
al., Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell 
self-renewal via alpha V beta 5 integrin. Stem Cells 2008, 26, 2257-2265. 
[16] Hakala, H., Rajala, K., Ojala, M., Panula, S., Areva, S., Kellomaki, M., et al., Comparison of 
Biomaterials and Extracellular Matrices as a Culture Platform for Multiple, Independently Derived Human 
Embryonic Stem Cell Lines. Tissue Engineering Part A 2009, 15, 1775-1785. 
[17] Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., et al., 
Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006, 24, 185-187. 
[18] Amit, M., Shariki, C., Margulets, V., Itskovitz-Eldor, J., Feeder layer- and serum-free culture of human 
embryonic stem cells. Biology of Reproduction 2004, 70, 837-845. 
[19] Manton, K. J., Richards, S., Van Lonkhuyzen, D., Cormack, L., Leavesley, D., Upton, Z., A chimeric 
vitronectin: igf-I protein supports feeder-cell-free and serum-free culture of human embryonic stem cells. 
Stem Cells Dev 2010, 19, 1297-1305. 
[20] Mei, Y., Saha, K., Bogatyrev, S. R., Yang, J., Hook, A. L., Kalcioglu, Z. I., et al., Combinatorial 
development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater 2010, 9, 768-
778. 
[21] Klim, J. R., Li, L. Y., Wrighton, P. J., Piekarczyk, M. S., Kiessling, L. L., A defined glycosaminoglycan-
binding substratum for human pluripotent stem cells. Nature Methods 2010, 7, 989-U972. 
110 
 
[22] Harb, N., Archer, T. K., Sato, N., The Rho-Rock-Myosin Signaling Axis Determines Cell-Cell Integrity 
of Self-Renewing Pluripotent Stem Cells. Plos One 2008, 3, -. 
[23] Miyazaki, T., Futaki, S., Hasegawa, K., Kawasaki, M., Sanzen, N., Hayashi, M., et al., Recombinant 
human laminin isoforms can support the undifferentiated growth of human embryonic stem cells. 
Biochemical and Biophysical Research Communications 2008, 375, 27-32. 
[24] Vuoristo, S., Virtanen, I., Takkunen, M., Palgi, J., Kikkawa, Y., Rousselle, P., et al., Laminin isoforms 
in human embryonic stem cells: synthesis, receptor usage and growth support. Journal of Cellular and 
Molecular Medicine 2009, 13, 2622-2633. 
[25] Derda, R., Li, L., Orner, B. P., Lewis, R. L., Thomson, J. A., Kiessling, L. L., Defined substrates for 
human embryonic stem cell growth identified from surface arrays. ACS Chem Biol 2007, 2, 347-355. 
[26] Brafman, D. A., Chang, C. W., Fernandez, A., Willert, K., Varghese, S., Chien, S., Long-term human 
pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials 2010, 31, 9135-9144. 
[27] Kolhar, P., Kotamraju, V. R., Hikita, S. T., Clegg, D. O., Ruoslahti, E., Synthetic surfaces for human 
embryonic stem cell culture. J Biotechnol 2010, 146, 143-146. 
[28] Melkoumian, Z., Weber, J. L., Weber, D. M., Fadeev, A. G., Zhou, Y., Dolley-Sonneville, P., et al., 
Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human 
embryonic stem cells. Nat Biotechnol 2010, 28, 606-610. 
[29] Steiner, D., Khaner, H., Cohen, M., Even-Ram, S., Gil, Y., Itsykson, P., et al., Derivation, propagation 
and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnol 2010, 28, 
361-364. 
[30] Meng, G. L., Liu, S. Y., Li, X. Y., Krawetz, R., Rancourt, D. E., Extracellular Matrix Isolated From 
Foreskin Fibroblasts Supports Long-Term Xeno-Free Human Embryonic Stem Cell Culture. Stem Cells 
and Development 2010, 19, 547-556. 
[31] Amit, M., Margulets, V., Segev, H., Shariki, K., Laevsky, I., Coleman, R., et al., Human feeder layers 
for human embryonic stem cells. Biology of Reproduction 2003, 68, 2150-2156. 
[32] Chen, H. F., Chuang, C. Y., Shieh, Y. K., Chang, H. W., Ho, H. N., Kuo, H. C., Novel autogenic 
feeders derived from human embryonic stem cells (hESCs) support an undifferentiated status of hESCs 
in xeno-free culture conditions. Human Reproduction 2009, 24, 1114-1125. 
[33] Hovatta, O., Mikkola, M., Gertow, K., Stromberg, A. M., Inzunza, J., Hreinsson, J., et al., A culture 
system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem 
cells. Human Reproduction 2003, 18, 1404-1409. 
[34] Kibschull, M., Mileikovsky, M., Nagy, A., Lye, S. J., Human Embryonic Fibroblast Lines Provide 
Enhanced Support of Human Embryonic Stem Cells in Xeno-Free Culture Conditions. Reproductive 
Sciences 2009, 16, 282a-282a. 
[35] Swistowski, A., Peng, J., Han, Y., Swistowska, A. M., Rao, M. S., Zeng, X., Xeno-free defined 
conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons 
derived from them. Plos One 2009, 4, e6233. 
[36] Hakala, H., Rajala, K., Ojala, M., Panula, S., Areva, S., Kellomaki, M., et al., Comparison of 
Biomaterials and Extracellular Matrices as a Culture Platform for Multiple, Independently Derived Human 
Embryonic Stem Cell Lines. Tissue Eng Part A 2009. 
[37] Lu, J., Hou, R. H., Booth, C. J., Yang, S. H., Snyder, M., Defined culture conditions of human 
embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 
2006, 103, 5688-5693. 
[38] Mallon, B. S., Park, K. Y., Chen, K. G., Hamilton, R. S., McKay, R. D. G., Toward xeno-free culture of 
human embryonic stem cells. International Journal of Biochemistry & Cell Biology 2006, 38, 1063-1075. 
[39] Li, Q., Wang, J., Shahani, S., Sun, D. D., Sharma, B., Elisseeff, J. H., et al., Biodegradable and 
photocrosslinkable polyphosphoester hydrogel. Biomaterials 2006, 27, 1027-1034. 
[40] Chen, S. S., Fitzgerald, W., Zimmerberg, J., Kleinman, H. K., Margolis, L., Cell-cell and cell-
extracellular matrix interactions regulate embryonic stem cell differentiation. Stem Cells 2007, 25, 553-
561. 
[41] Philp, D., Chen, S. S., Fitzgerald, W., Orenstein, J., Margolis, L., Kleinman, H. K., Complex 
extracellular matrices promote tissue-specific stem cell differentiation. Stem Cells 2005, 23, 288-296. 
[42] McCloskey, K. E., Gilroy, M. E., Nerem, R. M., Use of embryonic stem cell-derived endothelial cells 
as a cell source to generate vessel structures in vitro. Tissue Engineering 2005, 11, 497-505. 
111 
 
[43] Kim, M. S., Hwang, N. S., Lee, J., Kim, T. K., Leong, K., Shamblott, M. J., et al., Musculoskeletal 
differentiation of cells derived from human embryonic germ cells. Stem Cells 2005, 23, 113-123. 
[44] Battista, S., Guarnieri, D., Borselli, C., Zeppetelli, S., Borzacchiello, A., Mayol, L., et al., The effect of 
matrix composition of 3D constructs on embryonic stem cell differentiation. Biomaterials 2005, 26, 6194-
6207. 
[45] Baxter, M. A., Camarasa, M. V., Bates, N., Small, F., Murray, P., Edgar, D., et al., Analysis of the 
distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal 
of human embryonic stem cell lines. Stem Cell Res 2009. 
[46] Bendall, S. C., Hughes, C., Campbell, J. L., Stewart, M. H., Pittock, P., Liu, S., et al., An Enhanced 
Mass Spectrometry Approach Reveals Human Embryonic Stem Cell Growth Factors in Culture. Molecular 
& Cellular Proteomics 2009, 8, 421-432. 
[47] Prowse, A. B. J., McQuade, L. R., Bryant, K. J., Marcal, H., Gray, P. P., Identification of potential 
pluripotency determinants for human embryonic stem cells following proteomic analysis of human and 
mouse fibroblast conditioned media. Journal of Proteome Research 2007, 6, 3796-3807. 
[48] Prowse, A. B. J., McQuade, L. R., Bryant, K. J., Van Dyk, D. D., Tuch, B. E., Gray, P. P., A proteome 
analysis of conditioned media from human neonatal fibroblasts used in the maintenance of human 
embryonic stem cells. Proteomics 2005, 5, 978-989. 
[49] Lim, J. W. E., Bodnar, A., Proteome analysis of conditioned medium from mouse embryonic fibroblast 
feeder layers which support the growth of human embryonic stem cells. Proteomics 2002, 2, 1187-1203. 
[50] Chin, A. C. P., Fong, W. J., Goh, L. T., Philp, R., Oh, S. K. W., Choo, A. B. H., Identification of 
proteins from feeder conditioned medium that support human embryonic stem cells. Journal of 
Biotechnology 2007, 130, 320-328. 
[51] Faca, V., Pitteri, S. J., Newcomb, L., Glukhova, V., Phanstiel, D., Krasnoselsky, A., et al., 
Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome 
Res 2007, 6, 3558-3565. 
[52] de Godoy, L. M., Olsen, J. V., de Souza, G. A., Li, G., Mortensen, P., Mann, M., Status of complete 
proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol 2006, 7, 
R50. 
[53] Washburn, M. P., Wolters, D., Yates, J. R., 3rd, Large-scale analysis of the yeast proteome by 
multidimensional protein identification technology. Nat Biotechnol 2001, 19, 242-247. 
[54] Fang, Y., Robinson, D. P., Foster, L. J., Quantitative analysis of proteome coverage and recovery 
rates for upstream fractionation methods in proteomics. J Proteome Res 2010, 9, 1902-1912. 
[55] Wang, N., Li, L., Exploring the precursor ion exclusion feature of liquid chromatography-electrospray 
ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun 
proteome analysis. Anal Chem 2008, 80, 4696-4710. 
[56] Klimanskaya, I., Chung, Y., Meisner, L., Johnson, J., West, M. D., Lanza, R., Human embryonic stem 
cells derived without feeder cells. Lancet 2005, 365, 1636-1641. 
[57] Bendall, S. C., Stewart, M. H., Menendez, P., George, D., Vijayaragavan, K., Werbowetski-Ogilvie, 
T., et al., IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in 
vitro. Nature 2007, 448, 1015-1021. 
[58] Fava, R. A., McClure, D. B., Fibronectin-associated transforming growth factor. J Cell Physiol 1987, 
131, 184-189. 
[59] Ruoslahti, E., Yamaguchi, Y., Hildebrand, A., Border, W. A., Extracellular matrix/growth factor 
interactions. Cold Spring Harb Symp Quant Biol 1992, 57, 309-315. 
[60] Nakamura, T., Sugino, K., Titani, K., Sugino, H., Follistatin, an activin-binding protein, associates with 
heparan sulfate chains of proteoglycans on follicular granulosa cells. J Biol Chem 1991, 266, 19432-
19437. 
[61] Murphy-Ullrich, J. E., Schultz-Cherry, S., Hook, M., Transforming growth factor-beta complexes with 
thrombospondin. Mol Biol Cell 1992, 3, 181-188. 
[62] Rahman, S., Patel, Y., Murray, J., Patel, K. V., Sumathipala, R., Sobel, M., et al., Novel hepatocyte 
growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified 
Met-integrin induced signalling pathway in endothelial cells. BMC Cell Biol 2005, 6, 8. 
[63] Wijelath, E. S., Rahman, S., Namekata, M., Murray, J., Nishimura, T., Mostafavi-Pour, Z., et al., 
Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain - Enhancement of 
112 
 
VEGF biological activity by a singular growth factor/matrix protein synergism. Circulation Research 2006, 
99, 853-860. 
[64] Golombick, T., Dajee, D., Bezwoda, W. R., Extracellular matrix interactions. 2: Extracellular matrix 
structure is important for growth factor localization and function. In Vitro Cell Dev Biol Anim 1995, 31, 
396-403. 
[65] Taipale, J., Keski-Oja, J., Growth factors in the extracellular matrix. FASEB J 1997, 11, 51-59. 
[66] Dinbergs, I. D., Brown, L., Edelman, E. R., Cellular response to transforming growth factor-beta1 and 
basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol 
Chem 1996, 271, 29822-29829. 
[67] Butzow, R., Fukushima, D., Twardzik, D. R., Ruoslahti, E., A 60-kD protein mediates the binding of 
transforming growth factor-beta to cell surface and extracellular matrix proteoglycans. J Cell Biol 1993, 
122, 721-727. 
[68] Evseenko, D., Schenke-Layland, K., Dravid, G., Zhu, Y. H., Hao, Q. L., Scholes, J., et al., 
Identification of the Critical Extracellular Matrix Proteins that Promote Human Embryonic Stem Cell 
Assembly. Stem Cells and Development 2009, 18, 919-927. 
[69] Li, Y., Powell, S., Brunette, E., Lebkowski, J., Mandalam, R., Expansion of human embryonic stem 
cells in defined serum-free medium devoid of animal-derived products. Biotechnology and Bioengineering 
2005, 91, 688-698. 
[70] Furue, M. K., Na, J., Jackson, J. P., Okamoto, T., Jones, M., Baker, D., et al., Heparin promotes the 
growth of human embryonic stem cells in a defined serum-free medium (vol 105, art no 13409, 2008). 
Proceedings of the National Academy of Sciences of the United States of America 2008, 105, 18071-
18071. 
[71] Draper, J. S., Moore, H. D., Ruban, L. N., Gokhale, P. J., Andrews, P. W., Culture and 
characterization of human embryonic stem cells. Stem Cells and Development 2004, 13, 325-336. 
[72] Baxter, M. A., Camarasa, M. V., Bates, N., Small, F., Murray, P., Edgar, D., et al., Analysis of the 
distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal 
of human embryonic stem cell lines. Stem Cell Research 2009, 3, 28-38. 
[73] Meng, Y., Eshghi, S., Li, Y. J., Schmidt, R., Schaffer, D. V., Healy, K. E., Characterization of integrin 
engagement during defined human embryonic stem cell culture. FASEB J 2010, 24, 1056-1065. 
[74] Vallier, L., Alexander, M., Pedersen, R. A., Activin/Nodal and FGF pathways cooperate to maintain 
pluripotency of human embryonic stem cells. J Cell Sci 2005, 118, 4495-4509. 
[75] Gonzalez, R., Jennings, L. L., Knuth, M., Orth, A. P., Klock, H. E., Ou, W., et al., Screening the 
mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency. Proc Natl 
Acad Sci U S A 2010, 107, 3552-3557. 
[76] Seguin, C. A., Draper, J. S., Nagy, A., Rossant, J., Establishment of endoderm progenitors by SOX 
transcription factor expression in human embryonic stem cells. Cell Stem Cell 2008, 3, 182-195. 
[77] Peerani, R., Rao, B. M., Bauwens, C., Yin, T., Wood, G. A., Nagy, A., et al., Niche-mediated control 
of human embryonic stem cell self-renewal and differentiation. EMBO J 2007, 26, 4744-4755. 
[78] Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V., Mann, M., In-gel digestion for mass 
spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1, 2856-2860. 
[79] Ma, B., Zhang, K. Z., Hendrie, C., Liang, C. Z., Li, M., Doherty-Kirby, A., et al., PEAKS: powerful 
software for peptide de novo sequencing by tandem mass spectrometry. Rapid Communications in Mass 
Spectrometry 2003, 17, 2337-2342. 
[80] Zhang, J., Xin, L., Shan, B., Chen, W., Xie, M., Yuen, D., et al., PEAKS DB: De Novo sequencing 
assisted database search for sensitive and accurate peptide identification. Mol Cell Proteomics. 
[81] Zhang, J., Xin, L., Shan, B., Chen, W., Xie, M., Yuen, D., et al., PEAKS DB: De Novo Sequencing 
Assisted Database Search for Sensitive and Accurate Peptide Identification. Mol Cell Proteomics 2012, 
11, M111 010587. 
 
 
112 
 
Chapter 4 
Proteomic Analysis of the Human Embryonic Stem Cell Depositome 
 
4.1 Introduction 
The ECM is a complex network of structural proteins and glycosaminoglycans that 
function to support cells through the regulation of processes such as adhesion and 
growth factor signaling [1].  It is not surprising that the generation of a well-defined 
matrix supportive of these processes in the complex hESC microenvironment has been 
difficult.  Although gelatin is sufficient for the maintenance of mESCs in the presence of 
specific growth factors, hESCs cannot be propagated in the same conditions.  Currently, 
in the absence of a suitable alternative, Matrigel™ remains the matrix of choice for 
hESC culture in vitro.  However, the complex nature of Matrigel™ has been 
demonstrated previously in this thesis (Chapter 3), and has been described by others 
who have revealed that it contains numerous growth factors and signaling proteins [2].  
Although recent studies have revealed that a variety of defined matrices support the 
growth of hESCs, few of these can maintain a wide array of stem cell lines and as such 
are typically not used in place of Matrigel™ [3].   The universality of Matrigel™ indicates 
that current defined matrices are lacking in critical components required to generate a 
supportive hESC microenvironment.   
This chapter contains excerpts from the following paper:  
Hughes, C.S., Radan, L., Stanford, W., Postovit, L.M., Lajoie, G.A.. (2012) “Proteomics 
Analysis of the Human Embryonic Stem Cell Depositome”. (In Preparation) 
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Because of the challenge proteomic examination of the ECM presents, the majority of 
studies that have analyzed the hESC microenvironment have focused on support cells 
and paracrine signaling pathways.  The desire to generate well-defined conditions for 
hESC culture in vitro has prompted these investigations into the factors critical for the 
maintenance of stem cells.  Proteomic studies have focused on the analysis of media 
conditioned by hESC supportive feeder cell layers to elucidate pathways important for 
maintaining the balance between self-renewal and differentiation [4-9].  These analyses 
were important contributors to our current knowledge of how hESCs are regulated in the 
extracellular space by pathways in the soluble portion of the microenvironment.  
However, there is still a lack of information of how the ECM modulates hESC behavior 
in vitro through interactions with both the cells themselves and the soluble cytokines 
present in the extracellular milieu.  
Given the common underlying plasticity of stem and cancer cells, recent studies have 
established the ability of embryonic microenvironments to alter the tumorigenic 
properties of cancer cells (reviewed in [10]).  Building on these findings, it was later 
observed that metastatic melanoma cells could be ‘reprogrammed’ to a more benign 
melanocyte phenotype following exposure to a matrix microenvironment generated from 
hESCs [11].  Importantly, this effect was found to be dependent on the exposure of 
metastatic cells to the conditioned matrix, and was not observed after treatment with 
hESC conditioned medium.  It was later found that the left-right determination (Lefty) 
proteins that were deposited in the matrix by hESCs were effectors of the cellular 
change observed in metastatic cells [12].  The Lefty proteins are antagonists of TGF-β 
signaling that act directly on Nodal protein.  Differences in the methylation status and 
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microRNA profiles for genes and pathways directly related to Lefty/Nodal signaling in 
metastatic cells on conditioned matrix have recently been observed [13].  Subsequent 
work with conditioned matrix utilizing mESCs implicated the bone morphogenic protein 
(BMP) 4 antagonist Gremlin as a primary regulator of the observed changes in 
metastatic cells [14].  Collectively, these studies were all biased by a targeted analysis 
of potential effectors of metastatic cells.  A comprehensive proteomic analysis of the 
matrix microenvironment could potentially reveal other factors involved in metastatic cell 
reprogramming.  Furthermore, proteomic analysis of the conditioned matrix could reveal 
factors important in the regulation of hESC and human induced pluripotent stem cell 
(hiPSC) pluripotency by the microenvironment in vitro.        
To this end, we have employed a mass spectrometry (MS)-based proteomics screen to 
identify proteins deposited by hESCs and hiPSCs grown on Matrigel™ in vitro.  To 
investigate the hESC-derived matrix, we utilize a metabolic labeling technique known as 
stable isotope labeling with amino acids in cell culture (SILAC) [15].  SILAC facilitates 
the identification of hESC-derived proteins in the presence of significant background 
protein complexity from Matrigel™.  Additionally, in order to minimize intracellular 
protein contamination in our analysis, we have developed methods that remove the 
requirement for cell lysis to generate CMTX.   From proteomic analysis of H9, CA1, and 
BJ-1D pluripotent stem cell lines, we identify a total of 621, 1355, and 1350 unique 
proteins respectively.  This work represents the first analysis of a stem cell conditioned 
matrix and resulted in the identification of at least one new microenvironmental 
contributor responsible for the regulation of hESCs and hiPSCs.  
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4.2 Results 
4.2.1 Proteomic Analysis of Pluripotent Stem Cell Derived CMTX.  To determine factors 
being deposited by hESCs during growth on Matrigel™, we employed a global MS-
based proteomics approach to screen CMTX.  Previous studies that have illustrated the 
effects of CMTX on metastatic cells have employed an NH4OH cellular lysis protocol to 
remove hESCs from Matrigel™.  Lysis of cells on the matrix could potentially confound 
our analysis by releasing high abundance intracellular proteins.  To limit the potential for 
intracellular protein contamination in the CMTX resulting from lysis, we developed a 
protocol based on Matrigel™ de-polymerization to remove intact cells from the matrix.  
With this method, the vast majority of the hESCs that were removed remained intact 
and viable as indicated by 7-AAD staining in flow cytometry (Figure 4.1 B).  Moreover, 
the removal of cell-lysis from the protocol permitted analysis of the undifferentiated state 
and differentiation capacity of the cells that deposited the matrix (Figure 4.1 A, C).    
After cell removal and concentration of the CMTX solution, a combination of strong 
cation and anion exchange (SCX, SAX), and 1D-Gel methods was employed for 
fractionation of the complex ECM-like mixture with iterative exclusion MS analysis as 
discussed previously (Chapter 3).  MS analysis of these samples illustrated the limited 
ability of our assay to determine hESC-derived proteins in our list of identifications 
(Figure 4.2 A – B).  This limitation is directly the result of performing the CMTX 
experiments on Matrigel™.  Since the mixture that gets analyzed by MS represents a 
mixture of hESC-derived and Matrigel™ proteins, identification specificity is reliant on 
non-homology between human and mouse proteins.  However, by searching the 
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Figure 4.1. Cell viability and pluripotency during generation and harvest of CMTX.  
H9 and CA1 hESCs as well as BJ-1D iPSCs were used to generate CMTX.  Following 
harvesting using our cell recovery method that eliminates cell lysis, remaining cells were 
assayed for viability and markers of pluripotency.  (A) RT-PCR analysis of harvested 
cells for the markers Oct3/4 and Nanog.  Values are relative to undifferentiated cells 
grown in feeder-free conditions not exposed to the CMTX harvesting methods.  Error 
bars represent SD, n=3.  (B) Flow cytometry analysis of cells harvested from CMTX.  
Cells were assayed for SSEA4 and SSEA1.  Viability was determining using 7-AAD 
staining.  (C) Cells harvested from CMTX were used to generate embryoid bodies.  
Following 14 days in culture, embryoid bodies were harvested and assayed for markers 
of pluripotency (Oct3/4, Nanog), trophoblast (CDX2), ectoderm (NeuroD1, PAX6), 
endoderm (GATA6, GATA4, alpha-fetoprotein), and mesoderm (T).  Error bars 
represent SD, n=2.  Values are fold change relative to undifferentiated cells.  Phase 
contrast images of embryoid bodies are provided above.  Scale bars represent 250um.  
In both (A) and (C), RPLPO is used as a positive control. 
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data set against a concatenated human and mouse sequence database, we observe 
that few proteins are identified as belonging to a single species (Figure 4.2 A - B).  
Many of the identified proteins have also been found in Matrigel™ in our previous 
proteomic analysis (Figure 4.2 A - B).  Taken together, these complications severely 
limit the specificity and sensitivity of the proteomic analysis.  To overcome these 
challenges, we employed a metabolic labeling approach known as SILAC that we have 
previously optimized for application in hESCs and hiPSCs (Chapter 2).  Using this 
approach, hESCs and hiPSCs would be fully labeled with ‘heavy’ arginine and lysine 
prior to being plated for CMTX generation (Figure 4.3).  In this approach, proteins that 
were deposited during CMTX generation will carry a heavy label and can be 
distinguished on the MS from Matrigel™ contaminants.     
With this protocol, we analyzed CMTX from H9 and CA1 hESCs, as well as BJ-1D 
hiPSCs.  MS analysis yielded a total of 621, 1355, and 1350 labeled proteins identified 
for H9, CA1, and BJ-1D cell lines respectively (Figure 4.4 A, Appendix Tables 1.9 - 
1.11).  Comparison of protein identifiers between the cell lines indicates a ~30% overlap 
between the three datasets (Figure 4.4 A).  The gain in the number of proteins in the 
CA1 and BJ-1D stem cell lines is due to their decreased stability in the StemPro SILAC 
medium.  We observed an increase in cell death and subsequent lysis during general 
growth of the CA1 and BJ-1D cell lines compared with H9 in StemPro SILAC medium 
resulting in the identification of additional intracellular proteins.  Gene ontology analysis 
revealed that in the dataset corresponding to each cell line there are proteins 
representative of several cellular components present.  This suggests that a variable 
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Figure 4.2. Proteomic analysis of unlabeled hESC derived CMTX.   H9 (A) and CA1 
(B) hESC CMTX generated using unlabeled cells was analyzed using an MS-based 
proteomics approach.  Data were searched simultaneously against a concatenated 
database containing all Mouse and Human protein sequences available in UniProt.  
Human vs. Matrigel represents the overlap between proteins identified as Human 
derived in CMTX by PEAKS 5.3 compared with those found in Matrigel (Chapter 3).  
Mouse vs. Matrigel represents the overlap between proteins identified as Mouse derived 
in CMTX by PEAKS 5.3 compared with those found in Matrigel.  Human vs. Mouse 
represents the overlap within the CMTX dataset between proteins specified as Human 
or Mouse derived by PEAKS 5.3.  To facilitate inter-species comparisons, protein 
descriptions were used in all cases.  Comparisons were done manually.  Overlapping 
identifications are denoted by a solid black box, and those that are unique by a grey 
box.  For both H9 and CA1 derived CMTX, n=1. 
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Figure 4.3. Proteomic analysis of CMTX from hESCs cultured in SILAC medium.   
H9 and CA1 hESCs, and BJ-1D iPSCs are grown in defined SILAC medium containing 
[13C6, 15N4] - arginine and [13C6, 15N2] - lysine optimized previously (Chapter 2).  After 
culture for a sufficient amount of time to obtain complete labeling, cells are passaged to 
culture dishes pre-coated with Matrigel.  After 4-5 days of culture on Matrigel in medium 
containing the heavy isotopic labels, cells are removed using a protocol that does not 
induce lysis of the cells (see Methods).  The remaining conditioned matrix layer is rinsed 
and harvested.  The conditioned matrix solution is then enzymatically digested and 
fractionated using protocols optimized previously (Chapter 3).  Mass spectrometry 
analysis of the conditioned matrix generated using labeled hESCs permits identification 
of human proteins.  Peptides derived from hESCs will carry an isotopic label and will 
display a resultant mass shift in the MS, whereas those previously present in Matrigel 
will not have this difference. 
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amount of cell lysis is occurring during growth or harvest of the CMTX for all the cell 
lines.  
To limit the contaminants from cell lysis, the dataset was filtered using the “extracellular” 
and “cell surface” cellular component gene ontology terms.  Filtering reduced the 
number of proteins identified in each dataset to 71, 100, and 95 labeled proteins for H9, 
CA1, and BJ-1D respectively (Figure 4.4 A, Appendix Tables 1.12 – 1.14).  However, 
the data still contained numerous intracellular proteins (histones, mitochondrial, and 
cytoskeleton associated).  This is primarily the result of the limited specificity of the gene 
ontology assignments.  The overlap between the three individual CMTX datasets is 
~35% based on protein identifiers after gene ontology filtering.  However, coverage 
between biological replicates of the same cell line using the identical fractionation 
methods overlap a minimum of 71% across the samples in the experiment.  The 
reproducibility between biological replicates from single stem cell lines illustrates the 
consistency of not only the proteomics method, but of the CMTX assay itself.  
The hESC and hiPSC CMTX proteomics data indicate that numerous cell line specific 
factors were deposited based on comparisons between the protein lists.  When 
comparing core ECM proteins, isoforms of fibronectin and laminins, and heparan sulfate 
proteoglycan linked proteins were present at similar abundance levels based on the 
number of unique peptides in CMTX from H9 and BJ-1D cell lines.  However, BJ-1D 
CMTX was enriched in matrix remodeling factors, such as matrix metalloproteinase-14 
and -15.  On the other hand, CMTX derived from CA1 hESCs was found to contain 
multiple collagen and laminin isoforms not identified in the matrices from the other stem 
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cell lines.  Low abundance factors such as soluble frizzled related protein (sFRP) 1 and 
2, and Lefty A and B were identified in CMTX from all cell lines.  Interestingly, 
connective tissue growth factor (CTGF) was identified in CMTX from both hESC lines, 
but not in that from BJ-1D hiPSCs.  In addition, other low abundance factors such as 
Cerberus and fibroblast growth factor-15 were only identified in CA1 CMTX.     
4.2.2 Secretome Analysis of the hESC Microenvironment. To further validate and enrich 
for candidates in the CMTX data, a comparison was performed with a previously 
published proteomics screen of the H9 hESC secretome obtained from the analysis of 
hESC conditioned medium [6].  We performed a re-analysis of the H9 hESC secretome 
raw dataset in the same software (PEAKS 5.3) used to process the CMTX data, to 
facilitate comparison and minimize variability from protein assignments or identifiers.  
Comparison with the H9 hESC secretome protein identifiers revealed a 73%, 55%, and 
54% overlap between the unfiltered and 77%, 72%, and 68% for the filtered H9, CA1, 
and BJ-1D CMTX datasets (Figure 4.4 B).  These data indicate that although there was 
a significant variability in the cellular localization of proteins in the unfiltered dataset, this 
distribution is not unexpected since proteins in the secretome and CMTX datasets share 
similar profiles.  Comparison with the Matrigel™ dataset previously acquired (Chapter 3) 
revealed that 53%, 40%, and 40% of proteins for H9, CA1, and BJ-1D cell lines are 
identified in both matrices prior to filtering (Figure 4.4 C).  Gene ontology filtered 
datasets share 62%, 55%, and 50% of proteins with Matrigel™ for H9, CA1, and BJ-1D 
cell lines.  These data illustrate the necessity for SILAC when performing this analysis 
because many of the proteins found in the CMTX are also found in Matrigel™.  
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Furthermore, it highlights the ability of this methodology to enhance the sensitivity of our 
analysis by increasing the confidence in the identification of hESC-derived proteins.      
4.2.3 Factors Identified in Stem Cell Derived CMTX. As mentioned previously, 
investigation of the CMTX dataset revealed the presence of numerous hESC and hiPSC 
regulatory proteins.  In order to enrich for hESC and hiPSC derived proteins that are 
facilitating the maintenance of an undifferentiated state on CMTX, we opted to focus on 
only those classified as extracellular or cell surface by gene ontology.  Not surprisingly, 
within this filtered dataset we find many core ECM proteins that are also present in 
Matrigel™ (Figure 4.5 A).  The presence of hESC and hiPSC-derived labeled versions 
of these proteins indicates that the stem cells are generating a self-supporting matrix 
microenvironment in vitro.  Further investigation of the filtered CMTX dataset revealed 
the presence of numerous factors with potential roles in hESC and hiPSC pluripotency 
(Figure 4.5 B).  Other identified factors, such as hepatoma derived (HDGF) and 
connective tissue growth factor (CTGF) are of particular interest due to their relevance 
in cancer cell systems, as well as the known interactions of CTGF with the ECM [16-18].  
Interestingly, after pathway analysis of the filtered datasets we observe a significant 
enrichment for molecules involved in cell motility as well as apoptosis or invasion of 
cancer cells (Figure 4.5 C).   
Also of interest in the list of hESC proteins identified are the potential extracellular 
regulators of hESCs (Figure 4.5 B).  The soluble frizzled related proteins (sFRP) 1 and 
2 are inhibitors of canonical Wnt signaling [19].  Wnt signaling has been observed to  
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Figure 4.4. Proteomic analysis of SILAC hESC and hiPSC derived CMTX.  (A) 
CMTX from H9 and CA1 hESCs, as well as BJ-1D hiPSCs was analyzed in biological 
triplicate using an MS-based proteomics protocol.  Data files were analyzed using 
PEAKS 5.3 software.  Numbers within the Venn diagrams represent the total number of 
protein identifications found in each matrix for the specific overlap.  Data sets were also 
filtered using gene ontology classification for cellular component based on the terms 
“extracellular” and “cell surface”.  These values are represented in the lower diagram. 
(B) CMTX identifications were further compared with a secretome data set acquired 
through proteomic analysis of hESC conditioned medium.  (C) Each data set was 
individually compared with that previously acquired for Matrigel (Chapter 3).  
Overlapping identifications are denoted by a black box, and unique identifications are 
found in grey.  The total number of overlapping identifications can be found at the top of 
the bar in text.  All comparisons were done manually based upon protein identifiers.  In 
the case of Matrigel data, protein descriptions were used for comparison as identifiers 
are species specific.  Gene ontology filtered data were compared against entire Matrigel 
or Secretome data sets.  The rightmost bar in the top graphs of (B) and (C) represent 
total identifications found in Matrigel respectivelyand the Secretome.  * - datasets can 
be found in reference 6 and Chapter 3. 
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Figure 4.5. Proteins and pathways identified in CMTX from hESCs and hiPSCs.  
CMTX was analyzed using an IE-MS proteomics based approach.  Proteins were 
identified using PEAKS 5.3 software.  (A) Represents a subset of the core ECM proteins 
found in CMTX that were also identified in the previous proteomics analysis of Matrigel 
(Chapter 3).  In the case of collagen, the top isoform was chosen.  (B) Represents 
growth factors and proteins known to regulate core hESC pluripotency pathways found 
in CMTX.  * - indicates when a protein was identified as a single peptide hit.  Only 
proteins with 2 unique peptides are retained, such that these single peptide hits are lost 
in the final dataset. (C) Pathway analysis performed using Ingenuity Systems Software.  
The top biological functions identified in all three cell lines were related to cellular 
movement, growth, and death or invasion of tumor cell lines.  Number of molecules 
denotes the number of candidate proteins identified as being involved with that function 
found in our dataset.  Black boxes represent the -log(p-value) for the probability of 
identifying these pathways as being enriched in our dataset by chance. 
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contribute to the regulation of both mESCs and hESCs [20].  Extracellular antagonists of 
Activin/Nodal signaling, left-right determination factors (Lefty) A and B, are also found in 
the CMTX [21].  Since the Lefty proteins were previously implicated as being involved in 
the reprogramming of metastatic cells with CMTX, their identification provides additional 
validation of our proteomics approach [12].  We also identify Cerberus in the CMTX, a 
regulator of both TGF-β and bone morphogenic protein (BMP) signaling.  Previous 
studies directed at the analysis of hESC-derived CMTX have focused on antagonism of 
the BMP pathway using Gremlin, a protein which shares significant overlap in 
functionality with Cerberus [14, 21].  The presence of these factors is not surprising 
since several have previously been identified in screens of MEF and hESC conditioned 
medium [6].  However, their identification in the CMTX indicates that the ECM is 
potentially playing a role in their activity.     
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4.3 Discussion 
A thorough knowledge of the processes that control the maintenance of pluripotency or 
differentiation to lineage specific cell types will be critical as hESC research moves 
toward the clinic.  Central to this goal is comprehensive characterization of the 
extracellular processes governing regulation of hESCs and hiPSCs in their niche.  
Proteomic analysis of conditioned medium has aided in the development of an 
understanding of signaling pathways present in the microenvironment.  However, few 
studies have examined the direct interactions of hESCs with the matrix portion of the 
microenvironment.  Utilizing cell culture and proteomics methods developed earlier, we 
report the characterization of matrices conditioned by hESCs as well as hiPSCs.   
The presence of core ECM components in CMTX, such as isoforms of fibronectin, 
collagen, and laminin illustrates that hESCs and hiPSCs generate a self-supportive 
niche for attachment and proliferation.  All three of these matrix proteins have been 
shown to promote the growth of hESCs when used as the sole growth support [3, 22-
25].  These core proteins regulate critical cellular processes such as cell attachment 
through integrin binding.  Integrin interactions are capable of mediating signal 
transduction responses similar to those triggered by soluble ligands [26, 27].  Therefore, 
hESCs potentially utilize these interactions to regulate a diverse array of cellular 
functions.  The presence of these core ECM proteins in the matrix likely promotes these 
interactions, and explains why matrices that contain them in combination are better at 
facilitating hESC and hiPSC growth, such as is the case with Matrigel™ [3, 28]. 
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The identification of multiple growth factors and their binding partners in CMTX 
highlights another potential function for these core fibrous ECM proteins in the matrix.  
The ECM has been proposed to contribute to the regulation of growth factor signaling in 
the microenvironment (reviewed in [1]).  Central to this function is the presence of 
specialized domains designed to bind growth factors like VEGF, EGF, HGF, and PDGF 
on proteins such as fibronectin and laminin.  Furthermore, fibronectin has been 
observed to contribute to TGF-β signaling through interaction with latent-TGF-β binding 
proteins [29, 30].   Binding between growth factors and these glycoproteins can also be 
mediated by interactions with heparan sulfate, a molecule that has been shown to 
regulate the self-renewal of hESCs [1, 31].  In addition to core ECM proteins, the CMTX 
also contains an array of binding proteins involved in pathways such as IGF, BMP, and 
EGF signaling.  These binding partners can complement interactions with glycoproteins 
such as fibronectin.  The result of these interactions potentially implicates the ECM in 
the direction of cellular processes through binding and sequestering of growth factors.   
The importance of controlling the activity and concentration of growth factors present in 
the microenvironment is critical for maintenance of the hESC and hiPSC state.  Three 
key pathways from which we identified regulatory proteins in the CMTX are Wnt, TGF-β 
through Activin/Nodal, and BMP signaling.  The sFRP1 and sFRP2 proteins are thought 
to regulate canonical Wnt signaling through direct binding to the Wnt proteins, although 
their role in hESCs remains unclear (reviewed in [32]).  Wnt signaling through the 
canonical pathway has been shown to be important in the maintenance of mESC and 
hESC self-renewal and pluripotency [20].  Lefty A and B are known to regulate TGF-β 
signaling through antagonism of the activating protein Nodal [33].  TGF-β activation 
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through Activin/Nodal signaling is one of the core pathways critical for the maintenance 
of self-renewal and pluripotency of hESCs [21].  The Lefty proteins were also identified 
in the original CMTX work involving metastatic cells as a potential regulator of the 
observed phenotype, acting through hESC-derived matrix deposition [12].  Inhibition of 
BMP mediated activation of TGFβ signaling also promotes the maintenance of hESC 
pluripotency.  BMP activates SMAD1/5/8 mediated TGF-β pathways that have been 
implicated in the differentiation of hESCs [21].  Cerberus is an inhibitor of BMP 
mediated activation that acts through antagonism of BMP-4 [34, 35].  Interestingly, 
Cerberus has also been shown to inhibit Nodal as well as Wnt signaling pathways [35, 
36].     
The identification of sFRP1 and sFRP2 as well as the Lefty A and Lefty B proteins 
further validates the ability of our CMTX proteomic analysis to identify potential 
regulators of hESC fate.  Aside from their activity in the regulation of core hESC 
pluripotency pathways, both sFRP and Lefty proteins are known to be matrix deposited 
[37, 38].  Taken together, the findings of this study highlight the ability of MS-based 
proteomics screening of CMTX to determine in vitro effectors of hESC control involving 
the ECM microenvironment. 
129 
 
4.4 Methods 
4.4.1 Cell culture and harvest – H9 (passage 26) and CA1 (passage 20) hESCs, and 
BJ-1D (passage 65) iPSCs were maintained on CF-1 irradiated mouse embryonic 
fibroblast (MEF) feeder layers (GlobalStem, Rockville, MD) using media composed of 
knockout DMEM/F12, 20% knockout serum replacement, 1% non-essential amino 
acids, 2mM glutamine (CellGro, Manassas, VA), 0.1 mM 2-mercaptoethanol (Fisher, 
Toronto, ON), and 4 ng/mL of basic fibroblast growth factor.  All media reagents were 
obtained from Invitrogen unless noted otherwise.  H9 cells were obtained from WiCell 
(WISC, Wisconsin).  The CA1 hESC line used in all experiments was obtained from Dr. 
Cheryle Séguin of The University of Western Ontario [39, 40].  The hiPSC line BJ-1D 
was derived by reprogramming using retroviral transduction of BJ fibroblasts with the 
Yamanaka factors essentially as we have previously described [41] and validated as 
pluripotent using in vitro and in vivo differentiation assays and expression profiling 
(unpublished results).  Cells were passaged mechanically in all experiments and for 
general maintenance.  
For SILAC experiments, hESC and hiPSC cell lines were grown in feeder-free 
conditions on Matrigel™ (BD Biosciences, Franklin Lake, NJ).  Custom DMEM/F12-
glutamax that contained no L-arginine or L-lysine was ordered from Invitrogen.  SILAC 
medium was prepared using the StemPro hESC Media system with our custom 
DMEM/F12 (Invitrogen) according to manufacturer instructions.  [13C6, 15N4] – L-arginine 
and [13C6, 15N2] – L-lysine (Cambridge Isotope Laboratories, Andover, MA) were 
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supplemented into the SILAC medium at 90mg/L and 92mg/L respectively.  Unlabeled 
L-proline was added to the SILAC medium at a final concentration of 800 mg/L [42].   
Embryoid bodies (EB) were generated using Aggrewell 400Ex plates (StemCell 
Technologies, Vancouver, Canada). Briefly, 2 x 106 hESCs were harvested 
enzymatically using Accutase (Invitrogen) from Matrigel™ coated plates.  Cells were 
reconstituted in Aggrewell medium supplemented with Rock inhibitor (Y-27632, Sigma-
Aldrich, St. Louis, MO) at a final concentration of 10 μM.  After plating in Aggrewell 
dishes, EBs were grown for 48 hours at 37°C prior to transfer to ultra-low adherence 
tissue culture dishes (Corning, Lowell, MA).  After 15 days of culture, EB RNA was 
harvested using Trizol extraction according to the manufacturer’s instructions 
(Invitrogen).  EBs were assayed for expression of CDX2, alpha-feto protein (AFP), 
GATA-6, GATA-4, Oct3/4, PAX-6, T-brachyury, Nanog, and Neurogenic differentiation 1 
(NeuroD1) using TaqMan primer probe sets (Invitrogen).  Details of this assay can be 
found in Appendix Table 1.15.  All EB assays were performed in biological and technical 
duplicate for each cell line and each condition.    
4.4.2 Generation and Harvest of Conditioned Matrix – H9, CA1, or BJ-1D stem cells 
were grown in feeder-free conditions on Matrigel™ in heavy-isotope containing SILAC 
medium for 7 days prior to passaging to plates for CMTX preparation.  SILAC labeled 
stem cells were permitted to grow for a period of 5 days on Matrigel™ in SILAC medium 
for generation of CMTX.  Wells were then rinsed thoroughly with PBS to ensure removal 
of medium components and cells removed from the Matrigel™ layer using Cell 
Recovery Solution according to the manufacturer’s instructions (BD Biosciences).  The 
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remaining CMTX layer was incubated in a solution containing 8 M urea, 100 mM 
ammonium bicarbonate (ABC), and 1 M NaCl for 24 hours at 4°C.  After the removal of 
stem cells by spinning, the cell recovery solution was combined with the urea solution 
and concentrated using high-capacity C18 cartridges (Phenomenex, Torrance, CA).  
Eluted components were dried using a SpeedVac and reconstituted in 8 M urea with 
100 mM ABC for analysis by 1D-SDS-PAGE, strong cation exchange (SCX), or strong 
anion exchange (SAX) fractionation.  CMTX was analyzed in technical duplicate and 
biological triplicate for each cell line.   
4.4.3 In-solution trypsin digestion – Matrix samples were reduced with 10 mM 
dithiothreitol (DTT) for 60 minutes.  Samples were then alkylated with 40 mM 
iodoacetamide (IAA) for 60 minutes.  The reactions were quenched through the addition 
of DTT and left to incubate for another 60 minutes.  Samples were then diluted 1/6 in 50  
mM ABC.  Trypsin (Promega, Madison, WI) at a concentration of 1 ug enzyme to 25 µg 
of total protein was added to the mixtures and left to incubate for 24 hours at 37°C.  The 
next day, digests were acidified using neat trifluoroacetic acid and desalted on C18 
cartridges (Phenomenex, Torrance, CA).  After elution with 50% acetonitrile, samples 
were evaporated using a SpeedVac.  Dried samples were reconstituted in 0.5% formic 
acid at a pH of ~2 prior to loading on an SCX column.  Samples for SAX analysis were 
reconstituted in 0.5% NaOH at a pH of ~12.   
4.4.4 Column preparation – Columns were packed in 360 O.D. x 200 I.D. capillaries 
(PolyMicro Technologies, Phoenix, AZ) using a conventional pressure bomb (Next 
Advance, Averill Park, NY).  Frits were prepared by mixing 75 µL of potassium silicate 
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with 25 µL of formamide, vortexing for 1 minute and rapidly inserting and removing the 
capillary end from the resulting mixture.  Capillary frits were dried in a 100°C oven for 2 
hours.  Capillaries were then rinsed with forward and reverse flow of methanol using the 
pressure bomb at 200 psi.  Prior to packing, capillaries were rinsed for 30 minutes with 
0.5% formic acid or 0.5% NaOH for SCX and SAX respectively.  PolySULFOETHYL A 
SCX beads (5 µM, 300Å, CAT# PLBMSE0503) were purchased from PolyLC 
(Columbia, MD) and reconstituted in 50% MeOH.  SAX beads were purchased from 
Varian Inc. (10um, 1000Å, CAT# PL1451-2102, Palo Alto, CA) and used in the vendor 
supplied buffer.  SCX and SAX columns were packed to a length of 3 cm for all 
experiments.  All packing was done at a pressure of 200 psi until the desired column 
length was obtained, then pressurized to 1000 psi to complete packing.  Packed 
columns were rinsed with solvents for conditioning as recommended by the 
manufacturer. 
4.4.5 Peptide Fractionation – Peptides were fractionated off of SCX and SAX columns 
using a CapLC system (Waters, Milford, MA) with a flow rate of 2 µL/min.  Mobile phase 
A was composed of 20 mM citric acid at a pH of ~2.3, mobile phase B was pH 11.4 20 
mM NH4OH.  Mobile phases were all prepared fresh prior to fractionation to ensure the 
stability of pH from run to run.  Fractionation with pH was carried out using a 120 minute 
gradient from pH 2 to 12 for SCX, and 12 to 2 for SAX.  Each fraction was collected 
offline at a volume of 20 µL.  Fractions were dried using a SpeedVac, and reconstituted 
in 10% formic acid prior to injection on the MS.  
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4.4.6 In-gel trypsin digestion – 60 μg of conditioned matrix was diluted in Laemmli 
buffer.  Matrix samples were loaded in each of two lanes on a 10% SDS-Gel.  After 
staining of the gel with Coomassie blue, gel lanes were divided into fractions based on 
visual assessment of protein concentration.  Gel cubes in each fraction were destained 
using 20% acetonitrile (ACN) in 1 M ABC.  Proteins were reduced using 10 mM DTT for 
60 minutes, followed by alkylation with 100mM IAA for 60 minutes.  Digestions were 
carried out using trypsin at a 1/25 ratio overnight in a 37°C water bath.  Fractions were 
extracted the next day using 10% formic acid and ACN with sonication.  Each fraction 
was dried using a SpeedVac and reconstituted in 10% formic acid prior to injection on 
the MS.   
4.4.7 MS analysis – Fractions were injected and separated using a nanoAcquity system 
(Waters, Milford, MA) equipped with a 25 cm x 75 µm I.D. C18 column.  Fractions were 
separated using a 1 to 40% ACN gradient over 150 minutes at a flow rate of 300 
nL/min.  MS analysis was done on a Q-ToF Ultima (Micromass/Waters) using data-
dependent acquisition with selection of the four top precursor masses per survey scan.  
Survey scans were set at 1 s, and MS/MS acquisition set at 1 s or 8000 cps TIC cut-off.  
Exclusion lists were generated using in-house software that automatically adds 0.7 amu 
to the precursor masses selected in previous runs and outputs a file also containing 
retention time information.  Each fraction was analyzed for a four exclusion rounds (5 
injections total), adjusting the injection volume dependent on signal intensity in the MS 
survey scan. 
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4.4.8 Proteomic Data analysis – Data analysis for all samples was performed in PEAKS 
5.3 software (Bioinformatics Solutions Inc., Waterloo, Canada) [43, 44].  After import 
into PEAKS, MS/MS spectra from raw data files were refined using the following 
settings: merge spectra – true (100 ppm mass tolerance, 60 second retention time 
tolerance), correct precursor mass – true, determine precursor charge state – true 
(minimum charge +2, maximum charge +5), spectral quality filter – true (0.65 threshold), 
centroid, deisotope, and deconvolute – true.  Resulting MS/MS spectra were then de 
novo sequenced using the following parameters: parent monoisotopic mass tolerance – 
100ppm, fragment monoisotopic mass tolerance – 0.15 daltons, enzyme specificity – 
semi-Trypsin, fixed modifications – carbamidomethylation and +10 daltons on Arginine 
and +8 daltons on Lysine for SILAC, variable modifications – N-terminal acetylation and 
oxidized methionine.  After de novo analysis, data were searched against the UniProt 
sequence database (Human taxonomy specified, 20236 total entries) using the 
following parameters: parent monoisotopic mass tolerance – 100 ppm, fragment 
monoisotopic mass tolerance – 0.15 daltons, enzyme specificity – semi-Trypsin, fixed 
modifications – carbamidomethylation and +10 daltons on Arginine and +8 daltons on 
Lysine for SILAC, variable modifications – N-terminal acetylation and oxidized 
methionine, estimate false-discovery rate – true.    
Resultant protein identification data from the database search were further processed 
using PEAKS 5.3 software.  Proteins were filtered by assigned score to give a <1.0% 
false-discovery rate for peptide-spectral matches based on estimation from a decoy-
fusion method of database search.  Identified proteins were also required to be derived 
by >2 unique peptides.  Proteins that contained similar peptides and could not be 
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differentiated based on MS/MS analysis alone were grouped to satisfy the principles of 
parsimony.  For all matrices analyzed, keratin hits were manually removed from the final 
datasets.  Gene ontology analysis was performed using STRAP software (CPC Tools).   
4.4.9 Real-time PCR – RNA was purified using Trizol reagent according to the 
manufacturer’s instructions (Invitrogen) with the following modification: precipitated RNA 
pellets in isopropanol were centrifuged for 60 minutes at 12000 g at room temperature.  
After NanoDrop quantification, 1 µg of cDNA was synthesized using the High Capacity 
cDNA Reverse Transcription Kit with RNase inhibitor (Invitrogen).  Real-time PCR was 
performed using the TaqMan® Universal PCR Master Mix (Invitrogen).  Samples were 
incubated at 50°C for 2 minutes followed by 10 minutes at 95°C.  DNA was then 
amplified at 95°C for 15 seconds followed by 1 minute at 58°C for 46 cycles.  All 
samples were normalized to the large ribosomal protein RPLPO as a positive control.  
All primers were obtained from Invitrogen and details of the assay can be found in 
Appendix Table 1.15.  Each biological replicate was run in triplicate for every marker 
assayed.  All reagents were used according to the manufacturer’s instructions.   
4.4.10 Flow Cytometry – All reagents and probes for flow cytometry were obtained from 
eBiosciences (San Diego, CA) unless noted otherwise.  Cells were enzymatically 
harvested using Accutase (Invitrogen) to obtain a single cell suspension.  After 
centrifugation, cell pellets were resuspended in 5% FBS in PBS.  Alexa-488 conjugated 
SSEA-4 and Alexa-647 conjugated SSEA1 were diluted into the cell mixture according 
to the manufacturer’s instructions.  Negative control samples contained respective 
isotype controls for the primary antibodies used.  Solutions were incubated for 2 hours 
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and analyzed using an Accuri C6 (BD Biosciences) flow cytometer after rinsing to 
remove unbound antibody.  Populations were gated according to forward and side 
scatter patterns with filtering for viable cells using 7-aminoactinomycin D staining.  Data 
was analyzed using FlowJo software (Tree Star, Ashland, OR). 
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Chapter 5 
Functional Characterization of hESC-Derived CMTX 
 
5.1 Introduction        
The two defining characteristics of human embryonic stem cells (hESC), self-renewal 
and pluripotency, are maintained by a delicate balance of intracellular and extracellular 
signaling processes.  Extracellular regulation is primarily the result of changes in the 
microenvironment surrounding the cells during growth in vitro or in vivo.  hESCs interact 
with this ‘niche’ through support cells, extracellular matrix (ECM) components, and 
autocrine/paracrine signaling (reviewed in [1-3]).  Modulation of any of these supportive 
elements individually or in combination has been used extensively to alter hESC 
behavior [1-3].  For example, exogenous growth factor supplementation is used to 
facilitate the maintenance of hESCs as well as to induce their differentiation.  Moreover, 
recent studies have illustrated that hESC self-renewal and differentiation can be altered 
through modulation of the properties of the ECM using synthetic mimics, highlighting its 
importance in the microenvironment (reviewed in [4]). 
 
 
 
This chapter contains excerpts from the following paper:  
Hughes, C.S., Radan, L., Stanford, W., Betts, D., Postovit, L.M., Lajoie, G.A.. (2012) 
“Proteomics Analysis of the Human Embryonic Stem Cell Depositome”. (In Preparation) 
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A number of proteomics studies have been conducted to determine factors secreted by 
feeder layers in an attempt to elucidate proteins and pathways essential for hESC 
survival [5-8].  Currently only one of these studies has identified members of the soluble 
frizzled related protein (sFRP) family [9].  As part of our proteomics investigation into the 
components of CMTX, we identified sFRP1 and 2 across multiple cell lines. The sFRP 
family of proteins has been shown to regulate canonical Wnt signaling through direct 
binding to the secreted Wnt cytokines [10].  Central to this role is the direct interaction of 
sFRP1 and sFRP2 with Wnt3a [11].  The Wnt family is a group of secreted 
glycoproteins consisting of 19 members that contain 22 - 24 conserved cysteine 
residues (reviewed in [12]).  Wnt signaling plays a prominent role during development 
and its aberrant regulation plays a role in multiple disease phenotypes (reviewed in 
[13]).      
In humans, the sFRP family is made up of 5 members, sFRP1 – 5 [14].  The sFRPs 
were originally discovered due to their shared sequence similarity with the frizzled 
receptors that are directly involved with Wnt signaling [15, 16].  This family now 
constitutes the largest group of Wnt antagonists [17].  Structurally, the sFRP proteins 
contain two distinctive domains, an N-terminal cysteine rich domain (CRD) and a C-
terminal netrin-like domain [18].  The CRD contains ten conserved cysteine residues 
and shares a significant similarity with the extracellular domain of the frizzled receptors 
[19].  The C-terminal netrin domain is postulated to confer heparin binding properties 
[18, 20, 21].  The primary interest in the sFRPs however, stems from the properties of 
the N-terminal CRD, that because of the sequence homology with the frizzled receptors, 
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has been proposed to bind Wnt proteins.  This ability to bind Wnt proteins has 
subsequently been verified and intensely studied since that time (reviewed in [17]). 
The sFRP family of proteins have been shown to encompass a diverse profile of 
expression patterns and context dependent interactions in a variety of tissues and 
cellular systems (reviewed in [22]).  However, although sFRPs family members are 
known to be important during embryonic development, very little is known about their 
role in the regulation of ESCs [22].  This is surprising when it is considered that Wnt 
signaling has been shown to be involved in the direct regulation of the pluripotent state 
of ESCs (reviewed in [23]).  Furthermore, in a recent study comparing 59 different hESC 
lines a positive correlation between Nanog and sFRP2 gene expression was observed 
[24].  In addition, sFRP2 was identified as a potential target for Nanog in ChIP on CHIP 
analyses of hESCs [25].  Taken together, these findings indicate that sFRP family 
members are potentially playing a vital role in hESC pluripotency. 
Here we investigate the ability of hESC conditioned matrix (CMTX) to enhance the 
maintenance of undifferentiated stem cells.  To identify and characterize factors 
potentially responsible for this effect, we utilize the data generated in our proteomics 
screen of CMTX (Chapter 4) to validate the role of sFRP1 and sFRP2.  A combination 
of techniques is used to characterize the role of the sFRP candidates in the regulation 
of hESC pluripotency in vitro.  Additionally, utilizing a metastatic melanoma cell line we 
demonstrate the effects of exogenous supplementation of sFRP1 and sFRP2.  This 
work represents the first investigation of the hESC and hiPSC matrix microenvironment.  
142 
 
5.2 Results 
5.2.1 hESC Derived Matrix for the Maintenance of an Undifferentiated State. The ability 
of embryonic microenvironments to suppress the tumorigenic phenotype has been 
previously illustrated in a number of developmental and cellular systems (reviewed in 
[26]).  However, a limited number of studies have focused on reprogramming stem cells 
with these same microenvironments.  Analogous to metastatic cells, embryonic stem 
cells can direct cellular changes in response to cues from their microenvironment.  With 
the recent observation that a hESC-derived matrix microenvironment could modulate 
the behavior of metastatic cells [27], we sought determine what effect exposure would 
have on the stem cell phenotype.  To this end, we monitored changes in the gene and 
protein expression of hESCs grown on CMTX in the absence of exogenous growth 
factor supplementation.  In this way, matrix dependent changes in hESC behavior could 
be monitored without interference from soluble factors present in MEF-CM.    
After 4 days of culture in medium that contained no exogenous bFGF (embryoid body 
medium, EB medium), a decrease in Oct3/4 and Nanog gene and protein expression 
was observed for H9 hESCs grown on control Matrigel™ and CMTX.  However, the 
reduction in expression was significantly smaller in H9 hESCs grown on CMTX when 
compared with control cells (Figure 5.1 A-B).  A similar trend was observed when H9 
hESCs were measured using flow cytometry for SSEA4 and SSEA1 fluorescence.  H9 
hESCs induced to differentiate on CMTX exhibited an increase in SSEA4 mean 
fluorescence intensity relative to SSEA1 when compared with control cells (Figure 5.1 
C-D).  When cultures were examined by immunofluorescence, pockets of SSEA1  
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Figure 5.1. hESC generated CMTX enhances the maintenance of an 
undifferentiated state in H9 cells when compared to those grown on Matrigel™.  
Matrigel™/CMTX was generated by growing H9 hESCs on Matrigel™ for 4 days.  
Following cell removal, fresh H9 hESCs were plated on the CMTX layers.  Control 
Matrigel™ was generated by treating normal Matrigel™ with the cell removal procedure 
prior to the plating of fresh hESCs as discussed in the Methods.  Cells in both 
conditions were fed with medium not containing bFGF for 4 days.  Control samples are 
hESCs grown on normal Matrigel™ in MEF-CM.  (A) RT-PCR data for H9 hESCs 
cultured on control Matrigel™ and Matrigel™/CMTX.  Values represent fold change of 
Oct3/4 or Nanog expression relative to control hESCs cultured under standard 
conditions. RPLPO was used as an internal control for both samples.  Error bars 
represent SEM, n=3.  (B) Western blot for Oct3/4 and Nanog in H9 hESCs grown on 
CMTX.  Actin is shown as a control.  (C) Flow cytometry data for H9 hESCs grown on 
CMTX.  For each sample, plot (i) shows SSEA4 fluorescence (blue) relative to a 
matched isotype control (solid red), (ii) shows SSEA1 fluorescence relative to isotype 
control, (iii) scatter plot with the gated cell population shown, (iv) scatter plot with the 
viable cell population gated.  Percentages denote fraction of cells within the gates 
shown.  (D) Results from flow cytometry analysis of H9 hESCs grown on CMTX for the 
markers SSEA4 and SSEA1.  Values represent mean fluorescence intensity of SSEA4 
relative to SSEA1 for Matrigel™ Control or Matrigel™/CMTX samples.  Values are 
derived from the data in (C).  Error bars represent SEM, n=3.  (D) Immunocytochemistry 
for H9 hESCs grown on Control Matrigel™ or Matrigel™/CMTX.  Cells were stained 
with Oct3/4, SSEA4, DAPI, and SSEA1.  Scale bars represent 250um. 
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Figure 5.2. hESC generated CMTX enhances the maintenance of an 
undifferentiated state in CA1 cells when compared to those grown on Matrigel™.  
Matrigel™/CMTX was generated by growing CA1 hESCs on Matrigel™ for 4 days.  
Following cell removal, fresh CA1 hESCs were plated on the CMTX layers.  Control 
Matrigel™ was generated by treating normal Matrigel™ with the cell removal procedure 
prior to the plating of fresh hESCs as discussed in the Methods.  Cells in both 
conditions were fed with medium not containing bFGF for 4 days.  Control samples are 
hESCs grown on normal Matrigel™ in MEF-CM.  (A) RT-PCR data for CA1 hESCs 
cultured on control Matrigel™ and Matrigel™/CMTX.  Values represent fold change of 
Oct3/4 or Nanog expression relative to control hESCs cultured under standard 
conditions. RPLPO was used as an internal control for both samples.  Error bars 
represent SEM, n=3.  (B) Western blot for Oct3/4 and Nanog in CA1 hESCs grown on 
CMTX.  Actin is shown as a control.  (C) Flow cytometry data for CA1 hESCs grown on 
CMTX.  For each sample, plot (i) shows SSEA4 fluorescence (blue) relative to a 
matched isotype control (solid red), (ii) shows SSEA1 fluorescence relative to isotype 
control, (iii) scatter plot with the gated cell population shown, (iv) scatter plot with the 
viable cell population gated.  Percentages denote fraction of cells within the gates 
shown.  (D) Results from flow cytometry analysis of CA1 hESCs grown on CMTX for the 
markers SSEA4 and SSEA1.  Values represent mean fluorescence intensity of SSEA4 
relative to SSEA1 for Matrigel™ Control or Matrigel™/CMTX samples.  Values are 
derived from the data in (C).  Error bars represent SEM, n=3.  (D) Immunocytochemistry 
for CA1 hESCs grown on Control Matrigel™ or Matrigel™/CMTX.  Cells were stained 
with Oct3/4, SSEA4, DAPI, and SSEA1.  Scale bars represent 250um. 
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positive cells could be observed in control cells, indicating differentiation (Figure 5.1 E). 
SSEA1 positive colonies were observed with a reduced frequency in cells cultured on 
CMTX.  Subsequent analysis of a second hESC line, CA1, revealed similar trends 
(Figure 5.2 A-E).  Taken together, these data indicate that CMTX promotes the 
preservation of an undifferentiated state and hESCs secrete factors into the matrix that 
are beneficial for their own maintenance.   
5.2.2 Generation and Testing of an Artificial CMTX.  To functionally validate the 
proteomics method for profiling the CMTX to identify hESC regulatory proteins, we 
investigated the roles of sFRP1, sFRP2, Lefty A, and Gremlin further.  These proteins 
were selected on the basis of their suspected roles in hESC regulation as well as their 
previous implications in CMTX studies involving metastatic cells [27-29].  Moreover, 
these proteins were not identified in Matrigel™ itself, making their functional validation 
possible in a CMTX assay that utilizes this matrix without background interference.  To 
determine the potential roles of these candidates in the CMTX, we repeated the hESC 
CMTX experiments utilizing two separate platforms for analysis. 
We first sought to determine if supplementation of recombinant proteins to the matrix, in 
the absence of conditioning prior to hESC plating, could enhance the maintenance of an 
undifferentiated state.  Recombinant versions of sFRP1 and sFRP2, Lefty A, and 
Gremlin were supplemented into Matrigel™ at a maximum concentration of 5μg/mL 
prior to gelation.  To ensure maximal recombinant protein incorporation into the matrix, 
undiluted Matrigel™ was used in all assays to coat culture dishes.  The Matrigel™™ 
layer was then treated with the lysis-free cell removal process (see Chapter 4) prior to 
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hESC plating to ensure reproducibility with the previous experiments.  In H9 hESCs, 
supplementation with any of the selected proteins did not significantly enhance the 
expression of the markers of pluripotency Oct3/4 and Nanog (Figure 5.3 A).  Alone or in 
combination, none of the proteins were able to fully replicate the effect observed on 
CMTX.  Similar trends are seen in the CA1 hESC line, where individually or in 
combination, the matrix supplemented proteins are unable to promote maintenance of 
an undifferentiated state (Figure 5.3 C).  In immunoblotting for Oct3/4 and Nanog we 
observe analogous changes in Oct3/4 and Nanog protein abundance in both H9 and 
CA1 hESCs (Figure 5.3 E).  These data suggest that sFRP1, sFRP2, Gremlin, and Lefty 
A are unable to replicate the effects observed on hESC-derived CMTX.   However, 
previous studies have shown that recombinant proteins are not as effective as their 
equivalent hESC-derived versions [27].   
Antibody blocking experiments were performed to further investigate the potential role of 
the sFRP and Lefty proteins in the CMTX.  CMTX was generated by growing H9 or CA1 
hESCs on Matrigel™ as before.  After cell removal, CMTX was treated with antibodies 
specific for sFRP1, sFRP2, or Lefty A candidates, individually or in combination, to 
generate a ‘knockdown’ CMTX.  Unbound antibody was removed by washing and fresh 
hESCs were plated and grown in EB medium.  In this way, sFRP or Lefty proteins that 
had been deposited in the CMTX during hESC growth would no longer be available for 
interaction with the newly plated cells.   Monitoring changes in gene expression and 
protein abundance of Oct3/4 and Nanog revealed that none of the antibody treatments 
promoted a reduction in the maintenance of an undifferentiated state of H9 hESCs 
when compared with a secondary antibody control (Figure 5.3 B, F).  Assay of the CA1  
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Figure 5.3. Characteristics of hESCs on recombinant and knockdown CMTX.  
Recombinant CMTX was generated by supplementing Matrigel™ with recombinant 
versions of sFRP1, sFRP2, Lefty, or Gremlin alone or in combination.  Knockdown 
CMTX was made by incubating hESC-derived CMTX with antibodies specific for 
sFRP1, sFRP2, or Lefty A and Lefty B prior to plating of fresh hESCs.  (A) Oct3/4 and 
Nanog expression in H9 hESCs grown on Recombinant CMTX as determined by RT-
PCR.  Values represent fold change relative to hESCs grown on Control Matrigel™ 
(treated with the cell removal process, but not supplemented with recombinant protein).  
Error bars indicate SD, n=3. (B) Oct3/4 and Nanog expression in H9 hESCs grown on 
Knockdown CMTX as determined by RT-PCR.  Values represent fold change relative to 
hESCs grown on Matrigel™/CMTX (hESC-derived CMTX treated with the cell removal 
process, not treated with antibody).  Error bars represent SD, n=3.  Secondary denotes 
CMTX treated with a secondary antibody as a control (C) Oct3/4 and Nanog expression 
in CA1 hESCs on Recombinant CMTX .  Error bars indicate SD, n=5.   (D) CA1 hESCs 
on Knockdown CMTX.  Error bars indicate SD, n=4.  All RT-PCR experiments used 
RPLPO as an internal control for each sample.  (E) Western blots for Oct3/4 and Nanog 
in H9 and CA1 hESCs grown on Recombinant CMTX.  Actin is shown as a control.  (F) 
Western blots for Oct3/4 and Nanog in H9 and CA1 hESCs grown on Knockdown 
CMTX.  Actin is shown as a control. 
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hESC line revealed identical trends to the H9 cell line (Figure 5.3 D, F).  Taken together, 
these experiments indicate that the sFRP and Lefty proteins do not solely modulate the 
state of hESCs on the CMTX.  This suggests that there are other factors potentially 
acting to enhance undifferentiated hESC maintenance on CMTX.  However, it is also 
possible that the antibodies utilized are potentially unable to block the function of the 
selected proteins, or are unable to bind if the target is localized in the matrix.  
5.2.3 Roles of sFRP Proteins in hESC Pluripotency.  Canonical Wnt signaling is a 
critical pathway with characterized roles during development as well as in ESCs 
themselves (reviewed in [12]).  However, the regulation of hESC pluripotency through 
Wnt signaling is poorly understood, specifically how the pathway is controlled in the 
extracellular space.  The sFRP family of proteins are known Wnt antagonists whose 
differential expression has been shown to have significant effects in a variety of cell 
types and pathological conditions (reviewed in [17]).  Interactions between the sFRPs 
and hESCs and the resultant effects on self-renewal or differentiation are inadequately 
characterized.  Given the importance of Wnt signaling in developmental processes, we 
chose to investigate the role of the sFRP1 and sFRP2 in the maintenance and 
regulation of hESC pluripotency.      
To measure the effect of sFRP1 and sFRP2 on hESC behavior, we employed shRNA 
mediated knockdowns of each target gene.  Initially we attempted to utilize the 
tetracycline inducible vector, pTRIPZ (Open Biosystems).  An inducible system was 
chosen to permit generation of a homogenous population of undifferentiated cells 
should our shRNA promote differentiation.  We successfully generated stable lines in 
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HEK293 cells and subsequently verified sFRP1 and sFRP2 knockdown.  However, after 
production of stable H9 and CA1 hESC lines, we were unable to induce shRNA or 
reporter gene expression using doxycycline in any of the clones tested.  Since the 
puromycin resistance and shRNA genes are on separate promoters, the effect we 
observe is potentially the result of promoter silencing, a common occurrence in hESCs 
[30].  To overcome this problem, we utilized a separate tetracycline inducible vector 
system known as pSUPERIOR.  Along with the tetracycline repressor vector, pTetRnls, 
pSUPERIOR had previously been used to generate stable inducible Oct3/4 shRNA 
expressing cell lines [31].  However, although we were able to successfully generate 
stable H9 and CA1 lines, the cells grew poorly under dual-antibiotic selection and were 
prone to differentiation.    
Because of these difficulties, we decided to employ a transient expression of our 
shRNAs in hESCs.  Transient knockdown of gene expression in hESCs is challenging 
due to the poor efficiency of transfection of these cells.  Using cationic lipid based 
transfection of H9 and CA1 hESCs we were able to achieve >60% efficiency based on 
GFP reporter expression (Figure 5.4 A-B).  Expression of the shRNA constructs could 
be maintained by transfection on multiple days during experimentation as we did not 
observe a global reduction in viability as a result of the protocol (Figure 5.4 B).  
However, when examining colonies that contained small numbers of cells in conditions 
containing sFRP1 and sFRP2 shRNAs (<10 total cells), we observed a significant 
reduction in viability in both H9 and CA1 hESCs compared with controls (Figure 5.4 C).  
Using transient expression of our shRNA constructs, we were only able to obtain ~30% 
knockdown for both sFRP1 and sFRP2 based on gene expression in H9 and CA1  
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Figure 5.4. shRNA mediated knockdown of sFRP1 and sFRP2 expression.  sFRP1 
and sFRP2 expression were individually knocked down in H9 and CA1 hESCs using 
pSUPERIOR plasmid containing shRNA constructs against target transcripts.  (A) 
Phase contrast and fluorescence images of H9 and CA1 hESC colonies transfected 
with pSUPERIOR plasmid expressing GFP and a scrambled shRNA control.  Scale bars 
represent 250um.  (B)  Efficiency of transfection using flow cytometry detection of GFP 
positive cells after treatment.  Smaller plots show viability using 7-AAD staining.  N=2 for 
both cell lines.  (C) Phase contrast images demonstrating the poor viability of small 
hESC colonies following transfection compared with scrambled control hESC lines.  
Scale bars represent 250um.  (D) Knockdown of sFRP1 and sFRP2 expression in H9 
and CA1 hESCs as measured by RT-PCR.  Values are fold change relative to control 
samples transfected with a scrambled shRNA.  Error bars depict SD, n=3.  (E) Oct3/4 
and Nanog expression in knockdown cells as determined by RT-PCR.  Error bars show 
SD, n=3.  For all RT-PCR experiments RPLPO is used as an internal sample control.  
(F) Immunoblot for Oct3/4, Nanog, sFRP1, and sFRP2 in knockdown and control H9 
and CA1 hESCs.  Actin is shown as a control for both cell lines. 
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hESCs (Figure 5.4 D).  To test the effects of these knockdowns on hESC behavior, H9 
and CA1 cells were grown in MEF-CM for 4 days post-transfection.  In hESCs 
containing sFRP1 or sFRP2 shRNA expressing plasmids grown in MEF-CM, we 
observed no significant change in Oct3/4 and Nanog at both the transcript and protein 
level (Figure 5.4 E-F).  Taken together, these data suggest that sFRP1 and sFRP2 are 
unable, on their own, to modulate pluripotency marker expression in MEF-CM.  
However, the effectiveness of the shRNA treatment is potentially confounded by the 
limited extent of knockdown achieved.     
Although we obtained a knockdown of gene expression for sFRP1 and 2 in the hESC 
lines tested, we observed that the protein level remained relatively unchanged 
compared with control cells (Figure 5.4 F).  To effect sFRP signaling at the protein level, 
we utilized two separate small molecule inhibitors specific for sFRP1 (herein referred to 
as sFRP1 Inhibitor A and sFRP1 Inhibitor B) [32].  When H9 or CA1 hESCs grown in 
MEF-CM were supplemented with either inhibitor, we observed only minor alterations in 
Oct3/4 and Nanog expression that were not significant at the transcript level (Figure 5.5 
A-B).  Additionally, we observed no differences based on immunoblot data, indicating 
that the changes observed at the transcript level were not biologically significant (Figure 
5.5 C).  Taken together, these results suggest that inhibition of sFRP1 cannot, on its 
own, promote the changes in the expression of genes directly involved in the 
maintenance of the stem cell phenotype in MEF-CM.   
To test whether inhibition of sFRP1 by small molecule inhibitors has an effect on the 
differentiation of hESCs, we supplemented multiple concentrations of either inhibitor in  
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Figure 5.5. hESCs in MEF-CM supplemented with sFRP1 inhibitors.  H9 and CA1 
hESCs were grown in MEF-CM that was supplemented with small molecule inhibitors of 
sFRP1.  Oct3/4 and Nanog expression were assayed by RT-PCR following 4 days of 
culture in the presence of supplementation.  (A) Fold change of Oct3/4 and Nanog 
expression relative to control for H9 and CA1 hESCs grown in MEF-CM supplemented 
with sFRP1 inhibitor A.  (B) Fold change of Oct3/4 and Nanog expression relative to 
control for H9 and CA1 hESCs grown in MEF-CM supplemented with sFRP1 inhibitor B.  
Error bars represent SD, n=3.  All RT-PCR experiments used RPLPO as an internal 
control.  (C) Western blots depicting Oct3/4 and Nanog protein expression for H9 and 
CA1 hESCs grown in MEF-CM supplemented with sFRP1 inhibitors.  Actin is shown as 
a control. 
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EB medium.  Similar to the observed effect in MEF-CM, neither sFRP1 inhibitor was 
able to alter the expression of Oct3/4 or Nanog in H9 or CA1 hESCs (Figure 5.6 A-B).  
Analogous to MEF-CM, no observable changes were seen in immunoblots for Oct3/4 
and Nanog (Figure 5.6 C).  However, due to the poor abundance of Nanog following 
differentiation based on immunoblots, correlation of gene expression and protein 
abundance data is challenging.   
Since Wnt signaling is known to be involved in the induction of mesendoderm, we 
examined whether hESCs grown in EB medium supplemented with sFRP1 inhibitors 
would display an induction of this lineage type [33].  As indicators of mesendoderm, we 
monitored Goosecoid (GSC) [34]  and Mix paired-like homeobox 1 (MIXL1) [35] 
expression.  We observed a significant decrease in GSC expression and subsequent 
increase in MIXL1 in H9 hESCs grown in the presence of sFRP1 inhibitor A in EB 
medium (Figure 5.6 D).  We observe a similar trend for H9 hESCs grown in the 
presence of sFRP1 inhibitor B; although significance is not reached in the case of 
MIXL1 (Figure 5.6 E).  We observe no significant change in GSC or MIXL1 expression 
in CA1 hESCs grown in the presence of either sFRP1 inhibitor in EB medium (Figure 
5.6 D).   
In order to maximize the knockdown in sFRP1 and sFRP2 activity, we combined 
transient transfection of the hESCs with small molecule inhibition in both MEF-CM and 
EB medium.  Similar to the previous results in MEF-CM and EB medium supplemented 
with either sFRP1 inhibitor, we observed no significant changes Oct3/4 in transcript or 
protein abundance in sFRP1 and sFRP2 shRNA expressing hESCs (Figure 5.7 A-D).   
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Figure 5.6. hESCs in embryoid body medium supplemented with sFRP1 
inhibitors.  H9 and CA1 hESCs were grown in EB medium that was supplemented with 
small molecule inhibitors of sFRP1.  Oct3/4 and Nanog expression were assayed by 
RT-PCR following 4 days of culture in the presence of supplementation.  (A) Fold 
change of Oct3/4 and Nanog expression relative to control for H9 and CA1 hESCs 
grown in EB medium supplemented with sFRP1 inhibitor A.  (B) Fold change of Oct3/4 
and Nanog expression relative to control for H9 and CA1 hESCs grown in EB medium 
supplemented with sFRP1 inhibitor B.  Error bars represent SD, n=3.  (C) Western blots 
depicting Oct3/4 and Nanog protein expression for H9 and CA1 hESCs grown in 
embryoid body medium supplemented with sFRP1 inhibitors.  Actin is shown as a 
control.  (D) Goosecoid and MIXL1 expression as indicators of mesendoderm induction 
for H9 and CA1 hESCs grown in the presence of sFRP1 inhibitor A.  (E) Goosecoid and 
MIXL1 expression as indicators of mesendoderm induction for H9 and CA1 hESCs 
grown in the presence of sFRP1 inhibitor B.  Significance was determined through 
comparison with embryoid body controls.  Error bars represent SD, n=3.  All RT-PCR 
experiments used RPLPO as an internal control. 
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Examination of hESCs grown in EB medium supplemented with sFRP1 inhibitor A or B 
revealed significant increases in GSC and MIXL1 expression in the sFRP2 knockdown 
CA1 lines (Figure 5.7 G-J).  No significant changes were observed in the H9 hESC line 
in the presence of either inhibitor (Figure 5.7 G-J).  Taken together, these results 
suggest that modulation of sFRP using sFRP1 inhibitors or shRNA knockdowns are 
unable to direct changes in hESCs in MEF-CM.     
To further examine the potential effects of sFRP1 and sFRP2 on hESCs, we 
supplemented recombinant versions of these proteins in MEF-CM and EB medium.  
Since the sFRP family is known to regulate Wnt signaling, and sFRP1 and sFRP2 act 
directly on Wnt3a, we decided to investigate what role this pathway plays in hESCs [11].  
Direct supplementation of Wnt3a in either MEF-CM or EB medium proved beneficial for 
the maintenance of Oct3/4 and Nanog expression (Figure 5.8 A - C).  Supplementation 
with Wnt3a in EB medium also induced the expression of GSC in H9 and CA1 hESCs 
(Figure 5.8 D).  MIXL1 expression was also significantly upregulated in CA1 hESCs 
grown in the presence of Wnt3a (Figure 5.8 E).  
When H9 and CA1 hESCs were supplemented with recombinant sFRP1, sFRP2, and 
Wnt3a in MEF-CM, we observed that no significant changes were present at both the 
transcript and protein level (Figure 5.9 A, C, E).  However, in EB medium, we observed 
a significant increase in Nanog expression when sFRP1 or sFRP2 were supplemented 
in combination with Wnt3a (Figure 5.9 D, F).  In CA1 hESCs, we also observed an 
increase in Oct3/4 expression in the presence of Wnt3a and sFRP1 or sFRP2 (Figure 
5.9 B, F).  Unfortunately, the low-abundance of Nanog in differentiated hESCs 
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Figure 5.7. hESCs with combined exposure to sFRP1 inhibitors and shRNA 
mediated knockdowns.  H9 and CA1 hESCs transfected with shRNA expressing 
vectors against sFRP1, sFRP2, or scrambled control were grown in MEF-CM or 
embryoid body medium that was supplemented with small molecule inhibitors of sFRP1.  
Oct3/4 and Nanog expression were assayed by RT-PCR following 4 days of culture in 
the presence of supplementation.  (A) Fold change of Oct3/4 and Nanog expression 
relative to control for H9 and CA1 hESCs grown in MEF-CM supplemented with sFRP1 
inhibitor A.  Error bars represent SD, n=3.  (B) Fold change of Oct3/4 and Nanog 
expression relative to control for H9 and CA1 hESCs grown in embryoid body medium 
supplemented with sFRP1 inhibitor A.  Error bars represent SD, n=3.  (C) Fold change 
of Oct3/4 and Nanog expression relative to control for H9 and CA1 hESCs grown in 
MEF-CM supplemented with sFRP1 inhibitor B.  Error bars represent SD, n=3.  (D) Fold 
change of Oct3/4 and Nanog expression relative to control for H9 and CA1 hESCs 
grown in embryoid body medium supplemented with sFRP1 inhibitor B.  Error bars 
represent SD, n=3.  (E) Western blots for Oct3/4 and Nanog in H9 and CA1 hESCs 
transfected with shRNA expressing vectors grown in MEF-CM supplemented with 
sFRP1 inhibitors.  Actin is shown as an internal control.  (F) Western blots for Oct3/4 
and Nanog in H9 and CA1 hESCs transfected with shRNA expressing vectors grown in 
embryoid body medium supplemented with sFRP1 inhibitors.  Actin is shown as an 
internal control.  (G-J) Fold change of Goosecoid and MIXL1 expression relative to 
control for H9 and CA1 hESCs grown in embryoid body medium supplemented with 
sFRP1 inhibitor A (G-H) or sFRP1 inhibitor B (I-J).  Error bars represent SD, n=3.  All 
RT-PCR experiments used RPLPO as an internal control. 
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Figure 5.8. hESCs in MEF-CM and embryoid body medium with recombinant 
Wnt3a supplementation.  H9 and CA1 hESCs were grown in MEF-CM or embryoid 
body medium that was supplemented with recombinant Wnt3a.  Oct3/4 and Nanog 
expression were assayed by RT-PCR following 4 days of culture in the presence of 
supplementation.  (A) Fold change of Oct3/4 expression relative to control for H9 and 
CA1 hESCs grown in MEF-CM or EB medium supplemented with recombinant Wnt3a at 
100ng/mL.  Error bars represent SD, n=3. (B) Fold change of Nanog expression relative 
to control for H9 and CA1 hESCs grown in MEF-CM or EB medium supplemented with 
recombinant Wnt3a at 100ng/mL.  Error bars represent SD, n=3. (C) Western blots for 
Oct3/4 and Nanog in H9 and CA1 hESCs grown in the presence or absence of 100 
ng/mL of Wnt3a.  Actin is shown as a control.  (D) Fold change of Goosecoid 
expression relative to control for H9 and CA1 hESCs grown in embryoid body medium 
supplemented with recombinant Wnt3a,  at 100ng/mL.  Significance was determined 
through comparison with the appropriate EB medium control.  Error bars represent SD, 
n=3.  (E) Fold change of Goosecoid expression relative to control for H9 and CA1 
hESCs grown in embryoid body medium supplemented with recombinant Wnt3a,  at 
100ng/mL.  Significance was determined through comparison with the appropriate EB 
medium control.  Error bars represent SD, n=3.  All RT-PCR experiments use RPLPO 
as an internal control. 
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 confounded the validation of gene expression results at the protein level (Figure 5.9 E-
F).  Examination of GSC expression revealed significant increases in H9 hESCs in the 
presence of Wnt3a and sFRP1 or sFRP2 (Figure 5.9 G).  GSC could be reduced 
through the addition of sFRP1 and sFRP2 in CA1 hESCs (Figure 5.9 G).  However, this 
reduction could be reversed through the addition of Wnt3a (Figure 5.9 G).  In CA1 
hESCs we also observed a significant induction in MIXL1 expression in the presence of 
Wnt3a, sFRP1, and sFRP2 (Figure 5.8 H).  These data indicate that sFRP1 and sFRP2 
proteins are able to act on hESCs during differentiation on their own or through 
interaction with Wnt3a dependent on the growth factor composition of the 
microenvironment. 
5.2.4 Effect of sFRP Expression in Metastatic Melanoma Cells.  sFRP1 and sFRP2 
have multiple convergent and divergent roles in metastatic cell types (reviewed in [10]).  
To examine the effects of sFRP1 and sFRP2 expression we utilized a metastatic 
melanoma cell line (C8161) that was previously employed to demonstrate the 
reprogramming ability of hESC-derived CMTX [27, 36].  Expression of sFRP2 was 
found to be minimal in C8161 cells when compared with hESCs and HEK293 lines 
(Figure 5.10 A).  Interestingly, sFRP1 expression was similar to H9 hESCs based on 
RT-PCR data (Figure 5.10 A).  Since sFRP2 expression was found to be low, we 
transfected the C8161 cells with a vector containing the sFRP2 open-reading frame 
(ORF) under the control of a constitutive promoter.  After 48 hours post-transfection, 
C8161s transfected with the sFRP2 ORF had a significant decrease in total cell number 
compared to control cells transfected with the same vector without the sFRP2 ORF 
(Figure 5.10 B).  After selection with puromycin, no cells were able to form stable cell 
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lines from those transfected with the sFRP2 ORF, whereas numerous clones were 
derived from the control plate (Figure 5.10 B).  However, validation of sFRP2 
expression in C8161 cells was difficult due to the inability to harvest cellular RNA and 
protein as a result of cell death. 
To further assess the effects of sFRP1 and sFRP2 on the C8161s we carried out an 
anchorage independent growth assay.  C8161 cells that had been supplemented with 
200 ng/mL of sFRP1 and sFRP2 for 4 and 7 days were seeded into soft-agar and 
permitted to form colonies for 14 days.  Cells exposed to sFRP1 and sFRP2 had a 
significant increase in colony formation relative to control, whereas those exposed to 
sFRP2 had a significant decrease (Figure 5.10 C).  Although the sFRP2 supplemented 
wells displayed colonies, they tended to be smaller than those found in the sFRP1 or 
control wells (Figure 5.10 D).  Taken together, these data indicate divergent roles for 
sFRP1 and sFRP2 in metastatic C8161 cells.   
168 
 
 
 
 
 
 
Figure 5.9. hESCs in MEF-CM and embryoid body medium with recombinant 
protein supplementation.  H9 and CA1 hESCs were grown in MEF-CM or embryoid 
body medium that was supplemented with recombinant versions of sFRP1, sFRP2, and 
Wnt3a.  Oct3/4 and Nanog expression were assayed by RT-PCR following 4 days of 
culture in the presence of supplementation.  (A) Fold change of Oct3/4 expression 
relative to control for H9 and CA1 hESCs grown in MEF-CM medium supplemented with 
recombinant sFRP1, sFRP2, and Wnt3a, each at 100ng/mL.  (B) Fold change of Oct3/4 
expression relative to control for H9 and CA1 hESCs grown in embryoid body medium 
supplemented with recombinant sFRP1, sFRP2, and Wnt3a, each at 100ng/mL.  (C) 
Fold change of Nanog expression relative to control for H9 and CA1 hESCs grown in 
MEF-CM medium supplemented with recombinant sFRP1, sFRP2, and Wnt3a, each at 
100ng/mL.  (D) Fold change of Nanog expression relative to control for H9 and CA1 
hESCs grown in embryoid body medium supplemented with recombinant sFRP1, 
sFRP2, and Wnt3a, each at 100ng/mL.  Significance was determined through 
comparison with the appropriate MEF-CM or EB medium control.  Error bars represent 
SD, n=3.  (E-F) Western blots depicting Oct3/4 and Nanog protein expression for all 
experiments.  Actin is shown as a control.  (G-H) Goosecoid and MIXL1 expression as 
indicators of mesendoderm induction for H9 and CA1 hESCs grown in embryoid body 
medium supplemented with recombinant sFRP1, sFRP2, and Wnt3a, each at 
100ng/mL.  Significance was determined by comparison with MEF-CM and EB medium 
controls .  All RT-PCR experiments use RPLPO as an internal control.
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Figure 5.10. Metastatic melanoma cell line characteristics following sFRP1 and 
sFRP2 modulation.  C8161 metastatic melanoma cells were grown in the presence or 
absence of recombinant sFRP1 and sFRP2 or transfected with the sFRP2 open-reading 
frame under the control of a constitutive promoter.  (A) Expression of sFRP1 and sFRP2 
in H9 and CA1 hESCs, HEK293, and C8161 cells as determined by RT-PCR.  RT-PCR 
values are fold change relative to H9 hESCs using RPLPO as an internal control.  Error 
bars represent SEM, n=2.  (B) C8161 cells were transfected with either a vector 
containing the sFRP2 open-reading frame or with the same vector containing no insert.  
Cells were counted 48 hours post transfection and 7-days following the addition of 
puromycin to assess survival. Error bars represent SD, n=3.  (C) C8161 cells grown in 
the presence or absence of 200 ng/mL of sFRP1 and sFRP2 for 4 or 7 days were tested 
for anchorage independent growth using a soft-agar assay.  Pictures were taken after 7 
days, colonies were allowed to form for a total of 14 days prior to counting.  Error bars 
represent SD, n=3.  Significance was determined relative to control for all treatments.
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5.3 Discussion 
The interactions between hESCs and their soluble microenvironment are essential for 
control over pathways related to self-renewal and differentiation.  Cytokines involved in 
the regulation of these core pathways are often associated with other factors in the 
microenvironment that aid in the management of their activity or stability.  Many of these 
co-factors can be bound to, or present in the ECM.  As such, the study of the 
interactions between hESCs and the ECM represents a potentially rich source of 
information regarding regulation of core pluripotency pathways.  Highlighting this is the 
recent observation that hESC-derived matrix microenvironments can reprogram 
metastatic melanoma cells [27, 36].  Bioactive factors deposited by hESCs during 
growth are able to direct cell-fate through activity in extracellular pathways within the 
microenvironment [27].  However, currently there are few studies that aim to investigate 
the interactions of hESCs with the ECM mediated by protein deposition in the 
extracellular space.   
Based on our work, growth on CMTX in the absence of bFGF promotes the 
maintenance of an undifferentiated state in hESCs.  This indicates that hESCs are 
depositing factors in the CMTX that serve to regulate the stem cell state.  To investigate 
this finding further and to validate the ability of our MS-based proteomics screen to 
identify hESC regulatory factors in the matrix, we targeted sFRP1 and sFRP2 for 
functional analysis.  sFRP1 and sFRP2 are thought to regulate canonical Wnt signaling 
through direct binding to the soluble Wnt cytokines or their cognate membrane 
receptors (reviewed in [23]).  However, the role of sFRP1 and sFRP2 in hESCs remains 
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unclear.  By utilizing a combination of methods, we analyzed the roles of these Wnt 
regulators in hESCs.   
Using shRNA mediated inhibition of sFRP1 and 2 we observed no significant change in 
Oct3/4 and Nanog in MEF-CM.  Similar trends can be observed in the sFRP1 inhibitor 
data, where neither inhibitor is able to direct a significant change in pluripotency marker 
expression at both the transcript and protein level.  When shRNA mediated knockdown 
of expression sFRP1 or sFRP2 is combined with the sFRP1 inhibitors, we observe no 
significant change in Oct3/4 and Nanog expression at the transcript and protein level.  
Taken together, these findings indicate that sFRP1 and sFRP2 are not able to direct a 
significant change in hESCs grown in the complex growth factor microenvironment 
provided by MEF-CM.  However, these findings are limited by the lack of positive control 
for the small molecule inhibitor due to the poor transfectability coupled with the low 
activity of the canonical Wnt pathway in hESCs.   
To determine whether sFRP1 or sFRP2 were acting through Wnt signaling activated by 
Wnt3a, we investigated their effects when supplemented exogenously.  Previous 
studies have demonstrated that Wnt signaling in ESCs functions in an ‘activation’ type 
model [37, 38].  In this model, Wnt signaling induced by Wnt3a promotes hESC survival 
and proliferation, but also differentiation to mesendoderm, dependent on the culture 
conditions.  However, there is discordance in the literature regarding the activity of Wnt 
signaling in hESCs, where activation of canonical signaling through Wnt3a is believed to 
prevent differentiation, referred to as the ‘maintenance’ model [39].  Based on our 
observations Wnt3a functions in the ‘activation’ model to promote stem cell fate 
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determination.  Supplementation of exogenous Wnt3a promotes hESC survival and 
proliferation, as well as differentiation dependent on the growth factor conditions.  
Addition of recombinant sFRP1 and sFRP2 in combination with Wnt3a were able to 
induce pluripotency marker expression, but only in EB medium in the absence of other 
exogenous growth factors.  When supplemented into Matrigel™ matrix to generate an 
artificial CMTX, both sFRP1 and sFRP2 could not induce maintenance of an 
undifferentiated state of hESCs.  These data suggest that sFRP1 and sFRP2 are not 
required for the maintenance of hESC pluripotency in the presence of other growth 
factors, such as in MEF-CM.  However, based on the observation that sFRP1 and 
sFRP2 can regulate the expression of GSC and MIXL1, they are potentially acting to 
regulate Wnt induced formation of mesendoderm in differentiating hESCs.   
These findings are in agreement with the current ‘activation’ type model suggested for 
Wnt regulation in hESCs and recent data regarding the cooperative action of the Wnt, 
FGF, and Activin/Nodal pathways [37].  Wnt activation in hESCs grown in the presence 
of a supportive growth factor environment can help promote survival and proliferation 
[39].  However, in MEF-CM Wnt signaling is not required for the maintenance of self-
renewal or pluripotency, and cannot direct a cellular change in the presence of strong 
activation of the core stem cell Activin/Nodal and FGF signaling pathways [40].  In the 
absence of growth factor supplementation, activation of Wnt signaling promotes 
differentiation to mesendoderm, a process that can potentially be regulated by sFRP1 
and sFRP2.    
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Due to the biphasic mode of activity for sFRPs as well as Wnt signaling, the ability of 
sFRP1 or sFRP2 to regulate hESC behavior is potentially dependent on the dynamic 
balance between the interacting partners [20, 41].  The recombinant protein 
concentrations tested in our assay may not have been optimal for sFRP activity in the 
presence of other Wnt regulatory proteins.  Previous studies that have attempted to 
study the effects of sFRP supplementation on hESCs have required the use of non-
physiological amounts of recombinant protein to observe a minor effect [42, 43].  The 
interactions between sFRP proteins and Wnt ligands may also require facilitation 
through binding with the ECM, as indicated by the identification of sFRP1 and sFRP2 in 
the CMTX.  sFRP action is known to be regulated by heparin mediated binding to Wnt 
as well as to the ECM [20, 44].  These interacting factors may cooperate to promote 
hESC fate determination through regulation of Wnt ligand availability.  In other cell 
types, the sFRP proteins have been reported to antagonize, but also augment canonical 
Wnt signaling [11, 45].  In the metastatic C8161 cell line we observed that sFRP1 
promoted and sFRP2 inhibited their malignant potential based on colony formation in a 
soft-agar assay.  In addition, overexpression of sFRP2 prompted a significant decrease 
in viable cell number.  These findings are not surprising given the divergent roles for 
sFRP1 and sFRP2 in a variety of pathological conditions (reviewed in [17, 22]).  
However, based on the limited effects of sFRP1 and sFRP2 on hESC state, it is likely 
that other factors are combining to contribute to the dynamic regulation of the core 
pluripotency pathways in vitro.        
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5.4 Methods 
5.4.1 Cell culture and harvest – H9 (passage 26) and CA1 (passage 20) hESCs were 
maintained on CF-1 irradiated mouse embryonic fibroblast (MEF) feeder layers 
(GlobalStem, Rockville, MD) using media composed of knockout DMEM/F12, 20% 
knockout serum replacement, 1% non-essential amino acids, 2 mM glutamine (CellGro, 
Manassas, VA), 0.1 mM 2-mercaptoethanol (Fisher, Toronto, ON), and 4 ng/mL of basic 
fibroblast growth factor.  For feeder-free growth, conventional hESC medium that was 
conditioned on a layer of mouse embryonic fibroblast feeders (MEF-CM) was used with 
Matrigel™ (BD Biosciences, Franklin Lake, NJ) coated plates.  Medium used for the 
induction of differentiation in CMTX experiments uses the same recipe as conventional 
hESC media for growth on MEF feeders as outlined above, minus basic FGF.  All media 
reagents were obtained from Invitrogen unless noted otherwise.  H9 cells were obtained 
from WiCell (WISC, Wisconsin).  The CA1 hESC line used in all experiments was 
obtained from Dr. Cheryle Séguin of The University of Western Ontario [46, 47].  The 
hiPSC line BJ-1D was derived by reprogramming using retroviral transduction of BJ 
fibroblasts with the Yamanaka factors essentially as we have previously described [48] 
and validated as pluripotent using in vitro and in vivo differentiation assays and 
expression profiling (unpublished results).  Cells were passaged mechanically in all 
experiments and for general maintenance.  
Embryoid bodies (EB) were generated using Aggrewell 400Ex plates (StemCell 
Technologies, Vancouver, Canada). Briefly, 2 x 106 hESCs were harvested 
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enzymatically using Accutase (Invitrogen) from Matrigel™ coated plates.  Cells were 
reconstituted in Aggrewell medium supplemented with Rock inhibitor (Y-27632, Sigma-
Aldrich, St. Louis, MO) at a final concentration of 10 μM.  After plating in Aggrewell 
dishes, EBs were grown for 48 hours at 37°C prior to transfer to ultra-low adherence 
tissue culture dishes (Corning, Lowell, MA).  After 15 days of culture, EB RNA was 
harvested using Trizol extraction according to the manufacturer’s instructions 
(Invitrogen).  EBs were assayed for expression of CDX2, alpha-feto protein (AFP), 
GATA-6, GATA-4, Oct3/4, PAX-6, T-brachyury, Nanog, and Neurogenic differentiation 1 
(NeuroD1) using TaqMan primer probe sets (Invitrogen).  Assay information can be 
found in Appendix Table 1.15.  All EB assays were performed in biological and technical 
duplicate for each cell line and condition.    
5.4.2 sFRP Knockdown and Inhibition - sFRP2 and sFRP1 shRNA knockdown cell lines 
were generated using the pSUPERIOR.neo + GFP vector (Oligoengine, Seattle, USA).  
shRNA sequences were obtained using the shRNA design tool from Ambion.  Oligos 
were designed to contain 5’ XhoI and 3’ HindIII restriction enzyme sites.  All oligos were 
synthesized by Invitrogen unless otherwise noted.  Oligos were ligated into 
pSUPERIOR.neo + GFP vector that was previously digested with XhoI and HindIII (New 
England Bioloabs, Ontario, Canada) and transformed into TOP10 chemically competent 
E. coli (Invitrogen). Transformed clones were selected based on ampicillin resistance 
and plasmid purified using a PureLink HiPure Midi-prep kit (Invitrogen).  shRNA 
effectiveness was tested in HEK293 cells stably transfected with the pCAGTetRnls 
vector (Addgene.org).  After transfection with pSUPERIOR, HEK293 cells were 
maintained in RPMI + 10% FBS containing 700 ng/mL puromycin and 700 µg/mL G418.  
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shRNA efficiency was determined after 4 days of induction using 1 µg/mL of 
doxycycline.  Sequences for the shRNA constructs found to give the greatest decrease 
in specific gene expression were selected for use in hESCs.  Selected shRNA 
sequences can be found in Appendix Table 1.16.     
hESC lines were transiently transfected with GeneIn reagent (GlobalStem, Rockville, 
MD).  H9 (p30) and CA1 (p22) hESCs were plated at ~80% confluence 24 hours prior to 
transfection.  GeneIn reagents (1:1 mixing ratio) were combined with 4 μg of vector and 
supplemented into MEF-CM.  hESCs were incubated in the media-transfection reagent 
mixture for 24 hours, followed by a second treatment for a further 24 hours.  In cases 
where differentiation was induced, the second transfection was performed in hESC 
media –bFGF.  Transfection efficiency was determined using flow cytometry based on 
detection of the GFP reported on the pSUPERIOR vector. 
Inhibition of sFRP-1 was carried out using two separate small molecules obtained from 
Calbiochem (EMD Biosciences, Darmstadt, Germany) [32].  Inhibitors were 
supplemented at concentrations of 5, 10, 20, 40, and 80 μM in MEF-CM or medium that 
contained no bFGF.  Controls were supplemented with the maximum amount of DMSO 
used in the experiments with inhibitors present.  hESCs were grown in the presence of 
inhibitor for a period of 4 days during which medium was changed daily. 
5.4.3 Generation of Conditioned Matrix – H9 or CA1 stem cells were grown in feeder-
free conditions on Matrigel™ in MEF-CM.  Stem cells were permitted to grow for a 
period of 5 days on Matrigel™ for generation of CMTX.  Wells were then rinsed 
thoroughly with PBS to ensure removal of medium components and cells removed from 
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the Matrigel™ layer using Cell Recovery Solution according to the manufacturer’s 
instructions (BD Biosciences).    Fresh hESCs were plated on the after rinsing of the 
matrix layer.  After 24h of culture, hESCs were induced to differentiate through feeding 
with conventional hESC media –bFGF.  Control experiments were prepared using 
regular Matrigel™ that had not been conditioned but had been treated with the cell 
removal process.   
In antibody blocking CMTX experiments, antibodies were obtained as follows: sFRP2 
(Origene, Rockville, MD), sFRP1, Lefty 1, 2 (Epitomics, Burlingame, CA).  Anti-rabbit 
IgG secondary antibody was used as a control.  After cell removal from the conditioned 
Matrigel™, layers were rinsed with 1:1000 dilutions of manufacturer antibody stocks in 
1% bovine albumin in PBS.  Matrices were incubated for 2 hours at 37°C.  After 
incubation, layers were rinsed multiple times with PBS prior to plating of fresh hESCs.  
In supplementation CMTX experiments, recombinant sFRP1, sFRP2, Lefty A or B, or 
Gremlin were added to Matrigel™ prior to polymerization at a concentration of 5 μg/mL.  
After incubation at 37°C for 1 hour, matrices were treated with the cell removal process 
and rinsed prior to playing of fresh hESCs.  Recombinant sFRP1 & 2, Lefty A, and 
Gremlin proteins were obtained from R&D Systems (Minneapolis, MN).  Recombinant 
Lefty B was obtained from Sigma (St. Louis, MO).  In all cases, cells were fed daily with 
hESC media –bFGF for 3 days prior to harvest. 
5.4.4 Metastatic Melanoma Cell Experimentation – C8161 cells (described in [49]) were 
cultured in RPMI containing 10% FBS (Invitrogen).  In anchorage independent growth 
assays, C8161 cells were maintained in the presence or absence of 200ng/mL of 
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sFRP1 and sFRP2 for 4 – 7 days.  At each time point, cells were harvested by 
trypsinization and counted.  Soft-agar experiments were performed by resuspending 
9,000 cells in a mixture of RPMI/10% FBS + 0.35% agarose.  This mixture was plated 
onto a previously prepared layer of RPMI/10% FBS + 0.5% agarose in single well of a 
6-well dish.  Cells in soft-agar were fed every 3 days.  Colonies were allowed to form for 
14 days after plating.  Colonies were counted after staining with 0.005% crystal violet in 
PBS.  Soft-agar assays were performed in triplicate for each time point and condition 
tested. 
C8161 transfections were carried out using GeneIn Reagent (GlobalStem).  For each 
transfection, 2 µg of total DNA was diluted in 200 µL of OptiMEM with 3 µL of each 
GeneIn reagent.  Approximately 10,000 C8161 cells were plated in a single well of a 6-
well dish 24 hours prior to transfection.  Cells were transfected with the pCMV-IRES-
GFP-Puro (Origene, Rockville, MD) vector with or without the sFRP2 open reading 
frame (Origene).  Transfection efficiency was monitored using GFP expression.  Cells 
were selected using 700 ng/mL of puromycin 48 hours after transfection.  Total viable 
cells were counted using typan blue exclusion 48 hours and 7-days post transfection.  
Experiments were repeated in triplicate for each treatment.           
5.4.5 Real-time PCR – RNA was purified using Trizol reagent according to the 
manufacturer’s instructions (Invitrogen) with the following modification: precipitated RNA 
pellets in isopropanol were centrifuged for 60 minutes at 12000 g at room temperature.  
After NanoDrop quantification, 1 µg of cDNA was synthesized using the High Capacity 
cDNA Reverse Transcription Kit with RNase inhibitor (Invitrogen).  Real-time PCR was 
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performed using the TaqMan® Universal PCR Master Mix (Invitrogen).  Samples were 
incubated at 50°C for 2 minutes followed by 10 minutes at 95°C.  Samples were then 
amplified at 95°C for 15 seconds followed by 1 minute at 58°C for 46 cycles.  All 
samples were normalized to the large ribosomal protein RPLPO as a positive control.  
All primers were obtained from Invitrogen and assay information can be found in 
Appendix Table 1.15.  Each biological replicate was run in triplicate for every marker 
assayed.  All reagents were used according to the manufacturer’s instructions.   
5.4.6 Immunofluorescence – Immunofluorescence was performed as described 
previously [50].  Briefly, cells were rinsed and fixed with 4% para-formaldehyde 
containing 20 mM sucrose.  Fixed cells were permeabilized using 0.1% Triton-X100.  
Prior to staining, cells were blocked using the Dako Serum Free Protein Block solution 
(Dako, Cambridgeshire, UK).  Oct-4 (clone 10H11.2), SSEA-4 (clone MC-813-70), and 
SSEA-1 (clone MC-480) primary antibodies were obtained from Millipore (Billerica, MA).  
Cells for Oct-4 labeling were permeabilized using a 0.1% Triton X-100 solution prior to 
blocking.  Cells were labeled with primary antibodies for Oct-4 or SSEA-4 as 
undifferentiated markers and SSEA-1 for differentiated cells all at concentrations 
concentrations of 2 μg/mL for 60 minutes at room temperature.  Secondary Alexa-fluor 
488 goat anti-mouse IgG and Alexa-fluor 568 goat anti-mouse IgM were obtained from 
Invitrogen (Carlsbad, CA).  Secondary antibodies were probed at concentrations of 1 
μg/mL for 60 minutes at room temperature.  All products were used according to 
manufacturer’s instructions. 
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5.4.7 Flow Cytometry – All reagents and probes for flow cytometry were obtained from 
eBiosciences (San Diego, CA) unless noted otherwise.  Cells were enzymatically 
harvested using Accutase (Invitrogen) to obtain a single cell suspension.  After 
centrifugation, cell pellets were resuspended in 5% FBS in PBS.  Alexa-488 conjugated 
SSEA-4 and Alexa-647 conjugated SSEA1 were diluted into the cell mixture according 
to the manufacturer’s instructions.  Negative control samples contained respective 
isotype controls for the primary antibodies used.  Solutions were incubated for 2 hours 
and analyzed using an Accuri C6 (BD Biosciences) flow cytometer after rinsing to 
remove unbound antibody.  Populations were gated according to forward and side 
scatter patterns with filtering for viable cells using 7-aminoactinomycin D staining.  Data 
was analyzed using FlowJo software (Tree Star, Ashland, OR). 
5.4.8 Immunoblotting –   Harvested cell pellets were reconstituted in mammalian protein 
extraction reagent containing protease inhibitor cocktail (Thermo Fisher, Toronto, 
Canada).  20 µg of protein based on Bradford assay was run on an 8% SDS-Gel.  
Proteins were transferred to a PVDF membrane (Millipore) and incubated in 5% milk 
overnight at 4°C.  After rinsing in TBS containing 0.1% Tween-20, membranes were 
incubated for 4 hours with primary antibodies.  Oct3/4, Nanog, sFRP1, and sFRP2 
antibodies were obtained from Epitomics (Burlingame, CA).  β-Actin antibody was 
obtained from Santa Cruz Biotech (Santa Cruz, CA).  After rinsing, membranes were 
incubated with specific HRP-conjugated secondary antibodies for 1 hour.  Blots were 
developed using Pierce ECL reagent and CL-Xposure film (Thermo).     
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5.4.9 Statistical Analysis – Statistical analyses were performed using GraphPad Prism 
software.  Results are expressed as SD or SEM as indicated in figure legends.  
Statistical significance was determined using one-way ANOVA with Tukey post-hoc 
analysis.  When only two samples were being compared, unpaired Students T-tests 
were applied.  Differences were reported as follows: * p < 0.05, ** p < 0.01, *** p < 
0.001.
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Chapter 6 
Discussion 
 
6.1 Summary of Accomplishments 
It is clear that the microenvironment plays a critical role in the regulation of hESC fate.  
Central to the potential application of hESCs in therapeutic applications are advances in 
controlled methods for modulating the pluripotent state.  Paramount for development is 
increasing our knowledge of the processes eliciting control in this dynamic environment.  
To obtain a complete understanding of the in vitro stem cell niche, analysis of soluble 
and ECM contributors to this environment is necessary.  Due to the complex 
requirements for the in vitro maintenance of hESCs, direct analysis of the ECM presents 
a significant challenge.  To this end, we have developed proteomic methodologies for 
the direct study of the ECM portion of the microenvironment (Chapters 2 – 3).  
Additionally, we have demonstrated the application of these methods to the analysis of 
this complex environment, and in doing so have elucidated novel factors involved in 
hESC regulation (Chapters 4-5). 
 
 
This chapter contains excerpts from the following paper:  
Hughes, C.S., Radan, L., Stanford, W., Betts, D., Postovit, L.M., Lajoie, G.. (2012) 
“Mass Spectrometry-Based Proteomics Analysis of the Matrix Microenvironment in 
Pluripotent Stem Cell Culture”. (In Preparation) 
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The complexity of Matrigel™ necessitates the use of quantitative proteomics techniques 
to study the ECM portion of the microenvironment.  To this end, we have developed 
conditions for the application of the metabolic labeling approach, SILAC, to hESCs 
(Chapter 2).  This new protocol eliminates conversion of isotopically labeled arginine 
amino acids to proline derivatives and represents a significant increase in simplicity and 
reduction in cost when compared with alternative methods for addressing this 
conversion.  We also further extend our SILAC approach to a defined hESC media 
formulation.  This defined alternative offers an attractive platform for the study of the 
microenvironment free of contaminating contributions from MEF feeder layers present in 
conditioned medium.  Furthermore, the extension of this defined medium to the growth 
of hiPSCs presents new opportunities for the quantitative study of stem cell biology. 
A secondary challenge for the analysis of the ECM portion of the microenvironment is 
the protein complexity of these matrices.  MS-based proteomics studies consistently 
struggle to identify the low-abundance components of complex mixtures in the face of a 
large dynamic range of protein concentration.  This is further complicated with ECM 
mixtures due to their propensity to polymerize when not chilled.  Although our 
quantitative SILAC strategy would enable distinction between hESC and Matrigel 
derived proteins, the presence of candidates derived from both sources significantly 
increases the complexity of the CMTX solution.  In order to facilitate the detection of low 
abundance hESC derived proteins, we have shown the benefits of using a combination 
of conventional proteomics techniques (Chapter 3).  Upon application for the analysis of 
Matrigel and other cell-derived matrices, we successfully achieve significant depth of 
coverage in these complex samples.  Furthermore, we illustrated the utility of analyzing 
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matrices used in stem cell culture for the elucidation of components critical for the 
maintenance of hESC pluripotency. 
Finally, through application of the SILAC (Chapter 2) and ECM analysis methodologies 
(Chapter 3), we obtained a proteomic profile of a matrix layer preconditioned by hESCs 
(Chapter 4).  We then reconcile proteomic datasets from the soluble and ECM portions 
of the microenvironment previously obtained.  Investigation of the CMTX revealed that 
hESCs generate a self-sustaining niche rich in supportive factors found in Matrigel, as 
well as in conditioned medium.  Functional validation of candidate factors illustrates the 
complexity of hESC-ECM interactions (Chapter 5).  Taken together, these studies will 
aid in the development of tools for studying the complex interactions between hESCs 
and their microenvironment.             
6.2 The hESC Niche and the ECM 
One of the primary goals of research focused on the microenvironment is to elucidate all 
the processes involved in the control of hESC fate.  The ability to control if a stem cell 
self-renews or differentiates is critical to the potential therapeutic application of hESCs.  
Parallel to this need is the ability to direct lineage specific differentiation to generate 
pure populations of tissue-specific cell types.  Currently, hESC differentiation is directed 
through the use of cocktails of exogenously supplemented growth factors (reviewed in 
[1]).  Depending on the desired cell type, multiple differing cocktails can be required 
dependent on the time point of the differentiation protocol [2].  Which factors are 
supplemented is conventionally determined through large screens of proteins involved 
in pathways that are known to be critical for the regulation of pluripotency.  However, 
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many of these generated protocols struggle to produce pure populations of tissue-
specific cell types.  This shortcoming stems from an incomplete understanding of all of 
the processes contributing to hESC control within the in vitro microenvironment.  As we 
have shown in this thesis, these processes can potentially be governed by interactions 
of hESCs or cytokines with the ECM. 
6.2.1 Wnt Signaling in the Microenvironment  
There are three primary pathways that are activated upon binding of Wnt ligands to their 
cognate receptors (For a review of Wnt signaling, see [3, 4]).  The canonical pathway 
involves interaction of Wnt ligands at the cell surface with Frizzled (Fz)/low-density 
lipoprotein receptor-related protein (LRP) complexes.  In the absence of Wnt, 
cytoplasmic β-catenin is associated with a complex containing Axin and Adenomatous 
Polyposis Coli (APC).  This complex facilitates the phosphorylation of β-catenin by 
glycogen synthase kinase 3-β (GSK-3β) resulting in its subsequent degradation.  Upon 
binding of Wnt ligands, phosphorylation of β-catenin is inhibited allowing it to translocate 
to the nucleus where it regulates gene expression through interaction with lymphoid 
enhancer factor (LEF)/T-cell factor (TCF) transcription factors.   
In the extracellular space, Wnt proteins are relatively insoluble due to the presence of a 
palmitoyl lipid modification.  This modification has been shown to be important for the 
secretion, activity, and solubility of Wnt proteins as well as for their interactions with 
binding partners [5].  In the extracellular space Wnt signaling is antagonized through 
interactions with a variety of inhibitors (reviewed in [6]).  The two main groups are the 
soluble frizzled related proteins (sFRP) and the Dikkopf (Dkk) family.  Dkk proteins are 
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believed to inhibit canonical Wnt signaling through interaction with the LRP receptors 
[6].  The sFRP family is thought to bind directly to the Wnt ligands themselves, leading 
to a diverse array of potential roles for these proteins other than antagonism.  This is 
emphasized by the multiple divergent roles for the sFRP family members in a variety of 
pathological conditions (reviewed in [7, 8]). 
In mouse ESCs, activation of the canonical Wnt pathway is understood to promote the 
maintenance of self-renewal and pluripotency (reviewed in [9]).  In human ESCs, the 
picture is less clear, and contrasting roles for canonical Wnt signaling have been 
suggested [10, 11].  However, recent data has garnered support for a model of Wnt 
signaling activation that supports stem cell fate determination [12, 13].  Activation of 
canonical Wnt signaling enhances hESC growth and survival in an undifferentiated 
state, as well as their differentiation.  However, aberrant regulation of the canonical 
pathway is thought to be involved in diseases such as cancer [3].  Therefore, control 
over the activity of Wnt ligands in the extracellular space is potentially critical for the 
proper maintenance of the ES cell phenotype.                         
From our analysis it remains unclear what role the sFRP proteins play in the regulation 
of Wnt signaling in the extracellular space and the resultant changes in hESC 
phenotype (Chapter 5).  shRNA mediated knockdown of sFRP1 or 2 gene expression or 
direct inhibition of sFRP1 protein using a small molecule inhibitor results in no change in 
expression for Oct3/4 and Nanog, hallmarks of pluripotency.  Based on our findings with 
direct supplementation of soluble recombinant Wnt3a, it is clear that Wnt3a promotes 
stem cell fate determination dependent on the growth factor microenvironment.  sFRP1 
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and sFRP2 are unable to inhibit Wnt3a induced changes when supplemented in MEF-
CM.  These data are potentially confounded by the presence of numerous other Wnt 
regulatory proteins in both hESC conditioned medium [14] and in the CMTX (Chapter 4-
5), such as Cerberus.  The reduction of sFRP activity through small molecule inhibition 
or shRNA knockdown is potentially compensated for by these other regulatory proteins 
or increased activity of additional sFRP family members.  The effects of direct 
supplementation of sFRP1 and sFRP2 are also potentially reduced in this way, where 
other proteins can restore the proper balance of Wnt activity.  The complexity and 
cross-talk in signaling pathways present in the microenvironment suggests that a 
combination of factors act on hESCs.  This is highlighted by the results of our 
proteomics screen where other antagonists of core pluripotency pathways were 
identified.    
6.2.2 TGF-β Signaling in the Microenvironment 
In the MS-based proteomics screen of CMTX we identified factors implicated in the 
regulation of TGF-β pathways, specifically Lefty 1 and 2 and Cerberus proteins (Chapter 
4).  The TGF-β superfamily of proteins consists of over 30 members, including Activins, 
Nodal, and bone morphogenic proteins (BMP).  TGF-β family members are directly 
involved in processes such as cell growth and apoptosis.  Furthermore, this family has 
been implicated as playing a prominent role during embryonic development in 
processes such as gastrulation and patterning (reviewed in [15]).  TGF-β signaling 
primarily operates via transmission of extracellular signals through complexes of type-I 
(activin receptor-like kinases, e.g. ALK4, ALK7) and type-II (activin receptor IIB, 
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ActRIIB) transmembrane receptors and their associated co-factors (e.g. Cripto).  These 
signals are translated to phosphorylation events in different complexes of Smad 
proteins that in turn regulate target gene expression in the nucleus (reviewed in [15]).     
TGF-β signaling is mediated through interactions between soluble factors in the 
microenvironment.  The Lefty proteins are extracellular antagonists of TGF-β signaling 
that act through inhibition of the embryonic morphogen Nodal [16].  Regulation of Nodal 
activity through inhibition by Lefty has been shown to be critical for proper development 
during embryogenesis [16].  In hESCs, activation of the Smad2/3 branch of the TGF-β 
pathway mediated by Nodal or Activin is known to be one of the core processes critical 
for the maintenance of self-renewal and pluripotency [17, 18].  Defined media such as 
E8 and the defined SILAC medium employed here contain exogenous Activin or Nodal 
to facilitate the maintenance of undifferentiated hESCs [19, 20].  Activin has also been 
found in MEF conditioned medium screened using MS-based proteomics [14, 21].  
Inhibition of Lefty proteins has been shown to promote maintenance of undifferentiated 
hESCs; however, correct differentiation of these cells is impaired [22].  Interestingly 
however, inhibition of Nodal using Lefty does not induce differentiation of hESCs [18].  
Moreover, induction of Lefty has been observed to be important for exit from the 
pluripotent state in embryoid body formation assays [23].  Taken together, these 
findings indicate that Lefty functions to maintain a balance of Nodal induced TGF-β 
initiation in hESCs.    
Detection of Lefty isoforms in CMTX illustrates that hESCs are secreting factors to 
generate a matrix microenvironment designed to regulate extracellular signaling 
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involving soluble factors.  Although the direct supplementation of recombinant Lefty was 
not able to enhance the maintenance of an undifferentiated state in hESCs induced to 
differentiate, regulation of Nodal signaling by Lefty in the microenvironment has 
previously been observed to be facilitated through interactions with the ECM [24].  In 
Xenopus embryos, the interaction of Lefty with ECM linked heparan sulfate 
proteoglycans has been observed to facilitate control over Nodal signaling [24].  The 
ECM enhances the stability, transport, and effective range of the Lefty and Nodal 
proteins [24].  These effects aid in the generation of morphogen gradients important for 
proper development.  Similar processes in the microenvironment potentially contribute 
to maintenance of a ‘primed’ hESC state, wherein control over differentiation is 
enhanced by interactions between Lefty and Nodal facilitated by the ECM.    
The ability of Lefty containing CMTX to enhance maintenance of an undifferentiated 
state is potentially acting through pathways alternative to Nodal induced TGF-β 
activation.  The positive effects of Nodal signaling on hESCs are well established [17, 
18].  However, exogenous supplementation with Lefty does not induce differentiation of 
hESCs [18].  Expression of Nodal and Lefty proteins are known to be rapidly decreased 
following the induction of differentiation [25].  The presence of Lefty in the CMTX and 
the absence of hESC derived Nodal following differentiation potentially confer an 
enhancement in the maintenance of undifferentiated cells through other TGF-β 
pathways.  BMP signaling through Smad 1/5/8 is observed to be increased specifically 
in differentiated hESCs [25].  Moreover, BMP signaling induced by the extracellular 
cytokine BMP-4 is known to induce differentiation of hESCs, and its inhibition using 
antagonists such as Noggin to block differentiation [26, 27].  Lefty has been observed to 
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inhibit BMP-4 induced TGF-β activation by blocking the phosphorylation of Smad 
proteins in P19 embryonal carcinoma cells [28].  In our CMTX experiments, Lefty may 
be acting on BMP-4 induced TGF-β signaling and thereby inhibiting differentiation 
resulting from activation of this pathway.  This is highlighted by the presence of other 
factors in the CMTX that inhibit Nodal/BMP signaling, such as Cerberus.       
6.2.3 New View of the hESC Microenvironment  
Using the assays presented here we observed the ability of the CMTX, containing 
regulators of the Wnt and TGF-β pathways, to alter the behavior of hESCs in the 
microenvironment.  However, in our recombinant and antibody blocking CMTX 
experiments, both of these pathways were monitored individually and neither was able 
to fully recapitulate the positive effect observed for hESCs on CMTX.  The 
microenvironment is considered to be an effector of cellular change acting through a 
dynamic balance resulting from an array of contributors.  As such, it is likely that the 
core pathways we have investigated here function together in the CMTX to generate the 
observed effect.  Indeed, multiple levels of cross-talk have been suggested amongst the 
FGF/TGF-β/Wnt pathways [13, 29].  In hESCs, the maintenance of self-renewal and 
pluripotency is controlled by the co-operative activity of these three core pathways.  The 
addition of the ECM to this model adds an additional layer of complexity, wherein 
proteins bound to the matrix can act to regulate individual pathways, the effects of which 
are subsequently potentiated through cross-talk with others.  Given the known roles of 
the ECM in the contribution to the generation of morphogen gradients in other 
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developmental systems, it is not hard to envision a similar activity regulating 
pluripotency in the hESC niche.    
6.3 Development of ECM Environments for hESCs 
The ECM is one of the core elements governing cellular changes in the 
microenvironment.  Not only can the ECM regulate cell growth, attachment, and 
movement, but in hESC culture can affect processes such as differentiation.  The 
beneficial effects of the ECM are further highlighted by the positive outcome observed 
when in vivo injections directed at teratoma formation are performed using hESCs 
diluted in Matrigel™ [30].  The proposed mechanism for the enhancement observed in 
the presence of Matrigel™ is related to the reduction of apoptosis through interactions 
with the ECM and the potential for Matrigel to induce growth factor stimulation [30].  The 
xenogenic nature of Matrigel inhibits its use with injections or otherwise in potential 
therapeutic strategies.  Developing an understanding of the processes and factors 
regulated by the components of Matrigel, or other hESC supportive matrices will aid in 
the generation of xeno-free matrices for use in vitro or in vivo.   
Using the techniques presented in this thesis, analysis of the diverse range of matrices 
available for hESC culture will assist in the development of ECM supports suitable for a 
wide range of hESCs.  Using MS-based proteomics we demonstrate the utility of 
determining the composition of cell-derived and recombinant growth matrices used in 
hESC culture (Chapter 3).  From these studies we were able to elucidate factors directly 
related to the enhancement of hESC growth in in vitro culture.  Moreover, using the 
methods developed and optimized here to facilitate the analysis of hESC-derived 
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matrices, we were able to characterize a novel self-supportive matrix microenvironment 
generated by the stem cells during growth in vitro.  The findings of these works will have 
a direct application towards obtaining a comprehensive understanding of hESC 
interactions within the microenvironment.  Perhaps more importantly however, the 
information contained in this thesis can be used to aid in the development of 
biomaterials designed to mimic the ECM. 
In recent years, as a direct result of the potential for the application of stem cells in 
therapeutic applications, numerous biomaterials have been tested for their viability for 
the maintenance of hESCs (reviewed in [31]).  Natural materials such as collagen, 
hyaluronic acid, and alginate have all shown promise for the control of self-renewal or 
differentiation of stem cells [32-34].  Synthetic materials such as PLGA and PEG have 
also been utilized to control the properties of stem cells in vitro (reviewed in [35]).  
Pioneering work from the Langer group was one of the first studies to analyze hESC-
ECM interactions on a large-scale using synthetic polymer based arrays [36, 37].  
Utilizing different combinations of acrylate, diacrylate, dimethacrylate, and triacrylate 
monomers, they profile over 1700 ECM interactions in a single array.  In recent years, 
nano-scale array platforms that utilize conventional DNA spotting technology have 
facilitated the analysis of a wide range of biomaterials for their effect on stem cell 
maintenance and differentiation [38-42].  The designs of polymers or bioactive materials 
to be screened are typically done in a discovery type fashion, or through mimicry of 
known cell-ECM interactions.  Elucidating core ECM factors present in cell-derived 
matrices can potentially aid in directing these array-based screens.  By focusing on 
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matrices known to be beneficial for stem cell maintenance, factors identified in our 
proteomics screen can be used to generate biomaterials tailored for hESCs.     
Aside from the ability to regulate the activity of these matrices through modulation of 
properties such as stiffness, size, and shape, other physical modifications can be made 
to promote the desired experimental outcome [35].  The addition of bioactive growth 
factors directly to the polymerized matrix has been used to modulate the self-renewal 
and differentiation of hESCs [43, 44].  Controlling the availability of these growth factors 
can be regulated through the addition of compounds such as heparan sulfate to the 
matrix [35].  Based on the findings presented here, the presence of multiple soluble 
growth factor binding and regulatory proteins in the matrix can regulate the 
differentiation of stem cells.  By determining the pathways that are potentially regulated 
by candidate proteins identified in the CMTX, our proteomic analyses can aid in the 
development of biomaterials that mimic the necessary binding or cytokine requirements.  
Furthermore, investigating components of hESC-derived matrix microenvironments as 
we have attempted to do here can be completed on defined matrices instead of 
Matrigel.  The ability to control the deposition and release of bioactive growth factors 
from the matrix through the use of synthetic alternatives will permit direct validation of 
deposited factors.  Together, these complementary studies would be beneficial for 
determining ECM-associated regulatory proteins that can be combined with biomaterials 
to control pathways related to self-renewal and differentiation.          
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6.4 Studying hESCs using Quantitative Proteomics 
With the increase in research focused on ESCs, the number of developmentally related 
cell types that can be successfully cultured in vitro is rising.  It is clear that comparison 
of pluripotent or multipotent progenitor cells with differentiated sub-types can provide 
valuable information on stem cell regulation.  The application of high-throughput 
genomic technologies in these areas has already resulted in advancement in our 
understanding of stem cells.  However, global screening using proteomics methods has 
lagged behind, partially due to the difficulty in achieving cell quantities amenable to 
these experiments.  This is particularly difficult for hESCs due to their strict culture 
requirements. 
Application of metabolic labeling approaches such as SILAC opens new avenues for 
performing comparative analyses of multipotent and differentiated cell types.  Utilization 
of our SILAC protocol provides researchers with the tools necessary to acquire the 
quantities of cells required, in a reproducible fashion, for proteomics experiments.  
Currently there is only one other example of a defined hESC culture medium amenable 
to SILAC experimentation presented in the literature [45].  However, as the efficiency of 
methods for the in vitro culture of hESCs continues to increase, so too will the 
development of enhanced media for their culture.  This is highlighted by recent work 
from the Thomson lab where they systematically tested individual medium components 
to assess their necessity for the maintenance of hESCs and hiPSCs [20].  They 
demonstrated that the SCs could be maintained for extended periods in media 
containing just eight ingredients, referred to as E8 (insulin, selenium, transferrin, 
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l-ascorbic acid, FGF2 and TGF-β (or Nodal) in DMEM/F12).  E8 has the added benefit 
of being serum-free, offering an attractive platform for the analysis of conditioned media 
from hESCs grown in feeder-free conditions.  As we have demonstrated here (Chapter 
2), the adaption of chemically defined culture media such as E8 to SILAC 
experimentation can be achieved simply by modulating the amino acid composition, 
even for metabolically sensitive cell types such as hESCs.   
Outside of direct comparisons of pluripotent and differentiated cell types, quantitative 
proteomics methods like SILAC offer many other attractive research avenues in the 
study of hESC biology.  An emerging area where quantitative mass spectrometry 
approaches have a direct application is in the analysis of global protein turnover in 
hESCs.  The metabolic incorporation of the SILAC label permits time-dependent 
analysis of protein synthesis and degradation rates, analogous to a pulse-chase style 
experiment [46].  Currently there are no examples of the direct analysis of protein 
turnover on a global scale in mouse or human ESCs.  The most comprehensive 
proteomics studies of hESCs and hiPSCs to date have focused on measuring 
abundance snapshots [47].  Recent work from the Selbach lab has demonstrated the 
utility of measuring protein and mRNA degradation rates to obtain a picture of global cell 
regulation as a function of turnover [48].   
It is not hard to envision the potential applications for SILAC derived turnover 
measurements in hESCs or their niches.  Direct examination of the pathways that feed 
into the maintenance of homeostasis through modulation of the synthesis and 
degradation of proteins on a global scale can potentially clarify the mechanisms 
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governing pluripotency of hESCs and preservation of a state primed for differentiation.  
Furthermore, metabolic labeling with SILAC can be used to unlock the potential 
mechanisms that regulate the switch from a primed state to differentiation in stem cell 
populations.  When coupled with established methods for measuring mRNA turnover 
[49], or high-resolution screens of global translation rates using ribosome density 
profiling [50], the potential acquisition of a global measurement of hESC control makes 
the application of SILAC protocols such as those developed here (Chapter 2) an 
attractive platform in stem cell research.  Additionally, coupling these quantitative 
proteomics analysis platforms to investigation of hESC niches offers the opportunity to 
monitor temporal signaling patterns as indicated by differential protein levels in 
conditioned media or matrices.        
6.5 Future Applications in Stem Cell Research 
6.5.1 Niches from other stem cells 
The hESC niche represents a dynamic environment that is critical for control over 
decisions concerning cell fate and its analysis is crucial for a complete understanding of 
pluripotency.  However, the recent expansion of research involving adult stem cells 
(ASC) offers new opportunities for studies directed at investigation of the 
microenvironment.  Furthermore, the rapid expansion of derived induced pluripotent 
stem (iPS) cells from a variety of tissue and disease types offers interesting new 
avenues for study of the microenvironment.  The analysis of CMTX completed here 
(Chapter 4) was performed on a single iPS cell line.  Our findings indicate significant 
similarity between the hESC and iPS cell derived matrices analyzed.  However, due to 
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the distinct differences between iPS lines dependent on their derivation method or 
parental cell origin [51, 52] (reviewed in [53]), expansion of our analysis to include other 
lines is desirable.   
The application of quantitative proteomic methodologies such as those developed here 
(Chapter 2) also offer interesting avenues for continuing exploratory studies in stem cell 
niches in vitro.  The induction of pluripotency in iPS cells is known to take upwards of 30 
days following transgene expression in culture [54].  Quantitative changes of protein 
turnover during reprogramming coupled with temporal examination of secreted factors 
in the niche would provide valuable insight into processes contributing to the induction 
of pluripotency.  The assessment of expression patterns during reprogramming of 
candidate proteins identified in this thesis (Chapter 4) could reveal valuable information 
on factors such as the sFRP, Cerberus, and Lefty proteins.  With the previous 
knowledge that these proteins function at the crossroads of the undifferentiated and 
differentiated state, their examination during reprogramming could reveal distinct 
expression patterns that contribute to pluripotency.  Additionally, these trends can be 
compared to data generated in this and other studies of the microenvironment to 
characterize their correlation to known roles in hESCs.   
6.5.2 Addressing heterogeneity in stem cell cultures 
Two of the core components of the microenvironment are the ECM support and 
paracrine/autocrine signaling regulated by soluble factors.  In the hESC niche this can 
be expanded to include accessory or support cells that contribute to processes involved 
with both of the previously mentioned core components.  In two-dimensional adherent 
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cultures in vitro hESCs tend to grow as tight aggregates.  hESCs are refractory to 
passaging or maintenance as single cells.   Within these cell clusters, recent work has 
observed the ability of hESCs to generate colony specific niches that contain signaling 
gradients that effect core pluripotency pathways [55].  These findings suggest that a 
level of cellular heterogeneity exists within hESC cultures and even within specific 
colonies.  The non-homogeneous nature of stem cell culture has been noted before in 
the literature [56-60].  This variability can be the result of differences in cell cycle 
progression as well as spontaneous differentiation.  Even in a wholly undifferentiated 
population, differences in core pluripotency genes such as Nanog have been observed 
[61].  Considering the ability of the microenvironment to elicit changes in cell behavior, 
differences in hESC colony specific niches can potentially be a significant contributor to 
this heterogeneity.  By collecting data that represents an average of a heterogeneous 
population, the potential sensitivity of the results is limited as changes represented in a 
sub-type of cells will be diluted.  Therefore, developing methods directed at monitoring 
hESC characteristics at a single-cell level are critical for in-depth microenvironment 
analysis. 
Recent developments in methods for single-cell monitoring of global processes such as 
transcription and translation offer new avenues for stem cell research (reviewed in [62, 
63]).  Furthermore, with the development of methods for high-throughput analysis of 
matrices using spotted arrays (see Section 5.3), single-cell analysis of the hESC niche 
is now potentially viable.  As such, studies directed at single-cell analysis of behavior 
patterns in hESC niches have been presented [55].  The work presented here offers 
potential extensions for modeling of single-cells in hESC niches.  Using factors 
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identified in our proteomic characterizations of matrices (Chapter 3 – 4) in combination 
with micropatterning techniques for generating ECM arrays, the activity of single cells 
within colonies in response to seeded gradients of deposited factors could be assayed.  
Arrays such as these can potentially reveal the specific regulatory mechanisms of 
factors identified in our analysis of CMTX, such as the sFRP and Lefty proteins.  The 
expression of Lefty B has previously been observed to change dependent on hESC 
colony size, indicating the potentially dynamic nature of these inhibitors [55].  
Furthermore, the established gradient signaling mechanisms of both the Wnt and Nodal 
pathways in development indicate that a similar process may be occurring in vitro in the 
hESC niche.  The ability to perform directed screens based off of factors identified in our 
study coupled with high-resolution single-cell data acquisition offers an attractive 
platform for addressing key questions concerning the hESC microenvironment. 
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Appendix I 
Supporting Datasets and Information for the Analysis of the 
Pluripotent Stem Cell Depositome 
 
 
Table A1.1 N-GFR Matrigel Protein Identifications.  List of all proteins identified in N-
GFR Matrigel (non-growth factor reduced) with corresponding accession, description, 
PEAKS score, unique peptide numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
P19137|LAMA1_MOUSE Laminin subunit alpha-1 OS=M     548.72 73 299
P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=M     534.59 81 232
P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus   506.09 91 199
P02468|LAMC1_MOUSE Laminin subunit gamma-1 OS     521.29 88 198
Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus G   445.87 74 117
Q05793|PGBM_MOUSE Basement membrane-specific          426.69 56 115
P16546|SPTA2_MOUSE Spectrin alpha chain, brain OS     399.37 77 113
P07724|ALBU_MOUSE Serum albumin OS=Mus musc    394.86 93 79
P20029|GRP78_MOUSE 78 kDa glucose-regulated prot      418.33 86 78
P19324|SERPH_MOUSE Serpin H1 OS=Mus musculus   385.85 87 77
P63038|CH60_MOUSE 60 kDa heat shock protein, mi      380.07 92 74
P01027|CO3_MOUSE Complement C3 OS=Mus mus    330.22 67 67
P07214|SPRC_MOUSE SPARC OS=Mus musculus G   395.48 80 66
P20152|VIME_MOUSE Vimentin OS=Mus musculus G   390.87 96 66
P09103|PDIA1_MOUSE Protein disulfide-isomerase OS     372.59 93 66
Q80X90|FLNB_MOUSE Filamin-B OS=Mus musculus   322.12 52 59
Q62261|SPTB2_MOUSE Spectrin beta chain, brain 1 OS     307.59 61 59
Q9QXS1|PLEC_MOUSE Plectin OS=Mus musculus GN   255.85 52 58
P63017|HSP7C_MOUSE Heat shock cognate 71 kDa pr      415.5 89 56
Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus    364.3 72 56
Q01853|TERA_MOUSE Transitional endoplasmic retic       333.88 72 55
P27773|PDIA3_MOUSE Protein disulfide-isomerase A3     333.85 80 54
Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy ch       282.97 49 54
P14733|LMNB1_MOUSE Lamin-B1 OS=Mus musculus   373.76 86 52
Q6P5E4|UGGG1_MOUSE UDP-glucose:glycoprotein gluc       325.06 61 52
Q921I1|TRFE_MOUSE Serotransferrin OS=Mus musc    335.58 78 50
Q9D0E1|HNRPM_MOUSE Heterogeneous nuclear ribonu       305.06 83 50
Q61838|A2M_MOUSE Alpha-2-macroglobulin OS=Mu     319.31 66 46
A2ARV4|LRP2_MOUSE Low-density lipoprotein recepto        253.95 51 46
P48678|LMNA_MOUSE Prelamin-A/C OS=Mus muscu    311.51 74 45
P08113|ENPL_MOUSE Endoplasmin OS=Mus muscu    284.57 64 44
Q8VIJ6|SFPQ_MOUSE Splicing factor, proline- and glu      311.2 69 43
Q9R0B9|PLOD2_MOUSE Procollagen-lysine,2-oxoglutar        302.4 71 43
Q64727|VINC_MOUSE Vinculin OS=Mus musculus G   290.92 81 43
P38647|GRP75_MOUSE Stress-70 protein, mitochondri      317.3 74 42
Q8K310|MATR3_MOUSE Matrin-3 OS=Mus musculus G   310.31 65 40
Q61879|MYH10_MOUSE Myosin-10 OS=Mus musculus   328.74 54 39
P26039|TLN1_MOUSE Talin-1 OS=Mus musculus GN   216.74 48 39
Q8CGC7|SYEP_MOUSE Bifunctional aminoacyl-tRNA s      283.42 51 38
P14211|CALR_MOUSE Calreticulin OS=Mus musculus   300.3 91 37
P08003|PDIA4_MOUSE Protein disulfide-isomerase A4     285.22 69 37
Q68FD5|CLH_MOUSE Clathrin heavy chain 1 OS=Mu     244.47 51 37
P11276|FINC_MOUSE Fibronectin OS=Mus musculus   298.28 37 36
P13020|GELS_MOUSE Gelsolin OS=Mus musculus G   277.29 59 35
P16858|G3P_MOUSE Glyceraldehyde-3-phosphate d      323.25 84 33
P62806|H4_MOUSE Histone H4 OS=Mus musculus   247.47 82 33
Q922R8|PDIA6_MOUSE Protein disulfide-isomerase A6     328.41 80 32
O08677|KNG1_MOUSE Kininogen-1 OS=Mus musculu    310.69 53 32
P56480|ATPB_MOUSE ATP synthase subunit beta, m      287.08 86 31
Q99PV0|PRP8_MOUSE Pre-mRNA-processing-splicing       247.66 40 31
Q6PDQ2|CHD4_MOUSE Chromodomain-helicase-DNA        241.84 43 31
P09405|NUCL_MOUSE Nucleolin OS=Mus musculus G   266.11 69 30
P06909|CFAH_MOUSE Complement factor H OS=Mus    263.83 41 30
P10126|EF1A1_MOUSE Elongation factor 1-alpha 1 OS     252.38 71 29
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P08032|SPTA1_MOUSE Spectrin alpha chain, erythrocy      249.83 39 29
O70133|DHX9_MOUSE ATP-dependent RNA helicase      229.17 42 29
O88569|ROA2_MOUSE Heterogeneous nuclear ribonu       297.94 78 28
Q8K0E8|FIBB_MOUSE Fibrinogen beta chain OS=Mu     315.58 74 27
P08249|MDHM_MOUSE Malate dehydrogenase, mitoch      307.82 77 27
Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus   240.2 31 27
P17742|PPIA_MOUSE Peptidyl-prolyl cis-trans isome       294.46 83 26
P52480|KPYM_MOUSE Pyruvate kinase isozymes M1/      254.26 59 26
Q8VCM7|FIBG_MOUSE Fibrinogen gamma chain OS=     289.26 72 25
Q03265|ATPA_MOUSE ATP synthase subunit alpha, m      280.6 75 25
P29341|PABP1_MOUSE Polyadenylate-binding protein      265.8 59 25
Q91W90|TXND5_MOUSE Thioredoxin domain-containing       276.26 78 24
O08795|GLU2B_MOUSE Glucosidase 2 subunit beta OS     265.43 59 24
Q9D8E6|RL4_MOUSE 60S ribosomal protein L4 OS=     243.16 59 24
P29533|VCAM1_MOUSE Vascular cell adhesion protein      228.91 54 24
P05202|AATM_MOUSE Aspartate aminotransferase, m      223.94 67 24
Q99PL5|RRBP1_MOUSE Ribosome-binding protein 1 O     202.39 28 24
P11499|HS90B_MOUSE Heat shock protein HSP 90-be      294.42 69 23
O88322|NID2_MOUSE Nidogen-2 OS=Mus musculus   271.23 40 23
P21614|VTDB_MOUSE Vitamin D-binding protein OS=     257.96 67 22
Q9R0E2|PLOD1_MOUSE Procollagen-lysine,2-oxoglutar        243.69 48 22
P39061|COIA1_MOUSE Collagen alpha-1(XVIII) chain     228.75 34 22
Q61001|LAMA5_MOUSE Laminin subunit alpha-5 OS=M     227.53 28 22
Q91W39|NCOA5_MOUSE Nuclear receptor coactivator 5     216.62 47 22
P47911|RL6_MOUSE 60S ribosomal protein L6 OS=     215.87 67 22
P20108|PRDX3_MOUSE Thioredoxin-dependent peroxi        273.48 86 21
Q8R326|PSPC1_MOUSE Paraspeckle component 1 OS     223.02 53 21
Q9JKR6|HYOU1_MOUSE Hypoxia up-regulated protein 1     219.62 50 21
P14206|RSSA_MOUSE 40S ribosomal protein SA OS=     272.53 71 20
Q01405|SC23A_MOUSE Protein transport protein Sec2      270.64 62 20
Q9WTP6|KAD2_MOUSE Adenylate kinase 2, mitochond      247.36 80 20
P01942|HBA_MOUSE Hemoglobin subunit alpha OS     243.8 100 20
P61979|HNRPK_MOUSE Heterogeneous nuclear ribonu       242.52 71 20
P58252|EF2_MOUSE Elongation factor 2 OS=Mus m    241.7 45 20
Q9D8N0|EF1G_MOUSE Elongation factor 1-gamma OS     227.23 62 20
Q00623|APOA1_MOUSE Apolipoprotein A-I OS=Mus m    223.26 73 20
Q99K48|NONO_MOUSE Non-POU domain-containing o       216.7 65 20
Q3U1J4|DDB1_MOUSE DNA damage-binding protein 1     214.68 34 20
Q8BU30|SYIC_MOUSE Isoleucyl-tRNA synthetase, cyt      208.43 39 20
P62259|1433E_MOUSE 14-3-3 protein epsilon OS=Mu     279.64 87 19
P17225|PTBP1_MOUSE Polypyrimidine tract-binding pr       273.25 71 19
P02088|HBB1_MOUSE Hemoglobin subunit beta-1 OS     269.07 83 19
Q91X72|HEMO_MOUSE Hemopexin OS=Mus musculu    242.73 60 19
Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus GN=   208 28 19
P57759|ERP29_MOUSE Endoplasmic reticulum residen        244.39 68 18
Q9Z247|FKBP9_MOUSE Peptidyl-prolyl cis-trans isome       230.77 51 18
Q9DC23|DJC10_MOUSE DnaJ homolog subfamily C me       217.63 56 18
Q61595|KTN1_MOUSE Kinectin OS=Mus musculus G   209.35 42 18
Q9EQK5|MVP_MOUSE Major vault protein OS=Mus m    182.04 42 18
Q9CU62|SMC1A_MOUSE Structural maintenance of chro        176.97 30 18
Q7TPR4|ACTN1_MOUSE Alpha-actinin-1 OS=Mus musc    318.99 62 17
Q61292|LAMB2_MOUSE Laminin subunit beta-2 OS=M     218.1 25 17
P62301|RS13_MOUSE 40S ribosomal protein S13 OS     209.86 44 17
P62908|RS3_MOUSE 40S ribosomal protein S3 OS=     191.2 70 17
P61982|1433G_MOUSE 14-3-3 protein gamma OS=Mu     270.33 96 16
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Q61937|NPM_MOUSE Nucleophosmin OS=Mus mus    224.16 63 16
Q9Z1Q9|SYVC_MOUSE Valyl-tRNA synthetase OS=Mu     216.69 31 16
Q9CZU6|CISY_MOUSE Citrate synthase, mitochondria      198.63 42 16
Q64433|CH10_MOUSE 10 kDa heat shock protein, mi      197.06 85 16
P25444|RS2_MOUSE 40S ribosomal protein S2 OS=     193.63 72 16
P29758|OAT_MOUSE Ornithine aminotransferase, m      192.73 46 16
Q9WTM5|RUVB2_MOUSE RuvB-like 2 OS=Mus musculu    164.84 51 16
A2ASS6|TITIN_MOUSE Titin OS=Mus musculus GN=T   70.94 6 16
Q9Z2X1|HNRPF_MOUSE Heterogeneous nuclear ribonu       249.84 70 15
P27659|RL3_MOUSE 60S ribosomal protein L3 OS=     237.73 63 15
P23780|BGAL_MOUSE Beta-galactosidase OS=Mus m    229.32 45 15
Q9WV54|ASAH1_MOUSE Acid ceramidase OS=Mus mu    224.05 46 15
P57776|EF1D_MOUSE Elongation factor 1-delta OS=M     223.25 76 15
Q8R3Q6|CCD58_MOUSE Coiled-coil domain-containing       212.39 81 15
Q922B2|SYDC_MOUSE Aspartyl-tRNA synthetase, cyto      207.71 50 15
O08810|U5S1_MOUSE 116 kDa U5 small nuclear ribo       205.25 31 15
O08749|DLDH_MOUSE Dihydrolipoyl dehydrogenase,      204.92 62 15
P61358|RL27_MOUSE 60S ribosomal protein L27 OS     191.92 53 15
P53026|RL10A_MOUSE 60S ribosomal protein L10a O     188.98 43 15
Q9Z1Z0|USO1_MOUSE General vesicular transport fac       100.33 43 15
O35643|AP1B1_MOUSE AP-1 complex subunit beta-1 O     248.1 50 14
Q9D1M4|MCA3_MOUSE Eukaryotic translation elongati         230.67 84 14
Q9DBG5|PLIN3_MOUSE Perilipin-3 OS=Mus musculus   222.6 73 14
P62962|PROF1_MOUSE Profilin-1 OS=Mus musculus G   222.4 86 14
P97496|SMRC1_MOUSE SWI/SNF complex subunit SM      219.45 54 14
Q61207|SAP_MOUSE Sulfated glycoprotein 1 OS=M     215.05 51 14
Q3UPH1|PRRC1_MOUSE Protein PRRC1 OS=Mus musc    209.4 55 14
Q587J6|LITD1_MOUSE LINE-1 type transposase doma        206.2 42 14
P40142|TKT_MOUSE Transketolase OS=Mus musc    205.43 39 14
P62918|RL8_MOUSE 60S ribosomal protein L8 OS=     202.4 70 14
P62082|RS7_MOUSE 40S ribosomal protein S7 OS=     192.4 63 14
Q91VM5|RBMXL_MOUSE Heterogeneous nuclear ribonu        184.22 51 14
P29699|FETUA_MOUSE Alpha-2-HS-glycoprotein OS=M     286.43 69 13
P62843|RS15_MOUSE 40S ribosomal protein S15 OS     240.01 82 13
P07901|HS90A_MOUSE Heat shock protein HSP 90-alp      230.89 57 13
Q3THW5|H2AV_MOUSE Histone H2A.V OS=Mus musc    222.74 79 13
P12970|RL7A_MOUSE 60S ribosomal protein L7a OS     218.32 50 13
Q61576|FKB10_MOUSE Peptidyl-prolyl cis-trans isome       211.94 50 13
Q99JR5|TINAL_MOUSE Tubulointerstitial nephritis antig      211.76 47 13
P24369|PPIB_MOUSE Peptidyl-prolyl cis-trans isome       207.16 63 13
Q9CYZ2|TPD54_MOUSE Tumor protein D54 OS=Mus m    204.5 71 13
Q8BG05|ROA3_MOUSE Heterogeneous nuclear ribonu       197.34 36 13
Q9DBJ1|PGAM1_MOUSE Phosphoglycerate mutase 1 O     191.64 72 13
Q8BP92|RCN2_MOUSE Reticulocalbin-2 OS=Mus mus    169.45 66 13
Q62376|RU17_MOUSE U1 small nuclear ribonucleopro        169 31 13
P62270|RS18_MOUSE 40S ribosomal protein S18 OS     152.31 62 13
P63101|1433Z_MOUSE 14-3-3 protein zeta/delta OS=M     278.83 85 12
Q9CQU0|TXD12_MOUSE Thioredoxin domain-containing       237.42 85 12
Q9D1Q6|ERP44_MOUSE Endoplasmic reticulum residen        227.11 72 12
P31001|DESM_MOUSE Desmin OS=Mus musculus G   224.21 54 12
P62317|SMD2_MOUSE Small nuclear ribonucleoprote        213.65 72 12
Q8BWT1|THIM_MOUSE 3-ketoacyl-CoA thiolase, mitoc      212.23 64 12
P18242|CATD_MOUSE Cathepsin D OS=Mus musculu    198.86 54 12
Q3V1T4|P3H1_MOUSE Prolyl 3-hydroxylase 1 OS=Mu     197.25 34 12
Q9CXW3|CYBP_MOUSE Calcyclin-binding protein OS=M     197.07 54 12
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Q8BH97|RCN3_MOUSE Reticulocalbin-3 OS=Mus mus    186.96 63 12
P62754|RS6_MOUSE 40S ribosomal protein S6 OS=     181.51 41 12
Q99JI4|PSMD6_MOUSE 26S proteasome non-ATPase        171.19 60 12
Q9CSN1|SNW1_MOUSE SNW domain-containing prote       163.32 40 12
Q8BJ71|NUP93_MOUSE Nuclear pore complex protein      160.84 57 12
P80316|TCPE_MOUSE T-complex protein 1 subunit ep      155.97 52 12
Q8BH61|F13A_MOUSE Coagulation factor XIII A chain     142.51 22 12
P57780|ACTN4_MOUSE Alpha-actinin-4 OS=Mus musc    261.83 52 11
P49312|ROA1_MOUSE Heterogeneous nuclear ribonu       225.25 60 11
O35658|C1QBP_MOUSE Complement component 1 Q s        225.2 64 11
O89086|RBM3_MOUSE Putative RNA-binding protein 3     209.29 80 11
Q99020|ROAA_MOUSE Heterogeneous nuclear ribonu       209.03 46 11
Q9EQH3|VPS35_MOUSE Vacuolar protein sorting-assoc        195.32 37 11
P31230|AIMP1_MOUSE Aminoacyl tRNA synthase com         191.2 59 11
Q9JKF1|IQGA1_MOUSE Ras GTPase-activating-like pr       188.25 29 11
Q9WVA4|TAGL2_MOUSE Transgelin-2 OS=Mus muscul    187.6 60 11
Q922Q8|LRC59_MOUSE Leucine-rich repeat-containing       187.54 44 11
Q9Z2N8|ACL6A_MOUSE Actin-like protein 6A OS=Mus    186.72 46 11
Q60716|P4HA2_MOUSE Prolyl 4-hydroxylase subunit a      186.15 47 11
P97351|RS3A_MOUSE 40S ribosomal protein S3a OS     178.15 46 11
P06151|LDHA_MOUSE L-lactate dehydrogenase A ch      177.41 40 11
Q9CPR4|RL17_MOUSE 60S ribosomal protein L17 OS     170.26 49 11
Q8C854|MYEF2_MOUSE Myelin expression factor 2 OS     170.12 38 11
P20918|PLMN_MOUSE Plasminogen OS=Mus muscu    167.79 28 11
Q9EPU0|RENT1_MOUSE Regulator of nonsense transcr       164.61 26 11
P63085|MK01_MOUSE Mitogen-activated protein kina       161.4 45 11
Q8BMS1|ECHA_MOUSE Trifunctional enzyme subunit a       149.87 44 11
P32067|LA_MOUSE Lupus La protein homolog OS     147.52 51 11
Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus GN   133.07 17 11
Q60902|EP15R_MOUSE Epidermal growth factor recep         125.71 29 11
P26443|DHE3_MOUSE Glutamate dehydrogenase 1, m      118.4 31 11
P68254|1433T_MOUSE 14-3-3 protein theta OS=Mus m    251.79 82 10
O35887|CALU_MOUSE Calumenin OS=Mus musculus   217.5 82 10
P62307|RUXF_MOUSE Small nuclear ribonucleoprote       209.92 99 10
Q8VHX6|FLNC_MOUSE Filamin-C OS=Mus musculus   188.92 25 10
Q8CG70|P3H3_MOUSE Prolyl 3-hydroxylase 3 OS=Mu     187.37 39 10
O08547|SC22B_MOUSE Vesicle-trafficking protein SEC      185.45 60 10
Q02257|PLAK_MOUSE Junction plakoglobin OS=Mus    182.85 37 10
P62264|RS14_MOUSE 40S ribosomal protein S14 OS     182.34 72 10
Q9R0E1|PLOD3_MOUSE Procollagen-lysine,2-oxoglutar        179.05 31 10
P16675|PPGB_MOUSE Lysosomal protective protein O     176.42 24 10
P07356|ANXA2_MOUSE Annexin A2 OS=Mus musculu    170.13 43 10
Q99KI0|ACON_MOUSE Aconitate hydratase, mitochon      169.72 28 10
Q9Z204|HNRPC_MOUSE Heterogeneous nuclear ribonu       169.56 36 10
P60122|RUVB1_MOUSE RuvB-like 1 OS=Mus musculu    153.17 41 10
Q60864|STIP1_MOUSE Stress-induced-phosphoprotei       151.8 29 10
P23249|MOV10_MOUSE Putative helicase MOV-10 OS     149.84 19 10
P70699|LYAG_MOUSE Lysosomal alpha-glucosidase     143.05 19 10
Q8BX10|PGAM5_MOUSE Serine/threonine-protein phosp        138.1 55 10
Q8R1Q8|DC1L1_MOUSE Cytoplasmic dynein 1 light inte        137.93 41 10
P35700|PRDX1_MOUSE Peroxiredoxin-1 OS=Mus mus    137.09 59 10
Q6PDM2|SRSF1_MOUSE Serine/arginine-rich splicing fa       135.94 47 10
O08585|CLCA_MOUSE Clathrin light chain A OS=Mus    127.56 22 10
Q8R4X3|RBM12_MOUSE RNA-binding protein 12 OS=M     123.46 14 10
P62204|CALM_MOUSE Calmodulin OS=Mus musculus   233.23 99 9
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P62315|SMD1_MOUSE Small nuclear ribonucleoprote        214.63 81 9
Q8R2Z5|VWA1_MOUSE von Willebrand factor A domai        191.31 53 9
Q9CQ92|FIS1_MOUSE Mitochondrial fission 1 protein     190.05 75 9
Q9CQF3|CPSF5_MOUSE Cleavage and polyadenylation         189.59 62 9
P36552|HEM6_MOUSE Coproporphyrinogen-III oxidas       185.7 47 9
P56959|FUS_MOUSE RNA-binding protein FUS OS=     184.78 27 9
Q62167|DDX3X_MOUSE ATP-dependent RNA helicase      182.47 46 9
Q9WTX5|SKP1_MOUSE S-phase kinase-associated pro       178.41 66 9
P60335|PCBP1_MOUSE Poly(rC)-binding protein 1 OS=     176.4 54 9
Q8R081|HNRPL_MOUSE Heterogeneous nuclear ribonu       174.18 34 9
Q60715|P4HA1_MOUSE Prolyl 4-hydroxylase subunit a      173.86 35 9
Q99KN9|EPN4_MOUSE Clathrin interactor 1 OS=Mus m    170.43 22 9
P47963|RL13_MOUSE 60S ribosomal protein L13 OS     169.23 44 9
P46412|GPX3_MOUSE Glutathione peroxidase 3 OS=     169.14 41 9
Q9R0U0|SRS10_MOUSE Serine/arginine-rich splicing fa       169 24 9
Q9WU78|PDC6I_MOUSE Programmed cell death 6-inter       166.5 30 9
P99029|PRDX5_MOUSE Peroxiredoxin-5, mitochondria      164.98 43 9
P48036|ANXA5_MOUSE Annexin A5 OS=Mus musculu    162.59 50 9
Q61147|CERU_MOUSE Ceruloplasmin OS=Mus musc    161.4 21 9
Q9CYR0|SSBP_MOUSE Single-stranded DNA-binding p       158.75 56 9
Q60749|KHDR1_MOUSE KH domain-containing, RNA-b          157.57 53 9
Q60597|ODO1_MOUSE 2-oxoglutarate dehydrogenase       155 30 9
Q6ZQI3|MLEC_MOUSE Malectin OS=Mus musculus G   153.92 42 9
Q8C0C7|SYFA_MOUSE Phenylalanyl-tRNA synthetase       149.8 30 9
Q3U0V1|FUBP2_MOUSE Far upstream element-binding       148.22 26 9
Q91YN9|BAG2_MOUSE BAG family molecular chapero        147.76 59 9
Q501J6|DDX17_MOUSE Probable ATP-dependent RNA       147.43 26 9
Q7TMK9|HNRPQ_MOUSE Heterogeneous nuclear ribonu       145.1 23 9
Q60631|GRB2_MOUSE Growth factor receptor-bound       137.42 52 9
Q6NZJ6|IF4G1_MOUSE Eukaryotic translation initiation         131.75 15 9
Q9Z110|P5CS_MOUSE Delta-1-pyrroline-5-carboxylate      129.88 20 9
Q61656|DDX5_MOUSE Probable ATP-dependent RNA       126.9 23 9
Q9R1C7|PR40A_MOUSE Pre-mRNA-processing factor 4        120.39 15 9
P24270|CATA_MOUSE Catalase OS=Mus musculus G   120.12 37 9
Q9Z0X1|AIFM1_MOUSE Apoptosis-inducing factor 1, m      115.55 23 9
Q9Z1D1|EIF3G_MOUSE Eukaryotic translation initiation         111.96 20 9
Q61696|HS71A_MOUSE Heat shock 70 kDa protein 1A     273.85 61 8
Q01768|NDKB_MOUSE Nucleoside diphosphate kinas       236.67 72 8
P07759|SPA3K_MOUSE Serine protease inhibitor A3K     225.39 54 8
P15532|NDKA_MOUSE Nucleoside diphosphate kinas       215.23 74 8
P61924|COPZ1_MOUSE Coatomer subunit zeta-1 OS=     206.86 77 8
Q9CPT4|CS010_MOUSE UPF0556 protein C19orf10 ho      199.77 49 8
Q60605|MYL6_MOUSE Myosin light polypeptide 6 OS=     198.17 67 8
Q9D3D9|ATPD_MOUSE ATP synthase subunit delta, m      196.56 64 8
P16045|LEG1_MOUSE Galectin-1 OS=Mus musculus   193.94 77 8
Q8BL97|SRSF7_MOUSE Serine/arginine-rich splicing fa       192.06 39 8
Q9DB20|ATPO_MOUSE ATP synthase subunit O, mitoc      186.39 55 8
Q9JIQ3|DBLOH_MOUSE Diablo homolog, mitochondria      179.04 58 8
Q9QXT0|CNPY2_MOUSE Protein canopy homolog 2 OS     176.77 66 8
P17751|TPIS_MOUSE Triosephosphate isomerase O     171.23 53 8
Q61584|FXR1_MOUSE Fragile X mental retardation sy        170.2 36 8
Q9JHJ0|TMOD3_MOUSE Tropomodulin-3 OS=Mus mus    169.13 45 8
Q3TCN2|PLBL2_MOUSE Putative phospholipase B-like      168.8 30 8
P62983|RS27A_MOUSE Ubiquitin-40S ribosomal protei       168.18 67 8
P63276|RS17_MOUSE 40S ribosomal protein S17 OS     167.5 50 8
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Q08879|FBLN1_MOUSE Fibulin-1 OS=Mus musculus G   159.57 35 8
Q61171|PRDX2_MOUSE Peroxiredoxin-2 OS=Mus mus    157.72 63 8
P28656|NP1L1_MOUSE Nucleosome assembly protein       156.32 42 8
Q9D2G2|ODO2_MOUSE Dihydrolipoyllysine-residue suc            150.86 34 8
P62858|RS28_MOUSE 40S ribosomal protein S28 OS     148.94 61 8
Q99PT1|GDIR1_MOUSE Rho GDP-dissociation inhibito       148.52 41 8
P08228|SODC_MOUSE Superoxide dismutase [Cu-Zn]     144.71 44 8
Q06890|CLUS_MOUSE Clusterin OS=Mus musculus G   143.09 33 8
P21107|TPM3_MOUSE Tropomyosin alpha-3 chain OS     141.88 43 8
Q9D0I9|SYRC_MOUSE Arginyl-tRNA synthetase, cytop      135.72 20 8
Q9D338|RM19_MOUSE 39S ribosomal protein L19, mi      135.71 37 8
P10605|CATB_MOUSE Cathepsin B OS=Mus musculu    134.87 25 8
P70372|ELAV1_MOUSE ELAV-like protein 1 OS=Mus m    134.43 31 8
Q9CX56|PSMD8_MOUSE 26S proteasome non-ATPase        131.98 42 8
Q61646|HPT_MOUSE Haptoglobin OS=Mus musculu    131.2 38 8
P55302|AMRP_MOUSE Alpha-2-macroglobulin recepto       130.45 24 8
Q8BGD9|IF4B_MOUSE Eukaryotic translation initiation       127.26 31 8
O70493|SNX12_MOUSE Sorting nexin-12 OS=Mus mus    120.16 53 8
P39447|ZO1_MOUSE Tight junction protein ZO-1 OS     117.3 21 8
Q61464|ZN638_MOUSE Zinc finger protein 638 OS=Mu     116.1 17 8
Q6ZWN5|RS9_MOUSE 40S ribosomal protein S9 OS=     114.88 41 8
Q6NV83|SR140_MOUSE U2 snRNP-associated SURP m       108.89 17 8
Q8CGK3|LONM_MOUSE Lon protease homolog, mitoch      95.66 31 8
P17156|HSP72_MOUSE Heat shock-related 70 kDa pro       297.25 50 7
Q00898|A1AT5_MOUSE Alpha-1-antitrypsin 1-5 OS=Mu     244.08 56 7
Q9CQV8|1433B_MOUSE 14-3-3 protein beta/alpha OS=     231.61 80 7
Q03734|SPA3M_MOUSE Serine protease inhibitor A3M     231.04 68 7
Q91WP6|SPA3N_MOUSE Serine protease inhibitor A3N     210.64 50 7
P28665|MUG1_MOUSE Murinoglobulin-1 OS=Mus mu    191.6 27 7
P63242|IF5A1_MOUSE Eukaryotic translation initiation       183.7 60 7
P62830|RL23_MOUSE 60S ribosomal protein L23 OS     183.07 79 7
P21619|LMNB2_MOUSE Lamin-B2 OS=Mus musculus   181.24 41 7
P29788|VTNC_MOUSE Vitronectin OS=Mus musculus   179.24 35 7
Q9QUR7|PIN1_MOUSE Peptidyl-prolyl cis-trans isome        177.79 75 7
P62996|TRA2B_MOUSE Transformer-2 protein homolo       176.31 45 7
P58022|LOXL2_MOUSE Lysyl oxidase homolog 2 OS=     173.8 38 7
Q62093|SRSF2_MOUSE Serine/arginine-rich splicing fa       172.65 50 7
P83877|TXN4A_MOUSE Thioredoxin-like protein 4A OS     171.32 77 7
Q9D0W5|PPIL1_MOUSE Peptidyl-prolyl cis-trans isome       165.4 55 7
Q9Z2U0|PSA7_MOUSE Proteasome subunit alpha type      163.82 48 7
Q9CQR2|RS21_MOUSE 40S ribosomal protein S21 OS     159.77 66 7
P35564|CALX_MOUSE Calnexin OS=Mus musculus G   159.57 34 7
Q9Z2U1|PSA5_MOUSE Proteasome subunit alpha type      158.72 56 7
P61458|PHS_MOUSE Pterin-4-alpha-carbinolamine d      157.62 58 7
Q9CQL1|MGNR_MOUSE Protein mago nashi homolog 1      155.58 58 7
P61327|MGN_MOUSE Protein mago nashi homolog O     155.58 58 7
P35980|RL18_MOUSE 60S ribosomal protein L18 OS     147.12 46 7
Q8R4R6|NUP53_MOUSE Nucleoporin NUP53 OS=Mus    142.03 45 7
P70670|NACAM_MOUSE Nascent polypeptide-associate           141.54 18 7
Q8VDM4|PSMD2_MOUSE 26S proteasome non-ATPase        139.68 36 7
P03975|IGEB_MOUSE IgE-binding protein OS=Mus m    138.53 20 7
Q9CXI5|MANF_MOUSE Mesencephalic astrocyte-deriv        138.06 51 7
P08905|LYZ2_MOUSE Lysozyme C-2 OS=Mus musc    135.63 61 7
Q04447|KCRB_MOUSE Creatine kinase B-type OS=M     134.76 40 7
O09061|PSB1_MOUSE Proteasome subunit beta type      133.9 54 7
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Q9D6Z1|NOP56_MOUSE Nucleolar protein 56 OS=Mus    133.24 32 7
Q62189|SNRPA_MOUSE U1 small nuclear ribonucleopro       130.42 32 7
P84089|ERH_MOUSE Enhancer of rudimentary homo      129.86 38 7
Q9QZH3|PPIE_MOUSE Peptidyl-prolyl cis-trans isome       129.57 49 7
Q6ZQ38|CAND1_MOUSE Cullin-associated NEDD8-diss        126.99 22 7
P14148|RL7_MOUSE 60S ribosomal protein L7 OS=     118.82 27 7
P30416|FKBP4_MOUSE Peptidyl-prolyl cis-trans isome       117.11 22 7
Q03173|ENAH_MOUSE Protein enabled homolog OS=     116.98 15 7
P17427|AP2A2_MOUSE AP-2 complex subunit alpha-2     116.16 21 7
Q91WJ8|FUBP1_MOUSE Far upstream element-binding       114.06 17 7
Q9CZX8|RS19_MOUSE 40S ribosomal protein S19 OS     108.86 37 7
Q8R180|ERO1A_MOUSE ERO1-like protein alpha OS=M     107.75 26 7
P09411|PGK1_MOUSE Phosphoglycerate kinase 1 OS     105.87 34 7
Q3UPL0|SC31A_MOUSE Protein transport protein Sec3      99.98 15 7
Q8BX70|VP13C_MOUSE Vacuolar protein sorting-assoc        92.49 8 7
P22599|A1AT2_MOUSE Alpha-1-antitrypsin 1-2 OS=Mu     267.66 71 6
Q9QZQ8|H2AY_MOUSE Core histone macro-H2A.1 OS     202.82 47 6
P62305|RUXE_MOUSE Small nuclear ribonucleoprote       191.04 77 6
P62897|CYC_MOUSE Cytochrome c, somatic OS=M     189.27 63 6
Q6IRU2|TPM4_MOUSE Tropomyosin alpha-4 chain OS     169.6 75 6
Q8CDN6|TXNL1_MOUSE Thioredoxin-like protein 1 OS=     166.23 57 6
Q6PDG5|SMRC2_MOUSE SWI/SNF complex subunit SM      160.75 36 6
Q7M6Y3|PICA_MOUSE Phosphatidylinositol-binding cl        160.26 21 6
P40124|CAP1_MOUSE Adenylyl cyclase-associated p       157.78 33 6
P16110|LEG3_MOUSE Galectin-3 OS=Mus musculus   157.13 26 6
Q921F2|TADBP_MOUSE TAR DNA-binding protein 43 O     155.04 28 6
Q9CXZ1|NDUS4_MOUSE NADH dehydrogenase [ubiquin          154.95 51 6
Q9CWZ3|RBM8A_MOUSE RNA-binding protein 8A OS=M     152.18 53 6
O55135|IF6_MOUSE Eukaryotic translation initiation       151.91 34 6
P99028|QCR6_MOUSE Cytochrome b-c1 complex sub        147.81 61 6
P11404|FABPH_MOUSE Fatty acid-binding protein, hea      145.61 65 6
Q9D967|MGDP1_MOUSE Magnesium-dependent phosp       139.1 54 6
P97807|FUMH_MOUSE Fumarate hydratase, mitochon      138.43 31 6
P56391|CX6B1_MOUSE Cytochrome c oxidase subunit      136.35 63 6
P28798|GRN_MOUSE Granulins OS=Mus musculus   135.27 41 6
Q76MZ3|2AAA_MOUSE Serine/threonine-protein phosp              134.5 33 6
Q9D0F9|PGM1_MOUSE Phosphoglucomutase-1 OS=M     130.29 30 6
Q9CVB6|ARPC2_MOUSE Actin-related protein 2/3 comp        127.56 49 6
P47962|RL5_MOUSE 60S ribosomal protein L5 OS=     126.81 25 6
P06728|APOA4_MOUSE Apolipoprotein A-IV OS=Mus m    125.6 32 6
Q68FL6|SYMC_MOUSE Methionyl-tRNA synthetase, cy      125.23 35 6
Q6NVF9|CPSF6_MOUSE Cleavage and polyadenylation         125.21 23 6
O55128|SAP18_MOUSE Histone deacetylase complex       124.82 48 6
Q61704|ITIH3_MOUSE Inter-alpha-trypsin inhibitor hea        123.95 40 6
P47738|ALDH2_MOUSE Aldehyde dehydrogenase, mito      122.02 19 6
Q8BND5|QSOX1_MOUSE Sulfhydryl oxidase 1 OS=Mus    121.41 22 6
P62911|RL32_MOUSE 60S ribosomal protein L32 OS     119.51 45 6
O35206|COFA1_MOUSE Collagen alpha-1(XV) chain O     118.93 12 6
Q9D620|RFIP1_MOUSE Rab11 family-interacting prote       118.52 39 6
P14131|RS16_MOUSE 40S ribosomal protein S16 OS     115.94 42 6
P26369|U2AF2_MOUSE Splicing factor U2AF 65 kDa s      113.64 18 6
Q6Y7W8|PERQ2_MOUSE PERQ amino acid-rich with GY         113.33 11 6
P08226|APOE_MOUSE Apolipoprotein E OS=Mus mus    110.83 43 6
P62702|RS4X_MOUSE 40S ribosomal protein S4, X is      107.6 37 6
P62751|RL23A_MOUSE 60S ribosomal protein L23a O     106.34 33 6
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P97311|MCM6_MOUSE DNA replication licensing facto       105.9 32 6
Q9CPP6|NDUA5_MOUSE NADH dehydrogenase [ubiquin           102.93 60 6
Q8K297|GT251_MOUSE Procollagen galactosyltransfer       102.73 24 6
O88477|IF2B1_MOUSE Insulin-like growth factor 2 mR        102.59 27 6
Q9CQE1|NPS3A_MOUSE Protein NipSnap homolog 3A O     99.65 31 6
Q91VA6|PDIP2_MOUSE Polymerase delta-interacting p       97.93 30 6
Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus muscul    97.25 38 6
Q08943|SSRP1_MOUSE FACT complex subunit SSRP1     95.91 18 6
Q8VEK3|HNRPU_MOUSE Heterogeneous nuclear ribonu       94.26 13 6
P04186|CFAB_MOUSE Complement factor B OS=Mus    93.37 19 6
Q99ME9|NOG1_MOUSE Nucleolar GTP-binding protein      92.9 19 6
Q99K30|ES8L2_MOUSE Epidermal growth factor recep           89.96 28 6
P17182|ENOA_MOUSE Alpha-enolase OS=Mus musc    85.55 28 6
Q8VDP4|K1967_MOUSE Protein KIAA1967 homolog OS    85.25 15 6
Q8C7E9|CSTFT_MOUSE Cleavage stimulation factor su         81.11 31 6
O54724|PTRF_MOUSE Polymerase I and transcript re       75.87 30 6
Q61830|MRC1_MOUSE Macrophage mannose recepto       74.94 15 6
P27661|H2AX_MOUSE Histone H2A.x OS=Mus musc    298.05 80 5
P68033|ACTC_MOUSE Actin, alpha cardiac muscle 1     288.9 79 5
P99024|TBB5_MOUSE Tubulin beta-5 chain OS=Mus    276.71 72 5
Q64475|H2B1B_MOUSE Histone H2B type 1-B OS=Mu     230.53 69 5
Q6ZWY9|H2B1C_MOUSE Histone H2B type 1-C/E/G OS     230.53 69 5
P10853|H2B1F_MOUSE Histone H2B type 1-F/J/L OS=     230.53 69 5
Q64478|H2B1H_MOUSE Histone H2B type 1-H OS=Mu     230.53 69 5
P10854|H2B1M_MOUSE Histone H2B type 1-M OS=Mu     230.53 69 5
Q8CGP2|H2B1P_MOUSE Histone H2B type 1-P OS=Mu     230.53 69 5
Q64525|H2B2B_MOUSE Histone H2B type 2-B OS=Mu     230.53 69 5
O35737|HNRH1_MOUSE Heterogeneous nuclear ribonu       209.95 45 5
P62960|YBOX1_MOUSE Nuclease-sensitive element-bi        179.02 48 5
Q9EPJ9|ARFG1_MOUSE ADP-ribosylation factor GTPas        157.19 43 5
Q99KR7|PPIF_MOUSE Peptidyl-prolyl cis-trans isome        149.63 50 5
P23506|PIMT_MOUSE Protein-L-isoaspartate(D-aspa       147.94 48 5
P01837|IGKC_MOUSE Ig kappa chain C region OS=M    146.11 68 5
P01872|IGHM_MOUSE Ig mu chain C region secreted      145.64 18 5
P01873|MUCM_MOUSE Ig mu chain C region membra       145.64 17 5
P61089|UBE2N_MOUSE Ubiquitin-conjugating enzyme       145.42 68 5
P62320|SMD3_MOUSE Small nuclear ribonucleoprote        145.08 69 5
P62492|RB11A_MOUSE Ras-related protein Rab-11A O     144.29 38 5
Q9WVA2|TIM8A_MOUSE Mitochondrial import inner mem          142.52 82 5
Q91WK2|EIF3H_MOUSE Eukaryotic translation initiation         142.35 42 5
Q8K2C9|HACD3_MOUSE 3-hydroxyacyl-CoA dehydratas       142.17 27 5
Q923G2|RPAB3_MOUSE DNA-directed RNA polymeras            141.08 47 5
Q62523|ZYX_MOUSE Zyxin OS=Mus musculus GN=   139.77 33 5
Q6P5E6|GGA2_MOUSE ADP-ribosylation factor-binding       139.48 39 5
P62242|RS8_MOUSE 40S ribosomal protein S8 OS=     137.35 32 5
P23198|CBX3_MOUSE Chromobox protein homolog 3     137.04 32 5
O88696|CLPP_MOUSE Putative ATP-dependent Clp p         136.87 50 5
O70325|GPX41_MOUSE Phospholipid hydroperoxide gl        131.66 32 5
Q9WV98|TIM9_MOUSE Mitochondrial import inner mem         131.61 74 5
Q8BKC5|IPO5_MOUSE Importin-5 OS=Mus musculus   131.18 50 5
P14115|RL27A_MOUSE 60S ribosomal protein L27a O     130.47 39 5
Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathoge        130.25 61 5
Q61990|PCBP2_MOUSE Poly(rC)-binding protein 2 OS=     129.95 42 5
P80317|TCPZ_MOUSE T-complex protein 1 subunit ze      129.84 38 5
P68037|UB2L3_MOUSE Ubiquitin-conjugating enzyme       129.59 64 5
217
P98078|DAB2_MOUSE Disabled homolog 2 OS=Mus    129.02 16 5
P18760|COF1_MOUSE Cofilin-1 OS=Mus musculus G   128.27 57 5
P68510|1433F_MOUSE 14-3-3 protein eta OS=Mus m    127.7 63 5
Q9WV55|VAPA_MOUSE Vesicle-associated membrane        127.6 46 5
P49722|PSA2_MOUSE Proteasome subunit alpha type      125.75 34 5
Q9QYJ0|DNJA2_MOUSE DnaJ homolog subfamily A me       125.55 44 5
P84099|RL19_MOUSE 60S ribosomal protein L19 OS     124.59 26 5
Q61233|PLSL_MOUSE Plastin-2 OS=Mus musculus G   124.26 26 5
Q3TXS7|PSMD1_MOUSE 26S proteasome non-ATPase        123.94 21 5
P14824|ANXA6_MOUSE Annexin A6 OS=Mus musculu    123.83 23 5
Q6DFW4|NOP58_MOUSE Nucleolar protein 58 OS=Mus    123.27 38 5
Q8K2B3|DHSA_MOUSE Succinate dehydrogenase [ubi         121.47 28 5
P52196|THTR_MOUSE Thiosulfate sulfurtransferase O     120.95 31 5
Q61545|EWS_MOUSE RNA-binding protein EWS OS     120.79 20 5
Q9CQF9|PCYOX_MOUSE Prenylcysteine oxidase OS=M     120.7 30 5
Q60668|HNRPD_MOUSE Heterogeneous nuclear ribonu       120.36 32 5
Q8C0E2|VP26B_MOUSE Vacuolar protein sorting-assoc        119.49 38 5
Q9CZM2|RL15_MOUSE 60S ribosomal protein L15 OS     119.27 36 5
Q8BP40|PPA6_MOUSE Lysophosphatidic acid phosph        119.24 29 5
Q8QZT1|THIL_MOUSE Acetyl-CoA acetyltransferase,      117.51 25 5
Q6GU68|ISLR_MOUSE Immunoglobulin superfamily c         117 25 5
Q61166|MARE1_MOUSE Microtubule-associated protein         116.89 35 5
P68040|GBLP_MOUSE Guanine nucleotide-binding pr         116.23 32 5
Q8CG71|P3H2_MOUSE Prolyl 3-hydroxylase 2 OS=Mu     116.03 25 5
P80314|TCPB_MOUSE T-complex protein 1 subunit be      114.83 21 5
Q99KJ8|DCTN2_MOUSE Dynactin subunit 2 OS=Mus m    110.29 21 5
Q02819|NUCB1_MOUSE Nucleobindin-1 OS=Mus musc    110.19 28 5
Q9JJI8|RL38_MOUSE 60S ribosomal protein L38 OS     109.1 37 5
Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor su       108.24 39 5
P01868|IGHG1_MOUSE Ig gamma-1 chain C region se       107.77 23 5
P01869|IGH1M_MOUSE Ig gamma-1 chain C region, m       107.77 19 5
Q9D6R2|IDH3A_MOUSE Isocitrate dehydrogenase [NAD         106.01 31 5
P01864|GCAB_MOUSE Ig gamma-2A chain C region s      105.64 25 5
Q9DBH5|LMAN2_MOUSE Vesicular integral-membrane p       105.5 16 5
P60843|IF4A1_MOUSE Eukaryotic initiation factor 4A-      104.88 39 5
P60867|RS20_MOUSE 40S ribosomal protein S20 OS     103.56 36 5
Q9CXF4|TBC15_MOUSE TBC1 domain family member      103.27 20 5
Q05117|PPA5_MOUSE Tartrate-resistant acid phosph        102.8 25 5
Q8K2C7|OS9_MOUSE Protein OS-9 OS=Mus muscu    101.23 21 5
Q61768|KINH_MOUSE Kinesin-1 heavy chain OS=Mu     101.04 18 5
Q9CR09|UFC1_MOUSE Ubiquitin-fold modifier-conjuga        100.86 29 5
P53994|RAB2A_MOUSE Ras-related protein Rab-2A OS     100.6 35 5
Q9CQA3|DHSB_MOUSE Succinate dehydrogenase [ubi         98.53 48 5
Q8BTV2|CPSF7_MOUSE Cleavage and polyadenylation         95.34 25 5
Q9CQE8|CN166_MOUSE UPF0568 protein C14orf166 h     94.34 43 5
Q9DCW4|ETFB_MOUSE Electron transfer flavoprotein s       93.52 24 5
P26516|PSD7_MOUSE 26S proteasome non-ATPase        92.26 29 5
O35593|PSDE_MOUSE 26S proteasome non-ATPase        91.81 35 5
P14685|PSMD3_MOUSE 26S proteasome non-ATPase        89.43 17 5
P28653|PGS1_MOUSE Biglycan OS=Mus musculus G   89.11 18 5
Q921X9|PDIA5_MOUSE Protein disulfide-isomerase A5     89.11 25 5
P09671|SODM_MOUSE Superoxide dismutase [Mn], m      88.39 43 5
Q9D1M0|SEC13_MOUSE Protein SEC13 homolog OS=M     86.18 47 5
Q5XJY5|COPD_MOUSE Coatomer subunit delta OS=M     84.37 20 5
Q8CGF7|TCRG1_MOUSE Transcription elongation regula       83.91 11 5
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P62281|RS11_MOUSE 40S ribosomal protein S11 OS     81.73 22 5
P15508|SPTB1_MOUSE Spectrin beta chain, erythrocyt      80.59 12 5
P12023|A4_MOUSE Amyloid beta A4 protein OS=M     62.12 18 5
Q80UW8|RPAB1_MOUSE DNA-directed RNA polymeras            61.88 40 5
O88685|PRS6A_MOUSE 26S protease regulatory subun       57.92 25 5
A2AAJ9|OBSCN_MOUSE Obscurin OS=Mus musculus G   26.01 4 5
Q8BFZ3|ACTBL_MOUSE Beta-actin-like protein 2 OS=M     267.16 65 4
O08638|MYH11_MOUSE Myosin-11 OS=Mus musculus   214.94 29 4
Q3THE2|ML12B_MOUSE Myosin regulatory light chain 1      192.28 77 4
P85094|ISC2A_MOUSE Isochorismatase domain-conta         179.06 63 4
Q6URW6|MYH14_MOUSE Myosin-14 OS=Mus musculus   171.93 23 4
Q9QZM0|UBQL2_MOUSE Ubiquilin-2 OS=Mus musculus   160.23 18 4
O08807|PRDX4_MOUSE Peroxiredoxin-4 OS=Mus mus    153.87 40 4
P84078|ARF1_MOUSE ADP-ribosylation factor 1 OS=     152.99 58 4
P61205|ARF3_MOUSE ADP-ribosylation factor 3 OS=     152.99 58 4
Q64213|SF01_MOUSE Splicing factor 1 OS=Mus mus    145.58 13 4
Q08369|GATA4_MOUSE Transcription factor GATA-4 O     144.96 18 4
Q9DB15|RM12_MOUSE 39S ribosomal protein L12, mi      141.47 66 4
P84104|SRSF3_MOUSE Serine/arginine-rich splicing fa       139.23 36 4
P09542|MYL3_MOUSE Myosin light chain 3 OS=Mus m    137.71 36 4
P62748|HPCL1_MOUSE Hippocalcin-like protein 1 OS=     137.1 52 4
Q9D1B9|RM28_MOUSE 39S ribosomal protein L28, mi      133.83 48 4
Q9QUM9|PSA6_MOUSE Proteasome subunit alpha type      131.26 21 4
P99027|RLA2_MOUSE 60S acidic ribosomal protein P      130.62 63 4
Q80UM7|MOGS_MOUSE Mannosyl-oligosaccharide gluc      130.11 22 4
Q9DBR0|AKAP8_MOUSE A-kinase anchor protein 8 OS=     129.59 34 4
O70251|EF1B_MOUSE Elongation factor 1-beta OS=M     129.02 32 4
Q64010|CRK_MOUSE Adapter molecule crk OS=Mus    128.1 26 4
Q9DBG6|RPN2_MOUSE Dolichyl-diphosphooligosaccha         125.84 18 4
Q3UZ39|LRRF1_MOUSE Leucine-rich repeat flightless-i        124.96 19 4
P62075|TIM13_MOUSE Mitochondrial import inner mem         124.46 54 4
Q99LT0|DPY30_MOUSE Protein dpy-30 homolog OS=M     123.87 83 4
Q9R099|TBL2_MOUSE Transducin beta-like protein 2     123.17 18 4
Q3V1L4|5NTC_MOUSE Cytosolic purine 5'-nucleotidas      123.14 18 4
Q9Z2D8|MBD3_MOUSE Methyl-CpG-binding domain p       122.12 30 4
P43274|H14_MOUSE Histone H1.4 OS=Mus muscu    119.7 37 4
P63323|RS12_MOUSE 40S ribosomal protein S12 OS     118.78 36 4
P59708|PM14_MOUSE Pre-mRNA branch site protein      117.18 44 4
O55029|COPB2_MOUSE Coatomer subunit beta' OS=M     116.91 18 4
Q9CYD3|CRTAP_MOUSE Cartilage-associated protein O     116.23 31 4
Q9WVK4|EHD1_MOUSE EH domain-containing protein      115.68 17 4
P62309|RUXG_MOUSE Small nuclear ribonucleoprote       115.17 83 4
P30412|PPIC_MOUSE Peptidyl-prolyl cis-trans isome       114.97 34 4
P97371|PSME1_MOUSE Proteasome activator complex       114.85 29 4
O09167|RL21_MOUSE 60S ribosomal protein L21 OS     112.76 38 4
Q9CZU3|SK2L2_MOUSE Superkiller viralicidic activity 2-       112.67 22 4
Q8CIE6|COPA_MOUSE Coatomer subunit alpha OS=M     111.18 16 4
O35900|LSM2_MOUSE U6 snRNA-associated Sm-like       111.13 62 4
P62267|RS23_MOUSE 40S ribosomal protein S23 OS     111.05 64 4
Q8QZY1|EIF3L_MOUSE Eukaryotic translation initiation         110.88 15 4
Q7TPV4|MBB1A_MOUSE Myb-binding protein 1A OS=M     110.37 19 4
P45878|FKBP2_MOUSE Peptidyl-prolyl cis-trans isome       109.14 68 4
P14869|RLA0_MOUSE 60S acidic ribosomal protein P      109.08 24 4
P97493|THIOM_MOUSE Thioredoxin, mitochondrial OS     108.77 51 4
Q9DAR7|DCPS_MOUSE Scavenger mRNA-decapping       108.34 43 4
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P51410|RL9_MOUSE 60S ribosomal protein L9 OS=     108.33 37 4
Q5SUC9|SCO1_MOUSE Protein SCO1 homolog, mitoc      107.84 37 4
Q9ERK4|XPO2_MOUSE Exportin-2 OS=Mus musculus   106.79 18 4
Q99JB2|STML2_MOUSE Stomatin-like protein 2 OS=Mu     106.55 33 4
Q99P88|NU155_MOUSE Nuclear pore complex protein      106.13 25 4
O88653|LTOR3_MOUSE Ragulator complex protein LAM      105.85 50 4
P08122|CO4A2_MOUSE Collagen alpha-2(IV) chain OS     104.41 11 4
Q9Z0R4|ITSN1_MOUSE Intersectin-1 OS=Mus musculu    104.23 13 4
Q9CR57|RL14_MOUSE 60S ribosomal protein L14 OS     104.03 27 4
Q9QX47|SON_MOUSE Protein SON OS=Mus muscul    103.93 13 4
Q8R1B4|EIF3C_MOUSE Eukaryotic translation initiation         103.41 18 4
P05064|ALDOA_MOUSE Fructose-bisphosphate aldolas       103.26 21 4
Q9DAW9|CNN3_MOUSE Calponin-3 OS=Mus musculus   103.23 25 4
Q6ZWY3|RS27L_MOUSE 40S ribosomal protein S27-like     102.88 39 4
Q9JJH1|RNAS4_MOUSE Ribonuclease 4 OS=Mus mus    102.87 36 4
B2RY56|RBM25_MOUSE RNA-binding protein 25 OS=M     102.76 16 4
P46938|YAP1_MOUSE Yorkie homolog OS=Mus mus    102.71 37 4
Q8BP67|RL24_MOUSE 60S ribosomal protein L24 OS     102.26 19 4
P25206|MCM3_MOUSE DNA replication licensing facto       100.52 17 4
P70318|TIAR_MOUSE Nucleolysin TIAR OS=Mus mu    99.09 26 4
Q61733|RT31_MOUSE 28S ribosomal protein S31, mi      97.62 19 4
Q9WTP7|KAD3_MOUSE GTP:AMP phosphotransferase       96.96 33 4
Q9WUK2|IF4H_MOUSE Eukaryotic translation initiation       95.49 22 4
P81117|NUCB2_MOUSE Nucleobindin-2 OS=Mus musc    93.85 27 4
Q3UQN2|FCHO2_MOUSE FCH domain only protein 2 OS     93.43 8 4
P61759|PFD3_MOUSE Prefoldin subunit 3 OS=Mus m    93.36 24 4
Q6ZQL4|WDR43_MOUSE WD repeat-containing protein      93.31 15 4
Q9QXC1|FETUB_MOUSE Fetuin-B OS=Mus musculus G   92.2 26 4
O54962|BAF_MOUSE Barrier-to-autointegration facto      91.84 51 4
Q9R1P0|PSA4_MOUSE Proteasome subunit alpha type      91.52 28 4
Q9R0N0|GALK1_MOUSE Galactokinase OS=Mus musc    90.6 20 4
O08788|DCTN1_MOUSE Dynactin subunit 1 OS=Mus m    90.59 24 4
P62073|TIM10_MOUSE Mitochondrial import inner mem         88.1 50 4
Q8VE22|RT23_MOUSE 28S ribosomal protein S23, mi      87.88 47 4
P62869|ELOB_MOUSE Transcription elongation factor        87.83 34 4
Q8BG32|PSD11_MOUSE 26S proteasome non-ATPase        86.82 25 4
P18572|BASI_MOUSE Basigin OS=Mus musculus GN   86.81 15 4
Q07813|BAX_MOUSE Apoptosis regulator BAX OS=M     86.37 28 4
Q8BI84|MIA3_MOUSE Melanoma inhibitory activity pr       85.77 15 4
Q8CJ69|BMPER_MOUSE BMP-binding endothelial regul       85.61 8 4
Q9JII6|AK1A1_MOUSE Alcohol dehydrogenase [NADP      83.12 17 4
Q9D2M8|UB2V2_MOUSE Ubiquitin-conjugating enzyme        82.5 30 4
Q9CZY3|UB2V1_MOUSE Ubiquitin-conjugating enzyme        82.5 24 4
P63158|HMGB1_MOUSE High mobility group protein B1     82.49 30 4
Q9QZD9|EIF3I_MOUSE Eukaryotic translation initiation         81.23 15 4
Q8BHN3|GANAB_MOUSE Neutral alpha-glucosidase AB     80.52 17 4
Q01279|EGFR_MOUSE Epidermal growth factor recep      80.35 8 4
P0C6F1|DYH2_MOUSE Dynein heavy chain 2, axonem      79.82 5 4
Q64012|RALY_MOUSE RNA-binding protein Raly OS=     79.36 24 4
P51150|RAB7A_MOUSE Ras-related protein Rab-7a OS     78.31 27 4
Q9Z1Y4|TRIP6_MOUSE Thyroid receptor-interacting pr       78.28 18 4
P54728|RD23B_MOUSE UV excision repair protein RAD        76.89 16 4
P62852|RS25_MOUSE 40S ribosomal protein S25 OS     74.95 36 4
Q6NWW9|FND3B_MOUSE Fibronectin type III domain-con        74.33 7 4
P45376|ALDR_MOUSE Aldose reductase OS=Mus mu    74.17 17 4
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Q921M3|SF3B3_MOUSE Splicing factor 3B subunit 3 OS     73.92 10 4
Q99LC5|ETFA_MOUSE Electron transfer flavoprotein s        70.88 19 4
P23116|EIF3A_MOUSE Eukaryotic translation initiation         69.55 12 4
P62245|RS15A_MOUSE 40S ribosomal protein S15a O     69.42 32 4
Q8BMF4|ODP2_MOUSE Dihydrolipoyllysine-residue ace            69.37 15 4
Q8VHN8|SDOS_MOUSE Protein syndesmos OS=Mus m    68.74 32 4
Q60675|LAMA2_MOUSE Laminin subunit alpha-2 OS=M     67.04 13 4
Q91VD9|NDUS1_MOUSE NADH-ubiquinone oxidoreduct          65.74 15 4
Q9Z0R6|ITSN2_MOUSE Intersectin-2 OS=Mus musculu    54.58 14 4
Q6NS46|RRP5_MOUSE Protein RRP5 homolog OS=M     53.84 7 4
Q91YU8|SSF1_MOUSE Suppressor of SWI4 1 homolo      51.26 20 4
Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein rece        49.22 6 4
Q62407|SPEG_MOUSE Striated muscle-specific serine       43.9 4 4
Q6GSS7|H2A2A_MOUSE Histone H2A type 2-A OS=Mu     299.33 88 3
P16627|HS71L_MOUSE Heat shock 70 kDa protein 1-li      245.91 63 3
P84228|H32_MOUSE Histone H3.2 OS=Mus muscu    225.13 78 3
Q60972|RBBP4_MOUSE Histone-binding protein RBBP4     181.84 37 3
O08583|THOC4_MOUSE THO complex subunit 4 OS=M     177.44 55 3
Q9R0B6|LAMC3_MOUSE Laminin subunit gamma-3 OS     157.72 12 3
Q8VEA4|MIA40_MOUSE Mitochondrial intermembrane           147.38 32 3
Q61029|LAP2B_MOUSE Lamina-associated polypeptide        141.23 28 3
Q9DBG9|TX1B3_MOUSE Tax1-binding protein 3 OS=Mu     127.96 47 3
P61971|NTF2_MOUSE Nuclear transport factor 2 OS=     124.44 57 3
Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonu         122.56 29 3
Q60973|RBBP7_MOUSE Histone-binding protein RBBP      121.86 28 3
Q8BFY9|TNPO1_MOUSE Transportin-1 OS=Mus muscu    121.11 35 3
P24452|CAPG_MOUSE Macrophage-capping protein O     116.32 21 3
P70296|PEBP1_MOUSE Phosphatidylethanolamine-bin        115.57 33 3
Q5SFM8|RBM27_MOUSE RNA-binding protein 27 OS=M     114.99 14 3
Q99P27|PG12B_MOUSE Group XIIB secretory phospho        114.95 42 3
P05201|AATC_MOUSE Aspartate aminotransferase, c      112.61 17 3
O88630|GOSR1_MOUSE Golgi SNAP receptor complex       112.52 26 3
Q9DCJ5|NDUA8_MOUSE NADH dehydrogenase [ubiquin           111.93 23 3
Q91ZW3|SMCA5_MOUSE SWI/SNF-related matrix-assoc              110.71 20 3
Q9CXW4|RL11_MOUSE 60S ribosomal protein L11 OS     109.24 20 3
Q99KE1|MAOM_MOUSE NAD-dependent malic enzyme       109.22 18 3
P24472|GSTA4_MOUSE Glutathione S-transferase A4 O     108.91 30 3
Q6ZWV7|RL35_MOUSE 60S ribosomal protein L35 OS     108.47 22 3
Q9EQU5|SET_MOUSE Protein SET OS=Mus musculu    108.04 22 3
Q61581|IBP7_MOUSE Insulin-like growth factor-bindi        107.86 31 3
Q9D7V9|NAAA_MOUSE N-acylethanolamine-hydrolyzin        106.78 16 3
P51660|DHB4_MOUSE Peroxisomal multifunctional en        106.33 11 3
O55057|PDE6D_MOUSE Retinal rod rhodopsin-sensitive          106.28 29 3
P12787|COX5A_MOUSE Cytochrome c oxidase subunit       105.87 70 3
Q61247|A2AP_MOUSE Alpha-2-antiplasmin OS=Mus    105.7 15 3
Q920A5|RISC_MOUSE Retinoid-inducible serine carbo      105.45 13 3
P62849|RS24_MOUSE 40S ribosomal protein S24 OS     105.44 29 3
P12265|BGLR_MOUSE Beta-glucuronidase OS=Mus m    103.8 9 3
P29391|FRIL1_MOUSE Ferritin light chain 1 OS=Mus m    103.19 31 3
Q08093|CNN2_MOUSE Calponin-2 OS=Mus musculus   103.04 21 3
Q91VC3|IF4A3_MOUSE Eukaryotic initiation factor 4A-      102.5 27 3
P70168|IMB1_MOUSE Importin subunit beta-1 OS=M     102.1 9 3
P11438|LAMP1_MOUSE Lysosome-associated membra        101.69 27 3
P35979|RL12_MOUSE 60S ribosomal protein L12 OS     101.62 42 3
Q9CY16|RT28_MOUSE 28S ribosomal protein S28, mi      100.73 29 3
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Q80UY2|KCMF1_MOUSE E3 ubiquitin-protein ligase KCM      99.9 16 3
Q9ES28|ARHG7_MOUSE Rho guanine nucleotide excha        99.82 13 3
P97429|ANXA4_MOUSE Annexin A4 OS=Mus musculu    99.76 29 3
Q3TKT4|SMCA4_MOUSE Transcription activator BRG1 O     99.26 8 3
Q8VH51|RBM39_MOUSE RNA-binding protein 39 OS=M     98.83 16 3
Q61823|PDCD4_MOUSE Programmed cell death protein      98.32 23 3
Q8BGS0|MAK16_MOUSE Protein MAK16 homolog OS=M     98.24 24 3
P08074|CBR2_MOUSE Carbonyl reductase [NADPH]      97.51 26 3
Q61703|ITIH2_MOUSE Inter-alpha-trypsin inhibitor hea        97.11 15 3
Q9D8U8|SNX5_MOUSE Sorting nexin-5 OS=Mus musc    96.46 18 3
P63028|TCTP_MOUSE Translationally-controlled tumo       95.69 28 3
P63325|RS10_MOUSE 40S ribosomal protein S10 OS     95.03 31 3
Q9Z0H3|SNF5_MOUSE SWI/SNF-related matrix-assoc              94.48 21 3
P00920|CAH2_MOUSE Carbonic anhydrase 2 OS=Mu     92.49 16 3
Q9CR68|UCRI_MOUSE Cytochrome b-c1 complex sub        92.31 35 3
Q9CPX7|RT16_MOUSE 28S ribosomal protein S16, mi      92.02 29 3
P97390|VPS45_MOUSE Vacuolar protein sorting-assoc        91.87 12 3
Q922Y1|UBXN1_MOUSE UBX domain-containing protei       91.79 26 3
Q6ZQ88|KDM1A_MOUSE Lysine-specific histone demeth       90.79 7 3
P24547|IMDH2_MOUSE Inosine-5'-monophosphate de       90.54 18 3
Q9R0X4|ACOT9_MOUSE Acyl-coenzyme A thioesterase       90.19 24 3
P29416|HEXA_MOUSE Beta-hexosaminidase subunit      90.14 18 3
Q8BYK6|YTHD3_MOUSE YTH domain family protein 3 O     89.41 16 3
Q9R1P3|PSB2_MOUSE Proteasome subunit beta type      89.33 28 3
P99026|PSB4_MOUSE Proteasome subunit beta type      89.03 26 3
P46467|VPS4B_MOUSE Vacuolar protein sorting-assoc        88.96 20 3
P62821|RAB1A_MOUSE Ras-related protein Rab-1A OS     88.86 38 3
Q60649|CLPB_MOUSE Caseinolytic peptidase B prote       88.36 10 3
Q6ZPY7|KDM3B_MOUSE Lysine-specific demethylase 3      87.93 12 3
P07146|TRY2_MOUSE Anionic trypsin-2 OS=Mus mus    87.92 19 3
Q7TN75|PEG10_MOUSE Retrotransposon-derived prote       87.76 17 3
P04117|FABP4_MOUSE Fatty acid-binding protein, adip      87.65 27 3
Q9QYS9|QKI_MOUSE Protein quaking OS=Mus mus    87.43 29 3
P19536|COX5B_MOUSE Cytochrome c oxidase subunit       87.3 30 3
Q8VE88|F1142_MOUSE Protein FAM114A2 OS=Mus m    87 35 3
Q9Z0P5|TWF2_MOUSE Twinfilin-2 OS=Mus musculus   86.77 10 3
Q9CQ40|RM49_MOUSE 39S ribosomal protein L49, mi      86.41 22 3
Q9EQS3|MYCBP_MOUSE C-Myc-binding protein OS=Mu     86.21 58 3
P42932|TCPQ_MOUSE T-complex protein 1 subunit th      86.11 18 3
Q921G8|GCP2_MOUSE Gamma-tubulin complex comp       86.02 26 3
Q8R010|AIMP2_MOUSE Aminoacyl tRNA synthase com         85.74 26 3
Q06138|CAB39_MOUSE Calcium-binding protein 39 OS     84.6 12 3
Q922V4|PLRG1_MOUSE Pleiotropic regulator 1 OS=Mu     83.77 8 3
Q9D0F3|LMAN1_MOUSE Protein ERGIC-53 OS=Mus m    83.65 10 3
Q9CPV4|GLOD4_MOUSE Glyoxalase domain-containing       83.52 22 3
Q64511|TOP2B_MOUSE DNA topoisomerase 2-beta OS     82.94 6 3
P46935|NEDD4_MOUSE E3 ubiquitin-protein ligase NED      82.54 20 3
Q3U7R1|ESYT1_MOUSE Extended synaptotagmin-1 OS     82.33 12 3
Q9JMA1|UBP14_MOUSE Ubiquitin carboxyl-terminal hyd       82.27 16 3
Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 O     82.26 11 3
Q3U9G9|LBR_MOUSE Lamin-B receptor OS=Mus mu    82.19 10 3
O88544|CSN4_MOUSE COP9 signalosome complex s       82.02 31 3
Q3UKC1|TAXB1_MOUSE Tax1-binding protein 1 homolo      81.85 22 3
A2AGT5|CKAP5_MOUSE Cytoskeleton-associated prote       80.73 11 3
Q9DBY8|NVL_MOUSE Nuclear valosin-containing pro      80.32 10 3
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Q9DBG7|SRPR_MOUSE Signal recognition particle rece        79.88 10 3
Q8VC70|RBMS2_MOUSE RNA-binding motif, single-stra        78.67 30 3
Q921F4|HNRLL_MOUSE Heterogeneous nuclear ribonu       78.49 13 3
P01029|CO4B_MOUSE Complement C4-B OS=Mus m    77.2 10 3
Q9CZ44|NSF1C_MOUSE NSFL1 cofactor p47 OS=Mus    76.88 12 3
P61961|UFM1_MOUSE Ubiquitin-fold modifier 1 OS=M     75.89 69 3
P41105|RL28_MOUSE 60S ribosomal protein L28 OS     75.18 29 3
Q6ZWV3|RL10_MOUSE 60S ribosomal protein L10 OS     75.07 19 3
O55023|IMPA1_MOUSE Inositol monophosphatase 1 O     75.02 28 3
Q9D1K7|CT027_MOUSE UPF0687 protein C20orf27 ho     74.68 25 3
P62827|RAN_MOUSE GTP-binding nuclear protein R      74.63 17 3
Q7TQH0|ATX2L_MOUSE Ataxin-2-like protein OS=Mus    74.44 8 3
Q9QXV1|CBX8_MOUSE Chromobox protein homolog 8     74.42 9 3
Q80WJ7|LYRIC_MOUSE Protein LYRIC OS=Mus musc    74.26 24 3
Q3V4B5|COMD6_MOUSE COMM domain-containing pro       73.82 47 3
Q9CQP2|TPPC2_MOUSE Trafficking protein particle com        73.21 35 3
Q99J99|THTM_MOUSE 3-mercaptopyruvate sulfurtran      73.12 14 3
P62900|RL31_MOUSE 60S ribosomal protein L31 OS     72.65 40 3
P59325|IF5_MOUSE Eukaryotic translation initiation       72.42 12 3
P61965|WDR5_MOUSE WD repeat-containing protein      71.65 16 3
Q8BX22|SALL4_MOUSE Sal-like protein 4 OS=Mus mu    71.53 11 3
O88508|DNM3A_MOUSE DNA (cytosine-5)-methyltransf       71.08 7 3
Q6PB66|LPPRC_MOUSE Leucine-rich PPR motif-contai        70.76 6 3
Q9CR00|PSMD9_MOUSE 26S proteasome non-ATPase        70.41 22 3
Q9CR21|ACPM_MOUSE Acyl carrier protein, mitochond      70.38 14 3
Q6PGN1|F132B_MOUSE Protein FAM132B OS=Mus mu    69.87 9 3
Q8BL66|EEA1_MOUSE Early endosome antigen 1 OS     69.47 8 3
Q9Z1N2|ORC1_MOUSE Origin recognition complex sub       68.93 9 3
Q8C5Q4|GRSF1_MOUSE G-rich sequence factor 1 OS=     68.88 20 3
Q61263|SOAT1_MOUSE Sterol O-acyltransferase 1 OS     68.41 43 3
Q9R087|GPC6_MOUSE Glypican-6 OS=Mus musculus   67.47 21 3
P63168|DYL1_MOUSE Dynein light chain 1, cytoplasm      67.42 48 3
Q80U93|NU214_MOUSE Nuclear pore complex protein      67.23 10 3
Q9WUU7|CATZ_MOUSE Cathepsin Z OS=Mus musculu    65.2 25 3
Q9CZG9|PDZ11_MOUSE PDZ domain-containing protei       64.59 65 3
O35604|NPC1_MOUSE Niemann-Pick C1 protein OS=     64.28 8 3
P11983|TCPA_MOUSE T-complex protein 1 subunit al      63.34 13 3
Q9Z1N5|DX39B_MOUSE Spliceosome RNA helicase Dd      62.3 16 3
Q9D6J6|NDUV2_MOUSE NADH dehydrogenase [ubiquin         61.76 24 3
Q80W00|PP1RA_MOUSE Serine/threonine-protein phosp          60.53 17 3
P80318|TCPG_MOUSE T-complex protein 1 subunit ga      59.81 38 3
P54775|PRS6B_MOUSE 26S protease regulatory subun       59.62 8 3
Q9CQM9|GLRX3_MOUSE Glutaredoxin-3 OS=Mus musc    59.13 16 3
P14901|HMOX1_MOUSE Heme oxygenase 1 OS=Mus m    58.37 19 3
Q8BMJ2|SYLC_MOUSE Leucyl-tRNA synthetase, cytop      58 8 3
P29268|CTGF_MOUSE Connective tissue growth facto      57.19 13 3
Q6P5F9|XPO1_MOUSE Exportin-1 OS=Mus musculus   57.04 7 3
Q9CR98|F136A_MOUSE Protein FAM136A OS=Mus mu    56.87 25 3
Q9DCD5|TJAP1_MOUSE Tight junction-associated prote       54.46 5 3
P83940|ELOC_MOUSE Transcription elongation factor        53.8 44 3
Q9JJ28|FLII_MOUSE Protein flightless-1 homolog O     53.33 10 3
Q63870|CO7A1_MOUSE Collagen alpha-1(VII) chain OS     48.67 11 3
Q80T85|DCAF5_MOUSE DDB1- and CUL4-associated f       47.52 10 3
P70336|ROCK2_MOUSE Rho-associated protein kinase      47.44 7 3
Q99KW3|TARA_MOUSE TRIO and F-actin-binding prot      43.34 8 3
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P16056|MET_MOUSE Hepatocyte growth factor rece      42.77 9 3
Q6QIY3|SCNAA_MOUSE Sodium channel protein type 1        41.52 6 3
Q9CW03|SMC3_MOUSE Structural maintenance of chro        40.92 12 3
Q8BJ37|TYDP1_MOUSE Tyrosyl-DNA phosphodiestera       40.08 12 3
Q6ZWQ0|SYNE2_MOUSE Nesprin-2 OS=Mus musculus   37.4 7 3
O88700|BLM_MOUSE Bloom syndrome protein homo      36.33 8 3
Q6NZC7|S23IP_MOUSE SEC23-interacting protein OS=     34.81 6 3
Q6PDK2|MLL2_MOUSE Histone-lysine N-methyltransfe       34.74 3 3
A2A7S8|K1522_MOUSE Uncharacterized protein KIAA1      34 7 3
Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking       33.73 4 3
Q924A2|CIC_MOUSE Protein capicua homolog OS=     33.17 4 3
Q99PJ1|PCD15_MOUSE Protocadherin-15 OS=Mus mu    32.93 5 3
Q6R5N8|TLR13_MOUSE Toll-like receptor 13 OS=Mus    32.86 13 3
Q9CXA2|PRCM_MOUSE Probable proline racemase OS    30.3 8 3
B2RX88|CSPP1_MOUSE Centrosome and spindle pole        30.26 8 3
Q6PGL7|FAM21_MOUSE WASH complex subunit FAM2      30.03 8 3
Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=M     29.79 8 3
B9EKI3|TMF1_MOUSE TATA element modulatory fac      29.2 7 3
A2AAE1|K1109_MOUSE Uncharacterized protein KIAA1      27.33 7 3
Q766D5|B4GN4_MOUSE N-acetyl-beta-glucosaminyl-gly        26.91 9 3
Q3UHU5|K0802_MOUSE Uncharacterized protein KIAA0      26.9 4 3
Q80TY5|VP13B_MOUSE Vacuolar protein sorting-assoc        26.69 4 3
Q6GQT6|SCAP_MOUSE Sterol regulatory element-bind         26.49 9 3
Q9R244|TRPC2_MOUSE Short transient receptor potent        25.77 8 3
A2ARZ3|FSIP2_MOUSE Fibrous sheath-interacting pro       25.37 5 3
O88491|NSD1_MOUSE Histone-lysine N-methyltransfe            24.67 4 3
Q4VK74|IL28A_MOUSE Interleukin-28A OS=Mus musc    24.52 13 3
Q8CGK6|IL28B_MOUSE Interleukin-28B OS=Mus musc    24.52 13 3
P06800|PTPRC_MOUSE Receptor-type tyrosine-protein       21.91 7 3
P63260|ACTG_MOUSE Actin, cytoplasmic 2 OS=Mus    354.61 86 2
Q64522|H2A2B_MOUSE Histone H2A type 2-B OS=Mu     301.18 90 2
P07758|A1AT1_MOUSE Alpha-1-antitrypsin 1-1 OS=Mu     257.13 61 2
P68372|TBB2C_MOUSE Tubulin beta-2C chain OS=Mu     256.34 65 2
Q7TMM9|TBB2A_MOUSE Tubulin beta-2A chain OS=Mu     245.26 60 2
Q9CWF2|TBB2B_MOUSE Tubulin beta-2B chain OS=Mu     245.26 60 2
Q64524|H2B2E_MOUSE Histone H2B type 2-E OS=Mu     212.55 72 2
Q922F4|TBB6_MOUSE Tubulin beta-6 chain OS=Mus    210.98 45 2
P70333|HNRH2_MOUSE Heterogeneous nuclear ribonu       178.13 29 2
Q9CQ19|MYL9_MOUSE Myosin regulatory light polypep       176.32 81 2
P63163|RSMN_MOUSE Small nuclear ribonucleoprote        165.88 50 2
Q9JKB3|DBPA_MOUSE DNA-binding protein A OS=Mu     149.05 29 2
P26040|EZRI_MOUSE Ezrin OS=Mus musculus GN=   133.84 17 2
P35550|FBRL_MOUSE rRNA 2'-O-methyltransferase f      131.03 30 2
P26043|RADI_MOUSE Radixin OS=Mus musculus GN   130.02 22 2
Q6PFR5|TRA2A_MOUSE Transformer-2 protein homolo       125.44 26 2
Q6P1F6|2ABA_MOUSE Serine/threonine-protein phosp              122.58 30 2
P35278|RAB5C_MOUSE Ras-related protein Rab-5C O     121.99 25 2
Q62241|RU1C_MOUSE U1 small nuclear ribonucleopro       118.52 40 2
P01644|KV5AB_MOUSE Ig kappa chain V-V region HP     117.47 47 2
P26041|MOES_MOUSE Moesin OS=Mus musculus GN   115.89 25 2
P97461|RS5_MOUSE 40S ribosomal protein S5 OS=     111.9 50 2
P97290|IC1_MOUSE Plasma protease C1 inhibitor O     110.09 15 2
Q60590|A1AG1_MOUSE Alpha-1-acid glycoprotein 1 OS     109.67 38 2
Q9CQN1|TRAP1_MOUSE Heat shock protein 75 kDa, m      106.44 15 2
Q9R1P1|PSB3_MOUSE Proteasome subunit beta type      101.53 27 2
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Q921H8|THIKA_MOUSE 3-ketoacyl-CoA thiolase A, per      101.43 25 2
Q99JX3|GORS2_MOUSE Golgi reassembly-stacking pro       100.57 17 2
Q62426|CYTB_MOUSE Cystatin-B OS=Mus musculus   100.39 33 2
Q9ESB3|HRG_MOUSE Histidine-rich glycoprotein OS=     97.47 10 2
Q9CS42|PRPS2_MOUSE Ribose-phosphate pyrophosph       97.36 25 2
P26883|FKB1A_MOUSE Peptidyl-prolyl cis-trans isome       97.14 25 2
Q9ET22|DPP2_MOUSE Dipeptidyl peptidase 2 OS=Mu     96.81 14 2
Q9ES46|PARVB_MOUSE Beta-parvin OS=Mus musculu    96.59 11 2
Q9JJV2|PROF2_MOUSE Profilin-2 OS=Mus musculus G   96.56 32 2
P97379|G3BP2_MOUSE Ras GTPase-activating protein        95.87 15 2
Q9DCH4|EIF3F_MOUSE Eukaryotic translation initiation         95.71 16 2
Q5I1X5|IASPP_MOUSE RelA-associated inhibitor OS=     93.77 17 2
Q9DCD6|GBRAP_MOUSE Gamma-aminobutyric acid rec       93.28 32 2
P47955|RLA1_MOUSE 60S acidic ribosomal protein P      92.16 42 2
P10639|THIO_MOUSE Thioredoxin OS=Mus musculu    91.4 21 2
O88968|TCO2_MOUSE Transcobalamin-2 OS=Mus m    91.23 12 2
P70663|SPRL1_MOUSE SPARC-like protein 1 OS=Mus    90.96 10 2
Q8BHD7|ROD1_MOUSE Regulator of differentiation 1 O     90.78 21 2
Q61510|TRI25_MOUSE E3 ubiquitin/ISG15 ligase TRIM      89.97 12 2
Q9Z1B5|MD2L1_MOUSE Mitotic spindle assembly chec        89.56 24 2
Q8CI43|MYL6B_MOUSE Myosin light chain 6B OS=Mus    88.95 25 2
O35744|CH3L3_MOUSE Chitinase-3-like protein 3 OS=     88.68 18 2
Q8BRG8|TM209_MOUSE Transmembrane protein 209 O     88.01 12 2
Q04857|CO6A1_MOUSE Collagen alpha-1(VI) chain OS     86.6 8 2
Q7TPD3|ROBO2_MOUSE Roundabout homolog 2 OS=M     86.24 9 2
P26618|PGFRA_MOUSE Alpha-type platelet-derived gro        86.16 20 2
P62196|PRS8_MOUSE 26S protease regulatory subun       85.38 16 2
P04919|B3AT_MOUSE Band 3 anion transport protein     85.3 9 2
Q6NZN0|RBM26_MOUSE RNA-binding protein 26 OS=M     84.87 10 2
Q64324|STXB2_MOUSE Syntaxin-binding protein 2 OS     84.53 12 2
Q8K183|PDXK_MOUSE Pyridoxal kinase OS=Mus mus    83.89 14 2
Q6ZWM4|NAA38_MOUSE N-alpha-acetyltransferase 38,        83.77 34 2
Q9WVJ2|PSD13_MOUSE 26S proteasome non-ATPase        83.47 18 2
P60824|CIRBP_MOUSE Cold-inducible RNA-binding pr      83.03 36 2
Q9CQT2|RBM7_MOUSE RNA-binding protein 7 OS=Mu     83.02 14 2
P97360|ETV6_MOUSE Transcription factor ETV6 OS=     82.86 12 2
Q8BSQ9|PB1_MOUSE Protein polybromo-1 OS=Mus    82.61 9 2
P67984|RL22_MOUSE 60S ribosomal protein L22 OS     82.26 20 2
P22892|AP1G1_MOUSE AP-1 complex subunit gamma      82.25 15 2
P62855|RS26_MOUSE 40S ribosomal protein S26 OS     82.11 39 2
Q6A065|CE170_MOUSE Centrosomal protein of 170 kD      82.04 8 2
Q91YD3|DCP1A_MOUSE mRNA-decapping enzyme 1A     80.74 9 2
P51885|LUM_MOUSE Lumican OS=Mus musculus G   80.71 24 2
Q9CSU0|RPR1B_MOUSE Regulation of nuclear pre-mRN         80.64 15 2
O35114|SCRB2_MOUSE Lysosome membrane protein      80.59 9 2
Q8BKG3|PTK7_MOUSE Inactive tyrosine-protein kinase      80.26 10 2
P97425|ECP2_MOUSE Eosinophil cationic protein 2 O     80.11 38 2
Q9Z1Z2|STRAP_MOUSE Serine-threonine kinase recep       80.08 24 2
Q9Z175|LOXL3_MOUSE Lysyl oxidase homolog 3 OS=     79.56 4 2
Q69ZQ2|ISY1_MOUSE Pre-mRNA-splicing factor ISY       78.99 19 2
Q9Z0M5|LICH_MOUSE Lysosomal acid lipase/choleste        78.41 29 2
Q6A4J8|UBP7_MOUSE Ubiquitin carboxyl-terminal hyd       78.11 7 2
P02463|CO4A1_MOUSE Collagen alpha-1(IV) chain OS     77.9 9 2
P10649|GSTM1_MOUSE Glutathione S-transferase Mu      77.56 19 2
Q80W21|GSTM7_MOUSE Glutathione S-transferase Mu      77.56 32 2
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P15626|GSTM2_MOUSE Glutathione S-transferase Mu      77.56 18 2
Q8CHU3|EPN2_MOUSE Epsin-2 OS=Mus musculus GN   77.46 10 2
P97855|G3BP1_MOUSE Ras GTPase-activating protein        77.44 16 2
Q8K221|ARFP2_MOUSE Arfaptin-2 OS=Mus musculus   77.15 24 2
O35841|API5_MOUSE Apoptosis inhibitor 5 OS=Mus    76.97 14 2
P01887|B2MG_MOUSE Beta-2-microglobulin OS=Mus    76.51 29 2
Q3UIA2|RHG17_MOUSE Rho GTPase-activating protein      76.47 11 2
P17047|LAMP2_MOUSE Lysosome-associated membra        76.26 10 2
Q9DCT8|CRIP2_MOUSE Cysteine-rich protein 2 OS=Mu     76.03 35 2
O35207|CDKA1_MOUSE Cyclin-dependent kinase 2-ass        75.84 20 2
P54823|DDX6_MOUSE Probable ATP-dependent RNA       75.65 13 2
A2ASQ1|AGRIN_MOUSE Agrin OS=Mus musculus GN=   75.62 8 2
O08709|PRDX6_MOUSE Peroxiredoxin-6 OS=Mus mus    75.59 14 2
P26231|CTNA1_MOUSE Catenin alpha-1 OS=Mus mus    75.57 15 2
Q9QZ23|NFU1_MOUSE NFU1 iron-sulfur cluster scaffo        75.47 16 2
Q920B9|SP16H_MOUSE FACT complex subunit SPT16     75.44 11 2
Q9WU28|PFD5_MOUSE Prefoldin subunit 5 OS=Mus m    75.37 29 2
Q69ZW3|EHBP1_MOUSE EH domain-binding protein 1 O     75.32 4 2
Q60692|PSB6_MOUSE Proteasome subunit beta type      74.74 16 2
Q91VR2|ATPG_MOUSE ATP synthase subunit gamma       74.65 25 2
Q9Z2Y8|PROSC_MOUSE Proline synthase co-transcribe         74.53 19 2
Q60737|CSK21_MOUSE Casein kinase II subunit alpha     74.48 17 2
Q9QUI0|RHOA_MOUSE Transforming protein RhoA OS     74.2 20 2
O55234|PSB5_MOUSE Proteasome subunit beta type      74.17 16 2
Q9D8C6|MED11_MOUSE Mediator of RNA polymerase I         74.11 23 2
Q01730|RSU1_MOUSE Ras suppressor protein 1 OS=     73.76 24 2
P10518|HEM2_MOUSE Delta-aminolevulinic acid dehy      73.27 13 2
O08740|RPB11_MOUSE DNA-directed RNA polymeras         73.26 47 2
Q99KV1|DJB11_MOUSE DnaJ homolog subfamily B me       73.11 19 2
Q78HU3|F125A_MOUSE Multivesicular body subunit 12      73.1 15 2
Q9D8W5|PSD12_MOUSE 26S proteasome non-ATPase        73.01 13 2
P06745|G6PI_MOUSE Glucose-6-phosphate isomera      72.55 10 2
Q62419|SH3G1_MOUSE Endophilin-A2 OS=Mus muscu    72.42 30 2
Q3UPF5|ZCCHV_MOUSE Zinc finger CCCH-type antivira        72.3 12 2
P35441|TSP1_MOUSE Thrombospondin-1 OS=Mus m    71.94 13 2
O70435|PSA3_MOUSE Proteasome subunit alpha type      71.91 14 2
Q91VY9|ZN622_MOUSE Zinc finger protein 622 OS=Mu     71.75 12 2
Q9JJY4|DDX20_MOUSE Probable ATP-dependent RNA       71.52 22 2
Q91ZA3|PCCA_MOUSE Propionyl-CoA carboxylase alp        71.5 11 2
Q9JHW2|NIT2_MOUSE Omega-amidase NIT2 OS=Mu     70.81 18 2
P06683|CO9_MOUSE Complement component C9 O     70.71 13 2
P21460|CYTC_MOUSE Cystatin-C OS=Mus musculus   70.4 20 2
Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus m    70.39 10 2
Q9CQ75|NDUA2_MOUSE NADH dehydrogenase [ubiquin           70.08 24 2
O35459|ECH1_MOUSE Delta(3,5)-Delta(2,4)-dienoyl-C        69.16 18 2
Q9JII5|DAZP1_MOUSE DAZ-associated protein 1 OS=     68.92 15 2
Q8VDT9|RM50_MOUSE 39S ribosomal protein L50, mi      68.59 44 2
P47941|CRKL_MOUSE Crk-like protein OS=Mus musc    68.58 15 2
Q5RKR3|ISLR2_MOUSE Immunoglobulin superfamily c          68.47 16 2
Q9D883|U2AF1_MOUSE Splicing factor U2AF 35 kDa s      68.36 32 2
Q9ESP1|SDF2L_MOUSE Stromal cell-derived factor 2-li        67.99 24 2
Q923D2|BLVRB_MOUSE Flavin reductase OS=Mus mus    67.58 18 2
Q8BX90|FND3A_MOUSE Fibronectin type-III domain-co        67.34 8 2
Q8BIW1|PRUNE_MOUSE Protein prune homolog OS=M     67.18 7 2
Q9Z2I0|LETM1_MOUSE LETM1 and EF-hand domain-c         67 9 2
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Q9ERE7|MESD_MOUSE LDLR chaperone MESD OS=M     66.71 17 2
Q9CPY7|AMPL_MOUSE Cytosol aminopeptidase OS=M     65.46 16 2
P13634|CAH1_MOUSE Carbonic anhydrase 1 OS=Mu     65.02 8 2
Q9R1P4|PSA1_MOUSE Proteasome subunit alpha type      64.79 24 2
Q91Z31|PTBP2_MOUSE Polypyrimidine tract-binding pr       64.7 18 2
P53996|CNBP_MOUSE Cellular nucleic acid-binding p      64.63 13 2
P10107|ANXA1_MOUSE Annexin A1 OS=Mus musculu    64.25 11 2
P80313|TCPH_MOUSE T-complex protein 1 subunit et      64.06 9 2
P19157|GSTP1_MOUSE Glutathione S-transferase P 1     63.76 15 2
Q923D4|SF3B5_MOUSE Splicing factor 3B subunit 5 OS     63.72 33 2
Q9DCT2|NDUS3_MOUSE NADH dehydrogenase [ubiquin          63.55 26 2
Q8CCS6|PABP2_MOUSE Polyadenylate-binding protein      63.08 11 2
P39054|DYN2_MOUSE Dynamin-2 OS=Mus musculus   63.07 8 2
Q80X50|UBP2L_MOUSE Ubiquitin-associated protein 2-      62.83 12 2
O88531|PPT1_MOUSE Palmitoyl-protein thioesterase      62.02 8 2
Q9CWP6|MSPD2_MOUSE Motile sperm domain-containin        61.36 8 2
Q9R0L7|AKP8L_MOUSE A-kinase anchor protein 8-like     60.88 6 2
Q9DBT5|AMPD2_MOUSE AMP deaminase 2 OS=Mus m    60.77 13 2
Q91W69|EPN3_MOUSE Epsin-3 OS=Mus musculus GN   60.37 5 2
P19253|RL13A_MOUSE 60S ribosomal protein L13a O     60.35 19 2
O35857|TIM44_MOUSE Mitochondrial import inner mem         60.22 12 2
Q6ZWX6|IF2A_MOUSE Eukaryotic translation initiation         60.12 9 2
O35166|GOSR2_MOUSE Golgi SNAP receptor complex       60.01 24 2
O55013|TPPC3_MOUSE Trafficking protein particle com        59.05 14 2
P70335|ROCK1_MOUSE Rho-associated protein kinase      59 8 2
O70439|STX7_MOUSE Syntaxin-7 OS=Mus musculus   58.91 21 2
Q91YW3|DNJC3_MOUSE DnaJ homolog subfamily C me       58.85 6 2
Q9Z108|STAU1_MOUSE Double-stranded RNA-binding         58.73 5 2
Q9JLV6|PNKP_MOUSE Bifunctional polynucleotide pho      58.49 10 2
P47757|CAPZB_MOUSE F-actin-capping protein subun       57.36 25 2
Q9WTR2|M3K6_MOUSE Mitogen-activated protein kina         57.36 3 2
Q62296|TEAD4_MOUSE Transcriptional enhancer facto       57.16 12 2
Q8C170|MYO9A_MOUSE Myosin-IXa OS=Mus musculus   57.04 4 2
P19096|FAS_MOUSE Fatty acid synthase OS=Mus m    56.94 6 2
Q9CXY6|ILF2_MOUSE Interleukin enhancer-binding fa       56.84 11 2
Q7TQ95|LNP_MOUSE Protein lunapark OS=Mus mus    56.79 14 2
Q8CCK0|H2AW_MOUSE Core histone macro-H2A.2 OS     56.69 20 2
Q8QZY9|SF3B4_MOUSE Splicing factor 3B subunit 4 OS     56.55 17 2
Q61702|ITIH1_MOUSE Inter-alpha-trypsin inhibitor hea        56.44 7 2
P63037|DNJA1_MOUSE DnaJ homolog subfamily A me       56.28 18 2
P80315|TCPD_MOUSE T-complex protein 1 subunit de      56 11 2
P15306|TRBM_MOUSE Thrombomodulin OS=Mus mu    55.83 12 2
Q8CGR5|KLK14_MOUSE Kallikrein-14 OS=Mus musculu    55.64 13 2
P61211|ARL1_MOUSE ADP-ribosylation factor-like pro       55.52 9 2
O70400|PDLI1_MOUSE PDZ and LIM domain protein 1     55.42 24 2
P56565|S10A1_MOUSE Protein S100-A1 OS=Mus mus    55.32 38 2
Q9CYI4|LUC7L_MOUSE Putative RNA-binding protein L       55.29 9 2
Q61598|GDIB_MOUSE Rab GDP dissociation inhibitor      55.15 12 2
P35951|LDLR_MOUSE Low-density lipoprotein recepto      55.07 9 2
Q9Z0J0|NPC2_MOUSE Epididymal secretory protein E      55.07 12 2
P19221|THRB_MOUSE Prothrombin OS=Mus musculu    54.98 8 2
Q8R3C6|RBM19_MOUSE Probable RNA-binding protein      54.96 11 2
P62889|RL30_MOUSE 60S ribosomal protein L30 OS     54.55 16 2
Q7TT37|ELP1_MOUSE Elongator complex protein 1 O     54.52 8 2
P34022|RANG_MOUSE Ran-specific GTPase-activatin       54.33 29 2
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Q9Z2L6|MINP1_MOUSE Multiple inositol polyphosphate       53.85 11 2
Q9D945|LLPH_MOUSE Protein LLP homolog OS=Mus    53.66 37 2
P70460|VASP_MOUSE Vasodilator-stimulated phosph      53.54 23 2
Q8K1J6|TRNT1_MOUSE CCA tRNA nucleotidyltransfera        53.46 18 2
P47753|CAZA1_MOUSE F-actin-capping protein subun       52.82 10 2
Q00PI9|HNRL2_MOUSE Heterogeneous nuclear ribonu         52.71 7 2
Q8CH25|SLTM_MOUSE SAFB-like transcription modula      52.65 6 2
Q8BRF7|SCFD1_MOUSE Sec1 family domain-containing       52.61 14 2
P23953|ESTN_MOUSE Liver carboxylesterase N OS=     52.28 6 2
Q9CPW4|ARPC5_MOUSE Actin-related protein 2/3 comp        52.22 21 2
Q569Z6|TR150_MOUSE Thyroid hormone receptor-ass        52.02 4 2
Q148V7|K1468_MOUSE LisH domain and HEAT repea        51.88 15 2
Q91VZ6|SMAP1_MOUSE Stromal membrane-associated       51.54 13 2
Q9EPU4|CPSF1_MOUSE Cleavage and polyadenylation         51.23 3 2
P32921|SYWC_MOUSE Tryptophanyl-tRNA synthetase       51.1 11 2
Q62318|TIF1B_MOUSE Transcription intermediary fact       50.94 8 2
Q8BL99|DOP1_MOUSE Protein dopey-1 OS=Mus mus    50.82 5 2
P21126|UBL4A_MOUSE Ubiquitin-like protein 4A OS=M     50.79 27 2
Q8K4M5|COMD1_MOUSE COMM domain-containing pro       50.73 16 2
O08715|AKAP1_MOUSE A-kinase anchor protein 1, mit      50.43 5 2
O88543|CSN3_MOUSE COP9 signalosome complex s       50.16 19 2
Q9WTQ5|AKA12_MOUSE A-kinase anchor protein 12 OS     49.83 8 2
O88958|GNPI1_MOUSE Glucosamine-6-phosphate iso       49.58 21 2
P09528|FRIH_MOUSE Ferritin heavy chain OS=Mus m    48.67 12 2
Q9CWK8|SNX2_MOUSE Sorting nexin-2 OS=Mus musc    48.6 13 2
Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanB      47.93 5 2
Q07456|AMBP_MOUSE Protein AMBP OS=Mus muscu    46.96 6 2
P05532|KIT_MOUSE Mast/stem cell growth factor re      46.9 8 2
Q9D5V5|CUL5_MOUSE Cullin-5 OS=Mus musculus GN   46.6 13 2
Q8BNJ6|NETO2_MOUSE Neuropilin and tolloid-like prote       46.6 10 2
Q6P3D0|NUD16_MOUSE U8 snoRNA-decapping enzym      46.36 16 2
Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus   46.01 4 2
Q8CG48|SMC2_MOUSE Structural maintenance of chro        45.84 6 2
Q8BMK4|CKAP4_MOUSE Cytoskeleton-associated prote       45.28 16 2
Q6PE15|ABHDA_MOUSE Abhydrolase domain-containin         44.99 17 2
O70591|PFD2_MOUSE Prefoldin subunit 2 OS=Mus m    44.78 27 2
Q8VHK9|DHX36_MOUSE Probable ATP-dependent RNA       44.73 5 2
P70288|HDAC2_MOUSE Histone deacetylase 2 OS=Mu     44.49 13 2
O09106|HDAC1_MOUSE Histone deacetylase 1 OS=Mu     44.49 8 2
Q8BTS4|NUP54_MOUSE Nuclear pore complex protein      44.27 10 2
Q05D44|IF2P_MOUSE Eukaryotic translation initiation       43.78 11 2
Q9D1R9|RL34_MOUSE 60S ribosomal protein L34 OS     43.66 15 2
P47964|RL36_MOUSE 60S ribosomal protein L36 OS     42.33 12 2
Q61329|ZFHX3_MOUSE Zinc finger homeobox protein      41.92 5 2
Q99LI8|HGS_MOUSE Hepatocyte growth factor-regu         41.86 11 2
Q9CPN8|IF2B3_MOUSE Insulin-like growth factor 2 mR        41.86 7 2
Q91YT0|NDUV1_MOUSE NADH dehydrogenase [ubiquin         41.39 9 2
Q8R311|CTGE5_MOUSE Cutaneous T-cell lymphoma-a         41.3 6 2
Q61599|GDIR2_MOUSE Rho GDP-dissociation inhibito       40.99 16 2
Q8BYC4|GPR20_MOUSE G-protein coupled receptor 20     40.87 13 2
Q99MY8|ASH1L_MOUSE Probable histone-lysine N-met       39.28 5 2
Q9Z1P6|NDUA7_MOUSE NADH dehydrogenase [ubiquin           38.74 34 2
Q62504|MINT_MOUSE Msx2-interacting protein OS=M     38.6 6 2
Q91Z58|CF132_MOUSE Uncharacterized protein C6orf      38.28 5 2
Q60952|CP250_MOUSE Centrosome-associated protei       38.05 5 2
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Q9JKP5|MBNL1_MOUSE Muscleblind-like protein 1 OS=     37.89 5 2
Q8C181|MBNL2_MOUSE Muscleblind-like protein 2 OS=     37.89 5 2
Q9CX34|SUGT1_MOUSE Suppressor of G2 allele of SKP       37.85 8 2
Q8JZM7|CDC73_MOUSE Parafibromin OS=Mus muscul    37.15 4 2
Q80TC6|ZSWM5_MOUSE Zinc finger SWIM domain-cont        37 6 2
Q9QYC0|ADDA_MOUSE Alpha-adducin OS=Mus musc    36.46 5 2
Q8BPY9|FIGL1_MOUSE Fidgetin-like protein 1 OS=Mus    35.84 6 2
Q8R105|VP37C_MOUSE Vacuolar protein sorting-assoc        35.71 25 2
Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 O     35.38 4 2
Q6ZQA0|NBEL2_MOUSE Neurobeachin-like protein 2 O     34.98 3 2
P11369|POL2_MOUSE Retrovirus-related Pol polyprot       34.9 5 2
Q8BH31|MFSD8_MOUSE Major facilitator superfamily do        34.85 5 2
Q04750|TOP1_MOUSE DNA topoisomerase 1 OS=Mu     34.45 11 2
Q571H0|NPA1P_MOUSE Nucleolar pre-ribosomal-assoc        34.37 4 2
Q9JK83|PAR6B_MOUSE Partitioning defective 6 homolo       34.28 17 2
Q91ZI0|CELR3_MOUSE Cadherin EGF LAG seven-pas         33.62 6 2
Q61390|TCPW_MOUSE T-complex protein 1 subunit ze      33.6 24 2
Q8BGQ7|SYAC_MOUSE Alanyl-tRNA synthetase, cytop      33.42 8 2
Q69ZH9|RHG23_MOUSE Rho GTPase-activating protein      33.16 3 2
P49718|MCM5_MOUSE DNA replication licensing facto       33.11 6 2
Q69ZN7|MYOF_MOUSE Myoferlin OS=Mus musculus G   32.75 6 2
Q9WTS6|TEN3_MOUSE Teneurin-3 OS=Mus musculus   32.67 4 2
P98200|AT8A2_MOUSE Probable phospholipid-transpo        32.61 9 2
O35071|KIF1C_MOUSE Kinesin-like protein KIF1C OS     32.57 8 2
Q8BLX7|COGA1_MOUSE Collagen alpha-1(XVI) chain O     32.23 7 2
P48725|PCNT_MOUSE Pericentrin OS=Mus musculus   32.23 5 2
Q61245|COBA1_MOUSE Collagen alpha-1(XI) chain OS     31.75 6 2
Q9QZ09|PHTF1_MOUSE Putative homeodomain transc        31.6 15 2
Q8CH77|NAV1_MOUSE Neuron navigator 1 OS=Mus m    31.46 6 2
O35161|CELR1_MOUSE Cadherin EGF LAG seven-pas         31.22 7 2
Q5QNQ9|CORA1_MOUSE Collagen alpha-1(XXVII) chain     31.2 5 2
Q30D77|COOA1_MOUSE Collagen alpha-1(XXIV) chain     30.6 8 2
Q9Z1X4|ILF3_MOUSE Interleukin enhancer-binding fa       30.52 3 2
Q3URV1|BROMI_MOUSE Protein broad-minded OS=Mu     30.52 6 2
Q9Z2U2|ZN292_MOUSE Zinc finger protein 292 OS=Mu     30.51 2 2
Q3V1M1|IGS10_MOUSE Immunoglobulin superfamily m       30.43 7 2
Q9ERR7|SEP15_MOUSE 15 kDa selenoprotein OS=Mus    30.42 23 2
Q8VCW8|ACSF2_MOUSE Acyl-CoA synthetase family m        30.34 9 2
Q8BGA5|KRR1_MOUSE KRR1 small subunit processom        30.25 8 2
Q8BWT5|DIP2A_MOUSE Disco-interacting protein 2 hom       30.17 4 2
Q9JHI4|S13A1_MOUSE Solute carrier family 13 memb       29.98 15 2
P17710|HXK1_MOUSE Hexokinase-1 OS=Mus muscu    29.84 5 2
Q80YF9|RHG33_MOUSE Rho GTPase-activating protein      29.76 5 2
Q6AW69|CGNL1_MOUSE Cingulin-like protein 1 OS=Mu     29.54 8 2
Q91WC3|ACSL6_MOUSE Long-chain-fatty-acid--CoA liga       29.1 11 2
Q0GGX2|ZN541_MOUSE Zinc finger protein 541 OS=Mu     29.07 9 2
P14873|MAP1B_MOUSE Microtubule-associated protein      29.05 3 2
Q91XQ0|DYH8_MOUSE Dynein heavy chain 8, axonem      28.88 2 2
Q811P8|RHG32_MOUSE Rho GTPase-activating protein      28.64 2 2
Q8BRB7|MYST4_MOUSE Histone acetyltransferase MYS      28.53 4 2
Q5SSE9|ABCAD_MOUSE ATP-binding cassette sub-fam         28.36 4 2
Q3UNW5|TF2L1_MOUSE Transcription factor CP2-like p       28.33 9 2
Q9JLN9|MTOR_MOUSE Serine/threonine-protein kinas       28.02 5 2
Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus G   27.89 5 2
Q69ZR2|HECD1_MOUSE E3 ubiquitin-protein ligase HEC      27.85 6 2
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Q8CGE9|RGS12_MOUSE Regulator of G-protein signalin       27.55 8 2
Q8BN57|CC033_MOUSE Uncharacterized protein C3orf      27.51 17 2
Q80YV3|TRRAP_MOUSE Transformation/transcription d       27.46 7 2
Q61941|NNTM_MOUSE NAD(P) transhydrogenase, mi      27.45 16 2
Q91YD6|VILL_MOUSE Villin-like protein OS=Mus mus    27.43 5 2
P11881|ITPR1_MOUSE Inositol 1,4,5-trisphosphate rec        27.36 7 2
Q3UHK3|GREB1_MOUSE Protein GREB1 OS=Mus musc    27.29 7 2
Q80WE4|KI20B_MOUSE Kinesin-like protein KIF20B OS     27.16 3 2
P58749|TM6S1_MOUSE Transmembrane 6 superfamily       27.15 12 2
Q812E0|CPEB2_MOUSE Cytoplasmic polyadenylation e        27 11 2
Q571C7|BDP1_MOUSE Transcription factor TFIIIB com        26.97 4 2
P54276|MSH6_MOUSE DNA mismatch repair protein M      26.93 7 2
P14719|ILRL1_MOUSE Interleukin-1 receptor-like 1 OS     26.87 6 2
Q60584|FBXW2_MOUSE F-box/WD repeat-containing p       26.72 9 2
Q0VF58|COJA1_MOUSE Collagen alpha-1(XIX) chain O     26.52 4 2
Q61290|CAC1E_MOUSE Voltage-dependent R-type calc         26.47 4 2
P53995|APC1_MOUSE Anaphase-promoting complex       26.44 6 2
Q9JHJ3|NCUG1_MOUSE Lysosomal protein NCU-G1 O    26.39 11 2
Q8R554|OTU7A_MOUSE OTU domain-containing protei       26.36 6 2
P31938|MP2K1_MOUSE Dual specificity mitogen-activa          26.34 18 2
O88737|BSN_MOUSE Protein bassoon OS=Mus mus    26.32 6 2
P70227|ITPR3_MOUSE Inositol 1,4,5-trisphosphate rec        26.31 3 2
Q45VK7|DYHC2_MOUSE Cytoplasmic dynein 2 heavy ch       26.3 7 2
Q3U108|ARI5A_MOUSE AT-rich interactive domain-con        25.88 3 2
Q3UVY5|CN135_MOUSE Pecanex-like protein C14orf13      25.81 4 2
Q9R016|BIR1E_MOUSE Baculoviral IAP repeat-contain        25.69 6 2
Q8JZM8|MUC4_MOUSE Mucin-4 OS=Mus musculus G   25.62 5 2
A2RSQ0|DEN5B_MOUSE DENN domain-containing prot       25.55 12 2
Q9Z351|KCNQ2_MOUSE Potassium voltage-gated chan          25.49 5 2
Q9ESK9|RBCC1_MOUSE RB1-inducible coiled-coil prote       25.35 5 2
Q9CW46|RAVR1_MOUSE Ribonucleoprotein PTB-bindin       25.22 10 2
Q9JMG7|HDGR3_MOUSE Hepatoma-derived growth fact        25.17 6 2
Q8C0P7|ZN451_MOUSE Zinc finger protein 451 OS=Mu     25.05 8 2
Q9QYT7|PIGQ_MOUSE Phosphatidylinositol N-acetylg        24.96 12 2
Q68FH0|PKP4_MOUSE Plakophilin-4 OS=Mus muscul    24.79 5 2
Q8CG73|FTM_MOUSE Protein fantom OS=Mus musc    24.77 6 2
Q8BLG0|PHF20_MOUSE PHD finger protein 20 OS=Mu     24.69 6 2
C4P6S0|SHTAP_MOUSE Sperm head and tail associate       24.58 2 2
Q69ZC8|K1704_MOUSE Uncharacterized protein KIAA1      24.49 12 2
Q8CJ27|ASPM_MOUSE Abnormal spindle-like microce        24.17 5 2
O70481|UBR1_MOUSE E3 ubiquitin-protein ligase UBR      24.17 5 2
P35546|RET_MOUSE Proto-oncogene tyrosine-prote         23.92 3 2
P16283|B3A3_MOUSE Anion exchange protein 3 OS=     23.68 3 2
Q2EY15|PRTG_MOUSE Protogenin OS=Mus musculus   23.6 2 2
Q80VM7|ANR24_MOUSE Ankyrin repeat domain-contain        23.57 11 2
Q4QRL3|CC88B_MOUSE Coiled-coil domain-containing       23.41 8 2
A2APU8|CI14B_MOUSE Transmembrane protein C9orf      23.41 7 2
Q9WU42|NCOR2_MOUSE Nuclear receptor corepressor      23.33 6 2
Q3UH53|SDK1_MOUSE Protein sidekick-1 OS=Mus m    23.02 5 2
Q91V27|MELPH_MOUSE Melanophilin OS=Mus muscul    21.77 9 2
Q69ZX6|MOR2A_MOUSE MORC family CW-type zinc fin        21.43 5 2
Q9Z0J4|NOS1_MOUSE Nitric oxide synthase, brain OS     21.29 7 2
Q6PAJ1|BCR_MOUSE Breakpoint cluster region prote      21.12 6 2
Q9Z0E1|CB065_MOUSE Uncharacterized protein C2orf       20.12 3 2
Q69ZU6|THS7A_MOUSE Thrombospondin type-1 doma        20.03 6 2
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Accession Description Score Coverage (%) #Unique
P19137|LAMA1_MOUSE Laminin subunit alpha-1 OS=Mus    628.63 84 416
P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus G   578.16 94 306
P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus    567.28 80 267
P02468|LAMC1_MOUSE Laminin subunit gamma-1 OS=M     569.94 87 245
Q05793|PGBM_MOUSE Basement membrane-specific he          501.41 67 159
Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus GN   450.04 81 108
P16546|SPTA2_MOUSE Spectrin alpha chain, brain OS=M     368.54 76 103
P20152|VIME_MOUSE Vimentin OS=Mus musculus GN   420.08 97 90
Q9QXS1|PLEC_MOUSE Plectin OS=Mus musculus GN=P   289.16 66 79
P01027|CO3_MOUSE Complement C3 OS=Mus muscu    345.76 72 78
Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chai       295.63 60 76
P19324|SERPH_MOUSE Serpin H1 OS=Mus musculus GN   392.76 87 73
P63038|CH60_MOUSE 60 kDa heat shock protein, mitoc      377.09 91 67
P20029|GRP78_MOUSE 78 kDa glucose-regulated protein     393.79 80 66
Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus m    366.86 71 63
Q62261|SPTB2_MOUSE Spectrin beta chain, brain 1 OS=     292.18 64 58
P14733|LMNB1_MOUSE Lamin-B1 OS=Mus musculus GN   381.83 92 55
P07724|ALBU_MOUSE Serum albumin OS=Mus muscul    381.35 88 55
Q8VIJ6|SFPQ_MOUSE Splicing factor, proline- and gluta      342.28 75 55
Q9D0E1|HNRPM_MOUSE Heterogeneous nuclear ribonucle       315.82 88 53
P63017|HSP7C_MOUSE Heat shock cognate 71 kDa prote      408.96 92 49
P09103|PDIA1_MOUSE Protein disulfide-isomerase OS=     337.38 93 49
Q80X90|FLNB_MOUSE Filamin-B OS=Mus musculus GN   279.12 52 49
P48678|LMNA_MOUSE Prelamin-A/C OS=Mus musculus   314.07 83 46
Q01853|TERA_MOUSE Transitional endoplasmic reticulu       315.18 67 44
O88322|NID2_MOUSE Nidogen-2 OS=Mus musculus G   312.75 57 44
Q68FD5|CLH_MOUSE Clathrin heavy chain 1 OS=Mus m    268.36 67 43
Q61879|MYH10_MOUSE Myosin-10 OS=Mus musculus G   326.98 66 41
Q8K310|MATR3_MOUSE Matrin-3 OS=Mus musculus GN=   312.04 67 40
Q8CGC7|SYEP_MOUSE Bifunctional aminoacyl-tRNA syn      307.57 70 40
P29341|PABP1_MOUSE Polyadenylate-binding protein 1 O     304.55 71 40
P26039|TLN1_MOUSE Talin-1 OS=Mus musculus GN=T   259.38 56 40
Q64727|VINC_MOUSE Vinculin OS=Mus musculus GN=   253.67 67 38
Q8K0E8|FIBB_MOUSE Fibrinogen beta chain OS=Mus m    294.75 72 37
P16858|G3P_MOUSE Glyceraldehyde-3-phosphate deh      332.58 87 36
P38647|GRP75_MOUSE Stress-70 protein, mitochondrial     285.7 78 36
O88569|ROA2_MOUSE Heterogeneous nuclear ribonucle       330.65 69 35
P11276|FINC_MOUSE Fibronectin OS=Mus musculus G   250.45 36 35
Q03265|ATPA_MOUSE ATP synthase subunit alpha, mito      292.18 80 32
Q61001|LAMA5_MOUSE Laminin subunit alpha-5 OS=Mus    263.25 38 32
Q9D8E6|RL4_MOUSE 60S ribosomal protein L4 OS=Mu     259.07 69 32
P56480|ATPB_MOUSE ATP synthase subunit beta, mito      311.5 79 31
P27773|PDIA3_MOUSE Protein disulfide-isomerase A3 O     254.3 68 30
Q921I1|TRFE_MOUSE Serotransferrin OS=Mus musculu    259.15 54 29
Q99K48|NONO_MOUSE Non-POU domain-containing oct       248.34 73 28
Q61595|KTN1_MOUSE Kinectin OS=Mus musculus GN=   225.51 51 28
O08677|KNG1_MOUSE Kininogen-1 OS=Mus musculus G   321.8 58 27
Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus GN   214.25 31 27
Q8VCM7|FIBG_MOUSE Fibrinogen gamma chain OS=Mu     305.52 62 26
Q922R8|PDIA6_MOUSE Protein disulfide-isomerase A6 O     289.63 89 26
P14211|CALR_MOUSE Calreticulin OS=Mus musculus G   283.76 84 26
P08249|MDHM_MOUSE Malate dehydrogenase, mitochon      274.69 81 26
P08032|SPTA1_MOUSE Spectrin alpha chain, erythrocyte     227.32 45 25
A2ASS6|TITIN_MOUSE Titin OS=Mus musculus GN=Ttn  79.26 8 25
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Q61838|A2M_MOUSE Alpha-2-macroglobulin OS=Mus    237.43 39 24
Q9EQK5|MVP_MOUSE Major vault protein OS=Mus mus    234.07 65 24
P58252|EF2_MOUSE Elongation factor 2 OS=Mus mus    210.56 45 24
P52480|KPYM_MOUSE Pyruvate kinase isozymes M1/M2     263.15 73 23
Q9R0B9|PLOD2_MOUSE Procollagen-lysine,2-oxoglutarate       225.37 52 23
Q9CSN1|SNW1_MOUSE SNW domain-containing protein      223.7 74 23
P08113|ENPL_MOUSE Endoplasmin OS=Mus musculus   210.35 44 23
P07214|SPRC_MOUSE SPARC OS=Mus musculus GN=   328.36 86 22
P61979|HNRPK_MOUSE Heterogeneous nuclear ribonucle       275.26 78 22
Q6P5E4|UGGG1_MOUSE UDP-glucose:glycoprotein glucos       245.58 46 22
Q8R326|PSPC1_MOUSE Paraspeckle component 1 OS=M     237.26 72 22
O70133|DHX9_MOUSE ATP-dependent RNA helicase A     231.54 39 22
Q9Z1Q9|SYVC_MOUSE Valyl-tRNA synthetase OS=Mus    229.3 50 22
Q9R0E2|PLOD1_MOUSE Procollagen-lysine,2-oxoglutarate       220.66 47 22
Q60902|EP15R_MOUSE Epidermal growth factor receptor        204.53 57 22
P11499|HS90B_MOUSE Heat shock protein HSP 90-beta     287.33 77 21
Q01405|SC23A_MOUSE Protein transport protein Sec23A     253.94 51 21
P06909|CFAH_MOUSE Complement factor H OS=Mus m    239.29 42 21
Q61576|FKB10_MOUSE Peptidyl-prolyl cis-trans isomeras       231.43 70 21
Q8BU30|SYIC_MOUSE Isoleucyl-tRNA synthetase, cytop      226.03 53 21
Q9DC23|DJC10_MOUSE DnaJ homolog subfamily C mem       216.46 43 21
P57776|EF1D_MOUSE Elongation factor 1-delta OS=Mu     245.75 59 20
P12970|RL7A_MOUSE 60S ribosomal protein L7a OS=M     234.46 65 20
P10126|EF1A1_MOUSE Elongation factor 1-alpha 1 OS=M     230.27 64 20
P62908|RS3_MOUSE 40S ribosomal protein S3 OS=M     227.08 74 20
P28665|MUG1_MOUSE Murinoglobulin-1 OS=Mus muscu    225.66 42 20
O08810|U5S1_MOUSE 116 kDa U5 small nuclear ribonu       215.23 50 20
Q99PV0|PRP8_MOUSE Pre-mRNA-processing-splicing fa       205.05 44 20
Q80U93|NU214_MOUSE Nuclear pore complex protein Nu      202.82 37 20
P25444|RS2_MOUSE 40S ribosomal protein S2 OS=M     248.19 74 19
P27659|RL3_MOUSE 60S ribosomal protein L3 OS=Mu     243.55 75 19
Q8BG05|ROA3_MOUSE Heterogeneous nuclear ribonucle       239.4 56 19
P21614|VTDB_MOUSE Vitamin D-binding protein OS=M     219.5 80 19
Q91X72|HEMO_MOUSE Hemopexin OS=Mus musculus G   214.76 47 19
P47911|RL6_MOUSE 60S ribosomal protein L6 OS=Mu     213.42 63 19
P62806|H4_MOUSE Histone H4 OS=Mus musculus G   211.8 89 19
Q8BMS1|ECHA_MOUSE Trifunctional enzyme subunit alph       176.45 57 19
P17742|PPIA_MOUSE Peptidyl-prolyl cis-trans isomeras       262.45 87 18
Q91W90|TXND5_MOUSE Thioredoxin domain-containing p       243.31 72 18
Q60716|P4HA2_MOUSE Prolyl 4-hydroxylase subunit alph      235.78 74 18
Q9Z247|FKBP9_MOUSE Peptidyl-prolyl cis-trans isomeras       230.13 59 18
O08795|GLU2B_MOUSE Glucosidase 2 subunit beta OS=     212.02 42 18
Q7TQH0|ATX2L_MOUSE Ataxin-2-like protein OS=Mus mu    183.98 33 18
P56959|FUS_MOUSE RNA-binding protein FUS OS=M     217.44 44 17
P06151|LDHA_MOUSE L-lactate dehydrogenase A chain     214.78 58 17
Q3V1T4|P3H1_MOUSE Prolyl 3-hydroxylase 1 OS=Mus m    202.57 41 17
Q60749|KHDR1_MOUSE KH domain-containing, RNA-bind          167.03 64 17
Q99P88|NU155_MOUSE Nuclear pore complex protein Nu      144.18 51 17
O35643|AP1B1_MOUSE AP-1 complex subunit beta-1 OS     251.4 56 16
P14206|RSSA_MOUSE 40S ribosomal protein SA OS=M     236.01 65 16
P17225|PTBP1_MOUSE Polypyrimidine tract-binding prote       233.6 69 16
P21619|LMNB2_MOUSE Lamin-B2 OS=Mus musculus GN   226.76 68 16
P80316|TCPE_MOUSE T-complex protein 1 subunit epsi      212.14 72 16
Q06890|CLUS_MOUSE Clusterin OS=Mus musculus GN   208.92 61 16
Q60715|P4HA1_MOUSE Prolyl 4-hydroxylase subunit alph      202.55 48 16
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Q91VM5|RBMXL_MOUSE Heterogeneous nuclear ribonucle        191.2 49 16
P62918|RL8_MOUSE 60S ribosomal protein L8 OS=Mu     187.04 45 16
Q8R0W0|EPIPL_MOUSE Epiplakin OS=Mus musculus GN   138.44 22 16
P29699|FETUA_MOUSE Alpha-2-HS-glycoprotein OS=Mu     254.26 78 15
Q9Z2X1|HNRPF_MOUSE Heterogeneous nuclear ribonucle       246.37 73 15
Q99JR5|TINAL_MOUSE Tubulointerstitial nephritis antigen      221.83 49 15
Q61292|LAMB2_MOUSE Laminin subunit beta-2 OS=Mus    199.43 33 15
P97496|SMRC1_MOUSE SWI/SNF complex subunit SMAR      199 54 15
P53026|RL10A_MOUSE 60S ribosomal protein L10a OS=     197.71 50 15
Q3U0V1|FUBP2_MOUSE Far upstream element-binding pr       196.1 40 15
Q9EPU0|RENT1_MOUSE Regulator of nonsense transcript       194.67 50 15
Q99020|ROAA_MOUSE Heterogeneous nuclear ribonucle       194.01 53 15
Q00623|APOA1_MOUSE Apolipoprotein A-I OS=Mus musc    189.43 80 15
Q9Z110|P5CS_MOUSE Delta-1-pyrroline-5-carboxylate s      184.08 42 15
Q8BMJ2|SYLC_MOUSE Leucyl-tRNA synthetase, cytoplas      168.22 35 15
P19096|FAS_MOUSE Fatty acid synthase OS=Mus mu    143.77 33 15
P98078|DAB2_MOUSE Disabled homolog 2 OS=Mus mu    236.55 36 14
P31001|DESM_MOUSE Desmin OS=Mus musculus GN=   235.27 63 14
P57759|ERP29_MOUSE Endoplasmic reticulum resident p       221.56 70 14
Q9WV54|ASAH1_MOUSE Acid ceramidase OS=Mus muscu    221.17 61 14
P39061|COIA1_MOUSE Collagen alpha-1(XVIII) chain OS     199.06 32 14
Q9WU78|PDC6I_MOUSE Programmed cell death 6-interac       198.76 35 14
P62301|RS13_MOUSE 40S ribosomal protein S13 OS=M     197.1 54 14
Q9D0I9|SYRC_MOUSE Arginyl-tRNA synthetase, cytopla      187.49 60 14
Q68FL6|SYMC_MOUSE Methionyl-tRNA synthetase, cyto      184.53 54 14
Q8K2B3|DHSA_MOUSE Succinate dehydrogenase [ubiqu         184.26 53 14
P24270|CATA_MOUSE Catalase OS=Mus musculus GN   179.58 44 14
Q3TXS7|PSMD1_MOUSE 26S proteasome non-ATPase reg        178.57 55 14
P09405|NUCL_MOUSE Nucleolin OS=Mus musculus GN   176.22 62 14
P02088|HBB1_MOUSE Hemoglobin subunit beta-1 OS=M     221.35 88 13
Q9DB20|ATPO_MOUSE ATP synthase subunit O, mitocho      215.62 78 13
Q08879|FBLN1_MOUSE Fibulin-1 OS=Mus musculus GN=   209.08 50 13
P61358|RL27_MOUSE 60S ribosomal protein L27 OS=M     196.06 59 13
P42567|EPS15_MOUSE Epidermal growth factor receptor       185.33 48 13
Q9JKR6|HYOU1_MOUSE Hypoxia up-regulated protein 1 O     179.9 43 13
Q8BH97|RCN3_MOUSE Reticulocalbin-3 OS=Mus muscu    172.07 54 13
Q8BHN3|GANAB_MOUSE Neutral alpha-glucosidase AB OS     167.31 56 13
Q9R0E1|PLOD3_MOUSE Procollagen-lysine,2-oxoglutarate       160.58 42 13
Q99PL5|RRBP1_MOUSE Ribosome-binding protein 1 OS=     157.4 19 13
P62270|RS18_MOUSE 40S ribosomal protein S18 OS=M     157.37 65 13
Q8K297|GT251_MOUSE Procollagen galactosyltransferas       144.08 55 13
P49312|ROA1_MOUSE Heterogeneous nuclear ribonucle       238.04 68 12
P62843|RS15_MOUSE 40S ribosomal protein S15 OS=M     233.43 83 12
Q8CG70|P3H3_MOUSE Prolyl 3-hydroxylase 3 OS=Mus m    191.34 51 12
Q8R081|HNRPL_MOUSE Heterogeneous nuclear ribonucle       188.9 38 12
Q8C0E2|VP26B_MOUSE Vacuolar protein sorting-associat        184.32 63 12
Q501J6|DDX17_MOUSE Probable ATP-dependent RNA h       166.08 31 12
Q9D8N0|EF1G_MOUSE Elongation factor 1-gamma OS=     162.74 43 12
Q61545|EWS_MOUSE RNA-binding protein EWS OS=M     162.55 32 12
P63085|MK01_MOUSE Mitogen-activated protein kinase      162.49 58 12
O35887|CALU_MOUSE Calumenin OS=Mus musculus G   161.42 57 12
P10605|CATB_MOUSE Cathepsin B OS=Mus musculus   147 38 12
Q8BH61|F13A_MOUSE Coagulation factor XIII A chain O     127.1 24 12
P07901|HS90A_MOUSE Heat shock protein HSP 90-alpha     244.17 53 11
P62259|1433E_MOUSE 14-3-3 protein epsilon OS=Mus m    224.63 87 11
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Q9CQU0|TXD12_MOUSE Thioredoxin domain-containing p       204.43 78 11
P31230|AIMP1_MOUSE Aminoacyl tRNA synthase compl         195.67 57 11
Q3UPH1|PRRC1_MOUSE Protein PRRC1 OS=Mus muscul    191.79 45 11
Q9CPR4|RL17_MOUSE 60S ribosomal protein L17 OS=M     185.15 61 11
Q91W39|NCOA5_MOUSE Nuclear receptor coactivator 5 O     170.94 51 11
Q9Z204|HNRPC_MOUSE Heterogeneous nuclear ribonucle       169.11 48 11
Q64433|CH10_MOUSE 10 kDa heat shock protein, mitoc      167.21 74 11
P97461|RS5_MOUSE 40S ribosomal protein S5 OS=M     158.99 80 11
Q8CIE6|COPA_MOUSE Coatomer subunit alpha OS=Mus    158.19 44 11
Q7TPV4|MBB1A_MOUSE Myb-binding protein 1A OS=Mus    153.13 42 11
P80313|TCPH_MOUSE T-complex protein 1 subunit eta O     142.58 47 11
Q9Z1Z0|USO1_MOUSE General vesicular transport facto       104.98 49 11
P63101|1433Z_MOUSE 14-3-3 protein zeta/delta OS=Mu     238.87 73 10
Q60605|MYL6_MOUSE Myosin light polypeptide 6 OS=M     201.05 88 10
P01942|HBA_MOUSE Hemoglobin subunit alpha OS=M     197.41 92 10
Q8BP92|RCN2_MOUSE Reticulocalbin-2 OS=Mus muscu    190.72 67 10
P13020|GELS_MOUSE Gelsolin OS=Mus musculus GN=   187.12 40 10
P62830|RL23_MOUSE 60S ribosomal protein L23 OS=M     185.19 74 10
P62317|SMD2_MOUSE Small nuclear ribonucleoprotein S       184.64 72 10
Q3THW5|H2AV_MOUSE Histone H2A.V OS=Mus musculu    184.51 90 10
P0C0S6|H2AZ_MOUSE Histone H2A.Z OS=Mus musculu    184.51 84 10
Q76MZ3|2AAA_MOUSE Serine/threonine-protein phospha              168.96 71 10
P09411|PGK1_MOUSE Phosphoglycerate kinase 1 OS=M     168.15 48 10
Q64478|H2B1H_MOUSE Histone H2B type 1-H OS=Mus m    165.46 59 10
Q64525|H2B2B_MOUSE Histone H2B type 2-B OS=Mus m    165.46 60 10
Q64475|H2B1B_MOUSE Histone H2B type 1-B OS=Mus m    165.46 54 10
Q6ZWY9|H2B1C_MOUSE Histone H2B type 1-C/E/G OS=M     165.46 54 10
P10853|H2B1F_MOUSE Histone H2B type 1-F/J/L OS=Mu     165.46 54 10
Q8CGP1|H2B1K_MOUSE Histone H2B type 1-K OS=Mus m    165.46 54 10
P10854|H2B1M_MOUSE Histone H2B type 1-M OS=Mus m    165.46 54 10
Q9WTM5|RUVB2_MOUSE RuvB-like 2 OS=Mus musculus G   163.48 37 10
Q9CQF3|CPSF5_MOUSE Cleavage and polyadenylation sp         162.33 72 10
P29533|VCAM1_MOUSE Vascular cell adhesion protein 1     147.87 26 10
P40142|TKT_MOUSE Transketolase OS=Mus musculu    147.23 41 10
Q8BFY9|TNPO1_MOUSE Transportin-1 OS=Mus musculus   145.26 51 10
Q8C854|MYEF2_MOUSE Myelin expression factor 2 OS=M     140.81 29 10
Q9D6R2|IDH3A_MOUSE Isocitrate dehydrogenase [NAD]        140.48 36 10
Q3UPL0|SC31A_MOUSE Protein transport protein Sec31A     136.87 18 10
Q9CU62|SMC1A_MOUSE Structural maintenance of chrom        131.66 19 10
Q91VD9|NDUS1_MOUSE NADH-ubiquinone oxidoreductas          130.52 30 10
A2AN08|UBR4_MOUSE E3 ubiquitin-protein ligase UBR4     130.21 14 10
O08788|DCTN1_MOUSE Dynactin subunit 1 OS=Mus mus    123.77 28 10
P39447|ZO1_MOUSE Tight junction protein ZO-1 OS=M     122.52 12 10
Q7TPR4|ACTN1_MOUSE Alpha-actinin-1 OS=Mus musculu    231.84 61 9
P62962|PROF1_MOUSE Profilin-1 OS=Mus musculus GN   213.75 98 9
P61982|1433G_MOUSE 14-3-3 protein gamma OS=Mus    205.68 68 9
Q8R2Z5|VWA1_MOUSE von Willebrand factor A domain-c        190.66 45 9
P16045|LEG1_MOUSE Galectin-1 OS=Mus musculus G   186.91 84 9
P63276|RS17_MOUSE 40S ribosomal protein S17 OS=M     185.97 70 9
P17182|ENOA_MOUSE Alpha-enolase OS=Mus musculu    182.71 71 9
Q8R4R6|NUP53_MOUSE Nucleoporin NUP53 OS=Mus mu    182.35 63 9
P62754|RS6_MOUSE 40S ribosomal protein S6 OS=M     174.7 40 9
Q922Q8|LRC59_MOUSE Leucine-rich repeat-containing pr       173.54 34 9
Q8BJ71|NUP93_MOUSE Nuclear pore complex protein Nu      173.53 60 9
P17751|TPIS_MOUSE Triosephosphate isomerase OS=     172.68 57 9
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Q91VA6|PDIP2_MOUSE Polymerase delta-interacting prot       170.25 53 9
P35980|RL18_MOUSE 60S ribosomal protein L18 OS=M     169.27 45 9
Q8BWT1|THIM_MOUSE 3-ketoacyl-CoA thiolase, mitocho      162.73 50 9
P47963|RL13_MOUSE 60S ribosomal protein L13 OS=M     162.64 50 9
Q8R3Q6|CCD58_MOUSE Coiled-coil domain-containing pro       161.95 77 9
P80314|TCPB_MOUSE T-complex protein 1 subunit beta     161.92 49 9
P09542|MYL3_MOUSE Myosin light chain 3 OS=Mus mu    160.79 77 9
Q61937|NPM_MOUSE Nucleophosmin OS=Mus muscu    155.24 52 9
P35564|CALX_MOUSE Calnexin OS=Mus musculus GN   153.24 34 9
P62264|RS14_MOUSE 40S ribosomal protein S14 OS=M     142.15 68 9
P08003|PDIA4_MOUSE Protein disulfide-isomerase A4 O     141.22 32 9
P60122|RUVB1_MOUSE RuvB-like 1 OS=Mus musculus G   138.76 43 9
P80318|TCPG_MOUSE T-complex protein 1 subunit gam      138.39 39 9
P42932|TCPQ_MOUSE T-complex protein 1 subunit theta     136.09 20 9
Q6P5F9|XPO1_MOUSE Exportin-1 OS=Mus musculus G   134.69 21 9
P80315|TCPD_MOUSE T-complex protein 1 subunit delta     130.63 66 9
Q60864|STIP1_MOUSE Stress-induced-phosphoprotein 1     127.75 38 9
P14148|RL7_MOUSE 60S ribosomal protein L7 OS=Mu     127.72 54 9
P97807|FUMH_MOUSE Fumarate hydratase, mitochondr      127.56 31 9
Q6Y7W8|PERQ2_MOUSE PERQ amino acid-rich with GYF        120.16 19 9
P15508|SPTB1_MOUSE Spectrin beta chain, erythrocyte O     117.5 25 9
A2ASQ1|AGRIN_MOUSE Agrin OS=Mus musculus GN=Ag   95.72 15 9
Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus GN=M   95.68 12 9
P07759|SPA3K_MOUSE Serine protease inhibitor A3K OS     232.17 69 8
Q921F2|TADBP_MOUSE TAR DNA-binding protein 43 OS     184.85 33 8
Q8BMF4|ODP2_MOUSE Dihydrolipoyllysine-residue acety            181.28 23 8
Q64213|SF01_MOUSE Splicing factor 1 OS=Mus muscu    177.48 38 8
P56391|CX6B1_MOUSE Cytochrome c oxidase subunit 6B      164.45 76 8
Q61584|FXR1_MOUSE Fragile X mental retardation synd        162.87 33 8
P47941|CRKL_MOUSE Crk-like protein OS=Mus muscul    162.46 38 8
Q9D1M0|SEC13_MOUSE Protein SEC13 homolog OS=Mu     162.4 53 8
Q9D1Q6|ERP44_MOUSE Endoplasmic reticulum resident p       157.31 52 8
Q91WJ8|FUBP1_MOUSE Far upstream element-binding pr       156.44 22 8
Q8CJ69|BMPER_MOUSE BMP-binding endothelial regulato       149.26 26 8
Q61656|DDX5_MOUSE Probable ATP-dependent RNA h       147.46 28 8
P03975|IGEB_MOUSE IgE-binding protein OS=Mus mus    145.94 22 8
P54775|PRS6B_MOUSE 26S protease regulatory subunit      145.91 61 8
Q9QZD9|EIF3I_MOUSE Eukaryotic translation initiation fa         145.41 58 8
P62858|RS28_MOUSE 40S ribosomal protein S28 OS=M     144.16 61 8
Q99MD9|NASP_MOUSE Nuclear autoantigenic sperm pro      141.9 38 8
P62082|RS7_MOUSE 40S ribosomal protein S7 OS=M     136.64 44 8
P84089|ERH_MOUSE Enhancer of rudimentary homolo      136.12 62 8
Q02819|NUCB1_MOUSE Nucleobindin-1 OS=Mus musculu    135.8 36 8
Q9CYR0|SSBP_MOUSE Single-stranded DNA-binding pro       135.27 55 8
Q8QZT1|THIL_MOUSE Acetyl-CoA acetyltransferase, mi      134.28 35 8
P58022|LOXL2_MOUSE Lysyl oxidase homolog 2 OS=Mu     130.35 32 8
P62702|RS4X_MOUSE 40S ribosomal protein S4, X isofo      128.4 42 8
Q80X50|UBP2L_MOUSE Ubiquitin-associated protein 2-lik      120.98 12 8
Q9Z0R4|ITSN1_MOUSE Intersectin-1 OS=Mus musculus   113.86 21 8
Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking fa       87.91 10 8
P70670|NACAM_MOUSE Nascent polypeptide-associated          74.36 15 8
Q8BFZ3|ACTBL_MOUSE Beta-actin-like protein 2 OS=Mus    245.03 90 7
Q3THE2|ML12B_MOUSE Myosin regulatory light chain 12B     219.34 86 7
P57780|ACTN4_MOUSE Alpha-actinin-4 OS=Mus musculu    207.71 43 7
O35658|C1QBP_MOUSE Complement component 1 Q sub        194.88 49 7
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P20108|PRDX3_MOUSE Thioredoxin-dependent peroxide       192.15 66 7
Q9CYZ2|TPD54_MOUSE Tumor protein D54 OS=Mus mus    187.91 71 7
P62204|CALM_MOUSE Calmodulin OS=Mus musculus G   181 92 7
P29788|VTNC_MOUSE Vitronectin OS=Mus musculus G   172.36 40 7
Q8BL97|SRSF7_MOUSE Serine/arginine-rich splicing facto       160.71 52 7
P62242|RS8_MOUSE 40S ribosomal protein S8 OS=M     160.65 37 7
P14115|RL27A_MOUSE 60S ribosomal protein L27a OS=     158.67 59 7
Q9R0U0|SRS10_MOUSE Serine/arginine-rich splicing facto       154.71 50 7
Q8R1Q8|DC1L1_MOUSE Cytoplasmic dynein 1 light interm        154.07 32 7
Q9D0W5|PPIL1_MOUSE Peptidyl-prolyl cis-trans isomeras       146.53 52 7
Q9D1M4|MCA3_MOUSE Eukaryotic translation elongation        145.93 81 7
P46412|GPX3_MOUSE Glutathione peroxidase 3 OS=Mu     139.92 46 7
Q61207|SAP_MOUSE Sulfated glycoprotein 1 OS=Mus    137.18 24 7
Q9CPT4|CS010_MOUSE UPF0556 protein C19orf10 homo      136.72 66 7
Q9JKF1|IQGA1_MOUSE Ras GTPase-activating-like prote       134.51 29 7
P97351|RS3A_MOUSE 40S ribosomal protein S3a OS=M     131.15 35 7
P47962|RL5_MOUSE 60S ribosomal protein L5 OS=Mu     129.5 35 7
Q922B2|SYDC_MOUSE Aspartyl-tRNA synthetase, cytopl      126.34 19 7
O08585|CLCA_MOUSE Clathrin light chain A OS=Mus m    125.67 28 7
P14131|RS16_MOUSE 40S ribosomal protein S16 OS=M     124.48 49 7
P20918|PLMN_MOUSE Plasminogen OS=Mus musculus   122.47 29 7
Q9WVK4|EHD1_MOUSE EH domain-containing protein 1 O     121.32 47 7
Q60597|ODO1_MOUSE 2-oxoglutarate dehydrogenase, m      120.05 22 7
Q9CQN1|TRAP1_MOUSE Heat shock protein 75 kDa, mitoc      117.9 57 7
P23116|EIF3A_MOUSE Eukaryotic translation initiation fa         117.34 19 7
P61965|WDR5_MOUSE WD repeat-containing protein 5 O     115.35 41 7
P68040|GBLP_MOUSE Guanine nucleotide-binding prote         108.25 35 7
Q8VDP4|K1967_MOUSE Protein KIAA1967 homolog OS=    86.8 12 7
Q9R1C7|PR40A_MOUSE Pre-mRNA-processing factor 40       84.49 16 7
A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-        83.4 14 7
P68033|ACTC_MOUSE Actin, alpha cardiac muscle 1 OS     297.4 82 6
P68254|1433T_MOUSE 14-3-3 protein theta OS=Mus mu    191.19 67 6
Q61029|LAP2B_MOUSE Lamina-associated polypeptide 2        167.55 32 6
Q9CQR2|RS21_MOUSE 40S ribosomal protein S21 OS=M     163.47 63 6
Q62523|ZYX_MOUSE Zyxin OS=Mus musculus GN=Zy   156.93 32 6
O89086|RBM3_MOUSE Putative RNA-binding protein 3 O     156.82 84 6
O08583|THOC4_MOUSE THO complex subunit 4 OS=Mus    156.48 52 6
Q9DB15|RM12_MOUSE 39S ribosomal protein L12, mitoc      150.59 58 6
P16110|LEG3_MOUSE Galectin-3 OS=Mus musculus G   146.21 25 6
Q6IRU2|TPM4_MOUSE Tropomyosin alpha-4 chain OS=     145.92 72 6
P24369|PPIB_MOUSE Peptidyl-prolyl cis-trans isomeras       142.75 61 6
P18760|COF1_MOUSE Cofilin-1 OS=Mus musculus GN=   140.58 44 6
O70251|EF1B_MOUSE Elongation factor 1-beta OS=Mus    139.33 33 6
P84099|RL19_MOUSE 60S ribosomal protein L19 OS=M     131.61 37 6
P47738|ALDH2_MOUSE Aldehyde dehydrogenase, mitoch      130.38 23 6
Q8VDM4|PSMD2_MOUSE 26S proteasome non-ATPase reg        130.05 47 6
P62996|TRA2B_MOUSE Transformer-2 protein homolog b      129.59 36 6
Q9CZU3|SK2L2_MOUSE Superkiller viralicidic activity 2-lik       128.24 36 6
P60335|PCBP1_MOUSE Poly(rC)-binding protein 1 OS=M     126.85 41 6
Q9QZM0|UBQL2_MOUSE Ubiquilin-2 OS=Mus musculus G   125.92 19 6
Q9CZM2|RL15_MOUSE 60S ribosomal protein L15 OS=M     125.6 43 6
P18242|CATD_MOUSE Cathepsin D OS=Mus musculus   124.75 36 6
P19536|COX5B_MOUSE Cytochrome c oxidase subunit 5B       124.52 81 6
P35700|PRDX1_MOUSE Peroxiredoxin-1 OS=Mus muscu    122.67 52 6
P26443|DHE3_MOUSE Glutamate dehydrogenase 1, mit      122.19 18 6
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B2RY56|RBM25_MOUSE RNA-binding protein 25 OS=Mus    121.82 16 6
Q9R0N0|GALK1_MOUSE Galactokinase OS=Mus musculu    119.87 32 6
Q9DBG5|PLIN3_MOUSE Perilipin-3 OS=Mus musculus GN   117.38 29 6
P08228|SODC_MOUSE Superoxide dismutase [Cu-Zn] O     116.16 44 6
Q9CYA6|ZCHC8_MOUSE Zinc finger CCHC domain-contai        116.06 28 6
P02463|CO4A1_MOUSE Collagen alpha-1(IV) chain OS=M     113.52 25 6
Q9WVA4|TAGL2_MOUSE Transgelin-2 OS=Mus musculus   112.12 48 6
Q8K2C9|HACD3_MOUSE 3-hydroxyacyl-CoA dehydratase      112.08 47 6
Q8R1B4|EIF3C_MOUSE Eukaryotic translation initiation fa         105.56 16 6
Q8BX22|SALL4_MOUSE Sal-like protein 4 OS=Mus muscu    100.89 18 6
Q61646|HPT_MOUSE Haptoglobin OS=Mus musculus G   100.85 36 6
P36552|HEM6_MOUSE Coproporphyrinogen-III oxidase,      100.71 26 6
Q60675|LAMA2_MOUSE Laminin subunit alpha-2 OS=Mus    99.81 21 6
Q99KI0|ACON_MOUSE Aconitate hydratase, mitochondri      97.86 21 6
Q8CGK3|LONM_MOUSE Lon protease homolog, mitochon      97.43 24 6
Q6ZWN5|RS9_MOUSE 40S ribosomal protein S9 OS=M     79.64 34 6
Q6PDK2|MLL2_MOUSE Histone-lysine N-methyltransfera       38.25 9 6
P99024|TBB5_MOUSE Tubulin beta-5 chain OS=Mus m    308.45 75 5
P22599|A1AT2_MOUSE Alpha-1-antitrypsin 1-2 OS=Mus    197.39 51 5
Q01768|NDKB_MOUSE Nucleoside diphosphate kinase B     184.91 79 5
Q9CQV8|1433B_MOUSE 14-3-3 protein beta/alpha OS=Mu     174.06 65 5
Q9DBG3|AP2B1_MOUSE AP-2 complex subunit beta OS=M     173.99 30 5
Q9CQ92|FIS1_MOUSE Mitochondrial fission 1 protein OS     159.79 67 5
P62315|SMD1_MOUSE Small nuclear ribonucleoprotein S       154.51 50 5
Q9QZQ8|H2AY_MOUSE Core histone macro-H2A.1 OS=M     151.84 51 5
Q61171|PRDX2_MOUSE Peroxiredoxin-2 OS=Mus muscu    147.28 55 5
Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor subu       145.22 40 5
Q9QYJ0|DNJA2_MOUSE DnaJ homolog subfamily A mem       144.03 48 5
P62983|RS27A_MOUSE Ubiquitin-40S ribosomal protein S      142.44 51 5
Q9Z2D8|MBD3_MOUSE Methyl-CpG-binding domain prot       140.79 49 5
Q61147|CERU_MOUSE Ceruloplasmin OS=Mus musculu    135.87 20 5
Q6PDG5|SMRC2_MOUSE SWI/SNF complex subunit SMAR      135.55 35 5
Q99KV1|DJB11_MOUSE DnaJ homolog subfamily B mem       130.5 43 5
P07356|ANXA2_MOUSE Annexin A2 OS=Mus musculus G   129.89 42 5
Q8BKC5|IPO5_MOUSE Importin-5 OS=Mus musculus GN   126.81 36 5
P28798|GRN_MOUSE Granulins OS=Mus musculus GN   126.15 27 5
Q5SFM8|RBM27_MOUSE RNA-binding protein 27 OS=Mus    125.54 30 5
O35206|COFA1_MOUSE Collagen alpha-1(XV) chain OS=     125.53 14 5
Q8VEK3|HNRPU_MOUSE Heterogeneous nuclear ribonucle       124.81 23 5
Q9WTP6|KAD2_MOUSE Adenylate kinase 2, mitochondria      122.92 46 5
P59708|PM14_MOUSE Pre-mRNA branch site protein p1      122.52 42 5
P63323|RS12_MOUSE 40S ribosomal protein S12 OS=M     121.74 39 5
Q9DCJ5|NDUA8_MOUSE NADH dehydrogenase [ubiquinon           119.56 49 5
P70372|ELAV1_MOUSE ELAV-like protein 1 OS=Mus mu    119.23 37 5
P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus    117.19 28 5
P16675|PPGB_MOUSE Lysosomal protective protein OS     115.23 15 5
Q91VC3|IF4A3_MOUSE Eukaryotic initiation factor 4A-III O     114.73 30 5
Q9CPP6|NDUA5_MOUSE NADH dehydrogenase [ubiquinon           113.59 59 5
P23780|BGAL_MOUSE Beta-galactosidase OS=Mus mu    112.54 23 5
Q8BTV2|CPSF7_MOUSE Cleavage and polyadenylation sp         112.13 28 5
Q9QUR7|PIN1_MOUSE Peptidyl-prolyl cis-trans isomeras        112.03 57 5
Q5XJY5|COPD_MOUSE Coatomer subunit delta OS=Mus    110.78 30 5
Q99JB2|STML2_MOUSE Stomatin-like protein 2 OS=Mus    107.75 58 5
P63163|RSMN_MOUSE Small nuclear ribonucleoprotein-a        106.13 53 5
P27048|RSMB_MOUSE Small nuclear ribonucleoprotein-a        106.13 42 5
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P35979|RL12_MOUSE 60S ribosomal protein L12 OS=M     104.43 39 5
P61161|ARP2_MOUSE Actin-related protein 2 OS=Mus m    104.22 45 5
Q6ZQ38|CAND1_MOUSE Cullin-associated NEDD8-dissoc        102.51 23 5
Q80YR5|SAFB2_MOUSE Scaffold attachment factor B2 OS     101.78 10 5
P41105|RL28_MOUSE 60S ribosomal protein L28 OS=M     101.76 30 5
Q61164|CTCF_MOUSE Transcriptional repressor CTCF O     101.23 31 5
Q6NVF9|CPSF6_MOUSE Cleavage and polyadenylation sp         98.57 18 5
Q60631|GRB2_MOUSE Growth factor receptor-bound pro       97.96 30 5
P81117|NUCB2_MOUSE Nucleobindin-2 OS=Mus musculu    97.27 35 5
P01887|B2MG_MOUSE Beta-2-microglobulin OS=Mus m    96.82 40 5
Q6NZJ6|IF4G1_MOUSE Eukaryotic translation initiation fa         94.61 9 5
P07146|TRY2_MOUSE Anionic trypsin-2 OS=Mus muscu    93.95 33 5
P17427|AP2A2_MOUSE AP-2 complex subunit alpha-2 O     93.87 18 5
Q62318|TIF1B_MOUSE Transcription intermediary factor      93.2 19 5
Q8BX70|VP13C_MOUSE Vacuolar protein sorting-associat        91.94 8 5
Q99KN9|EPN4_MOUSE Clathrin interactor 1 OS=Mus mu    91.69 21 5
Q9DCH4|EIF3F_MOUSE Eukaryotic translation initiation fa         90.42 34 5
P26369|U2AF2_MOUSE Splicing factor U2AF 65 kDa sub      89.38 24 5
Q921M4|GOGA2_MOUSE Golgin subfamily A member 2 OS     88.85 18 5
Q9JIF7|COPB_MOUSE Coatomer subunit beta OS=Mus    79.81 17 5
Q9EQH3|VPS35_MOUSE Vacuolar protein sorting-associat        77.21 19 5
Q60865|CAPR1_MOUSE Caprin-1 OS=Mus musculus GN=   76.84 15 5
P62281|RS11_MOUSE 40S ribosomal protein S11 OS=M     75.98 34 5
Q8BYA0|TBCD_MOUSE Tubulin-specific chaperone D OS     75.81 30 5
P62192|PRS4_MOUSE 26S protease regulatory subunit      72.86 18 5
Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus GN   59.7 6 5
B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS     47.93 9 5
Q8BYK6|YTHD3_MOUSE YTH domain family protein 3 OS=     47.63 13 5
P27661|H2AX_MOUSE Histone H2A.x OS=Mus musculu    244.51 77 4
Q61696|HS71A_MOUSE Heat shock 70 kDa protein 1A O     225.55 69 4
P17879|HS71B_MOUSE Heat shock 70 kDa protein 1B O     225.55 70 4
O08638|MYH11_MOUSE Myosin-11 OS=Mus musculus G   193.41 35 4
Q00898|A1AT5_MOUSE Alpha-1-antitrypsin 1-5 OS=Mus    187.58 40 4
Q62167|DDX3X_MOUSE ATP-dependent RNA helicase D      185.97 62 4
Q02257|PLAK_MOUSE Junction plakoglobin OS=Mus m    141.54 40 4
Q99JX3|GORS2_MOUSE Golgi reassembly-stacking protei       131.66 36 4
Q9D6Z1|NOP56_MOUSE Nucleolar protein 56 OS=Mus mu    131.47 23 4
Q9WTX5|SKP1_MOUSE S-phase kinase-associated prote       127.34 28 4
Q9Z175|LOXL3_MOUSE Lysyl oxidase homolog 3 OS=Mu     126.2 14 4
Q9D3D9|ATPD_MOUSE ATP synthase subunit delta, mito      125.78 64 4
Q9CX56|PSMD8_MOUSE 26S proteasome non-ATPase reg        123.85 31 4
Q9CQT2|RBM7_MOUSE RNA-binding protein 7 OS=Mus m    123.77 42 4
Q99LC5|ETFA_MOUSE Electron transfer flavoprotein sub        122.83 39 4
Q8CG71|P3H2_MOUSE Prolyl 3-hydroxylase 2 OS=Mus m    122.13 27 4
P62307|RUXF_MOUSE Small nuclear ribonucleoprotein F     121.18 60 4
P08122|CO4A2_MOUSE Collagen alpha-2(IV) chain OS=M     119.75 18 4
P01837|IGKC_MOUSE Ig kappa chain C region OS=Mus   118.81 42 4
O55029|COPB2_MOUSE Coatomer subunit beta' OS=Mus    118.73 29 4
Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus GN=H   118.34 16 4
Q61704|ITIH3_MOUSE Inter-alpha-trypsin inhibitor heavy       117.12 16 4
Q9EPJ9|ARFG1_MOUSE ADP-ribosylation factor GTPase-        115.62 21 4
Q9EPU4|CPSF1_MOUSE Cleavage and polyadenylation sp         115.05 21 4
Q8VHX6|FLNC_MOUSE Filamin-C OS=Mus musculus GN   114.76 10 4
O88968|TCO2_MOUSE Transcobalamin-2 OS=Mus mus    114.39 36 4
P32261|ANT3_MOUSE Antithrombin-III OS=Mus muscul    112.82 37 4
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P62897|CYC_MOUSE Cytochrome c, somatic OS=Mus    112.2 47 4
Q9D0F9|PGM1_MOUSE Phosphoglucomutase-1 OS=Mus    111.21 20 4
P80317|TCPZ_MOUSE T-complex protein 1 subunit zeta     111.11 21 4
Q9JHJ0|TMOD3_MOUSE Tropomodulin-3 OS=Mus muscu    109.41 32 4
P51410|RL9_MOUSE 60S ribosomal protein L9 OS=Mu     109.2 47 4
O08749|DLDH_MOUSE Dihydrolipoyl dehydrogenase, mi      108.8 29 4
Q9JLV5|CUL3_MOUSE Cullin-3 OS=Mus musculus GN=   108.1 20 4
Q08369|GATA4_MOUSE Transcription factor GATA-4 OS=     107.3 35 4
Q8C0C7|SYFA_MOUSE Phenylalanyl-tRNA synthetase al       107.25 30 4
Q8BX10|PGAM5_MOUSE Serine/threonine-protein phospha        106.16 22 4
Q9D1B9|RM28_MOUSE 39S ribosomal protein L28, mitoc      106.04 39 4
Q9CR57|RL14_MOUSE 60S ribosomal protein L14 OS=M     105.64 28 4
P40124|CAP1_MOUSE Adenylyl cyclase-associated prot       105.1 19 4
Q6NZN0|RBM26_MOUSE RNA-binding protein 26 OS=Mus    103.31 13 4
Q3U7R1|ESYT1_MOUSE Extended synaptotagmin-1 OS=M     102.59 30 4
O09167|RL21_MOUSE 60S ribosomal protein L21 OS=M     101.91 41 4
P01864|GCAB_MOUSE Ig gamma-2A chain C region sec      99.17 35 4
P97927|LAMA4_MOUSE Laminin subunit alpha-4 OS=Mus    99.06 12 4
P60867|RS20_MOUSE 40S ribosomal protein S20 OS=M     98.94 29 4
P61924|COPZ1_MOUSE Coatomer subunit zeta-1 OS=Mu     98.59 52 4
Q8BTS4|NUP54_MOUSE Nuclear pore complex protein Nu      96.43 18 4
Q9DBJ1|PGAM1_MOUSE Phosphoglycerate mutase 1 OS=     94.45 19 4
P05064|ALDOA_MOUSE Fructose-bisphosphate aldolase      94.27 21 4
Q04447|KCRB_MOUSE Creatine kinase B-type OS=Mus    93.86 22 4
P62855|RS26_MOUSE 40S ribosomal protein S26 OS=M     93.07 32 4
P21107|TPM3_MOUSE Tropomyosin alpha-3 chain OS=     93.01 23 4
Q9CQL1|MGNR_MOUSE Protein mago nashi homolog 1-re      92.09 64 4
P61327|MGN_MOUSE Protein mago nashi homolog OS     92.09 64 4
Q00PI9|HNRL2_MOUSE Heterogeneous nuclear ribonucle         91.8 23 4
Q91WK2|EIF3H_MOUSE Eukaryotic translation initiation fa         91.09 27 4
Q8C5Q4|GRSF1_MOUSE G-rich sequence factor 1 OS=Mu     90.98 22 4
P61458|PHS_MOUSE Pterin-4-alpha-carbinolamine deh      90.06 44 4
Q9Z2W0|DNPEP_MOUSE Aspartyl aminopeptidase OS=Mu     89.81 23 4
Q9WVG6|CARM1_MOUSE Histone-arginine methyltransfera       89.1 17 4
P99029|PRDX5_MOUSE Peroxiredoxin-5, mitochondrial O     87.21 24 4
Q62093|SRSF2_MOUSE Serine/arginine-rich splicing facto       85.94 32 4
Q6PDQ2|CHD4_MOUSE Chromodomain-helicase-DNA-bi        85.9 13 4
P62267|RS23_MOUSE 40S ribosomal protein S23 OS=M     84.59 51 4
Q6ZQI3|MLEC_MOUSE Malectin OS=Mus musculus GN=   84.3 36 4
Q9Z1D1|EIF3G_MOUSE Eukaryotic translation initiation fa         84.07 10 4
Q07417|ACADS_MOUSE Short-chain specific acyl-CoA de       83.73 17 4
Q8BH74|NU107_MOUSE Nuclear pore complex protein Nu      83.48 20 4
Q6NV83|SR140_MOUSE U2 snRNP-associated SURP mo       81.53 15 4
Q9CWE0|FA54B_MOUSE Protein FAM54B OS=Mus muscu    80.94 27 4
P01898|HA10_MOUSE H-2 class I histocompatibility anti         80.38 20 4
Q9JJF3|NO66_MOUSE Lysine-specific demethylase NO6      80.04 15 4
Q62189|SNRPA_MOUSE U1 small nuclear ribonucleoprote       79.57 18 4
Q8BGQ7|SYAC_MOUSE Alanyl-tRNA synthetase, cytoplas      79.19 11 4
P11404|FABPH_MOUSE Fatty acid-binding protein, heart O     77.86 41 4
P28656|NP1L1_MOUSE Nucleosome assembly protein 1-       77.2 17 4
Q8R4X3|RBM12_MOUSE RNA-binding protein 12 OS=Mus    77.13 14 4
P19253|RL13A_MOUSE 60S ribosomal protein L13a OS=     76.89 25 4
O88685|PRS6A_MOUSE 26S protease regulatory subunit      72.54 26 4
P30416|FKBP4_MOUSE Peptidyl-prolyl cis-trans isomeras       71.67 18 4
Q61464|ZN638_MOUSE Zinc finger protein 638 OS=Mus    66.84 9 4
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P62852|RS25_MOUSE 40S ribosomal protein S25 OS=M     65.93 42 4
Q9D0F3|LMAN1_MOUSE Protein ERGIC-53 OS=Mus mus    63.66 7 4
Q9CW46|RAVR1_MOUSE Ribonucleoprotein PTB-binding 1     53.82 20 4
Q8BTI8|SRRM2_MOUSE Serine/arginine repetitive matrix p       53.64 6 4
A2AAJ9|OBSCN_MOUSE Obscurin OS=Mus musculus GN   49.59 7 4
Q6NZC7|S23IP_MOUSE SEC23-interacting protein OS=M     47.32 13 4
Q63870|CO7A1_MOUSE Collagen alpha-1(VII) chain OS=     45.39 13 4
Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase S      43.86 6 4
Q69Z38|PEAK1_MOUSE Pseudopodium-enriched atypical       42.38 4 4
Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus    33.16 11 4
P68372|TBB2C_MOUSE Tubulin beta-2C chain OS=Mus m    293.24 76 3
P17156|HSP72_MOUSE Heat shock-related 70 kDa prote       274.47 53 3
Q922F4|TBB6_MOUSE Tubulin beta-6 chain OS=Mus m    243.61 68 3
Q8R1M2|H2AJ_MOUSE Histone H2A.J OS=Mus musculu    232.45 76 3
Q03734|SPA3M_MOUSE Serine protease inhibitor A3M OS     224.13 62 3
P16627|HS71L_MOUSE Heat shock 70 kDa protein 1-like     209.77 54 3
Q9R0B6|LAMC3_MOUSE Laminin subunit gamma-3 OS=M     201.59 23 3
Q91WP6|SPA3N_MOUSE Serine protease inhibitor A3N OS     176.74 47 3
P70333|HNRH2_MOUSE Heterogeneous nuclear ribonucle       176.34 32 3
Q8R010|AIMP2_MOUSE Aminoacyl tRNA synthase compl         142.86 48 3
Q61033|LAP2A_MOUSE Lamina-associated polypeptide 2        142.83 28 3
P15532|NDKA_MOUSE Nucleoside diphosphate kinase A     140.62 61 3
P84228|H32_MOUSE Histone H3.2 OS=Mus musculus   140.31 81 3
O08807|PRDX4_MOUSE Peroxiredoxin-4 OS=Mus muscu    127.14 37 3
Q923G2|RPAB3_MOUSE DNA-directed RNA polymerases           124.51 37 3
Q6DFW4|NOP58_MOUSE Nucleolar protein 58 OS=Mus mu    122.6 34 3
Q9WV55|VAPA_MOUSE Vesicle-associated membrane pr        122.18 29 3
P62196|PRS8_MOUSE 26S protease regulatory subunit      115.88 33 3
P84104|SRSF3_MOUSE Serine/arginine-rich splicing facto       114.67 33 3
Q7M6Y3|PICA_MOUSE Phosphatidylinositol-binding clath        114.26 22 3
Q9QXT0|CNPY2_MOUSE Protein canopy homolog 2 OS=M     113.92 26 3
P12787|COX5A_MOUSE Cytochrome c oxidase subunit 5A       113.87 66 3
Q9CR68|UCRI_MOUSE Cytochrome b-c1 complex subun        109.02 41 3
Q9JJI8|RL38_MOUSE 60S ribosomal protein L38 OS=M     108.21 57 3
P62320|SMD3_MOUSE Small nuclear ribonucleoprotein S       105.51 36 3
Q8K4L0|DDX54_MOUSE ATP-dependent RNA helicase D      105.45 18 3
P99028|QCR6_MOUSE Cytochrome b-c1 complex subun        105.09 66 3
Q99JX4|EIF3M_MOUSE Eukaryotic translation initiation fa         104.91 45 3
Q921H8|THIKA_MOUSE 3-ketoacyl-CoA thiolase A, perox      104.91 11 3
Q9DCT8|CRIP2_MOUSE Cysteine-rich protein 2 OS=Mus    104.25 24 3
P63242|IF5A1_MOUSE Eukaryotic translation initiation fa       103.75 69 3
Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=     103.51 12 3
P62821|RAB1A_MOUSE Ras-related protein Rab-1A OS=     101.93 37 3
P46938|YAP1_MOUSE Yorkie homolog OS=Mus muscu    101.48 26 3
P62075|TIM13_MOUSE Mitochondrial import inner memb         101.22 57 3
Q8BP67|RL24_MOUSE 60S ribosomal protein L24 OS=M     100.87 26 3
Q3TCN2|PLBL2_MOUSE Putative phospholipase B-like 2 O     100.78 22 3
Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucle         99.82 25 3
Q6ZWV7|RL35_MOUSE 60S ribosomal protein L35 OS=M     98.56 27 3
Q9QX47|SON_MOUSE Protein SON OS=Mus musculus   97.42 17 3
Q9R0L7|AKP8L_MOUSE A-kinase anchor protein 8-like OS     96.95 30 3
P23198|CBX3_MOUSE Chromobox protein homolog 3 O     96.8 32 3
O88630|GOSR1_MOUSE Golgi SNAP receptor complex m       96.36 14 3
Q3UIA2|RHG17_MOUSE Rho GTPase-activating protein 1      95.21 27 3
P70318|TIAR_MOUSE Nucleolysin TIAR OS=Mus musc    93.44 10 3
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Q9ESB3|HRG_MOUSE Histidine-rich glycoprotein OS=M     93.38 23 3
Q9CYD3|CRTAP_MOUSE Cartilage-associated protein OS=     93.18 16 3
P46935|NEDD4_MOUSE E3 ubiquitin-protein ligase NEDD      93.03 19 3
Q9DC61|MPPA_MOUSE Mitochondrial-processing peptida        92.32 26 3
Q9R0I7|YLPM1_MOUSE YLP motif-containing protein 1 O     91.61 13 3
P56399|UBP5_MOUSE Ubiquitin carboxyl-terminal hydro       91.43 31 3
P26231|CTNA1_MOUSE Catenin alpha-1 OS=Mus muscu    90.91 22 3
O88477|IF2B1_MOUSE Insulin-like growth factor 2 mRNA        90.65 16 3
Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogene        90.52 34 3
Q8VC70|RBMS2_MOUSE RNA-binding motif, single-strand        90.27 23 3
P62849|RS24_MOUSE 40S ribosomal protein S24 OS=M     90.26 44 3
P05202|AATM_MOUSE Aspartate aminotransferase, mito      89.84 17 3
P68510|1433F_MOUSE 14-3-3 protein eta OS=Mus musc    89.59 51 3
P62827|RAN_MOUSE GTP-binding nuclear protein Ran     88.18 17 3
P04186|CFAB_MOUSE Complement factor B OS=Mus m    88.15 9 3
P70335|ROCK1_MOUSE Rho-associated protein kinase 1     87.37 9 3
Q64010|CRK_MOUSE Adapter molecule crk OS=Mus m    87.25 26 3
Q9D824|FIP1_MOUSE Pre-mRNA 3'-end-processing fac       86.98 13 3
Q64737|PUR2_MOUSE Trifunctional purine biosynthetic p       86.81 14 3
P62309|RUXG_MOUSE Small nuclear ribonucleoprotein G     86.46 33 3
P30412|PPIC_MOUSE Peptidyl-prolyl cis-trans isomeras       86.31 34 3
Q9DCT2|NDUS3_MOUSE NADH dehydrogenase [ubiquinon          86.01 25 3
Q9CZ13|QCR1_MOUSE Cytochrome b-c1 complex subun        85.07 18 3
Q63850|NUP62_MOUSE Nuclear pore glycoprotein p62 OS     85 11 3
Q8R0F3|SUMF1_MOUSE Sulfatase-modifying factor 1 OS=     84.76 10 3
Q7TSC1|PRC2A_MOUSE Protein PRRC2A OS=Mus musc    84.41 12 3
P62960|YBOX1_MOUSE Nuclease-sensitive element-bind        84.26 29 3
Q9JJH1|RNAS4_MOUSE Ribonuclease 4 OS=Mus muscul    83.51 57 3
Q02053|UBA1_MOUSE Ubiquitin-like modifier-activating       82.99 18 3
Q99KJ8|DCTN2_MOUSE Dynactin subunit 2 OS=Mus mus    82.91 16 3
Q8QZY1|EIF3L_MOUSE Eukaryotic translation initiation fa         82.54 15 3
O08547|SC22B_MOUSE Vesicle-trafficking protein SEC22      81.07 20 3
Q9CXF4|TBC15_MOUSE TBC1 domain family member 15     80.43 11 3
Q99JI4|PSMD6_MOUSE 26S proteasome non-ATPase reg        78.02 34 3
P25206|MCM3_MOUSE DNA replication licensing factor M      77.85 12 3
Q3U2P1|SC24A_MOUSE Protein transport protein Sec24A     76.92 10 3
Q9Z2I8|SUCB2_MOUSE Succinyl-CoA ligase [GDP-formin         76.36 15 3
Q8BSQ9|PB1_MOUSE Protein polybromo-1 OS=Mus mu    76.31 11 3
Q9JJY4|DDX20_MOUSE Probable ATP-dependent RNA h       76.04 10 3
Q99PU8|DHX30_MOUSE Putative ATP-dependent RNA he       75.5 14 3
Q61753|SERA_MOUSE D-3-phosphoglycerate dehydroge      75.46 8 3
P21126|UBL4A_MOUSE Ubiquitin-like protein 4A OS=Mus    75.08 29 3
Q6ZWV3|RL10_MOUSE 60S ribosomal protein L10 OS=M     75.02 22 3
Q8C7E9|CSTFT_MOUSE Cleavage stimulation factor subu         74.97 56 3
P14685|PSMD3_MOUSE 26S proteasome non-ATPase reg        74.42 17 3
O54774|AP3D1_MOUSE AP-3 complex subunit delta-1 OS     74.23 11 3
Q9CZX8|RS19_MOUSE 40S ribosomal protein S19 OS=M     73.41 19 3
Q6ZQH8|NU188_MOUSE Nucleoporin NUP188 homolog O     72.13 8 3
Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription comple        72.11 9 3
Q9D8W5|PSD12_MOUSE 26S proteasome non-ATPase reg        71.65 22 3
Q9D6J6|NDUV2_MOUSE NADH dehydrogenase [ubiquinon         69.31 21 3
Q8CGR5|KLK14_MOUSE Kallikrein-14 OS=Mus musculus   68.68 19 3
Q922D8|C1TC_MOUSE C-1-tetrahydrofolate synthase, cy      68.32 6 3
Q8BJZ4|RT35_MOUSE 28S ribosomal protein S35, mitoc      67.61 25 3
Q9CQA3|DHSB_MOUSE Succinate dehydrogenase [ubiqu         67.39 22 3
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Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2     66.14 5 3
Q80W00|PP1RA_MOUSE Serine/threonine-protein phospha          65.76 20 3
Q3UQN2|FCHO2_MOUSE FCH domain only protein 2 OS=M     65.28 8 3
P46735|MYO1B_MOUSE Myosin-Ib OS=Mus musculus GN   64.08 16 3
P62869|ELOB_MOUSE Transcription elongation factor B       63.71 25 3
Q61768|KINH_MOUSE Kinesin-1 heavy chain OS=Mus m    62.2 14 3
Q05186|RCN1_MOUSE Reticulocalbin-1 OS=Mus muscu    61.69 17 3
P62911|RL32_MOUSE 60S ribosomal protein L32 OS=M     61.32 33 3
Q921G8|GCP2_MOUSE Gamma-tubulin complex compon       59.65 8 3
Q60737|CSK21_MOUSE Casein kinase II subunit alpha O     58.98 25 3
Q62425|NDUA4_MOUSE NADH dehydrogenase [ubiquinon           58.48 52 3
P08226|APOE_MOUSE Apolipoprotein E OS=Mus muscu    56.71 14 3
Q7TMK9|HNRPQ_MOUSE Heterogeneous nuclear ribonucle       55.71 10 3
Q8JZQ9|EIF3B_MOUSE Eukaryotic translation initiation fa         54.55 9 3
Q8R180|ERO1A_MOUSE ERO1-like protein alpha OS=Mus    54.17 9 3
P70336|ROCK2_MOUSE Rho-associated protein kinase 2     53.06 22 3
Q8BHP7|OLM2A_MOUSE Olfactomedin-like protein 2A OS=     52.24 5 3
Q80YT7|MYOME_MOUSE Myomegalin OS=Mus musculus   50.3 6 3
P39054|DYN2_MOUSE Dynamin-2 OS=Mus musculus G   48.76 16 3
Q921G7|ETFD_MOUSE Electron transfer flavoprotein-ubi        45.85 15 3
Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus GN   44.73 5 3
Q6PE13|PRRT3_MOUSE Proline-rich transmembrane prot       44.01 16 3
Q2UY11|COSA1_MOUSE Collagen alpha-1(XXVIII) chain O     43.61 6 3
Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus GN   41.9 7 3
Q8C0S4|TT21A_MOUSE Tetratricopeptide repeat protein 2      41.45 10 3
P58871|TB182_MOUSE 182 kDa tankyrase-1-binding pro      40.05 7 3
Q9DBT5|AMPD2_MOUSE AMP deaminase 2 OS=Mus mus    38.76 4 3
Q8BRH4|MLL3_MOUSE Histone-lysine N-methyltransfera       38.58 3 3
Q9WU60|ATRN_MOUSE Attractin OS=Mus musculus GN=   37.9 4 3
O88700|BLM_MOUSE Bloom syndrome protein homolo      36.94 7 3
Q8CC88|K0564_MOUSE Uncharacterized protein KIAA056       36.03 7 3
Q99KW3|TARA_MOUSE TRIO and F-actin-binding protein     35.79 5 3
Q60750|EPHA1_MOUSE Ephrin type-A receptor 1 OS=Mu     35.56 7 3
P14404|EVI1_MOUSE MDS1 and EVI1 complex locus p       35.51 5 3
Q8R3Y8|I2BP1_MOUSE Interferon regulatory factor 2-bind        35.49 14 3
A2A884|ZEP3_MOUSE Transcription factor HIVEP3 OS=     35.11 4 3
O88799|ZAN_MOUSE Zonadhesin OS=Mus musculus G   34.79 6 3
Q64331|MYO6_MOUSE Myosin-VI OS=Mus musculus GN   33.61 13 3
Q70FJ1|AKAP9_MOUSE A-kinase anchor protein 9 OS=M     32.52 8 3
O88935|SYN1_MOUSE Synapsin-1 OS=Mus musculus G   31.79 6 3
Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musc    31.21 4 3
Q80TL7|MON2_MOUSE Protein MON2 homolog OS=Mus    30.86 6 3
Q8BUV3|GEPH_MOUSE Gephyrin OS=Mus musculus GN   30.01 12 3
Q9WTS5|TEN2_MOUSE Teneurin-2 OS=Mus musculus G   29.3 10 3
Q8CIQ7|DOCK3_MOUSE Dedicator of cytokinesis protein 3     29.23 9 3
Q62059|CSPG2_MOUSE Versican core protein OS=Mus m    29.06 2 3
Q99MZ6|MYO7B_MOUSE Myosin-VIIb OS=Mus musculus G   28.57 15 3
A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus   27.44 3 3
Q9Z0W3|NU160_MOUSE Nuclear pore complex protein Nu      27.33 14 3
Q6ZQ93|UBP34_MOUSE Ubiquitin carboxyl-terminal hydro       26.94 7 3
Q8C115|PKHH2_MOUSE Pleckstrin homology domain-con          25.61 8 3
O88737|BSN_MOUSE Protein bassoon OS=Mus muscu    24.57 7 3
Q8R4Y4|STAB1_MOUSE Stabilin-1 OS=Mus musculus GN   24.53 7 3
P63260|ACTG_MOUSE Actin, cytoplasmic 2 OS=Mus mu    320.19 81 2
Q64523|H2A2C_MOUSE Histone H2A type 2-C OS=Mus m    225.53 81 2
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Q6GSS7|H2A2A_MOUSE Histone H2A type 2-A OS=Mus m    225.53 75 2
O35737|HNRH1_MOUSE Heterogeneous nuclear ribonucle       200.41 36 2
P68368|TBA4A_MOUSE Tubulin alpha-4A chain OS=Mus    200.31 69 2
Q6URW6|MYH14_MOUSE Myosin-14 OS=Mus musculus G   167.87 32 2
P84084|ARF5_MOUSE ADP-ribosylation factor 5 OS=Mu     151.3 48 2
Q5SX39|MYH4_MOUSE Myosin-4 OS=Mus musculus GN   141.44 23 2
P61205|ARF3_MOUSE ADP-ribosylation factor 3 OS=Mu     140.45 60 2
P84078|ARF1_MOUSE ADP-ribosylation factor 1 OS=Mu     140.45 56 2
P61750|ARF4_MOUSE ADP-ribosylation factor 4 OS=Mu     139.9 46 2
Q91Z83|MYH7_MOUSE Myosin-7 OS=Mus musculus GN   126.27 19 2
Q62241|RU1C_MOUSE U1 small nuclear ribonucleoprote       120.71 33 2
P13541|MYH3_MOUSE Myosin-3 OS=Mus musculus GN   119.13 16 2
Q9CZU6|CISY_MOUSE Citrate synthase, mitochondrial O     111.29 36 2
Q99LT0|DPY30_MOUSE Protein dpy-30 homolog OS=Mus    110.44 45 2
Q60668|HNRPD_MOUSE Heterogeneous nuclear ribonucle       110.12 17 2
P26040|EZRI_MOUSE Ezrin OS=Mus musculus GN=Ez   108.86 11 2
Q9ES28|ARHG7_MOUSE Rho guanine nucleotide exchang        103.72 18 2
Q9DBR0|AKAP8_MOUSE A-kinase anchor protein 8 OS=M     102.68 30 2
P21550|ENOB_MOUSE Beta-enolase OS=Mus musculus   102.22 42 2
Q71LX4|TLN2_MOUSE Talin-2 OS=Mus musculus GN=T   101.27 15 2
O35593|PSDE_MOUSE 26S proteasome non-ATPase reg        98.43 30 2
Q9JIQ3|DBLOH_MOUSE Diablo homolog, mitochondrial O     97.61 22 2
Q9CXW3|CYBP_MOUSE Calcyclin-binding protein OS=Mu     97.32 24 2
P01644|KV5AB_MOUSE Ig kappa chain V-V region HP R1     96.08 51 2
P01645|KV5AC_MOUSE Ig kappa chain V-V region HP 93     96.08 51 2
Q8BGS0|MAK16_MOUSE Protein MAK16 homolog OS=Mu     95.36 27 2
P26043|RADI_MOUSE Radixin OS=Mus musculus GN=   95.27 16 2
P17183|ENOG_MOUSE Gamma-enolase OS=Mus muscu    94.51 49 2
Q60710|SAMH1_MOUSE SAM domain and HD domain-co        93.34 23 2
Q6P1F6|2ABA_MOUSE Serine/threonine-protein phospha              93.13 33 2
Q9CWZ3|RBM8A_MOUSE RNA-binding protein 8A OS=Mus    92.05 26 2
Q8R105|VP37C_MOUSE Vacuolar protein sorting-associat        91.68 24 2
P51660|DHB4_MOUSE Peroxisomal multifunctional enzy        90.69 7 2
O70325|GPX41_MOUSE Phospholipid hydroperoxide gluta        89.86 19 2
P35922|FMR1_MOUSE Fragile X mental retardation prote        89.72 19 2
Q91VR2|ATPG_MOUSE ATP synthase subunit gamma, m      89.66 13 2
Q9CXW4|RL11_MOUSE 60S ribosomal protein L11 OS=M     89.42 17 2
P10639|THIO_MOUSE Thioredoxin OS=Mus musculus G   88.05 47 2
Q8VDV3|R3GEF_MOUSE Guanine nucleotide exchange fac        87.69 21 2
Q9CQF9|PCYOX_MOUSE Prenylcysteine oxidase OS=Mus    86.94 19 2
Q8BGD9|IF4B_MOUSE Eukaryotic translation initiation fa       86.82 20 2
P61971|NTF2_MOUSE Nuclear transport factor 2 OS=M     86.8 32 2
P48962|ADT1_MOUSE ADP/ATP translocase 1 OS=Mus    86.62 29 2
Q9QZH3|PPIE_MOUSE Peptidyl-prolyl cis-trans isomeras       86.47 26 2
Q61733|RT31_MOUSE 28S ribosomal protein S31, mitoc      86.07 18 2
P67778|PHB_MOUSE Prohibitin OS=Mus musculus GN   85.99 31 2
Q80UY2|KCMF1_MOUSE E3 ubiquitin-protein ligase KCMF      85.6 34 2
Q9R099|TBL2_MOUSE Transducin beta-like protein 2 OS     85.11 31 2
Q9DCX2|ATP5H_MOUSE ATP synthase subunit d, mitocho      84.95 15 2
Q91YD3|DCP1A_MOUSE mRNA-decapping enzyme 1A OS     84.92 6 2
Q6ZWX6|IF2A_MOUSE Eukaryotic translation initiation fa         83.58 13 2
Q8R0G9|NU133_MOUSE Nuclear pore complex protein Nu      83.05 12 2
Q9JJV2|PROF2_MOUSE Profilin-2 OS=Mus musculus GN   82.6 28 2
P63325|RS10_MOUSE 40S ribosomal protein S10 OS=M     82.56 10 2
Q9ERK4|XPO2_MOUSE Exportin-2 OS=Mus musculus G   82.54 17 2
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Q9D620|RFIP1_MOUSE Rab11 family-interacting protein      82.51 26 2
P54071|IDHP_MOUSE Isocitrate dehydrogenase [NADP       81.51 8 2
P97371|PSME1_MOUSE Proteasome activator complex su       81.37 27 2
P11983|TCPA_MOUSE T-complex protein 1 subunit alph      81.29 15 2
Q5SUF2|LC7L3_MOUSE Luc7-like protein 3 OS=Mus mus    80.99 13 2
P61963|DCAF7_MOUSE DDB1- and CUL4-associated fac       80.62 31 2
P61211|ARL1_MOUSE ADP-ribosylation factor-like prote       80.03 27 2
Q9R1Z8|VINEX_MOUSE Vinexin OS=Mus musculus GN=S   80.02 14 2
P26516|PSD7_MOUSE 26S proteasome non-ATPase reg        79.54 14 2
Q9DBG9|TX1B3_MOUSE Tax1-binding protein 3 OS=Mus    78.73 43 2
P26883|FKB1A_MOUSE Peptidyl-prolyl cis-trans isomeras       78.72 34 2
Q61990|PCBP2_MOUSE Poly(rC)-binding protein 2 OS=M     78.55 22 2
Q9CY57|FOP_MOUSE Friend of PRMT1 protein OS=Mu     77.41 25 2
Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus musculus   77.35 10 2
P62835|RAP1A_MOUSE Ras-related protein Rap-1A OS=     77.17 13 2
Q99JI6|RAP1B_MOUSE Ras-related protein Rap-1b OS=     77.17 13 2
Q99LF4|RTCB_MOUSE tRNA-splicing ligase RtcB homol      77.06 12 2
Q9CXI5|MANF_MOUSE Mesencephalic astrocyte-derived       76.98 13 2
P63168|DYL1_MOUSE Dynein light chain 1, cytoplasmic     76.6 35 2
Q8C5L3|CNOT2_MOUSE CCR4-NOT transcription comple        75.71 13 2
P01868|IGHG1_MOUSE Ig gamma-1 chain C region secre       75.09 19 2
P01869|IGH1M_MOUSE Ig gamma-1 chain C region, mem       75.09 16 2
Q80UM7|MOGS_MOUSE Mannosyl-oligosaccharide glucos      74.72 8 2
P14901|HMOX1_MOUSE Heme oxygenase 1 OS=Mus mu    74.63 40 2
P42227|STAT3_MOUSE Signal transducer and activator o        74.54 19 2
Q9Z0H3|SNF5_MOUSE SWI/SNF-related matrix-associat              74.19 15 2
P70365|NCOA1_MOUSE Nuclear receptor coactivator 1 O     73.53 15 2
P47955|RLA1_MOUSE 60S acidic ribosomal protein P1 O     72.92 37 2
P99027|RLA2_MOUSE 60S acidic ribosomal protein P2 O     72.78 30 2
Q9Z0X1|AIFM1_MOUSE Apoptosis-inducing factor 1, mito      72.22 10 2
P63037|DNJA1_MOUSE DnaJ homolog subfamily A mem       71.92 38 2
Q7TQC7|GPTC2_MOUSE G patch domain-containing prote       71.08 11 2
Q8R0S2|IQEC1_MOUSE IQ motif and SEC7 domain-conta        70.66 12 2
O35207|CDKA1_MOUSE Cyclin-dependent kinase 2-assoc        70.32 20 2
P43274|H14_MOUSE Histone H1.4 OS=Mus musculus   70.04 22 2
Q9QXC1|FETUB_MOUSE Fetuin-B OS=Mus musculus GN=   69.89 11 2
P70663|SPRL1_MOUSE SPARC-like protein 1 OS=Mus m    69.73 4 2
Q8R0J7|VP37B_MOUSE Vacuolar protein sorting-associat        69.64 22 2
Q91VC4|PLVAP_MOUSE Plasmalemma vesicle-associated      69.64 14 2
Q9QZE5|COPG_MOUSE Coatomer subunit gamma OS=M     69.47 15 2
Q80UW2|FBX2_MOUSE F-box only protein 2 OS=Mus mu    69.44 14 2
Q9Z1Y4|TRIP6_MOUSE Thyroid receptor-interacting prote       68.81 14 2
Q9D554|SF3A3_MOUSE Splicing factor 3A subunit 3 OS=     68.44 12 2
P49717|MCM4_MOUSE DNA replication licensing factor M      68.17 10 2
P62334|PRS10_MOUSE 26S protease regulatory subunit      67.7 23 2
Q99PT1|GDIR1_MOUSE Rho GDP-dissociation inhibitor 1     67.44 18 2
Q04857|CO6A1_MOUSE Collagen alpha-1(VI) chain OS=M     67.17 7 2
Q3TKT4|SMCA4_MOUSE Transcription activator BRG1 OS     65.58 11 2
Q9DCW4|ETFB_MOUSE Electron transfer flavoprotein sub       65.47 9 2
P28653|PGS1_MOUSE Biglycan OS=Mus musculus GN=   65.22 8 2
P97360|ETV6_MOUSE Transcription factor ETV6 OS=M     65.13 6 2
Q9DCT5|SDF2_MOUSE Stromal cell-derived factor 2 OS=     64.76 18 2
Q99NG0|ARIP4_MOUSE Helicase ARIP4 OS=Mus muscu    64.35 4 2
Q91YN9|BAG2_MOUSE BAG family molecular chaperone       64.27 29 2
Q8BMP6|GCP60_MOUSE Golgi resident protein GCP60 OS     64.12 13 2
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Q99K28|ARFG2_MOUSE ADP-ribosylation factor GTPase-        63.52 6 2
P67984|RL22_MOUSE 60S ribosomal protein L22 OS=M     63.41 19 2
P83877|TXN4A_MOUSE Thioredoxin-like protein 4A OS=M     62.35 26 2
Q78YZ6|SCOC_MOUSE Short coiled-coil protein OS=Mus    62.26 30 2
Q9JII5|DAZP1_MOUSE DAZ-associated protein 1 OS=M     62.03 19 2
P28658|ATX10_MOUSE Ataxin-10 OS=Mus musculus GN   62 6 2
P16125|LDHB_MOUSE L-lactate dehydrogenase B chain     61.36 24 2
Q9CT10|RANB3_MOUSE Ran-binding protein 3 OS=Mus m    61.25 4 2
Q921N6|DDX27_MOUSE Probable ATP-dependent RNA h       61.05 7 2
Q62376|RU17_MOUSE U1 small nuclear ribonucleoprote        60.8 13 2
Q3UJB9|EDC4_MOUSE Enhancer of mRNA-decapping p       60.77 11 2
Q8BFR5|EFTU_MOUSE Elongation factor Tu, mitochondr      60.42 18 2
Q8JZN5|ACAD9_MOUSE Acyl-CoA dehydrogenase family        58.91 18 2
P62748|HPCL1_MOUSE Hippocalcin-like protein 1 OS=Mu     57.74 17 2
P26638|SYSC_MOUSE Seryl-tRNA synthetase, cytoplasm      57.45 18 2
Q06335|APLP2_MOUSE Amyloid-like protein 2 OS=Mus m    57.27 11 2
Q925F2|ESAM_MOUSE Endothelial cell-selective adhesio       56.91 12 2
P01872|IGHM_MOUSE Ig mu chain C region secreted fo      56.77 6 2
P01873|MUCM_MOUSE Ig mu chain C region membrane-       56.77 6 2
Q920Q4|VPS16_MOUSE Vacuolar protein sorting-associat         56.71 6 2
P97452|BOP1_MOUSE Ribosome biogenesis protein BO      56.65 12 2
Q9CXY6|ILF2_MOUSE Interleukin enhancer-binding fact       56.64 11 2
Q3TW96|UAP1L_MOUSE UDP-N-acetylhexosamine pyroph        56.56 12 2
Q8R317|UBQL1_MOUSE Ubiquilin-1 OS=Mus musculus G   56.49 22 2
P53995|APC1_MOUSE Anaphase-promoting complex su       55.99 6 2
Q64012|RALY_MOUSE RNA-binding protein Raly OS=M     55.47 7 2
Q8CCS6|PABP2_MOUSE Polyadenylate-binding protein 2 O     55.34 11 2
P34884|MIF_MOUSE Macrophage migration inhibitory      55.3 28 2
O54941|SMCE1_MOUSE SWI/SNF-related matrix-associat             55.22 8 2
P29758|OAT_MOUSE Ornithine aminotransferase, mito      54.74 7 2
P18572|BASI_MOUSE Basigin OS=Mus musculus GN=   54.49 12 2
Q99KR7|PPIF_MOUSE Peptidyl-prolyl cis-trans isomeras        54.09 16 2
Q8BI84|MIA3_MOUSE Melanoma inhibitory activity prote       53.97 4 2
Q99N92|RM27_MOUSE 39S ribosomal protein L27, mitoc      53.9 17 2
P62814|VATB2_MOUSE V-type proton ATPase subunit B,       53.54 13 2
P40646|SOX7_MOUSE Transcription factor SOX-7 OS=M     53.49 17 2
P60766|CDC42_MOUSE Cell division control protein 42 ho      53.08 10 2
O35286|DHX15_MOUSE Putative pre-mRNA-splicing facto          52.9 8 2
Q99K30|ES8L2_MOUSE Epidermal growth factor receptor          52.7 14 2
Q9CW03|SMC3_MOUSE Structural maintenance of chrom        52.28 6 2
O35864|CSN5_MOUSE COP9 signalosome complex sub       52.05 20 2
Q60972|RBBP4_MOUSE Histone-binding protein RBBP4 O     51.91 13 2
P01867|IGG2B_MOUSE Ig gamma-2B chain C region OS     51.91 6 2
Q8BGA5|KRR1_MOUSE KRR1 small subunit processome       51.9 16 2
Q64324|STXB2_MOUSE Syntaxin-binding protein 2 OS=M     51.85 17 2
Q8BMK4|CKAP4_MOUSE Cytoskeleton-associated protein      51.81 7 2
P46471|PRS7_MOUSE 26S protease regulatory subunit      51.55 13 2
Q9WUU7|CATZ_MOUSE Cathepsin Z OS=Mus musculus   51.49 12 2
Q3UPH7|ARH40_MOUSE Rho guanine nucleotide exchang        50.93 11 2
Q8BYC4|GPR20_MOUSE G-protein coupled receptor 20 OS     50.69 19 2
O35218|CPSF2_MOUSE Cleavage and polyadenylation sp         50.31 18 2
Q8BPM0|DAAM1_MOUSE Disheveled-associated activator        50.02 11 2
Q8VCW8|ACSF2_MOUSE Acyl-CoA synthetase family mem        49.9 15 2
Q9WUM5|SUCA_MOUSE Succinyl-CoA ligase [GDP-formin         49.64 12 2
Q9WTR2|M3K6_MOUSE Mitogen-activated protein kinase        49.27 6 2
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Q6A0A9|F120A_MOUSE Constitutive coactivator of PPAR        49.24 5 2
Q8C0T5|SI1L1_MOUSE Signal-induced proliferation-asso         49.08 7 2
Q9D1A2|CNDP2_MOUSE Cytosolic non-specific dipeptidas      48.79 12 2
O55201|SPT5H_MOUSE Transcription elongation factor S      48.38 12 2
Q921M3|SF3B3_MOUSE Splicing factor 3B subunit 3 OS=     47.94 8 2
Q8CDN6|TXNL1_MOUSE Thioredoxin-like protein 1 OS=M     47.36 28 2
Q8VHN7|GPR98_MOUSE G-protein coupled receptor 98 OS     47.22 3 2
P37889|FBLN2_MOUSE Fibulin-2 OS=Mus musculus GN=   47.03 8 2
Q8CGF7|TCRG1_MOUSE Transcription elongation regulato       46.76 8 2
Q61510|TRI25_MOUSE E3 ubiquitin/ISG15 ligase TRIM2      46.03 6 2
Q8VD65|PI3R4_MOUSE Phosphoinositide 3-kinase regula        45.7 9 2
Q8CH18|CCAR1_MOUSE Cell division cycle and apoptosis        45.46 3 2
Q6A4J8|UBP7_MOUSE Ubiquitin carboxyl-terminal hydro       45.28 13 2
Q9CXZ1|NDUS4_MOUSE NADH dehydrogenase [ubiquinon          45.15 19 2
P24547|IMDH2_MOUSE Inosine-5'-monophosphate dehyd       44.07 10 2
Q9EP97|SENP3_MOUSE Sentrin-specific protease 3 OS=M     43.8 8 2
O88783|FA5_MOUSE Coagulation factor V OS=Mus m    43.75 5 2
Q8K4Z5|SF3A1_MOUSE Splicing factor 3A subunit 1 OS=     43.58 5 2
O55057|PDE6D_MOUSE Retinal rod rhodopsin-sensitive c          43.32 21 2
O88543|CSN3_MOUSE COP9 signalosome complex sub       43.24 16 2
Q9WTQ5|AKA12_MOUSE A-kinase anchor protein 12 OS=M     43.17 3 2
Q8VE97|SRSF4_MOUSE Serine/arginine-rich splicing facto       42.77 10 2
O35465|FKBP8_MOUSE Peptidyl-prolyl cis-trans isomeras       42.75 14 2
Q8C419|GP158_MOUSE Probable G-protein coupled rece       42.71 10 2
P97379|G3BP2_MOUSE Ras GTPase-activating protein-b        42.53 9 2
Q61425|HCDH_MOUSE Hydroxyacyl-coenzyme A dehydr       42.22 20 2
Q9Z0R6|ITSN2_MOUSE Intersectin-2 OS=Mus musculus   42.1 10 2
Q8C9B9|DIDO1_MOUSE Death-inducer obliterator 1 OS=M     41.39 5 2
Q8BU51|BPIL3_MOUSE Bactericidal/permeability-increas        40.62 14 2
P97479|MYO7A_MOUSE Myosin-VIIa OS=Mus musculus G   39.51 9 2
Q91YT0|NDUV1_MOUSE NADH dehydrogenase [ubiquinon         39.51 14 2
Q08943|SSRP1_MOUSE FACT complex subunit SSRP1 O     38.94 14 2
A2AAE1|K1109_MOUSE Uncharacterized protein KIAA110      38.91 6 2
P70390|SHOX2_MOUSE Short stature homeobox protein 2     38.86 8 2
O88444|ADCY1_MOUSE Adenylate cyclase type 1 OS=Mu     38.61 12 2
P48725|PCNT_MOUSE Pericentrin OS=Mus musculus G   38.53 11 2
Q9D7N3|RT09_MOUSE 28S ribosomal protein S9, mitoch      38.32 13 2
Q64430|ATP7A_MOUSE Copper-transporting ATPase 1 O     38.3 11 2
Q99PP2|ZN318_MOUSE Zinc finger protein 318 (Fragmen      37.87 5 2
P84091|AP2M1_MOUSE AP-2 complex subunit mu OS=M     37.8 14 2
Q8CGN4|BCOR_MOUSE BCL-6 corepressor OS=Mus mus    37.77 4 2
Q9DC33|HM20A_MOUSE High mobility group protein 20A O     37.72 10 2
P97384|ANX11_MOUSE Annexin A11 OS=Mus musculus   37.56 4 2
P11531|DMD_MOUSE Dystrophin OS=Mus musculus G   37.56 9 2
Q5SF07|IF2B2_MOUSE Insulin-like growth factor 2 mRNA        37.18 12 2
Q01320|TOP2A_MOUSE DNA topoisomerase 2-alpha OS=     37.16 8 2
P08121|CO3A1_MOUSE Collagen alpha-1(III) chain OS=M     37.05 9 2
Q69ZU6|THS7A_MOUSE Thrombospondin type-1 domain-        36.94 6 2
Q9QZ09|PHTF1_MOUSE Putative homeodomain transcript        36.62 7 2
P52734|FGD1_MOUSE FYVE, RhoGEF and PH domain-        36.61 4 2
Q91YW3|DNJC3_MOUSE DnaJ homolog subfamily C mem       36.34 4 2
Q8CFE4|SCYL2_MOUSE SCY1-like protein 2 OS=Mus mu    36.23 6 2
Q4QY64|ATAD5_MOUSE ATPase family AAA domain-cont        35.76 7 2
Q8R0L9|TADA3_MOUSE Transcriptional adapter 3 OS=Mu     35.73 14 2
O35954|PITM1_MOUSE Membrane-associated phosphati         35.43 11 2
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Q6PGN1|F132B_MOUSE Protein FAM132B OS=Mus musc    35.41 8 2
Q9Z329|ITPR2_MOUSE Inositol 1,4,5-trisphosphate recep        35.37 10 2
P54320|ELN_MOUSE Elastin OS=Mus musculus GN=E   35.17 20 2
Q9Z108|STAU1_MOUSE Double-stranded RNA-binding pr         34.73 23 2
O88491|NSD1_MOUSE Histone-lysine N-methyltransfera            34.66 9 2
Q3UFQ8|LR16B_MOUSE Leucine-rich repeat-containing pr       34.6 8 2
Q6PHB0|I20RA_MOUSE Interleukin-20 receptor subunit a      34.47 4 2
Q9DCC4|P5CR3_MOUSE Pyrroline-5-carboxylate reductase      34.09 15 2
O54724|PTRF_MOUSE Polymerase I and transcript relea       33.88 8 2
O88705|HCN3_MOUSE Potassium/sodium hyperpolariza          33.88 11 2
Q61290|CAC1E_MOUSE Voltage-dependent R-type calciu         33.64 7 2
Q6ZQ88|KDM1A_MOUSE Lysine-specific histone demethyla       33.6 11 2
Q61702|ITIH1_MOUSE Inter-alpha-trypsin inhibitor heavy       33.31 8 2
Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS     33.25 8 2
Q8BN57|CC033_MOUSE Uncharacterized protein C3orf33     33.07 11 2
Q3UHK3|GREB1_MOUSE Protein GREB1 OS=Mus muscul    33.07 5 2
Q91VR5|DDX1_MOUSE ATP-dependent RNA helicase D      32.87 15 2
Q6ZWQ0|SYNE2_MOUSE Nesprin-2 OS=Mus musculus GN   32.74 8 2
O35071|KIF1C_MOUSE Kinesin-like protein KIF1C OS=M     32.69 12 2
Q922B9|SSFA2_MOUSE Sperm-specific antigen 2 homolo      32.01 9 2
A8C756|THADA_MOUSE Thyroid adenoma-associated pro       31.65 6 2
P0C5E4|PTPRQ_MOUSE Phosphotidylinositol phosphatase      31.6 4 2
Q5DTT2|PSD1_MOUSE PH and SEC7 domain-containing       31.4 8 2
Q6QIY3|SCNAA_MOUSE Sodium channel protein type 10 s       31.28 8 2
Q0VGM9|RTEL1_MOUSE Regulator of telomere elongation       31.22 5 2
Q8CH25|SLTM_MOUSE SAFB-like transcription modulato      31.21 3 2
P55012|S12A2_MOUSE Solute carrier family 12 member      31.03 10 2
Q8BXR5|NALCN_MOUSE Sodium leak channel non-selecti       30.84 7 2
A1L3T7|FA65C_MOUSE Protein FAM65C OS=Mus muscu    30.82 9 2
Q8VE73|CUL7_MOUSE Cullin-7 OS=Mus musculus GN=   30.65 7 2
Q8C0P7|ZN451_MOUSE Zinc finger protein 451 OS=Mus    30.59 8 2
Q2EG98|PK1L3_MOUSE Polycystic kidney disease protein       30.59 7 2
P13705|MSH3_MOUSE DNA mismatch repair protein Ms      30.41 7 2
Q3URY6|ARMC2_MOUSE Armadillo repeat-containing prote       30.02 11 2
P46737|BRCC3_MOUSE Lys-63-specific deubiquitinase BR      29.91 9 2
P97311|MCM6_MOUSE DNA replication licensing factor M      29.82 11 2
Q8C267|SETB2_MOUSE Histone-lysine N-methyltransfera       29.53 7 2
A7L9Z8|AT2C2_MOUSE Calcium-transporting ATPase typ         29.51 10 2
Q4G0F8|UBN1_MOUSE Ubinuclein-1 OS=Mus musculus   29.46 9 2
A2BH40|ARI1A_MOUSE AT-rich interactive domain-conta        29.41 6 2
Q80WQ9|ZBED4_MOUSE Zinc finger BED domain-containi        29.14 11 2
Q9JJN0|POLH_MOUSE DNA polymerase eta OS=Mus m    29.05 9 2
P49582|ACHA7_MOUSE Neuronal acetylcholine receptor s       28.31 3 2
Q8C0R9|YG015_MOUSE Leucine-rich repeat and death do        28.02 8 2
Q8JZR4|EAA5_MOUSE Excitatory amino acid transporter      27.86 13 2
Q80TS3|LPHN3_MOUSE Latrophilin-3 OS=Mus musculus   27.7 4 2
Q61037|TSC2_MOUSE Tuberin OS=Mus musculus GN=   27.63 8 2
Q14BI7|TDRD9_MOUSE Putative ATP-dependent RNA he       27.57 10 2
P04187|GRAB_MOUSE Granzyme B(G,H) OS=Mus mus    27.37 20 2
Q91YU6|LZTS2_MOUSE Leucine zipper putative tumor su       27.34 11 2
Q01815|CAC1C_MOUSE Voltage-dependent L-type calcium        27.26 13 2
Q8C120|SH3R3_MOUSE SH3 domain-containing RING fin        27.05 5 2
Q09XV5|CHD8_MOUSE Chromodomain-helicase-DNA-bi        27.02 9 2
P59997|KDM2A_MOUSE Lysine-specific demethylase 2A O     27.01 8 2
P55937|GOGA3_MOUSE Golgin subfamily A member 3 OS     27 8 2
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Q8BG67|EFR3A_MOUSE Protein EFR3 homolog A OS=Mu     26.89 11 2
Q6R5N8|TLR13_MOUSE Toll-like receptor 13 OS=Mus mu    26.88 7 2
Q9QZS7|NPHN_MOUSE Nephrin OS=Mus musculus GN=   26.87 5 2
P48356|LEPR_MOUSE Leptin receptor OS=Mus musculu    26.62 8 2
Q9WV34|MPP2_MOUSE MAGUK p55 subfamily member 2     26.62 4 2
Q6P1C6|LRIG3_MOUSE Leucine-rich repeats and immuno         26.43 7 2
P11247|PERM_MOUSE Myeloperoxidase OS=Mus musc    26.16 14 2
Q61493|DPOLZ_MOUSE DNA polymerase zeta catalytic su      26.14 8 2
A2ARZ3|FSIP2_MOUSE Fibrous sheath-interacting protein      26.03 5 2
P97714|ADA1D_MOUSE Alpha-1D adrenergic receptor OS     26.02 9 2
Q9D415|DLGP1_MOUSE Disks large-associated protein 1     25.97 6 2
Q6IQX7|CHSS2_MOUSE Chondroitin sulfate synthase 2 O     25.97 9 2
P57080|UBP25_MOUSE Ubiquitin carboxyl-terminal hydro       25.95 7 2
Q8CHY3|DYM_MOUSE Dymeclin OS=Mus musculus GN   25.91 7 2
B2RQE8|RHG42_MOUSE Rho GTPase-activating protein 4      25.9 6 2
Q9D168|INT12_MOUSE Integrator complex subunit 12 OS     25.79 10 2
P51557|STAR_MOUSE Steroidogenic acute regulatory p       25.79 13 2
Q9D2K4|IQCH_MOUSE IQ domain-containing protein H O     25.76 6 2
Q7TSH4|CP110_MOUSE Centrosomal protein CP110 OS=     25.63 2 2
Q9Z1S0|BUB1B_MOUSE Mitotic checkpoint serine/threonin         25.45 8 2
Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=     25.35 9 2
Q9QXL1|KI21B_MOUSE Kinesin-like protein KIF21B OS=     25.33 5 2
Q921C3|BRWD1_MOUSE Bromodomain and WD repeat-co        25.28 4 2
P58742|AAAS_MOUSE Aladin OS=Mus musculus GN=A   25.27 8 2
Q3TEI4|CO039_MOUSE Uncharacterized protein C15orf3      25.22 10 2
Q7TSH7|KCNF1_MOUSE Potassium voltage-gated channe          24.92 13 2
Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus muscu    24.89 13 2
Q8CJ12|GPR64_MOUSE G-protein coupled receptor 64 OS     24.82 6 2
Q6PIX5|RHDF1_MOUSE Inactive rhomboid protein 1 OS=     24.8 13 2
Q9QXH4|ITAX_MOUSE Integrin alpha-X OS=Mus muscu    24.77 10 2
Q8K0L0|ASB2_MOUSE Ankyrin repeat and SOCS box pr       24.35 3 2
Q80T85|DCAF5_MOUSE DDB1- and CUL4-associated fac       24.16 6 2
P70327|TBX6_MOUSE T-box transcription factor TBX6 O     24.04 9 2
Q60603|KCNH1_MOUSE Potassium voltage-gated channe          24 4 2
Q62388|ATM_MOUSE Serine-protein kinase ATM OS=M     23.89 10 2
Q9JHW4|SELB_MOUSE Selenocysteine-specific elongatio       23.85 17 2
Q6PR54|RIF1_MOUSE Telomere-associated protein RIF      23.75 7 2
P59808|SASH1_MOUSE SAM and SH3 domain-containing       23.72 6 2
P0CW70|D19L2_MOUSE Protein dpy-19 homolog 2 OS=M     23.51 13 2
Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus GN   23.41 6 2
P53349|M3K1_MOUSE Mitogen-activated protein kinase        23.32 5 2
Q9R155|S26A4_MOUSE Pendrin OS=Mus musculus GN=   23.04 8 2
Q00519|XDH_MOUSE Xanthine dehydrogenase/oxidase     22.92 7 2
C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-        22.87 5 2
P97303|BACH2_MOUSE Transcription regulator protein BA      22.77 3 2
Q8BNJ2|ATS4_MOUSE A disintegrin and metalloproteina          22.72 5 2
A7M7C7|SKOR2_MOUSE SKI family transcriptional corepre       21.59 4 2
O88196|TTC3_MOUSE E3 ubiquitin-protein ligase TTC3     21.07 6 2
Q8CI32|BAG5_MOUSE BAG family molecular chaperone       20.8 11 2
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Table A1.3 Cell Start Protein Identifications.  List of all proteins identified in Cell Start 
growth matrix with corresponding accession, description, PEAKS score, unique peptide 
numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=A   740.91 92 508
P02751|FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 P  590.06 67 213
P01023|A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens   355.02 44 37
P02790|HEMO_HUMAN Hemopexin OS=Homo sapiens GN=HPX  379.25 68 34
P43652|AFAM_HUMAN Afamin OS=Homo sapiens GN=AFM PE=  308.01 62 25
P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens GN=HP P  398.12 67 23
P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens   300.96 64 22
P02671|FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens   239.94 35 18
P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapie    253.11 53 17
P02765|FETUA_HUMAN Alpha-2-HS-glycoprotein OS=Homo sapie    253.45 62 16
P02749|APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens   250.57 59 13
P04217|A1BG_HUMAN Alpha-1B-glycoprotein OS=Homo sapiens   246.04 39 12
P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN   234.22 73 10
P02766|TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR  225.45 68 10
P08253|MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sa    197.89 32 8
Q96PD5|PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase OS=     179.89 27 6
P01871|IGHM_HUMAN Ig mu chain C region OS=Homo sapiens G   169.57 36 6
P01834|IGKC_HUMAN Ig kappa chain C region OS=Homo sapien    189.08 78 5
P10909|CLUS_HUMAN Clusterin OS=Homo sapiens GN=CLU PE  180.73 35 5
Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 S 50.51 2 5
P01876|IGHA1_HUMAN Ig alpha-1 chain C region OS=Homo sapie    151.25 22 4
P69905|HBA_HUMAN Hemoglobin subunit alpha OS=Homo sap    138.46 49 4
P02760|AMBP_HUMAN Protein AMBP OS=Homo sapiens GN=AM   112.1 18 4
P00450|CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP  103.12 8 4
P68871|HBB_HUMAN Hemoglobin subunit beta OS=Homo sapie    176.25 48 3
P01860|IGHG3_HUMAN Ig gamma-3 chain C region OS=Homo sa    166.83 34 3
P01024|CO3_HUMAN Complement C3 OS=Homo sapiens GN=C   146.6 19 3
P35030|TRY3_HUMAN Trypsin-3 OS=Homo sapiens GN=PRSS3  145.59 13 3
P0CG05|LAC2_HUMAN Ig lambda-2 chain C regions OS=Homo sa    136.88 68 3
P0CG06|LAC3_HUMAN Ig lambda-3 chain C regions OS=Homo sa    136.88 68 3
B9A064|IGLL5_HUMAN Immunoglobulin lambda-like polypeptide 5     136.88 28 3
P0CG04|LAC1_HUMAN Ig lambda-1 chain C regions OS=Homo sa    136.88 42 3
P05155|IC1_HUMAN Plasma protease C1 inhibitor OS=Homo s    129.22 19 3
P0C0L4|CO4A_HUMAN Complement C4-A OS=Homo sapiens GN   113.65 23 3
P0C0L5|CO4B_HUMAN Complement C4-B OS=Homo sapiens GN   113.65 23 3
P02763|A1AG1_HUMAN Alpha-1-acid glycoprotein 1 OS=Homo sa    110.28 46 3
P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN   88.02 12 3
P02771|FETA_HUMAN Alpha-fetoprotein OS=Homo sapiens GN=   69.2 4 3
P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 P  45.74 5 3
Q2PPJ7|RGPA2_HUMAN Ral GTPase-activating protein subunit alp      38.22 2 3
P20929|NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=  37.95 3 3
O15018|PDZD2_HUMAN PDZ domain-containing protein 2 OS=Hom     32.88 3 3
P07477|TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1  143.81 26 2
Q16610|ECM1_HUMAN Extracellular matrix protein 1 OS=Homo s    103.56 35 2
P02774|VTDB_HUMAN Vitamin D-binding protein OS=Homo sapie    83.32 31 2
O14647|CHD2_HUMAN Chromodomain-helicase-DNA-binding pro       43.46 4 2
Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase CDC      43.19 6 2
Q9Y6W5|WASF2_HUMAN Wiskott-Aldrich syndrome protein family m       38.65 2 2
P24821|TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE  36.58 3 2
Q3L8U1|CHD9_HUMAN Chromodomain-helicase-DNA-binding pro       35.78 2 2
Q96KC8|DNJC1_HUMAN DnaJ homolog subfamily C member 1 OS     35.29 12 2
Q95IE3|2B1C_HUMAN HLA class II histocompatibility antigen, DR        32.1 10 2
P01911|2B1F_HUMAN HLA class II histocompatibility antigen, DR        32.1 8 2
Q29974|2B1G_HUMAN HLA class II histocompatibility antigen, DR        32.1 8 2
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P04229|2B11_HUMAN HLA class II histocompatibility antigen, DR        32.1 5 2
P01912|2B13_HUMAN HLA class II histocompatibility antigen, DR       32.1 5 2
P20039|2B1B_HUMAN HLA class II histocompatibility antigen, DR        32.1 5 2
Q5Y7A7|2B1D_HUMAN HLA class II histocompatibility antigen, DR        32.1 5 2
Q9GIY3|2B1E_HUMAN HLA class II histocompatibility antigen, DR        32.1 5 2
Q30154|DRB5_HUMAN HLA class II histocompatibility antigen, DR        32.1 5 2
Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens G   31.9 3 2
Q9Y4H2|IRS2_HUMAN Insulin receptor substrate 2 OS=Homo sa    30.26 5 2
Q7L4P6|BEND5_HUMAN BEN domain-containing protein 5 OS=Hom     30.07 8 2
O15083|ERC2_HUMAN ERC protein 2 OS=Homo sapiens GN=ER   29.66 3 2
Q07075|AMPE_HUMAN Glutamyl aminopeptidase OS=Homo sapie    29.26 3 2
O00555|CAC1A_HUMAN Voltage-dependent P/Q-type calcium chan        29.06 3 2
Q07869|PPARA_HUMAN Peroxisome proliferator-activated receptor      28.92 2 2
Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatas       28.88 5 2
Q96T88|UHRF1_HUMAN E3 ubiquitin-protein ligase UHRF1 OS=Ho     28.46 3 2
Q2M329|CCD96_HUMAN Coiled-coil domain-containing protein 96 O     27.76 3 2
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Table A1.4 Human BME Protein Identifications.  List of all proteins identified in 
Human BME growth matrix with corresponding accession, description, PEAKS score, 
unique peptide numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
P02751|FINC_HUMAN Fibronectin OS=Homo sapiens G   341.22 45 102
P24043|LAMA2_HUMAN Laminin subunit alpha-2 OS=Hom     304.77 30 66
P55268|LAMB2_HUMAN Laminin subunit beta-2 OS=Hom     283.73 35 46
Q05707|COEA1_HUMAN Collagen alpha-1(XIV) chain OS=     264.19 41 46
P01023|A2MG_HUMAN Alpha-2-macroglobulin OS=Hom     289 38 45
P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=H     279.33 39 43
P98160|PGBM_HUMAN Basement membrane-specific he          258.87 19 42
P08670|VIME_HUMAN Vimentin OS=Homo sapiens GN   258.73 73 37
O15230|LAMA5_HUMAN Laminin subunit alpha-5 OS=Hom     253.7 16 34
P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Hom     238.75 24 27
P14543|NID1_HUMAN Nidogen-1 OS=Homo sapiens G   237.82 30 27
P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=H     226.55 19 27
Q16363|LAMA4_HUMAN Laminin subunit alpha-4 OS=Hom     224.5 27 25
P01024|CO3_HUMAN Complement C3 OS=Homo sapi    205.4 23 24
P11021|GRP78_HUMAN 78 kDa glucose-regulated protein     235.26 46 23
P14625|ENPL_HUMAN Endoplasmin OS=Homo sapiens   215.43 38 22
O43707|ACTN4_HUMAN Alpha-actinin-4 OS=Homo sapie    281.68 56 21
P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens   213.42 47 21
P02768|ALBU_HUMAN Serum albumin OS=Homo sapie    200.8 42 21
P12814|ACTN1_HUMAN Alpha-actinin-1 OS=Homo sapie    269.31 58 20
P07237|PDIA1_HUMAN Protein disulfide-isomerase OS=     206.6 45 19
Q13813|SPTA2_HUMAN Spectrin alpha chain, brain OS=H     186.17 21 17
P02671|FIBA_HUMAN Fibrinogen alpha chain OS=Hom     172.58 26 16
P23142|FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN   200.91 25 15
Q15084|PDIA6_HUMAN Protein disulfide-isomerase A6 O     197.7 42 15
P18206|VINC_HUMAN Vinculin OS=Homo sapiens GN=   183.25 27 14
O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens GN   175.11 14 14
P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo    169.47 42 14
P01243|CSH_HUMAN Chorionic somatomammotropin h      222.66 69 13
P11277|SPTB1_HUMAN Spectrin beta chain, erythrocyte O     181.32 19 13
P04083|ANXA1_HUMAN Annexin A1 OS=Homo sapiens G   178.26 42 13
P08603|CFAH_HUMAN Complement factor H OS=Homo    177.55 19 13
P10809|CH60_HUMAN 60 kDa heat shock protein, mitoc      176.8 45 13
P32119|PRDX2_HUMAN Peroxiredoxin-2 OS=Homo sapie    183.65 38 12
P07355|ANXA2_HUMAN Annexin A2 OS=Homo sapiens G   177.18 44 12
P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Ho     189.08 38 11
P30101|PDIA3_HUMAN Protein disulfide-isomerase A3 O     155.47 33 11
Q15582|BGH3_HUMAN Transforming growth factor-beta-        154.17 36 11
P69905|HBA_HUMAN Hemoglobin subunit alpha OS=H     180.04 64 10
P06576|ATPB_HUMAN ATP synthase subunit beta, mito      174.82 34 10
P49748|ACADV_HUMAN Very long-chain specific acyl-CoA       174.26 26 10
P21980|TGM2_HUMAN Protein-glutamine gamma-glutam       161.7 24 10
P35579|MYH9_HUMAN Myosin-9 OS=Homo sapiens GN   158.65 15 10
Q03252|LMNB2_HUMAN Lamin-B2 OS=Homo sapiens GN   155.23 25 10
P51884|LUM_HUMAN Lumican OS=Homo sapiens GN   140.59 34 10
P50454|SERPH_HUMAN Serpin H1 OS=Homo sapiens GN   180.83 33 9
P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens GN   154.91 13 9
Q14112|NID2_HUMAN Nidogen-2 OS=Homo sapiens G   146.91 12 9
P39059|COFA1_HUMAN Collagen alpha-1(XV) chain OS=     163.68 18 8
Q9Y6N6|LAMC3_HUMAN Laminin subunit gamma-3 OS=H     158.79 17 8
P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=     148.61 31 8
P60660|MYL6_HUMAN Myosin light polypeptide 6 OS=H     145.14 75 8
P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens GN   144.74 26 8
P55072|TERA_HUMAN Transitional endoplasmic reticulu       142.86 15 8
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P10909|CLUS_HUMAN Clusterin OS=Homo sapiens GN   137.86 25 8
P38646|GRP75_HUMAN Stress-70 protein, mitochondrial     145.13 27 7
P36957|ODO2_HUMAN Dihydrolipoyllysine-residue succi            135.47 22 7
P00747|PLMN_HUMAN Plasminogen OS=Homo sapiens   133.52 10 7
P02549|SPTA1_HUMAN Spectrin alpha chain, erythrocyte     131.8 8 7
P30048|PRDX3_HUMAN Thioredoxin-dependent peroxide       121.33 29 7
P00488|F13A_HUMAN Coagulation factor XIII A chain O     116.64 18 7
P01857|IGHG1_HUMAN Ig gamma-1 chain C region OS=     186.51 53 6
P11142|HSP7C_HUMAN Heat shock cognate 71 kDa prot      184 28 6
P68871|HBB_HUMAN Hemoglobin subunit beta OS=Ho     167.04 48 6
P04792|HSPB1_HUMAN Heat shock protein beta-1 OS=H     151.58 36 6
P20774|MIME_HUMAN Mimecan OS=Homo sapiens GN   135.79 34 6
P08758|ANXA5_HUMAN Annexin A5 OS=Homo sapiens G   132.3 23 6
P21810|PGS1_HUMAN Biglycan OS=Homo sapiens GN=   132.24 22 6
P62805|H4_HUMAN Histone H4 OS=Homo sapiens G   130.91 41 6
P62937|PPIA_HUMAN Peptidyl-prolyl cis-trans isomeras       129.29 42 6
P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sap    127.95 25 6
P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens G   127.76 16 6
P07585|PGS2_HUMAN Decorin OS=Homo sapiens GN=   124 16 6
P00367|DHE3_HUMAN Glutamate dehydrogenase 1, mit      122.42 21 6
P06396|GELS_HUMAN Gelsolin OS=Homo sapiens GN=   119.73 13 6
Q12805|FBLN3_HUMAN EGF-containing fibulin-like extrac         116.62 19 6
P63104|1433Z_HUMAN 14-3-3 protein zeta/delta OS=Ho     116.55 47 6
P63267|ACTH_HUMAN Actin, gamma-enteric smooth mu      194.38 40 5
P62736|ACTA_HUMAN Actin, aortic smooth muscle OS=     194.38 40 5
P68032|ACTC_HUMAN Actin, alpha cardiac muscle 1 OS     194.38 40 5
P68133|ACTS_HUMAN Actin, alpha skeletal muscle OS=     194.38 40 5
Q9NYU2|UGGG1_HUMAN UDP-glucose:glycoprotein glucos       135.54 7 5
P39060|COIA1_HUMAN Collagen alpha-1(XVIII) chain OS     130.82 12 5
P51888|PRELP_HUMAN Prolargin OS=Homo sapiens GN   127.01 14 5
P17661|DESM_HUMAN Desmin OS=Homo sapiens GN=   126.75 25 5
P80303|NUCB2_HUMAN Nucleobindin-2 OS=Homo sapie    124.47 28 5
P09211|GSTP1_HUMAN Glutathione S-transferase P OS=     120.59 33 5
P25705|ATPA_HUMAN ATP synthase subunit alpha, mit      114.16 18 5
P02748|CO9_HUMAN Complement component C9 OS=     106.89 13 5
P0C0L4|CO4A_HUMAN Complement C4-A OS=Homo sa    102.47 7 5
P0C0L5|CO4B_HUMAN Complement C4-B OS=Homo sa    102.47 7 5
P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens G   102.39 8 5
Q9NR28|DBLOH_HUMAN Diablo homolog, mitochondrial O     101.43 24 5
P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN   97.14 4 5
P07954|FUMH_HUMAN Fumarate hydratase, mitochondr      89.86 17 5
Q01082|SPTB2_HUMAN Spectrin beta chain, brain 1 OS=     87.78 6 5
P02765|FETUA_HUMAN Alpha-2-HS-glycoprotein OS=Ho     80.75 25 5
P08238|HS90B_HUMAN Heat shock protein HSP 90-beta     140.06 19 4
P40926|MDHM_HUMAN Malate dehydrogenase, mitochon      132.99 30 4
Q06830|PRDX1_HUMAN Peroxiredoxin-1 OS=Homo sapie    121.31 29 4
P24534|EF1B_HUMAN Elongation factor 1-beta OS=Hom     119.55 30 4
Q13162|PRDX4_HUMAN Peroxiredoxin-4 OS=Homo sapie    116.87 21 4
P13667|PDIA4_HUMAN Protein disulfide-isomerase A4 O     110.55 11 4
Q14257|RCN2_HUMAN Reticulocalbin-2 OS=Homo sapie    108.08 25 4
Q96HE7|ERO1A_HUMAN ERO1-like protein alpha OS=Hom     106.34 13 4
P07737|PROF1_HUMAN Profilin-1 OS=Homo sapiens GN   102.52 45 4
Q9BS26|ERP44_HUMAN Endoplasmic reticulum resident p       97.38 14 4
Q9UBS4|DJB11_HUMAN DnaJ homolog subfamily B mem       96.49 14 4
Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase, m      93.16 21 4
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Q07954|LRP1_HUMAN Prolow-density lipoprotein recept        90.68 3 4
Q15008|PSMD6_HUMAN 26S proteasome non-ATPase re        87.94 14 4
P30041|PRDX6_HUMAN Peroxiredoxin-6 OS=Homo sapie    85.61 29 4
P00450|CERU_HUMAN Ceruloplasmin OS=Homo sapien    83.68 8 4
P30044|PRDX5_HUMAN Peroxiredoxin-5, mitochondrial O     82.93 28 4
P24821|TENA_HUMAN Tenascin OS=Homo sapiens GN   54.92 6 4
Q8IZT6|ASPM_HUMAN Abnormal spindle-like microceph       44.64 5 4
P54652|HSP72_HUMAN Heat shock-related 70 kDa prote       162.58 23 3
Q00887|PSG9_HUMAN Pregnancy-specific beta-1-glycop       162.56 24 3
P34931|HS71L_HUMAN Heat shock 70 kDa protein 1-like     129.92 20 3
P04040|CATA_HUMAN Catalase OS=Homo sapiens GN   112.92 21 3
P62258|1433E_HUMAN 14-3-3 protein epsilon OS=Homo    108.22 16 3
P61604|CH10_HUMAN 10 kDa heat shock protein, mitoc      108.04 35 3
P01834|IGKC_HUMAN Ig kappa chain C region OS=Hom     106.98 56 3
Q08380|LG3BP_HUMAN Galectin-3-binding protein OS=H     100.86 8 3
P07437|TBB5_HUMAN Tubulin beta chain OS=Homo sa    93.94 9 3
P09525|ANXA4_HUMAN Annexin A4 OS=Homo sapiens G   92.2 15 3
Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens GN=T   90.4 2 3
Q09666|AHNK_HUMAN Neuroblast differentiation-associa        89.83 3 3
Q9BQE3|TBA1C_HUMAN Tubulin alpha-1C chain OS=Hom     88 9 3
P35232|PHB_HUMAN Prohibitin OS=Homo sapiens GN   85.74 15 3
P09382|LEG1_HUMAN Galectin-1 OS=Homo sapiens G   85.61 30 3
P27797|CALR_HUMAN Calreticulin OS=Homo sapiens G   83.22 19 3
P68104|EF1A1_HUMAN Elongation factor 1-alpha 1 OS=H     81.94 13 3
Q5VTE0|EF1A3_HUMAN Putative elongation factor 1-alph       81.94 13 3
Q12874|SF3A3_HUMAN Splicing factor 3A subunit 3 OS=     81.59 12 3
P04406|G3P_HUMAN Glyceraldehyde-3-phosphate deh      78.53 16 3
P31942|HNRH3_HUMAN Heterogeneous nuclear ribonucle       77.15 12 3
Q10567|AP1B1_HUMAN AP-1 complex subunit beta-1 OS     77.02 9 3
P20936|RASA1_HUMAN Ras GTPase-activating protein 1     76.73 5 3
P01031|CO5_HUMAN Complement C5 OS=Homo sapi    74.8 5 3
P54819|KAD2_HUMAN Adenylate kinase 2, mitochondria      72.1 26 3
P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucle       71.44 23 3
Q13561|DCTN2_HUMAN Dynactin subunit 2 OS=Homo sa    68.74 13 3
Q01518|CAP1_HUMAN Adenylyl cyclase-associated prot       67.94 9 3
P60709|ACTB_HUMAN Actin, cytoplasmic 1 OS=Homo s    216.5 44 2
P63261|ACTG_HUMAN Actin, cytoplasmic 2 OS=Homo s    214.32 44 2
P01860|IGHG3_HUMAN Ig gamma-3 chain C region OS=     175.52 51 2
P69892|HBG2_HUMAN Hemoglobin subunit gamma-2 O     173.02 61 2
P69891|HBG1_HUMAN Hemoglobin subunit gamma-1 O     170.8 61 2
P11465|PSG2_HUMAN Pregnancy-specific beta-1-glycop       137.96 21 2
P07900|HS90A_HUMAN Heat shock protein HSP 90-alpha     131.12 23 2
P25815|S100P_HUMAN Protein S100-P OS=Homo sapie    91.58 39 2
P63220|RS21_HUMAN 40S ribosomal protein S21 OS=H     90.01 30 2
P04206|KV307_HUMAN Ig kappa chain V-III region GOL    89.85 45 2
P01620|KV302_HUMAN Ig kappa chain V-III region SIE O    89.85 31 2
P01622|KV304_HUMAN Ig kappa chain V-III region Ti OS    89.85 31 2
P01623|KV305_HUMAN Ig kappa chain V-III region WOL    89.85 31 2
P18135|KV312_HUMAN Ig kappa chain V-III region HAH    89.85 26 2
P18136|KV313_HUMAN Ig kappa chain V-III region HIC O    89.85 26 2
P15311|EZRI_HUMAN Ezrin OS=Homo sapiens GN=EZ   88.03 9 2
P23396|RS3_HUMAN 40S ribosomal protein S3 OS=Ho     85.87 11 2
P01019|ANGT_HUMAN Angiotensinogen OS=Homo sap    85.07 12 2
P42126|ECI1_HUMAN Enoyl-CoA delta isomerase 1, m      83.5 15 2
P01009|A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sa    82 9 2
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P98095|FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN   80.14 2 2
P01593|KV101_HUMAN Ig kappa chain V-I region AG OS    79.95 31 2
P31949|S10AB_HUMAN Protein S100-A11 OS=Homo sap    78.4 34 2
P62993|GRB2_HUMAN Growth factor receptor-bound pro       76.56 11 2
Q6NZI2|PTRF_HUMAN Polymerase I and transcript relea       76.06 10 2
P01617|KV204_HUMAN Ig kappa chain V-II region TEW O    75.38 29 2
P06309|KV205_HUMAN Ig kappa chain V-II region GM60      75.38 19 2
P23528|COF1_HUMAN Cofilin-1 OS=Homo sapiens GN=   75.06 14 2
Q15149|PLEC_HUMAN Plectin OS=Homo sapiens GN=P   72.18 7 2
P01766|HV305_HUMAN Ig heavy chain V-III region BRO O    71.59 25 2
P51659|DHB4_HUMAN Peroxisomal multifunctional enzy        69.47 6 2
P19404|NDUV2_HUMAN NADH dehydrogenase [ubiquino         68.9 9 2
P30049|ATPD_HUMAN ATP synthase subunit delta, mito      68.54 14 2
P05160|F13B_HUMAN Coagulation factor XIII B chain O     68.43 4 2
Q13219|PAPP1_HUMAN Pappalysin-1 OS=Homo sapiens   67.72 3 2
Q04837|SSBP_HUMAN Single-stranded DNA-binding pro       65.41 18 2
P46109|CRKL_HUMAN Crk-like protein OS=Homo sapie    65.25 11 2
P01042|KNG1_HUMAN Kininogen-1 OS=Homo sapiens   64.19 3 2
Q08830|FGL1_HUMAN Fibrinogen-like protein 1 OS=Ho     64.04 11 2
P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens   63.2 6 2
Q8IVN8|RPESP_HUMAN RPE-spondin OS=Homo sapiens   62.23 9 2
P04843|RPN1_HUMAN Dolichyl-diphosphooligosaccharid         61.45 4 2
Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Hom     61.2 2 2
O43852|CALU_HUMAN Calumenin OS=Homo sapiens G   58.94 17 2
Q15293|RCN1_HUMAN Reticulocalbin-1 OS=Homo sapie    57.79 8 2
P30040|ERP29_HUMAN Endoplasmic reticulum resident p       57.42 21 2
P11940|PABP1_HUMAN Polyadenylate-binding protein 1 O     52.1 5 2
Q9H361|PABP3_HUMAN Polyadenylate-binding protein 3 O     52.1 6 2
P78371|TCPB_HUMAN T-complex protein 1 subunit beta     49.77 9 2
P10412|H14_HUMAN Histone H1.4 OS=Homo sapiens   46.66 13 2
Q14571|ITPR2_HUMAN Inositol 1,4,5-trisphosphate recep        35.19 1 2
Q9P2P6|STAR9_HUMAN StAR-related lipid transfer protein      31.91 2 2
Q9P2D1|CHD7_HUMAN Chromodomain-helicase-DNA-bi        31.53 1 2
Q7Z2Z1|TICRR_HUMAN Treslin OS=Homo sapiens GN=T   30.44 2 2
Q5TZA2|CROCC_HUMAN Rootletin OS=Homo sapiens GN   30.02 4 2
Q03001|DYST_HUMAN Dystonin OS=Homo sapiens GN   29.73 2 2
Q9P2F8|SI1L2_HUMAN Signal-induced proliferation-asso         29.63 3 2
Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens GN=TTN  29.6 2 2
Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type            28.41 1 2
Q8IVF2|AHNK2_HUMAN Protein AHNAK2 OS=Homo sap    26.15 1 2
Q9NW75|GPTC2_HUMAN G patch domain-containing prote       25.7 12 2
P07478|TRY2_HUMAN Trypsin-2 OS=Homo sapiens GN   25.63 10 2
Q8IVL0|NAV3_HUMAN Neuron navigator 3 OS=Homo sa    25.51 2 2
Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens GN=   24.63 2 2
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Table A1.5 StemXVivo Protein Identifications.  List of all proteins identified in 
StemXVivo growth matrix with corresponding accession, description, PEAKS score, 
unique peptide numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens GN=   388.02 71 115
P14543|NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=   412.42 53 109
P34741|SDC2_HUMAN Syndecan-2 OS=Homo sapiens GN   239.36 43 22
P11142|HSP7C_HUMAN Heat shock cognate 71 kDa protein     219.5 32 11
P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens   176.5 13 11
P26641|EF1G_HUMAN Elongation factor 1-gamma OS=Ho     176.44 33 8
P34932|HSP74_HUMAN Heat shock 70 kDa protein 4 OS=H     187.57 19 7
O94985|CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens G   129.26 10 6
P01024|CO3_HUMAN Complement C3 OS=Homo sapien    141.05 11 5
P07900|HS90A_HUMAN Heat shock protein HSP 90-alpha O     196.22 24 4
P63261|ACTG_HUMAN Actin, cytoplasmic 2 OS=Homo sap    146.59 30 4
P60709|ACTB_HUMAN Actin, cytoplasmic 1 OS=Homo sap    146.59 27 4
P14618|KPYM_HUMAN Pyruvate kinase isozymes M1/M2 O     140.5 21 4
P01023|A2MG_HUMAN Alpha-2-macroglobulin OS=Homo    133.62 12 4
P23142|FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN=F   118.99 6 4
P04083|ANXA1_HUMAN Annexin A1 OS=Homo sapiens GN   118.41 11 4
P08238|HS90B_HUMAN Heat shock protein HSP 90-beta O     199.68 28 3
Q9BQE3|TBA1C_HUMAN Tubulin alpha-1C chain OS=Homo    121.93 20 3
P68363|TBA1B_HUMAN Tubulin alpha-1B chain OS=Homo    121.93 20 3
P23396|RS3_HUMAN 40S ribosomal protein S3 OS=Hom     119.7 20 3
Q5VTE0|EF1A3_HUMAN Putative elongation factor 1-alpha-l       109.9 15 3
P68104|EF1A1_HUMAN Elongation factor 1-alpha 1 OS=Ho     109.9 11 3
P00450|CERU_HUMAN Ceruloplasmin OS=Homo sapiens   100.07 6 3
Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=H     90.9 19 3
P0C0L4|CO4A_HUMAN Complement C4-A OS=Homo sapi    77.95 5 3
P0C0L5|CO4B_HUMAN Complement C4-B OS=Homo sapi    77.95 5 3
Q9Y623|MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=M   67.15 4 3
P08865|RSSA_HUMAN 40S ribosomal protein SA OS=Hom     112.46 10 2
P19823|ITIH2_HUMAN Inter-alpha-trypsin inhibitor heavy c       102.91 7 2
P67809|YBOX1_HUMAN Nuclease-sensitive element-binding       101.59 20 2
P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sap    98.62 16 2
P62263|RS14_HUMAN 40S ribosomal protein S14 OS=Ho     98.35 16 2
P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapie    96.73 21 2
P01031|CO5_HUMAN Complement C5 OS=Homo sapien    95.88 4 2
Q66LE6|2ABD_HUMAN Serine/threonine-protein phosphata              94.37 9 2
P63151|2ABA_HUMAN Serine/threonine-protein phosphata              94.37 11 2
P33778|H2B1B_HUMAN Histone H2B type 1-B OS=Homo s    94.29 19 2
P62807|H2B1C_HUMAN Histone H2B type 1-C/E/F/G/I OS=     94.29 19 2
P58876|H2B1D_HUMAN Histone H2B type 1-D OS=Homo s    94.29 19 2
Q93079|H2B1H_HUMAN Histone H2B type 1-H OS=Homo s    94.29 19 2
P06899|H2B1J_HUMAN Histone H2B type 1-J OS=Homo sa    94.29 19 2
O60814|H2B1K_HUMAN Histone H2B type 1-K OS=Homo s    94.29 19 2
Q99880|H2B1L_HUMAN Histone H2B type 1-L OS=Homo sa    94.29 19 2
Q99879|H2B1M_HUMAN Histone H2B type 1-M OS=Homo s    94.29 19 2
Q99877|H2B1N_HUMAN Histone H2B type 1-N OS=Homo s    94.29 19 2
P23527|H2B1O_HUMAN Histone H2B type 1-O OS=Homo s    94.29 19 2
Q16778|H2B2E_HUMAN Histone H2B type 2-E OS=Homo s    94.29 19 2
Q5QNW6|H2B2F_HUMAN Histone H2B type 2-F OS=Homo s    94.29 19 2
Q8N257|H2B3B_HUMAN Histone H2B type 3-B OS=Homo s    94.29 19 2
P57053|H2BFS_HUMAN Histone H2B type F-S OS=Homo s    94.29 19 2
P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo    91.65 6 2
P36955|PEDF_HUMAN Pigment epithelium-derived factor O     89.1 6 2
P60842|IF4A1_HUMAN Eukaryotic initiation factor 4A-I OS=     83.3 7 2
P53396|ACLY_HUMAN ATP-citrate synthase OS=Homo sa    82.41 6 2
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P31749|AKT1_HUMAN RAC-alpha serine/threonine-protein      82.32 12 2
P68871|HBB_HUMAN Hemoglobin subunit beta OS=Hom     78.59 25 2
P55072|TERA_HUMAN Transitional endoplasmic reticulum      76.98 4 2
P46782|RS5_HUMAN 40S ribosomal protein S5 OS=Hom     76.59 11 2
O00506|STK25_HUMAN Serine/threonine-protein kinase 25     75.38 9 2
P78371|TCPB_HUMAN T-complex protein 1 subunit beta O     74.84 8 2
P05388|RLA0_HUMAN 60S acidic ribosomal protein P0 OS     74.81 15 2
Q8NHW5|RLA0L_HUMAN 60S acidic ribosomal protein P0-lik      74.81 11 2
P62269|RS18_HUMAN 40S ribosomal protein S18 OS=Ho     69.34 20 2
P62826|RAN_HUMAN GTP-binding nuclear protein Ran O     68.52 27 2
P81605|DCD_HUMAN Dermcidin OS=Homo sapiens GN=   59.42 13 2
O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens GN=AX   47.22 3 2
P05546|HEP2_HUMAN Heparin cofactor 2 OS=Homo sapi    37.09 4 2
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Table A1.6 StemXVivo Protein Identifications (not species restricted).  List of all 
proteins identified in StemXVivo growth matrix when searched against the entire 
UniProt database (not species restricted) with corresponding accession, description, 
PEAKS score, unique peptide numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
Q7SIH1|A2MG_BOVIN Alpha-2-macroglobulin OS=Bos taur    291.83 37 41
P15497|APOA1_BOVIN Apolipoprotein A-I OS=Bos taurus G   286.69 75 32
Q2UVX4|CO3_BOVIN Complement C3 OS=Bos taurus GN   253.94 33 29
P02769|ALBU_BOVIN Serum albumin OS=Bos taurus GN=   297.68 67 22
P50448|F12AI_BOVIN Factor XIIa inhibitor OS=Bos taurus  203.22 39 16
P02081|HBBF_BOVIN Hemoglobin fetal subunit beta OS=B    201.32 66 14
P33433|HRG_BOVIN Histidine-rich glycoprotein (Fragmen      196.95 28 10
Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy ch       177.34 17 8
Q32PJ2|APOA4_BOVIN Apolipoprotein A-IV OS=Bos taurus   136.8 28 8
P01030|CO4_BOVIN Complement C4 (Fragments) OS=B     172.36 16 7
P80109|PHLD_BOVIN Phosphatidylinositol-glycan-specific       141.5 10 6
P17697|CLUS_BOVIN Clusterin OS=Bos taurus GN=CLU P  122.97 15 6
Q32KY0|APOD_BOVIN Apolipoprotein D OS=Bos taurus GN   110.26 27 6
P34955|A1AT_BOVIN Alpha-1-antiproteinase OS=Bos taur    151.74 23 5
P56652|ITIH3_BOVIN Inter-alpha-trypsin inhibitor heavy ch       123.99 9 5
P12763|FETUA_BOVIN Alpha-2-HS-glycoprotein OS=Bos ta    148.64 25 4
P01044|KNG1_BOVIN Kininogen-1 OS=Bos taurus GN=KN   176.7 21 3
Q3MHN5|VTDB_BOVIN Vitamin D-binding protein OS=Bos ta    103.11 12 3
P01045|KNG2_BOVIN Kininogen-2 OS=Bos taurus GN=KN   170.41 19 2
Q3SZ57|FETA_BOVIN Alpha-fetoprotein OS=Bos taurus GN   116.63 8 2
P00735|THRB_BOVIN Prothrombin OS=Bos taurus GN=F2  98.14 7 2
Q29443|TRFE_BOVIN Serotransferrin OS=Bos taurus GN=   90.11 5 2
P81644|APOA2_BOVIN Apolipoprotein A-II OS=Bos taurus G   80.49 26 2
Q32PF2|ACLY_BOVIN ATP-citrate synthase OS=Bos tauru    77.96 7 2
Q3MHN2|CO9_BOVIN Complement component C9 OS=Bo     71.57 6 2
Q03247|APOE_BOVIN Apolipoprotein E OS=Bos taurus GN   57.34 8 2
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Table A1.7 MEF-CMTX Protein Identifications.  List of all proteins identified in MEF-
CMTX (mouse embryonic fibroblast conditioned matrix) with corresponding accession, 
description, PEAKS score, unique peptide numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
P11276|FINC_MOUSE Fibronectin OS=Mus musculus GN   581.48 74 357
Q05793|PGBM_MOUSE Basement membrane-specific hepa          439.44 49 109
P37889|FBLN2_MOUSE Fibulin-2 OS=Mus musculus GN=F   355.86 44 53
Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus GN=F   365.34 34 51
P20152|VIME_MOUSE Vimentin OS=Mus musculus GN=V   360.59 79 51
P35441|TSP1_MOUSE Thrombospondin-1 OS=Mus muscu    349.48 54 45
Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus GN=M   350.89 51 38
P56480|ATPB_MOUSE ATP synthase subunit beta, mitoch      314.42 75 28
P11087|CO1A1_MOUSE Collagen alpha-1(I) chain OS=Mus    282.08 47 26
Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mu     253.63 28 26
P16858|G3P_MOUSE Glyceraldehyde-3-phosphate dehyd      319.04 72 24
P19324|SERPH_MOUSE Serpin H1 OS=Mus musculus GN=   295.98 75 24
Q80YX1|TENA_MOUSE Tenascin OS=Mus musculus GN=T   307.73 27 22
P08113|ENPL_MOUSE Endoplasmin OS=Mus musculus G   275.18 49 21
P48036|ANXA5_MOUSE Annexin A5 OS=Mus musculus GN   246.52 45 20
P27773|PDIA3_MOUSE Protein disulfide-isomerase A3 OS=     240.13 59 20
P48678|LMNA_MOUSE Prelamin-A/C OS=Mus musculus G   202.89 41 19
P08249|MDHM_MOUSE Malate dehydrogenase, mitochondr      277.85 64 18
P20029|GRP78_MOUSE 78 kDa glucose-regulated protein O     258.38 48 18
Q60932|VDAC1_MOUSE Voltage-dependent anion-selective        245.44 61 18
P09103|PDIA1_MOUSE Protein disulfide-isomerase OS=Mu     242.36 55 18
P62806|H4_MOUSE Histone H4 OS=Mus musculus GN   214.42 54 18
Q99K41|EMIL1_MOUSE EMILIN-1 OS=Mus musculus GN=   267.68 48 17
P10107|ANXA1_MOUSE Annexin A1 OS=Mus musculus GN   248.47 62 17
Q68FD5|CLH_MOUSE Clathrin heavy chain 1 OS=Mus mu    215.3 36 17
Q61879|MYH10_MOUSE Myosin-10 OS=Mus musculus GN=   276.25 42 16
P07356|ANXA2_MOUSE Annexin A2 OS=Mus musculus GN   267.91 65 16
P10126|EF1A1_MOUSE Elongation factor 1-alpha 1 OS=Mu     231.29 49 16
Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain      198.4 26 16
P01027|CO3_MOUSE Complement C3 OS=Mus musculu    191.3 29 16
Q99LC5|ETFA_MOUSE Electron transfer flavoprotein subun        254.74 57 15
P67778|PHB_MOUSE Prohibitin OS=Mus musculus GN=P   243.64 79 15
Q99JR5|TINAL_MOUSE Tubulointerstitial nephritis antigen-l      242 47 15
P17742|PPIA_MOUSE Peptidyl-prolyl cis-trans isomerase      233.89 59 15
P19783|COX41_MOUSE Cytochrome c oxidase subunit 4 iso        227.74 47 15
Q01149|CO1A2_MOUSE Collagen alpha-2(I) chain OS=Mus    223.78 39 15
Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus GN=   203.11 22 15
O35129|PHB2_MOUSE Prohibitin-2 OS=Mus musculus GN   224.33 67 14
Q9WTI7|MYO1C_MOUSE Myosin-Ic OS=Mus musculus GN=   210.49 41 14
P52480|KPYM_MOUSE Pyruvate kinase isozymes M1/M2 O     188.48 56 14
Q9QXS1|PLEC_MOUSE Plectin OS=Mus musculus GN=Ple   172.22 25 14
O88322|NID2_MOUSE Nidogen-2 OS=Mus musculus GN=   248.24 20 13
Q9DCN2|NB5R3_MOUSE NADH-cytochrome b5 reductase 3     245.19 52 13
Q9DBJ1|PGAM1_MOUSE Phosphoglycerate mutase 1 OS=M     227.39 68 13
Q9DCX2|ATP5H_MOUSE ATP synthase subunit d, mitochond      224.83 76 13
P07724|ALBU_MOUSE Serum albumin OS=Mus musculus   188.34 34 13
Q03265|ATPA_MOUSE ATP synthase subunit alpha, mitoc      247.63 56 12
P22777|PAI1_MOUSE Plasminogen activator inhibitor 1 O     233.08 64 12
Q8BMK4|CKAP4_MOUSE Cytoskeleton-associated protein 4 O     227.44 45 12
P06151|LDHA_MOUSE L-lactate dehydrogenase A chain O     222.32 49 12
P09055|ITB1_MOUSE Integrin beta-1 OS=Mus musculus   221.29 30 12
O88207|CO5A1_MOUSE Collagen alpha-1(V) chain OS=Mus    184.56 35 12
P37804|TAGL_MOUSE Transgelin OS=Mus musculus GN=   181.07 76 12
P63038|CH60_MOUSE 60 kDa heat shock protein, mitocho      243.31 53 11
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P51655|GPC4_MOUSE Glypican-4 OS=Mus musculus GN=   218.62 40 11
P17182|ENOA_MOUSE Alpha-enolase OS=Mus musculus   207.07 59 11
P26039|TLN1_MOUSE Talin-1 OS=Mus musculus GN=Tln   198.41 30 11
P17751|TPIS_MOUSE Triosephosphate isomerase OS=M     196.62 53 11
Q8CG19|LTBP1_MOUSE Latent-transforming growth factor b        185.33 17 11
Q8BMS1|ECHA_MOUSE Trifunctional enzyme subunit alpha       212.35 39 10
P35564|CALX_MOUSE Calnexin OS=Mus musculus GN=C   205.29 42 10
Q80X90|FLNB_MOUSE Filamin-B OS=Mus musculus GN=   180.59 24 10
P35700|PRDX1_MOUSE Peroxiredoxin-1 OS=Mus musculus   142.73 57 10
P01942|HBA_MOUSE Hemoglobin subunit alpha OS=Mus    127.01 70 10
Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musc    228.51 41 9
P16045|LEG1_MOUSE Galectin-1 OS=Mus musculus GN=   200.58 65 9
Q61703|ITIH2_MOUSE Inter-alpha-trypsin inhibitor heavy c       193.6 22 9
P14069|S10A6_MOUSE Protein S100-A6 OS=Mus musculu    184.59 75 9
P38647|GRP75_MOUSE Stress-70 protein, mitochondrial OS     173.67 33 9
Q9D1D4|TMEDA_MOUSE Transmembrane emp24 domain-co        163.9 34 9
P63017|HSP7C_MOUSE Heat shock cognate 71 kDa protein     216.39 36 8
P62962|PROF1_MOUSE Profilin-1 OS=Mus musculus GN=P   184.52 64 8
P58252|EF2_MOUSE Elongation factor 2 OS=Mus muscu    179.44 31 8
O08756|HCD2_MOUSE 3-hydroxyacyl-CoA dehydrogenase      174.7 52 8
P49817|CAV1_MOUSE Caveolin-1 OS=Mus musculus GN=   173.56 56 8
P42208|SEPT2_MOUSE Septin-2 OS=Mus musculus GN=S   173.24 43 8
P99029|PRDX5_MOUSE Peroxiredoxin-5, mitochondrial OS=     168.5 51 8
P05064|ALDOA_MOUSE Fructose-bisphosphate aldolase A     160.07 38 8
P08121|CO3A1_MOUSE Collagen alpha-1(III) chain OS=Mu     159.6 20 8
P24369|PPIB_MOUSE Peptidyl-prolyl cis-trans isomerase      156.06 61 8
P32261|ANT3_MOUSE Antithrombin-III OS=Mus musculus   155.97 40 8
Q60605|MYL6_MOUSE Myosin light polypeptide 6 OS=Mus    197.87 74 7
P61982|1433G_MOUSE 14-3-3 protein gamma OS=Mus mu    197.21 48 7
P48962|ADT1_MOUSE ADP/ATP translocase 1 OS=Mus m    195.35 53 7
P63101|1433Z_MOUSE 14-3-3 protein zeta/delta OS=Mus m    187.73 45 7
P62259|1433E_MOUSE 14-3-3 protein epsilon OS=Mus mu    186.09 49 7
Q02257|PLAK_MOUSE Junction plakoglobin OS=Mus mus    182.94 36 7
Q9DB77|QCR2_MOUSE Cytochrome b-c1 complex subunit       181.77 34 7
Q62009|POSTN_MOUSE Periostin OS=Mus musculus GN=P   169.26 33 7
Q9DBG6|RPN2_MOUSE Dolichyl-diphosphooligosaccharide-         167.93 18 7
Q99P72|RTN4_MOUSE Reticulon-4 OS=Mus musculus GN   162.74 12 7
Q3V1M1|IGS10_MOUSE Immunoglobulin superfamily memb       160.41 22 7
Q64433|CH10_MOUSE 10 kDa heat shock protein, mitocho      158.56 53 7
P14211|CALR_MOUSE Calreticulin OS=Mus musculus GN   156.64 41 7
P47738|ALDH2_MOUSE Aldehyde dehydrogenase, mitocho      152.71 28 7
Q9CPT4|CS010_MOUSE UPF0556 protein C19orf10 homolo      151.83 50 7
P01831|THY1_MOUSE Thy-1 membrane glycoprotein OS=     150.21 32 7
P30999|CTND1_MOUSE Catenin delta-1 OS=Mus musculus   132.85 34 7
Q00623|APOA1_MOUSE Apolipoprotein A-I OS=Mus muscu    111.33 14 7
P29699|FETUA_MOUSE Alpha-2-HS-glycoprotein OS=Mus m    93.03 12 7
P99024|TBB5_MOUSE Tubulin beta-5 chain OS=Mus mus    300.34 70 6
Q922R8|PDIA6_MOUSE Protein disulfide-isomerase A6 OS=     177.82 28 6
P14206|RSSA_MOUSE 40S ribosomal protein SA OS=Mus    172.96 37 6
O54724|PTRF_MOUSE Polymerase I and transcript release      165.27 41 6
Q9CQ60|6PGL_MOUSE 6-phosphogluconolactonase OS=M     163.4 58 6
Q9D6R2|IDH3A_MOUSE Isocitrate dehydrogenase [NAD] su        162.7 32 6
P16546|SPTA2_MOUSE Spectrin alpha chain, brain OS=Mu     154.23 30 6
Q64523|H2A2C_MOUSE Histone H2A type 2-C OS=Mus mu    153.48 63 6
Q6GSS7|H2A2A_MOUSE Histone H2A type 2-A OS=Mus mu    153.48 62 6
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P18760|COF1_MOUSE Cofilin-1 OS=Mus musculus GN=C   149.72 51 6
P19221|THRB_MOUSE Prothrombin OS=Mus musculus GN   142.61 23 6
Q3U7R1|ESYT1_MOUSE Extended synaptotagmin-1 OS=Mu     142.07 21 6
Q99JB2|STML2_MOUSE Stomatin-like protein 2 OS=Mus mu    140.46 36 6
P51150|RAB7A_MOUSE Ras-related protein Rab-7a OS=Mu     140.24 36 6
Q61704|ITIH3_MOUSE Inter-alpha-trypsin inhibitor heavy c       134.96 7 6
Q6GQT1|A2MP_MOUSE Alpha-2-macroglobulin-P OS=Mus    133.24 10 6
Q9R0Q3|TMED2_MOUSE Transmembrane emp24 domain-co        120.8 43 6
Q9Z0G4|WISP2_MOUSE WNT1-inducible-signaling pathway       95.85 14 6
Q7TPR4|ACTN1_MOUSE Alpha-actinin-1 OS=Mus musculus   209.95 29 5
Q9CPQ3|TOM22_MOUSE Mitochondrial import receptor subu        162.06 73 5
Q64449|MRC2_MOUSE C-type mannose receptor 2 OS=Mu     161.05 28 5
P97429|ANXA4_MOUSE Annexin A4 OS=Mus musculus GN   160.41 25 5
Q9D051|ODPB_MOUSE Pyruvate dehydrogenase E1 compo         158.08 31 5
Q6IRU2|TPM4_MOUSE Tropomyosin alpha-4 chain OS=Mu     152.53 35 5
Q9WV54|ASAH1_MOUSE Acid ceramidase OS=Mus musculu    151.8 36 5
Q9CQQ7|AT5F1_MOUSE ATP synthase subunit b, mitochond      151.39 42 5
Q9CPQ8|ATP5L_MOUSE ATP synthase subunit g, mitochond      148.8 43 5
Q9DB20|ATPO_MOUSE ATP synthase subunit O, mitochon      145.36 55 5
Q9DCS9|NDUBA_MOUSE NADH dehydrogenase [ubiquinone           144.59 40 5
Q91V41|RAB14_MOUSE Ras-related protein Rab-14 OS=Mu     144.13 34 5
P63242|IF5A1_MOUSE Eukaryotic translation initiation facto       141.88 52 5
Q8QZT1|THIL_MOUSE Acetyl-CoA acetyltransferase, mitoc      139.92 25 5
P12787|COX5A_MOUSE Cytochrome c oxidase subunit 5A,      137.05 52 5
Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=     134.64 50 5
P62908|RS3_MOUSE 40S ribosomal protein S3 OS=Mus    134.44 25 5
P08207|S10AA_MOUSE Protein S100-A10 OS=Mus muscu    132.92 49 5
P16460|ASSY_MOUSE Argininosuccinate synthase OS=Mu     132.88 32 5
P62492|RB11A_MOUSE Ras-related protein Rab-11A OS=M     132.84 26 5
P46638|RB11B_MOUSE Ras-related protein Rab-11B OS=M     132.84 26 5
P57776|EF1D_MOUSE Elongation factor 1-delta OS=Mus m    132.4 20 5
P14602|HSPB1_MOUSE Heat shock protein beta-1 OS=Mus    131.71 58 5
Q9DCW4|ETFB_MOUSE Electron transfer flavoprotein subun       130.32 26 5
P29758|OAT_MOUSE Ornithine aminotransferase, mitoch      127.65 28 5
Q08879|FBLN1_MOUSE Fibulin-1 OS=Mus musculus GN=F   126.94 7 5
P57759|ERP29_MOUSE Endoplasmic reticulum resident pro       126.22 30 5
Q3THE2|ML12B_MOUSE Myosin regulatory light chain 12B O     123.64 31 5
O08807|PRDX4_MOUSE Peroxiredoxin-4 OS=Mus musculus   120.68 36 5
P56395|CYB5_MOUSE Cytochrome b5 OS=Mus musculus   114.04 25 5
Q02248|CTNB1_MOUSE Catenin beta-1 OS=Mus musculus   113.49 17 5
O08709|PRDX6_MOUSE Peroxiredoxin-6 OS=Mus musculus   113.38 33 5
P01029|CO4B_MOUSE Complement C4-B OS=Mus muscu    109.12 23 5
P11688|ITA5_MOUSE Integrin alpha-5 OS=Mus musculus   108.93 5 5
Q8VDP6|CDIPT_MOUSE CDP-diacylglycerol--inositol 3-phos      107.11 26 5
P62301|RS13_MOUSE 40S ribosomal protein S13 OS=Mu     101.37 32 5
Q922F4|TBB6_MOUSE Tubulin beta-6 chain OS=Mus mus    247.93 55 4
P57780|ACTN4_MOUSE Alpha-actinin-4 OS=Mus musculus   193 30 4
O08638|MYH11_MOUSE Myosin-11 OS=Mus musculus GN=   182.1 37 4
P97298|PEDF_MOUSE Pigment epithelium-derived factor O     161.86 29 4
P00405|COX2_MOUSE Cytochrome c oxidase subunit 2 OS     160.13 33 4
P05202|AATM_MOUSE Aspartate aminotransferase, mitoch      157.02 47 4
Q9R001|ATS5_MOUSE A disintegrin and metalloproteinase         155.55 22 4
P68254|1433T_MOUSE 14-3-3 protein theta OS=Mus musc    153.89 38 4
Q64727|VINC_MOUSE Vinculin OS=Mus musculus GN=Vc   148.88 39 4
Q9JKR6|HYOU1_MOUSE Hypoxia up-regulated protein 1 OS     147.92 24 4
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P09411|PGK1_MOUSE Phosphoglycerate kinase 1 OS=Mu     146.68 35 4
P53994|RAB2A_MOUSE Ras-related protein Rab-2A OS=Mu     145.57 42 4
Q9WVA4|TAGL2_MOUSE Transgelin-2 OS=Mus musculus G   145.29 31 4
Q62186|SSRD_MOUSE Translocon-associated protein subu       142.72 45 4
P34884|MIF_MOUSE Macrophage migration inhibitory fac      141.34 46 4
Q6URW6|MYH14_MOUSE Myosin-14 OS=Mus musculus GN=   141.17 24 4
O35639|ANXA3_MOUSE Annexin A3 OS=Mus musculus GN   138.36 36 4
Q8CGP2|H2B1P_MOUSE Histone H2B type 1-P OS=Mus mu    136.6 46 4
Q64475|H2B1B_MOUSE Histone H2B type 1-B OS=Mus mu    136.6 37 4
Q6ZWY9|H2B1C_MOUSE Histone H2B type 1-C/E/G OS=Mus    136.6 37 4
P10853|H2B1F_MOUSE Histone H2B type 1-F/J/L OS=Mus    136.6 37 4
Q64478|H2B1H_MOUSE Histone H2B type 1-H OS=Mus mu    136.6 37 4
Q8CGP1|H2B1K_MOUSE Histone H2B type 1-K OS=Mus mu    136.6 37 4
P10854|H2B1M_MOUSE Histone H2B type 1-M OS=Mus mu    136.6 37 4
Q64525|H2B2B_MOUSE Histone H2B type 2-B OS=Mus mu    136.6 37 4
P07214|SPRC_MOUSE SPARC OS=Mus musculus GN=Sp   135.04 24 4
P43406|ITAV_MOUSE Integrin alpha-V OS=Mus musculus   132.86 14 4
Q61171|PRDX2_MOUSE Peroxiredoxin-2 OS=Mus musculus   129.18 27 4
Q64310|SURF4_MOUSE Surfeit locus protein 4 OS=Mus mu    127.56 22 4
Q9DBL1|ACDSB_MOUSE Short/branched chain specific acyl-        127.15 47 4
Q9DCT2|NDUS3_MOUSE NADH dehydrogenase [ubiquinone          125.81 13 4
Q9CXE7|TMED5_MOUSE Transmembrane emp24 domain-co        124.12 21 4
O08992|SDCB1_MOUSE Syntenin-1 OS=Mus musculus GN=   124.04 27 4
P97315|CSRP1_MOUSE Cysteine and glycine-rich protein 1     123.53 46 4
P14148|RL7_MOUSE 60S ribosomal protein L7 OS=Mus    117.96 31 4
Q9D6U8|F162A_MOUSE Protein FAM162A OS=Mus muscu    117.11 51 4
P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus   115.44 22 4
P0CG49|UBB_MOUSE Polyubiquitin-B OS=Mus musculus   115.44 40 4
P62983|RS27A_MOUSE Ubiquitin-40S ribosomal protein S2      115.44 37 4
P62984|RL40_MOUSE Ubiquitin-60S ribosomal protein L40     115.44 27 4
Q99JI6|RAP1B_MOUSE Ras-related protein Rap-1b OS=Mu     114.9 34 4
P62835|RAP1A_MOUSE Ras-related protein Rap-1A OS=Mu     114.9 26 4
O54962|BAF_MOUSE Barrier-to-autointegration factor OS     111.12 55 4
P10605|CATB_MOUSE Cathepsin B OS=Mus musculus GN   111.07 30 4
Q9D2G2|ODO2_MOUSE Dihydrolipoyllysine-residue succiny            110.35 35 4
Q9CZU6|CISY_MOUSE Citrate synthase, mitochondrial OS     108.32 21 4
Q8BH95|ECHM_MOUSE Enoyl-CoA hydratase, mitochondria      106.09 20 4
Q9WTP7|KAD3_MOUSE GTP:AMP phosphotransferase, mit      105.03 21 4
P15532|NDKA_MOUSE Nucleoside diphosphate kinase A O     104.98 43 4
Q9CQ92|FIS1_MOUSE Mitochondrial fission 1 protein OS=     103.52 39 4
P56135|ATPK_MOUSE ATP synthase subunit f, mitochond      103.42 36 4
O88783|FA5_MOUSE Coagulation factor V OS=Mus mus    102.44 10 4
Q60715|P4HA1_MOUSE Prolyl 4-hydroxylase subunit alpha-      101.08 16 4
Q9CRB9|CHCH3_MOUSE Coiled-coil-helix-coiled-coil-helix do         99.03 33 4
Q9R0P5|DEST_MOUSE Destrin OS=Mus musculus GN=Ds   97.52 29 4
Q99PT1|GDIR1_MOUSE Rho GDP-dissociation inhibitor 1 O     93.01 28 4
Q7TMF3|NDUAC_MOUSE NADH dehydrogenase [ubiquinone           88.86 28 4
Q07235|GDN_MOUSE Glia-derived nexin OS=Mus muscu    86.54 22 4
O09131|GSTO1_MOUSE Glutathione S-transferase omega-1     74.84 26 4
P51863|VA0D1_MOUSE V-type proton ATPase subunit d 1 O     72.57 13 4
Q8BFZ3|ACTBL_MOUSE Beta-actin-like protein 2 OS=Mus m    276.89 69 3
P62874|GBB1_MOUSE Guanine nucleotide-binding protein        174.49 34 3
Q9CQV8|1433B_MOUSE 14-3-3 protein beta/alpha OS=Mus    155.48 30 3
P62821|RAB1A_MOUSE Ras-related protein Rab-1A OS=Mu     146.8 59 3
P84084|ARF5_MOUSE ADP-ribosylation factor 5 OS=Mus    146.56 71 3
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Q9JKF1|IQGA1_MOUSE Ras GTPase-activating-like protein      135.47 23 3
P19157|GSTP1_MOUSE Glutathione S-transferase P 1 OS=     134.43 38 3
P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus GN=   132.54 19 3
P50543|S10AB_MOUSE Protein S100-A11 OS=Mus muscu    131.95 78 3
Q60930|VDAC2_MOUSE Voltage-dependent anion-selective        130.73 18 3
Q8VDN2|AT1A1_MOUSE Sodium/potassium-transporting AT        128.81 28 3
P62880|GBB2_MOUSE Guanine nucleotide-binding protein        127.98 29 3
Q08093|CNN2_MOUSE Calponin-2 OS=Mus musculus GN=   126.29 18 3
P68510|1433F_MOUSE 14-3-3 protein eta OS=Mus muscu    123.73 53 3
P61620|S61A1_MOUSE Protein transport protein Sec61 sub         122.41 23 3
Q9CYN9|RENR_MOUSE Renin receptor OS=Mus musculus   121.99 19 3
Q8BMF4|ODP2_MOUSE Dihydrolipoyllysine-residue acetyltra            119.27 15 3
Q9CXD9|LRC17_MOUSE Leucine-rich repeat-containing prot       118.67 19 3
Q9WVJ2|PSD13_MOUSE 26S proteasome non-ATPase regu        117.63 32 3
Q8VEM8|MPCP_MOUSE Phosphate carrier protein, mitochon      117.42 21 3
P19096|FAS_MOUSE Fatty acid synthase OS=Mus musc    116.59 10 3
O54734|OST48_MOUSE Dolichyl-diphosphooligosaccharide-          116.1 13 3
P27090|TGFB2_MOUSE Transforming growth factor beta-2     115.87 14 3
P61027|RAB10_MOUSE Ras-related protein Rab-10 OS=Mu     115.87 32 3
P17225|PTBP1_MOUSE Polypyrimidine tract-binding protein      114.52 17 3
P25444|RS2_MOUSE 40S ribosomal protein S2 OS=Mus    114.32 18 3
Q01730|RSU1_MOUSE Ras suppressor protein 1 OS=Mus    114.21 43 3
P10833|RRAS_MOUSE Ras-related protein R-Ras OS=Mus    113.73 30 3
P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus m    113.34 14 3
Q0GNC1|INF2_MOUSE Inverted formin-2 OS=Mus musculu    112.8 15 3
Q9R087|GPC6_MOUSE Glypican-6 OS=Mus musculus GN=   112.77 24 3
Q9CQ22|LTOR1_MOUSE Ragulator complex protein LAMTO      111.96 35 3
P60867|RS20_MOUSE 40S ribosomal protein S20 OS=Mu     111.21 23 3
Q923D2|BLVRB_MOUSE Flavin reductase OS=Mus musculu    110.61 23 3
P47911|RL6_MOUSE 60S ribosomal protein L6 OS=Mus    110.19 25 3
Q9Z1Q5|CLIC1_MOUSE Chloride intracellular channel prote       109.84 36 3
P20108|PRDX3_MOUSE Thioredoxin-dependent peroxide re       109.36 20 3
P19536|COX5B_MOUSE Cytochrome c oxidase subunit 5B,      109.24 30 3
P15626|GSTM2_MOUSE Glutathione S-transferase Mu 2 OS     108.99 43 3
P63323|RS12_MOUSE 40S ribosomal protein S12 OS=Mu     108.86 41 3
Q91YQ5|RPN1_MOUSE Dolichyl-diphosphooligosaccharide-         108.44 16 3
Q61469|LPP1_MOUSE Lipid phosphate phosphohydrolase      107.49 25 3
P14869|RLA0_MOUSE 60S acidic ribosomal protein P0 OS     107.32 21 3
Q9WU78|PDC6I_MOUSE Programmed cell death 6-interactin       106.72 24 3
P99028|QCR6_MOUSE Cytochrome b-c1 complex subunit       106.2 63 3
P63024|VAMP3_MOUSE Vesicle-associated membrane prot       106.02 46 3
P28653|PGS1_MOUSE Biglycan OS=Mus musculus GN=B   105.83 27 3
Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinas        104.74 19 3
P35279|RAB6A_MOUSE Ras-related protein Rab-6A OS=Mu     104.23 39 3
P35762|CD81_MOUSE CD81 antigen OS=Mus musculus G   104.22 29 3
Q62465|VAT1_MOUSE Synaptic vesicle membrane protein       103.84 15 3
Q8R2G6|CCD80_MOUSE Coiled-coil domain-containing prote       103.31 10 3
Q9CQH3|NDUB5_MOUSE NADH dehydrogenase [ubiquinone            102.14 15 3
P30412|PPIC_MOUSE Peptidyl-prolyl cis-trans isomerase      101.39 19 3
P14131|RS16_MOUSE 40S ribosomal protein S16 OS=Mu     99.66 27 3
P60843|IF4A1_MOUSE Eukaryotic initiation factor 4A-I OS=     99.53 18 3
P62827|RAN_MOUSE GTP-binding nuclear protein Ran O     98.85 16 3
P62270|RS18_MOUSE 40S ribosomal protein S18 OS=Mu     98.16 30 3
P09671|SODM_MOUSE Superoxide dismutase [Mn], mitoch      96.59 21 3
P62264|RS14_MOUSE 40S ribosomal protein S14 OS=Mu     95.11 17 3
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O70456|1433S_MOUSE 14-3-3 protein sigma OS=Mus mus    94.96 19 3
P62082|RS7_MOUSE 40S ribosomal protein S7 OS=Mus    94.49 26 3
P21614|VTDB_MOUSE Vitamin D-binding protein OS=Mus    92.81 21 3
P80317|TCPZ_MOUSE T-complex protein 1 subunit zeta O     92.62 16 3
Q9DAW9|CNN3_MOUSE Calponin-3 OS=Mus musculus GN=   91.81 23 3
P62702|RS4X_MOUSE 40S ribosomal protein S4, X isoform     91.05 15 3
P07091|S10A4_MOUSE Protein S100-A4 OS=Mus musculu    91.04 26 3
O55143|AT2A2_MOUSE Sarcoplasmic/endoplasmic reticulu         89.83 12 3
Q8K3J1|NDUS8_MOUSE NADH dehydrogenase [ubiquinone          88.76 15 3
Q9EP69|SAC1_MOUSE Phosphatidylinositide phosphatase      88.42 10 3
Q9R0P3|ESTD_MOUSE S-formylglutathione hydrolase OS=     85.32 19 3
P61622|ITA11_MOUSE Integrin alpha-11 OS=Mus musculu    85.14 14 3
Q9ERS2|NDUAD_MOUSE NADH dehydrogenase [ubiquinone           84.05 21 3
Q06185|ATP5I_MOUSE ATP synthase subunit e, mitochond      82.61 42 3
Q9QXS6|DREB_MOUSE Drebrin OS=Mus musculus GN=Db   81.93 10 3
Q9CQS8|SC61B_MOUSE Protein transport protein Sec61 sub       80.5 38 3
P97449|AMPN_MOUSE Aminopeptidase N OS=Mus muscu    80.24 6 3
Q8R5J9|PRAF3_MOUSE PRA1 family protein 3 OS=Mus mu    78.42 16 3
Q9QUI0|RHOA_MOUSE Transforming protein RhoA OS=Mu     78.31 33 3
Q99KF1|TMED9_MOUSE Transmembrane emp24 domain-co        77.07 16 3
Q8R2Q8|BST2_MOUSE Bone marrow stromal antigen 2 OS     74.79 12 3
P08228|SODC_MOUSE Superoxide dismutase [Cu-Zn] OS=     74.13 21 3
Q6PHZ2|KCC2D_MOUSE Calcium/calmodulin-dependent pro           72.44 14 3
Q9CQW9|IFM3_MOUSE Interferon-induced transmembrane       70.3 9 3
Q791V5|MTCH2_MOUSE Mitochondrial carrier homolog 2 OS     62 17 3
Q07456|AMBP_MOUSE Protein AMBP OS=Mus musculus G   57.51 6 3
Q8BFZ9|ERLN2_MOUSE Erlin-2 OS=Mus musculus GN=Erli   55.84 21 3
Q61838|A2M_MOUSE Alpha-2-macroglobulin OS=Mus m    53.7 20 3
P48722|HS74L_MOUSE Heat shock 70 kDa protein 4L OS=     45.77 5 3
A2ASS6|TITIN_MOUSE Titin OS=Mus musculus GN=Ttn P  40.13 3 3
P63260|ACTG_MOUSE Actin, cytoplasmic 2 OS=Mus musc    363.12 92 2
P62737|ACTA_MOUSE Actin, aortic smooth muscle OS=M     315.47 81 2
P63268|ACTH_MOUSE Actin, gamma-enteric smooth musc      315.47 81 2
Q7TMM9|TBB2A_MOUSE Tubulin beta-2A chain OS=Mus mu    280.71 63 2
P02088|HBB1_MOUSE Hemoglobin subunit beta-1 OS=Mu     177.89 50 2
P61750|ARF4_MOUSE ADP-ribosylation factor 4 OS=Mus    165.61 57 2
P51881|ADT2_MOUSE ADP/ATP translocase 2 OS=Mus m    163.06 35 2
P61205|ARF3_MOUSE ADP-ribosylation factor 3 OS=Mus    155.84 65 2
P84078|ARF1_MOUSE ADP-ribosylation factor 1 OS=Mus    155.84 60 2
P21107|TPM3_MOUSE Tropomyosin alpha-3 chain OS=Mu     148.08 33 2
P58771|TPM1_MOUSE Tropomyosin alpha-1 chain OS=Mu     146.22 36 2
P08752|GNAI2_MOUSE Guanine nucleotide-binding protein        136.24 33 2
P02104|HBE_MOUSE Hemoglobin subunit epsilon-Y2 OS     133.34 27 2
P84244|H33_MOUSE Histone H3.3 OS=Mus musculus G   130.48 54 2
Q03350|TSP2_MOUSE Thrombospondin-2 OS=Mus musc    128.66 23 2
P35278|RAB5C_MOUSE Ras-related protein Rab-5C OS=M     126.58 35 2
Q9D1G1|RAB1B_MOUSE Ras-related protein Rab-1B OS=Mu     122.28 49 2
O35459|ECH1_MOUSE Delta(3,5)-Delta(2,4)-dienoyl-CoA is       119.25 23 2
Q91V61|SFXN3_MOUSE Sideroflexin-3 OS=Mus musculus G   117.24 45 2
P61021|RAB5B_MOUSE Ras-related protein Rab-5B OS=Mu     114.26 22 2
Q01853|TERA_MOUSE Transitional endoplasmic reticulum      112.67 19 2
Q9JK53|PRELP_MOUSE Prolargin OS=Mus musculus GN=P   111.9 14 2
Q60931|VDAC3_MOUSE Voltage-dependent anion-selective        109.35 22 2
Q8BMD8|SCMC1_MOUSE Calcium-binding mitochondrial carr        105.08 16 2
P85094|ISC2A_MOUSE Isochorismatase domain-containing        104.94 31 2
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Q6ZQI3|MLEC_MOUSE Malectin OS=Mus musculus GN=M   103.42 22 2
P62830|RL23_MOUSE 60S ribosomal protein L23 OS=Mu     102.63 34 2
P39876|TIMP3_MOUSE Metalloproteinase inhibitor 3 OS=M     102.58 11 2
Q9CQM2|ERD22_MOUSE ER lumen protein retaining recepto       101.35 15 2
P68040|GBLP_MOUSE Guanine nucleotide-binding protein        101.13 20 2
P62196|PRS8_MOUSE 26S protease regulatory subunit 8 O     100.68 29 2
Q9CQ65|MTAP_MOUSE S-methyl-5'-thioadenosine phospho      98.09 13 2
Q9CQN1|TRAP1_MOUSE Heat shock protein 75 kDa, mitocho      97.72 10 2
Q9DB05|SNAA_MOUSE Alpha-soluble NSF attachment prot      97.66 14 2
O70251|EF1B_MOUSE Elongation factor 1-beta OS=Mus m    97.03 16 2
Q78IK2|USMG5_MOUSE Up-regulated during skeletal muscl         96.61 43 2
O08547|SC22B_MOUSE Vesicle-trafficking protein SEC22b     96.39 26 2
Q9DCJ5|NDUA8_MOUSE NADH dehydrogenase [ubiquinone           96.35 40 2
Q9CYR0|SSBP_MOUSE Single-stranded DNA-binding prote       95.48 18 2
O35640|ANXA8_MOUSE Annexin A8 OS=Mus musculus GN   95.41 18 2
O88456|CPNS1_MOUSE Calpain small subunit 1 OS=Mus m    94.89 30 2
O35682|MYADM_MOUSE Myeloid-associated differentiation m      94.64 10 2
Q9CR62|M2OM_MOUSE Mitochondrial 2-oxoglutarate/malate       94.6 11 2
P58022|LOXL2_MOUSE Lysyl oxidase homolog 2 OS=Mus    94.52 6 2
Q9CY50|SSRA_MOUSE Translocon-associated protein subu       93.99 20 2
Q9CXI5|MANF_MOUSE Mesencephalic astrocyte-derived n       93.77 36 2
Q62425|NDUA4_MOUSE NADH dehydrogenase [ubiquinone           93.05 27 2
Q9R118|HTRA1_MOUSE Serine protease HTRA1 OS=Mus m    93.04 9 2
Q61937|NPM_MOUSE Nucleophosmin OS=Mus musculus   92.11 32 2
P09535|IGF2_MOUSE Insulin-like growth factor II OS=Mus    91.89 23 2
Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenes        91.45 17 2
P27659|RL3_MOUSE 60S ribosomal protein L3 OS=Mus    90.38 14 2
Q9D8E6|RL4_MOUSE 60S ribosomal protein L4 OS=Mus    89.83 15 2
Q9QXT0|CNPY2_MOUSE Protein canopy homolog 2 OS=Mus    88.9 23 2
P13020|GELS_MOUSE Gelsolin OS=Mus musculus GN=G   88.48 18 2
P17710|HXK1_MOUSE Hexokinase-1 OS=Mus musculus G   88.14 6 2
Q8K482|EMIL2_MOUSE EMILIN-2 OS=Mus musculus GN=E   86.29 8 2
Q9D0S9|HINT2_MOUSE Histidine triad nucleotide-binding pr        86.18 31 2
P62245|RS15A_MOUSE 40S ribosomal protein S15a OS=M     86.18 34 2
P51174|ACADL_MOUSE Long-chain specific acyl-CoA dehyd       85.46 21 2
P62849|RS24_MOUSE 40S ribosomal protein S24 OS=Mu     84.93 20 2
Q99KV1|DJB11_MOUSE DnaJ homolog subfamily B membe       84.65 11 2
P62843|RS15_MOUSE 40S ribosomal protein S15 OS=Mu     83.57 15 2
Q91VR2|ATPG_MOUSE ATP synthase subunit gamma, mito      83.44 7 2
P06745|G6PI_MOUSE Glucose-6-phosphate isomerase O     83.39 9 2
Q8BIJ6|SYIM_MOUSE Isoleucyl-tRNA synthetase, mitocho      82.88 10 2
P67984|RL22_MOUSE 60S ribosomal protein L22 OS=Mu     82.75 27 2
P97807|FUMH_MOUSE Fumarate hydratase, mitochondrial     82.72 26 2
P36536|SAR1A_MOUSE GTP-binding protein SAR1a OS=M     82.69 16 2
Q9CQE8|CN166_MOUSE UPF0568 protein C14orf166 homol     82.45 19 2
Q8BG05|ROA3_MOUSE Heterogeneous nuclear ribonucleop       81.66 10 2
Q9CQA3|DHSB_MOUSE Succinate dehydrogenase [ubiquino         80.72 9 2
P61804|DAD1_MOUSE Dolichyl-diphosphooligosaccharide-         80.15 19 2
Q9CQZ6|NDUB3_MOUSE NADH dehydrogenase [ubiquinone           80.01 27 2
Q99KI0|ACON_MOUSE Aconitate hydratase, mitochondrial     79.04 10 2
Q921X9|PDIA5_MOUSE Protein disulfide-isomerase A5 OS=     78.78 16 2
Q64133|AOFA_MOUSE Amine oxidase [flavin-containing] A     78.48 10 2
Q99L13|3HIDH_MOUSE 3-hydroxyisobutyrate dehydrogenas       77.24 9 2
Q9CR68|UCRI_MOUSE Cytochrome b-c1 complex subunit       77.2 24 2
P29391|FRIL1_MOUSE Ferritin light chain 1 OS=Mus musc    76.87 21 2
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Q9CXW4|RL11_MOUSE 60S ribosomal protein L11 OS=Mu     76.66 15 2
Q9D8N0|EF1G_MOUSE Elongation factor 1-gamma OS=Mu     76.14 11 2
Q9JM76|ARPC3_MOUSE Actin-related protein 2/3 complex s       75.8 13 2
Q9CPP6|NDUA5_MOUSE NADH dehydrogenase [ubiquinone           75.54 25 2
Q9CQR4|ACO13_MOUSE Acyl-coenzyme A thioesterase 13 O     75.28 43 2
P10404|ENV1_MOUSE MLV-related proviral Env polyprotei     75.22 11 2
P11370|ENV2_MOUSE Retrovirus-related Env polyprotein f        75.22 2 2
P61022|CHP1_MOUSE Calcium-binding protein p22 OS=M     75.13 11 2
Q61207|SAP_MOUSE Sulfated glycoprotein 1 OS=Mus m    74.74 10 2
O88569|ROA2_MOUSE Heterogeneous nuclear ribonucleop       74.13 20 2
Q61702|ITIH1_MOUSE Inter-alpha-trypsin inhibitor heavy c       73.75 4 2
Q9Z2I9|SUCB1_MOUSE Succinyl-CoA ligase [ADP-forming]        72.79 12 2
P28301|LYOX_MOUSE Protein-lysine 6-oxidase OS=Mus m    72.7 8 2
P46935|NEDD4_MOUSE E3 ubiquitin-protein ligase NEDD4     72.13 9 2
Q8K4L4|POF1B_MOUSE Protein POF1B OS=Mus musculus   70.24 5 2
P23927|CRYAB_MOUSE Alpha-crystallin B chain OS=Mus m    70.2 18 2
Q8BKG3|PTK7_MOUSE Inactive tyrosine-protein kinase 7 O     68.51 5 2
Q9DAS9|GBG12_MOUSE Guanine nucleotide-binding protein        67.59 22 2
Q61425|HCDH_MOUSE Hydroxyacyl-coenzyme A dehydrog       67.29 14 2
P63085|MK01_MOUSE Mitogen-activated protein kinase 1     66.66 20 2
Q63844|MK03_MOUSE Mitogen-activated protein kinase 3     66.66 10 2
Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musc    65.7 4 2
O09111|NDUBB_MOUSE NADH dehydrogenase [ubiquinone            65.07 13 2
Q8R2Y8|PTH2_MOUSE Peptidyl-tRNA hydrolase 2, mitocho      64.81 20 2
Q60692|PSB6_MOUSE Proteasome subunit beta type-6 OS     64.69 9 2
P63001|RAC1_MOUSE Ras-related C3 botulinum toxin sub       64.06 20 2
Q9CZY3|UB2V1_MOUSE Ubiquitin-conjugating enzyme E2 va       63.86 35 2
Q9CPR4|RL17_MOUSE 60S ribosomal protein L17 OS=Mu     63.81 9 2
Q9CZD3|SYG_MOUSE Glycyl-tRNA synthetase OS=Mus m    63.72 6 2
Q3UIU2|NDUB6_MOUSE NADH dehydrogenase [ubiquinone           63.65 13 2
Q9CZW5|TOM70_MOUSE Mitochondrial import receptor subu       63.56 11 2
P12032|TIMP1_MOUSE Metalloproteinase inhibitor 1 OS=M     63.55 11 2
Q9JHR7|IDE_MOUSE Insulin-degrading enzyme OS=Mus    63.22 6 2
Q920A5|RISC_MOUSE Retinoid-inducible serine carboxype      62.58 11 2
P55002|MFAP2_MOUSE Microfibrillar-associated protein 2 O     61.8 9 2
P08905|LYZ2_MOUSE Lysozyme C-2 OS=Mus musculus   61.51 16 2
Q9D1M7|FKB11_MOUSE Peptidyl-prolyl cis-trans isomerase      61.33 10 2
Q9QUM9|PSA6_MOUSE Proteasome subunit alpha type-6 O     60.75 14 2
P47754|CAZA2_MOUSE F-actin-capping protein subunit alp      59.89 13 2
P59999|ARPC4_MOUSE Actin-related protein 2/3 complex s       59.63 18 2
P00493|HPRT_MOUSE Hypoxanthine-guanine phosphoribo      59.29 17 2
Q99M71|EPDR1_MOUSE Mammalian ependymin-related pro       58.98 9 2
Q61941|NNTM_MOUSE NAD(P) transhydrogenase, mitocho      54.41 4 2
Q9CZ13|QCR1_MOUSE Cytochrome b-c1 complex subunit       53.81 7 2
Q07813|BAX_MOUSE Apoptosis regulator BAX OS=Mus    52.34 12 2
O08999|LTBP2_MOUSE Latent-transforming growth factor b        50.49 4 2
Q9QZE5|COPG_MOUSE Coatomer subunit gamma OS=Mus    50.39 6 2
O35166|GOSR2_MOUSE Golgi SNAP receptor complex mem       44.67 13 2
Q04857|CO6A1_MOUSE Collagen alpha-1(VI) chain OS=Mu     44.59 6 2
Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mu     43.45 4 2
P62331|ARF6_MOUSE ADP-ribosylation factor 6 OS=Mus    40.97 21 2
Q62315|JARD2_MOUSE Protein Jumonji OS=Mus musculus   40.51 3 2
Q6GQT0|CC14A_MOUSE Dual specificity protein phosphatas       39.51 2 2
Q5GIG6|TNI3K_MOUSE Serine/threonine-protein kinase TN      38.89 4 2
P80315|TCPD_MOUSE T-complex protein 1 subunit delta O     38.75 10 2
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Q9CQE1|NPS3A_MOUSE Protein NipSnap homolog 3A OS=M     37.78 17 2
P28741|KIF3A_MOUSE Kinesin-like protein KIF3A OS=Mus    37.2 9 2
Q8BQM9|MD12L_MOUSE Mediator of RNA polymerase II tran         36.65 3 2
Q8R0P8|ABHD8_MOUSE Abhydrolase domain-containing pro       36.05 5 2
Q99LP6|GRPE1_MOUSE GrpE protein homolog 1, mitochond      35.76 9 2
Q9ET54|PALLD_MOUSE Palladin OS=Mus musculus GN=Pa   35.55 4 2
P26041|MOES_MOUSE Moesin OS=Mus musculus GN=Ms   34.74 7 2
Q9QYX7|PCLO_MOUSE Protein piccolo OS=Mus musculus   32.29 4 2
Q3V0M2|LRC36_MOUSE Leucine-rich repeat-containing prot       32.25 3 2
P49025|CTRO_MOUSE Citron Rho-interacting kinase OS=M     31.72 3 2
P97433|RGNEF_MOUSE Rho-guanine nucleotide exchange      31.29 3 2
Q8BV57|SRCRL_MOUSE Scavenger receptor cysteine-rich d        30.76 2 2
Q9JKY5|HIP1R_MOUSE Huntingtin-interacting protein 1-rela       30.61 3 2
Q8BXR9|OSBL6_MOUSE Oxysterol-binding protein-related pr       30.55 2 2
P58545|BTBD3_MOUSE BTB/POZ domain-containing protei       29.84 3 2
Q6A026|PDS5A_MOUSE Sister chromatid cohesion protein P        29.42 4 2
A2AAJ9|OBSCN_MOUSE Obscurin OS=Mus musculus GN=O   29 2 2
Q7TN37|TRPM4_MOUSE Transient receptor potential cation          29 5 2
Q99MZ6|MYO7B_MOUSE Myosin-VIIb OS=Mus musculus GN   28.07 9 2
Q9D0K0|TBCD7_MOUSE TBC1 domain family member 7 OS     27.8 4 2
Q8K4G1|LTBP4_MOUSE Latent-transforming growth factor b        27.49 2 2
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Table A1.8 Bridge ECM Protein Identifications.  List of all proteins identified in Bridge 
ECM with corresponding accession, description, PEAKS score, unique peptide 
numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens G   380.41 61 45
P01308|INS_HUMAN Insulin OS=Homo sapiens GN=INS P  246.91 55 11
P01008|ANT3_HUMAN Antithrombin-III OS=Homo sapiens G   203.89 42 10
P02753|RET4_HUMAN Retinol-binding protein 4 OS=Homo    242.54 42 7
P02774|VTDB_HUMAN Vitamin D-binding protein OS=Homo    240.19 40 7
P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapien    186.29 39 4
Q16270|IBP7_HUMAN Insulin-like growth factor-binding pro       158.22 38 4
P05121|PAI1_HUMAN Plasminogen activator inhibitor 1 OS     156.04 33 4
P02751|FINC_HUMAN Fibronectin OS=Homo sapiens GN=   154.81 14 4
Q15582|BGH3_HUMAN Transforming growth factor-beta-indu        153.91 27 4
P61769|B2MG_HUMAN Beta-2-microglobulin OS=Homo sap    139.26 59 4
P09486|SPRC_HUMAN SPARC OS=Homo sapiens GN=SPA   180.39 41 3
P01024|CO3_HUMAN Complement C3 OS=Homo sapiens   162.77 16 3
P69905|HBA_HUMAN Hemoglobin subunit alpha OS=Homo    159.17 53 3
P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapie    151.78 20 3
P08697|A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapie    145.85 21 3
P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapie    138.57 25 3
Q15063|POSTN_HUMAN Periostin OS=Homo sapiens GN=PO   127.09 23 3
P01861|IGHG4_HUMAN Ig gamma-4 chain C region OS=Hom     105.87 25 3
P01859|IGHG2_HUMAN Ig gamma-2 chain C region OS=Hom     105.87 27 3
P01857|IGHG1_HUMAN Ig gamma-1 chain C region OS=Hom     105.87 28 3
P0C0L4|CO4A_HUMAN Complement C4-A OS=Homo sapien    126.79 17 2
P0C0L5|CO4B_HUMAN Complement C4-B OS=Homo sapien    126.79 17 2
P05546|HEP2_HUMAN Heparin cofactor 2 OS=Homo sapien    95.37 2 2
Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase      44.58 8 2
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Table A1.9 H9 hESC CMTX Protein Identifications.  List of all proteins identified in 
CMTX from H9 hESCs with corresponding accession, description, PEAKS score, 
unique peptide numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
P18206|VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL PE  336.02 71 46
P49327|FAS_HUMAN Fatty acid synthase OS=Homo sapiens G   335.58 49 39
P55072|TERA_HUMAN Transitional endoplasmic reticulum ATPa      309.23 62 34
P04406|G3P_HUMAN Glyceraldehyde-3-phosphate dehydrogen      363.29 78 32
Q13813|SPTA2_HUMAN Spectrin alpha chain, brain OS=Homo sa    310.79 58 32
P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA  302.94 40 32
P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=   308.11 90 28
P62258|1433E_HUMAN 14-3-3 protein epsilon OS=Homo sapiens   320.22 72 26
P35579|MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9  300.44 56 25
P14625|ENPL_HUMAN Endoplasmin OS=Homo sapiens GN=HS   284.56 64 24
P13639|EF2_HUMAN Elongation factor 2 OS=Homo sapiens G   274.58 61 24
P53396|ACLY_HUMAN ATP-citrate synthase OS=Homo sapiens   293.82 59 23
P07900|HS90A_HUMAN Heat shock protein HSP 90-alpha OS=Ho     389.97 83 22
P07195|LDHB_HUMAN L-lactate dehydrogenase B chain OS=Ho     303.38 72 21
P08670|VIME_HUMAN Vimentin OS=Homo sapiens GN=VIM PE  265.5 66 21
P14618|KPYM_HUMAN Pyruvate kinase isozymes M1/M2 OS=Ho     290.21 81 20
P04075|ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=H     262.37 69 20
P08238|HS90B_HUMAN Heat shock protein HSP 90-beta OS=Ho     413.63 89 19
O75874|IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytopla      321.85 75 19
P30041|PRDX6_HUMAN Peroxiredoxin-6 OS=Homo sapiens GN=   245.25 76 19
P63104|1433Z_HUMAN 14-3-3 protein zeta/delta OS=Homo sapie    304.18 84 18
P00338|LDHA_HUMAN L-lactate dehydrogenase A chain OS=Ho     289.55 58 18
P13010|XRCC5_HUMAN X-ray repair cross-complementing protein      251.16 66 18
P23142|FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN=FBLN1  246.74 42 18
P62805|H4_HUMAN Histone H4 OS=Homo sapiens GN=HIST   236.13 58 18
P68104|EF1A1_HUMAN Elongation factor 1-alpha 1 OS=Homo sa    301.38 64 17
Q5VTE0|EF1A3_HUMAN Putative elongation factor 1-alpha-like 3 O     301.38 62 17
P50454|SERPH_HUMAN Serpin H1 OS=Homo sapiens GN=SERP   284.9 79 17
P07355|ANXA2_HUMAN Annexin A2 OS=Homo sapiens GN=ANX   282.38 75 17
P06733|ENOA_HUMAN Alpha-enolase OS=Homo sapiens GN=E   271.08 71 17
P08758|ANXA5_HUMAN Annexin A5 OS=Homo sapiens GN=ANX   267.87 71 17
Q9HB71|CYBP_HUMAN Calcyclin-binding protein OS=Homo sapie    247.66 80 17
P35580|MYH10_HUMAN Myosin-10 OS=Homo sapiens GN=MYH1   291.87 55 16
P62195|PRS8_HUMAN 26S protease regulatory subunit 8 OS=H     268.24 71 16
P29401|TKT_HUMAN Transketolase OS=Homo sapiens GN=T   267.48 58 16
Q01995|TAGL_HUMAN Transgelin OS=Homo sapiens GN=TAGL   255.39 91 16
O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB  249.62 37 16
P61247|RS3A_HUMAN 40S ribosomal protein S3a OS=Homo sa    247.05 65 16
P12956|XRCC6_HUMAN X-ray repair cross-complementing protein      241.39 58 16
Q99623|PHB2_HUMAN Prohibitin-2 OS=Homo sapiens GN=PHB   236.99 66 16
P63261|ACTG_HUMAN Actin, cytoplasmic 2 OS=Homo sapiens G   411.37 89 15
P12814|ACTN1_HUMAN Alpha-actinin-1 OS=Homo sapiens GN=A   288.91 71 15
P19338|NUCL_HUMAN Nucleolin OS=Homo sapiens GN=NCL P  283.04 74 15
P22314|UBA1_HUMAN Ubiquitin-like modifier-activating enzyme      275.66 50 15
P11021|GRP78_HUMAN 78 kDa glucose-regulated protein OS=Ho     263.96 54 15
P05455|LA_HUMAN Lupus La protein OS=Homo sapiens GN   262.72 65 14
Q01105|SET_HUMAN Protein SET OS=Homo sapiens GN=SET  253.98 53 14
P49321|NASP_HUMAN Nuclear autoantigenic sperm protein OS=     238.83 57 14
P31939|PUR9_HUMAN Bifunctional purine biosynthesis protein P      227.41 52 14
Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens   224.22 34 14
P46777|RL5_HUMAN 60S ribosomal protein L5 OS=Homo sap    216.48 56 14
P60174|TPIS_HUMAN Triosephosphate isomerase OS=Homo s    247.24 68 13
P62424|RL7A_HUMAN 60S ribosomal protein L7a OS=Homo sa    245.96 73 13
P28074|PSB5_HUMAN Proteasome subunit beta type-5 OS=Hom     239.92 48 13
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P62937|PPIA_HUMAN Peptidyl-prolyl cis-trans isomerase A OS=     238.61 74 13
P23396|RS3_HUMAN 40S ribosomal protein S3 OS=Homo sap    214.29 71 13
Q14697|GANAB_HUMAN Neutral alpha-glucosidase AB OS=Homo    194.72 37 13
P29692|EF1D_HUMAN Elongation factor 1-delta OS=Homo sapie    191.68 63 13
P11142|HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=     285.01 63 12
P12268|IMDH2_HUMAN Inosine-5'-monophosphate dehydrogenas       248.93 62 12
P15311|EZRI_HUMAN Ezrin OS=Homo sapiens GN=EZR PE=1 242.92 65 12
Q15008|PSMD6_HUMAN 26S proteasome non-ATPase regulatory       225.22 59 12
P62906|RL10A_HUMAN 60S ribosomal protein L10a OS=Homo s    220.28 51 12
Q01518|CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS     219.12 64 12
P10909|CLUS_HUMAN Clusterin OS=Homo sapiens GN=CLU P  218.1 47 12
P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS     211.9 45 12
P78371|TCPB_HUMAN T-complex protein 1 subunit beta OS=Ho     206.5 63 12
P50990|TCPQ_HUMAN T-complex protein 1 subunit theta OS=Ho     197.99 61 12
P62269|RS18_HUMAN 40S ribosomal protein S18 OS=Homo sa    180.58 65 12
Q9BWD1|THIC_HUMAN Acetyl-CoA acetyltransferase, cytosolic O     171.83 57 12
O14818|PSA7_HUMAN Proteasome subunit alpha type-7 OS=Ho     283.39 78 11
P51665|PSD7_HUMAN 26S proteasome non-ATPase regulatory       262.72 63 11
P34932|HSP74_HUMAN Heat shock 70 kDa protein 4 OS=Homo s    258.03 61 11
P05067|A4_HUMAN Amyloid beta A4 protein OS=Homo sapie    245.23 42 11
P06748|NPM_HUMAN Nucleophosmin OS=Homo sapiens GN=   244.29 58 11
Q9BT78|CSN4_HUMAN COP9 signalosome complex subunit 4 O     228.48 65 11
Q15019|SEPT2_HUMAN Septin-2 OS=Homo sapiens GN=SEPT2  227.76 68 11
P62277|RS13_HUMAN 40S ribosomal protein S13 OS=Homo sa    210.38 60 11
O00231|PSD11_HUMAN 26S proteasome non-ATPase regulatory       208.69 45 11
P33993|MCM7_HUMAN DNA replication licensing factor MCM7 O     197.51 53 11
Q14152|EIF3A_HUMAN Eukaryotic translation initiation factor 3 su       193.07 29 11
P31948|STIP1_HUMAN Stress-induced-phosphoprotein 1 OS=Ho     189.36 47 11
Q01082|SPTB2_HUMAN Spectrin beta chain, brain 1 OS=Homo sa    187.11 24 11
P30101|PDIA3_HUMAN Protein disulfide-isomerase A3 OS=Hom     187.11 44 11
O43175|SERA_HUMAN D-3-phosphoglycerate dehydrogenase O     226.38 46 10
P08865|RSSA_HUMAN 40S ribosomal protein SA OS=Homo sap    217.03 50 10
P62333|PRS10_HUMAN 26S protease regulatory subunit 10B OS=     204.95 63 10
P35998|PRS7_HUMAN 26S protease regulatory subunit 7 OS=H     193.65 49 10
P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, dec      183.14 45 10
P05388|RLA0_HUMAN 60S acidic ribosomal protein P0 OS=Hom     177.82 48 10
P49368|TCPG_HUMAN T-complex protein 1 subunit gamma OS=     158.53 31 10
P61254|RL26_HUMAN 60S ribosomal protein L26 OS=Homo sa    145.76 63 10
P07437|TBB5_HUMAN Tubulin beta chain OS=Homo sapiens G   349.97 77 9
P09211|GSTP1_HUMAN Glutathione S-transferase P OS=Homo s    238.92 68 9
P27348|1433T_HUMAN 14-3-3 protein theta OS=Homo sapiens G   231.58 77 9
P61978|HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein      228.4 68 9
Q04917|1433F_HUMAN 14-3-3 protein eta OS=Homo sapiens GN   220.77 63 9
Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens GN=TLN1 PE  212.9 47 9
P04792|HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sap    205.19 68 9
P62826|RAN_HUMAN GTP-binding nuclear protein Ran OS=Ho     205.06 54 9
Q9H9Z2|LN28A_HUMAN Protein lin-28 homolog A OS=Homo sapi    202.17 54 9
Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens GN=MFG   201.22 32 9
P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sap    190.38 26 9
P17980|PRS6A_HUMAN 26S protease regulatory subunit 6A OS=     180.2 57 9
P25391|LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapie    175.98 19 9
P26641|EF1G_HUMAN Elongation factor 1-gamma OS=Homo sa    157.43 36 9
P61160|ARP2_HUMAN Actin-related protein 2 OS=Homo sapien    154.07 43 9
Q9Y617|SERC_HUMAN Phosphoserine aminotransferase OS=Ho     129.68 38 9
O43707|ACTN4_HUMAN Alpha-actinin-4 OS=Homo sapiens GN=A   286.21 68 8
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P67936|TPM4_HUMAN Tropomyosin alpha-4 chain OS=Homo sa    271.24 69 8
P25787|PSA2_HUMAN Proteasome subunit alpha type-2 OS=Ho     233.19 60 8
P31946|1433B_HUMAN 14-3-3 protein beta/alpha OS=Homo sap    228.19 62 8
P07737|PROF1_HUMAN Profilin-1 OS=Homo sapiens GN=PFN1 P  220.45 69 8
P22626|ROA2_HUMAN Heterogeneous nuclear ribonucleoprotein       207.89 56 8
Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo s    207.71 44 8
P60900|PSA6_HUMAN Proteasome subunit alpha type-6 OS=Ho     202.72 53 8
Q9Y224|CN166_HUMAN UPF0568 protein C14orf166 OS=Homo s    197.1 45 8
P62314|SMD1_HUMAN Small nuclear ribonucleoprotein Sm D1 O     188.31 65 8
Q9Y265|RUVB1_HUMAN RuvB-like 1 OS=Homo sapiens GN=RUV   188.12 62 8
Q9Y4L1|HYOU1_HUMAN Hypoxia up-regulated protein 1 OS=Hom     185.61 39 8
Q9Y266|NUDC_HUMAN Nuclear migration protein nudC OS=Hom     180.71 58 8
P20618|PSB1_HUMAN Proteasome subunit beta type-1 OS=Hom     178.86 51 8
Q9P289|MST4_HUMAN Serine/threonine-protein kinase MST4 OS     172.08 30 8
P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapien    163.14 32 8
P62249|RS16_HUMAN 40S ribosomal protein S16 OS=Homo sa    162 46 8
Q12906|ILF3_HUMAN Interleukin enhancer-binding factor 3 OS     158.13 32 8
P40227|TCPZ_HUMAN T-complex protein 1 subunit zeta OS=Ho     157.28 40 8
Q15907|RB11B_HUMAN Ras-related protein Rab-11B OS=Homo    134.75 48 8
Q99613|EIF3C_HUMAN Eukaryotic translation initiation factor 3 su       106.16 16 8
Q00610|CLH1_HUMAN Clathrin heavy chain 1 OS=Homo sapien    262.2 47 7
P12277|KCRB_HUMAN Creatine kinase B-type OS=Homo sapien    228.22 54 7
P32119|PRDX2_HUMAN Peroxiredoxin-2 OS=Homo sapiens GN=   197.38 69 7
Q15084|PDIA6_HUMAN Protein disulfide-isomerase A6 OS=Hom     193.64 44 7
P22234|PUR6_HUMAN Multifunctional protein ADE2 OS=Homo s    190.82 46 7
P43686|PRS6B_HUMAN 26S protease regulatory subunit 6B OS=     189.68 56 7
P23246|SFPQ_HUMAN Splicing factor, proline- and glutamine-ric      188.3 44 7
P26038|MOES_HUMAN Moesin OS=Homo sapiens GN=MSN PE  187.8 51 7
O60664|PLIN3_HUMAN Perilipin-3 OS=Homo sapiens GN=PLIN3  185.14 41 7
O43809|CPSF5_HUMAN Cleavage and polyadenylation specificity        179.4 46 7
P25789|PSA4_HUMAN Proteasome subunit alpha type-4 OS=Ho     173.83 42 7
Q9UKK9|NUDT5_HUMAN ADP-sugar pyrophosphatase OS=Homo    169.15 35 7
Q7KZF4|SND1_HUMAN Staphylococcal nuclease domain-contain        168.24 35 7
P37837|TALDO_HUMAN Transaldolase OS=Homo sapiens GN=T   160.44 39 7
P14543|NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1  159.74 40 7
P11940|PABP1_HUMAN Polyadenylate-binding protein 1 OS=Hom     158.35 42 7
Q02790|FKBP4_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP      157.52 34 7
P62081|RS7_HUMAN 40S ribosomal protein S7 OS=Homo sap    157.04 39 7
P09661|RU2A_HUMAN U2 small nuclear ribonucleoprotein A' OS     156.58 28 7
P02751|FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1  155.38 19 7
P39019|RS19_HUMAN 40S ribosomal protein S19 OS=Homo sa    150.74 68 7
Q99832|TCPH_HUMAN T-complex protein 1 subunit eta OS=Hom     149.16 45 7
Q9Y230|RUVB2_HUMAN RuvB-like 2 OS=Homo sapiens GN=RUV   146.97 29 7
Q9Y3I0|RTCB_HUMAN tRNA-splicing ligase RtcB homolog OS=H     143.49 34 7
P25786|PSA1_HUMAN Proteasome subunit alpha type-1 OS=Ho     141.46 35 7
P54577|SYYC_HUMAN Tyrosyl-tRNA synthetase, cytoplasmic OS     141.08 46 7
O15144|ARPC2_HUMAN Actin-related protein 2/3 complex subunit      139.1 40 7
P09486|SPRC_HUMAN SPARC OS=Homo sapiens GN=SPARC  135.89 24 7
P06753|TPM3_HUMAN Tropomyosin alpha-3 chain OS=Homo sa    293.76 60 6
P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucleoprotein       214.86 53 6
P61981|1433G_HUMAN 14-3-3 protein gamma OS=Homo sapien    213.26 63 6
P28066|PSA5_HUMAN Proteasome subunit alpha type-5 OS=Ho     207.13 60 6
P02792|FRIL_HUMAN Ferritin light chain OS=Homo sapiens GN   203.6 51 6
Q13162|PRDX4_HUMAN Peroxiredoxin-4 OS=Homo sapiens GN=   199.84 52 6
Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=H     195.71 58 6
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P00558|PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sa    192.74 61 6
P35241|RADI_HUMAN Radixin OS=Homo sapiens GN=RDX PE  188.72 44 6
P09972|ALDOC_HUMAN Fructose-bisphosphate aldolase C OS=H     188.17 62 6
P62701|RS4X_HUMAN 40S ribosomal protein S4, X isoform OS=     187.43 51 6
P48643|TCPE_HUMAN T-complex protein 1 subunit epsilon OS=     183.95 72 6
P25398|RS12_HUMAN 40S ribosomal protein S12 OS=Homo sa    182.76 80 6
O00299|CLIC1_HUMAN Chloride intracellular channel protein 1 O     179.56 51 6
Q99598|TSNAX_HUMAN Translin-associated protein X OS=Homo    178.92 57 6
P50991|TCPD_HUMAN T-complex protein 1 subunit delta OS=Ho     177.82 49 6
P67809|YBOX1_HUMAN Nuclease-sensitive element-binding prote       176.18 38 6
Q06830|PRDX1_HUMAN Peroxiredoxin-1 OS=Homo sapiens GN=   175.86 54 6
Q16851|UGPA_HUMAN UTP--glucose-1-phosphate uridylyltransfe      173.41 43 6
Q99536|VAT1_HUMAN Synaptic vesicle membrane protein VAT-       172.83 66 6
P62750|RL23A_HUMAN 60S ribosomal protein L23a OS=Homo s    170.76 50 6
P49720|PSB3_HUMAN Proteasome subunit beta type-3 OS=Hom     169.9 67 6
P23528|COF1_HUMAN Cofilin-1 OS=Homo sapiens GN=CFL1 P  166.71 57 6
Q96IZ0|PAWR_HUMAN PRKC apoptosis WT1 regulator protein O     164.92 46 6
P25205|MCM3_HUMAN DNA replication licensing factor MCM3 O     163.19 32 6
P62888|RL30_HUMAN 60S ribosomal protein L30 OS=Homo sa    161.64 66 6
Q13561|DCTN2_HUMAN Dynactin subunit 2 OS=Homo sapiens G   160.54 46 6
P08708|RS17_HUMAN 40S ribosomal protein S17 OS=Homo sa    158.26 65 6
P13797|PLST_HUMAN Plastin-3 OS=Homo sapiens GN=PLS3 P  158.08 34 6
P10809|CH60_HUMAN 60 kDa heat shock protein, mitochondria      158 56 6
P61604|CH10_HUMAN 10 kDa heat shock protein, mitochondria      157.8 76 6
P37802|TAGL2_HUMAN Transgelin-2 OS=Homo sapiens GN=TA   154.49 46 6
P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGA      153.32 36 6
P62987|RL40_HUMAN Ubiquitin-60S ribosomal protein L40 OS=     151.42 73 6
P0CG48|UBC_HUMAN Polyubiquitin-C OS=Homo sapiens GN=U   151.42 44 6
P62979|RS27A_HUMAN Ubiquitin-40S ribosomal protein S27a OS     151.42 50 6
P0CG47|UBB_HUMAN Polyubiquitin-B OS=Homo sapiens GN=U   151.42 82 6
P11586|C1TC_HUMAN C-1-tetrahydrofolate synthase, cytoplasm      150.42 36 6
P62263|RS14_HUMAN 40S ribosomal protein S14 OS=Homo sa    146.9 46 6
Q9Y295|DRG1_HUMAN Developmentally-regulated GTP-binding       146.21 40 6
Q9P2J5|SYLC_HUMAN Leucyl-tRNA synthetase, cytoplasmic OS     144.85 31 6
P27816|MAP4_HUMAN Microtubule-associated protein 4 OS=Ho     139.1 35 6
P52788|SPSY_HUMAN Spermine synthase OS=Homo sapiens G   133.44 36 6
P62851|RS25_HUMAN 40S ribosomal protein S25 OS=Homo sa    133.38 39 6
Q92945|FUBP2_HUMAN Far upstream element-binding protein 2 O     132.08 31 6
Q14204|DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=     131.3 16 6
P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sa    131.01 23 6
P17987|TCPA_HUMAN T-complex protein 1 subunit alpha OS=H     124.66 35 6
P84243|H33_HUMAN Histone H3.3 OS=Homo sapiens GN=H3   118.62 47 6
P68431|H31_HUMAN Histone H3.1 OS=Homo sapiens GN=HIS   118.62 50 6
Q71DI3|H32_HUMAN Histone H3.2 OS=Homo sapiens GN=HIS   118.62 50 6
Q16695|H31T_HUMAN Histone H3.1t OS=Homo sapiens GN=HI   118.62 50 6
P18077|RL35A_HUMAN 60S ribosomal protein L35a OS=Homo s    105.88 44 6
P09493|TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo sa    288.32 69 5
P09651|ROA1_HUMAN Heterogeneous nuclear ribonucleoprotein      278.47 57 5
P18669|PGAM1_HUMAN Phosphoglycerate mutase 1 OS=Homo s    245.89 85 5
P60842|IF4A1_HUMAN Eukaryotic initiation factor 4A-I OS=Homo    216.02 60 5
P50395|GDIB_HUMAN Rab GDP dissociation inhibitor beta OS=     209.42 58 5
O60506|HNRPQ_HUMAN Heterogeneous nuclear ribonucleoprotein      197.27 41 5
Q16181|SEPT7_HUMAN Septin-7 OS=Homo sapiens GN=SEPT7  185.8 60 5
P09429|HMGB1_HUMAN High mobility group protein B1 OS=Homo    172.39 46 5
P61289|PSME3_HUMAN Proteasome activator complex subunit 3     172.33 56 5
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P06744|G6PI_HUMAN Glucose-6-phosphate isomerase OS=Ho     166.32 31 5
P51149|RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo sa    164.95 35 5
P55209|NP1L1_HUMAN Nucleosome assembly protein 1-like 1 O     163.61 35 5
Q13263|TIF1B_HUMAN Transcription intermediary factor 1-beta O     163.39 27 5
P08133|ANXA6_HUMAN Annexin A6 OS=Homo sapiens GN=ANX   159.78 38 5
Q8NC51|PAIRB_HUMAN Plasminogen activator inhibitor 1 RNA-bi       158.06 53 5
P23526|SAHH_HUMAN Adenosylhomocysteinase OS=Homo sap    157.63 40 5
P08195|4F2_HUMAN 4F2 cell-surface antigen heavy chain OS     157.23 28 5
P61353|RL27_HUMAN 60S ribosomal protein L27 OS=Homo sa    156.91 68 5
P02794|FRIH_HUMAN Ferritin heavy chain OS=Homo sapiens G   155.21 45 5
P09874|PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Hom     153.6 24 5
P37108|SRP14_HUMAN Signal recognition particle 14 kDa protein     153.37 71 5
Q7L2H7|EIF3M_HUMAN Eukaryotic translation initiation factor 3 su       153.35 35 5
Q8N474|SFRP1_HUMAN Secreted frizzled-related protein 1 OS=H     152.97 46 5
Q14566|MCM6_HUMAN DNA replication licensing factor MCM6 O     152.81 35 5
Q15717|ELAV1_HUMAN ELAV-like protein 1 OS=Homo sapiens G   152.1 33 5
P39060|COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo    151.31 31 5
P17174|AATC_HUMAN Aspartate aminotransferase, cytoplasmic     149.96 37 5
O75347|TBCA_HUMAN Tubulin-specific chaperone A OS=Homo    149.6 69 5
P30050|RL12_HUMAN 60S ribosomal protein L12 OS=Homo sa    149.08 46 5
P62316|SMD2_HUMAN Small nuclear ribonucleoprotein Sm D2 O     149.08 61 5
P50502|F10A1_HUMAN Hsc70-interacting protein OS=Homo sap    148.29 48 5
P63244|GBLP_HUMAN Guanine nucleotide-binding protein subun        145.32 30 5
P15880|RS2_HUMAN 40S ribosomal protein S2 OS=Homo sap    144.24 40 5
P43487|RANG_HUMAN Ran-specific GTPase-activating protein O     143.31 33 5
P63162|RSMN_HUMAN Small nuclear ribonucleoprotein-associat        141.93 45 5
P14678|RSMB_HUMAN Small nuclear ribonucleoprotein-associat          141.93 40 5
Q9Y2Z0|SUGT1_HUMAN Suppressor of G2 allele of SKP1 homolo      139.32 30 5
P16949|STMN1_HUMAN Stathmin OS=Homo sapiens GN=STMN   139.17 38 5
P49721|PSB2_HUMAN Proteasome subunit beta type-2 OS=Hom     136.22 38 5
Q15691|MARE1_HUMAN Microtubule-associated protein RP/EB fa        136.04 26 5
P78417|GSTO1_HUMAN Glutathione S-transferase omega-1 OS=     133.58 33 5
P62244|RS15A_HUMAN 40S ribosomal protein S15a OS=Homo s    132.41 48 5
P61758|PFD3_HUMAN Prefoldin subunit 3 OS=Homo sapiens G   132.03 52 5
O43399|TPD54_HUMAN Tumor protein D54 OS=Homo sapiens G   131.62 50 5
P46926|GNPI1_HUMAN Glucosamine-6-phosphate isomerase 1 O     130.85 39 5
P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=Ho     129.66 35 5
Q05682|CALD1_HUMAN Caldesmon OS=Homo sapiens GN=CAL   129.12 23 5
P50914|RL14_HUMAN 60S ribosomal protein L14 OS=Homo sa    128.61 50 5
P35232|PHB_HUMAN Prohibitin OS=Homo sapiens GN=PHB P  126.96 45 5
Q02878|RL6_HUMAN 60S ribosomal protein L6 OS=Homo sap    124.55 44 5
P59998|ARPC4_HUMAN Actin-related protein 2/3 complex subunit      122.31 31 5
P14868|SYDC_HUMAN Aspartyl-tRNA synthetase, cytoplasmic O     121.1 19 5
Q9P2E9|RRBP1_HUMAN Ribosome-binding protein 1 OS=Homo s    120.34 17 5
P98160|PGBM_HUMAN Basement membrane-specific heparan s         118.87 9 5
P49736|MCM2_HUMAN DNA replication licensing factor MCM2 O     118.52 28 5
P13667|PDIA4_HUMAN Protein disulfide-isomerase A4 OS=Hom     118.29 21 5
Q8N163|K1967_HUMAN Protein KIAA1967 OS=Homo sapiens GN   117.88 27 5
O43242|PSMD3_HUMAN 26S proteasome non-ATPase regulatory       116.46 30 5
P82979|SARNP_HUMAN SAP domain-containing ribonucleoprotein     112.71 42 5
P62899|RL31_HUMAN 60S ribosomal protein L31 OS=Homo sa    110.06 49 5
P30044|PRDX5_HUMAN Peroxiredoxin-5, mitochondrial OS=Hom     105.91 49 5
P46781|RS9_HUMAN 40S ribosomal protein S9 OS=Homo sap    105.12 45 5
Q14914|PTGR1_HUMAN Prostaglandin reductase 1 OS=Homo sa    102 17 5
Q9UHD8|SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9  96.07 12 5
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Q9BYT8|NEUL_HUMAN Neurolysin, mitochondrial OS=Homo sap    89.07 16 5
Q562R1|ACTBL_HUMAN Beta-actin-like protein 2 OS=Homo sapie    283.36 65 4
P15531|NDKA_HUMAN Nucleoside diphosphate kinase A OS=Ho     209.18 81 4
P84077|ARF1_HUMAN ADP-ribosylation factor 1 OS=Homo sap    198.78 68 4
P61204|ARF3_HUMAN ADP-ribosylation factor 3 OS=Homo sapi    198.78 67 4
P61158|ARP3_HUMAN Actin-related protein 3 OS=Homo sapien    186.94 55 4
A6NL28|TPM3L_HUMAN Putative tropomyosin alpha-3 chain-like p     177.37 30 4
P06493|CDK1_HUMAN Cyclin-dependent kinase 1 OS=Homo sa    176.85 45 4
P62917|RL8_HUMAN 60S ribosomal protein L8 OS=Homo sap    163.71 49 4
P98095|FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN2  161.78 22 4
Q9NTK5|OLA1_HUMAN Obg-like ATPase 1 OS=Homo sapiens G   160.13 39 4
P05198|IF2A_HUMAN Eukaryotic translation initiation factor 2 su       158.5 55 4
P14324|FPPS_HUMAN Farnesyl pyrophosphate synthase OS=H     156.36 43 4
P46778|RL21_HUMAN 60S ribosomal protein L21 OS=Homo sa    155.43 37 4
Q12904|AIMP1_HUMAN Aminoacyl tRNA synthase complex-intera         154.01 35 4
P54687|BCAT1_HUMAN Branched-chain-amino-acid aminotransfe       148.58 35 4
Q13310|PABP4_HUMAN Polyadenylate-binding protein 4 OS=Hom     148.03 38 4
Q15365|PCBP1_HUMAN Poly(rC)-binding protein 1 OS=Homo sap    147.77 42 4
P62841|RS15_HUMAN 40S ribosomal protein S15 OS=Homo sa    146.2 57 4
Q96FW1|OTUB1_HUMAN Ubiquitin thioesterase OTUB1 OS=Homo    145.27 56 4
P62191|PRS4_HUMAN 26S protease regulatory subunit 4 OS=H     144.04 49 4
P40925|MDHC_HUMAN Malate dehydrogenase, cytoplasmic OS=     143.7 36 4
P18621|RL17_HUMAN 60S ribosomal protein L17 OS=Homo sa    142.87 36 4
P46783|RS10_HUMAN 40S ribosomal protein S10 OS=Homo sa    140.61 65 4
P62847|RS24_HUMAN 40S ribosomal protein S24 OS=Homo sa    139.36 47 4
P62158|CALM_HUMAN Calmodulin OS=Homo sapiens GN=CAL   139.12 42 4
P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens GN=CTS   138.13 35 4
Q9UHV9|PFD2_HUMAN Prefoldin subunit 2 OS=Homo sapiens G   137.32 49 4
P12429|ANXA3_HUMAN Annexin A3 OS=Homo sapiens GN=ANX   136.03 25 4
P40926|MDHM_HUMAN Malate dehydrogenase, mitochondrial OS     134.76 52 4
Q14974|IMB1_HUMAN Importin subunit beta-1 OS=Homo sapien    133.4 21 4
O00487|PSDE_HUMAN 26S proteasome non-ATPase regulatory       132 59 4
P16401|H15_HUMAN Histone H1.5 OS=Homo sapiens GN=HIS   130.92 55 4
Q15366|PCBP2_HUMAN Poly(rC)-binding protein 2 OS=Homo sap    129.35 30 4
P62913|RL11_HUMAN 60S ribosomal protein L11 OS=Homo sa    126.26 26 4
P33991|MCM4_HUMAN DNA replication licensing factor MCM4 O     124.89 21 4
Q86VP6|CAND1_HUMAN Cullin-associated NEDD8-dissociated pro       122.03 21 4
Q01581|HMCS1_HUMAN Hydroxymethylglutaryl-CoA synthase, cyt      120.32 39 4
P00492|HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltra      119.62 31 4
Q15631|TSN_HUMAN Translin OS=Homo sapiens GN=TSN PE  119.35 37 4
P23381|SYWC_HUMAN Tryptophanyl-tRNA synthetase, cytoplasm      119.1 26 4
Q71UI9|H2AV_HUMAN Histone H2A.V OS=Homo sapiens GN=H   118.48 40 4
O75821|EIF3G_HUMAN Eukaryotic translation initiation factor 3 su       118.24 30 4
O15145|ARPC3_HUMAN Actin-related protein 2/3 complex subunit      118.05 26 4
O14974|MYPT1_HUMAN Protein phosphatase 1 regulatory subunit      117.1 32 4
P25788|PSA3_HUMAN Proteasome subunit alpha type-3 OS=Ho     116.52 20 4
P39023|RL3_HUMAN 60S ribosomal protein L3 OS=Homo sap    115.31 24 4
P27797|CALR_HUMAN Calreticulin OS=Homo sapiens GN=CAL   114.84 24 4
P22102|PUR2_HUMAN Trifunctional purine biosynthetic protein a      114.26 37 4
P26373|RL13_HUMAN 60S ribosomal protein L13 OS=Homo sa    109.44 27 4
Q7L5N1|CSN6_HUMAN COP9 signalosome complex subunit 6 O     108.68 25 4
O76003|GLRX3_HUMAN Glutaredoxin-3 OS=Homo sapiens GN=G   107.36 59 4
Q09666|AHNK_HUMAN Neuroblast differentiation-associated pro       107.34 12 4
P49755|TMEDA_HUMAN Transmembrane emp24 domain-containi        106.72 28 4
P24539|AT5F1_HUMAN ATP synthase subunit b, mitochondrial O     103.2 26 4
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Q16643|DREB_HUMAN Drebrin OS=Homo sapiens GN=DBN1 P  102.08 22 4
O43324|MCA3_HUMAN Eukaryotic translation elongation factor 1      100.42 66 4
P13798|ACPH_HUMAN Acylamino-acid-releasing enzyme OS=Ho     99.27 9 4
Q9NZL4|HPBP1_HUMAN Hsp70-binding protein 1 OS=Homo sapie    89.62 36 4
Q16555|DPYL2_HUMAN Dihydropyrimidinase-related protein 2 OS     87.34 21 4
Q9Y376|CAB39_HUMAN Calcium-binding protein 39 OS=Homo sa    70.45 25 4
Q13509|TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens   299.53 62 3
P62807|H2B1C_HUMAN Histone H2B type 1-C/E/F/G/I OS=Homo    219.86 70 3
O60814|H2B1K_HUMAN Histone H2B type 1-K OS=Homo sapiens   219.86 70 3
P05141|ADT2_HUMAN ADP/ATP translocase 2 OS=Homo sapie    179.31 58 3
Q9NZI8|IF2B1_HUMAN Insulin-like growth factor 2 mRNA-binding       170.99 45 3
O75610|LFTY1_HUMAN Left-right determination factor 1 OS=Hom     170.03 45 3
Q13765|NACA_HUMAN Nascent polypeptide-associated complex       165.46 37 3
P60660|MYL6_HUMAN Myosin light polypeptide 6 OS=Homo sap    159.68 56 3
P61163|ACTZ_HUMAN Alpha-centractin OS=Homo sapiens GN=   156.76 51 3
O43390|HNRPR_HUMAN Heterogeneous nuclear ribonucleoprotein      156.46 38 3
O14744|ANM5_HUMAN Protein arginine N-methyltransferase 5 O     146.45 37 3
P04216|THY1_HUMAN Thy-1 membrane glycoprotein OS=Homo    143.96 50 3
Q13126|MTAP_HUMAN S-methyl-5'-thioadenosine phosphorylase     133.09 47 3
P46782|RS5_HUMAN 40S ribosomal protein S5 OS=Homo sap    130.54 50 3
Q07020|RL18_HUMAN 60S ribosomal protein L18 OS=Homo sa    130.02 40 3
Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens GN=CAPRI   127.48 26 3
Q06323|PSME1_HUMAN Proteasome activator complex subunit 1     126.52 42 3
Q07021|C1QBP_HUMAN Complement component 1 Q subcompon        126.18 25 3
Q15056|IF4H_HUMAN Eukaryotic translation initiation factor 4H     125.33 34 3
P49903|SPS1_HUMAN Selenide, water dikinase 1 OS=Homo sa    123.68 30 3
P52907|CAZA1_HUMAN F-actin-capping protein subunit alpha-1 O     123.21 22 3
Q15417|CNN3_HUMAN Calponin-3 OS=Homo sapiens GN=CNN   122.16 28 3
P62873|GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G        121.55 19 3
P60866|RS20_HUMAN 40S ribosomal protein S20 OS=Homo sa    121.54 37 3
P51858|HDGF_HUMAN Hepatoma-derived growth factor OS=Hom     120.58 45 3
P39687|AN32A_HUMAN Acidic leucine-rich nuclear phosphoprote          119.87 42 3
P30086|PEBP1_HUMAN Phosphatidylethanolamine-binding protei       117.71 26 3
Q9UL46|PSME2_HUMAN Proteasome activator complex subunit 2     117.63 54 3
P31153|METK2_HUMAN S-adenosylmethionine synthase isoform      116.44 37 3
P16422|EPCAM_HUMAN Epithelial cell adhesion molecule OS=Ho     116.32 42 3
P30040|ERP29_HUMAN Endoplasmic reticulum resident protein 2      114.65 35 3
P38159|HNRPG_HUMAN Heterogeneous nuclear ribonucleoprotein      113.99 37 3
O43776|SYNC_HUMAN Asparaginyl-tRNA synthetase, cytoplasm      113.91 17 3
O15372|EIF3H_HUMAN Eukaryotic translation initiation factor 3 su       113.73 34 3
P55060|XPO2_HUMAN Exportin-2 OS=Homo sapiens GN=CSE1   113.11 28 3
P07741|APT_HUMAN Adenine phosphoribosyltransferase OS=     112.81 26 3
P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo    112.49 23 3
P07814|SYEP_HUMAN Bifunctional aminoacyl-tRNA synthetase     111.68 17 3
P61088|UBE2N_HUMAN Ubiquitin-conjugating enzyme E2 N OS=H     111.56 36 3
O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens GN=GPC   108.65 22 3
Q9NYL9|TMOD3_HUMAN Tropomodulin-3 OS=Homo sapiens GN=   105.91 36 3
Q96AE4|FUBP1_HUMAN Far upstream element-binding protein 1 O     105.87 27 3
Q13868|EXOS2_HUMAN Exosome complex component RRP4 OS     105.36 31 3
P23352|KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1  104.99 23 3
P28072|PSB6_HUMAN Proteasome subunit beta type-6 OS=Hom     104.25 13 3
P07093|GDN_HUMAN Glia-derived nexin OS=Homo sapiens GN   103.16 30 3
Q9BUL8|PDC10_HUMAN Programmed cell death protein 10 OS=H     103.14 30 3
Q9Y262|EIF3L_HUMAN Eukaryotic translation initiation factor 3 su       102.46 23 3
Q9NVA2|SEP11_HUMAN Septin-11 OS=Homo sapiens GN=SEPT   101.76 16 3
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Q99439|CNN2_HUMAN Calponin-2 OS=Homo sapiens GN=CNN   101.4 35 3
Q86V81|THOC4_HUMAN THO complex subunit 4 OS=Homo sapie    100.47 20 3
P19367|HXK1_HUMAN Hexokinase-1 OS=Homo sapiens GN=H   99.53 25 3
O43143|DHX15_HUMAN Putative pre-mRNA-splicing factor ATP-d         98.45 16 3
Q9NZL9|MAT2B_HUMAN Methionine adenosyltransferase 2 subun       96.34 20 3
Q15785|TOM34_HUMAN Mitochondrial import receptor subunit TO      95.81 30 3
O15347|HMGB3_HUMAN High mobility group protein B3 OS=Homo    94.94 30 3
P35613|BASI_HUMAN Basigin OS=Homo sapiens GN=BSG PE  94.46 21 3
O60701|UGDH_HUMAN UDP-glucose 6-dehydrogenase OS=Hom     94.26 15 3
P36404|ARL2_HUMAN ADP-ribosylation factor-like protein 2 OS=     94.05 18 3
Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding p       93.52 30 3
P62280|RS11_HUMAN 40S ribosomal protein S11 OS=Homo sa    92.73 26 3
P49588|SYAC_HUMAN Alanyl-tRNA synthetase, cytoplasmic OS     92.24 23 3
Q92820|GGH_HUMAN Gamma-glutamyl hydrolase OS=Homo s    91.51 14 3
P54709|AT1B3_HUMAN Sodium/potassium-transporting ATPase       90.93 13 3
P52272|HNRPM_HUMAN Heterogeneous nuclear ribonucleoprotein      90.72 29 3
P39656|OST48_HUMAN Dolichyl-diphosphooligosaccharide--prote          90.22 12 3
P29279|CTGF_HUMAN Connective tissue growth factor OS=Hom     89.8 26 3
O43852|CALU_HUMAN Calumenin OS=Homo sapiens GN=CALU  89.45 34 3
Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 88.5 10 3
Q9UNM6|PSD13_HUMAN 26S proteasome non-ATPase regulatory       87.85 29 3
P26640|SYVC_HUMAN Valyl-tRNA synthetase OS=Homo sapien    87.67 6 3
Q8WUD1|RAB2B_HUMAN Ras-related protein Rab-2B OS=Homo sa    86.44 37 3
P12109|CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sa    86.44 11 3
P11717|MPRI_HUMAN Cation-independent mannose-6-phospha       85.96 10 3
O00625|PIR_HUMAN Pirin OS=Homo sapiens GN=PIR PE=1 S 85.62 11 3
O15067|PUR4_HUMAN Phosphoribosylformylglycinamidine synth      85.19 14 3
P00505|AATM_HUMAN Aspartate aminotransferase, mitochondri      84.18 24 3
P48556|PSMD8_HUMAN 26S proteasome non-ATPase regulatory       83.86 19 3
P28070|PSB4_HUMAN Proteasome subunit beta type-4 OS=Hom     81.96 20 3
P30566|PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapie    81.94 14 3
P55786|PSA_HUMAN Puromycin-sensitive aminopeptidase OS     81.73 17 3
O00232|PSD12_HUMAN 26S proteasome non-ATPase regulatory       80.72 28 3
Q00688|FKBP3_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP      78.08 20 3
Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo s    77.65 12 3
Q01469|FABP5_HUMAN Fatty acid-binding protein, epidermal OS=     77.1 30 3
Q15233|NONO_HUMAN Non-POU domain-containing octamer-bin       76.95 20 3
O43237|DC1L2_HUMAN Cytoplasmic dynein 1 light intermediate c       76.74 15 3
Q13838|DX39B_HUMAN Spliceosome RNA helicase DDX39B OS     76.23 14 3
O00148|DX39A_HUMAN ATP-dependent RNA helicase DDX39A O     76.23 12 3
O75822|EIF3J_HUMAN Eukaryotic translation initiation factor 3 su       74.95 27 3
P60953|CDC42_HUMAN Cell division control protein 42 homolog O     74.69 16 3
O00303|EIF3F_HUMAN Eukaryotic translation initiation factor 3 su       73.8 21 3
P13984|T2FB_HUMAN General transcription factor IIF subunit 2     73.22 21 3
P33992|MCM5_HUMAN DNA replication licensing factor MCM5 O     71.25 19 3
Q92769|HDAC2_HUMAN Histone deacetylase 2 OS=Homo sapien    70.35 17 3
P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens G   69.44 11 3
A6NDG6|PGP_HUMAN Phosphoglycolate phosphatase OS=Hom     64.58 13 3
Q7Z4W1|DCXR_HUMAN L-xylulose reductase OS=Homo sapiens   63.74 18 3
Q58FF7|H90B3_HUMAN Putative heat shock protein HSP 90-beta      351.09 74 2
Q9BYX7|ACTBM_HUMAN Putative beta-actin-like protein 3 OS=Hom     242.61 54 2
P19105|ML12A_HUMAN Myosin regulatory light chain 12A OS=Ho     184.34 72 2
O14950|ML12B_HUMAN Myosin regulatory light chain 12B OS=Ho     184.34 72 2
O00292|LFTY2_HUMAN Left-right determination factor 2 OS=Hom     176.3 53 2
P63241|IF5A1_HUMAN Eukaryotic translation initiation factor 5A-      163.75 50 2
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P13929|ENOB_HUMAN Beta-enolase OS=Homo sapiens GN=EN   157.2 53 2
P21796|VDAC1_HUMAN Voltage-dependent anion-selective chann        146.33 35 2
P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 su       138.9 61 2
A6NK07|IF2BL_HUMAN Eukaryotic translation initiation factor 2 su       138.9 54 2
P60983|GMFB_HUMAN Glia maturation factor beta OS=Homo sa    132.25 51 2
P62136|PP1A_HUMAN Serine/threonine-protein phosphatase PP        123.53 30 2
P50453|SPB9_HUMAN Serpin B9 OS=Homo sapiens GN=SERP   123.16 28 2
Q13200|PSMD2_HUMAN 26S proteasome non-ATPase regulatory       122.62 29 2
P62829|RL23_HUMAN 60S ribosomal protein L23 OS=Homo sa    120.57 59 2
P60891|PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1     120.08 43 2
P68402|PA1B2_HUMAN Platelet-activating factor acetylhydrolase        119.43 46 2
P20290|BTF3_HUMAN Transcription factor BTF3 OS=Homo sap    119.35 50 2
P61026|RAB10_HUMAN Ras-related protein Rab-10 OS=Homo sa    119.09 32 2
Q9Y3B4|PM14_HUMAN Pre-mRNA branch site protein p14 OS=H     116.79 29 2
P35268|RL22_HUMAN 60S ribosomal protein L22 OS=Homo sa    116.54 27 2
O43765|SGTA_HUMAN Small glutamine-rich tetratricopeptide rep        115.19 22 2
Q92688|AN32B_HUMAN Acidic leucine-rich nuclear phosphoprote          114.51 26 2
Q5VYJ4|RUEL1_HUMAN Putative small nuclear ribonucleoprotein         113.85 48 2
P62304|RUXE_HUMAN Small nuclear ribonucleoprotein E OS=H     113.85 48 2
P62241|RS8_HUMAN 40S ribosomal protein S8 OS=Homo sap    112.85 33 2
Q99729|ROAA_HUMAN Heterogeneous nuclear ribonucleoprotein      112.38 22 2
P20339|RAB5A_HUMAN Ras-related protein Rab-5A OS=Homo sa    110.79 32 2
P25705|ATPA_HUMAN ATP synthase subunit alpha, mitochondr      110.15 42 2
P31943|HNRH1_HUMAN Heterogeneous nuclear ribonucleoprotein      109.47 21 2
P24534|EF1B_HUMAN Elongation factor 1-beta OS=Homo sapie    107.85 31 2
Q12905|ILF2_HUMAN Interleukin enhancer-binding factor 2 OS     107.42 21 2
Q92522|H1X_HUMAN Histone H1x OS=Homo sapiens GN=H1F   106.49 34 2
P30048|PRDX3_HUMAN Thioredoxin-dependent peroxide reducta       106.1 32 2
Q14103|HNRPD_HUMAN Heterogeneous nuclear ribonucleoprotein      104.99 19 2
Q15046|SYK_HUMAN Lysyl-tRNA synthetase OS=Homo sapien    103.8 19 2
O00151|PDLI1_HUMAN PDZ and LIM domain protein 1 OS=Hom     103.42 39 2
P61020|RAB5B_HUMAN Ras-related protein Rab-5B OS=Homo sa    103.21 33 2
O00264|PGRC1_HUMAN Membrane-associated progesterone rece        102.86 26 2
O15116|LSM1_HUMAN U6 snRNA-associated Sm-like protein LS      101.19 25 2
P06576|ATPB_HUMAN ATP synthase subunit beta, mitochondria      100.8 33 2
Q9UBT2|SAE2_HUMAN SUMO-activating enzyme subunit 2 OS=     100.15 15 2
P55327|TPD52_HUMAN Tumor protein D52 OS=Homo sapiens G   99.57 21 2
Q07866|KLC1_HUMAN Kinesin light chain 1 OS=Homo sapiens G   99.17 19 2
Q04760|LGUL_HUMAN Lactoylglutathione lyase OS=Homo sapie    98.72 23 2
P53367|ARFP1_HUMAN Arfaptin-1 OS=Homo sapiens GN=ARFIP   98.07 26 2
O15212|PFD6_HUMAN Prefoldin subunit 6 OS=Homo sapiens G   97.95 43 2
P09936|UCHL1_HUMAN Ubiquitin carboxyl-terminal hydrolase isoz       97.81 19 2
Q99873|ANM1_HUMAN Protein arginine N-methyltransferase 1 O     97.08 16 2
P41091|IF2G_HUMAN Eukaryotic translation initiation factor 2 su       97.06 22 2
Q2VIR3|IF2GL_HUMAN Eukaryotic translation initiation factor 2 su        97.06 17 2
P13861|KAP2_HUMAN cAMP-dependent protein kinase type II-a        95.1 23 2
P51571|SSRD_HUMAN Translocon-associated protein subunit de      94.78 39 2
P21741|MK_HUMAN Midkine OS=Homo sapiens GN=MDK PE  94.22 34 2
Q96CT7|CC124_HUMAN Coiled-coil domain-containing protein 124     93.73 21 2
Q13576|IQGA2_HUMAN Ras GTPase-activating-like protein IQGA      92.82 12 2
Q92890|UFD1_HUMAN Ubiquitin fusion degradation protein 1 hom      92.65 27 2
Q9BZZ5|API5_HUMAN Apoptosis inhibitor 5 OS=Homo sapiens   92.58 16 2
O95433|AHSA1_HUMAN Activator of 90 kDa heat shock protein AT        92.26 36 2
Q15818|NPTX1_HUMAN Neuronal pentraxin-1 OS=Homo sapiens   91.91 18 2
O15355|PPM1G_HUMAN Protein phosphatase 1G OS=Homo sapie    91.32 14 2
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P23284|PPIB_HUMAN Peptidyl-prolyl cis-trans isomerase B OS=     91.23 50 2
P48047|ATPO_HUMAN ATP synthase subunit O, mitochondrial O     90.81 57 2
Q00341|VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP P  90.4 18 2
Q99426|TBCB_HUMAN Tubulin-folding cofactor B OS=Homo sap    90.35 34 2
O14745|NHRF1_HUMAN Na(+)/H(+) exchange regulatory cofactor      89.18 20 2
P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapie    89 13 2
Q8WVM8|SCFD1_HUMAN Sec1 family domain-containing protein 1     88.71 9 2
Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 O     87.4 11 2
P19784|CSK22_HUMAN Casein kinase II subunit alpha' OS=Hom     87 21 2
P52565|GDIR1_HUMAN Rho GDP-dissociation inhibitor 1 OS=Ho     86.8 23 2
P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS     86.75 23 2
P48444|COPD_HUMAN Coatomer subunit delta OS=Homo sapie    86.37 17 2
P31350|RIR2_HUMAN Ribonucleoside-diphosphate reductase s       86.12 18 2
P47756|CAPZB_HUMAN F-actin-capping protein subunit beta OS=     85.76 25 2
P47914|RL29_HUMAN 60S ribosomal protein L29 OS=Homo sa    85.69 28 2
Q96HF1|SFRP2_HUMAN Secreted frizzled-related protein 2 OS=H     85.64 18 2
P46776|RL27A_HUMAN 60S ribosomal protein L27a OS=Homo s    85.06 45 2
P83731|RL24_HUMAN 60S ribosomal protein L24 OS=Homo sa    84.82 43 2
P46109|CRKL_HUMAN Crk-like protein OS=Homo sapiens GN=C   84.45 10 2
Q13347|EIF3I_HUMAN Eukaryotic translation initiation factor 3 su       84.43 36 2
Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein ki          84.24 22 2
Q93008|USP9X_HUMAN Probable ubiquitin carboxyl-terminal hydr       83.52 6 2
P31689|DNJA1_HUMAN DnaJ homolog subfamily A member 1 OS     83.1 17 2
P62753|RS6_HUMAN 40S ribosomal protein S6 OS=Homo sap    83.1 20 2
O75477|ERLN1_HUMAN Erlin-1 OS=Homo sapiens GN=ERLIN1 P  83.03 21 2
P48681|NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE=  82.69 7 2
Q15293|RCN1_HUMAN Reticulocalbin-1 OS=Homo sapiens GN=   82.52 15 2
Q08211|DHX9_HUMAN ATP-dependent RNA helicase A OS=Hom     82.38 12 2
P61201|CSN2_HUMAN COP9 signalosome complex subunit 2 O     82.3 30 2
P07237|PDIA1_HUMAN Protein disulfide-isomerase OS=Homo sa    82.12 23 2
Q99460|PSMD1_HUMAN 26S proteasome non-ATPase regulatory       81.85 15 2
P23921|RIR1_HUMAN Ribonucleoside-diphosphate reductase la       81.2 12 2
P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens GN=LMNB   81.12 16 2
Q9NR31|SAR1A_HUMAN GTP-binding protein SAR1a OS=Homo s    81.06 31 2
Q9Y4Z0|LSM4_HUMAN U6 snRNA-associated Sm-like protein LS      80.17 24 2
Q9UKM9|RALY_HUMAN RNA-binding protein Raly OS=Homo sap    80.15 23 2
Q13442|HAP28_HUMAN 28 kDa heat- and acid-stable phosphopro      79.27 18 2
P54578|UBP14_HUMAN Ubiquitin carboxyl-terminal hydrolase 14     77.51 12 2
P10155|RO60_HUMAN 60 kDa SS-A/Ro ribonucleoprotein OS=H     77.36 14 2
P62318|SMD3_HUMAN Small nuclear ribonucleoprotein Sm D3 O     77.19 30 2
P05937|CALB1_HUMAN Calbindin OS=Homo sapiens GN=CALB1  76.96 30 2
P31949|S10AB_HUMAN Protein S100-A11 OS=Homo sapiens GN   76.5 66 2
P83916|CBX1_HUMAN Chromobox protein homolog 1 OS=Homo    76.14 18 2
O60925|PFD1_HUMAN Prefoldin subunit 1 OS=Homo sapiens G   76.11 17 2
P62857|RS28_HUMAN 40S ribosomal protein S28 OS=Homo sa    76.11 64 2
Q9BPX5|ARP5L_HUMAN Actin-related protein 2/3 complex subunit       75.98 46 2
Q53GQ0|DHB12_HUMAN Estradiol 17-beta-dehydrogenase 12 OS=     75.89 26 2
P63220|RS21_HUMAN 40S ribosomal protein S21 OS=Homo sa    75.76 23 2
Q14166|TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS     75.74 12 2
P18065|IBP2_HUMAN Insulin-like growth factor-binding protein 2     75.65 26 2
O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=     75.28 11 2
P30419|NMT1_HUMAN Glycylpeptide N-tetradecanoyltransferase      74.95 13 2
Q04837|SSBP_HUMAN Single-stranded DNA-binding protein, mit      74.91 40 2
P61803|DAD1_HUMAN Dolichyl-diphosphooligosaccharide--prote         74.36 19 2
P35606|COPB2_HUMAN Coatomer subunit beta' OS=Homo sapie    73.93 9 2
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Q71UM5|RS27L_HUMAN 40S ribosomal protein S27-like OS=Hom     73.48 25 2
P42677|RS27_HUMAN 40S ribosomal protein S27 OS=Homo sa    73.48 25 2
P09012|SNRPA_HUMAN U1 small nuclear ribonucleoprotein A OS     72.57 17 2
Q9H9Q2|CSN7B_HUMAN COP9 signalosome complex subunit 7b O     72.26 18 2
P51572|BAP31_HUMAN B-cell receptor-associated protein 31 OS     72.21 26 2
Q9NR45|SIAS_HUMAN Sialic acid synthase OS=Homo sapiens G   71.88 22 2
P14174|MIF_HUMAN Macrophage migration inhibitory factor O     71.14 21 2
P35249|RFC4_HUMAN Replication factor C subunit 4 OS=Homo    71.04 19 2
Q09028|RBBP4_HUMAN Histone-binding protein RBBP4 OS=Hom     70.9 13 2
P54136|SYRC_HUMAN Arginyl-tRNA synthetase, cytoplasmic OS     70.83 10 2
O75531|BAF_HUMAN Barrier-to-autointegration factor OS=Hom     70.71 35 2
Q9UNZ2|NSF1C_HUMAN NSFL1 cofactor p47 OS=Homo sapiens G   69.71 19 2
Q96SM3|CPXM1_HUMAN Probable carboxypeptidase X1 OS=Hom     69.31 18 2
Q9Y5K8|VATD_HUMAN V-type proton ATPase subunit D OS=Hom     69.29 32 2
Q14257|RCN2_HUMAN Reticulocalbin-2 OS=Homo sapiens GN=   68.29 21 2
O00410|IPO5_HUMAN Importin-5 OS=Homo sapiens GN=IPO5  68.23 13 2
O95218|ZRAB2_HUMAN Zinc finger Ran-binding domain-containin        67.78 14 2
P08243|ASNS_HUMAN Asparagine synthetase [glutamine-hydrol      67.46 10 2
P12830|CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH   67.27 10 2
P18124|RL7_HUMAN 60S ribosomal protein L7 OS=Homo sap    67.2 16 2
P12081|SYHC_HUMAN Histidyl-tRNA synthetase, cytoplasmic OS     66.96 18 2
Q07157|ZO1_HUMAN Tight junction protein ZO-1 OS=Homo sa    66.86 11 2
P36578|RL4_HUMAN 60S ribosomal protein L4 OS=Homo sap    66.42 19 2
P29762|RABP1_HUMAN Cellular retinoic acid-binding protein 1 OS     65.26 28 2
Q9UBW8|CSN7A_HUMAN COP9 signalosome complex subunit 7a O     65.1 29 2
Q96K17|BT3L4_HUMAN Transcription factor BTF3 homolog 4 OS     65.06 22 2
Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sap    64.9 11 2
Q9BVK6|TMED9_HUMAN Transmembrane emp24 domain-containi        64.33 17 2
Q96S86|HPLN3_HUMAN Hyaluronan and proteoglycan link protein      63.53 27 2
P35221|CTNA1_HUMAN Catenin alpha-1 OS=Homo sapiens GN=   63.32 7 2
Q15758|AAAT_HUMAN Neutral amino acid transporter B(0) OS=     61.89 14 2
Q14980|NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=H     61.85 11 2
Q13098|CSN1_HUMAN COP9 signalosome complex subunit 1 O     61.49 9 2
Q96QK1|VPS35_HUMAN Vacuolar protein sorting-associated prote       60.93 20 2
P04843|RPN1_HUMAN Dolichyl-diphosphooligosaccharide--prote         60.23 13 2
Q9Y5K5|UCHL5_HUMAN Ubiquitin carboxyl-terminal hydrolase isoz       60.2 15 2
Q92922|SMRC1_HUMAN SWI/SNF complex subunit SMARCC1 O     58.63 13 2
Q9Y624|JAM1_HUMAN Junctional adhesion molecule A OS=Hom     58.15 14 2
Q92841|DDX17_HUMAN Probable ATP-dependent RNA helicase D      58.1 17 2
P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase D      58.1 16 2
Q9Y5K6|CD2AP_HUMAN CD2-associated protein OS=Homo sapie    58.01 12 2
Q13243|SRSF5_HUMAN Serine/arginine-rich splicing factor 5 OS=     57.91 18 2
P20810|ICAL_HUMAN Calpastatin OS=Homo sapiens GN=CAS   57.44 12 2
P46060|RAGP1_HUMAN Ran GTPase-activating protein 1 OS=Ho     56.23 11 2
P19623|SPEE_HUMAN Spermidine synthase OS=Homo sapiens   55.93 17 2
Q99614|TTC1_HUMAN Tetratricopeptide repeat protein 1 OS=Ho     55.64 21 2
P09960|LKHA4_HUMAN Leukotriene A-4 hydrolase OS=Homo sa    55.24 6 2
P62861|RS30_HUMAN 40S ribosomal protein S30 OS=Homo sa    54.98 34 2
Q96PK2|MACF4_HUMAN Microtubule-actin cross-linking factor 1, is       52.81 11 2
P10768|ESTD_HUMAN S-formylglutathione hydrolase OS=Homo    52.37 10 2
P07203|GPX1_HUMAN Glutathione peroxidase 1 OS=Homo sap    52.1 12 2
Q96P16|RPR1A_HUMAN Regulation of nuclear pre-mRNA domain        51.91 20 2
Q9BVC6|TM109_HUMAN Transmembrane protein 109 OS=Homo s    51.87 39 2
Q9UPG8|PLAL2_HUMAN Zinc finger protein PLAGL2 OS=Homo sa    51.33 10 2
Q99615|DNJC7_HUMAN DnaJ homolog subfamily C member 7 OS     50.77 10 2
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O94985|CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens GN=CL   50.13 6 2
Q9H4M9|EHD1_HUMAN EH domain-containing protein 1 OS=Hom     49.9 16 2
P11413|G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase O     49 22 2
Q9H0I2|CP048_HUMAN Uncharacterized protein C16orf48 OS=H     46.14 22 2
P06756|ITAV_HUMAN Integrin alpha-V OS=Homo sapiens GN=   45.34 7 2
O15078|CE290_HUMAN Centrosomal protein of 290 kDa OS=Hom     45.23 13 2
P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=A   44.59 24 2
Q13043|STK4_HUMAN Serine/threonine-protein kinase 4 OS=Ho     44.22 21 2
P40763|STAT3_HUMAN Signal transducer and activator of transcr       43.51 5 2
Q8NE01|CNNM3_HUMAN Metal transporter CNNM3 OS=Homo sap    42.32 21 2
P45974|UBP5_HUMAN Ubiquitin carboxyl-terminal hydrolase 5 O     41.68 9 2
P49454|CENPF_HUMAN Centromere protein F OS=Homo sapiens   41.67 10 2
Q08752|PPID_HUMAN Peptidyl-prolyl cis-trans isomerase D OS=     41.04 16 2
P10586|PTPRF_HUMAN Receptor-type tyrosine-protein phosphata       39.02 8 2
Q9BXP5|SRRT_HUMAN Serrate RNA effector molecule homolog     38.84 16 2
P63000|RAC1_HUMAN Ras-related C3 botulinum toxin substrate      37.18 17 2
Q7L4E1|FA73B_HUMAN Protein FAM73B OS=Homo sapiens GN=   36.38 15 2
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Table A1.10 CA1 hESC CMTX Protein Identifications.  List of all proteins identified in 
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Accession Description Score Coverage (%) #Unique
P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA  348.93 55 72
P49327|FAS_HUMAN Fatty acid synthase OS=Homo sapiens   346.52 58 67
Q13813|SPTA2_HUMAN Spectrin alpha chain, brain OS=Homo s    328.54 61 63
O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB  333.1 56 55
P13639|EF2_HUMAN Elongation factor 2 OS=Homo sapiens G   340.62 73 53
P04406|G3P_HUMAN Glyceraldehyde-3-phosphate dehydroge      333.99 91 52
P18206|VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL P  329.26 76 51
P29401|TKT_HUMAN Transketolase OS=Homo sapiens GN=T   331.75 78 46
P14618|KPYM_HUMAN Pyruvate kinase isozymes M1/M2 OS=H     332.22 90 44
Q01995|TAGL_HUMAN Transgelin OS=Homo sapiens GN=TAG   307.02 95 41
P35580|MYH10_HUMAN Myosin-10 OS=Homo sapiens GN=MYH   306.82 57 38
Q01082|SPTB2_HUMAN Spectrin beta chain, brain 1 OS=Homo    296.14 61 38
P30041|PRDX6_HUMAN Peroxiredoxin-6 OS=Homo sapiens GN   292.67 93 38
P06733|ENOA_HUMAN Alpha-enolase OS=Homo sapiens GN=   301.35 88 37
P55072|TERA_HUMAN Transitional endoplasmic reticulum ATP      275.21 62 36
P35579|MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9  314.85 63 35
P04075|ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=     311.67 82 33
P07355|ANXA2_HUMAN Annexin A2 OS=Homo sapiens GN=AN   303.45 91 33
P68104|EF1A1_HUMAN Elongation factor 1-alpha 1 OS=Homo s    315.8 76 32
P62258|1433E_HUMAN 14-3-3 protein epsilon OS=Homo sapien    302.7 87 32
Q06830|PRDX1_HUMAN Peroxiredoxin-1 OS=Homo sapiens GN   299.56 88 31
P53396|ACLY_HUMAN ATP-citrate synthase OS=Homo sapien    270.95 69 31
O75874|IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytop      294.86 76 30
P07195|LDHB_HUMAN L-lactate dehydrogenase B chain OS=H     292.67 73 30
P60174|TPIS_HUMAN Triosephosphate isomerase OS=Homo    279.5 96 30
P08758|ANXA5_HUMAN Annexin A5 OS=Homo sapiens GN=AN   271.34 70 30
P12814|ACTN1_HUMAN Alpha-actinin-1 OS=Homo sapiens GN=   315.82 71 28
P63104|1433Z_HUMAN 14-3-3 protein zeta/delta OS=Homo sap    308.88 83 27
P11142|HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=     282.81 66 27
P07737|PROF1_HUMAN Profilin-1 OS=Homo sapiens GN=PFN1  273.18 97 26
P62805|H4_HUMAN Histone H4 OS=Homo sapiens GN=HIS   261.7 63 26
Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC  259.7 42 26
P10809|CH60_HUMAN 60 kDa heat shock protein, mitochondria      257.33 75 26
P50454|SERPH_HUMAN Serpin H1 OS=Homo sapiens GN=SER   284.13 73 25
P00338|LDHA_HUMAN L-lactate dehydrogenase A chain OS=H     282.93 81 25
P07900|HS90A_HUMAN Heat shock protein HSP 90-alpha OS=H     321.76 60 24
O43707|ACTN4_HUMAN Alpha-actinin-4 OS=Homo sapiens GN=   316.9 69 24
P23528|COF1_HUMAN Cofilin-1 OS=Homo sapiens GN=CFL1  282.49 93 24
P05455|LA_HUMAN Lupus La protein OS=Homo sapiens GN   262.62 72 24
P31939|PUR9_HUMAN Bifunctional purine biosynthesis protein      254.56 72 24
P67936|TPM4_HUMAN Tropomyosin alpha-4 chain OS=Homo s    319.2 95 23
P62937|PPIA_HUMAN Peptidyl-prolyl cis-trans isomerase A OS     254.93 93 23
P61247|RS3A_HUMAN 40S ribosomal protein S3a OS=Homo s    240.82 77 23
P50990|TCPQ_HUMAN T-complex protein 1 subunit theta OS=H     229.91 58 23
P02794|FRIH_HUMAN Ferritin heavy chain OS=Homo sapiens   221.88 77 23
Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens GN=TLN1 P  215.08 50 23
Q14914|PTGR1_HUMAN Prostaglandin reductase 1 OS=Homo sa    261.73 69 22
P37802|TAGL2_HUMAN Transgelin-2 OS=Homo sapiens GN=TA   245.46 97 22
P14625|ENPL_HUMAN Endoplasmin OS=Homo sapiens GN=H   241.99 47 22
P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN   240.53 71 22
Q9Y617|SERC_HUMAN Phosphoserine aminotransferase OS=H     222.4 67 22
P27348|1433T_HUMAN 14-3-3 protein theta OS=Homo sapiens   300.35 76 21
P09211|GSTP1_HUMAN Glutathione S-transferase P OS=Homo    279.58 92 21
Q04917|1433F_HUMAN 14-3-3 protein eta OS=Homo sapiens G   273.6 77 21
P12956|XRCC6_HUMAN X-ray repair cross-complementing prote       251.79 61 21
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P08133|ANXA6_HUMAN Annexin A6 OS=Homo sapiens GN=AN   238.21 55 21
P30101|PDIA3_HUMAN Protein disulfide-isomerase A3 OS=Hom     229.71 60 21
P09651|ROA1_HUMAN Heterogeneous nuclear ribonucleoprote       268.74 90 20
P22314|UBA1_HUMAN Ubiquitin-like modifier-activating enzyme      253.05 57 20
P23396|RS3_HUMAN 40S ribosomal protein S3 OS=Homo sa    251.58 85 20
P26038|MOES_HUMAN Moesin OS=Homo sapiens GN=MSN P  231.03 52 20
P39019|RS19_HUMAN 40S ribosomal protein S19 OS=Homo s    213.37 81 20
P18669|PGAM1_HUMAN Phosphoglycerate mutase 1 OS=Homo    291.45 94 19
Q00610|CLH1_HUMAN Clathrin heavy chain 1 OS=Homo sapie    262.75 47 19
P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, de      252.13 74 19
P25398|RS12_HUMAN 40S ribosomal protein S12 OS=Homo s    250.95 92 19
P08670|VIME_HUMAN Vimentin OS=Homo sapiens GN=VIM P  247.55 59 19
P13010|XRCC5_HUMAN X-ray repair cross-complementing prote       247.19 66 19
P06576|ATPB_HUMAN ATP synthase subunit beta, mitochondr      246.2 72 19
Q99832|TCPH_HUMAN T-complex protein 1 subunit eta OS=Ho     241.03 68 19
P48643|TCPE_HUMAN T-complex protein 1 subunit epsilon OS     239.83 79 19
Q01469|FABP5_HUMAN Fatty acid-binding protein, epidermal OS     260.11 90 18
P04083|ANXA1_HUMAN Annexin A1 OS=Homo sapiens GN=AN   248.02 68 18
P02792|FRIL_HUMAN Ferritin light chain OS=Homo sapiens G   247.82 73 18
P78371|TCPB_HUMAN T-complex protein 1 subunit beta OS=H     239.24 67 18
P00558|PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo s    236.01 73 18
P37837|TALDO_HUMAN Transaldolase OS=Homo sapiens GN=T   234.66 59 18
P22234|PUR6_HUMAN Multifunctional protein ADE2 OS=Homo    233.69 64 18
O00231|PSD11_HUMAN 26S proteasome non-ATPase regulatory       226.15 67 18
P62333|PRS10_HUMAN 26S protease regulatory subunit 10B OS     217.59 62 18
P49368|TCPG_HUMAN T-complex protein 1 subunit gamma OS     214.46 57 18
Q14152|EIF3A_HUMAN Eukaryotic translation initiation factor 3       209.47 34 18
P84243|H33_HUMAN Histone H3.3 OS=Homo sapiens GN=H   175.68 66 18
P63241|IF5A1_HUMAN Eukaryotic translation initiation factor 5A      255.86 87 17
P40926|MDHM_HUMAN Malate dehydrogenase, mitochondrial O     252.14 77 17
P15311|EZRI_HUMAN Ezrin OS=Homo sapiens GN=EZR PE=  245.75 62 17
O00299|CLIC1_HUMAN Chloride intracellular channel protein 1 O     242.59 92 17
P34932|HSP74_HUMAN Heat shock 70 kDa protein 4 OS=Homo    240.68 44 17
P46777|RL5_HUMAN 60S ribosomal protein L5 OS=Homo sa    239.17 61 17
P62195|PRS8_HUMAN 26S protease regulatory subunit 8 OS=H     238.18 66 17
P11021|GRP78_HUMAN 78 kDa glucose-regulated protein OS=H     236.37 54 17
P62826|RAN_HUMAN GTP-binding nuclear protein Ran OS=H     236 68 17
P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQG      226.51 50 17
P11586|C1TC_HUMAN C-1-tetrahydrofolate synthase, cytoplasm      222.32 50 17
Q9P2E9|RRBP1_HUMAN Ribosome-binding protein 1 OS=Homo    203.88 25 17
P62081|RS7_HUMAN 40S ribosomal protein S7 OS=Homo sa    201.56 65 17
P62269|RS18_HUMAN 40S ribosomal protein S18 OS=Homo s    194.93 70 17
P50395|GDIB_HUMAN Rab GDP dissociation inhibitor beta OS     276.43 74 16
P61981|1433G_HUMAN 14-3-3 protein gamma OS=Homo sapie    258.46 86 16
P19338|NUCL_HUMAN Nucleolin OS=Homo sapiens GN=NCL  252 64 16
P51665|PSD7_HUMAN 26S proteasome non-ATPase regulatory       244.25 69 16
P09936|UCHL1_HUMAN Ubiquitin carboxyl-terminal hydrolase iso       239.85 83 16
P62424|RL7A_HUMAN 60S ribosomal protein L7a OS=Homo s    234.48 62 16
P09874|PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Ho     232.46 43 16
P32119|PRDX2_HUMAN Peroxiredoxin-2 OS=Homo sapiens GN   231.95 57 16
P25705|ATPA_HUMAN ATP synthase subunit alpha, mitochond      231.84 71 16
P28074|PSB5_HUMAN Proteasome subunit beta type-5 OS=Ho     230.33 59 16
O00410|IPO5_HUMAN Importin-5 OS=Homo sapiens GN=IPO5  225.82 44 16
Q99497|PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PA   225.33 84 16
P04792|HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sa    224.97 68 16
P31948|STIP1_HUMAN Stress-induced-phosphoprotein 1 OS=H     224.9 47 16
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Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=     216.01 45 16
P35232|PHB_HUMAN Prohibitin OS=Homo sapiens GN=PHB  215.51 82 16
P61604|CH10_HUMAN 10 kDa heat shock protein, mitochondria      200.28 83 16
P12277|KCRB_HUMAN Creatine kinase B-type OS=Homo sapie    231.14 69 15
P61978|HNRPK_HUMAN Heterogeneous nuclear ribonucleoprote       230.93 58 15
Q9Y224|CN166_HUMAN UPF0568 protein C14orf166 OS=Homo    227.23 89 15
P20618|PSB1_HUMAN Proteasome subunit beta type-1 OS=Ho     226.83 73 15
O60664|PLIN3_HUMAN Perilipin-3 OS=Homo sapiens GN=PLIN   225.59 69 15
P63244|GBLP_HUMAN Guanine nucleotide-binding protein sub        225.36 67 15
P35998|PRS7_HUMAN 26S protease regulatory subunit 7 OS=H     221.78 59 15
P12429|ANXA3_HUMAN Annexin A3 OS=Homo sapiens GN=AN   220.33 71 15
P06744|G6PI_HUMAN Glucose-6-phosphate isomerase OS=H     219.01 44 15
P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucleoprote       210.07 58 15
P62316|SMD2_HUMAN Small nuclear ribonucleoprotein Sm D2     204.96 69 15
Q9Y230|RUVB2_HUMAN RuvB-like 2 OS=Homo sapiens GN=RU   199.09 41 15
P08238|HS90B_HUMAN Heat shock protein HSP 90-beta OS=Ho     322.53 65 14
P31946|1433B_HUMAN 14-3-3 protein beta/alpha OS=Homo sa    273.43 78 14
P22626|ROA2_HUMAN Heterogeneous nuclear ribonucleoprote       245.9 60 14
O43175|SERA_HUMAN D-3-phosphoglycerate dehydrogenase O     239.46 69 14
Q9HB71|CYBP_HUMAN Calcyclin-binding protein OS=Homo sap    236.91 71 14
P06748|NPM_HUMAN Nucleophosmin OS=Homo sapiens GN=   223.88 69 14
P23246|SFPQ_HUMAN Splicing factor, proline- and glutamine-r      206.38 47 14
P60900|PSA6_HUMAN Proteasome subunit alpha type-6 OS=H     205.63 56 14
Q04760|LGUL_HUMAN Lactoylglutathione lyase OS=Homo sap    200.5 55 14
P52272|HNRPM_HUMAN Heterogeneous nuclear ribonucleoprote       199.66 69 14
P30044|PRDX5_HUMAN Peroxiredoxin-5, mitochondrial OS=Hom     198.85 79 14
Q01518|CAP1_HUMAN Adenylyl cyclase-associated protein 1 O     197.81 63 14
P62263|RS14_HUMAN 40S ribosomal protein S14 OS=Homo s    197.37 56 14
Q7KZF4|SND1_HUMAN Staphylococcal nuclease domain-contai        195.29 38 14
P62280|RS11_HUMAN 40S ribosomal protein S11 OS=Homo s    193.73 63 14
P46781|RS9_HUMAN 40S ribosomal protein S9 OS=Homo sa    174.48 42 14
P00441|SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Hom     238.57 94 13
P26641|EF1G_HUMAN Elongation factor 1-gamma OS=Homo s    218.09 45 13
P40227|TCPZ_HUMAN T-complex protein 1 subunit zeta OS=H     216.61 51 13
O75347|TBCA_HUMAN Tubulin-specific chaperone A OS=Homo    214.46 80 13
Q9H9Z2|LN28A_HUMAN Protein lin-28 homolog A OS=Homo sap    212.11 61 13
P25789|PSA4_HUMAN Proteasome subunit alpha type-4 OS=H     211.26 61 13
Q15631|TSN_HUMAN Translin OS=Homo sapiens GN=TSN P  210.85 49 13
P62906|RL10A_HUMAN 60S ribosomal protein L10a OS=Homo    208.71 41 13
Q01581|HMCS1_HUMAN Hydroxymethylglutaryl-CoA synthase, cy      207.81 58 13
P13796|PLSL_HUMAN Plastin-2 OS=Homo sapiens GN=LCP1  205.66 48 13
P54577|SYYC_HUMAN Tyrosyl-tRNA synthetase, cytoplasmic O     203.19 55 13
O15067|PUR4_HUMAN Phosphoribosylformylglycinamidine synt      203.17 36 13
Q14019|COTL1_HUMAN Coactosin-like protein OS=Homo sapien    195.2 61 13
P58107|EPIPL_HUMAN Epiplakin OS=Homo sapiens GN=EPPK   162.59 25 13
O14818|PSA7_HUMAN Proteasome subunit alpha type-7 OS=H     250.18 88 12
P09972|ALDOC_HUMAN Fructose-bisphosphate aldolase C OS=     244.1 74 12
P50453|SPB9_HUMAN Serpin B9 OS=Homo sapiens GN=SER   224.88 58 12
O75531|BAF_HUMAN Barrier-to-autointegration factor OS=Ho     218.95 76 12
A8MW06|TMSL3_HUMAN Thymosin beta-4-like protein 3 OS=Hom     213.97 89 12
P62328|TYB4_HUMAN Thymosin beta-4 OS=Homo sapiens GN   213.97 89 12
P62277|RS13_HUMAN 40S ribosomal protein S13 OS=Homo s    210.57 61 12
Q9UL46|PSME2_HUMAN Proteasome activator complex subunit 2     205.93 79 12
Q15008|PSMD6_HUMAN 26S proteasome non-ATPase regulatory       201.47 41 12
Q99623|PHB2_HUMAN Prohibitin-2 OS=Homo sapiens GN=PH   200.27 56 12
Q15056|IF4H_HUMAN Eukaryotic translation initiation factor 4H     199.77 86 12
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Q05682|CALD1_HUMAN Caldesmon OS=Homo sapiens GN=CA   199.43 38 12
P23284|PPIB_HUMAN Peptidyl-prolyl cis-trans isomerase B OS     197.78 58 12
P29692|EF1D_HUMAN Elongation factor 1-delta OS=Homo sap    197.36 46 12
P49321|NASP_HUMAN Nuclear autoantigenic sperm protein OS     196.07 45 12
P78417|GSTO1_HUMAN Glutathione S-transferase omega-1 OS=     195.01 44 12
Q13200|PSMD2_HUMAN 26S proteasome non-ATPase regulatory       188.9 53 12
P17980|PRS6A_HUMAN 26S protease regulatory subunit 6A OS     182.86 53 12
O15144|ARPC2_HUMAN Actin-related protein 2/3 complex subun       181.92 52 12
P61353|RL27_HUMAN 60S ribosomal protein L27 OS=Homo s    180.7 60 12
Q02878|RL6_HUMAN 60S ribosomal protein L6 OS=Homo sa    172.46 38 12
Q15907|RB11B_HUMAN Ras-related protein Rab-11B OS=Homo    172.3 68 12
P42704|LPPRC_HUMAN Leucine-rich PPR motif-containing prote       141.1 30 12
P30153|2AAA_HUMAN Serine/threonine-protein phosphatase 2             249.96 67 11
P07741|APT_HUMAN Adenine phosphoribosyltransferase OS     220.09 90 11
Q15084|PDIA6_HUMAN Protein disulfide-isomerase A6 OS=Hom     218.87 67 11
P05387|RLA2_HUMAN 60S acidic ribosomal protein P2 OS=Ho     205.56 83 11
P28066|PSA5_HUMAN Proteasome subunit alpha type-5 OS=H     204.62 72 11
P62158|CALM_HUMAN Calmodulin OS=Homo sapiens GN=CA   201.81 59 11
P30086|PEBP1_HUMAN Phosphatidylethanolamine-binding prote       201.55 68 11
Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo    197.04 34 11
P40925|MDHC_HUMAN Malate dehydrogenase, cytoplasmic OS     196.66 57 11
Q15691|MARE1_HUMAN Microtubule-associated protein RP/EB f        196.23 44 11
P25786|PSA1_HUMAN Proteasome subunit alpha type-1 OS=H     190.99 65 11
P17174|AATC_HUMAN Aspartate aminotransferase, cytoplasmi      190.75 49 11
P43487|RANG_HUMAN Ran-specific GTPase-activating protein     189.74 64 11
Q9BWD1|THIC_HUMAN Acetyl-CoA acetyltransferase, cytosolic     186.62 61 11
P26639|SYTC_HUMAN Threonyl-tRNA synthetase, cytoplasmic     183.97 41 11
Q04837|SSBP_HUMAN Single-stranded DNA-binding protein, m      179.68 72 11
P46782|RS5_HUMAN 40S ribosomal protein S5 OS=Homo sa    179.5 57 11
P48681|NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE  178.4 18 11
P18621|RL17_HUMAN 60S ribosomal protein L17 OS=Homo s    174.85 61 11
P07093|GDN_HUMAN Glia-derived nexin OS=Homo sapiens G   174.5 52 11
P60903|S10AA_HUMAN Protein S100-A10 OS=Homo sapiens G   173.03 80 11
P18124|RL7_HUMAN 60S ribosomal protein L7 OS=Homo sa    172.34 59 11
P62760|VISL1_HUMAN Visinin-like protein 1 OS=Homo sapiens   171.01 69 11
O15145|ARPC3_HUMAN Actin-related protein 2/3 complex subun       163 49 11
P07814|SYEP_HUMAN Bifunctional aminoacyl-tRNA synthetase     161.29 23 11
P09493|TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo s    304.36 90 10
P06753|TPM3_HUMAN Tropomyosin alpha-3 chain OS=Homo s    299.42 81 10
P31947|1433S_HUMAN 14-3-3 protein sigma OS=Homo sapiens   222.04 87 10
P62701|RS4X_HUMAN 40S ribosomal protein S4, X isoform OS     221.74 68 10
Q96FW1|OTUB1_HUMAN Ubiquitin thioesterase OTUB1 OS=Hom     214.87 47 10
Q9Y696|CLIC4_HUMAN Chloride intracellular channel protein 4 O     211.06 76 10
Q9NZI8|IF2B1_HUMAN Insulin-like growth factor 2 mRNA-bindin        203.41 43 10
P63220|RS21_HUMAN 40S ribosomal protein S21 OS=Homo s    202.13 71 10
Q13907|IDI1_HUMAN Isopentenyl-diphosphate Delta-isomeras       201.96 59 10
O95336|6PGL_HUMAN 6-phosphogluconolactonase OS=Homo    201.05 77 10
P27695|APEX1_HUMAN DNA-(apurinic or apyrimidinic site) lyase     200.37 61 10
P30084|ECHM_HUMAN Enoyl-CoA hydratase, mitochondrial OS     199.04 68 10
Q7L2H7|EIF3M_HUMAN Eukaryotic translation initiation factor 3       198.27 71 10
P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 O     197.36 54 10
Q16851|UGPA_HUMAN UTP--glucose-1-phosphate uridylyltrans      196.5 38 10
Q9Y265|RUVB1_HUMAN RuvB-like 1 OS=Homo sapiens GN=RU   191.5 54 10
P62829|RL23_HUMAN 60S ribosomal protein L23 OS=Homo s    191.41 69 10
P30040|ERP29_HUMAN Endoplasmic reticulum resident protein      190.48 56 10
P22102|PUR2_HUMAN Trifunctional purine biosynthetic protein      189.59 42 10
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P22061|PIMT_HUMAN Protein-L-isoaspartate(D-aspartate) O-m      188.54 70 10
P50991|TCPD_HUMAN T-complex protein 1 subunit delta OS=H     188.22 42 10
P24539|AT5F1_HUMAN ATP synthase subunit b, mitochondrial O     187.12 48 10
O00151|PDLI1_HUMAN PDZ and LIM domain protein 1 OS=Hom     184.55 42 10
O43242|PSMD3_HUMAN 26S proteasome non-ATPase regulatory       181.74 44 10
P48047|ATPO_HUMAN ATP synthase subunit O, mitochondrial     181.19 72 10
P15559|NQO1_HUMAN NAD(P)H dehydrogenase [quinone] 1 O     177.1 56 10
P62249|RS16_HUMAN 40S ribosomal protein S16 OS=Homo s    174.88 66 10
Q00839|HNRPU_HUMAN Heterogeneous nuclear ribonucleoprote       174.67 28 10
P51149|RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo s    174.17 56 10
Q14697|GANAB_HUMAN Neutral alpha-glucosidase AB OS=Hom     174 28 10
Q07020|RL18_HUMAN 60S ribosomal protein L18 OS=Homo s    172.96 48 10
P62750|RL23A_HUMAN 60S ribosomal protein L23a OS=Homo    172.53 61 10
P63173|RL38_HUMAN 60S ribosomal protein L38 OS=Homo s    168.34 61 10
P53634|CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapie    165.77 31 10
P07237|PDIA1_HUMAN Protein disulfide-isomerase OS=Homo s    165.08 39 10
P49755|TMEDA_HUMAN Transmembrane emp24 domain-contain        164.65 48 10
P27816|MAP4_HUMAN Microtubule-associated protein 4 OS=H     162.42 27 10
P17987|TCPA_HUMAN T-complex protein 1 subunit alpha OS=     160.58 48 10
P26373|RL13_HUMAN 60S ribosomal protein L13 OS=Homo s    144.94 37 10
Q9GZZ1|NAA50_HUMAN N-alpha-acetyltransferase 50, NatE cata       132.28 55 10
P12829|MYL4_HUMAN Myosin light chain 4 OS=Homo sapiens   209.03 63 9
P09429|HMGB1_HUMAN High mobility group protein B1 OS=Hom     205.41 61 9
P13797|PLST_HUMAN Plastin-3 OS=Homo sapiens GN=PLS3  201.43 57 9
P49588|SYAC_HUMAN Alanyl-tRNA synthetase, cytoplasmic OS     197.17 52 9
P12268|IMDH2_HUMAN Inosine-5'-monophosphate dehydrogena       194.48 37 9
P16401|H15_HUMAN Histone H1.5 OS=Homo sapiens GN=H   193.64 58 9
P15880|RS2_HUMAN 40S ribosomal protein S2 OS=Homo sa    188.02 65 9
P09960|LKHA4_HUMAN Leukotriene A-4 hydrolase OS=Homo s    186.75 46 9
P47756|CAPZB_HUMAN F-actin-capping protein subunit beta OS     185.32 64 9
P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=H     185.17 48 9
P14324|FPPS_HUMAN Farnesyl pyrophosphate synthase OS=H     183.31 48 9
Q9UNM6|PSD13_HUMAN 26S proteasome non-ATPase regulatory       182.21 55 9
P49720|PSB3_HUMAN Proteasome subunit beta type-3 OS=Ho     181.6 64 9
P12004|PCNA_HUMAN Proliferating cell nuclear antigen OS=Ho     180.66 59 9
P09382|LEG1_HUMAN Galectin-1 OS=Homo sapiens GN=LGA   177.62 74 9
Q15404|RSU1_HUMAN Ras suppressor protein 1 OS=Homo sa    174.31 68 9
P07108|ACBP_HUMAN Acyl-CoA-binding protein OS=Homo sap    173.46 85 9
P38646|GRP75_HUMAN Stress-70 protein, mitochondrial OS=Ho     171.62 31 9
Q99536|VAT1_HUMAN Synaptic vesicle membrane protein VAT       170.64 52 9
P43686|PRS6B_HUMAN 26S protease regulatory subunit 6B OS     169.89 27 9
P62244|RS15A_HUMAN 40S ribosomal protein S15a OS=Homo    167.74 76 9
P09661|RU2A_HUMAN U2 small nuclear ribonucleoprotein A' O     166.35 54 9
P14678|RSMB_HUMAN Small nuclear ribonucleoprotein-associa          165.31 71 9
P63162|RSMN_HUMAN Small nuclear ribonucleoprotein-associa        165.31 58 9
P60866|RS20_HUMAN 40S ribosomal protein S20 OS=Homo s    164.06 54 9
Q9Y295|DRG1_HUMAN Developmentally-regulated GTP-binding       155.66 48 9
Q5T7N2|LITD1_HUMAN LINE-1 type transposase domain-contai        154.94 32 9
P00505|AATM_HUMAN Aspartate aminotransferase, mitochond      153.16 33 9
Q8N163|K1967_HUMAN Protein KIAA1967 OS=Homo sapiens G   150.4 22 9
P41250|SYG_HUMAN Glycyl-tRNA synthetase OS=Homo sapi    147.43 20 9
P18077|RL35A_HUMAN 60S ribosomal protein L35a OS=Homo    133.07 30 9
P60842|IF4A1_HUMAN Eukaryotic initiation factor 4A-I OS=Hom     226.95 48 8
A6NL28|TPM3L_HUMAN Putative tropomyosin alpha-3 chain-like     208.17 50 8
P61758|PFD3_HUMAN Prefoldin subunit 3 OS=Homo sapiens G   199.6 68 8
Q01105|SET_HUMAN Protein SET OS=Homo sapiens GN=SE   195.99 62 8
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P54819|KAD2_HUMAN Adenylate kinase 2, mitochondrial OS=H     185.35 69 8
P08865|RSSA_HUMAN 40S ribosomal protein SA OS=Homo sa    182.55 38 8
Q13185|CBX3_HUMAN Chromobox protein homolog 3 OS=Hom     182.55 55 8
P60983|GMFB_HUMAN Glia maturation factor beta OS=Homo s    180.6 61 8
P49903|SPS1_HUMAN Selenide, water dikinase 1 OS=Homo s    180.22 53 8
P06493|CDK1_HUMAN Cyclin-dependent kinase 1 OS=Homo s    179.88 62 8
P46783|RS10_HUMAN 40S ribosomal protein S10 OS=Homo s    179.6 57 8
P60981|DEST_HUMAN Destrin OS=Homo sapiens GN=DSTN P  179.56 53 8
Q9Y3I0|RTCB_HUMAN tRNA-splicing ligase RtcB homolog OS=     178.44 61 8
P31949|S10AB_HUMAN Protein S100-A11 OS=Homo sapiens G   177.92 90 8
Q08J23|NSUN2_HUMAN tRNA (cytosine(34)-C(5))-methyltransfer      177.48 41 8
Q99714|HCD2_HUMAN 3-hydroxyacyl-CoA dehydrogenase type      174.35 54 8
O43809|CPSF5_HUMAN Cleavage and polyadenylation specificit         173.5 61 8
P61289|PSME3_HUMAN Proteasome activator complex subunit 3     172.4 56 8
P16152|CBR1_HUMAN Carbonyl reductase [NADPH] 1 OS=Ho     170.91 57 8
P62888|RL30_HUMAN 60S ribosomal protein L30 OS=Homo s    170.01 73 8
P60953|CDC42_HUMAN Cell division control protein 42 homolog     169.87 53 8
Q13838|DX39B_HUMAN Spliceosome RNA helicase DDX39B OS     168.78 32 8
Q14566|MCM6_HUMAN DNA replication licensing factor MCM6 O     168.26 18 8
P62241|RS8_HUMAN 40S ribosomal protein S8 OS=Homo sa    166.8 57 8
P14550|AK1A1_HUMAN Alcohol dehydrogenase [NADP+] OS=H     166.66 44 8
Q9NR30|DDX21_HUMAN Nucleolar RNA helicase 2 OS=Homo sa    165.94 33 8
P61158|ARP3_HUMAN Actin-related protein 3 OS=Homo sapie    165.63 31 8
P35268|RL22_HUMAN 60S ribosomal protein L22 OS=Homo s    164.76 71 8
O60701|UGDH_HUMAN UDP-glucose 6-dehydrogenase OS=Ho     164.38 26 8
P25788|PSA3_HUMAN Proteasome subunit alpha type-3 OS=H     164.07 49 8
O43765|SGTA_HUMAN Small glutamine-rich tetratricopeptide re        163.55 43 8
P10909|CLUS_HUMAN Clusterin OS=Homo sapiens GN=CLU P  161.11 26 8
Q9BT78|CSN4_HUMAN COP9 signalosome complex subunit 4 O     161 44 8
Q15233|NONO_HUMAN Non-POU domain-containing octamer-b       159.68 58 8
P30048|PRDX3_HUMAN Thioredoxin-dependent peroxide reduct       158.44 42 8
P16949|STMN1_HUMAN Stathmin OS=Homo sapiens GN=STMN   158.27 46 8
Q09666|AHNK_HUMAN Neuroblast differentiation-associated pr       156.33 19 8
P35573|GDE_HUMAN Glycogen debranching enzyme OS=Hom     155.97 22 8
Q9H9Q2|CSN7B_HUMAN COP9 signalosome complex subunit 7b     155.47 46 8
Q9Y266|NUDC_HUMAN Nuclear migration protein nudC OS=Ho     154.8 39 8
Q9P2J5|SYLC_HUMAN Leucyl-tRNA synthetase, cytoplasmic O     154.16 25 8
P06454|PTMA_HUMAN Prothymosin alpha OS=Homo sapiens G   153.41 62 8
P14868|SYDC_HUMAN Aspartyl-tRNA synthetase, cytoplasmic     150.83 26 8
Q16181|SEPT7_HUMAN Septin-7 OS=Homo sapiens GN=SEPT   149.87 45 8
Q07955|SRSF1_HUMAN Serine/arginine-rich splicing factor 1 OS     147.48 47 8
P82979|SARNP_HUMAN SAP domain-containing ribonucleoprote      146.35 57 8
P49721|PSB2_HUMAN Proteasome subunit beta type-2 OS=Ho     145.15 36 8
Q9P258|RCC2_HUMAN Protein RCC2 OS=Homo sapiens GN=R   140.96 34 8
P62851|RS25_HUMAN 40S ribosomal protein S25 OS=Homo s    138.86 38 8
Q15019|SEPT2_HUMAN Septin-2 OS=Homo sapiens GN=SEPT2  138.5 29 8
Q9UBE0|SAE1_HUMAN SUMO-activating enzyme subunit 1 OS=     129.01 39 8
Q15075|EEA1_HUMAN Early endosome antigen 1 OS=Homo sa    118.81 15 8
P07437|TBB5_HUMAN Tubulin beta chain OS=Homo sapiens G   336.6 82 7
P22392|NDKB_HUMAN Nucleoside diphosphate kinase B OS=H     246.77 92 7
P84077|ARF1_HUMAN ADP-ribosylation factor 1 OS=Homo sap    211.12 85 7
P61204|ARF3_HUMAN ADP-ribosylation factor 3 OS=Homo sap    211.12 80 7
Q16555|DPYL2_HUMAN Dihydropyrimidinase-related protein 2 O     197.25 55 7
P55209|NP1L1_HUMAN Nucleosome assembly protein 1-like 1 O     196.55 34 7
P25787|PSA2_HUMAN Proteasome subunit alpha type-2 OS=H     193.66 47 7
P60660|MYL6_HUMAN Myosin light polypeptide 6 OS=Homo sa    188.78 68 7
294
P23526|SAHH_HUMAN Adenosylhomocysteinase OS=Homo sa    185.35 45 7
Q99439|CNN2_HUMAN Calponin-2 OS=Homo sapiens GN=CNN   184.61 47 7
Q15181|IPYR_HUMAN Inorganic pyrophosphatase OS=Homo s    181.03 55 7
P02751|FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1  180.55 15 7
P30050|RL12_HUMAN 60S ribosomal protein L12 OS=Homo s    178.97 61 7
Q14195|DPYL3_HUMAN Dihydropyrimidinase-related protein 3 O     178.97 41 7
Q12906|ILF3_HUMAN Interleukin enhancer-binding factor 3 OS     178.57 40 7
P07602|SAP_HUMAN Proactivator polypeptide OS=Homo sap    174.69 49 7
P36405|ARL3_HUMAN ADP-ribosylation factor-like protein 3 OS     174.54 77 7
P27797|CALR_HUMAN Calreticulin OS=Homo sapiens GN=CA   174.41 33 7
P52907|CAZA1_HUMAN F-actin-capping protein subunit alpha-1     173.63 42 7
P45974|UBP5_HUMAN Ubiquitin carboxyl-terminal hydrolase 5     173.14 24 7
P68036|UB2L3_HUMAN Ubiquitin-conjugating enzyme E2 L3 OS     172.83 68 7
Q92499|DDX1_HUMAN ATP-dependent RNA helicase DDX1 OS     171.05 35 7
Q15942|ZYX_HUMAN Zyxin OS=Homo sapiens GN=ZYX PE=  170.75 29 7
Q71UI9|H2AV_HUMAN Histone H2A.V OS=Homo sapiens GN=   168.63 56 7
P0C0S5|H2AZ_HUMAN Histone H2A.Z OS=Homo sapiens GN=   168.63 56 7
P62753|RS6_HUMAN 40S ribosomal protein S6 OS=Homo sa    168.53 34 7
P53999|TCP4_HUMAN Activated RNA polymerase II transcriptio        168.38 51 7
Q13126|MTAP_HUMAN S-methyl-5'-thioadenosine phosphorylas      167.58 48 7
P61106|RAB14_HUMAN Ras-related protein Rab-14 OS=Homo s    166.8 52 7
P20290|BTF3_HUMAN Transcription factor BTF3 OS=Homo sa    166.72 66 7
Q9Y2B0|CNPY2_HUMAN Protein canopy homolog 2 OS=Homo sa    166.64 60 7
P37108|SRP14_HUMAN Signal recognition particle 14 kDa prote      166.3 43 7
P50502|F10A1_HUMAN Hsc70-interacting protein OS=Homo sa    165.92 33 7
P05067|A4_HUMAN Amyloid beta A4 protein OS=Homo sap    165.88 26 7
P33176|KINH_HUMAN Kinesin-1 heavy chain OS=Homo sapie    164.98 43 7
Q9H4A6|GOLP3_HUMAN Golgi phosphoprotein 3 OS=Homo sapi    164.79 39 7
Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapien    164.48 19 7
Q12904|AIMP1_HUMAN Aminoacyl tRNA synthase complex-inte         164.32 38 7
Q9Y3F4|STRAP_HUMAN Serine-threonine kinase receptor-assoc       163.17 37 7
P62841|RS15_HUMAN 40S ribosomal protein S15 OS=Homo s    161.77 51 7
P24534|EF1B_HUMAN Elongation factor 1-beta OS=Homo sap    161.67 39 7
Q13263|TIF1B_HUMAN Transcription intermediary factor 1-beta     159.97 28 7
P61019|RAB2A_HUMAN Ras-related protein Rab-2A OS=Homo    159.04 41 7
P63279|UBC9_HUMAN SUMO-conjugating enzyme UBC9 OS=     158.47 32 7
Q15843|NEDD8_HUMAN NEDD8 OS=Homo sapiens GN=NEDD8  157.58 62 7
P61088|UBE2N_HUMAN Ubiquitin-conjugating enzyme E2 N OS=     156.94 68 7
Q02790|FKBP4_HUMAN Peptidyl-prolyl cis-trans isomerase FKB      156.86 31 7
P46926|GNPI1_HUMAN Glucosamine-6-phosphate isomerase 1     156.83 42 7
Q9HC38|GLOD4_HUMAN Glyoxalase domain-containing protein 4     156.2 36 7
P30046|DOPD_HUMAN D-dopachrome decarboxylase OS=Hom     155.11 56 7
Q9Y2Z0|SUGT1_HUMAN Suppressor of G2 allele of SKP1 homol      154.77 47 7
Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein k          154.3 42 7
Q9H3K6|BOLA2_HUMAN BolA-like protein 2 OS=Homo sapiens G   153.94 72 7
Q08211|DHX9_HUMAN ATP-dependent RNA helicase A OS=Ho     153.93 17 7
Q02543|RL18A_HUMAN 60S ribosomal protein L18a OS=Homo    153.88 47 7
P08708|RS17_HUMAN 40S ribosomal protein S17 OS=Homo s    153.64 76 7
O00232|PSD12_HUMAN 26S proteasome non-ATPase regulatory       153.09 39 7
P59998|ARPC4_HUMAN Actin-related protein 2/3 complex subun       152.93 62 7
O75489|NDUS3_HUMAN NADH dehydrogenase [ubiquinone] iron         152.91 50 7
P43243|MATR3_HUMAN Matrin-3 OS=Homo sapiens GN=MATR   152.12 29 7
P32969|RL9_HUMAN 60S ribosomal protein L9 OS=Homo sa    151.38 58 7
P46778|RL21_HUMAN 60S ribosomal protein L21 OS=Homo s    151.07 40 7
P05937|CALB1_HUMAN Calbindin OS=Homo sapiens GN=CALB   150.86 45 7
Q15149|PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC P  149.19 18 7
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Q5VYK3|ECM29_HUMAN Proteasome-associated protein ECM29      149.05 37 7
Q9BYT8|NEUL_HUMAN Neurolysin, mitochondrial OS=Homo sa    148.81 24 7
Q9NZL4|HPBP1_HUMAN Hsp70-binding protein 1 OS=Homo sap    148.69 33 7
Q16658|FSCN1_HUMAN Fascin OS=Homo sapiens GN=FSCN1  148.66 32 7
P55145|MANF_HUMAN Mesencephalic astrocyte-derived neuro       148.56 54 7
P36578|RL4_HUMAN 60S ribosomal protein L4 OS=Homo sa    146.26 23 7
P62633|CNBP_HUMAN Cellular nucleic acid-binding protein OS     146.06 53 7
Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding       145.21 27 7
P55769|NH2L1_HUMAN NHP2-like protein 1 OS=Homo sapiens   144.72 41 7
P61081|UBC12_HUMAN NEDD8-conjugating enzyme Ubc12 OS     144.21 44 7
P62857|RS28_HUMAN 40S ribosomal protein S28 OS=Homo s    143.07 57 7
P63000|RAC1_HUMAN Ras-related C3 botulinum toxin substrat       142.95 35 7
Q86VP6|CAND1_HUMAN Cullin-associated NEDD8-dissociated p       141.54 17 7
Q9NP97|DLRB1_HUMAN Dynein light chain roadblock-type 1 OS=     139.12 91 7
Q92616|GCN1L_HUMAN Translational activator GCN1 OS=Homo    138.81 17 7
P27635|RL10_HUMAN 60S ribosomal protein L10 OS=Homo s    138.37 31 7
P25205|MCM3_HUMAN DNA replication licensing factor MCM3 O     137.11 38 7
Q15370|ELOB_HUMAN Transcription elongation factor B polype       136.92 49 7
P48556|PSMD8_HUMAN 26S proteasome non-ATPase regulatory       129.8 35 7
O75947|ATP5H_HUMAN ATP synthase subunit d, mitochondrial O     125.39 55 7
P52701|MSH6_HUMAN DNA mismatch repair protein Msh6 OS=     125.36 15 7
O43324|MCA3_HUMAN Eukaryotic translation elongation factor       117.5 40 7
Q9BXJ9|NAA15_HUMAN N-alpha-acetyltransferase 15, NatA aux       117.3 13 7
P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens   117 12 7
P62136|PP1A_HUMAN Serine/threonine-protein phosphatase P        243.73 62 6
Q9BUF5|TBB6_HUMAN Tubulin beta-6 chain OS=Homo sapiens   236.14 78 6
P15531|NDKA_HUMAN Nucleoside diphosphate kinase A OS=H     234.26 72 6
Q06323|PSME1_HUMAN Proteasome activator complex subunit 1     180.47 65 6
P21291|CSRP1_HUMAN Cysteine and glycine-rich protein 1 OS=     177.09 65 6
Q15121|PEA15_HUMAN Astrocytic phosphoprotein PEA-15 OS=     173.78 88 6
P36404|ARL2_HUMAN ADP-ribosylation factor-like protein 2 OS     172.92 53 6
P52292|IMA2_HUMAN Importin subunit alpha-2 OS=Homo sap    172.76 37 6
P21796|VDAC1_HUMAN Voltage-dependent anion-selective chan        168.48 43 6
Q9Y333|LSM2_HUMAN U6 snRNA-associated Sm-like protein L      168.45 86 6
O60610|DIAP1_HUMAN Protein diaphanous homolog 1 OS=Hom     168.43 26 6
Q99598|TSNAX_HUMAN Translin-associated protein X OS=Homo    167.99 57 6
Q9Y262|EIF3L_HUMAN Eukaryotic translation initiation factor 3       167.96 35 6
Q96FQ6|S10AG_HUMAN Protein S100-A16 OS=Homo sapiens G   165.62 56 6
P04632|CPNS1_HUMAN Calpain small subunit 1 OS=Homo sapi    164.99 63 6
Q14103|HNRPD_HUMAN Heterogeneous nuclear ribonucleoprote       164.86 45 6
Q15365|PCBP1_HUMAN Poly(rC)-binding protein 1 OS=Homo sa    164.63 64 6
P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens GN=LMN   163.92 33 6
P35221|CTNA1_HUMAN Catenin alpha-1 OS=Homo sapiens GN   162.63 41 6
Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate r      162.59 41 6
P13073|COX41_HUMAN Cytochrome c oxidase subunit 4 isoform       161.11 62 6
P63313|TYB10_HUMAN Thymosin beta-10 OS=Homo sapiens G   159.97 82 6
Q99471|PFD5_HUMAN Prefoldin subunit 5 OS=Homo sapiens G   155.84 60 6
Q16643|DREB_HUMAN Drebrin OS=Homo sapiens GN=DBN1 P  155.38 24 6
Q9Y3B8|ORN_HUMAN Oligoribonuclease, mitochondrial OS=H     155.01 45 6
P62913|RL11_HUMAN 60S ribosomal protein L11 OS=Homo s    154.16 30 6
Q9UKK9|NUDT5_HUMAN ADP-sugar pyrophosphatase OS=Homo    151.76 36 6
Q8WW12|PCNP_HUMAN PEST proteolytic signal-containing nucle       151.72 57 6
P29762|RABP1_HUMAN Cellular retinoic acid-binding protein 1 O     150.66 53 6
P84103|SRSF3_HUMAN Serine/arginine-rich splicing factor 3 OS     150.21 46 6
O14737|PDCD5_HUMAN Programmed cell death protein 5 OS=H     148.72 51 6
P33993|MCM7_HUMAN DNA replication licensing factor MCM7 O     148.56 30 6
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P11177|ODPB_HUMAN Pyruvate dehydrogenase E1 componen         147.9 45 6
P05388|RLA0_HUMAN 60S acidic ribosomal protein P0 OS=Ho     147.46 30 6
Q9NTK5|OLA1_HUMAN Obg-like ATPase 1 OS=Homo sapiens G   147.09 32 6
P50552|VASP_HUMAN Vasodilator-stimulated phosphoprotein O     145.35 46 6
P49736|MCM2_HUMAN DNA replication licensing factor MCM2 O     145.31 36 6
P62917|RL8_HUMAN 60S ribosomal protein L8 OS=Homo sa    144.43 38 6
P13667|PDIA4_HUMAN Protein disulfide-isomerase A4 OS=Hom     143.85 16 6
Q9Y4L1|HYOU1_HUMAN Hypoxia up-regulated protein 1 OS=Hom     143.53 25 6
Q12765|SCRN1_HUMAN Secernin-1 OS=Homo sapiens GN=SCR   143.3 26 6
P00492|HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltr      143.03 31 6
Q9Y5K6|CD2AP_HUMAN CD2-associated protein OS=Homo sapi    142.91 23 6
O00244|ATOX1_HUMAN Copper transport protein ATOX1 OS=H     142.36 78 6
P13693|TCTP_HUMAN Translationally-controlled tumor protein     141.86 40 6
O14579|COPE_HUMAN Coatomer subunit epsilon OS=Homo sa    140.79 39 6
P49915|GUAA_HUMAN GMP synthase [glutamine-hydrolyzing] O     140.65 31 6
O15372|EIF3H_HUMAN Eukaryotic translation initiation factor 3       140.43 38 6
P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=L   139.03 22 6
O15347|HMGB3_HUMAN High mobility group protein B3 OS=Hom     138.78 36 6
P49773|HINT1_HUMAN Histidine triad nucleotide-binding protein      138.55 44 6
P47985|UCRI_HUMAN Cytochrome b-c1 complex subunit Riesk       138.07 50 6
P50914|RL14_HUMAN 60S ribosomal protein L14 OS=Homo s    137.31 41 6
P33991|MCM4_HUMAN DNA replication licensing factor MCM4 O     136.27 29 6
Q92945|FUBP2_HUMAN Far upstream element-binding protein 2     136.11 21 6
P62899|RL31_HUMAN 60S ribosomal protein L31 OS=Homo s    134.45 49 6
O75223|GGCT_HUMAN Gamma-glutamylcyclotransferase OS=H     134.27 70 6
P54578|UBP14_HUMAN Ubiquitin carboxyl-terminal hydrolase 14     134.27 27 6
P07686|HEXB_HUMAN Beta-hexosaminidase subunit beta OS=     133.34 21 6
P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapie    132.97 23 6
P24666|PPAC_HUMAN Low molecular weight phosphotyrosine       132.04 51 6
P54136|SYRC_HUMAN Arginyl-tRNA synthetase, cytoplasmic O     131.23 21 6
P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens GN=CT   129.38 24 6
P09525|ANXA4_HUMAN Annexin A4 OS=Homo sapiens GN=AN   127.84 40 6
Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7     127.06 15 6
P27144|KAD4_HUMAN Adenylate kinase isoenzyme 4, mitocho      126.67 32 6
O95671|ASML_HUMAN N-acetylserotonin O-methyltransferase-       126.58 32 6
O76003|GLRX3_HUMAN Glutaredoxin-3 OS=Homo sapiens GN=   126.53 43 6
P20674|COX5A_HUMAN Cytochrome c oxidase subunit 5A, mitoc      126.09 43 6
P09669|COX6C_HUMAN Cytochrome c oxidase subunit 6C OS=H     124.52 61 6
Q14204|DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS     124.05 17 6
Q6PKG0|LARP1_HUMAN La-related protein 1 OS=Homo sapiens   123.34 17 6
Q9NUP9|LIN7C_HUMAN Protein lin-7 homolog C OS=Homo sapi    122.09 44 6
P46779|RL28_HUMAN 60S ribosomal protein L28 OS=Homo s    121.53 42 6
A0MZ66|SHOT1_HUMAN Shootin-1 OS=Homo sapiens GN=KIAA   119.09 16 6
P46821|MAP1B_HUMAN Microtubule-associated protein 1B OS=     117.05 12 6
P62312|LSM6_HUMAN U6 snRNA-associated Sm-like protein L      112.24 46 6
P14174|MIF_HUMAN Macrophage migration inhibitory factor O     107.42 21 6
Q14978|NOLC1_HUMAN Nucleolar and coiled-body phosphoprot       99.59 20 6
O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapie    97.88 13 6
Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 73.43 6 6
Q9H0U4|RAB1B_HUMAN Ras-related protein Rab-1B OS=Homo    192.63 70 5
Q13765|NACA_HUMAN Nascent polypeptide-associated comple        181.13 45 5
Q13310|PABP4_HUMAN Polyadenylate-binding protein 4 OS=Ho     178.55 39 5
O60506|HNRPQ_HUMAN Heterogeneous nuclear ribonucleoprote       176.7 37 5
Q92841|DDX17_HUMAN Probable ATP-dependent RNA helicase      175.85 36 5
Q99733|NP1L4_HUMAN Nucleosome assembly protein 1-like 4 O     162.28 31 5
P83916|CBX1_HUMAN Chromobox protein homolog 1 OS=Hom     160.03 36 5
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O43399|TPD54_HUMAN Tumor protein D54 OS=Homo sapiens G   158.98 63 5
P13804|ETFA_HUMAN Electron transfer flavoprotein subunit al       158.63 42 5
P46060|RAGP1_HUMAN Ran GTPase-activating protein 1 OS=H     158.3 59 5
O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapie    156.28 41 5
Q9Y5L4|TIM13_HUMAN Mitochondrial import inner membrane tra        156 79 5
P22087|FBRL_HUMAN rRNA 2'-O-methyltransferase fibrillarin O     155.35 45 5
Q9BUT1|BDH2_HUMAN 3-hydroxybutyrate dehydrogenase type      154.27 50 5
Q15185|TEBP_HUMAN Prostaglandin E synthase 3 OS=Homo    153.53 63 5
O75348|VATG1_HUMAN V-type proton ATPase subunit G 1 OS=     152.94 43 5
P62314|SMD1_HUMAN Small nuclear ribonucleoprotein Sm D1     150.93 54 5
P36969|GPX4_HUMAN Phospholipid hydroperoxide glutathione       150.71 42 5
P61970|NTF2_HUMAN Nuclear transport factor 2 OS=Homo sa    150.68 81 5
P61160|ARP2_HUMAN Actin-related protein 2 OS=Homo sapie    150.56 37 5
P52565|GDIR1_HUMAN Rho GDP-dissociation inhibitor 1 OS=H     148.99 41 5
Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens GN=CAPR   148.85 24 5
P28072|PSB6_HUMAN Proteasome subunit beta type-6 OS=Ho     148.75 60 5
P05198|IF2A_HUMAN Eukaryotic translation initiation factor 2       148.23 40 5
P17096|HMGA1_HUMAN High mobility group protein HMG-I/HMG      146.09 71 5
Q15785|TOM34_HUMAN Mitochondrial import receptor subunit TO      144.63 38 5
P55327|TPD52_HUMAN Tumor protein D52 OS=Homo sapiens G   143.28 45 5
A6NDG6|PGP_HUMAN Phosphoglycolate phosphatase OS=Ho     143.21 51 5
P43246|MSH2_HUMAN DNA mismatch repair protein Msh2 OS=     142.84 23 5
P54920|SNAA_HUMAN Alpha-soluble NSF attachment protein O     142.08 43 5
P56537|IF6_HUMAN Eukaryotic translation initiation factor 6     141.86 45 5
P08590|MYL3_HUMAN Myosin light chain 3 OS=Homo sapiens   141.71 54 5
P28838|AMPL_HUMAN Cytosol aminopeptidase OS=Homo sap    141.63 19 5
Q13619|CUL4A_HUMAN Cullin-4A OS=Homo sapiens GN=CUL4   141.56 22 5
Q6GMV3|CB079_HUMAN Uncharacterized protein C2orf79 OS=H     140.53 47 5
P35520|CBS_HUMAN Cystathionine beta-synthase OS=Homo    139.65 30 5
P04818|TYSY_HUMAN Thymidylate synthase OS=Homo sapien    137.73 42 5
P10599|THIO_HUMAN Thioredoxin OS=Homo sapiens GN=TX   137.64 55 5
P62304|RUXE_HUMAN Small nuclear ribonucleoprotein E OS=H     137.16 73 5
Q13616|CUL1_HUMAN Cullin-1 OS=Homo sapiens GN=CUL1 P  136.98 27 5
Q07021|C1QBP_HUMAN Complement component 1 Q subcompo        136.76 26 5
P28070|PSB4_HUMAN Proteasome subunit beta type-4 OS=Ho     136.62 39 5
Q15046|SYK_HUMAN Lysyl-tRNA synthetase OS=Homo sapie    136.46 19 5
Q13011|ECH1_HUMAN Delta(3,5)-Delta(2,4)-dienoyl-CoA isome       135.78 26 5
P42766|RL35_HUMAN 60S ribosomal protein L35 OS=Homo s    135.76 31 5
Q9BRX8|CJ058_HUMAN UPF0765 protein C10orf58 OS=Homo s    135.53 57 5
Q9UHV9|PFD2_HUMAN Prefoldin subunit 2 OS=Homo sapiens G   135.52 63 5
Q96AE4|FUBP1_HUMAN Far upstream element-binding protein 1     135.35 31 5
P30520|PURA2_HUMAN Adenylosuccinate synthetase isozyme 2     134.92 25 5
P26196|DDX6_HUMAN Probable ATP-dependent RNA helicase      134.91 32 5
Q9UBQ5|EIF3K_HUMAN Eukaryotic translation initiation factor 3       134.67 38 5
Q99622|C10_HUMAN Protein C10 OS=Homo sapiens GN=C1   134.51 48 5
Q15417|CNN3_HUMAN Calponin-3 OS=Homo sapiens GN=CNN   133.86 29 5
P63208|SKP1_HUMAN S-phase kinase-associated protein 1 OS     133.12 34 5
P30566|PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapi    132.58 24 5
Q08257|QOR_HUMAN Quinone oxidoreductase OS=Homo sap    131.97 36 5
Q9NZJ9|NUDT4_HUMAN Diphosphoinositol polyphosphate phosp       131.71 53 5
Q9H910|HN1L_HUMAN Hematological and neurological express        131.22 41 5
Q9Y4Z0|LSM4_HUMAN U6 snRNA-associated Sm-like protein L      130.73 55 5
Q99873|ANM1_HUMAN Protein arginine N-methyltransferase 1 O     128.61 20 5
Q13868|EXOS2_HUMAN Exosome complex component RRP4 OS     128.58 36 5
P23381|SYWC_HUMAN Tryptophanyl-tRNA synthetase, cytoplas      128.08 36 5
Q9Y5Y2|NUBP2_HUMAN Cytosolic Fe-S cluster assembly factor N      127.96 46 5
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Q53GQ0|DHB12_HUMAN Estradiol 17-beta-dehydrogenase 12 OS     126.82 29 5
P36542|ATPG_HUMAN ATP synthase subunit gamma, mitochon      126.11 20 5
P51571|SSRD_HUMAN Translocon-associated protein subunit d      125.65 36 5
P23142|FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN=FBLN   125.2 10 5
P36871|PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapi    125.04 25 5
P42574|CASP3_HUMAN Caspase-3 OS=Homo sapiens GN=CAS   124.36 34 5
Q14847|LASP1_HUMAN LIM and SH3 domain protein 1 OS=Hom     124.13 22 5
O00233|PSMD9_HUMAN 26S proteasome non-ATPase regulatory       122.79 24 5
O75083|WDR1_HUMAN WD repeat-containing protein 1 OS=Ho     122.74 27 5
P17858|K6PL_HUMAN 6-phosphofructokinase, liver type OS=H     122.52 29 5
P56385|ATP5I_HUMAN ATP synthase subunit e, mitochondrial O     121.73 62 5
P48739|PIPNB_HUMAN Phosphatidylinositol transfer protein bet       121.53 33 5
Q02952|AKA12_HUMAN A-kinase anchor protein 12 OS=Homo s    121.52 17 5
P19623|SPEE_HUMAN Spermidine synthase OS=Homo sapien    121.36 31 5
P23193|TCEA1_HUMAN Transcription elongation factor A protein      121.15 34 5
P14735|IDE_HUMAN Insulin-degrading enzyme OS=Homo sa    120.41 18 5
P49419|AL7A1_HUMAN Alpha-aminoadipic semialdehyde dehyd      120.33 22 5
P33316|DUT_HUMAN Deoxyuridine 5'-triphosphate nucleotido       120.29 33 5
P83731|RL24_HUMAN 60S ribosomal protein L24 OS=Homo s    120.2 38 5
P61221|ABCE1_HUMAN ATP-binding cassette sub-family E mem       119.89 26 5
Q07866|KLC1_HUMAN Kinesin light chain 1 OS=Homo sapiens   119.79 24 5
P62310|LSM3_HUMAN U6 snRNA-associated Sm-like protein L      119.72 71 5
Q9BUL8|PDC10_HUMAN Programmed cell death protein 10 OS=     119.72 29 5
O76094|SRP72_HUMAN Signal recognition particle 72 kDa prote      119.34 31 5
Q00341|VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP P  119.28 21 5
P62306|RUXF_HUMAN Small nuclear ribonucleoprotein F OS=H     117.29 58 5
Q9NR31|SAR1A_HUMAN GTP-binding protein SAR1a OS=Homo    117.12 25 5
P20340|RAB6A_HUMAN Ras-related protein Rab-6A OS=Homo    117.06 39 5
P49458|SRP09_HUMAN Signal recognition particle 9 kDa protein     116.38 57 5
O15143|ARC1B_HUMAN Actin-related protein 2/3 complex subun       116.24 29 5
Q96C36|P5CR2_HUMAN Pyrroline-5-carboxylate reductase 2 OS     115.93 32 5
P48061|SDF1_HUMAN Stromal cell-derived factor 1 OS=Homo    115.65 42 5
P35249|RFC4_HUMAN Replication factor C subunit 4 OS=Hom     115.58 22 5
Q8NFF5|FAD1_HUMAN FAD synthase OS=Homo sapiens GN=F   115.43 27 5
Q9BPW8|NIPS1_HUMAN Protein NipSnap homolog 1 OS=Homo    114.5 26 5
Q13242|SRSF9_HUMAN Serine/arginine-rich splicing factor 9 OS     114.01 34 5
Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo    113.75 27 5
Q15102|PA1B3_HUMAN Platelet-activating factor acetylhydrolase        113.18 35 5
Q14203|DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens G   112.77 27 5
P49591|SYSC_HUMAN Seryl-tRNA synthetase, cytoplasmic OS     112.66 24 5
P06730|IF4E_HUMAN Eukaryotic translation initiation factor 4E     108.68 20 5
P08243|ASNS_HUMAN Asparagine synthetase [glutamine-hydro      108.57 19 5
P13798|ACPH_HUMAN Acylamino-acid-releasing enzyme OS=H     108.49 12 5
P41091|IF2G_HUMAN Eukaryotic translation initiation factor 2       108.11 31 5
P07203|GPX1_HUMAN Glutathione peroxidase 1 OS=Homo sa    107.71 36 5
P55786|PSA_HUMAN Puromycin-sensitive aminopeptidase OS     102.38 12 5
Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase, mitocho      99.68 24 5
O60925|PFD1_HUMAN Prefoldin subunit 1 OS=Homo sapiens G   99.18 38 5
Q9UKM9|RALY_HUMAN RNA-binding protein Raly OS=Homo sa    97.85 32 5
P35612|ADDB_HUMAN Beta-adducin OS=Homo sapiens GN=A   97.71 21 5
Q15459|SF3A1_HUMAN Splicing factor 3A subunit 1 OS=Homo s    94.15 13 5
Q9BVK6|TMED9_HUMAN Transmembrane emp24 domain-contain        92.8 26 5
Q13509|TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens   295.38 75 4
P62140|PP1B_HUMAN Serine/threonine-protein phosphatase P        226.21 49 4
P16403|H12_HUMAN Histone H1.2 OS=Homo sapiens GN=H   216.11 54 4
Q99877|H2B1N_HUMAN Histone H2B type 1-N OS=Homo sapien    197.21 66 4
299
P62807|H2B1C_HUMAN Histone H2B type 1-C/E/F/G/I OS=Hom     197.21 57 4
P58876|H2B1D_HUMAN Histone H2B type 1-D OS=Homo sapien    197.21 57 4
Q93079|H2B1H_HUMAN Histone H2B type 1-H OS=Homo sapien    197.21 57 4
O60814|H2B1K_HUMAN Histone H2B type 1-K OS=Homo sapien    197.21 57 4
Q99879|H2B1M_HUMAN Histone H2B type 1-M OS=Homo sapie    197.21 57 4
Q5QNW6|H2B2F_HUMAN Histone H2B type 2-F OS=Homo sapien    197.21 57 4
P57053|H2BFS_HUMAN Histone H2B type F-S OS=Homo sapien    197.21 52 4
P18085|ARF4_HUMAN ADP-ribosylation factor 4 OS=Homo sap    187.48 81 4
P35241|RADI_HUMAN Radixin OS=Homo sapiens GN=RDX P  179.37 32 4
Q13162|PRDX4_HUMAN Peroxiredoxin-4 OS=Homo sapiens GN   179 38 4
Q96FJ2|DYL2_HUMAN Dynein light chain 2, cytoplasmic OS=H     174.74 65 4
P31943|HNRH1_HUMAN Heterogeneous nuclear ribonucleoprote       159.81 38 4
P26583|HMGB2_HUMAN High mobility group protein B2 OS=Hom     157.67 33 4
P38919|IF4A3_HUMAN Eukaryotic initiation factor 4A-III OS=Ho     157.14 33 4
O00425|IF2B3_HUMAN Insulin-like growth factor 2 mRNA-bindin        155.79 30 4
P39687|AN32A_HUMAN Acidic leucine-rich nuclear phosphoprot          154.16 31 4
Q9NUQ9|FA49B_HUMAN Protein FAM49B OS=Homo sapiens GN   151.38 41 4
Q15436|SC23A_HUMAN Protein transport protein Sec23A OS=H     149.19 27 4
P31153|METK2_HUMAN S-adenosylmethionine synthase isoform      147.82 32 4
P43490|NAMPT_HUMAN Nicotinamide phosphoribosyltransferase     146.85 54 4
P30085|KCY_HUMAN UMP-CMP kinase OS=Homo sapiens G   146.6 44 4
P09455|RET1_HUMAN Retinol-binding protein 1 OS=Homo sap    146.33 44 4
Q99729|ROAA_HUMAN Heterogeneous nuclear ribonucleoprote       145.1 36 4
P38159|HNRPG_HUMAN Heterogeneous nuclear ribonucleoprote       144.1 46 4
Q15366|PCBP2_HUMAN Poly(rC)-binding protein 2 OS=Homo sa    143.12 51 4
Q9NWU2|CT011_HUMAN Protein C20orf11 OS=Homo sapiens GN   141.57 48 4
Q9ULZ3|ASC_HUMAN Apoptosis-associated speck-like protein        141.54 40 4
P62847|RS24_HUMAN 40S ribosomal protein S24 OS=Homo s    138.89 44 4
P61923|COPZ1_HUMAN Coatomer subunit zeta-1 OS=Homo sap    138.84 40 4
Q9UI30|TR112_HUMAN tRNA methyltransferase 112 homolog O     137.88 56 4
P49411|EFTU_HUMAN Elongation factor Tu, mitochondrial OS=     136.06 23 4
Q9BRA2|TXD17_HUMAN Thioredoxin domain-containing protein 1      135.66 43 4
Q9UBQ0|VPS29_HUMAN Vacuolar protein sorting-associated prot       135.66 45 4
P34897|GLYM_HUMAN Serine hydroxymethyltransferase, mitoc      135.37 23 4
P05386|RLA1_HUMAN 60S acidic ribosomal protein P1 OS=Ho     135.35 66 4
P04216|THY1_HUMAN Thy-1 membrane glycoprotein OS=Hom     134.55 30 4
O75608|LYPA1_HUMAN Acyl-protein thioesterase 1 OS=Homo s    134.27 37 4
P13716|HEM2_HUMAN Delta-aminolevulinic acid dehydratase O     133.85 38 4
P62834|RAP1A_HUMAN Ras-related protein Rap-1A OS=Homo    133.82 27 4
P61224|RAP1B_HUMAN Ras-related protein Rap-1b OS=Homo s    133.82 27 4
P08579|RU2B_HUMAN U2 small nuclear ribonucleoprotein B'' O     133.69 30 4
Q9BS26|ERP44_HUMAN Endoplasmic reticulum resident protein      133.02 33 4
P55010|IF5_HUMAN Eukaryotic translation initiation factor 5     132.77 34 4
Q96AG4|LRC59_HUMAN Leucine-rich repeat-containing protein 5      131.75 33 4
Q16629|SRSF7_HUMAN Serine/arginine-rich splicing factor 7 OS     131.7 20 4
Q9UGI8|TES_HUMAN Testin OS=Homo sapiens GN=TES PE=  131.58 17 4
Q9Y3B4|PM14_HUMAN Pre-mRNA branch site protein p14 OS=     131.55 42 4
Q9BZZ5|API5_HUMAN Apoptosis inhibitor 5 OS=Homo sapiens   130.78 34 4
P41567|EIF1_HUMAN Eukaryotic translation initiation factor 1     130.36 63 4
Q9NY33|DPP3_HUMAN Dipeptidyl peptidase 3 OS=Homo sapie    130.1 23 4
Q00688|FKBP3_HUMAN Peptidyl-prolyl cis-trans isomerase FKB      129.99 38 4
Q8NBS9|TXND5_HUMAN Thioredoxin domain-containing protein 5     129.86 21 4
Q8IXM2|BAP18_HUMAN Chromatin complexes subunit BAP18 O     129.54 44 4
P61026|RAB10_HUMAN Ras-related protein Rab-10 OS=Homo s    129 52 4
Q9ULC4|MCTS1_HUMAN Malignant T cell-amplified sequence 1 O     128.22 51 4
P84090|ERH_HUMAN Enhancer of rudimentary homolog OS=H     127.9 53 4
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Q96IZ0|PAWR_HUMAN PRKC apoptosis WT1 regulator protein     127.53 34 4
Q9UBT2|SAE2_HUMAN SUMO-activating enzyme subunit 2 OS=     127.48 23 4
Q7L1Q6|BZW1_HUMAN Basic leucine zipper and W2 domain-co        127.41 23 4
P36639|8ODP_HUMAN 7,8-dihydro-8-oxoguanine triphosphatas      127.23 29 4
P13489|RINI_HUMAN Ribonuclease inhibitor OS=Homo sapie    126.94 15 4
Q9C005|DPY30_HUMAN Protein dpy-30 homolog OS=Homo sap    126.61 65 4
Q13158|FADD_HUMAN Protein FADD OS=Homo sapiens GN=F   126.59 50 4
P11216|PYGB_HUMAN Glycogen phosphorylase, brain form OS     126.5 16 4
P41208|CETN2_HUMAN Centrin-2 OS=Homo sapiens GN=CETN   125.68 42 4
Q07666|KHDR1_HUMAN KH domain-containing, RNA-binding, sig         125.54 41 4
Q13347|EIF3I_HUMAN Eukaryotic translation initiation factor 3       125.45 34 4
Q7L5N1|CSN6_HUMAN COP9 signalosome complex subunit 6 O     124.89 42 4
Q99584|S10AD_HUMAN Protein S100-A13 OS=Homo sapiens G   124.64 71 4
P67809|YBOX1_HUMAN Nuclease-sensitive element-binding pro       124.46 35 4
P11766|ADHX_HUMAN Alcohol dehydrogenase class-3 OS=Ho     124.39 15 4
P62942|FKB1A_HUMAN Peptidyl-prolyl cis-trans isomerase FKB      124.26 56 4
P35237|SPB6_HUMAN Serpin B6 OS=Homo sapiens GN=SER   124.21 25 4
O14745|NHRF1_HUMAN Na(+)/H(+) exchange regulatory cofacto       124.14 24 4
Q96CT7|CC124_HUMAN Coiled-coil domain-containing protein 12      123.93 35 4
O14979|HNRDL_HUMAN Heterogeneous nuclear ribonucleoprote       123.03 19 4
Q9GZT3|SLIRP_HUMAN SRA stem-loop-interacting RNA-binding       122.52 59 4
O75340|PDCD6_HUMAN Programmed cell death protein 6 OS=H     122.24 21 4
Q9Y6A5|TACC3_HUMAN Transforming acidic coiled-coil-containin        120.35 16 4
O95456|PSMG1_HUMAN Proteasome assembly chaperone 1 OS     120.27 43 4
O00264|PGRC1_HUMAN Membrane-associated progesterone rec        120.06 29 4
P46776|RL27A_HUMAN 60S ribosomal protein L27a OS=Homo    119.89 43 4
P10768|ESTD_HUMAN S-formylglutathione hydrolase OS=Hom     118.79 32 4
O75964|ATP5L_HUMAN ATP synthase subunit g, mitochondrial O     118.21 48 4
O95816|BAG2_HUMAN BAG family molecular chaperone regula       117.96 28 4
Q8TCD5|NT5C_HUMAN 5'(3')-deoxyribonucleotidase, cytosolic ty      117.95 38 4
P35244|RFA3_HUMAN Replication protein A 14 kDa subunit OS     117.26 51 4
P15121|ALDR_HUMAN Aldose reductase OS=Homo sapiens G   116.57 32 4
Q12905|ILF2_HUMAN Interleukin enhancer-binding factor 2 OS     116.36 26 4
O75368|SH3L1_HUMAN SH3 domain-binding glutamic acid-rich-       116.19 61 4
P61326|MGN_HUMAN Protein mago nashi homolog OS=Homo    115.68 32 4
Q96A72|MGN2_HUMAN Protein mago nashi homolog 2 OS=Hom     115.68 32 4
Q9P2M7|CING_HUMAN Cingulin OS=Homo sapiens GN=CGN P  115.57 14 4
P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme typ       115.3 23 4
Q92520|FAM3C_HUMAN Protein FAM3C OS=Homo sapiens GN=   114.77 33 4
Q8N1G4|LRC47_HUMAN Leucine-rich repeat-containing protein 4      114.53 22 4
P10606|COX5B_HUMAN Cytochrome c oxidase subunit 5B, mitoc      113.36 59 4
P51991|ROA3_HUMAN Heterogeneous nuclear ribonucleoprote       112.56 33 4
Q8NC51|PAIRB_HUMAN Plasminogen activator inhibitor 1 RNA-b       112.55 32 4
P12830|CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CD   112.39 9 4
O95372|LYPA2_HUMAN Acyl-protein thioesterase 2 OS=Homo s    111.76 40 4
P35613|BASI_HUMAN Basigin OS=Homo sapiens GN=BSG P  110.96 20 4
Q8IZQ5|SELH_HUMAN Selenoprotein H OS=Homo sapiens GN   110.76 30 4
O00743|PPP6_HUMAN Serine/threonine-protein phosphatase 6       110.46 21 4
O43252|PAPS1_HUMAN Bifunctional 3'-phosphoadenosine 5'-ph        109.93 16 4
P38606|VATA_HUMAN V-type proton ATPase catalytic subunit      109.75 21 4
P12081|SYHC_HUMAN Histidyl-tRNA synthetase, cytoplasmic O     108.91 18 4
P33992|MCM5_HUMAN DNA replication licensing factor MCM5 O     108.62 18 4
P48449|ERG7_HUMAN Lanosterol synthase OS=Homo sapiens   107.72 15 4
Q9NX63|CHCH3_HUMAN Coiled-coil-helix-coiled-coil-helix domain         107.59 22 4
O00303|EIF3F_HUMAN Eukaryotic translation initiation factor 3       106.68 25 4
Q8IYD1|ERF3B_HUMAN Eukaryotic peptide chain release factor        106.49 24 4
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O75475|PSIP1_HUMAN PC4 and SFRS1-interacting protein OS     105.59 22 4
Q92522|H1X_HUMAN Histone H1x OS=Homo sapiens GN=H1   103.64 42 4
Q8IXM3|RM41_HUMAN 39S ribosomal protein L41, mitochondria      103.23 41 4
Q8N8S7|ENAH_HUMAN Protein enabled homolog OS=Homo sa    103.14 20 4
Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sa    103.11 12 4
P40429|RL13A_HUMAN 60S ribosomal protein L13a OS=Homo    102.57 26 4
Q9H0D6|XRN2_HUMAN 5'-3' exoribonuclease 2 OS=Homo sapie    102.57 13 4
Q9NSD9|SYFB_HUMAN Phenylalanyl-tRNA synthetase beta cha      102.47 10 4
P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo s    102.28 16 4
Q86V81|THOC4_HUMAN THO complex subunit 4 OS=Homo sapi    102.08 28 4
Q99988|GDF15_HUMAN Growth/differentiation factor 15 OS=Hom     101.63 27 4
O14618|CCS_HUMAN Copper chaperone for superoxide dismu      101.48 16 4
Q08752|PPID_HUMAN Peptidyl-prolyl cis-trans isomerase D OS     101.47 24 4
P26640|SYVC_HUMAN Valyl-tRNA synthetase OS=Homo sapie    101.13 17 4
Q9BRG1|VPS25_HUMAN Vacuolar protein-sorting-associated pro       100.97 30 4
Q13561|DCTN2_HUMAN Dynactin subunit 2 OS=Homo sapiens G   100.02 26 4
P47914|RL29_HUMAN 60S ribosomal protein L29 OS=Homo s    98.91 21 4
Q9BVG4|CX026_HUMAN UPF0368 protein Cxorf26 OS=Homo sa    98.87 24 4
P31689|DNJA1_HUMAN DnaJ homolog subfamily A member 1 O     98.39 16 4
O15355|PPM1G_HUMAN Protein phosphatase 1G OS=Homo sap    98.26 20 4
P63165|SUMO1_HUMAN Small ubiquitin-related modifier 1 OS=H     98.05 57 4
Q99417|MYCBP_HUMAN C-Myc-binding protein OS=Homo sapien    97.87 58 4
P46379|BAG6_HUMAN Large proline-rich protein BAG6 OS=Ho     97.72 11 4
P29279|CTGF_HUMAN Connective tissue growth factor OS=Ho     93.72 15 4
Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=     93.41 14 4
P62993|GRB2_HUMAN Growth factor receptor-bound protein 2     93.17 29 4
Q9Y3U8|RL36_HUMAN 60S ribosomal protein L36 OS=Homo s    91.98 31 4
Q07065|CKAP4_HUMAN Cytoskeleton-associated protein 4 OS=     91.64 21 4
P47897|SYQ_HUMAN Glutaminyl-tRNA synthetase OS=Homo    90.69 27 4
P62070|RRAS2_HUMAN Ras-related protein R-Ras2 OS=Homo    90.49 33 4
Q9UHD8|SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT   90.49 22 4
P04181|OAT_HUMAN Ornithine aminotransferase, mitochondr      90.38 24 4
P46939|UTRO_HUMAN Utrophin OS=Homo sapiens GN=UTRN  88.37 9 4
Q9Y376|CAB39_HUMAN Calcium-binding protein 39 OS=Homo s    86.83 20 4
Q4VC31|CCD58_HUMAN Coiled-coil domain-containing protein 58     86.34 27 4
Q99436|PSB7_HUMAN Proteasome subunit beta type-7 OS=Ho     86.09 34 4
P61313|RL15_HUMAN 60S ribosomal protein L15 OS=Homo s    83.42 11 4
Q9UDR5|AASS_HUMAN Alpha-aminoadipic semialdehyde syntha       81.96 10 4
P22307|NLTP_HUMAN Non-specific lipid-transfer protein OS=H     81.42 11 4
Q9BRF8|CPPED_HUMAN Calcineurin-like phosphoesterase doma        81.31 37 4
P02452|CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sa    76.55 28 4
Q15369|ELOC_HUMAN Transcription elongation factor B polype       75.23 45 4
P49189|AL9A1_HUMAN 4-trimethylaminobutyraldehyde dehydro      73.78 12 4
P40616|ARL1_HUMAN ADP-ribosylation factor-like protein 1 OS     67.07 42 4
P09496|CLCA_HUMAN Clathrin light chain A OS=Homo sapiens   57.3 19 4
Q7L7L0|H2A3_HUMAN Histone H2A type 3 OS=Homo sapiens   220.39 68 3
P04908|H2A1B_HUMAN Histone H2A type 1-B/E OS=Homo sap    220.39 63 3
P10412|H14_HUMAN Histone H1.4 OS=Homo sapiens GN=H   216.2 69 3
P61586|RHOA_HUMAN Transforming protein RhoA OS=Homo s    207.08 68 3
P19105|ML12A_HUMAN Myosin regulatory light chain 12A OS=H     198.03 57 3
O14950|ML12B_HUMAN Myosin regulatory light chain 12B OS=H     198.03 56 3
Q02539|H11_HUMAN Histone H1.1 OS=Homo sapiens GN=H   186.73 48 3
P84085|ARF5_HUMAN ADP-ribosylation factor 5 OS=Homo sap    185.14 69 3
P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens GN=MYH   179.32 39 3
P05141|ADT2_HUMAN ADP/ATP translocase 2 OS=Homo sap    178.45 48 3
P63167|DYL1_HUMAN Dynein light chain 1, cytoplasmic OS=H     173.27 65 3
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O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X O     170.74 30 3
P61254|RL26_HUMAN 60S ribosomal protein L26 OS=Homo s    153.08 52 3
P62873|GBB1_HUMAN Guanine nucleotide-binding protein G(I)        149.03 29 3
P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase      147.94 22 3
Q92688|AN32B_HUMAN Acidic leucine-rich nuclear phosphoprot          145.49 39 3
Q12931|TRAP1_HUMAN Heat shock protein 75 kDa, mitochondri      139.38 23 3
P48735|IDHP_HUMAN Isocitrate dehydrogenase [NADP], mitoc      137.56 22 3
Q9P1F3|CF115_HUMAN Costars family protein C6orf115 OS=Ho     134.83 64 3
P42677|RS27_HUMAN 40S ribosomal protein S27 OS=Homo s    134.49 40 3
Q93062|RBPMS_HUMAN RNA-binding protein with multiple splicin      134.46 39 3
Q9NX02|NALP2_HUMAN NACHT, LRR and PYD domains-contain        133.77 24 3
Q16836|HCDH_HUMAN Hydroxyacyl-coenzyme A dehydrogenas       133.68 48 3
Q71UM5|RS27L_HUMAN 40S ribosomal protein S27-like OS=Hom     133.64 40 3
P80723|BASP1_HUMAN Brain acid soluble protein 1 OS=Homo s    130.23 48 3
P47755|CAZA2_HUMAN F-actin-capping protein subunit alpha-2     129.41 23 3
P68402|PA1B2_HUMAN Platelet-activating factor acetylhydrolase        129.2 44 3
Q9NZL9|MAT2B_HUMAN Methionine adenosyltransferase 2 subu       128.96 42 3
Q13526|PIN1_HUMAN Peptidyl-prolyl cis-trans isomerase NIMA       128.58 48 3
P51148|RAB5C_HUMAN Ras-related protein Rab-5C OS=Homo    128.3 39 3
P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sa    128.29 12 3
Q9H3R5|CENPH_HUMAN Centromere protein H OS=Homo sapien    126.82 49 3
P47813|IF1AX_HUMAN Eukaryotic translation initiation factor 1A       126.09 45 3
O14602|IF1AY_HUMAN Eukaryotic translation initiation factor 1A       126.09 45 3
Q96IX5|USMG5_HUMAN Up-regulated during skeletal muscle gro        125.63 47 3
Q13151|ROA0_HUMAN Heterogeneous nuclear ribonucleoprote       125.54 29 3
O75607|NPM3_HUMAN Nucleoplasmin-3 OS=Homo sapiens GN   124.93 29 3
Q99613|EIF3C_HUMAN Eukaryotic translation initiation factor 3       124.89 26 3
Q9NYL9|TMOD3_HUMAN Tropomodulin-3 OS=Homo sapiens GN   124.12 26 3
O75390|CISY_HUMAN Citrate synthase, mitochondrial OS=Hom     123.78 18 3
Q9P289|MST4_HUMAN Serine/threonine-protein kinase MST4 O     123.44 28 3
P62854|RS26_HUMAN 40S ribosomal protein S26 OS=Homo s    123.28 42 3
P17812|PYRG1_HUMAN CTP synthase 1 OS=Homo sapiens GN   123.12 21 3
P54687|BCAT1_HUMAN Branched-chain-amino-acid aminotrans       123 26 3
P52434|RPAB3_HUMAN DNA-directed RNA polymerases I, II, an         122.62 25 3
Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting pro      122.37 23 3
Q9BY32|ITPA_HUMAN Inosine triphosphate pyrophosphatase O     120.89 35 3
Q96AC1|FERM2_HUMAN Fermitin family homolog 2 OS=Homo sa    119.86 22 3
O43396|TXNL1_HUMAN Thioredoxin-like protein 1 OS=Homo sa    119.7 40 3
Q9Y3C6|PPIL1_HUMAN Peptidyl-prolyl cis-trans isomerase-like 1     119.47 31 3
Q9UQE7|SMC3_HUMAN Structural maintenance of chromosome        118.55 22 3
Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sap    118.03 25 3
P62877|RBX1_HUMAN E3 ubiquitin-protein ligase RBX1 OS=H     117.05 33 3
P04080|CYTB_HUMAN Cystatin-B OS=Homo sapiens GN=CST   116.74 65 3
O60869|EDF1_HUMAN Endothelial differentiation-related factor      116.26 43 3
Q9H773|DCTP1_HUMAN dCTP pyrophosphatase 1 OS=Homo sa    116.15 39 3
Q9UQ80|PA2G4_HUMAN Proliferation-associated protein 2G4 OS     115.83 22 3
Q13618|CUL3_HUMAN Cullin-3 OS=Homo sapiens GN=CUL3 P  115.72 15 3
P04179|SODM_HUMAN Superoxide dismutase [Mn], mitochondr      115.24 25 3
P16083|NQO2_HUMAN Ribosyldihydronicotinamide dehydrogen       114.81 30 3
O00273|DFFA_HUMAN DNA fragmentation factor subunit alpha     114.55 35 3
Q96DE0|NUD16_HUMAN U8 snoRNA-decapping enzyme OS=Ho     114.52 56 3
Q9P000|COMD9_HUMAN COMM domain-containing protein 9 OS     114.3 31 3
Q9UIL1|SCOC_HUMAN Short coiled-coil protein OS=Homo sapi    113.32 29 3
Q9NQP4|PFD4_HUMAN Prefoldin subunit 4 OS=Homo sapiens G   113.22 38 3
P23919|KTHY_HUMAN Thymidylate kinase OS=Homo sapiens   112.9 33 3
P61201|CSN2_HUMAN COP9 signalosome complex subunit 2 O     112.11 32 3
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Q15717|ELAV1_HUMAN ELAV-like protein 1 OS=Homo sapiens   112.02 20 3
Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens GN=KTN1  111.99 11 3
Q8TEA8|DTD1_HUMAN D-tyrosyl-tRNA(Tyr) deacylase 1 OS=Ho     111.97 32 3
Q6ZRY4|RBPS2_HUMAN RNA-binding protein with multiple splicin       111.74 32 3
O43143|DHX15_HUMAN Putative pre-mRNA-splicing factor ATP-         111.74 21 3
P62910|RL32_HUMAN 60S ribosomal protein L32 OS=Homo s    111.73 45 3
Q9NR45|SIAS_HUMAN Sialic acid synthase OS=Homo sapiens   111.51 20 3
P62266|RS23_HUMAN 40S ribosomal protein S23 OS=Homo s    111.48 16 3
P32321|DCTD_HUMAN Deoxycytidylate deaminase OS=Homo s    111.13 20 3
P35080|PROF2_HUMAN Profilin-2 OS=Homo sapiens GN=PFN2  110.75 57 3
O14773|TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapie    110.66 31 3
P45880|VDAC2_HUMAN Voltage-dependent anion-selective chan        110.22 22 3
P29966|MARCS_HUMAN Myristoylated alanine-rich C-kinase subs      109.99 14 3
P39023|RL3_HUMAN 60S ribosomal protein L3 OS=Homo sa    109.82 15 3
P98095|FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN   109.77 12 3
P06737|PYGL_HUMAN Glycogen phosphorylase, liver form OS=     109.33 13 3
Q16527|CSRP2_HUMAN Cysteine and glycine-rich protein 2 OS=     108.45 25 3
Q9NRV9|HEBP1_HUMAN Heme-binding protein 1 OS=Homo sapi    108.16 46 3
O14880|MGST3_HUMAN Microsomal glutathione S-transferase 3     108.14 26 3
P14923|PLAK_HUMAN Junction plakoglobin OS=Homo sapiens   107.99 21 3
P62318|SMD3_HUMAN Small nuclear ribonucleoprotein Sm D3     107.82 37 3
P46087|NOP2_HUMAN Putative ribosomal RNA methyltransfera       107.14 13 3
Q969H8|CS010_HUMAN UPF0556 protein C19orf10 OS=Homo s    106.3 21 3
P29373|RABP2_HUMAN Cellular retinoic acid-binding protein 2 O     106.07 51 3
Q9Y5J9|TIM8B_HUMAN Mitochondrial import inner membrane tra         105.86 52 3
O75190|DNJB6_HUMAN DnaJ homolog subfamily B member 6 O     105.52 18 3
Q86X76|NIT1_HUMAN Nitrilase homolog 1 OS=Homo sapiens   105.47 13 3
P60228|EIF3E_HUMAN Eukaryotic translation initiation factor 3       105.39 24 3
P41223|BUD31_HUMAN Protein BUD31 homolog OS=Homo sap    105.37 38 3
P52789|HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=H   104.68 18 3
O75663|TIPRL_HUMAN TIP41-like protein OS=Homo sapiens G   104.43 24 3
Q8TBC4|UBA3_HUMAN NEDD8-activating enzyme E1 catalytic s      104.42 18 3
Q96P16|RPR1A_HUMAN Regulation of nuclear pre-mRNA domai        104.32 28 3
P30626|SORCN_HUMAN Sorcin OS=Homo sapiens GN=SRI PE=  104.25 30 3
O43805|SSNA1_HUMAN Sjoegren syndrome nuclear autoantigen      104.04 21 3
P11279|LAMP1_HUMAN Lysosome-associated membrane glycop       103.74 14 3
O75821|EIF3G_HUMAN Eukaryotic translation initiation factor 3       103.54 22 3
P51911|CNN1_HUMAN Calponin-1 OS=Homo sapiens GN=CNN   103.35 22 3
Q14974|IMB1_HUMAN Importin subunit beta-1 OS=Homo sapie    102.69 14 3
Q15363|TMED2_HUMAN Transmembrane emp24 domain-contain        102.61 30 3
Q9Y5K5|UCHL5_HUMAN Ubiquitin carboxyl-terminal hydrolase iso       102.46 19 3
O75391|SPAG7_HUMAN Sperm-associated antigen 7 OS=Homo    102.31 27 3
Q7L190|DPPA4_HUMAN Developmental pluripotency-associated       102.08 25 3
Q56VL3|OCAD2_HUMAN OCIA domain-containing protein 2 OS=     101.96 24 3
Q8NCW5|AIBP_HUMAN Apolipoprotein A-I-binding protein OS=H     101.91 36 3
Q16795|NDUA9_HUMAN NADH dehydrogenase [ubiquinone] 1 a          101.49 20 3
Q9Y5J7|TIM9_HUMAN Mitochondrial import inner membrane tra        101.22 45 3
Q9NPJ3|ACO13_HUMAN Acyl-coenzyme A thioesterase 13 OS=H     100.73 22 3
O00622|CYR61_HUMAN Protein CYR61 OS=Homo sapiens GN=   100.58 16 3
Q8WU90|ZC3HF_HUMAN Zinc finger CCCH domain-containing pr       100.56 18 3
Q2Q1W2|LIN41_HUMAN Tripartite motif-containing protein 71 OS     100.38 9 3
Q14157|UBP2L_HUMAN Ubiquitin-associated protein 2-like OS=H     100.19 7 3
Q92979|NEP1_HUMAN Ribosomal RNA small subunit methyltra       99.69 34 3
Q9UBW8|CSN7A_HUMAN COP9 signalosome complex subunit 7a     99.23 18 3
Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8     99.16 16 3
Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens GN=MF   98.91 12 3
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P09012|SNRPA_HUMAN U1 small nuclear ribonucleoprotein A O     98.54 21 3
O60762|DPM1_HUMAN Dolichol-phosphate mannosyltransferas      97.75 39 3
P54886|P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase     97.38 13 3
P78330|SERB_HUMAN Phosphoserine phosphatase OS=Homo    97.17 29 3
Q14683|SMC1A_HUMAN Structural maintenance of chromosome        96.89 13 3
P10620|MGST1_HUMAN Microsomal glutathione S-transferase 1     96.84 30 3
Q9H444|CHM4B_HUMAN Charged multivesicular body protein 4b     96.69 24 3
P51970|NDUA8_HUMAN NADH dehydrogenase [ubiquinone] 1 a         96.5 23 3
P35659|DEK_HUMAN Protein DEK OS=Homo sapiens GN=DE   96.28 18 3
P49023|PAXI_HUMAN Paxillin OS=Homo sapiens GN=PXN PE  96.09 11 3
Q16891|IMMT_HUMAN Mitochondrial inner membrane protein O     95.78 11 3
Q8NBT2|SPC24_HUMAN Kinetochore protein Spc24 OS=Homo s    95.76 34 3
P19388|RPAB1_HUMAN DNA-directed RNA polymerases I, II, an         95.69 25 3
Q8WWM7|ATX2L_HUMAN Ataxin-2-like protein OS=Homo sapiens   95.21 13 3
P51858|HDGF_HUMAN Hepatoma-derived growth factor OS=Ho     94.92 26 3
Q96CN7|ISOC1_HUMAN Isochorismatase domain-containing pro       94.28 29 3
P98179|RBM3_HUMAN Putative RNA-binding protein 3 OS=Hom     93.74 42 3
O14974|MYPT1_HUMAN Protein phosphatase 1 regulatory subun       93.67 16 3
P67812|SC11A_HUMAN Signal peptidase complex catalytic subu       93.53 26 3
Q01860|PO5F1_HUMAN POU domain, class 5, transcription facto       93.19 14 3
O15212|PFD6_HUMAN Prefoldin subunit 6 OS=Homo sapiens G   93.17 53 3
P60468|SC61B_HUMAN Protein transport protein Sec61 subunit      93.17 49 3
O43447|PPIH_HUMAN Peptidyl-prolyl cis-trans isomerase H OS     93.05 24 3
Q15637|SF01_HUMAN Splicing factor 1 OS=Homo sapiens GN   92.68 9 3
P61011|SRP54_HUMAN Signal recognition particle 54 kDa prote      92.52 18 3
P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sa    92.41 25 3
P21741|MK_HUMAN Midkine OS=Homo sapiens GN=MDK P  92.16 23 3
Q9UHD1|CHRD1_HUMAN Cysteine and histidine-rich domain-cont        92.01 18 3
Q9NRN7|ADPPT_HUMAN L-aminoadipate-semialdehyde dehydrog       91.89 18 3
Q8WXX5|DNJC9_HUMAN DnaJ homolog subfamily C member 9 O     91.37 17 3
P11413|G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase     91.14 10 3
Q9HAV7|GRPE1_HUMAN GrpE protein homolog 1, mitochondrial O     90.4 27 3
Q9NQW7|XPP1_HUMAN Xaa-Pro aminopeptidase 1 OS=Homo s    89.9 11 3
O15230|LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sap    88.56 7 3
P53618|COPB_HUMAN Coatomer subunit beta OS=Homo sapie    88.36 12 3
Q9H7C9|CK067_HUMAN UPF0366 protein C11orf67 OS=Homo s    88.3 50 3
Q14498|RBM39_HUMAN RNA-binding protein 39 OS=Homo sapi    88.2 16 3
Q9BWJ5|SF3B5_HUMAN Splicing factor 3B subunit 5 OS=Homo s    87.94 59 3
O14561|ACPM_HUMAN Acyl carrier protein, mitochondrial OS=H     87.93 34 3
O00487|PSDE_HUMAN 26S proteasome non-ATPase regulatory       87.85 39 3
Q9UJ70|NAGK_HUMAN N-acetyl-D-glucosamine kinase OS=Hom     87.78 27 3
Q13867|BLMH_HUMAN Bleomycin hydrolase OS=Homo sapiens   87.64 11 3
P11441|UBL4A_HUMAN Ubiquitin-like protein 4A OS=Homo sap    87.52 23 3
P05556|ITB1_HUMAN Integrin beta-1 OS=Homo sapiens GN=   87.25 10 3
Q9BYD1|RM13_HUMAN 39S ribosomal protein L13, mitochondria      86.76 34 3
Q53GG5|PDLI3_HUMAN PDZ and LIM domain protein 3 OS=Hom     86.38 13 3
Q9UNE7|CHIP_HUMAN E3 ubiquitin-protein ligase CHIP OS=Ho     86.31 19 3
Q9NQ48|LZTL1_HUMAN Leucine zipper transcription factor-like p       86.21 22 3
Q02750|MP2K1_HUMAN Dual specificity mitogen-activated protei         85.56 13 3
Q14980|NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=     85.56 12 3
Q9NYU2|UGGG1_HUMAN UDP-glucose:glycoprotein glucosyltrans       85.38 8 3
O00483|NDUA4_HUMAN NADH dehydrogenase [ubiquinone] 1 a         84.09 37 3
P61599|NAA20_HUMAN N-alpha-acetyltransferase 20, NatB cata       83.25 17 3
O15305|PMM2_HUMAN Phosphomannomutase 2 OS=Homo sa    82.68 14 3
Q8WVJ2|NUDC2_HUMAN NudC domain-containing protein 2 OS=     82.57 19 3
P82930|RT34_HUMAN 28S ribosomal protein S34, mitochondri      82.32 31 3
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Q9P0J0|NDUAD_HUMAN NADH dehydrogenase [ubiquinone] 1 a         81.88 19 3
P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapie    81.64 24 3
P61457|PHS_HUMAN Pterin-4-alpha-carbinolamine dehydrata      81.29 49 3
Q9NX24|NHP2_HUMAN H/ACA ribonucleoprotein complex subu       80.98 19 3
O75935|DCTN3_HUMAN Dynactin subunit 3 OS=Homo sapiens G   80.82 16 3
O43776|SYNC_HUMAN Asparaginyl-tRNA synthetase, cytoplasm      78.81 12 3
Q9BV57|MTND_HUMAN 1,2-dihydroxy-3-keto-5-methylthiopenten       78.58 31 3
O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS     78.46 8 3
O60716|CTND1_HUMAN Catenin delta-1 OS=Homo sapiens GN=   78.31 13 3
Q32P28|P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapie    77.96 8 3
O94760|DDAH1_HUMAN N(G),N(G)-dimethylarginine dimethylam       77.81 13 3
O00762|UBE2C_HUMAN Ubiquitin-conjugating enzyme E2 C OS=     77.44 22 3
P62861|RS30_HUMAN 40S ribosomal protein S30 OS=Homo s    76.48 20 3
P39060|COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Hom     75.9 14 3
O60613|SEP15_HUMAN 15 kDa selenoprotein OS=Homo sapien    75.78 22 3
O14744|ANM5_HUMAN Protein arginine N-methyltransferase 5 O     75.63 15 3
Q96HQ2|C2AIL_HUMAN CDKN2AIP N-terminal-like protein OS=H     75.18 24 3
Q12841|FSTL1_HUMAN Follistatin-related protein 1 OS=Homo s    74.92 23 3
P36543|VATE1_HUMAN V-type proton ATPase subunit E 1 OS=     73.98 16 3
O60256|KPRB_HUMAN Phosphoribosyl pyrophosphate synthas        73.54 22 3
O75937|DNJC8_HUMAN DnaJ homolog subfamily C member 8 O     73.14 29 3
Q7LBC6|KDM3B_HUMAN Lysine-specific demethylase 3B OS=Ho     72.5 12 3
Q9NPE3|NOP10_HUMAN H/ACA ribonucleoprotein complex subu       72.2 62 3
P62253|UB2G1_HUMAN Ubiquitin-conjugating enzyme E2 G1 OS     71.77 15 3
Q8NFU3|TSTD1_HUMAN Thiosulfate sulfurtransferase/rhodanese         69.82 21 3
Q9BR76|COR1B_HUMAN Coronin-1B OS=Homo sapiens GN=CO   69.77 10 3
Q9Y547|HSB11_HUMAN Heat shock protein beta-11 OS=Homo s    67.64 49 3
Q8WUW1|BRK1_HUMAN Protein BRICK1 OS=Homo sapiens GN   67.4 37 3
Q00325|MPCP_HUMAN Phosphate carrier protein, mitochondria      66.68 17 3
Q13564|ULA1_HUMAN NEDD8-activating enzyme E1 regulatory      62.1 11 3
Q5T0N5|FBP1L_HUMAN Formin-binding protein 1-like OS=Homo    61.49 16 3
Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYN   61.01 6 3
P52788|SPSY_HUMAN Spermine synthase OS=Homo sapiens   59.64 17 3
P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens GN=L   59.01 5 3
P84098|RL19_HUMAN 60S ribosomal protein L19 OS=Homo s    58.49 24 3
P54727|RD23B_HUMAN UV excision repair protein RAD23 homo       54.59 15 3
O14949|QCR8_HUMAN Cytochrome b-c1 complex subunit 8 OS     50.95 39 3
P24043|LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sap    36.38 8 3
Q5T5P2|SKT_HUMAN Sickle tail protein homolog OS=Homo sa    36.23 9 3
Q9UMZ3|PTPRQ_HUMAN Phosphotidylinositol phosphatase PTPR      36.05 5 3
Q9BVA1|TBB2B_HUMAN Tubulin beta-2B chain OS=Homo sapie    330.95 80 2
Q13885|TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapie    329.55 80 2
P04350|TBB4_HUMAN Tubulin beta-4 chain OS=Homo sapiens   302.6 76 2
P07951|TPM2_HUMAN Tropomyosin beta chain OS=Homo sap    286.14 58 2
Q9BQE3|TBA1C_HUMAN Tubulin alpha-1C chain OS=Homo sapie    275.14 76 2
P62979|RS27A_HUMAN Ubiquitin-40S ribosomal protein S27a O     249.3 73 2
P36873|PP1G_HUMAN Serine/threonine-protein phosphatase P        230.3 53 2
P16402|H13_HUMAN Histone H1.3 OS=Homo sapiens GN=H   208.58 66 2
P11940|PABP1_HUMAN Polyadenylate-binding protein 1 OS=Ho     197.97 41 2
Q99867|TBB4Q_HUMAN Putative tubulin beta-4q chain OS=Hom     195.25 59 2
P08134|RHOC_HUMAN Rho-related GTP-binding protein RhoC     192.52 59 2
A6NKZ8|YI016_HUMAN Putative tubulin beta chain-like protein E     188.29 48 2
Q14240|IF4A2_HUMAN Eukaryotic initiation factor 4A-II OS=Ho     180.35 35 2
P30154|2AAB_HUMAN Serine/threonine-protein phosphatase 2             178.49 55 2
Q9H4B7|TBB1_HUMAN Tubulin beta-1 chain OS=Homo sapiens   172.85 30 2
P12235|ADT1_HUMAN ADP/ATP translocase 1 OS=Homo sap    168.81 39 2
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O43390|HNRPR_HUMAN Heterogeneous nuclear ribonucleoprote       149.02 26 2
O00292|LFTY2_HUMAN Left-right determination factor 2 OS=Ho     135.99 34 2
Q16576|RBBP7_HUMAN Histone-binding protein RBBP7 OS=Ho     132.75 30 2
P62191|PRS4_HUMAN 26S protease regulatory subunit 4 OS=H     125.52 41 2
P61020|RAB5B_HUMAN Ras-related protein Rab-5B OS=Homo    123.52 35 2
P61077|UB2D3_HUMAN Ubiquitin-conjugating enzyme E2 D3 OS     123.06 31 2
Q96RU2|UBP28_HUMAN Ubiquitin carboxyl-terminal hydrolase 28     122.59 12 2
P62879|GBB2_HUMAN Guanine nucleotide-binding protein G(I)        119.57 27 2
Q13404|UB2V1_HUMAN Ubiquitin-conjugating enzyme E2 varian       117.06 39 2
Q15819|UB2V2_HUMAN Ubiquitin-conjugating enzyme E2 varian       116.9 45 2
O00764|PDXK_HUMAN Pyridoxal kinase OS=Homo sapiens GN   116.49 35 2
Q09028|RBBP4_HUMAN Histone-binding protein RBBP4 OS=Ho     115.76 16 2
P20339|RAB5A_HUMAN Ras-related protein Rab-5A OS=Homo    115.52 26 2
P61163|ACTZ_HUMAN Alpha-centractin OS=Homo sapiens GN   114.53 26 2
O96008|TOM40_HUMAN Mitochondrial import receptor subunit TO       110.41 33 2
O60763|USO1_HUMAN General vesicular transport factor p115     109.9 23 2
Q9NVD7|PARVA_HUMAN Alpha-parvin OS=Homo sapiens GN=PA   109.79 26 2
P49902|5NTC_HUMAN Cytosolic purine 5'-nucleotidase OS=Ho     108.62 29 2
P18859|ATP5J_HUMAN ATP synthase-coupling factor 6, mitocho      107.86 41 2
Q9NXH9|TRM1_HUMAN N(2),N(2)-dimethylguanosine tRNA met      106.8 24 2
P31942|HNRH3_HUMAN Heterogeneous nuclear ribonucleoprote       106.42 37 2
Q14166|TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 O     106.11 26 2
P62330|ARF6_HUMAN ADP-ribosylation factor 6 OS=Homo sap    105.77 18 2
P63172|DYLT1_HUMAN Dynein light chain Tctex-type 1 OS=Hom     104.88 51 2
Q9NUG6|PDRG1_HUMAN p53 and DNA damage-regulated protein      104.32 23 2
O60502|NCOAT_HUMAN Bifunctional protein NCOAT OS=Homo    102.68 21 2
P48507|GSH0_HUMAN Glutamate--cysteine ligase regulatory su      102.5 24 2
O95983|MBD3_HUMAN Methyl-CpG-binding domain protein 3 O     102.05 18 2
Q9H2U2|IPYR2_HUMAN Inorganic pyrophosphatase 2, mitochon      102.01 20 2
Q9UBI1|COMD3_HUMAN COMM domain-containing protein 3 OS     101.68 31 2
P51153|RAB13_HUMAN Ras-related protein Rab-13 OS=Homo s    101.47 26 2
Q86Y39|NDUAB_HUMAN NADH dehydrogenase [ubiquinone] 1 a         101.07 32 2
P43034|LIS1_HUMAN Platelet-activating factor acetylhydrolase        100.5 23 2
Q9NRX4|PHP14_HUMAN 14 kDa phosphohistidine phosphatase O     100.38 42 2
P32322|P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1, mit      100.32 20 2
P55957|BID_HUMAN BH3-interacting domain death agonist O     100.01 38 2
Q9NZT2|OGFR_HUMAN Opioid growth factor receptor OS=Homo    99.66 18 2
P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory       99.41 19 2
P80294|MT1H_HUMAN Metallothionein-1H OS=Homo sapiens G   99.38 66 2
P47895|AL1A3_HUMAN Aldehyde dehydrogenase family 1 mem       99.32 19 2
P14543|NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID   99.03 9 2
Q9UJZ1|STML2_HUMAN Stomatin-like protein 2 OS=Homo sapie    98.98 29 2
Q9Y3C4|TPRKB_HUMAN TP53RK-binding protein OS=Homo sap    98.86 31 2
Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-rel        98.79 34 2
Q13418|ILK_HUMAN Integrin-linked protein kinase OS=Homo    98.7 18 2
Q9Y2V2|CHSP1_HUMAN Calcium-regulated heat stable protein 1     98.48 44 2
Q15024|EXOS7_HUMAN Exosome complex component RRP42 O     98.12 25 2
P50995|ANX11_HUMAN Annexin A11 OS=Homo sapiens GN=A   98.04 18 2
P07919|QCR6_HUMAN Cytochrome b-c1 complex subunit 6, mi      97.86 60 2
P49006|MRP_HUMAN MARCKS-related protein OS=Homo sap    97.19 29 2
Q92769|HDAC2_HUMAN Histone deacetylase 2 OS=Homo sapie    97.1 15 2
Q9H299|SH3L3_HUMAN SH3 domain-binding glutamic acid-rich-        97.09 31 2
Q6DKJ4|NXN_HUMAN Nucleoredoxin OS=Homo sapiens GN=   96.92 17 2
O43488|ARK72_HUMAN Aflatoxin B1 aldehyde reductase memb       96.74 22 2
O43852|CALU_HUMAN Calumenin OS=Homo sapiens GN=CAL   96.52 16 2
Q9Y3Y2|CHTOP_HUMAN Chromatin target of PRMT1 protein OS=     96.03 27 2
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Q9UK76|HN1_HUMAN Hematological and neurological express        95.88 32 2
P14854|CX6B1_HUMAN Cytochrome c oxidase subunit 6B1 OS=     95.77 40 2
P61966|AP1S1_HUMAN AP-1 complex subunit sigma-1A OS=Ho     95.37 28 2
Q9UBK9|UXT_HUMAN Protein UXT OS=Homo sapiens GN=UX   95.24 35 2
A0AVT1|UBA6_HUMAN Ubiquitin-like modifier-activating enzyme      94.73 18 2
Q9UBP6|TRMB_HUMAN tRNA (guanine-N(7)-)-methyltransferase     94.63 17 2
Q9P0S9|TM14C_HUMAN Transmembrane protein 14C OS=Homo    94.07 62 2
Q15427|SF3B4_HUMAN Splicing factor 3B subunit 4 OS=Homo s    93.81 26 2
P35250|RFC2_HUMAN Replication factor C subunit 2 OS=Hom     93.74 12 2
Q9UBC3|DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B     93.71 9 2
P06132|DCUP_HUMAN Uroporphyrinogen decarboxylase OS=H     93.6 24 2
O60888|CUTA_HUMAN Protein CutA OS=Homo sapiens GN=C   93.52 36 2
Q16540|RM23_HUMAN 39S ribosomal protein L23, mitochondria      93.41 31 2
P42167|LAP2B_HUMAN Lamina-associated polypeptide 2, isofor       92.93 20 2
P42166|LAP2A_HUMAN Lamina-associated polypeptide 2, isofor       92.93 14 2
O14907|TX1B3_HUMAN Tax1-binding protein 3 OS=Homo sapie    92.73 31 2
O43237|DC1L2_HUMAN Cytoplasmic dynein 1 light intermediate       92.59 21 2
Q13232|NDK3_HUMAN Nucleoside diphosphate kinase 3 OS=H     92 40 2
Q9H993|CF211_HUMAN UPF0364 protein C6orf211 OS=Homo s    91.98 13 2
O95232|LC7L3_HUMAN Luc7-like protein 3 OS=Homo sapiens G   91.9 18 2
Q9NXG2|THUM1_HUMAN THUMP domain-containing protein 1 OS     91.29 18 2
Q12849|GRSF1_HUMAN G-rich sequence factor 1 OS=Homo sap    90.84 26 2
O75688|PPM1B_HUMAN Protein phosphatase 1B OS=Homo sap    89.87 10 2
Q04323|UBXN1_HUMAN UBX domain-containing protein 1 OS=H     89.79 32 2
P14406|CX7A2_HUMAN Cytochrome c oxidase subunit 7A2, mito      89.65 39 2
Q9H6S3|ES8L2_HUMAN Epidermal growth factor receptor kinase         89.64 14 2
Q9BSD7|NTPCR_HUMAN Cancer-related nucleoside-triphosphata      89.21 24 2
P41214|EIF2D_HUMAN Eukaryotic translation initiation factor 2D     89.15 20 2
A6NDU8|CE051_HUMAN UPF0600 protein C5orf51 OS=Homo sa    88.97 15 2
Q14061|COX17_HUMAN Cytochrome c oxidase copper chaperon      88.94 48 2
Q9NYL4|FKB11_HUMAN Peptidyl-prolyl cis-trans isomerase FKB      88.82 15 2
P19387|RPB3_HUMAN DNA-directed RNA polymerase II subun       88.77 20 2
Q96GK7|FAH2A_HUMAN Fumarylacetoacetate hydrolase domain        88.33 13 2
Q15642|CIP4_HUMAN Cdc42-interacting protein 4 OS=Homo s    88.04 16 2
Q9BT73|PSMG3_HUMAN Proteasome assembly chaperone 3 OS     88.01 23 2
Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Hom     87.4 7 2
P56134|ATPK_HUMAN ATP synthase subunit f, mitochondrial O     87.36 26 2
P62273|RS29_HUMAN 40S ribosomal protein S29 OS=Homo s    87.36 48 2
P10619|PPGB_HUMAN Lysosomal protective protein OS=Homo    87.22 10 2
O60518|RNBP6_HUMAN Ran-binding protein 6 OS=Homo sapien    87.07 7 2
Q9Y3D6|FIS1_HUMAN Mitochondrial fission 1 protein OS=Hom     86.95 28 2
Q9HBM1|SPC25_HUMAN Kinetochore protein Spc25 OS=Homo s    86.86 21 2
P19367|HXK1_HUMAN Hexokinase-1 OS=Homo sapiens GN=H   86.41 8 2
Q96EK6|GNA1_HUMAN Glucosamine 6-phosphate N-acetyltrans      86.41 18 2
Q9H4M9|EHD1_HUMAN EH domain-containing protein 1 OS=Ho     86.24 15 2
P15374|UCHL3_HUMAN Ubiquitin carboxyl-terminal hydrolase iso       86.23 37 2
O95813|CER1_HUMAN Cerberus OS=Homo sapiens GN=CER1  86.12 21 2
P40937|RFC5_HUMAN Replication factor C subunit 5 OS=Hom     86.1 25 2
P55039|DRG2_HUMAN Developmentally-regulated GTP-binding       86.02 14 2
P20338|RAB4A_HUMAN Ras-related protein Rab-4A OS=Homo    85.98 35 2
Q15293|RCN1_HUMAN Reticulocalbin-1 OS=Homo sapiens GN   85.72 24 2
A2VDF0|FUCM_HUMAN Fucose mutarotase OS=Homo sapiens   85.71 26 2
P23588|IF4B_HUMAN Eukaryotic translation initiation factor 4B     85.61 17 2
Q7Z2W9|RM21_HUMAN 39S ribosomal protein L21, mitochondria      85.6 27 2
Q92905|CSN5_HUMAN COP9 signalosome complex subunit 5 O     85.48 19 2
Q7RTV0|PHF5A_HUMAN PHD finger-like domain-containing prote       85.47 32 2
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Q16774|KGUA_HUMAN Guanylate kinase OS=Homo sapiens G   84.97 12 2
O60783|RT14_HUMAN 28S ribosomal protein S14, mitochondri      84.75 27 2
Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4       84.69 9 2
Q05209|PTN12_HUMAN Tyrosine-protein phosphatase non-rece        84.65 16 2
Q9H2J4|PDCL3_HUMAN Phosducin-like protein 3 OS=Homo sap    84.64 29 2
O60884|DNJA2_HUMAN DnaJ homolog subfamily A member 2 O     84.63 18 2
P67870|CSK2B_HUMAN Casein kinase II subunit beta OS=Homo    84.56 9 2
Q9ULV4|COR1C_HUMAN Coronin-1C OS=Homo sapiens GN=CO   84.23 22 2
P49643|PRI2_HUMAN DNA primase large subunit OS=Homo s    84.03 17 2
Q7Z2Z2|ETUD1_HUMAN Elongation factor Tu GTP-binding doma        83.91 11 2
Q9BW83|IFT27_HUMAN Intraflagellar transport protein 27 homol      83.84 17 2
Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Ho     83.76 23 2
Q8WTX7|GATL3_HUMAN GATS-like protein 3 OS=Homo sapiens   83.64 20 2
P00568|KAD1_HUMAN Adenylate kinase isoenzyme 1 OS=Hom     83.62 14 2
Q96H20|SNF8_HUMAN Vacuolar-sorting protein SNF8 OS=Hom     83.59 16 2
P54105|ICLN_HUMAN Methylosome subunit pICln OS=Homo s    83.25 11 2
Q9NR28|DBLOH_HUMAN Diablo homolog, mitochondrial OS=Hom     83.12 25 2
Q9NS69|TOM22_HUMAN Mitochondrial import receptor subunit TO       83.03 37 2
Q9BX68|HINT2_HUMAN Histidine triad nucleotide-binding protein       82.54 34 2
O43617|TPPC3_HUMAN Trafficking protein particle complex subu       82.46 34 2
P46109|CRKL_HUMAN Crk-like protein OS=Homo sapiens GN=   82.28 12 2
O15116|LSM1_HUMAN U6 snRNA-associated Sm-like protein L      82.24 31 2
P15927|RFA2_HUMAN Replication protein A 32 kDa subunit OS     82.12 33 2
P09486|SPRC_HUMAN SPARC OS=Homo sapiens GN=SPARC  82.12 10 2
O95373|IPO7_HUMAN Importin-7 OS=Homo sapiens GN=IPO7  81.84 8 2
Q16186|ADRM1_HUMAN Proteasomal ubiquitin receptor ADRM1     81.75 13 2
Q13442|HAP28_HUMAN 28 kDa heat- and acid-stable phosphop      81.62 24 2
P48444|COPD_HUMAN Coatomer subunit delta OS=Homo sapi    81.29 12 2
O75380|NDUS6_HUMAN NADH dehydrogenase [ubiquinone] iron         81.2 27 2
A8MWD9|RUXGL_HUMAN Small nuclear ribonucleoprotein G-like p     81.11 37 2
P62308|RUXG_HUMAN Small nuclear ribonucleoprotein G OS=     81.11 17 2
Q96HE7|ERO1A_HUMAN ERO1-like protein alpha OS=Homo sap    81.11 15 2
P55854|SUMO3_HUMAN Small ubiquitin-related modifier 3 OS=H     80.97 24 2
P30049|ATPD_HUMAN ATP synthase subunit delta, mitochondr      80.77 27 2
Q9UKY7|CDV3_HUMAN Protein CDV3 homolog OS=Homo sapie    80.75 16 2
Q3LXA3|DHAK_HUMAN Bifunctional ATP-dependent dihydroxya         80.72 25 2
P29218|IMPA1_HUMAN Inositol monophosphatase 1 OS=Homo    80.63 8 2
P61803|DAD1_HUMAN Dolichyl-diphosphooligosaccharide--pro         80.51 34 2
O96000|NDUBA_HUMAN NADH dehydrogenase [ubiquinone] 1 b         80.43 27 2
Q9Y5S9|RBM8A_HUMAN RNA-binding protein 8A OS=Homo sapi    80.42 21 2
Q15833|STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sa    80.37 19 2
Q99447|PCY2_HUMAN Ethanolamine-phosphate cytidylyltransfe      80.21 23 2
Q96C90|PP14B_HUMAN Protein phosphatase 1 regulatory subun       80.1 59 2
P15954|COX7C_HUMAN Cytochrome c oxidase subunit 7C, mitoc      79.92 41 2
P35611|ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=   79.78 16 2
P52758|UK114_HUMAN Ribonuclease UK114 OS=Homo sapien    79.42 31 2
O95793|STAU1_HUMAN Double-stranded RNA-binding protein S        79.38 16 2
Q01081|U2AF1_HUMAN Splicing factor U2AF 35 kDa subunit OS     79.3 11 2
P00390|GSHR_HUMAN Glutathione reductase, mitochondrial OS     79.25 9 2
Q8N0X7|SPG20_HUMAN Spartin OS=Homo sapiens GN=SPG20  79.24 5 2
Q86SZ2|TPC6B_HUMAN Trafficking protein particle complex subu       79.01 17 2
O75431|MTX2_HUMAN Metaxin-2 OS=Homo sapiens GN=MTX   78.94 13 2
P49589|SYCC_HUMAN Cysteinyl-tRNA synthetase, cytoplasmic     78.77 17 2
Q9H944|MED20_HUMAN Mediator of RNA polymerase II transcrip        78.61 21 2
Q9Y285|SYFA_HUMAN Phenylalanyl-tRNA synthetase alpha ch      78.51 13 2
P78344|IF4G2_HUMAN Eukaryotic translation initiation factor 4       78.49 10 2
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P07311|ACYP1_HUMAN Acylphosphatase-1 OS=Homo sapiens   78.49 23 2
Q9UQ35|SRRM2_HUMAN Serine/arginine repetitive matrix protein      78.46 9 2
P25391|LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sap    78.39 9 2
Q9Y6M9|NDUB9_HUMAN NADH dehydrogenase [ubiquinone] 1 b         78.27 18 2
Q06481|APLP2_HUMAN Amyloid-like protein 2 OS=Homo sapien    78 11 2
Q9ULA0|DNPEP_HUMAN Aspartyl aminopeptidase OS=Homo sap    77.95 17 2
Q9UNH7|SNX6_HUMAN Sorting nexin-6 OS=Homo sapiens GN=   77.94 19 2
P04439|1A03_HUMAN HLA class I histocompatibility antigen, A        77.85 18 2
P56192|SYMC_HUMAN Methionyl-tRNA synthetase, cytoplasmic     77.47 8 2
P61086|UBE2K_HUMAN Ubiquitin-conjugating enzyme E2 K OS=     77.36 39 2
O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B     77.17 13 2
Q5TDH0|DDI2_HUMAN Protein DDI1 homolog 2 OS=Homo sap    77.15 6 2
P52815|RM12_HUMAN 39S ribosomal protein L12, mitochondria      76.8 21 2
Q92572|AP3S1_HUMAN AP-3 complex subunit sigma-1 OS=Hom     76.56 10 2
O00170|AIP_HUMAN AH receptor-interacting protein OS=Hom     76.24 25 2
Q9NTX5|ECHD1_HUMAN Enoyl-CoA hydratase domain-containing       76.14 15 2
Q9Y3D9|RT23_HUMAN 28S ribosomal protein S23, mitochondri      76.04 18 2
P53365|ARFP2_HUMAN Arfaptin-2 OS=Homo sapiens GN=ARF   75.97 14 2
A6NK07|IF2BL_HUMAN Eukaryotic translation initiation factor 2       75.91 13 2
P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2       75.91 13 2
P10155|RO60_HUMAN 60 kDa SS-A/Ro ribonucleoprotein OS=     75.88 11 2
P55060|XPO2_HUMAN Exportin-2 OS=Homo sapiens GN=CSE   75.51 13 2
Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB aux       75.31 9 2
Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo    74.94 14 2
Q96SM3|CPXM1_HUMAN Probable carboxypeptidase X1 OS=Hom     74.86 10 2
Q99426|TBCB_HUMAN Tubulin-folding cofactor B OS=Homo sa    74.55 9 2
Q92890|UFD1_HUMAN Ubiquitin fusion degradation protein 1 h      74.47 14 2
P37268|FDFT_HUMAN Squalene synthase OS=Homo sapiens   74.35 15 2
Q9UMY4|SNX12_HUMAN Sorting nexin-12 OS=Homo sapiens GN   74.31 17 2
Q9UL25|RAB21_HUMAN Ras-related protein Rab-21 OS=Homo s    74.11 28 2
Q9NPH2|INO1_HUMAN Inositol-3-phosphate synthase 1 OS=Ho     73.91 8 2
Q16706|MA2A1_HUMAN Alpha-mannosidase 2 OS=Homo sapien    73.43 9 2
Q9UJC5|SH3L2_HUMAN SH3 domain-binding glutamic acid-rich-        73.32 25 2
Q02978|M2OM_HUMAN Mitochondrial 2-oxoglutarate/malate car       73.19 21 2
Q9Y3B7|RM11_HUMAN 39S ribosomal protein L11, mitochondria      73.04 46 2
Q9BU89|DOHH_HUMAN Deoxyhypusine hydroxylase OS=Homo    73.02 18 2
P11233|RALA_HUMAN Ras-related protein Ral-A OS=Homo sa    72.88 22 2
O00625|PIR_HUMAN Pirin OS=Homo sapiens GN=PIR PE=1 72.82 16 2
Q9UHB9|SRP68_HUMAN Signal recognition particle 68 kDa prote      72.49 11 2
Q99543|DNJC2_HUMAN DnaJ homolog subfamily C member 2 O     72.4 12 2
P63272|SPT4H_HUMAN Transcription elongation factor SPT4 OS     72.32 21 2
Q9H8S9|MOL1B_HUMAN Mps one binder kinase activator-like 1B     72.25 19 2
Q7L9L4|MOL1A_HUMAN Mps one binder kinase activator-like 1A     72.25 14 2
Q9UBV8|PEF1_HUMAN Peflin OS=Homo sapiens GN=PEF1 PE  72.06 11 2
Q9NV35|NUD15_HUMAN Probable 7,8-dihydro-8-oxoguanine triph       71.94 7 2
Q5TZA2|CROCC_HUMAN Rootletin OS=Homo sapiens GN=CROC   71.86 9 2
Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens G   71.78 5 2
Q5SSJ5|HP1B3_HUMAN Heterochromatin protein 1-binding prote       71.74 12 2
Q96HR9|REEP6_HUMAN Receptor expression-enhancing protein      71.42 29 2
P01116|RASK_HUMAN GTPase KRas OS=Homo sapiens GN=   70.95 17 2
P01111|RASN_HUMAN GTPase NRas OS=Homo sapiens GN=   70.95 17 2
Q9NVA2|SEP11_HUMAN Septin-11 OS=Homo sapiens GN=SEPT   70.48 17 2
Q8TDP1|RNH2C_HUMAN Ribonuclease H2 subunit C OS=Homo s    70.4 15 2
Q9UH65|SWP70_HUMAN Switch-associated protein 70 OS=Homo    70.06 12 2
Q13153|PAK1_HUMAN Serine/threonine-protein kinase PAK 1 O     69.67 6 2
P56747|CLD6_HUMAN Claudin-6 OS=Homo sapiens GN=CLDN   69.55 13 2
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Q6IQ22|RAB12_HUMAN Ras-related protein Rab-12 OS=Homo s    69.4 13 2
Q7Z4H3|HDDC2_HUMAN HD domain-containing protein 2 OS=Ho     69.3 22 2
O00629|IMA4_HUMAN Importin subunit alpha-4 OS=Homo sap    69.15 8 2
Q8NC69|KCTD6_HUMAN BTB/POZ domain-containing protein KC      68.94 19 2
Q8IZ83|A16A1_HUMAN Aldehyde dehydrogenase family 16 mem       68.93 12 2
P29083|T2EA_HUMAN General transcription factor IIE subunit      68.87 11 2
Q9Y6E0|STK24_HUMAN Serine/threonine-protein kinase 24 OS=     68.56 15 2
P23378|GCSP_HUMAN Glycine dehydrogenase [decarboxylatin       68.21 4 2
Q5TFE4|NT5D1_HUMAN 5'-nucleotidase domain-containing prote       68.2 11 2
Q9UKF6|CPSF3_HUMAN Cleavage and polyadenylation specificit         67.53 8 2
O95218|ZRAB2_HUMAN Zinc finger Ran-binding domain-contain        67.15 9 2
P04183|KITH_HUMAN Thymidine kinase, cytosolic OS=Homo s    66.94 14 2
Q16718|NDUA5_HUMAN NADH dehydrogenase [ubiquinone] 1 a         66.93 30 2
P60510|PP4C_HUMAN Serine/threonine-protein phosphatase 4       66.73 10 2
P61225|RAP2B_HUMAN Ras-related protein Rap-2b OS=Homo s    66.56 21 2
Q03426|KIME_HUMAN Mevalonate kinase OS=Homo sapiens G   66.39 13 2
O00154|BACH_HUMAN Cytosolic acyl coenzyme A thioester hyd      66.35 22 2
O95235|KI20A_HUMAN Kinesin-like protein KIF20A OS=Homo s    65.81 13 2
Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=     65.66 22 2
O43583|DENR_HUMAN Density-regulated protein OS=Homo sa    65.64 19 2
P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=     65.59 17 2
Q8N5K1|CISD2_HUMAN CDGSH iron-sulfur domain-containing p       65.57 34 2
P52888|THOP1_HUMAN Thimet oligopeptidase OS=Homo sapie    65.26 4 2
Q9GZQ8|MLP3B_HUMAN Microtubule-associated proteins 1A/1B        65.03 23 2
A6NCE7|MP3B2_HUMAN Microtubule-associated proteins 1A/1B          65.03 23 2
O75534|CSDE1_HUMAN Cold shock domain-containing protein E      65.03 9 2
Q9BZL1|UBL5_HUMAN Ubiquitin-like protein 5 OS=Homo sapie    64.94 25 2
O14925|TIM23_HUMAN Mitochondrial import inner membrane tra        64.93 13 2
Q5SRD1|TI23B_HUMAN Putative mitochondrial import inner mem         64.93 11 2
Q9Y3B2|EXOS1_HUMAN Exosome complex component CSL4 OS     64.87 13 2
Q13636|RAB31_HUMAN Ras-related protein Rab-31 OS=Homo s    64.3 19 2
P05204|HMGN2_HUMAN Non-histone chromosomal protein HMG      64.24 56 2
P56377|AP1S2_HUMAN AP-1 complex subunit sigma-2 OS=Hom     64.03 17 2
P61960|UFM1_HUMAN Ubiquitin-fold modifier 1 OS=Homo sapi    63.89 27 2
P18065|IBP2_HUMAN Insulin-like growth factor-binding protein      63.87 8 2
Q9BRJ7|SDOS_HUMAN Protein syndesmos OS=Homo sapiens   63.48 17 2
O00217|NDUS8_HUMAN NADH dehydrogenase [ubiquinone] iron         63.33 18 2
Q96QK1|VPS35_HUMAN Vacuolar protein sorting-associated prot       63.32 13 2
Q13155|AIMP2_HUMAN Aminoacyl tRNA synthase complex-inte         63.04 10 2
Q07812|BAX_HUMAN Apoptosis regulator BAX OS=Homo sap    62.59 19 2
P52732|KIF11_HUMAN Kinesin-like protein KIF11 OS=Homo sa    62.44 5 2
O00115|DNS2A_HUMAN Deoxyribonuclease-2-alpha OS=Homo s    61.62 7 2
P49406|RM19_HUMAN 39S ribosomal protein L19, mitochondria      61.61 11 2
Q9H9J2|RM44_HUMAN 39S ribosomal protein L44, mitochondria      61.5 10 2
P49756|RBM25_HUMAN RNA-binding protein 25 OS=Homo sapi    61.38 3 2
Q6NVY1|HIBCH_HUMAN 3-hydroxyisobutyryl-CoA hydrolase, mito      61.25 11 2
P19404|NDUV2_HUMAN NADH dehydrogenase [ubiquinone] flav        61.16 16 2
Q96BM9|ARL8A_HUMAN ADP-ribosylation factor-like protein 8A O     61.03 15 2
Q9NVJ2|ARL8B_HUMAN ADP-ribosylation factor-like protein 8B O     61.03 15 2
O75251|NDUS7_HUMAN NADH dehydrogenase [ubiquinone] iron         60.96 8 2
Q9Y2R0|CCD56_HUMAN Coiled-coil domain-containing protein 56     60.9 27 2
O94826|TOM70_HUMAN Mitochondrial import receptor subunit TO      59.92 9 2
P14927|QCR7_HUMAN Cytochrome b-c1 complex subunit 7 OS     59.92 27 2
P63098|CANB1_HUMAN Calcineurin subunit B type 1 OS=Homo    59.79 11 2
P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprote       58.35 12 2
P21281|VATB2_HUMAN V-type proton ATPase subunit B, brain i      58.26 10 2
311
Q02218|ODO1_HUMAN 2-oxoglutarate dehydrogenase, mitocho      58.05 8 2
Q9Y2Q9|RT28_HUMAN 28S ribosomal protein S28, mitochondri      57.96 13 2
P31930|QCR1_HUMAN Cytochrome b-c1 complex subunit 1, mi      57.88 13 2
P56556|NDUA6_HUMAN NADH dehydrogenase [ubiquinone] 1 a         57.21 31 2
O43678|NDUA2_HUMAN NADH dehydrogenase [ubiquinone] 1 a         57.14 20 2
Q96K17|BT3L4_HUMAN Transcription factor BTF3 homolog 4 OS     56.73 33 2
O43865|SAHH2_HUMAN Putative adenosylhomocysteinase 2 OS     56.61 16 2
Q9Y530|CF130_HUMAN Uncharacterized protein C6orf130 OS=H     56.26 26 2
O15498|YKT6_HUMAN Synaptobrevin homolog YKT6 OS=Hom     55.34 10 2
Q14677|EPN4_HUMAN Clathrin interactor 1 OS=Homo sapiens   55.24 6 2
Q92747|ARC1A_HUMAN Actin-related protein 2/3 complex subun       54.89 26 2
Q99661|KIF2C_HUMAN Kinesin-like protein KIF2C OS=Homo sa    54.64 11 2
Q9NVM6|DJC17_HUMAN DnaJ homolog subfamily C member 17     54.21 22 2
O75718|CRTAP_HUMAN Cartilage-associated protein OS=Homo    53.78 6 2
Q02880|TOP2B_HUMAN DNA topoisomerase 2-beta OS=Homo s    53.64 5 2
Q13428|TCOF_HUMAN Treacle protein OS=Homo sapiens GN=   52.99 13 2
Q8WZA0|LZIC_HUMAN Protein LZIC OS=Homo sapiens GN=LZ   52.68 23 2
Q9H7Z7|PGES2_HUMAN Prostaglandin E synthase 2 OS=Homo    52.65 12 2
O95881|TXD12_HUMAN Thioredoxin domain-containing protein 1      51.81 14 2
P61513|RL37A_HUMAN 60S ribosomal protein L37a OS=Homo    51.22 28 2
P56381|ATP5E_HUMAN ATP synthase subunit epsilon, mitochon      51.1 53 2
O75438|NDUB1_HUMAN NADH dehydrogenase [ubiquinone] 1 b         51.05 48 2
Q7Z4W1|DCXR_HUMAN L-xylulose reductase OS=Homo sapiens   50.8 14 2
Q9UPG8|PLAL2_HUMAN Zinc finger protein PLAGL2 OS=Homo s    50.6 3 2
Q8TE73|DYH5_HUMAN Dynein heavy chain 5, axonemal OS=H     50.53 7 2
O00754|MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Hom     50.45 5 2
O75822|EIF3J_HUMAN Eukaryotic translation initiation factor 3       50.25 9 2
Q9BYN0|SRXN1_HUMAN Sulfiredoxin-1 OS=Homo sapiens GN=S   49.96 61 2
Q96HF1|SFRP2_HUMAN Secreted frizzled-related protein 2 OS=H     48.73 8 2
O15484|CAN5_HUMAN Calpain-5 OS=Homo sapiens GN=CAP   48.49 4 2
P49207|RL34_HUMAN 60S ribosomal protein L34 OS=Homo s    48.49 13 2
Q9NYF8|BCLF1_HUMAN Bcl-2-associated transcription factor 1 O     48.31 5 2
P38117|ETFB_HUMAN Electron transfer flavoprotein subunit be      47.14 20 2
Q8WVB6|CTF18_HUMAN Chromosome transmission fidelity prote        46.84 8 2
P61916|NPC2_HUMAN Epididymal secretory protein E1 OS=Ho     46.16 28 2
Q8IUR0|TPPC5_HUMAN Trafficking protein particle complex subu       44.87 27 2
Q86UW8|HPLN4_HUMAN Hyaluronan and proteoglycan link prote       42.29 10 2
P09038|FGF2_HUMAN Heparin-binding growth factor 2 OS=Ho     41.24 15 2
Q9Y5Z4|HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapi    40.86 16 2
P06703|S10A6_HUMAN Protein S100-A6 OS=Homo sapiens GN   40.68 17 2
Q9NRC6|SPTN5_HUMAN Spectrin beta chain, brain 4 OS=Homo    39.95 8 2
Q6IQ55|TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens   39.21 7 2
P49454|CENPF_HUMAN Centromere protein F OS=Homo sapien    39.1 4 2
Q8IVF4|DYH10_HUMAN Dynein heavy chain 10, axonemal OS=H     38.62 6 2
Q5JWR5|DOP1_HUMAN Protein dopey-1 OS=Homo sapiens GN   38.37 7 2
Q8NE71|ABCF1_HUMAN ATP-binding cassette sub-family F mem       38.26 6 2
Q14669|TRIPC_HUMAN Probable E3 ubiquitin-protein ligase TR      38.23 8 2
Q9BXM0|PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX P  38.04 9 2
Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens GN=MUC   37.93 6 2
Q9HB07|MYG1_HUMAN UPF0160 protein MYG1, mitochondrial     37.63 10 2
Q9Y4W2|LAS1L_HUMAN Protein LAS1 homolog OS=Homo sapie    36.25 9 2
P20929|NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB P  36.01 5 2
Q86TB3|ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapie    35.61 6 2
O75179|ANR17_HUMAN Ankyrin repeat domain-containing prote       35.5 4 2
Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolo      34.73 3 2
Q8N6I1|EID2_HUMAN EP300-interacting inhibitor of differentia       33.82 14 2
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O14815|CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAP   33.32 7 2
Q07157|ZO1_HUMAN Tight junction protein ZO-1 OS=Homo s    33.22 8 2
P08123|CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sa    33.2 26 2
Q5K651|SAMD9_HUMAN Sterile alpha motif domain-containing pr       31.36 3 2
Q17RW2|COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Hom     30.94 9 2
O75145|LIPA3_HUMAN Liprin-alpha-3 OS=Homo sapiens GN=P   30.5 4 2
Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-relat        29.94 6 2
Q96FE5|LIGO1_HUMAN Leucine-rich repeat and immunoglobulin           29.17 12 2
Q9H6A0|DEN2D_HUMAN DENN domain-containing protein 2D OS     28.18 14 2
Q8IXJ9|ASXL1_HUMAN Putative Polycomb group protein ASXL1     27.93 8 2
Q70EL4|UBP43_HUMAN Ubiquitin carboxyl-terminal hydrolase 43     27.56 7 2
P49761|CLK3_HUMAN Dual specificity protein kinase CLK3 OS     27.5 5 2
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Table A1.11 BJ-1D hiPSC CMTX Protein Identifications.  List of all proteins identified 
in CMTX from BJ-1D hiPSCs with corresponding accession, description, PEAKS score, 
unique peptide numbers, and coverage (in %). 
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Accession Description Score Coverage (%) #Unique
Q13813|SPTA2_HUMAN Spectrin alpha chain, brain OS=Homo sapi    415.57 69 88
P18206|VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL PE=  406.76 75 88
P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA P  420.58 60 83
P49327|FAS_HUMAN Fatty acid synthase OS=Homo sapiens GN   404.62 54 77
P04406|G3P_HUMAN Glyceraldehyde-3-phosphate dehydrogena      393.33 80 59
P08670|VIME_HUMAN Vimentin OS=Homo sapiens GN=VIM PE=  376.46 88 57
P13639|EF2_HUMAN Elongation factor 2 OS=Homo sapiens GN   376.7 74 56
P14618|KPYM_HUMAN Pyruvate kinase isozymes M1/M2 OS=Hom     388.34 84 55
P06733|ENOA_HUMAN Alpha-enolase OS=Homo sapiens GN=EN   378.09 91 53
P55072|TERA_HUMAN Transitional endoplasmic reticulum ATPase     320.9 66 48
Q01082|SPTB2_HUMAN Spectrin beta chain, brain 1 OS=Homo sap    340.04 53 47
P29401|TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT  341.77 71 46
P35579|MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 P  359.17 55 43
P68104|EF1A1_HUMAN Elongation factor 1-alpha 1 OS=Homo sap    382.81 83 41
P04075|ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Ho     363.24 90 40
P07737|PROF1_HUMAN Profilin-1 OS=Homo sapiens GN=PFN1 PE  331.51 97 40
P18669|PGAM1_HUMAN Phosphoglycerate mutase 1 OS=Homo sap    327.03 87 36
P35580|MYH10_HUMAN Myosin-10 OS=Homo sapiens GN=MYH10  346.9 57 35
P78371|TCPB_HUMAN T-complex protein 1 subunit beta OS=Hom     336.45 73 34
P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP      291.2 45 34
P60174|TPIS_HUMAN Triosephosphate isomerase OS=Homo sap    321.71 95 33
P62805|H4_HUMAN Histone H4 OS=Homo sapiens GN=HIST1   297.26 62 33
P50454|SERPH_HUMAN Serpin H1 OS=Homo sapiens GN=SERPIN   335.1 84 32
Q01995|TAGL_HUMAN Transgelin OS=Homo sapiens GN=TAGLN  303.06 85 32
Q14152|EIF3A_HUMAN Eukaryotic translation initiation factor 3 sub       272.93 40 32
P30101|PDIA3_HUMAN Protein disulfide-isomerase A3 OS=Homo    266.77 59 32
P12814|ACTN1_HUMAN Alpha-actinin-1 OS=Homo sapiens GN=AC   366.51 67 31
P22626|ROA2_HUMAN Heterogeneous nuclear ribonucleoproteins      315.99 68 31
P00558|PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sap    304.57 86 31
P61978|HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K     290.36 61 31
O75874|IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytoplas      327.63 82 30
P07355|ANXA2_HUMAN Annexin A2 OS=Homo sapiens GN=ANXA   315.97 72 30
P53396|ACLY_HUMAN ATP-citrate synthase OS=Homo sapiens G   293.91 42 30
P12956|XRCC6_HUMAN X-ray repair cross-complementing protein 6     290.56 63 30
P07814|SYEP_HUMAN Bifunctional aminoacyl-tRNA synthetase O     283.37 42 30
P50395|GDIB_HUMAN Rab GDP dissociation inhibitor beta OS=H     323.5 73 29
Q06830|PRDX1_HUMAN Peroxiredoxin-1 OS=Homo sapiens GN=P   312.03 81 29
P05455|LA_HUMAN Lupus La protein OS=Homo sapiens GN=S   308.2 74 29
P48643|TCPE_HUMAN T-complex protein 1 subunit epsilon OS=H     283.95 73 29
P62937|PPIA_HUMAN Peptidyl-prolyl cis-trans isomerase A OS=H     279.13 81 28
Q00610|CLH1_HUMAN Clathrin heavy chain 1 OS=Homo sapiens   346.23 61 27
P13010|XRCC5_HUMAN X-ray repair cross-complementing protein 5     301.23 64 27
P30041|PRDX6_HUMAN Peroxiredoxin-6 OS=Homo sapiens GN=P   297.01 85 27
P26038|MOES_HUMAN Moesin OS=Homo sapiens GN=MSN PE=1 289.19 70 27
P50990|TCPQ_HUMAN T-complex protein 1 subunit theta OS=Hom     261.43 57 27
P14625|ENPL_HUMAN Endoplasmin OS=Homo sapiens GN=HSP   257.85 45 27
P08238|HS90B_HUMAN Heat shock protein HSP 90-beta OS=Hom     381.28 73 26
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P23528|COF1_HUMAN Cofilin-1 OS=Homo sapiens GN=CFL1 PE  351.29 93 26
P62328|TYB4_HUMAN Thymosin beta-4 OS=Homo sapiens GN=T   311.08 93 26
O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB P  275.65 31 26
P34932|HSP74_HUMAN Heat shock 70 kDa protein 4 OS=Homo sa    270.13 55 26
P52272|HNRPM_HUMAN Heterogeneous nuclear ribonucleoprotein M     265.99 81 26
Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens GN=KTN1 PE  259.22 43 26
O43707|ACTN4_HUMAN Alpha-actinin-4 OS=Homo sapiens GN=AC   340.07 62 25
P40926|MDHM_HUMAN Malate dehydrogenase, mitochondrial OS=     321.36 87 25
Q99832|TCPH_HUMAN T-complex protein 1 subunit eta OS=Homo    297.49 76 25
P23246|SFPQ_HUMAN Splicing factor, proline- and glutamine-rich     281.88 51 25
P49368|TCPG_HUMAN T-complex protein 1 subunit gamma OS=H     262.99 61 25
P62258|1433E_HUMAN 14-3-3 protein epsilon OS=Homo sapiens G   316.26 73 24
P62158|CALM_HUMAN Calmodulin OS=Homo sapiens GN=CALM   288.06 73 24
P00338|LDHA_HUMAN L-lactate dehydrogenase A chain OS=Hom     272.17 80 24
O00231|PSD11_HUMAN 26S proteasome non-ATPase regulatory su       270.46 60 24
P61604|CH10_HUMAN 10 kDa heat shock protein, mitochondrial O     264.25 97 24
P11586|C1TC_HUMAN C-1-tetrahydrofolate synthase, cytoplasmic     261.8 48 24
P11142|HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=Ho     343.82 71 23
P09211|GSTP1_HUMAN Glutathione S-transferase P OS=Homo sap    311.37 67 23
P63104|1433Z_HUMAN 14-3-3 protein zeta/delta OS=Homo sapien    309.6 75 23
Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC P  269.23 28 23
P11021|GRP78_HUMAN 78 kDa glucose-regulated protein OS=Hom     268.24 55 23
Q9P2E9|RRBP1_HUMAN Ribosome-binding protein 1 OS=Homo sap    264.54 35 23
P49321|NASP_HUMAN Nuclear autoantigenic sperm protein OS=H     264.04 52 23
P08758|ANXA5_HUMAN Annexin A5 OS=Homo sapiens GN=ANXA   263.47 61 23
P10809|CH60_HUMAN 60 kDa heat shock protein, mitochondrial O     254.47 72 23
Q9P2J5|SYLC_HUMAN Leucyl-tRNA synthetase, cytoplasmic OS=     249.98 34 23
P27816|MAP4_HUMAN Microtubule-associated protein 4 OS=Hom     246.38 48 23
P06748|NPM_HUMAN Nucleophosmin OS=Homo sapiens GN=NP   297.11 57 22
P04083|ANXA1_HUMAN Annexin A1 OS=Homo sapiens GN=ANXA   293.21 82 22
O60664|PLIN3_HUMAN Perilipin-3 OS=Homo sapiens GN=PLIN3 P  286.02 68 22
P07195|LDHB_HUMAN L-lactate dehydrogenase B chain OS=Hom     280.74 70 22
P19338|NUCL_HUMAN Nucleolin OS=Homo sapiens GN=NCL PE  279.66 70 22
P37802|TAGL2_HUMAN Transgelin-2 OS=Homo sapiens GN=TAGL   265.75 90 22
P23396|RS3_HUMAN 40S ribosomal protein S3 OS=Homo sapie    264.34 79 22
P25398|RS12_HUMAN 40S ribosomal protein S12 OS=Homo sapi    255.07 87 22
P61247|RS3A_HUMAN 40S ribosomal protein S3a OS=Homo sapi    237.12 67 22
Q00839|HNRPU_HUMAN Heterogeneous nuclear ribonucleoprotein U     235.34 38 22
P67936|TPM4_HUMAN Tropomyosin alpha-4 chain OS=Homo sap    337.21 92 21
Q01469|FABP5_HUMAN Fatty acid-binding protein, epidermal OS=H     310.82 91 21
P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, deca      302.27 67 21
P22314|UBA1_HUMAN Ubiquitin-like modifier-activating enzyme 1     287.66 52 21
P15311|EZRI_HUMAN Ezrin OS=Homo sapiens GN=EZR PE=1 S 275.31 62 21
P08133|ANXA6_HUMAN Annexin A6 OS=Homo sapiens GN=ANXA   263.46 54 21
P06744|G6PI_HUMAN Glucose-6-phosphate isomerase OS=Hom     260.96 53 21
Q9UQE7|SMC3_HUMAN Structural maintenance of chromosomes p       246.91 43 21
Q9Y617|SERC_HUMAN Phosphoserine aminotransferase OS=Hom     235 63 21
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Q13263|TIF1B_HUMAN Transcription intermediary factor 1-beta OS     229.1 41 21
P07900|HS90A_HUMAN Heat shock protein HSP 90-alpha OS=Hom     354.61 61 20
P25205|MCM3_HUMAN DNA replication licensing factor MCM3 OS     241 43 20
P22102|PUR2_HUMAN Trifunctional purine biosynthetic protein ad      236.14 44 20
P43243|MATR3_HUMAN Matrin-3 OS=Homo sapiens GN=MATR3 P  234.49 38 20
P27348|1433T_HUMAN 14-3-3 protein theta OS=Homo sapiens GN   294.62 80 19
P09936|UCHL1_HUMAN Ubiquitin carboxyl-terminal hydrolase isozy       288.93 72 19
P62826|RAN_HUMAN GTP-binding nuclear protein Ran OS=Hom     265.32 67 19
P62333|PRS10_HUMAN 26S protease regulatory subunit 10B OS=H     253.46 62 19
Q05682|CALD1_HUMAN Caldesmon OS=Homo sapiens GN=CALD   247.38 42 19
P31948|STIP1_HUMAN Stress-induced-phosphoprotein 1 OS=Hom     245.14 54 19
Q14566|MCM6_HUMAN DNA replication licensing factor MCM6 OS     232.1 40 19
P07237|PDIA1_HUMAN Protein disulfide-isomerase OS=Homo sap    223.79 52 19
P36578|RL4_HUMAN 60S ribosomal protein L4 OS=Homo sapie    196.33 53 19
O43175|SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=     270.54 53 18
P40227|TCPZ_HUMAN T-complex protein 1 subunit zeta OS=Hom     265.84 67 18
P33993|MCM7_HUMAN DNA replication licensing factor MCM7 OS     260.76 58 18
P28074|PSB5_HUMAN Proteasome subunit beta type-5 OS=Homo    245.18 59 18
Q15691|MARE1_HUMAN Microtubule-associated protein RP/EB fam        238.96 62 18
P62081|RS7_HUMAN 40S ribosomal protein S7 OS=Homo sapie    197.73 68 18
P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens GN   196.85 25 18
P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins      261.66 66 17
P05387|RLA2_HUMAN 60S acidic ribosomal protein P2 OS=Homo    260.83 84 17
P61981|1433G_HUMAN 14-3-3 protein gamma OS=Homo sapiens   253.74 81 17
P32119|PRDX2_HUMAN Peroxiredoxin-2 OS=Homo sapiens GN=P   249.71 42 17
Q99623|PHB2_HUMAN Prohibitin-2 OS=Homo sapiens GN=PHB2  241.91 71 17
Q16851|UGPA_HUMAN UTP--glucose-1-phosphate uridylyltransfera      240.68 59 17
P17174|AATC_HUMAN Aspartate aminotransferase, cytoplasmic O     239.08 62 17
P31939|PUR9_HUMAN Bifunctional purine biosynthesis protein PU      235.43 46 17
P63244|GBLP_HUMAN Guanine nucleotide-binding protein subunit       234.94 62 17
P39019|RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapi    227.91 77 17
P62277|RS13_HUMAN 40S ribosomal protein S13 OS=Homo sapi    216.5 60 17
Q9Y4L1|HYOU1_HUMAN Hypoxia up-regulated protein 1 OS=Homo    215.56 43 17
P48681|NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE=1 208.5 26 17
O00232|PSD12_HUMAN 26S proteasome non-ATPase regulatory su       197.18 41 17
O75347|TBCA_HUMAN Tubulin-specific chaperone A OS=Homo sa    252.01 79 16
P09874|PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo    250.38 39 16
Q9HB71|CYBP_HUMAN Calcyclin-binding protein OS=Homo sapien    245.55 75 16
Q9BWD1|THIC_HUMAN Acetyl-CoA acetyltransferase, cytosolic OS     237.68 63 16
Q15008|PSMD6_HUMAN 26S proteasome non-ATPase regulatory su       232.3 62 16
Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Hom     224.69 47 16
P05556|ITB1_HUMAN Integrin beta-1 OS=Homo sapiens GN=ITG   223.84 34 16
Q08211|DHX9_HUMAN ATP-dependent RNA helicase A OS=Homo    213.57 33 16
P54136|SYRC_HUMAN Arginyl-tRNA synthetase, cytoplasmic OS=     182 37 16
P02794|FRIH_HUMAN Ferritin heavy chain OS=Homo sapiens GN   181.41 64 16
P62701|RS4X_HUMAN 40S ribosomal protein S4, X isoform OS=H     178.24 63 16
P35221|CTNA1_HUMAN Catenin alpha-1 OS=Homo sapiens GN=C   271.34 55 15
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P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=H     259.33 46 15
P62195|PRS8_HUMAN 26S protease regulatory subunit 8 OS=Hom     257.2 70 15
P02792|FRIL_HUMAN Ferritin light chain OS=Homo sapiens GN=   256.12 69 15
P09972|ALDOC_HUMAN Fructose-bisphosphate aldolase C OS=Ho     253.88 72 15
Q15084|PDIA6_HUMAN Protein disulfide-isomerase A6 OS=Homo    244.61 60 15
Q16658|FSCN1_HUMAN Fascin OS=Homo sapiens GN=FSCN1 PE  238.45 51 15
P31949|S10AB_HUMAN Protein S100-A11 OS=Homo sapiens GN=   232.54 89 15
P25705|ATPA_HUMAN ATP synthase subunit alpha, mitochondria      227.18 46 15
Q92499|DDX1_HUMAN ATP-dependent RNA helicase DDX1 OS=H     225.41 50 15
P29692|EF1D_HUMAN Elongation factor 1-delta OS=Homo sapien    224.66 70 15
P30044|PRDX5_HUMAN Peroxiredoxin-5, mitochondrial OS=Homo s    222.4 72 15
Q9BXP5|SRRT_HUMAN Serrate RNA effector molecule homolog OS     220.57 40 15
P08865|RSSA_HUMAN 40S ribosomal protein SA OS=Homo sapie    220.51 64 15
P17980|PRS6A_HUMAN 26S protease regulatory subunit 6A OS=Ho     218.83 59 15
P62316|SMD2_HUMAN Small nuclear ribonucleoprotein Sm D2 OS     215.67 87 15
Q01581|HMCS1_HUMAN Hydroxymethylglutaryl-CoA synthase, cytop      215.52 46 15
O43242|PSMD3_HUMAN 26S proteasome non-ATPase regulatory su       214.44 43 15
Q8NC51|PAIRB_HUMAN Plasminogen activator inhibitor 1 RNA-bind       206.55 56 15
P33991|MCM4_HUMAN DNA replication licensing factor MCM4 OS     206.07 39 15
P10599|THIO_HUMAN Thioredoxin OS=Homo sapiens GN=TXN P  201.64 78 15
P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=A   192.7 65 15
P10909|CLUS_HUMAN Clusterin OS=Homo sapiens GN=CLU PE=  190.18 30 15
Q12906|ILF3_HUMAN Interleukin enhancer-binding factor 3 OS=H     182.82 23 15
P07437|TBB5_HUMAN Tubulin beta chain OS=Homo sapiens GN=   436.88 80 14
P12268|IMDH2_HUMAN Inosine-5'-monophosphate dehydrogenase      255.92 46 14
P63220|RS21_HUMAN 40S ribosomal protein S21 OS=Homo sapi    250.13 84 14
Q9NZI8|IF2B1_HUMAN Insulin-like growth factor 2 mRNA-binding p       249.44 38 14
P13796|PLSL_HUMAN Plastin-2 OS=Homo sapiens GN=LCP1 PE  239.04 50 14
Q99497|PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK   233.87 65 14
P27695|APEX1_HUMAN DNA-(apurinic or apyrimidinic site) lyase OS     232.53 49 14
P22234|PUR6_HUMAN Multifunctional protein ADE2 OS=Homo sa    226.99 58 14
P43686|PRS6B_HUMAN 26S protease regulatory subunit 6B OS=Ho     226.07 53 14
P62424|RL7A_HUMAN 60S ribosomal protein L7a OS=Homo sapi    223.33 47 14
Q9H9Z2|LN28A_HUMAN Protein lin-28 homolog A OS=Homo sapien    219.49 56 14
P37837|TALDO_HUMAN Transaldolase OS=Homo sapiens GN=TAL   205.72 54 14
P47897|SYQ_HUMAN Glutaminyl-tRNA synthetase OS=Homo sa    204.3 38 14
P78417|GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Ho     200.85 49 14
P11717|MPRI_HUMAN Cation-independent mannose-6-phosphate      198.8 14 14
P41250|SYG_HUMAN Glycyl-tRNA synthetase OS=Homo sapiens   196.4 37 14
Q02878|RL6_HUMAN 60S ribosomal protein L6 OS=Homo sapie    189.81 50 14
P62269|RS18_HUMAN 40S ribosomal protein S18 OS=Homo sapi    182.87 73 14
P18124|RL7_HUMAN 60S ribosomal protein L7 OS=Homo sapie    172.62 58 14
P60842|IF4A1_HUMAN Eukaryotic initiation factor 4A-I OS=Homo s    272.09 70 13
Q04917|1433F_HUMAN 14-3-3 protein eta OS=Homo sapiens GN=   272.01 78 13
P30086|PEBP1_HUMAN Phosphatidylethanolamine-binding protein      237.8 79 13
Q9Y265|RUVB1_HUMAN RuvB-like 1 OS=Homo sapiens GN=RUVB   236.18 66 13
P18084|ITB5_HUMAN Integrin beta-5 OS=Homo sapiens GN=ITG   235.94 44 13
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P23526|SAHH_HUMAN Adenosylhomocysteinase OS=Homo sapie    234.94 57 13
Q9UNM6|PSD13_HUMAN 26S proteasome non-ATPase regulatory su       234.76 63 13
P25789|PSA4_HUMAN Proteasome subunit alpha type-4 OS=Hom     229.68 68 13
P16152|CBR1_HUMAN Carbonyl reductase [NADPH] 1 OS=Homo    226.77 69 13
Q14103|HNRPD_HUMAN Heterogeneous nuclear ribonucleoprotein D      225.83 52 13
P50991|TCPD_HUMAN T-complex protein 1 subunit delta OS=Hom     225.14 44 13
P07108|ACBP_HUMAN Acyl-CoA-binding protein OS=Homo sapien    219.18 90 13
P17987|TCPA_HUMAN T-complex protein 1 subunit alpha OS=Hom     213.66 48 13
P16401|H15_HUMAN Histone H1.5 OS=Homo sapiens GN=HIST   211.69 52 13
P43487|RANG_HUMAN Ran-specific GTPase-activating protein OS     205.19 75 13
Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens G   198.67 21 13
P14174|MIF_HUMAN Macrophage migration inhibitory factor OS=     195.3 79 13
Q9BQG0|MBB1A_HUMAN Myb-binding protein 1A OS=Homo sapiens   182.01 25 13
P09493|TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo sap    324.63 87 12
P09651|ROA1_HUMAN Heterogeneous nuclear ribonucleoprotein A      308.23 68 12
O14818|PSA7_HUMAN Proteasome subunit alpha type-7 OS=Hom     266.6 79 12
P22392|NDKB_HUMAN Nucleoside diphosphate kinase B OS=Hom     255.67 93 12
P80723|BASP1_HUMAN Brain acid soluble protein 1 OS=Homo sap    243.12 71 12
Q99536|VAT1_HUMAN Synaptic vesicle membrane protein VAT-1      237.69 51 12
P35998|PRS7_HUMAN 26S protease regulatory subunit 7 OS=Hom     223.13 43 12
P60900|PSA6_HUMAN Proteasome subunit alpha type-6 OS=Hom     216.15 49 12
P49756|RBM25_HUMAN RNA-binding protein 25 OS=Homo sapiens   214.61 31 12
P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=Hom     207.86 60 12
P46777|RL5_HUMAN 60S ribosomal protein L5 OS=Homo sapie    206.63 56 12
P62888|RL30_HUMAN 60S ribosomal protein L30 OS=Homo sapi    201.88 86 12
O00299|CLIC1_HUMAN Chloride intracellular channel protein 1 OS     201.7 56 12
P62263|RS14_HUMAN 40S ribosomal protein S14 OS=Homo sapi    201.49 42 12
Q00341|VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP PE=  201.21 37 12
Q8N163|K1967_HUMAN Protein KIAA1967 OS=Homo sapiens GN=   199.82 28 12
P49773|HINT1_HUMAN Histidine triad nucleotide-binding protein 1     198.96 87 12
P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapien    197.87 23 12
Q01518|CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=     193.62 42 12
Q15233|NONO_HUMAN Non-POU domain-containing octamer-bind       192.37 35 12
Q9Y224|CN166_HUMAN UPF0568 protein C14orf166 OS=Homo sa    191.72 52 12
P00505|AATM_HUMAN Aspartate aminotransferase, mitochondrial     189.9 44 12
P26641|EF1G_HUMAN Elongation factor 1-gamma OS=Homo sap    186.2 23 12
P23142|FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN=FBLN1 P  164.33 26 12
P46781|RS9_HUMAN 40S ribosomal protein S9 OS=Homo sapie    156.63 41 12
P54577|SYYC_HUMAN Tyrosyl-tRNA synthetase, cytoplasmic OS=     156.42 41 12
P00441|SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo s    248.33 75 11
Q01105|SET_HUMAN Protein SET OS=Homo sapiens GN=SET P  245.06 41 11
Q9UHB9|SRP68_HUMAN Signal recognition particle 68 kDa protein O     241.29 45 11
P20618|PSB1_HUMAN Proteasome subunit beta type-1 OS=Homo    227.06 60 11
P53999|TCP4_HUMAN Activated RNA polymerase II transcriptiona        226.58 76 11
Q9UBC3|DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS     225.72 35 11
O75531|BAF_HUMAN Barrier-to-autointegration factor OS=Homo    224.18 78 11
P16949|STMN1_HUMAN Stathmin OS=Homo sapiens GN=STMN1 P  221.6 56 11
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O60506|HNRPQ_HUMAN Heterogeneous nuclear ribonucleoprotein Q     221.25 53 11
P63313|TYB10_HUMAN Thymosin beta-10 OS=Homo sapiens GN=   220.92 84 11
Q14697|GANAB_HUMAN Neutral alpha-glucosidase AB OS=Homo s    220.41 30 11
Q16555|DPYL2_HUMAN Dihydropyrimidinase-related protein 2 OS=     208.62 48 11
P14868|SYDC_HUMAN Aspartyl-tRNA synthetase, cytoplasmic OS     208.43 39 11
P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L     198.09 40 11
P17096|HMGA1_HUMAN High mobility group protein HMG-I/HMG-Y     196.9 82 11
P08708|RS17_HUMAN 40S ribosomal protein S17 OS=Homo sapi    195.24 73 11
P38646|GRP75_HUMAN Stress-70 protein, mitochondrial OS=Homo    193.13 37 11
P41091|IF2G_HUMAN Eukaryotic translation initiation factor 2 sub       191.66 50 11
P23284|PPIB_HUMAN Peptidyl-prolyl cis-trans isomerase B OS=H     189.48 45 11
P60866|RS20_HUMAN 40S ribosomal protein S20 OS=Homo sapi    188.77 50 11
Q7KZF4|SND1_HUMAN Staphylococcal nuclease domain-containin        187.48 28 11
Q02790|FKBP4_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP4     186.94 35 11
P46783|RS10_HUMAN 40S ribosomal protein S10 OS=Homo sapi    186.53 58 11
P13693|TCTP_HUMAN Translationally-controlled tumor protein OS     182.69 74 11
P62829|RL23_HUMAN 60S ribosomal protein L23 OS=Homo sapi    182.08 60 11
Q14019|COTL1_HUMAN Coactosin-like protein OS=Homo sapiens G   178.96 65 11
P62280|RS11_HUMAN 40S ribosomal protein S11 OS=Homo sapi    171.23 73 11
A0MZ66|SHOT1_HUMAN Shootin-1 OS=Homo sapiens GN=KIAA159   168.93 37 11
P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMN   154.33 22 11
P13797|PLST_HUMAN Plastin-3 OS=Homo sapiens GN=PLS3 PE  241.79 51 10
A6NL28|TPM3L_HUMAN Putative tropomyosin alpha-3 chain-like pro     237.92 47 10
P61158|ARP3_HUMAN Actin-related protein 3 OS=Homo sapiens   213.13 49 10
P42166|LAP2A_HUMAN Lamina-associated polypeptide 2, isoform a      211.37 35 10
Q04760|LGUL_HUMAN Lactoylglutathione lyase OS=Homo sapien    209.72 63 10
P19367|HXK1_HUMAN Hexokinase-1 OS=Homo sapiens GN=HK1  208.28 28 10
Q9Y262|EIF3L_HUMAN Eukaryotic translation initiation factor 3 sub       206.56 35 10
O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens   206.48 49 10
P60981|DEST_HUMAN Destrin OS=Homo sapiens GN=DSTN PE=  205.47 47 10
Q9NR30|DDX21_HUMAN Nucleolar RNA helicase 2 OS=Homo sapie    204.61 33 10
P51991|ROA3_HUMAN Heterogeneous nuclear ribonucleoprotein A      203.9 43 10
O95336|6PGL_HUMAN 6-phosphogluconolactonase OS=Homo sa    202.04 59 10
P04792|HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sapie    199.56 66 10
Q9UHV9|PFD2_HUMAN Prefoldin subunit 2 OS=Homo sapiens GN   196.4 82 10
P07093|GDN_HUMAN Glia-derived nexin OS=Homo sapiens GN=   195.88 49 10
P56192|SYMC_HUMAN Methionyl-tRNA synthetase, cytoplasmic O     195.28 26 10
Q15843|NEDD8_HUMAN NEDD8 OS=Homo sapiens GN=NEDD8 P  192.98 59 10
P35613|BASI_HUMAN Basigin OS=Homo sapiens GN=BSG PE=1 191.53 32 10
Q9BXJ9|NAA15_HUMAN N-alpha-acetyltransferase 15, NatA auxilia       188.31 32 10
P12429|ANXA3_HUMAN Annexin A3 OS=Homo sapiens GN=ANXA   187.54 46 10
Q08J23|NSUN2_HUMAN tRNA (cytosine(34)-C(5))-methyltransferase     184.54 34 10
Q8NBS9|TXND5_HUMAN Thioredoxin domain-containing protein 5 O     180.98 36 10
P31942|HNRH3_HUMAN Heterogeneous nuclear ribonucleoprotein H      179.33 39 10
P54819|KAD2_HUMAN Adenylate kinase 2, mitochondrial OS=Hom     177.28 66 10
Q9BT78|CSN4_HUMAN COP9 signalosome complex subunit 4 OS=     174.7 46 10
O60701|UGDH_HUMAN UDP-glucose 6-dehydrogenase OS=Homo    173.53 29 10
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Q7Z478|DHX29_HUMAN ATP-dependent RNA helicase DHX29 OS=     168.63 23 10
Q9Y624|JAM1_HUMAN Junctional adhesion molecule A OS=Homo    160.72 31 10
P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD  160.67 35 10
P27635|RL10_HUMAN 60S ribosomal protein L10 OS=Homo sapi    159.37 35 10
O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=Ho     158.41 21 10
P49591|SYSC_HUMAN Seryl-tRNA synthetase, cytoplasmic OS=H     148.36 36 10
P06753|TPM3_HUMAN Tropomyosin alpha-3 chain OS=Homo sap    328.7 86 9
P31946|1433B_HUMAN 14-3-3 protein beta/alpha OS=Homo sapie    231.54 59 9
P35241|RADI_HUMAN Radixin OS=Homo sapiens GN=RDX PE=1 226.95 57 9
Q06323|PSME1_HUMAN Proteasome activator complex subunit 1 O     224.08 59 9
P12277|KCRB_HUMAN Creatine kinase B-type OS=Homo sapiens   215.57 64 9
P60660|MYL6_HUMAN Myosin light polypeptide 6 OS=Homo sapie    213.37 76 9
Q99729|ROAA_HUMAN Heterogeneous nuclear ribonucleoprotein A      203.41 42 9
Q15365|PCBP1_HUMAN Poly(rC)-binding protein 1 OS=Homo sapie    201.77 59 9
Q9Y3I0|RTCB_HUMAN tRNA-splicing ligase RtcB homolog OS=Ho     198.78 42 9
P30084|ECHM_HUMAN Enoyl-CoA hydratase, mitochondrial OS=H     197.31 47 9
O76003|GLRX3_HUMAN Glutaredoxin-3 OS=Homo sapiens GN=GL   193.53 54 9
P14550|AK1A1_HUMAN Alcohol dehydrogenase [NADP+] OS=Hom     189.89 51 9
Q07955|SRSF1_HUMAN Serine/arginine-rich splicing factor 1 OS=H     188.29 62 9
P61289|PSME3_HUMAN Proteasome activator complex subunit 3 O     187.73 48 9
Q9UL46|PSME2_HUMAN Proteasome activator complex subunit 2 O     187.62 53 9
Q13618|CUL3_HUMAN Cullin-3 OS=Homo sapiens GN=CUL3 PE=  186.78 47 9
Q14195|DPYL3_HUMAN Dihydropyrimidinase-related protein 3 OS=     183 30 9
Q15417|CNN3_HUMAN Calponin-3 OS=Homo sapiens GN=CNN3  182.31 31 9
P30040|ERP29_HUMAN Endoplasmic reticulum resident protein 29     182.2 42 9
O14737|PDCD5_HUMAN Programmed cell death protein 5 OS=Hom     181.55 56 9
P15880|RS2_HUMAN 40S ribosomal protein S2 OS=Homo sapie    178.29 36 9
P29966|MARCS_HUMAN Myristoylated alanine-rich C-kinase substra      175.91 34 9
Q9Y230|RUVB2_HUMAN RuvB-like 2 OS=Homo sapiens GN=RUVB   175.67 39 9
Q9BZZ5|API5_HUMAN Apoptosis inhibitor 5 OS=Homo sapiens G   175.1 36 9
P34897|GLYM_HUMAN Serine hydroxymethyltransferase, mitochon      172.74 26 9
P62249|RS16_HUMAN 40S ribosomal protein S16 OS=Homo sapi    172.1 45 9
Q9NTJ3|SMC4_HUMAN Structural maintenance of chromosomes p       171.69 19 9
P25786|PSA1_HUMAN Proteasome subunit alpha type-1 OS=Hom     169.93 46 9
O76094|SRP72_HUMAN Signal recognition particle 72 kDa protein O     168.49 35 9
O60502|NCOAT_HUMAN Bifunctional protein NCOAT OS=Homo sap    166.84 25 9
Q8N8S7|ENAH_HUMAN Protein enabled homolog OS=Homo sapie    164.96 31 9
Q9Y5X3|SNX5_HUMAN Sorting nexin-5 OS=Homo sapiens GN=SN   163.57 34 9
P62750|RL23A_HUMAN 60S ribosomal protein L23a OS=Homo sap    156.73 54 9
Q9NY33|DPP3_HUMAN Dipeptidyl peptidase 3 OS=Homo sapiens   154.57 24 9
P49915|GUAA_HUMAN GMP synthase [glutamine-hydrolyzing] OS=     151.81 18 9
P61088|UBE2N_HUMAN Ubiquitin-conjugating enzyme E2 N OS=Ho     149.84 61 9
P50453|SPB9_HUMAN Serpin B9 OS=Homo sapiens GN=SERPIN   139.99 36 9
P78347|GTF2I_HUMAN General transcription factor II-I OS=Homo    117.84 21 9
P06454|PTMA_HUMAN Prothymosin alpha OS=Homo sapiens GN=   202.36 44 8
P09429|HMGB1_HUMAN High mobility group protein B1 OS=Homo s    197.6 53 8
P68036|UB2L3_HUMAN Ubiquitin-conjugating enzyme E2 L3 OS=H     195.56 73 8
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Q99439|CNN2_HUMAN Calponin-2 OS=Homo sapiens GN=CNN2  194.23 38 8
P51665|PSD7_HUMAN 26S proteasome non-ATPase regulatory su       190.42 48 8
P62191|PRS4_HUMAN 26S protease regulatory subunit 4 OS=Hom     185.03 43 8
P49736|MCM2_HUMAN DNA replication licensing factor MCM2 OS     180.21 25 8
P06737|PYGL_HUMAN Glycogen phosphorylase, liver form OS=Ho     179.54 27 8
P07741|APT_HUMAN Adenine phosphoribosyltransferase OS=Ho     179.19 68 8
P63173|RL38_HUMAN 60S ribosomal protein L38 OS=Homo sapi    178.86 57 8
Q13126|MTAP_HUMAN S-methyl-5'-thioadenosine phosphorylase O     178.21 35 8
P22061|PIMT_HUMAN Protein-L-isoaspartate(D-aspartate) O-met      178.09 63 8
Q9Y696|CLIC4_HUMAN Chloride intracellular channel protein 4 OS     177.26 66 8
O00244|ATOX1_HUMAN Copper transport protein ATOX1 OS=Hom     174.55 76 8
P27797|CALR_HUMAN Calreticulin OS=Homo sapiens GN=CALR  172.97 46 8
P50552|VASP_HUMAN Vasodilator-stimulated phosphoprotein OS     172.41 42 8
P62244|RS15A_HUMAN 40S ribosomal protein S15a OS=Homo sap    172.26 72 8
P23381|SYWC_HUMAN Tryptophanyl-tRNA synthetase, cytoplasmi      172.23 46 8
Q15019|SEPT2_HUMAN Septin-2 OS=Homo sapiens GN=SEPT2 P  169.9 46 8
P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase DD      168.46 35 8
Q9Y266|NUDC_HUMAN Nuclear migration protein nudC OS=Homo    167.43 45 8
Q13561|DCTN2_HUMAN Dynactin subunit 2 OS=Homo sapiens GN=   166.59 32 8
Q7L2H7|EIF3M_HUMAN Eukaryotic translation initiation factor 3 sub       164.07 41 8
P62913|RL11_HUMAN 60S ribosomal protein L11 OS=Homo sapi    163.63 44 8
Q9UKK9|NUDT5_HUMAN ADP-sugar pyrophosphatase OS=Homo sa    163.22 30 8
P62633|CNBP_HUMAN Cellular nucleic acid-binding protein OS=H     161.71 31 8
Q9Y6G9|DC1L1_HUMAN Cytoplasmic dynein 1 light intermediate cha       161.68 36 8
Q9UKM9|RALY_HUMAN RNA-binding protein Raly OS=Homo sapie    160.61 32 8
P60903|S10AA_HUMAN Protein S100-A10 OS=Homo sapiens GN=   160.34 58 8
P62241|RS8_HUMAN 40S ribosomal protein S8 OS=Homo sapie    159 51 8
Q9H910|HN1L_HUMAN Hematological and neurological expressed       158.93 60 8
O15347|HMGB3_HUMAN High mobility group protein B3 OS=Homo s    158.66 51 8
P48444|COPD_HUMAN Coatomer subunit delta OS=Homo sapiens   156.83 22 8
P23921|RIR1_HUMAN Ribonucleoside-diphosphate reductase larg       155.77 27 8
P35268|RL22_HUMAN 60S ribosomal protein L22 OS=Homo sapi    155.7 51 8
Q96AE4|FUBP1_HUMAN Far upstream element-binding protein 1 OS     155.34 35 8
P18621|RL17_HUMAN 60S ribosomal protein L17 OS=Homo sapi    155.25 44 8
P31153|METK2_HUMAN S-adenosylmethionine synthase isoform typ      155.08 22 8
P39023|RL3_HUMAN 60S ribosomal protein L3 OS=Homo sapie    155 37 8
Q99471|PFD5_HUMAN Prefoldin subunit 5 OS=Homo sapiens GN   152.78 68 8
Q99459|CDC5L_HUMAN Cell division cycle 5-like protein OS=Homo    152.12 30 8
O15372|EIF3H_HUMAN Eukaryotic translation initiation factor 3 sub       149.94 36 8
P13667|PDIA4_HUMAN Protein disulfide-isomerase A4 OS=Homo    148.57 22 8
Q9P258|RCC2_HUMAN Protein RCC2 OS=Homo sapiens GN=RCC   147.38 34 8
P60228|EIF3E_HUMAN Eukaryotic translation initiation factor 3 sub       147.21 25 8
Q9GZZ1|NAA50_HUMAN N-alpha-acetyltransferase 50, NatE catalyt       145.55 53 8
P02751|FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 P  139.94 9 8
P62851|RS25_HUMAN 40S ribosomal protein S25 OS=Homo sapi    139.67 50 8
Q14683|SMC1A_HUMAN Structural maintenance of chromosomes p       137.71 16 8
P14678|RSMB_HUMAN Small nuclear ribonucleoprotein-associated         137.1 55 8
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P78344|IF4G2_HUMAN Eukaryotic translation initiation factor 4 gam       136.91 19 8
Q09666|AHNK_HUMAN Neuroblast differentiation-associated prote       136.7 9 8
Q6PKG0|LARP1_HUMAN La-related protein 1 OS=Homo sapiens GN   136.3 26 8
P53634|CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens   136.19 24 8
P56385|ATP5I_HUMAN ATP synthase subunit e, mitochondrial OS     133.41 71 8
P62899|RL31_HUMAN 60S ribosomal protein L31 OS=Homo sapi    132.46 43 8
O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens   130.34 24 8
Q15907|RB11B_HUMAN Ras-related protein Rab-11B OS=Homo sa    127.85 39 8
P23193|TCEA1_HUMAN Transcription elongation factor A protein 1     125.98 42 8
P27144|KAD4_HUMAN Adenylate kinase isoenzyme 4, mitochondr      122.02 51 8
Q6FI13|H2A2A_HUMAN Histone H2A type 2-A OS=Homo sapiens G   272.39 84 7
Q16777|H2A2C_HUMAN Histone H2A type 2-C OS=Homo sapiens G   272.39 77 7
P15531|NDKA_HUMAN Nucleoside diphosphate kinase A OS=Hom     243.59 73 7
O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=     209.3 54 7
P25787|PSA2_HUMAN Proteasome subunit alpha type-2 OS=Hom     208.64 56 7
P28066|PSA5_HUMAN Proteasome subunit alpha type-5 OS=Hom     207.79 55 7
P20290|BTF3_HUMAN Transcription factor BTF3 OS=Homo sapie    190.87 67 7
Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sap    187.69 29 7
Q16181|SEPT7_HUMAN Septin-7 OS=Homo sapiens GN=SEPT7 P  185.01 46 7
P06493|CDK1_HUMAN Cyclin-dependent kinase 1 OS=Homo sapi    184.69 40 7
P50502|F10A1_HUMAN Hsc70-interacting protein OS=Homo sapie    181.9 27 7
P26196|DDX6_HUMAN Probable ATP-dependent RNA helicase DD      180.68 37 7
O43809|CPSF5_HUMAN Cleavage and polyadenylation specificity fa        180.06 60 7
Q15185|TEBP_HUMAN Prostaglandin E synthase 3 OS=Homo sap    179.35 54 7
P54578|UBP14_HUMAN Ubiquitin carboxyl-terminal hydrolase 14 O     178.35 40 7
Q13765|NACA_HUMAN Nascent polypeptide-associated complex s       177.65 30 7
P32969|RL9_HUMAN 60S ribosomal protein L9 OS=Homo sapie    175.75 52 7
Q92945|FUBP2_HUMAN Far upstream element-binding protein 2 OS     175.63 24 7
Q99460|PSMD1_HUMAN 26S proteasome non-ATPase regulatory su       175.02 27 7
O75368|SH3L1_HUMAN SH3 domain-binding glutamic acid-rich-like      171.67 71 7
P11216|PYGB_HUMAN Glycogen phosphorylase, brain form OS=H     170.16 17 7
Q15046|SYK_HUMAN Lysyl-tRNA synthetase OS=Homo sapiens   169.41 26 7
Q96P16|RPR1A_HUMAN Regulation of nuclear pre-mRNA domain-c        168.28 47 7
Q9NP97|DLRB1_HUMAN Dynein light chain roadblock-type 1 OS=Ho     167.74 90 7
Q04837|SSBP_HUMAN Single-stranded DNA-binding protein, mitoc      166.94 62 7
P49903|SPS1_HUMAN Selenide, water dikinase 1 OS=Homo sapie    165.04 39 7
P49588|SYAC_HUMAN Alanyl-tRNA synthetase, cytoplasmic OS=H     163.95 25 7
P33992|MCM5_HUMAN DNA replication licensing factor MCM5 OS     162.73 28 7
Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sa    160.96 32 7
P61758|PFD3_HUMAN Prefoldin subunit 3 OS=Homo sapiens GN   160.86 64 7
O43399|TPD54_HUMAN Tumor protein D54 OS=Homo sapiens GN   160.49 41 7
P30520|PURA2_HUMAN Adenylosuccinate synthetase isozyme 2 OS     160.19 26 7
P62753|RS6_HUMAN 40S ribosomal protein S6 OS=Homo sapie    159.71 37 7
Q00688|FKBP3_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP3     158.13 44 7
Q9Y295|DRG1_HUMAN Developmentally-regulated GTP-binding pr       157.98 37 7
Q08752|PPID_HUMAN Peptidyl-prolyl cis-trans isomerase D OS=H     156.48 37 7
Q9UK76|HN1_HUMAN Hematological and neurological expressed       155.3 54 7
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O95347|SMC2_HUMAN Structural maintenance of chromosomes p       154.66 21 7
P63279|UBC9_HUMAN SUMO-conjugating enzyme UBC9 OS=Hom     154.41 28 7
P36405|ARL3_HUMAN ADP-ribosylation factor-like protein 3 OS=H     153.13 62 7
P05198|IF2A_HUMAN Eukaryotic translation initiation factor 2 sub       152.12 33 7
P61586|RHOA_HUMAN Transforming protein RhoA OS=Homo sap    151.4 50 7
Q07065|CKAP4_HUMAN Cytoskeleton-associated protein 4 OS=Hom     151.13 24 7
Q9Y3F4|STRAP_HUMAN Serine-threonine kinase receptor-associate       150.82 44 7
Q15121|PEA15_HUMAN Astrocytic phosphoprotein PEA-15 OS=Ho     149.34 71 7
Q9C005|DPY30_HUMAN Protein dpy-30 homolog OS=Homo sapien    148.58 57 7
O00273|DFFA_HUMAN DNA fragmentation factor subunit alpha OS     148.43 47 7
P62760|VISL1_HUMAN Visinin-like protein 1 OS=Homo sapiens GN   147.75 59 7
P37108|SRP14_HUMAN Signal recognition particle 14 kDa protein O     147.44 44 7
Q9HC38|GLOD4_HUMAN Glyoxalase domain-containing protein 4 OS     147.33 39 7
P12081|SYHC_HUMAN Histidyl-tRNA synthetase, cytoplasmic OS=     147.27 28 7
P54727|RD23B_HUMAN UV excision repair protein RAD23 homolog      144.2 22 7
Q15717|ELAV1_HUMAN ELAV-like protein 1 OS=Homo sapiens GN   143.63 32 7
P04843|RPN1_HUMAN Dolichyl-diphosphooligosaccharide--protein        142.15 20 7
Q15404|RSU1_HUMAN Ras suppressor protein 1 OS=Homo sapie    141.75 34 7
Q14204|DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=H     141.6 13 7
P46926|GNPI1_HUMAN Glucosamine-6-phosphate isomerase 1 OS     141.14 40 7
P06132|DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Hom     140.74 45 7
P62857|RS28_HUMAN 40S ribosomal protein S28 OS=Homo sapi    140.12 86 7
Q14980|NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=Ho     139.98 17 7
P52701|MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Ho     137.38 14 7
P50914|RL14_HUMAN 60S ribosomal protein L14 OS=Homo sapi    135.86 33 7
Q9H0D6|XRN2_HUMAN 5'-3' exoribonuclease 2 OS=Homo sapiens   133.65 20 7
P09661|RU2A_HUMAN U2 small nuclear ribonucleoprotein A' OS=     132.84 37 7
P23588|IF4B_HUMAN Eukaryotic translation initiation factor 4B O     132.64 15 7
P48556|PSMD8_HUMAN 26S proteasome non-ATPase regulatory su       129.93 32 7
P35249|RFC4_HUMAN Replication factor C subunit 4 OS=Homo s    127.73 31 7
P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sap    127.34 19 7
P15927|RFA2_HUMAN Replication protein A 32 kDa subunit OS=H     126.98 33 7
P08243|ASNS_HUMAN Asparagine synthetase [glutamine-hydrolyz      125.23 17 7
Q9UHD8|SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9 P  124.38 26 7
P61254|RL26_HUMAN 60S ribosomal protein L26 OS=Homo sapi    123.1 39 7
Q5T0N5|FBP1L_HUMAN Formin-binding protein 1-like OS=Homo sa    123.01 19 7
P62312|LSM6_HUMAN U6 snRNA-associated Sm-like protein LSm      119.5 91 7
Q15370|ELOB_HUMAN Transcription elongation factor B polypeptid       117.43 37 7
P48061|SDF1_HUMAN Stromal cell-derived factor 1 OS=Homo sa    116.68 44 7
P61353|RL27_HUMAN 60S ribosomal protein L27 OS=Homo sapi    114.35 61 7
P50570|DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2  114.2 17 7
P18077|RL35A_HUMAN 60S ribosomal protein L35a OS=Homo sap    98.79 30 7
P40222|TXLNA_HUMAN Alpha-taxilin OS=Homo sapiens GN=TXLN   84.34 21 7
Q9BUF5|TBB6_HUMAN Tubulin beta-6 chain OS=Homo sapiens G   262.48 62 6
P55209|NP1L1_HUMAN Nucleosome assembly protein 1-like 1 OS=     199.97 34 6
P61204|ARF3_HUMAN ADP-ribosylation factor 3 OS=Homo sapien    196.38 77 6
P84077|ARF1_HUMAN ADP-ribosylation factor 1 OS=Homo sapien    196.38 72 6
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Q92841|DDX17_HUMAN Probable ATP-dependent RNA helicase DD      192.35 29 6
P06576|ATPB_HUMAN ATP synthase subunit beta, mitochondrial O     190.16 37 6
P67809|YBOX1_HUMAN Nuclease-sensitive element-binding protein      190.09 44 6
O00487|PSDE_HUMAN 26S proteasome non-ATPase regulatory su       181.88 54 6
Q9Y5J9|TIM8B_HUMAN Mitochondrial import inner membrane trans         180.61 65 6
P30566|PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens   180.24 47 6
O00425|IF2B3_HUMAN Insulin-like growth factor 2 mRNA-binding p       177.95 36 6
P30046|DOPD_HUMAN D-dopachrome decarboxylase OS=Homo s    177.9 67 6
P60983|GMFB_HUMAN Glia maturation factor beta OS=Homo sapi    174.53 58 6
Q9Y333|LSM2_HUMAN U6 snRNA-associated Sm-like protein LSm      174.34 81 6
P49720|PSB3_HUMAN Proteasome subunit beta type-3 OS=Homo    172.88 57 6
P30050|RL12_HUMAN 60S ribosomal protein L12 OS=Homo sapi    169.81 59 6
P14324|FPPS_HUMAN Farnesyl pyrophosphate synthase OS=Hom     169.63 31 6
P35520|CBS_HUMAN Cystathionine beta-synthase OS=Homo sa    167.32 37 6
P33176|KINH_HUMAN Kinesin-1 heavy chain OS=Homo sapiens   166.59 17 6
Q12905|ILF2_HUMAN Interleukin enhancer-binding factor 2 OS=H     166.12 24 6
P62318|SMD3_HUMAN Small nuclear ribonucleoprotein Sm D3 OS     162.13 67 6
Q15056|IF4H_HUMAN Eukaryotic translation initiation factor 4H O     159.32 50 6
O95372|LYPA2_HUMAN Acyl-protein thioesterase 2 OS=Homo sapi    154.42 51 6
O00303|EIF3F_HUMAN Eukaryotic translation initiation factor 3 sub       153.11 48 6
Q8WVM8|SCFD1_HUMAN Sec1 family domain-containing protein 1 O     152.53 24 6
O14979|HNRDL_HUMAN Heterogeneous nuclear ribonucleoprotein D      152.45 23 6
O95816|BAG2_HUMAN BAG family molecular chaperone regulator      152.41 30 6
Q71UI9|H2AV_HUMAN Histone H2A.V OS=Homo sapiens GN=H2   151.34 31 6
P0C0S5|H2AZ_HUMAN Histone H2A.Z OS=Homo sapiens GN=H2   151.34 31 6
P31350|RIR2_HUMAN Ribonucleoside-diphosphate reductase sub       150.92 25 6
P45974|UBP5_HUMAN Ubiquitin carboxyl-terminal hydrolase 5 OS     150.74 25 6
P55265|DSRAD_HUMAN Double-stranded RNA-specific adenosine d      150.64 19 6
P05388|RLA0_HUMAN 60S acidic ribosomal protein P0 OS=Homo    150.45 36 6
P55769|NH2L1_HUMAN NHP2-like protein 1 OS=Homo sapiens GN   150.36 55 6
O60264|SMCA5_HUMAN SWI/SNF-related matrix-associated actin-d             148.81 17 6
P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens GN=LMNB1  148.41 28 6
Q5T7N2|LITD1_HUMAN LINE-1 type transposase domain-containin        147.44 19 6
O15212|PFD6_HUMAN Prefoldin subunit 6 OS=Homo sapiens GN   146.76 75 6
Q96AG4|LRC59_HUMAN Leucine-rich repeat-containing protein 59 O     146 42 6
O75223|GGCT_HUMAN Gamma-glutamylcyclotransferase OS=Hom     144.87 36 6
O15067|PUR4_HUMAN Phosphoribosylformylglycinamidine synthas      144.82 25 6
P22413|ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphod         140.99 18 6
P47756|CAPZB_HUMAN F-actin-capping protein subunit beta OS=H     139.26 33 6
Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding pro       138.61 22 6
P49411|EFTU_HUMAN Elongation factor Tu, mitochondrial OS=Ho     138.54 28 6
Q13616|CUL1_HUMAN Cullin-1 OS=Homo sapiens GN=CUL1 PE=  137.46 27 6
P62841|RS15_HUMAN 40S ribosomal protein S15 OS=Homo sapi    136.41 57 6
O43143|DHX15_HUMAN Putative pre-mRNA-splicing factor ATP-dep         136.26 22 6
Q9NZL4|HPBP1_HUMAN Hsp70-binding protein 1 OS=Homo sapien    136.07 29 6
Q8N474|SFRP1_HUMAN Secreted frizzled-related protein 1 OS=Hom     135.61 26 6
P84090|ERH_HUMAN Enhancer of rudimentary homolog OS=Hom     135.37 38 6
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O15145|ARPC3_HUMAN Actin-related protein 2/3 complex subunit 3     132.65 38 6
Q8N0X7|SPG20_HUMAN Spartin OS=Homo sapiens GN=SPG20 PE  130.8 22 6
Q86V81|THOC4_HUMAN THO complex subunit 4 OS=Homo sapiens   130.58 44 6
P59998|ARPC4_HUMAN Actin-related protein 2/3 complex subunit 4     128.79 55 6
O14974|MYPT1_HUMAN Protein phosphatase 1 regulatory subunit 1      128.79 21 6
P26373|RL13_HUMAN 60S ribosomal protein L13 OS=Homo sapi    128.59 32 6
P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme type 2     128.3 24 6
Q8IVW6|ARI3B_HUMAN AT-rich interactive domain-containing prote       127.95 32 6
O75489|NDUS3_HUMAN NADH dehydrogenase [ubiquinone] iron-su         127.71 26 6
Q13085|ACACA_HUMAN Acetyl-CoA carboxylase 1 OS=Homo sapie    127.4 13 6
P30153|2AAA_HUMAN Serine/threonine-protein phosphatase 2A 6            127.29 24 6
Q8IZQ5|SELH_HUMAN Selenoprotein H OS=Homo sapiens GN=S   127.24 39 6
P48047|ATPO_HUMAN ATP synthase subunit O, mitochondrial OS     127.13 41 6
P25788|PSA3_HUMAN Proteasome subunit alpha type-3 OS=Hom     126.49 25 6
O75947|ATP5H_HUMAN ATP synthase subunit d, mitochondrial OS     125.19 45 6
Q15369|ELOC_HUMAN Transcription elongation factor B polypeptid       123.91 41 6
Q9UKV3|ACINU_HUMAN Apoptotic chromatin condensation inducer        121.49 12 6
Q9UBE0|SAE1_HUMAN SUMO-activating enzyme subunit 1 OS=Ho     120.57 32 6
Q16891|IMMT_HUMAN Mitochondrial inner membrane protein OS=     120.48 12 6
Q9Y2X3|NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens GN   114.23 25 6
P15121|ALDR_HUMAN Aldose reductase OS=Homo sapiens GN=A   112.92 39 6
P55145|MANF_HUMAN Mesencephalic astrocyte-derived neurotrop       112.85 47 6
P06730|IF4E_HUMAN Eukaryotic translation initiation factor 4E O     110.98 28 6
P62273|RS29_HUMAN 40S ribosomal protein S29 OS=Homo sapi    109.59 52 6
P61081|UBC12_HUMAN NEDD8-conjugating enzyme Ubc12 OS=Ho     109.41 37 6
P99999|CYC_HUMAN Cytochrome c OS=Homo sapiens GN=CYC   101.03 28 6
P28340|DPOD1_HUMAN DNA polymerase delta catalytic subunit OS     99.12 12 6
P09669|COX6C_HUMAN Cytochrome c oxidase subunit 6C OS=Hom     88.88 49 6
Q93077|H2A1C_HUMAN Histone H2A type 1-C OS=Homo sapiens G   262.76 75 5
P31947|1433S_HUMAN 14-3-3 protein sigma OS=Homo sapiens G   189.81 56 5
Q15366|PCBP2_HUMAN Poly(rC)-binding protein 2 OS=Homo sapie    177.41 42 5
Q8N1G4|LRC47_HUMAN Leucine-rich repeat-containing protein 47 O     172.96 34 5
Q9P289|MST4_HUMAN Serine/threonine-protein kinase MST4 OS=     163.93 32 5
Q9P1F3|CF115_HUMAN Costars family protein C6orf115 OS=Homo    163.39 80 5
Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate redu      158.58 28 5
Q13151|ROA0_HUMAN Heterogeneous nuclear ribonucleoprotein A      158.36 38 5
P11388|TOP2A_HUMAN DNA topoisomerase 2-alpha OS=Homo sa    157.26 18 5
Q13907|IDI1_HUMAN Isopentenyl-diphosphate Delta-isomerase      156.78 45 5
P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprot       156.01 37 5
P20962|PTMS_HUMAN Parathymosin OS=Homo sapiens GN=PTM   155.16 24 5
P24534|EF1B_HUMAN Elongation factor 1-beta OS=Homo sapien    154.83 44 5
P26583|HMGB2_HUMAN High mobility group protein B2 OS=Homo s    153.44 52 5
Q9Y2B0|CNPY2_HUMAN Protein canopy homolog 2 OS=Homo sapie    152.97 58 5
Q16643|DREB_HUMAN Drebrin OS=Homo sapiens GN=DBN1 PE=  152.54 21 5
Q99598|TSNAX_HUMAN Translin-associated protein X OS=Homo sa    149.52 36 5
Q07020|RL18_HUMAN 60S ribosomal protein L18 OS=Homo sapi    149.43 31 5
Q9NTK5|OLA1_HUMAN Obg-like ATPase 1 OS=Homo sapiens GN   148.08 29 5
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P52565|GDIR1_HUMAN Rho GDP-dissociation inhibitor 1 OS=Hom     147.64 38 5
Q15942|ZYX_HUMAN Zyxin OS=Homo sapiens GN=ZYX PE=1 S 147.47 17 5
P62314|SMD1_HUMAN Small nuclear ribonucleoprotein Sm D1 OS     146.59 56 5
Q15181|IPYR_HUMAN Inorganic pyrophosphatase OS=Homo sap    145.07 34 5
Q9UQ80|PA2G4_HUMAN Proliferation-associated protein 2G4 OS=H     143.18 26 5
Q14166|TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=     142.77 22 5
P38159|HNRPG_HUMAN Heterogeneous nuclear ribonucleoprotein G     142.73 40 5
P62993|GRB2_HUMAN Growth factor receptor-bound protein 2 OS     142.24 33 5
Q4V328|GRAP1_HUMAN GRIP1-associated protein 1 OS=Homo sap    142.03 20 5
O75475|PSIP1_HUMAN PC4 and SFRS1-interacting protein OS=Ho     141.93 23 5
P05067|A4_HUMAN Amyloid beta A4 protein OS=Homo sapien    140.83 19 5
Q9P2M7|CING_HUMAN Cingulin OS=Homo sapiens GN=CGN PE=  140.29 18 5
Q9H9Q2|CSN7B_HUMAN COP9 signalosome complex subunit 7b OS     139.8 37 5
P29762|RABP1_HUMAN Cellular retinoic acid-binding protein 1 OS=     139.76 53 5
O60256|KPRB_HUMAN Phosphoribosyl pyrophosphate synthase-a        139.74 30 5
P40121|CAPG_HUMAN Macrophage-capping protein OS=Homo sa    139.14 25 5
Q99613|EIF3C_HUMAN Eukaryotic translation initiation factor 3 sub       137.87 15 5
P47813|IF1AX_HUMAN Eukaryotic translation initiation factor 1A, X      137.72 36 5
O14602|IF1AY_HUMAN Eukaryotic translation initiation factor 1A, Y      137.72 36 5
P36871|PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapiens   137.46 20 5
O43776|SYNC_HUMAN Asparaginyl-tRNA synthetase, cytoplasmic     136.71 16 5
P55327|TPD52_HUMAN Tumor protein D52 OS=Homo sapiens GN   136.6 41 5
P62847|RS24_HUMAN 40S ribosomal protein S24 OS=Homo sapi    135.34 30 5
O60220|TIM8A_HUMAN Mitochondrial import inner membrane trans         134.53 44 5
Q6IBS0|TWF2_HUMAN Twinfilin-2 OS=Homo sapiens GN=TWF2 P  134.5 28 5
P54709|AT1B3_HUMAN Sodium/potassium-transporting ATPase su       134.47 41 5
Q8N1F7|NUP93_HUMAN Nuclear pore complex protein Nup93 OS=H     134.36 18 5
Q9NYL9|TMOD3_HUMAN Tropomodulin-3 OS=Homo sapiens GN=TM   134.17 25 5
O00151|PDLI1_HUMAN PDZ and LIM domain protein 1 OS=Homo    134.16 30 5
P83731|RL24_HUMAN 60S ribosomal protein L24 OS=Homo sapi    133.95 22 5
P83916|CBX1_HUMAN Chromobox protein homolog 1 OS=Homo s    133.15 36 5
Q9BPW8|NIPS1_HUMAN Protein NipSnap homolog 1 OS=Homo sap    132.84 36 5
P14854|CX6B1_HUMAN Cytochrome c oxidase subunit 6B1 OS=Ho     132.84 50 5
P28072|PSB6_HUMAN Proteasome subunit beta type-6 OS=Homo    131.74 31 5
Q9Y3B8|ORN_HUMAN Oligoribonuclease, mitochondrial OS=Hom     131.32 39 5
P35080|PROF2_HUMAN Profilin-2 OS=Homo sapiens GN=PFN2 PE  131.06 54 5
Q9BUL8|PDC10_HUMAN Programmed cell death protein 10 OS=Hom     130.56 49 5
Q99417|MYCBP_HUMAN C-Myc-binding protein OS=Homo sapiens G   130.13 46 5
P49458|SRP09_HUMAN Signal recognition particle 9 kDa protein OS     129.82 63 5
Q9Y2V2|CHSP1_HUMAN Calcium-regulated heat stable protein 1 OS     129.71 35 5
P35611|ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=AD   128.57 15 5
Q13098|CSN1_HUMAN COP9 signalosome complex subunit 1 OS=     128.2 22 5
Q93062|RBPMS_HUMAN RNA-binding protein with multiple splicing O     127.94 42 5
P28070|PSB4_HUMAN Proteasome subunit beta type-4 OS=Homo    127.88 29 5
P21796|VDAC1_HUMAN Voltage-dependent anion-selective channe        127.14 27 5
Q7L190|DPPA4_HUMAN Developmental pluripotency-associated pro       127.02 34 5
Q15637|SF01_HUMAN Splicing factor 1 OS=Homo sapiens GN=S   126.72 14 5
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Q9UGI8|TES_HUMAN Testin OS=Homo sapiens GN=TES PE=1 125.18 20 5
P55010|IF5_HUMAN Eukaryotic translation initiation factor 5 OS     124.23 22 5
Q9Y4Z0|LSM4_HUMAN U6 snRNA-associated Sm-like protein LSm      124.15 45 5
P61916|NPC2_HUMAN Epididymal secretory protein E1 OS=Homo    124 48 5
P62942|FKB1A_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP1A     123.45 64 5
Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 OS     122.55 12 5
P33316|DUT_HUMAN Deoxyuridine 5'-triphosphate nucleotidohyd       121.34 30 5
P32321|DCTD_HUMAN Deoxycytidylate deaminase OS=Homo sap    121.14 42 5
Q13242|SRSF9_HUMAN Serine/arginine-rich splicing factor 9 OS=H     120.63 38 5
P63165|SUMO1_HUMAN Small ubiquitin-related modifier 1 OS=Hom     119.88 50 5
O43795|MYO1B_HUMAN Myosin-Ib OS=Homo sapiens GN=MYO1B  119.86 15 5
P51114|FXR1_HUMAN Fragile X mental retardation syndrome-rela        119.51 12 5
P26639|SYTC_HUMAN Threonyl-tRNA synthetase, cytoplasmic OS     119.35 17 5
Q9NVP1|DDX18_HUMAN ATP-dependent RNA helicase DDX18 OS=     118.06 19 5
P36404|ARL2_HUMAN ADP-ribosylation factor-like protein 2 OS=H     117.48 30 5
P24539|AT5F1_HUMAN ATP synthase subunit b, mitochondrial OS     115.66 30 5
P45973|CBX5_HUMAN Chromobox protein homolog 5 OS=Homo s    115.4 43 5
Q9P0J0|NDUAD_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha        114.53 31 5
P17677|NEUM_HUMAN Neuromodulin OS=Homo sapiens GN=GAP   114.53 26 5
Q9BRP8|WIBG_HUMAN Partner of Y14 and mago OS=Homo sapie    114.21 24 5
O95865|DDAH2_HUMAN N(G),N(G)-dimethylarginine dimethylamino       112.71 26 5
Q14847|LASP1_HUMAN LIM and SH3 domain protein 1 OS=Homo    111.79 29 5
Q92878|RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapi    109.33 10 5
Q9BQ04|RBM4B_HUMAN RNA-binding protein 4B OS=Homo sapiens   109.23 17 5
Q9BWF3|RBM4_HUMAN RNA-binding protein 4 OS=Homo sapiens   109.23 16 5
Q15020|SART3_HUMAN Squamous cell carcinoma antigen recogniz         109.09 16 5
Q9UBQ0|VPS29_HUMAN Vacuolar protein sorting-associated protein      108.11 32 5
P39748|FEN1_HUMAN Flap endonuclease 1 OS=Homo sapiens G   106.17 26 5
O43447|PPIH_HUMAN Peptidyl-prolyl cis-trans isomerase H OS=H     103.73 40 5
P82979|SARNP_HUMAN SAP domain-containing ribonucleoprotein O     103.56 29 5
Q15075|EEA1_HUMAN Early endosome antigen 1 OS=Homo sapie    101.05 9 5
Q9BVG4|CX026_HUMAN UPF0368 protein Cxorf26 OS=Homo sapie    100.76 31 5
P20674|COX5A_HUMAN Cytochrome c oxidase subunit 5A, mitocho      100.34 37 5
Q99436|PSB7_HUMAN Proteasome subunit beta type-7 OS=Homo    97.33 24 5
O75643|U520_HUMAN U5 small nuclear ribonucleoprotein 200 kD       95.25 4 5
P78330|SERB_HUMAN Phosphoserine phosphatase OS=Homo sa    95.03 24 5
P55957|BID_HUMAN BH3-interacting domain death agonist OS=     94.65 33 5
Q14978|NOLC1_HUMAN Nucleolar and coiled-body phosphoprotein      92.44 22 5
P11413|G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS     92.21 13 5
Q96PY5|FMNL2_HUMAN Formin-like protein 2 OS=Homo sapiens G   88.46 9 5
P98160|PGBM_HUMAN Basement membrane-specific heparan sulf         84.39 4 5
P61326|MGN_HUMAN Protein mago nashi homolog OS=Homo sa    83.83 40 5
Q96A72|MGN2_HUMAN Protein mago nashi homolog 2 OS=Homo    83.83 39 5
P29373|RABP2_HUMAN Cellular retinoic acid-binding protein 2 OS=     83.11 61 5
Q9NPE3|NOP10_HUMAN H/ACA ribonucleoprotein complex subunit      78.6 70 5
Q4VC31|CCD58_HUMAN Coiled-coil domain-containing protein 58 O     77.49 47 5
P19388|RPAB1_HUMAN DNA-directed RNA polymerases I, II, and I        71.27 23 5
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P63241|IF5A1_HUMAN Eukaryotic translation initiation factor 5A-1     286.42 81 4
P11940|PABP1_HUMAN Polyadenylate-binding protein 1 OS=Homo    242.19 43 4
P08107|HSP71_HUMAN Heat shock 70 kDa protein 1A/1B OS=Hom     217.74 44 4
P62140|PP1B_HUMAN Serine/threonine-protein phosphatase PP1        195.3 47 4
P31943|HNRH1_HUMAN Heterogeneous nuclear ribonucleoprotein H     184.88 44 4
Q06210|GFPT1_HUMAN Glucosamine--fructose-6-phosphate amino        175.37 28 4
P41567|EIF1_HUMAN Eukaryotic translation initiation factor 1 OS     164.11 79 4
P04216|THY1_HUMAN Thy-1 membrane glycoprotein OS=Homo s    154.44 25 4
Q9UI30|TR112_HUMAN tRNA methyltransferase 112 homolog OS=     153.69 42 4
Q8IXM2|BAP18_HUMAN Chromatin complexes subunit BAP18 OS=     149.65 54 4
Q13185|CBX3_HUMAN Chromobox protein homolog 3 OS=Homo s    148.56 39 4
P51858|HDGF_HUMAN Hepatoma-derived growth factor OS=Homo    148.24 49 4
P43246|MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Ho     147.07 20 4
Q9H3K6|BOLA2_HUMAN BolA-like protein 2 OS=Homo sapiens GN=   144.1 43 4
Q16630|CPSF6_HUMAN Cleavage and polyadenylation specificity fa        143.95 20 4
Q13347|EIF3I_HUMAN Eukaryotic translation initiation factor 3 sub       143.07 18 4
P17812|PYRG1_HUMAN CTP synthase 1 OS=Homo sapiens GN=C   139.55 21 4
Q9NQT4|EXOS5_HUMAN Exosome complex component RRP46 OS=     139.28 33 4
P84103|SRSF3_HUMAN Serine/arginine-rich splicing factor 3 OS=H     138.96 30 4
P61970|NTF2_HUMAN Nuclear transport factor 2 OS=Homo sapie    138.45 69 4
P52907|CAZA1_HUMAN F-actin-capping protein subunit alpha-1 OS     138.21 31 4
P36969|GPX4_HUMAN Phospholipid hydroperoxide glutathione pe       138.12 29 4
Q9Y2Z0|SUGT1_HUMAN Suppressor of G2 allele of SKP1 homolog     136.71 24 4
Q9BRA2|TXD17_HUMAN Thioredoxin domain-containing protein 17 O     136.32 42 4
P62917|RL8_HUMAN 60S ribosomal protein L8 OS=Homo sapie    136.01 24 4
Q15029|U5S1_HUMAN 116 kDa U5 small nuclear ribonucleoprotei       135.96 12 4
Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens GN=CAPRIN1  135.89 24 4
O75607|NPM3_HUMAN Nucleoplasmin-3 OS=Homo sapiens GN=N   135.26 41 4
O43765|SGTA_HUMAN Small glutamine-rich tetratricopeptide repea        135.11 23 4
P11177|ODPB_HUMAN Pyruvate dehydrogenase E1 component su        134.41 16 4
Q9NRX4|PHP14_HUMAN 14 kDa phosphohistidine phosphatase OS=     131.26 56 4
Q13619|CUL4A_HUMAN Cullin-4A OS=Homo sapiens GN=CUL4A P  131.24 21 4
Q9Y3B4|PM14_HUMAN Pre-mRNA branch site protein p14 OS=Ho     129.85 35 4
P35232|PHB_HUMAN Prohibitin OS=Homo sapiens GN=PHB PE  126.82 37 4
P30048|PRDX3_HUMAN Thioredoxin-dependent peroxide reductase       125.71 36 4
P62306|RUXF_HUMAN Small nuclear ribonucleoprotein F OS=Hom     124.69 56 4
Q9Y5L4|TIM13_HUMAN Mitochondrial import inner membrane trans        124.68 54 4
P00492|HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltrans      124.39 25 4
O75348|VATG1_HUMAN V-type proton ATPase subunit G 1 OS=Ho     124.33 42 4
Q9NPH2|INO1_HUMAN Inositol-3-phosphate synthase 1 OS=Homo    123.91 17 4
P36639|8ODP_HUMAN 7,8-dihydro-8-oxoguanine triphosphatase O     123.84 19 4
P10606|COX5B_HUMAN Cytochrome c oxidase subunit 5B, mitocho      123.61 60 4
O00622|CYR61_HUMAN Protein CYR61 OS=Homo sapiens GN=CY   122.93 20 4
Q5VYJ4|RUEL1_HUMAN Putative small nuclear ribonucleoprotein po         122.73 62 4
P62304|RUXE_HUMAN Small nuclear ribonucleoprotein E OS=Hom     122.73 62 4
Q9UNZ2|NSF1C_HUMAN NSFL1 cofactor p47 OS=Homo sapiens GN   122.61 35 4
P12004|PCNA_HUMAN Proliferating cell nuclear antigen OS=Homo    121.45 20 4
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Q9UNH7|SNX6_HUMAN Sorting nexin-6 OS=Homo sapiens GN=SN   120.33 18 4
Q9BQI0|AIF1L_HUMAN Allograft inflammatory factor 1-like OS=Hom     119.91 38 4
Q96AC1|FERM2_HUMAN Fermitin family homolog 2 OS=Homo sapie    119.84 15 4
P35244|RFA3_HUMAN Replication protein A 14 kDa subunit OS=H     119.22 40 4
Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapie    118.67 9 4
Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protei      118.37 19 4
Q9NUQ9|FA49B_HUMAN Protein FAM49B OS=Homo sapiens GN=F   118.02 19 4
P07203|GPX1_HUMAN Glutathione peroxidase 1 OS=Homo sapie    117.92 34 4
Q13158|FADD_HUMAN Protein FADD OS=Homo sapiens GN=FAD   117.5 53 4
O60888|CUTA_HUMAN Protein CutA OS=Homo sapiens GN=CUTA  117.22 43 4
Q13442|HAP28_HUMAN 28 kDa heat- and acid-stable phosphoprote      116.43 24 4
Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Ho     116.32 43 4
P09525|ANXA4_HUMAN Annexin A4 OS=Homo sapiens GN=ANXA   116.04 31 4
Q9H299|SH3L3_HUMAN SH3 domain-binding glutamic acid-rich-like       115.58 52 4
P31930|QCR1_HUMAN Cytochrome b-c1 complex subunit 1, mitoc      115 23 4
Q9Y371|SHLB1_HUMAN Endophilin-B1 OS=Homo sapiens GN=SH3   114.92 11 4
Q96SM3|CPXM1_HUMAN Probable carboxypeptidase X1 OS=Homo    114.6 17 4
P14735|IDE_HUMAN Insulin-degrading enzyme OS=Homo sapie    114.59 14 4
P46779|RL28_HUMAN 60S ribosomal protein L28 OS=Homo sapi    114.42 28 4
Q99873|ANM1_HUMAN Protein arginine N-methyltransferase 1 OS     114.31 18 4
Q07666|KHDR1_HUMAN KH domain-containing, RNA-binding, signa         114.08 27 4
Q9H444|CHM4B_HUMAN Charged multivesicular body protein 4b OS     113.93 43 4
P40937|RFC5_HUMAN Replication factor C subunit 5 OS=Homo s    113.69 22 4
Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxilia       113.62 12 4
P39687|AN32A_HUMAN Acidic leucine-rich nuclear phosphoprotein         113.27 31 4
Q15257|PTPA_HUMAN Serine/threonine-protein phosphatase 2A a      112.87 24 4
Q99584|S10AD_HUMAN Protein S100-A13 OS=Homo sapiens GN=   112.84 45 4
P42285|SK2L2_HUMAN Superkiller viralicidic activity 2-like 2 OS=H     112.73 17 4
P30626|SORCN_HUMAN Sorcin OS=Homo sapiens GN=SRI PE=1 S112.51 22 4
Q99961|SH3G1_HUMAN Endophilin-A2 OS=Homo sapiens GN=SH3   112.33 16 4
Q9H1E3|NUCKS_HUMAN Nuclear ubiquitous casein and cyclin-depen        111.79 27 4
P63208|SKP1_HUMAN S-phase kinase-associated protein 1 OS=H     111.35 27 4
P09382|LEG1_HUMAN Galectin-1 OS=Homo sapiens GN=LGALS   110.41 39 4
Q9ULC4|MCTS1_HUMAN Malignant T cell-amplified sequence 1 OS=     109.93 38 4
O75821|EIF3G_HUMAN Eukaryotic translation initiation factor 3 sub       109.22 21 4
Q8WWY3|PRP31_HUMAN U4/U6 small nuclear ribonucleoprotein Prp      109.11 33 4
P24666|PPAC_HUMAN Low molecular weight phosphotyrosine pro       108.01 22 4
P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapie    107.92 29 4
O60925|PFD1_HUMAN Prefoldin subunit 1 OS=Homo sapiens GN   107.79 24 4
P52788|SPSY_HUMAN Spermine synthase OS=Homo sapiens GN   107.68 23 4
O75312|ZPR1_HUMAN Zinc finger protein ZPR1 OS=Homo sapien    107.14 19 4
O75955|FLOT1_HUMAN Flotillin-1 OS=Homo sapiens GN=FLOT1 P  106.47 26 4
Q9Y285|SYFA_HUMAN Phenylalanyl-tRNA synthetase alpha chain     105.83 18 4
P05937|CALB1_HUMAN Calbindin OS=Homo sapiens GN=CALB1 P  104.54 31 4
P35606|COPB2_HUMAN Coatomer subunit beta' OS=Homo sapiens   104.41 6 4
P09455|RET1_HUMAN Retinol-binding protein 1 OS=Homo sapien    104.33 51 4
P55786|PSA_HUMAN Puromycin-sensitive aminopeptidase OS=H     104.15 7 4
330
Q07866|KLC1_HUMAN Kinesin light chain 1 OS=Homo sapiens GN   102.84 18 4
P51149|RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo sap    102.73 36 4
P05204|HMGN2_HUMAN Non-histone chromosomal protein HMG-17     102.58 51 4
Q9Y376|CAB39_HUMAN Calcium-binding protein 39 OS=Homo sap    102.37 23 4
O43324|MCA3_HUMAN Eukaryotic translation elongation factor 1 e      102.05 39 4
Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Hom     101.96 9 4
P12830|CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1  101.75 7 4
P40429|RL13A_HUMAN 60S ribosomal protein L13a OS=Homo sap    101.69 29 4
O43252|PAPS1_HUMAN Bifunctional 3'-phosphoadenosine 5'-phosp        101.48 19 4
P63000|RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1     100.68 26 4
P19623|SPEE_HUMAN Spermidine synthase OS=Homo sapiens G   100.49 24 4
Q9GZT3|SLIRP_HUMAN SRA stem-loop-interacting RNA-binding pro       100.31 55 4
Q9BYT8|NEUL_HUMAN Neurolysin, mitochondrial OS=Homo sapie    99.07 13 4
Q9NSD9|SYFB_HUMAN Phenylalanyl-tRNA synthetase beta chain O     98.12 11 4
P51148|RAB5C_HUMAN Ras-related protein Rab-5C OS=Homo sap    97.15 31 4
Q9BS26|ERP44_HUMAN Endoplasmic reticulum resident protein 44     95.98 16 4
P61086|UBE2K_HUMAN Ubiquitin-conjugating enzyme E2 K OS=Ho     95.94 36 4
Q99426|TBCB_HUMAN Tubulin-folding cofactor B OS=Homo sapie    95.64 16 4
Q02543|RL18A_HUMAN 60S ribosomal protein L18a OS=Homo sap    94.95 29 4
A6NDG6|PGP_HUMAN Phosphoglycolate phosphatase OS=Homo    94.5 15 4
A8MWD9|RUXGL_HUMAN Small nuclear ribonucleoprotein G-like prot     94.4 26 4
P62308|RUXG_HUMAN Small nuclear ribonucleoprotein G OS=Hom     94.4 26 4
Q32P28|P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens G   94.24 7 4
Q969H8|CS010_HUMAN UPF0556 protein C19orf10 OS=Homo sap    93.93 26 4
Q14203|DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=   91.52 11 4
Q9UKY7|CDV3_HUMAN Protein CDV3 homolog OS=Homo sapiens   90.41 19 4
P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS=     88.59 24 4
O00154|BACH_HUMAN Cytosolic acyl coenzyme A thioester hydrol      86.47 12 4
Q03701|CEBPZ_HUMAN CCAAT/enhancer-binding protein zeta OS=     83.82 8 4
Q5TZA2|CROCC_HUMAN Rootletin OS=Homo sapiens GN=CROCC  83.36 7 4
Q9Y2S6|CCD72_HUMAN Coiled-coil domain-containing protein 72 O     83.29 36 4
P36542|ATPG_HUMAN ATP synthase subunit gamma, mitochondr      83.27 27 4
P38117|ETFB_HUMAN Electron transfer flavoprotein subunit beta     82.51 29 4
P13073|COX41_HUMAN Cytochrome c oxidase subunit 4 isoform 1,      81.1 32 4
P61221|ABCE1_HUMAN ATP-binding cassette sub-family E membe       73.47 15 4
Q8WWM7|ATX2L_HUMAN Ataxin-2-like protein OS=Homo sapiens GN   73.05 7 4
Q13435|SF3B2_HUMAN Splicing factor 3B subunit 2 OS=Homo sap    71.02 8 4
Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gam       68.82 6 4
Q96PK6|RBM14_HUMAN RNA-binding protein 14 OS=Homo sapiens   68.35 10 4
Q86X55|CARM1_HUMAN Histone-arginine methyltransferase CARM1     58.7 16 4
Q8TDI0|CHD5_HUMAN Chromodomain-helicase-DNA-binding prot       57.07 6 4
Q9HCM1|CL035_HUMAN Uncharacterized protein C12orf35 OS=Hom     56.46 5 4
P35659|DEK_HUMAN Protein DEK OS=Homo sapiens GN=DEK  52.16 11 4
Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV 50.28 4 4
Q8IZC6|CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo s    46.19 10 4
Q13509|TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens G   328.66 65 3
P16403|H12_HUMAN Histone H1.2 OS=Homo sapiens GN=HIST   246.08 54 3
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P19105|ML12A_HUMAN Myosin regulatory light chain 12A OS=Hom     218.29 64 3
O14950|ML12B_HUMAN Myosin regulatory light chain 12B OS=Hom     218.29 63 3
P62136|PP1A_HUMAN Serine/threonine-protein phosphatase PP1        214.64 50 3
P36873|PP1G_HUMAN Serine/threonine-protein phosphatase PP1        207.58 51 3
P80297|MT1X_HUMAN Metallothionein-1X OS=Homo sapiens GN=   173.44 93 3
O00292|LFTY2_HUMAN Left-right determination factor 2 OS=Homo    171.99 39 3
Q13526|PIN1_HUMAN Peptidyl-prolyl cis-trans isomerase NIMA-in       157.53 56 3
P84085|ARF5_HUMAN ADP-ribosylation factor 5 OS=Homo sapien    155.55 56 3
Q9Y6M1|IF2B2_HUMAN Insulin-like growth factor 2 mRNA-binding p       152.9 22 3
P13804|ETFA_HUMAN Electron transfer flavoprotein subunit alpha       145.32 53 3
Q9BUT1|BDH2_HUMAN 3-hydroxybutyrate dehydrogenase type 2 O     138.72 40 3
P22087|FBRL_HUMAN rRNA 2'-O-methyltransferase fibrillarin OS=     138.49 42 3
P61163|ACTZ_HUMAN Alpha-centractin OS=Homo sapiens GN=A   138.07 57 3
P42677|RS27_HUMAN 40S ribosomal protein S27 OS=Homo sapi    137.93 40 3
Q5VTR2|BRE1A_HUMAN E3 ubiquitin-protein ligase BRE1A OS=Hom     136.26 19 3
Q6GMV3|CB079_HUMAN Uncharacterized protein C2orf79 OS=Hom     135.56 52 3
Q16629|SRSF7_HUMAN Serine/arginine-rich splicing factor 7 OS=H     135.25 20 3
P12829|MYL4_HUMAN Myosin light chain 4 OS=Homo sapiens GN   135.23 70 3
O43768|ENSA_HUMAN Alpha-endosulfine OS=Homo sapiens GN=   133.61 69 3
P14923|PLAK_HUMAN Junction plakoglobin OS=Homo sapiens G   132.84 17 3
Q9BX68|HINT2_HUMAN Histidine triad nucleotide-binding protein 2,      132.21 40 3
P04080|CYTB_HUMAN Cystatin-B OS=Homo sapiens GN=CSTB P  130.76 55 3
Q92769|HDAC2_HUMAN Histone deacetylase 2 OS=Homo sapiens   129.78 22 3
Q15437|SC23B_HUMAN Protein transport protein Sec23B OS=Hom     129.03 16 3
Q9BQ52|RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 O     128.98 14 3
P48735|IDHP_HUMAN Isocitrate dehydrogenase [NADP], mitocho      128.95 25 3
P62873|GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(        128.14 17 3
P46782|RS5_HUMAN 40S ribosomal protein S5 OS=Homo sapie    128.04 30 3
P49006|MRP_HUMAN MARCKS-related protein OS=Homo sapien    127.99 28 3
Q9Y3C6|PPIL1_HUMAN Peptidyl-prolyl cis-trans isomerase-like 1 O     127.31 39 3
Q7L1Q6|BZW1_HUMAN Basic leucine zipper and W2 domain-conta        126.41 28 3
P54920|SNAA_HUMAN Alpha-soluble NSF attachment protein OS=     126.36 25 3
O76021|RL1D1_HUMAN Ribosomal L1 domain-containing protein 1     125.66 32 3
Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS     124.22 15 3
Q9NPJ3|ACO13_HUMAN Acyl-coenzyme A thioesterase 13 OS=Hom     124.06 21 3
Q96PU8|QKI_HUMAN Protein quaking OS=Homo sapiens GN=Q   122.86 48 3
Q9H0A0|NAT10_HUMAN N-acetyltransferase 10 OS=Homo sapiens   122.86 14 3
Q15833|STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sapie    122.7 20 3
P10768|ESTD_HUMAN S-formylglutathione hydrolase OS=Homo s    122.62 29 3
O00264|PGRC1_HUMAN Membrane-associated progesterone recep        122.35 36 3
Q12996|CSTF3_HUMAN Cleavage stimulation factor subunit 3 OS=     121.58 17 3
Q99733|NP1L4_HUMAN Nucleosome assembly protein 1-like 4 OS=     120.55 26 3
P19784|CSK22_HUMAN Casein kinase II subunit alpha' OS=Homo    120.09 22 3
P11172|PYR5_HUMAN Uridine 5'-monophosphate synthase OS=H     119.61 34 3
P62854|RS26_HUMAN 40S ribosomal protein S26 OS=Homo sapi    118.32 31 3
O00567|NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens GN   118.13 20 3
A6NDU8|CE051_HUMAN UPF0600 protein C5orf51 OS=Homo sapie    116.57 50 3
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P05386|RLA1_HUMAN 60S acidic ribosomal protein P1 OS=Homo    115.59 49 3
O43278|SPIT1_HUMAN Kunitz-type protease inhibitor 1 OS=Homo    115.29 7 3
P46776|RL27A_HUMAN 60S ribosomal protein L27a OS=Homo sap    114.98 39 3
Q9NRN7|ADPPT_HUMAN L-aminoadipate-semialdehyde dehydrogen       114.55 21 3
Q15555|MARE2_HUMAN Microtubule-associated protein RP/EB fam        114.43 29 3
P0CG34|TB15A_HUMAN Thymosin beta-15A OS=Homo sapiens GN   113.57 36 3
P0CG35|TB15B_HUMAN Thymosin beta-15B OS=Homo sapiens GN   113.57 36 3
Q9H0U4|RAB1B_HUMAN Ras-related protein Rab-1B OS=Homo sap    113.53 31 3
Q92928|RAB1C_HUMAN Putative Ras-related protein Rab-1C OS=H     113.53 30 3
P16422|EPCAM_HUMAN Epithelial cell adhesion molecule OS=Hom     113.42 10 3
P46109|CRKL_HUMAN Crk-like protein OS=Homo sapiens GN=CR   111.98 17 3
Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens GN=MFGE   111.36 14 3
Q12874|SF3A3_HUMAN Splicing factor 3A subunit 3 OS=Homo sap    110.95 13 3
Q96IZ0|PAWR_HUMAN PRKC apoptosis WT1 regulator protein OS     110.95 25 3
Q9Y6E2|BZW2_HUMAN Basic leucine zipper and W2 domain-conta        110.32 16 3
O00764|PDXK_HUMAN Pyridoxal kinase OS=Homo sapiens GN=P   110.13 23 3
P52888|THOP1_HUMAN Thimet oligopeptidase OS=Homo sapiens   110.12 15 3
O75494|SRS10_HUMAN Serine/arginine-rich splicing factor 10 OS=     109.44 30 3
P49589|SYCC_HUMAN Cysteinyl-tRNA synthetase, cytoplasmic OS     108.74 12 3
O75340|PDCD6_HUMAN Programmed cell death protein 6 OS=Hom     108.64 26 3
Q13451|FKBP5_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP5     108.23 13 3
Q01081|U2AF1_HUMAN Splicing factor U2AF 35 kDa subunit OS=H     108.04 17 3
Q71UM5|RS27L_HUMAN 40S ribosomal protein S27-like OS=Homo    107.95 40 3
P54687|BCAT1_HUMAN Branched-chain-amino-acid aminotransfera       107.36 18 3
P40925|MDHC_HUMAN Malate dehydrogenase, cytoplasmic OS=H     106.84 24 3
Q9NV70|EXOC1_HUMAN Exocyst complex component 1 OS=Homo    106.75 18 3
P62906|RL10A_HUMAN 60S ribosomal protein L10a OS=Homo sap    106.18 31 3
Q9H4M9|EHD1_HUMAN EH domain-containing protein 1 OS=Homo    104.8 25 3
Q9NZL9|MAT2B_HUMAN Methionine adenosyltransferase 2 subunit      104.76 24 3
P04179|SODM_HUMAN Superoxide dismutase [Mn], mitochondrial     104.75 17 3
P09960|LKHA4_HUMAN Leukotriene A-4 hydrolase OS=Homo sapie    104.56 9 3
Q15785|TOM34_HUMAN Mitochondrial import receptor subunit TOM      104.54 24 3
P23919|KTHY_HUMAN Thymidylate kinase OS=Homo sapiens GN   104.02 25 3
P42766|RL35_HUMAN 60S ribosomal protein L35 OS=Homo sapi    103.1 39 3
P52434|RPAB3_HUMAN DNA-directed RNA polymerases I, II, and I        102.78 21 3
O75608|LYPA1_HUMAN Acyl-protein thioesterase 1 OS=Homo sapi    102.13 27 3
Q86U42|PABP2_HUMAN Polyadenylate-binding protein 2 OS=Homo    102.09 22 3
Q14677|EPN4_HUMAN Clathrin interactor 1 OS=Homo sapiens GN   102.05 17 3
Q9Y5Z4|HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens   101.95 20 3
Q96K17|BT3L4_HUMAN Transcription factor BTF3 homolog 4 OS=H     101.61 36 3
Q9UMY4|SNX12_HUMAN Sorting nexin-12 OS=Homo sapiens GN=S   101.15 40 3
P61201|CSN2_HUMAN COP9 signalosome complex subunit 2 OS=     100.4 21 3
P58546|MTPN_HUMAN Myotrophin OS=Homo sapiens GN=MTPN  100.02 25 3
O43805|SSNA1_HUMAN Sjoegren syndrome nuclear autoantigen 1     99.99 28 3
O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B O     99.32 12 3
P49023|PAXI_HUMAN Paxillin OS=Homo sapiens GN=PXN PE=1 98.54 14 3
Q9Y6Y8|S23IP_HUMAN SEC23-interacting protein OS=Homo sapie    98.24 13 3
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Q96CT7|CC124_HUMAN Coiled-coil domain-containing protein 124 O     97.64 26 3
P51511|MMP15_HUMAN Matrix metalloproteinase-15 OS=Homo sap    97.07 8 3
Q8NFU3|TSTD1_HUMAN Thiosulfate sulfurtransferase/rhodanese-lik         96.82 31 3
O75330|HMMR_HUMAN Hyaluronan mediated motility receptor OS=     96.74 24 3
Q9Y2W1|TR150_HUMAN Thyroid hormone receptor-associated prote       96.6 12 3
O75400|PR40A_HUMAN Pre-mRNA-processing factor 40 homolog A     96.29 7 3
Q9H0S4|DDX47_HUMAN Probable ATP-dependent RNA helicase DD      96.18 25 3
P62861|RS30_HUMAN 40S ribosomal protein S30 OS=Homo sapi    96.07 34 3
Q5T6F2|UBAP2_HUMAN Ubiquitin-associated protein 2 OS=Homo s    95.19 7 3
Q16186|ADRM1_HUMAN Proteasomal ubiquitin receptor ADRM1 OS     95.01 11 3
P49902|5NTC_HUMAN Cytosolic purine 5'-nucleotidase OS=Homo    94.73 15 3
P49721|PSB2_HUMAN Proteasome subunit beta type-2 OS=Homo    94.17 19 3
P53367|ARFP1_HUMAN Arfaptin-1 OS=Homo sapiens GN=ARFIP1  94.01 14 3
Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sap    93.97 11 3
Q9H9A6|LRC40_HUMAN Leucine-rich repeat-containing protein 40 O     93.81 10 3
O60869|EDF1_HUMAN Endothelial differentiation-related factor 1 O     93.76 41 3
Q9UQ35|SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 O     93.59 11 3
Q15435|PP1R7_HUMAN Protein phosphatase 1 regulatory subunit 7     93.13 23 3
P27694|RFA1_HUMAN Replication protein A 70 kDa DNA-binding      93.02 15 3
P08579|RU2B_HUMAN U2 small nuclear ribonucleoprotein B'' OS=     93.01 28 3
P38606|VATA_HUMAN V-type proton ATPase catalytic subunit A O     92.51 9 3
Q96TA1|NIBL1_HUMAN Niban-like protein 1 OS=Homo sapiens GN   92.31 10 3
Q9NQP4|PFD4_HUMAN Prefoldin subunit 4 OS=Homo sapiens GN   91.87 22 3
P49419|AL7A1_HUMAN Alpha-aminoadipic semialdehyde dehydrog      91.7 11 3
Q8WVJ2|NUDC2_HUMAN NudC domain-containing protein 2 OS=Ho     91.06 19 3
Q9BY32|ITPA_HUMAN Inosine triphosphate pyrophosphatase OS=     90.55 28 3
Q13895|BYST_HUMAN Bystin OS=Homo sapiens GN=BYSL PE=1 90.54 5 3
Q9NZD2|GLTP_HUMAN Glycolipid transfer protein OS=Homo sapie    90.2 17 3
Q7L014|DDX46_HUMAN Probable ATP-dependent RNA helicase DD      90.09 11 3
Q14914|PTGR1_HUMAN Prostaglandin reductase 1 OS=Homo sapie    89.81 16 3
P13489|RINI_HUMAN Ribonuclease inhibitor OS=Homo sapiens   89.8 14 3
Q15393|SF3B3_HUMAN Splicing factor 3B subunit 3 OS=Homo sap    89.75 7 3
Q8WW12|PCNP_HUMAN PEST proteolytic signal-containing nuclear      89.66 15 3
Q8IXM3|RM41_HUMAN 39S ribosomal protein L41, mitochondrial O     89.42 36 3
Q16527|CSRP2_HUMAN Cysteine and glycine-rich protein 2 OS=Ho     89.24 13 3
P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 sub       88.58 25 3
A6NK07|IF2BL_HUMAN Eukaryotic translation initiation factor 2 sub       88.58 20 3
Q99622|C10_HUMAN Protein C10 OS=Homo sapiens GN=C12o   88.42 48 3
Q96RU2|UBP28_HUMAN Ubiquitin carboxyl-terminal hydrolase 28 O     88.14 13 3
O15514|RPB4_HUMAN DNA-directed RNA polymerase II subunit R      88.11 37 3
O60341|KDM1A_HUMAN Lysine-specific histone demethylase 1A OS     88.07 11 3
Q8IX90|SKA3_HUMAN Spindle and kinetochore-associated protein      87.95 10 3
P62266|RS23_HUMAN 40S ribosomal protein S23 OS=Homo sapi    87.56 23 3
O60716|CTND1_HUMAN Catenin delta-1 OS=Homo sapiens GN=CT   87.52 16 3
Q56VL3|OCAD2_HUMAN OCIA domain-containing protein 2 OS=Hom     87.45 42 3
O75822|EIF3J_HUMAN Eukaryotic translation initiation factor 3 sub       87.24 20 3
P18859|ATP5J_HUMAN ATP synthase-coupling factor 6, mitochond      87.1 31 3
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Q9Y5K6|CD2AP_HUMAN CD2-associated protein OS=Homo sapiens   87.04 15 3
O60749|SNX2_HUMAN Sorting nexin-2 OS=Homo sapiens GN=SN   86.95 13 3
Q92522|H1X_HUMAN Histone H1x OS=Homo sapiens GN=H1FX  86.88 31 3
P49643|PRI2_HUMAN DNA primase large subunit OS=Homo sap    86.84 9 3
Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS     86.7 14 3
Q9UII2|ATIF1_HUMAN ATPase inhibitor, mitochondrial OS=Homo    86.28 25 3
Q9BTE3|MCMBP_HUMAN Mini-chromosome maintenance complex-b       86.04 9 3
Q8WUW1|BRK1_HUMAN Protein BRICK1 OS=Homo sapiens GN=C   85.16 40 3
O00159|MYO1C_HUMAN Myosin-Ic OS=Homo sapiens GN=MYO1C  84.93 6 3
Q96G03|PGM2_HUMAN Phosphoglucomutase-2 OS=Homo sapiens   84.79 17 3
O60306|AQR_HUMAN Intron-binding protein aquarius OS=Homo    84.76 9 3
Q15642|CIP4_HUMAN Cdc42-interacting protein 4 OS=Homo sap    84.55 14 3
O94760|DDAH1_HUMAN N(G),N(G)-dimethylarginine dimethylamino       83.98 32 3
P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapie    83.87 6 3
O43264|ZW10_HUMAN Centromere/kinetochore protein zw10 hom      83.24 12 3
Q9UMS4|PRP19_HUMAN Pre-mRNA-processing factor 19 OS=Homo    82.92 10 3
Q8N6M0|OTU6B_HUMAN OTU domain-containing protein 6B OS=Ho     82.7 25 3
Q15293|RCN1_HUMAN Reticulocalbin-1 OS=Homo sapiens GN=R   82.62 16 3
Q92917|GPKOW_HUMAN G patch domain and KOW motifs-containin       82.51 18 3
Q8NCW5|AIBP_HUMAN Apolipoprotein A-I-binding protein OS=Hom     82.16 14 3
Q86XP3|DDX42_HUMAN ATP-dependent RNA helicase DDX42 OS=     82.1 13 3
Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Hom     81.36 9 3
O14618|CCS_HUMAN Copper chaperone for superoxide dismutas      80.6 25 3
O43865|SAHH2_HUMAN Putative adenosylhomocysteinase 2 OS=H     79.39 16 3
P07311|ACYP1_HUMAN Acylphosphatase-1 OS=Homo sapiens GN   78.94 35 3
Q9HB07|MYG1_HUMAN UPF0160 protein MYG1, mitochondrial OS     78.78 12 3
Q15102|PA1B3_HUMAN Platelet-activating factor acetylhydrolase IB       77.77 11 3
Q52LJ0|FA98B_HUMAN Protein FAM98B OS=Homo sapiens GN=F   77.62 12 3
O60832|DKC1_HUMAN H/ACA ribonucleoprotein complex subunit      77.26 18 3
Q13868|EXOS2_HUMAN Exosome complex component RRP4 OS=H     77.13 30 3
Q14061|COX17_HUMAN Cytochrome c oxidase copper chaperone O     77.09 75 3
Q9NQ48|LZTL1_HUMAN Leucine zipper transcription factor-like prot       76.86 9 3
Q8IV08|PLD3_HUMAN Phospholipase D3 OS=Homo sapiens GN=   76.83 12 3
P09496|CLCA_HUMAN Clathrin light chain A OS=Homo sapiens G   76.59 11 3
P10155|RO60_HUMAN 60 kDa SS-A/Ro ribonucleoprotein OS=Ho     74 12 3
P62330|ARF6_HUMAN ADP-ribosylation factor 6 OS=Homo sapien    72.99 18 3
Q9Y3U8|RL36_HUMAN 60S ribosomal protein L36 OS=Homo sapi    72.72 29 3
O43237|DC1L2_HUMAN Cytoplasmic dynein 1 light intermediate cha       72.09 9 3
Q9Y2Q9|RT28_HUMAN 28S ribosomal protein S28, mitochondrial O     71.69 31 3
P35237|SPB6_HUMAN Serpin B6 OS=Homo sapiens GN=SERPIN   71.25 19 3
Q9BWJ5|SF3B5_HUMAN Splicing factor 3B subunit 5 OS=Homo sap    71.1 41 3
O95239|KIF4A_HUMAN Chromosome-associated kinesin KIF4A OS     70.97 6 3
P30419|NMT1_HUMAN Glycylpeptide N-tetradecanoyltransferase 1     70.75 11 3
Q9Y3D9|RT23_HUMAN 28S ribosomal protein S23, mitochondrial O     70.5 17 3
Q7LBC6|KDM3B_HUMAN Lysine-specific demethylase 3B OS=Homo    70.24 3 3
O00762|UBE2C_HUMAN Ubiquitin-conjugating enzyme E2 C OS=Ho     69.93 36 3
Q14157|UBP2L_HUMAN Ubiquitin-associated protein 2-like OS=Hom     69.67 8 3
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Q92879|CELF1_HUMAN CUGBP Elav-like family member 1 OS=Ho     68.9 8 3
Q9NQW7|XPP1_HUMAN Xaa-Pro aminopeptidase 1 OS=Homo sapi    68.7 9 3
Q5TFE4|NT5D1_HUMAN 5'-nucleotidase domain-containing protein      68.33 8 3
Q86V88|MGDP1_HUMAN Magnesium-dependent phosphatase 1 OS     67.49 27 3
P07686|HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Ho     67.18 12 3
O94973|AP2A2_HUMAN AP-2 complex subunit alpha-2 OS=Homo s    67.1 12 3
P62253|UB2G1_HUMAN Ubiquitin-conjugating enzyme E2 G1 OS=H     66.99 11 3
P24752|THIL_HUMAN Acetyl-CoA acetyltransferase, mitochondria      66.66 16 3
Q9Y4C1|KDM3A_HUMAN Lysine-specific demethylase 3A OS=Homo    65.93 7 3
Q9C0C9|UBE2O_HUMAN Ubiquitin-conjugating enzyme E2 O OS=Ho     64.65 11 3
P47985|UCRI_HUMAN Cytochrome b-c1 complex subunit Rieske,      64.15 20 3
P0C7P4|UCRIL_HUMAN Putative cytochrome b-c1 complex subunit        64.15 19 3
O00115|DNS2A_HUMAN Deoxyribonuclease-2-alpha OS=Homo sap    63.14 9 3
P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo s    62.42 8 3
P16083|NQO2_HUMAN Ribosyldihydronicotinamide dehydrogenase      61.65 18 3
Q9UHD1|CHRD1_HUMAN Cysteine and histidine-rich domain-contain        61.41 15 3
Q92485|ASM3B_HUMAN Acid sphingomyelinase-like phosphodieste       60.83 9 3
Q6DKJ4|NXN_HUMAN Nucleoredoxin OS=Homo sapiens GN=NX   60.58 13 3
Q8NE71|ABCF1_HUMAN ATP-binding cassette sub-family F membe       56.4 8 3
Q9HAV7|GRPE1_HUMAN GrpE protein homolog 1, mitochondrial OS     56.04 28 3
Q9H1B7|I2BPL_HUMAN Interferon regulatory factor 2-binding prote      54.33 11 3
Q01970|PLCB3_HUMAN 1-phosphatidylinositol-4,5-bisphosphate ph       46.82 5 3
P36406|TRI23_HUMAN E3 ubiquitin-protein ligase TRIM23 OS=Ho     42.95 13 3
Q5U5R9|HECD2_HUMAN Probable E3 ubiquitin-protein ligase HECT      40.01 5 3
P25391|LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapien    35.67 5 3
P68371|TBB2C_HUMAN Tubulin beta-2C chain OS=Homo sapiens   424.6 82 2
P63261|ACTG_HUMAN Actin, cytoplasmic 2 OS=Homo sapiens GN   415.2 86 2
Q9BVA1|TBB2B_HUMAN Tubulin beta-2B chain OS=Homo sapiens G   407.9 80 2
P04350|TBB4_HUMAN Tubulin beta-4 chain OS=Homo sapiens G   389.06 76 2
Q9BQE3|TBA1C_HUMAN Tubulin alpha-1C chain OS=Homo sapiens   327.76 74 2
P62979|RS27A_HUMAN Ubiquitin-40S ribosomal protein S27a OS=     291.21 63 2
P0CG48|UBC_HUMAN Polyubiquitin-C OS=Homo sapiens GN=UB   279.3 75 2
P0CG47|UBB_HUMAN Polyubiquitin-B OS=Homo sapiens GN=UB   279.3 93 2
P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens GN=MYH11  207.27 34 2
Q8TAA3|PSA7L_HUMAN Proteasome subunit alpha type-7-like OS=     205.77 54 2
Q13310|PABP4_HUMAN Polyadenylate-binding protein 4 OS=Homo    201.17 41 2
P68431|H31_HUMAN Histone H3.1 OS=Homo sapiens GN=HIST   182.91 72 2
Q71DI3|H32_HUMAN Histone H3.2 OS=Homo sapiens GN=HIST   182.91 72 2
P13929|ENOB_HUMAN Beta-enolase OS=Homo sapiens GN=ENO   176.46 51 2
P56545|CTBP2_HUMAN C-terminal-binding protein 2 OS=Homo sap    174.47 37 2
Q13162|PRDX4_HUMAN Peroxiredoxin-4 OS=Homo sapiens GN=P   157.8 25 2
P63167|DYL1_HUMAN Dynein light chain 1, cytoplasmic OS=Hom     157.64 61 2
O75610|LFTY1_HUMAN Left-right determination factor 1 OS=Homo    157.28 31 2
Q13363|CTBP1_HUMAN C-terminal-binding protein 1 OS=Homo sap    153.58 32 2
Q96FJ2|DYL2_HUMAN Dynein light chain 2, cytoplasmic OS=Hom     152.48 40 2
O43390|HNRPR_HUMAN Heterogeneous nuclear ribonucleoprotein R     147.99 24 2
P52597|HNRPF_HUMAN Heterogeneous nuclear ribonucleoprotein F     136.85 27 2
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Q15436|SC23A_HUMAN Protein transport protein Sec23A OS=Hom     133.71 12 2
P38919|IF4A3_HUMAN Eukaryotic initiation factor 4A-III OS=Homo    132.82 26 2
Q13404|UB2V1_HUMAN Ubiquitin-conjugating enzyme E2 variant 1     130.6 50 2
Q96FW1|OTUB1_HUMAN Ubiquitin thioesterase OTUB1 OS=Homo s    127.92 17 2
P18085|ARF4_HUMAN ADP-ribosylation factor 4 OS=Homo sapien    127.46 48 2
O60282|KIF5C_HUMAN Kinesin heavy chain isoform 5C OS=Homo    125.8 14 2
P46778|RL21_HUMAN 60S ribosomal protein L21 OS=Homo sapi    125.05 35 2
Q15819|UB2V2_HUMAN Ubiquitin-conjugating enzyme E2 variant 2     124.61 44 2
Q9ULZ3|ASC_HUMAN Apoptosis-associated speck-like protein co        124.37 32 2
P04899|GNAI2_HUMAN Guanine nucleotide-binding protein G(i) su       121.44 24 2
P61160|ARP2_HUMAN Actin-related protein 2 OS=Homo sapiens   121.32 14 2
Q9Y6E0|STK24_HUMAN Serine/threonine-protein kinase 24 OS=Ho     119.76 26 2
Q96C90|PP14B_HUMAN Protein phosphatase 1 regulatory subunit 1      118.44 48 2
Q13155|AIMP2_HUMAN Aminoacyl tRNA synthase complex-interac         116.73 33 2
Q9UHY1|NRBP_HUMAN Nuclear receptor-binding protein OS=Homo    113.38 14 2
P62910|RL32_HUMAN 60S ribosomal protein L32 OS=Homo sapi    111.91 24 2
P61077|UB2D3_HUMAN Ubiquitin-conjugating enzyme E2 D3 OS=H     109.06 35 2
Q9P287|BCCIP_HUMAN BRCA2 and CDKN1A-interacting protein O     108.56 17 2
Q9BSD7|NTPCR_HUMAN Cancer-related nucleoside-triphosphatase     108.32 45 2
Q9UJQ4|SALL4_HUMAN Sal-like protein 4 OS=Homo sapiens GN=S   106.89 21 2
O14579|COPE_HUMAN Coatomer subunit epsilon OS=Homo sapie    105.69 23 2
P09234|RU1C_HUMAN U1 small nuclear ribonucleoprotein C OS=H     105.67 19 2
P68402|PA1B2_HUMAN Platelet-activating factor acetylhydrolase IB       104.35 17 2
P48739|PIPNB_HUMAN Phosphatidylinositol transfer protein beta is      102.3 22 2
Q96IX5|USMG5_HUMAN Up-regulated during skeletal muscle growth       101.49 45 2
Q9H6R4|NOL6_HUMAN Nucleolar protein 6 OS=Homo sapiens GN   101.44 6 2
O43598|RCL_HUMAN Deoxyribonucleoside 5'-monophosphate N      101.42 26 2
Q9BRG1|VPS25_HUMAN Vacuolar protein-sorting-associated protein      101.28 14 2
Q8WXF1|PSPC1_HUMAN Paraspeckle component 1 OS=Homo sapie    99.71 22 2
P67775|PP2AA_HUMAN Serine/threonine-protein phosphatase 2A c         99.63 16 2
Q07021|C1QBP_HUMAN Complement component 1 Q subcompone        98.8 15 2
Q99567|NUP88_HUMAN Nuclear pore complex protein Nup88 OS=H     98.75 14 2
Q13177|PAK2_HUMAN Serine/threonine-protein kinase PAK 2 OS     97.58 21 2
Q92922|SMRC1_HUMAN SWI/SNF complex subunit SMARCC1 OS=     97.06 8 2
Q8NBT2|SPC24_HUMAN Kinetochore protein Spc24 OS=Homo sapi    96.91 24 2
P15954|COX7C_HUMAN Cytochrome c oxidase subunit 7C, mitocho      96.87 52 2
Q9BPX5|ARP5L_HUMAN Actin-related protein 2/3 complex subunit 5       96.72 27 2
P47755|CAZA2_HUMAN F-actin-capping protein subunit alpha-2 OS     96.54 20 2
Q9UIL1|SCOC_HUMAN Short coiled-coil protein OS=Homo sapiens   96.47 32 2
P63151|2ABA_HUMAN Serine/threonine-protein phosphatase 2A 5            95.89 24 2
Q5JWF2|GNAS1_HUMAN Guanine nucleotide-binding protein G(s) su         95.78 9 2
Q9UJZ1|STML2_HUMAN Stomatin-like protein 2 OS=Homo sapiens   94.74 23 2
O95989|NUDT3_HUMAN Diphosphoinositol polyphosphate phospho       94.72 18 2
Q12904|AIMP1_HUMAN Aminoacyl tRNA synthase complex-interac         94.7 15 2
Q8IUD2|RB6I2_HUMAN ELKS/Rab6-interacting/CAST family memb       94.12 20 2
P04632|CPNS1_HUMAN Calpain small subunit 1 OS=Homo sapiens   93.86 18 2
Q14766|LTBP1_HUMAN Latent-transforming growth factor beta-bind        93.84 6 2
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Q15631|TSN_HUMAN Translin OS=Homo sapiens GN=TSN PE=  93.49 25 2
Q15397|K0020_HUMAN Pumilio domain-containing protein KIAA002      93.09 18 2
Q3KQU3|MA7D1_HUMAN MAP7 domain-containing protein 1 OS=Ho     92.59 15 2
Q8TEA8|DTD1_HUMAN D-tyrosyl-tRNA(Tyr) deacylase 1 OS=Homo    90.6 25 2
P60953|CDC42_HUMAN Cell division control protein 42 homolog OS     90.45 28 2
Q9UBI6|GBG12_HUMAN Guanine nucleotide-binding protein G(I)/G(        90.45 36 2
Q9Y263|PLAP_HUMAN Phospholipase A-2-activating protein OS=H     90.34 11 2
O75934|SPF27_HUMAN Pre-mRNA-splicing factor SPF27 OS=Hom     89.59 18 2
P08195|4F2_HUMAN 4F2 cell-surface antigen heavy chain OS=H     89.5 8 2
P50281|MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sap    89.06 10 2
P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo s    88.78 19 2
Q02952|AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sap    88.6 11 2
O15042|SR140_HUMAN U2 snRNP-associated SURP motif-contain       87.91 11 2
Q8NDC0|MISSL_HUMAN MAPK-interacting and spindle-stabilizing pr      87.78 12 2
P07919|QCR6_HUMAN Cytochrome b-c1 complex subunit 6, mitoc      87.64 27 2
O00499|BIN1_HUMAN Myc box-dependent-interacting protein 1 O     87.42 24 2
Q5TAP6|UT14C_HUMAN U3 small nucleolar RNA-associated protein        87.38 10 2
Q15276|RABE1_HUMAN Rab GTPase-binding effector protein 1 OS     86.97 9 2
Q04323|UBXN1_HUMAN UBX domain-containing protein 1 OS=Hom     86.92 16 2
Q9NV35|NUD15_HUMAN Probable 7,8-dihydro-8-oxoguanine triphos       86.9 13 2
O75152|ZC11A_HUMAN Zinc finger CCCH domain-containing prote       86.73 10 2
Q9Y5A9|YTHD2_HUMAN YTH domain family protein 2 OS=Homo sa    86.69 8 2
O75391|SPAG7_HUMAN Sperm-associated antigen 7 OS=Homo sa    86.47 27 2
P09012|SNRPA_HUMAN U1 small nuclear ribonucleoprotein A OS=H     86.26 11 2
P42574|CASP3_HUMAN Caspase-3 OS=Homo sapiens GN=CASP3  85.84 18 2
Q13011|ECH1_HUMAN Delta(3,5)-Delta(2,4)-dienoyl-CoA isomeras       85.79 15 2
P00568|KAD1_HUMAN Adenylate kinase isoenzyme 1 OS=Homo s    85.73 13 2
Q9Y520|PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=P   85.45 7 2
Q9NR19|ACSA_HUMAN Acetyl-coenzyme A synthetase, cytoplasmi      85.41 7 2
P21291|CSRP1_HUMAN Cysteine and glycine-rich protein 1 OS=Ho     85.25 25 2
O60258|FGF17_HUMAN Fibroblast growth factor 17 OS=Homo sapi    85.07 21 2
O75390|CISY_HUMAN Citrate synthase, mitochondrial OS=Homo    84.95 14 2
Q9NR28|DBLOH_HUMAN Diablo homolog, mitochondrial OS=Homo s    84.46 13 2
Q7Z2W4|ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 O     83.81 4 2
Q9BUJ2|HNRL1_HUMAN Heterogeneous nuclear ribonucleoprotein U        83.64 7 2
Q969V3|NCLN_HUMAN Nicalin OS=Homo sapiens GN=NCLN PE=  83.57 13 2
Q14181|DPOA2_HUMAN DNA polymerase alpha subunit B OS=Hom     83.52 9 2
Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sa    82.87 14 2
Q9UBT2|SAE2_HUMAN SUMO-activating enzyme subunit 2 OS=Ho     82.82 14 2
O95218|ZRAB2_HUMAN Zinc finger Ran-binding domain-containing       82.24 13 2
Q5SSJ5|HP1B3_HUMAN Heterochromatin protein 1-binding protein 3     82.15 18 2
P09132|SRP19_HUMAN Signal recognition particle 19 kDa protein O     81.87 32 2
Q9NRF8|PYRG2_HUMAN CTP synthase 2 OS=Homo sapiens GN=C   81.59 8 2
Q9Y3E1|HDGR3_HUMAN Hepatoma-derived growth factor-related pr       81.54 18 2
O00233|PSMD9_HUMAN 26S proteasome non-ATPase regulatory su       81.3 13 2
P00390|GSHR_HUMAN Glutathione reductase, mitochondrial OS=H     81.01 14 2
P62875|RPAB5_HUMAN DNA-directed RNA polymerases I, II, and I        80.88 30 2
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P61956|SUMO2_HUMAN Small ubiquitin-related modifier 2 OS=Hom     80.85 43 2
Q9UJC3|HOOK1_HUMAN Protein Hook homolog 1 OS=Homo sapien    80.74 8 2
Q9NVA2|SEP11_HUMAN Septin-11 OS=Homo sapiens GN=SEPT11  80.42 13 2
Q15007|FL2D_HUMAN Pre-mRNA-splicing regulator WTAP OS=H     80.32 18 2
O43290|SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 O     80.28 15 2
P41227|NAA10_HUMAN N-alpha-acetyltransferase 10, NatA catalyt       80.28 21 2
Q15126|PMVK_HUMAN Phosphomevalonate kinase OS=Homo sap    80.19 20 2
A6NIZ1|RP1BL_HUMAN Ras-related protein Rap-1b-like protein OS    79.86 22 2
P61224|RAP1B_HUMAN Ras-related protein Rap-1b OS=Homo sap    79.86 17 2
P62834|RAP1A_HUMAN Ras-related protein Rap-1A OS=Homo sap    79.86 8 2
P56134|ATPK_HUMAN ATP synthase subunit f, mitochondrial OS=     79.85 26 2
Q7Z739|YTHD3_HUMAN YTH domain family protein 3 OS=Homo sa    79.7 7 2
Q9UBW8|CSN7A_HUMAN COP9 signalosome complex subunit 7a OS     79.56 17 2
P51571|SSRD_HUMAN Translocon-associated protein subunit delt      79.5 23 2
Q15363|TMED2_HUMAN Transmembrane emp24 domain-containing       79.08 9 2
Q9P2I0|CPSF2_HUMAN Cleavage and polyadenylation specificity fa        79 13 2
Q9H3R5|CENPH_HUMAN Centromere protein H OS=Homo sapiens G   78.83 17 2
O95793|STAU1_HUMAN Double-stranded RNA-binding protein Stau        78.65 6 2
Q93034|CUL5_HUMAN Cullin-5 OS=Homo sapiens GN=CUL5 PE=  78.64 12 2
Q13464|ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo    77.86 5 2
Q16706|MA2A1_HUMAN Alpha-mannosidase 2 OS=Homo sapiens G   77.77 4 2
Q14738|2A5D_HUMAN Serine/threonine-protein phosphatase 2A 5           77.77 11 2
P55263|ADK_HUMAN Adenosine kinase OS=Homo sapiens GN=   77.29 9 2
P18065|IBP2_HUMAN Insulin-like growth factor-binding protein 2     77.23 27 2
P62310|LSM3_HUMAN U6 snRNA-associated Sm-like protein LSm      77.04 34 2
O60885|BRD4_HUMAN Bromodomain-containing protein 4 OS=Ho     76.79 9 2
P55039|DRG2_HUMAN Developmentally-regulated GTP-binding pr       76.74 20 2
P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo s    76.61 9 2
Q9P0K7|RAI14_HUMAN Ankycorbin OS=Homo sapiens GN=RAI14  76.54 9 2
Q9NQG5|RPR1B_HUMAN Regulation of nuclear pre-mRNA domain-c        76.47 23 2
O75190|DNJB6_HUMAN DnaJ homolog subfamily B member 6 OS=     76.03 8 2
Q86YP4|P66A_HUMAN Transcriptional repressor p66-alpha OS=H     75.65 12 2
P67870|CSK2B_HUMAN Casein kinase II subunit beta OS=Homo sa    75.58 13 2
Q9H223|EHD4_HUMAN EH domain-containing protein 4 OS=Homo    75.44 9 2
Q9UJC5|SH3L2_HUMAN SH3 domain-binding glutamic acid-rich-like       75.06 25 2
O60346|PHLP1_HUMAN PH domain leucine-rich repeat-containing p        74.43 9 2
Q9NR45|SIAS_HUMAN Sialic acid synthase OS=Homo sapiens GN   74.15 15 2
Q9BV57|MTND_HUMAN 1,2-dihydroxy-3-keto-5-methylthiopentene d      74.05 15 2
Q9NUP9|LIN7C_HUMAN Protein lin-7 homolog C OS=Homo sapiens   74.02 36 2
O43678|NDUA2_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha        73.91 32 2
P60510|PP4C_HUMAN Serine/threonine-protein phosphatase 4 ca       73.7 16 2
Q01780|EXOSX_HUMAN Exosome component 10 OS=Homo sapien    73.54 6 2
Q9Y5S9|RBM8A_HUMAN RNA-binding protein 8A OS=Homo sapiens   72.87 25 2
Q12765|SCRN1_HUMAN Secernin-1 OS=Homo sapiens GN=SCRN   72.58 7 2
Q9UNF1|MAGD2_HUMAN Melanoma-associated antigen D2 OS=Hom     72.46 11 2
Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens   72.11 15 2
Q99829|CPNE1_HUMAN Copine-1 OS=Homo sapiens GN=CPNE1  71.96 12 2
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O95456|PSMG1_HUMAN Proteasome assembly chaperone 1 OS=Ho     71.94 20 2
P30837|AL1B1_HUMAN Aldehyde dehydrogenase X, mitochondrial     71.86 7 2
Q08257|QOR_HUMAN Quinone oxidoreductase OS=Homo sapien    71.79 17 2
Q9NQ88|TIGAR_HUMAN Probable fructose-2,6-bisphosphatase TIG      71.65 7 2
Q9HCD5|NCOA5_HUMAN Nuclear receptor coactivator 5 OS=Homo s    71.43 7 2
Q9C0C2|TB182_HUMAN 182 kDa tankyrase-1-binding protein OS=H     71.43 9 2
Q96QK1|VPS35_HUMAN Vacuolar protein sorting-associated protein      71.43 10 2
O60613|SEP15_HUMAN 15 kDa selenoprotein OS=Homo sapiens G   71.28 23 2
O00754|MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo    70.84 4 2
O75937|DNJC8_HUMAN DnaJ homolog subfamily C member 8 OS=     70.81 20 2
Q13867|BLMH_HUMAN Bleomycin hydrolase OS=Homo sapiens G   70.58 15 2
Q92979|NEP1_HUMAN Ribosomal RNA small subunit methyltransf       70.53 17 2
P22307|NLTP_HUMAN Non-specific lipid-transfer protein OS=Hom     69.7 9 2
Q16718|NDUA5_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha        69.22 38 2
P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory su       69.05 15 2
Q71RC2|LARP4_HUMAN La-related protein 4 OS=Homo sapiens GN   68.92 5 2
Q9Y6M9|NDUB9_HUMAN NADH dehydrogenase [ubiquinone] 1 beta        68.86 13 2
Q9BW83|IFT27_HUMAN Intraflagellar transport protein 27 homolog     68.69 13 2
Q99661|KIF2C_HUMAN Kinesin-like protein KIF2C OS=Homo sapie    68.2 6 2
Q02818|NUCB1_HUMAN Nucleobindin-1 OS=Homo sapiens GN=NU   68.14 13 2
P52292|IMA2_HUMAN Importin subunit alpha-2 OS=Homo sapien    67.93 8 2
Q9NUQ6|SPS2L_HUMAN SPATS2-like protein OS=Homo sapiens G   67.55 6 2
Q9H4A6|GOLP3_HUMAN Golgi phosphoprotein 3 OS=Homo sapiens   67.46 13 2
Q9UHX1|PUF60_HUMAN Poly(U)-binding-splicing factor PUF60 OS=     67.43 24 2
Q9H074|PAIP1_HUMAN Polyadenylate-binding protein-interacting p       67.38 10 2
Q9ULV4|COR1C_HUMAN Coronin-1C OS=Homo sapiens GN=CORO   67.35 12 2
O00471|EXOC5_HUMAN Exocyst complex component 5 OS=Homo    67.21 3 2
Q9NPJ6|MED4_HUMAN Mediator of RNA polymerase II transcriptio        67.18 22 2
Q14155|ARHG7_HUMAN Rho guanine nucleotide exchange factor 7     67.04 9 2
P42704|LPPRC_HUMAN Leucine-rich PPR motif-containing protein,      67 10 2
O95232|LC7L3_HUMAN Luc7-like protein 3 OS=Homo sapiens GN=   66.75 8 2
Q9NR31|SAR1A_HUMAN GTP-binding protein SAR1a OS=Homo sap    66.74 21 2
Q9Y6B6|SAR1B_HUMAN GTP-binding protein SAR1b OS=Homo sap    66.74 17 2
Q13596|SNX1_HUMAN Sorting nexin-1 OS=Homo sapiens GN=SN   66.53 11 2
Q96MW1|CCD43_HUMAN Coiled-coil domain-containing protein 43 O     66.27 18 2
Q9Y2R0|CCD56_HUMAN Coiled-coil domain-containing protein 56 O     65.91 21 2
Q9P0V9|SEP10_HUMAN Septin-10 OS=Homo sapiens GN=SEPT10  65.67 7 2
Q8WVB6|CTF18_HUMAN Chromosome transmission fidelity protein 1       65.6 8 2
P12955|PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens G   65.51 4 2
Q12849|GRSF1_HUMAN G-rich sequence factor 1 OS=Homo sapien    65.37 13 2
Q13492|PICAL_HUMAN Phosphatidylinositol-binding clathrin assem       65.24 10 2
Q96C01|F136A_HUMAN Protein FAM136A OS=Homo sapiens GN=   64.59 14 2
Q9BU89|DOHH_HUMAN Deoxyhypusine hydroxylase OS=Homo sap    64.54 14 2
Q9NX63|CHCH3_HUMAN Coiled-coil-helix-coiled-coil-helix domain-co         64.42 21 2
O14929|HAT1_HUMAN Histone acetyltransferase type B catalytic s      64.35 13 2
Q03426|KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN   64.12 7 2
P08473|NEP_HUMAN Neprilysin OS=Homo sapiens GN=MME PE  64.01 3 2
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Q15750|TAB1_HUMAN TGF-beta-activated kinase 1 and MAP3K7        63.83 7 2
P62070|RRAS2_HUMAN Ras-related protein R-Ras2 OS=Homo sap    63.79 18 2
P61960|UFM1_HUMAN Ubiquitin-fold modifier 1 OS=Homo sapiens   63.63 35 2
P49755|TMEDA_HUMAN Transmembrane emp24 domain-containing       63.6 13 2
Q12841|FSTL1_HUMAN Follistatin-related protein 1 OS=Homo sapi    63.48 7 2
Q13153|PAK1_HUMAN Serine/threonine-protein kinase PAK 1 OS     63.03 14 2
Q08379|GOGA2_HUMAN Golgin subfamily A member 2 OS=Homo s    62.85 6 2
Q13564|ULA1_HUMAN NEDD8-activating enzyme E1 regulatory su      62.68 6 2
P19525|E2AK2_HUMAN Interferon-induced, double-stranded RNA-a        62.6 5 2
P54886|P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase O     62.58 9 2
Q9NX40|OCAD1_HUMAN OCIA domain-containing protein 1 OS=Hom     61.98 11 2
Q8N983|RM43_HUMAN 39S ribosomal protein L43, mitochondrial O     61.98 20 2
P32322|P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1, mitoch      61.29 14 2
P51003|PAPOA_HUMAN Poly(A) polymerase alpha OS=Homo sapie    60.84 7 2
Q9NRJ5|PAPOB_HUMAN Poly(A) polymerase beta OS=Homo sapien    60.84 6 2
Q07960|RHG01_HUMAN Rho GTPase-activating protein 1 OS=Hom     60.52 12 2
Q13428|TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TC   60.45 7 2
Q8IZ83|A16A1_HUMAN Aldehyde dehydrogenase family 16 membe       60.3 8 2
P56537|IF6_HUMAN Eukaryotic translation initiation factor 6 OS     60.12 18 2
P21281|VATB2_HUMAN V-type proton ATPase subunit B, brain isof      59.64 12 2
Q96P48|ARAP1_HUMAN Arf-GAP with Rho-GAP domain, ANK repe           59.42 6 2
Q9NX58|LYAR_HUMAN Cell growth-regulating nucleolar protein OS     59.29 13 2
O00217|NDUS8_HUMAN NADH dehydrogenase [ubiquinone] iron-su         58.56 13 2
P46060|RAGP1_HUMAN Ran GTPase-activating protein 1 OS=Hom     58.21 16 2
Q9BXF3|CECR2_HUMAN Cat eye syndrome critical region protein 2 O     58 5 2
A6NHR9|SMHD1_HUMAN Structural maintenance of chromosomes fle          57.73 5 2
Q96RE7|NACC1_HUMAN Nucleus accumbens-associated protein 1 O     57.73 7 2
Q9BRP1|PDD2L_HUMAN Programmed cell death protein 2-like OS=H     57.11 12 2
Q14498|RBM39_HUMAN RNA-binding protein 39 OS=Homo sapiens   56.94 6 2
Q05519|SRS11_HUMAN Serine/arginine-rich splicing factor 11 OS=     56.7 15 2
P19404|NDUV2_HUMAN NADH dehydrogenase [ubiquinone] flavopr        56.23 17 2
O75251|NDUS7_HUMAN NADH dehydrogenase [ubiquinone] iron-su         56.15 8 2
Q9BZL1|UBL5_HUMAN Ubiquitin-like protein 5 OS=Homo sapiens   55.86 25 2
Q00059|TFAM_HUMAN Transcription factor A, mitochondrial OS=H     55.73 16 2
P35612|ADDB_HUMAN Beta-adducin OS=Homo sapiens GN=ADD   54.77 15 2
Q9Y5K5|UCHL5_HUMAN Ubiquitin carboxyl-terminal hydrolase isozy       54.46 8 2
Q9UPT5|EXOC7_HUMAN Exocyst complex component 7 OS=Homo    54.28 4 2
P19387|RPB3_HUMAN DNA-directed RNA polymerase II subunit R      54.09 12 2
P60468|SC61B_HUMAN Protein transport protein Sec61 subunit be      53.55 36 2
O00479|HMGN4_HUMAN High mobility group nucleosome-binding do        53.51 33 2
P45880|VDAC2_HUMAN Voltage-dependent anion-selective channe        53.49 7 2
Q9UHY7|ENOPH_HUMAN Enolase-phosphatase E1 OS=Homo sapie    53.36 13 2
P46939|UTRO_HUMAN Utrophin OS=Homo sapiens GN=UTRN PE  53.05 4 2
Q86X76|NIT1_HUMAN Nitrilase homolog 1 OS=Homo sapiens GN   52.26 14 2
Q92520|FAM3C_HUMAN Protein FAM3C OS=Homo sapiens GN=FA   51.99 15 2
P21912|DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron        51.74 7 2
P20936|RASA1_HUMAN Ras GTPase-activating protein 1 OS=Hom     51.56 4 2
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Q9H3S7|PTN23_HUMAN Tyrosine-protein phosphatase non-recepto        51.35 5 2
P52732|KIF11_HUMAN Kinesin-like protein KIF11 OS=Homo sapie    51.09 4 2
Q9H4B8|DPEP3_HUMAN Dipeptidase 3 OS=Homo sapiens GN=DPE   50.87 7 2
Q9NYJ1|CHCH8_HUMAN Coiled-coil-helix-coiled-coil-helix domain-co        50.55 48 2
Q15545|TAF7_HUMAN Transcription initiation factor TFIID subunit      50.54 9 2
P35968|VGFR2_HUMAN Vascular endothelial growth factor receptor      50.16 3 2
Q96A26|F162A_HUMAN Protein FAM162A OS=Homo sapiens GN=   49.71 20 2
P61513|RL37A_HUMAN 60S ribosomal protein L37a OS=Homo sap    49.06 39 2
Q9Y530|CF130_HUMAN Uncharacterized protein C6orf130 OS=Hom     48.84 21 2
Q14690|RRP5_HUMAN Protein RRP5 homolog OS=Homo sapiens   48.67 3 2
Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase, mitochond      48.44 19 2
Q9Y2W2|WBP11_HUMAN WW domain-binding protein 11 OS=Homo    48.14 4 2
Q7L4E1|FA73B_HUMAN Protein FAM73B OS=Homo sapiens GN=F   47.7 5 2
Q13416|ORC2_HUMAN Origin recognition complex subunit 2 OS=H     47.54 7 2
Q15388|TOM20_HUMAN Mitochondrial import receptor subunit TOM       47.43 24 2
P49792|RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Hom     47.42 6 2
P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Ho     47.22 10 2
O94906|PRP6_HUMAN Pre-mRNA-processing factor 6 OS=Homo    47.09 8 2
P46013|KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI   46.36 5 2
O15144|ARPC2_HUMAN Actin-related protein 2/3 complex subunit 2     46.29 22 2
P46821|MAP1B_HUMAN Microtubule-associated protein 1B OS=Hom     45.98 3 2
Q9Y6A5|TACC3_HUMAN Transforming acidic coiled-coil-containing p       45.75 6 2
Q9UPG8|PLAL2_HUMAN Zinc finger protein PLAGL2 OS=Homo sap    45.47 3 2
Q9UK45|LSM7_HUMAN U6 snRNA-associated Sm-like protein LSm      44.9 22 2
Q9Y2R5|RT17_HUMAN 28S ribosomal protein S17, mitochondrial O     44.81 20 2
P43490|NAMPT_HUMAN Nicotinamide phosphoribosyltransferase O     43.41 12 2
Q9NY12|GAR1_HUMAN H/ACA ribonucleoprotein complex subunit      42.8 20 2
Q9Y4F1|FARP1_HUMAN FERM, RhoGEF and pleckstrin domain-con        42.61 5 2
P49207|RL34_HUMAN 60S ribosomal protein L34 OS=Homo sapi    42.29 13 2
Q9P2P6|STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Ho     42.21 4 2
O95139|NDUB6_HUMAN NADH dehydrogenase [ubiquinone] 1 beta        41.56 21 2
O00562|PITM1_HUMAN Membrane-associated phosphatidylinositol        41.45 5 2
O75155|CAND2_HUMAN Cullin-associated NEDD8-dissociated prote       41 7 2
P82933|RT09_HUMAN 28S ribosomal protein S9, mitochondrial O     39.74 8 2
A8MVX0|ARG33_HUMAN Rho guanine nucleotide exchange factor 3      39.66 7 2
P60891|PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 O     38.75 9 2
P11908|PRPS2_HUMAN Ribose-phosphate pyrophosphokinase 2 O     38.75 9 2
P20929|NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=  38.67 2 2
Q8NHP8|PLBL2_HUMAN Putative phospholipase B-like 2 OS=Homo    38.66 13 2
P61599|NAA20_HUMAN N-alpha-acetyltransferase 20, NatB catalyt       38.53 20 2
Q9Y618|NCOR2_HUMAN Nuclear receptor corepressor 2 OS=Homo    38.36 3 2
Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1  38.27 6 2
Q92833|JARD2_HUMAN Protein Jumonji OS=Homo sapiens GN=JA   37.86 7 2
P20930|FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=  37.59 2 2
Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sa    37.51 3 2
Q0VF96|CGNL1_HUMAN Cingulin-like protein 1 OS=Homo sapiens G   37.38 8 2
Q99541|PLIN2_HUMAN Perilipin-2 OS=Homo sapiens GN=PLIN2 P  36.46 14 2
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Q8IWZ3|ANKH1_HUMAN Ankyrin repeat and KH domain-containing       36.02 5 2
Q9NRV9|HEBP1_HUMAN Heme-binding protein 1 OS=Homo sapiens   35.77 11 2
Q15027|ACAP1_HUMAN Arf-GAP with coiled-coil, ANK repeat and P         35.73 5 2
Q5JPE7|NOMO2_HUMAN Nodal modulator 2 OS=Homo sapiens GN=   35.63 3 2
O60488|ACSL4_HUMAN Long-chain-fatty-acid--CoA ligase 4 OS=Ho     35.57 8 2
O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT  35.1 3 2
O43157|PLXB1_HUMAN Plexin-B1 OS=Homo sapiens GN=PLXNB1  34.97 4 2
O00555|CAC1A_HUMAN Voltage-dependent P/Q-type calcium chan        33.97 3 2
Q9Y566|SHAN1_HUMAN SH3 and multiple ankyrin repeat domains p       33.87 4 2
Q9H2Z4|NKX24_HUMAN Homeobox protein Nkx-2.4 OS=Homo sap    32.67 8 2
Q702N8|XIRP1_HUMAN Xin actin-binding repeat-containing protein      32.65 3 2
Q92630|DYRK2_HUMAN Dual specificity tyrosine-phosphorylation-re        32.04 4 2
O95935|TBX18_HUMAN T-box transcription factor TBX18 OS=Hom     31.95 5 2
Q13490|BIRC2_HUMAN Baculoviral IAP repeat-containing protein 2     31.77 7 2
O14802|RPC1_HUMAN DNA-directed RNA polymerase III subunit R      31.77 4 2
Q7Z3I7|ZN572_HUMAN Zinc finger protein 572 OS=Homo sapiens   31.45 4 2
Q7L2E3|DHX30_HUMAN Putative ATP-dependent RNA helicase DH      31.4 8 2
Q9NRS4|TMPS4_HUMAN Transmembrane protease serine 4 OS=Ho     31.25 8 2
P31689|DNJA1_HUMAN DnaJ homolog subfamily A member 1 OS=     30.78 13 2
Q9UJU5|FOXD3_HUMAN Forkhead box protein D3 OS=Homo sapien    30.14 10 2
Q15543|TAF13_HUMAN Transcription initiation factor TFIID subunit      29.7 22 2
Q8N9L9|ACOT4_HUMAN Acyl-coenzyme A thioesterase 4 OS=Homo    29.08 5 2
Q13206|DDX10_HUMAN Probable ATP-dependent RNA helicase DD      28.86 7 2
Q5JRC9|FA47A_HUMAN Protein FAM47A OS=Homo sapiens GN=F   28.76 4 2
Q9NYF0|DACT1_HUMAN Dapper homolog 1 OS=Homo sapiens GN=   28.41 6 2
Q8N302|AGGF1_HUMAN Angiogenic factor with G patch and FHA do       28.11 5 2
Q9Y485|DMXL1_HUMAN DmX-like protein 1 OS=Homo sapiens GN=   28.08 2 2
Q6ZQQ6|WDR87_HUMAN WD repeat-containing protein 87 OS=Hom     27.55 5 2
Q96A46|MFRN2_HUMAN Mitoferrin-2 OS=Homo sapiens GN=SLC25   27.52 11 2
Q9C0G0|ZN407_HUMAN Zinc finger protein 407 OS=Homo sapiens   27.46 4 2
Q96M20|CT152_HUMAN Uncharacterized protein C20orf152 OS=Ho     26.88 6 2
Q9NRL3|STRN4_HUMAN Striatin-4 OS=Homo sapiens GN=STRN4 P  26.4 6 2
Q96PK2|MACF4_HUMAN Microtubule-actin cross-linking factor 1, iso       26.39 6 2
Q92616|GCN1L_HUMAN Translational activator GCN1 OS=Homo sa    25.57 5 2
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Table A1.12 H9 hESC Extracellular and Cell Surface Protein Identifications.  List of 
all proteins identified in CMTX from H9 hESCs that are classified as ‘extracellular’ or 
‘cell surface’ by cellular component gene ontology.  Corresponding accession, 
description, unique peptide numbers are shown. 
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UniProt ID Name # Unique Peptides
P18206 Vinculin 46
P21333 Filamin-A 32
P02649 Apolipoprotein E 28
P04075 Fructose-bisphosphate aldolase A 20
P23142 Fibulin-1 18
P62805 Histone H4 18
P07355 Annexin A2 17
P11021 78 kDa glucose-regulated protein 15
P12814 Alpha-actinin-1 15
Q92626 Peroxidasin homolog 14
P62937 Peptidyl-prolyl cis-trans isomerase A 13
P11142 Heat shock cognate 71 kDa protein 12
P10909 Clusterin 12
P05067 Amyloid beta A4 protein 11
P04792 Heat shock protein beta-1 9
Q9Y490 Talin-1 9
P11047 Laminin subunit gamma-1 9
P25391 Laminin subunit alpha-1 9
P07942 Laminin subunit beta-1 8
O43707 Alpha-actinin-4 8
Q92598 Heat shock protein 105 kDa 8
P02751 Fibronectin 7
P54577 Tyrosyl-tRNA synthetase, cytoplasmic 7
P09486 SPARC 7
P10809 60 kDa heat shock protein, mitochondrial 6
P67809 Nuclease-sensitive element-binding protein 1 6
P84243 Histone H3.3 6
P68431 Histone H3.1 6
Q71DI3 Histone H3.2 6
P09429 High mobility group protein B1 5
Q8N474 Secreted frizzled-related protein 1 5
P50395 Rab GDP dissociation inhibitor beta 5
P08195 4F2 cell-surface antigen heavy chain 5
P06744 Glucose-6-phosphate isomerase 5
P98160 Basement membrane-specific heparan sulfate proteoglycan c  5
P39060 Collagen alpha-1(XVIII) chain 5
P62158 Calmodulin 4
P98095 Fibulin-2 4
Q12904 Aminoacyl tRNA synthase complex-interacting multifunctional  4
P07339 Cathepsin D 4
P27797 Calreticulin 4
P11717 Cation-independent mannose-6-phosphate receptor 3
O75487 Glypican-4 3
P23352 Anosmin-1 3
P07093 Glia-derived nexin 3
P29279 Connective tissue growth factor 3
O75610 Left-right determination factor 1 3
P52907 F-actin-capping protein subunit alpha-1 3
P51858 Hepatoma-derived growth factor 3
P38159 Heterogeneous nuclear ribonucleoprotein G 3
Q92820 Gamma-glutamyl hydrolase 3
O43852 Calumenin 3
Q8WZ42 Titin 3
P12109 Collagen alpha-1(VI) chain 3
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P07237 Protein disulfide-isomerase 2
P14174 Macrophage migration inhibitory factor 2
O00264 Membrane-associated progesterone receptor component 1 2
P06576 ATP synthase subunit beta, mitochondrial 2
P54578 Ubiquitin carboxyl-terminal hydrolase 14 2
O15078 Centrosomal protein of 290 kDa 2
Q15046 Lysyl-tRNA synthetase 2
Q00341 Vigilin 2
Q96HF1 Secreted frizzled-related protein 2 2
Q9BYX7 Putative beta-actin-like protein 3 2
O00292 Left-right determination factor 2 2
P50453 Serpin B9 2
P21741 Midkine 2
P53621 Coatomer subunit alpha 2
P18065 Insulin-like growth factor-binding protein 2 2
Q96S86 Hyaluronan and proteoglycan link protein 3 2
P02768 Serum albumin 2
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Table A1.13 CA1 hESC Extracellular and Cell Surface Protein Identifications.  List 
of all proteins identified in CMTX from CA1 hESCs that are classified as ‘extracellular’ or 
‘cell surface’ by cellular component gene ontology.  Corresponding accession, 
description, unique peptide numbers are shown. 
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UniProt ID Name # Unique Peptides
P21333 Filamin-A 72
P18206 Vinculin 51
P04075 Fructose-bisphosphate aldolase A 33
P07355 Annexin A2 33
P12814 Alpha-actinin-1 28
P11142 Heat shock cognate 71 kDa protein 27
P10809 60 kDa heat shock protein, mitochondrial 26
P62805 Histone H4 26
O43707 Alpha-actinin-4 24
Q9Y490 Talin-1 23
P62937 Peptidyl-prolyl cis-trans isomerase A 23
P02649 Apolipoprotein E 22
P06576 ATP synthase subunit beta, mitochondrial 19
P84243 Histone H3.3 18
P11021 78 kDa glucose-regulated protein 17
P50395 Rab GDP dissociation inhibitor beta 16
P04792 Heat shock protein beta-1 16
P06744 Glucose-6-phosphate isomerase 15
P00441 Superoxide dismutase [Cu-Zn] 13
P54577 Tyrosyl-tRNA synthetase, cytoplasmic 13
P50453 Serpin B9 12
P62328 Thymosin beta-4 12
P62158 Calmodulin 11
P07093 Glia-derived nexin 11
Q92598 Heat shock protein 105 kDa 11
P07237 Protein disulfide-isomerase 10
Q9Y696 Chloride intracellular channel protein 4 10
Q00839 Heterogeneous nuclear ribonucleoprotein U 10
P31947 14-3-3 protein sigma 10
P09429 High mobility group protein B1 9
P38646 Stress-70 protein, mitochondrial 9
P09382 Galectin-1 9
P10909 Clusterin 8
P05067 Amyloid beta A4 protein 7
P02751 Fibronectin 7
P07602 Proactivator polypeptide 7
P27797 Calreticulin 7
P52907 F-actin-capping protein subunit alpha-1 7
Q92626 Peroxidasin homolog 7
Q12904 Aminoacyl tRNA synthase complex-interacting multifunctional p  7
P55145 Mesencephalic astrocyte-derived neurotrophic factor 7
P14174 Macrophage migration inhibitory factor 6
P54578 Ubiquitin carboxyl-terminal hydrolase 14 6
P07942 Laminin subunit beta-1 6
P13693 Translationally-controlled tumor protein 6
P07339 Cathepsin D 6
Q8WZ42 Titin 6
P14735 Insulin-degrading enzyme 5
Q15046 Lysyl-tRNA synthetase 5
Q00341 Vigilin 5
P10599 Thioredoxin 5
Q9BRX8 Redox-regulatory protein PAMM 5
P23142 Fibulin-1 5
O75083 WD repeat-containing protein 1 5
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P48061 Stromal cell-derived factor 1 5
O00264 Membrane-associated progesterone receptor component 1 4
P29279 Connective tissue growth factor 4
P02452 Collagen alpha-1(I) chain 4
P26583 High mobility group protein B2 4
P38159 Heterogeneous nuclear ribonucleoprotein G 4
P13489 Ribonuclease inhibitor 4
Q99584 Protein S100-A13 4
P67809 Nuclease-sensitive element-binding protein 1 4
P15121 Aldose reductase 4
Q92520 Protein FAM3C 4
Q99988 Growth/differentiation factor 15 4
P05556 Integrin beta-1 3
P47755 F-actin-capping protein subunit alpha-2 3
P11047 Laminin subunit gamma-1 3
Q9UQE7 Structural maintenance of chromosomes protein 3 3
Q00796 Sorbitol dehydrogenase 3
P98095 Fibulin-2 3
Q9NRV9 Heme-binding protein 1 3
Q969H8 UPF0556 protein C19orf10 3
Q8NCW5 Apolipoprotein A-I-binding protein 3
O00622 Protein CYR61 3
P51858 Hepatoma-derived growth factor 3
P21741 Midkine 3
O15230 Laminin subunit alpha-5 3
Q32P28 Prolyl 3-hydroxylase 1 3
P39060 Collagen alpha-1(XVIII) chain 3
Q12841 Follistatin-related protein 1 3
P24043 Laminin subunit alpha-2 3
P11233 Ras-related protein Ral-A 2
O75145 Liprin-alpha-3 2
Q96HF1 Secreted frizzled-related protein 2 2
P08123 Collagen alpha-2(I) chain 2
O00292 Left-right determination factor 2 2
Q9H4G4 Golgi-associated plant pathogenesis-related protein 1 2
O43852 Calumenin 2
O95813 Cerberus 2
P09486 SPARC 2
P25391 Laminin subunit alpha-1 2
P18065 Insulin-like growth factor-binding protein 2 2
O75718 Cartilage-associated protein 2
P61916 Epididymal secretory protein E1 2
Q86UW8 Hyaluronan and proteoglycan link protein 4 2
P09038 Heparin-binding growth factor 2 2
Q7Z5P9 Mucin-19 2
Q17RW2 Collagen alpha-1(XXIV) chain 2
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Table A1.14 BJ-1D hiPSC Extracellular and Cell Surface Protein Identifications.  
List of all proteins identified in CMTX from BJ-1D hiPSCs that are classified as 
‘extracellular’ or ‘cell surface’ by cellular component gene ontology.  Corresponding 
accession, description, unique peptide numbers are shown. 
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Uniprot ID Name # Unique Peptides
P18206 Vinculin 88
P21333 Filamin-A 83
P04075 Fructose-bisphosphate aldolase A 40
P62805 Histone H4 33
P12814 Alpha-actinin-1 31
P07355 Annexin A2 30
P50395 Rab GDP dissociation inhibitor beta 29
P62937 Peptidyl-prolyl cis-trans isomerase A 28
P62328 Thymosin beta-4 26
O43707 Alpha-actinin-4 25
P62158 Calmodulin 24
P10809 60 kDa heat shock protein, mitochondrial 23
P11142 Heat shock cognate 71 kDa protein 23
P11021 78 kDa glucose-regulated protein 23
Q00839 Heterogeneous nuclear ribonucleoprotein U 22
P06744 Glucose-6-phosphate isomerase 21
Q9UQE7 Structural maintenance of chromosomes protein 3 21
P07237 Protein disulfide-isomerase 19
P05556 Integrin beta-1 16
P10599 Thioredoxin 15
P02649 Apolipoprotein E 15
P10909 Clusterin 15
P11717 Cation-independent mannose-6-phosphate receptor 14
Q92626 Peroxidasin homolog 13
P14174 Macrophage migration inhibitory factor 13
Q00341 Vigilin 12
P53621 Coatomer subunit alpha 12
P23142 Fibulin-1 12
P54577 Tyrosyl-tRNA synthetase, cytoplasmic 12
P00441 Superoxide dismutase [Cu-Zn] 11
P13693 Translationally-controlled tumor protein 11
P38646 Stress-70 protein, mitochondrial 11
P07093 Glia-derived nexin 10
P07339 Cathepsin D 10
P04792 Heat shock protein beta-1 10
P50453 Serpin B9 9
P27797 Calreticulin 8
P02751 Fibronectin 8
P09429 High mobility group protein B1 8
Q9Y696 Chloride intracellular channel protein 4 8
Q15046 Lysyl-tRNA synthetase 7
Q92598 Heat shock protein 105 kDa 7
P48061 Stromal cell-derived factor 1 7
P40222 Alpha-taxilin 7
P54578 Ubiquitin carboxyl-terminal hydrolase 14 7
P67809 Nuclease-sensitive element-binding protein 1 6
P15121 Aldose reductase 6
P55145 Mesencephalic astrocyte-derived neurotrophic factor 6
P22413 Ectonucleotide pyrophosphatase/phosphodiesterase family member 6
Q8N474 Secreted frizzled-related protein 1 6
P06576 ATP synthase subunit beta, mitochondrial 6
P98160 Basement membrane-specific heparan sulfate proteoglycan core pr 5
P31947 14-3-3 protein sigma 5
P26583 High mobility group protein B2 5
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P38159 Heterogeneous nuclear ribonucleoprotein G 5
P61916 Epididymal secretory protein E1 5
P05067 Amyloid beta A4 protein 5
P51858 Hepatoma-derived growth factor 4
P52907 F-actin-capping protein subunit alpha-1 4
O00622 Protein CYR61 4
Q99584 Protein S100-A13 4
P09382 Galectin-1 4
Q32P28 Prolyl 3-hydroxylase 1 4
Q969H8 UPF0556 protein C19orf10 4
Q8WZ42 Titin 4
P14735 Insulin-degrading enzyme 4
P51511 Matrix metalloproteinase-15 3
O00292 Left-right determination factor 2 3
O43278 Kunitz-type protease inhibitor 1 3
P13489 Ribonuclease inhibitor 3
P11047 Laminin subunit gamma-1 3
Q8NCW5 Apolipoprotein A-I-binding protein 3
Q92485 Acid sphingomyelinase-like phosphodiesterase 3b 3
P25391 Laminin subunit alpha-1 3
O00264 Membrane-associated progesterone receptor component 1 3
O75330 Hyaluronan mediated motility receptor 3
Q9UII2 ATPase inhibitor, mitochondrial 3
P50281 Matrix metalloproteinase-14 2
Q99541 Perilipin-2 2
O43157 Plexin-B1 2
P68431 Histone H3.1 2
Q71DI3 Histone H3.2 2
O75610 Left-right determination factor 1 2
P47755 F-actin-capping protein subunit alpha-2 2
Q12904 Aminoacyl tRNA synthase complex-interacting multifunctional protei  2
Q14766 Latent-transforming growth factor beta-binding protein 1 2
O60258 Fibroblast growth factor 17 2
P18065 Insulin-like growth factor-binding protein 2 2
Q00796 Sorbitol dehydrogenase 2
Q02818 Nucleobindin-1 2
Q12841 Follistatin-related protein 1 2
Q92520 Protein FAM3C 2
Q9NRV9 Heme-binding protein 1 2
Q8N302 Angiogenic factor with G patch and FHA domains 1 2
P08195 4F2 cell-surface antigen heavy chain 2
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Table A1.15 Real Time PCR Primer Information.  List of all primers used in real-time 
PCR experiments in this thesis with corresponding target, assay identification, and 
NCBI gene reference. 
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Target Assay ID NCBI Gene Reference
SRY (sex determining region Y)-box 1 Hs01057642_s1 NM_005986.2
alpha-fetoprotein Hs00173490_m1 NM_001134.1
GATA binding protein 4 Hs00171403_m1 NM_002052.3
T, brachyury homolog (mouse) Hs00610080_m1 NM_003181.2
GATA binding protein 6 Hs00232018_m1 NM_005257.3
paired box 6 Hs01088112_m1 NM_001127612.1
neurogenic differentiation 1 Hs00159598_m1 NM_002500.2
caudal type homeobox 2 Hs01078080_m1 NM_001265.3
Nanog homeobox Hs02387400_g1 NM_024865.2
Pou class 5 homeobox 1 Hs00742896_s1 NM_203289.3
Secreted frizzled related protein - 1 Hs00610060_m1 NM_003012.4
Secreted frizzled related protein - 2 Hs00293258_m1 NM_003013.2
Wingless-type MMTV Integration Site Family Member 3A Hs00263977_m1 NM_033131.3
Goosecoid Hs00418279_m1 NM_173849.2
Mix paired-like homeobox 1 Hs00430824_g1 NM_031944.1
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Table A1.16 shRNA Sequence Information.  List of all short hairpin sequences used 
in transient knockdown experiments in this thesis with corresponding sequence and 
oligo name shown. 
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Oligo sequence (5' to 3') Oligo name
GATCCGGGCCATTTAGATTAGGAATTCAAGAGATTCCTAATCTAAATGGCCCTTTTTTC sFRP1 shRNA Top
TCGAGAAAAAAGGGCCATTTAGATTAGGAATCTCTTGAATTCCTAATCTAAATGGCCCG sFRP1 shRNA Bottom
GATCCGCCCACCCGAATCTTGTAGTTCAAGAGACTACAAGATTCGGGTGGGCTTTTTTC sFRP2 shRNA Top
TCGAGAAAAAAGCCCACCCGAATCTTGTAGTCTCTTGAACTACAAGATTCGGGTGGGCG sFRP2 shRNA Bottom
GATCCGCTTGAACCGCCAGATCTATTCAAGAGATAGATCTGGCGGTTCAAGCTTTTTTC Control Top
TCGAGAAAAAAGCTTGAACCGCCAGATCTATCTCTTGAATAGATCTGGCGGTTCAAGCG Control Bottom
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